PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moy, CM; Seltzer, GO; Rodbell, DT; Anderson, DM				Moy, CM; Seltzer, GO; Rodbell, DT; Anderson, DM			Variability of El Nino/Southern Oscillation activity at millennial timescales during the Holocene epoch	NATURE			English	Article							SOUTHERN-OSCILLATION; TROPICAL PACIFIC; NINO; ECUADOR; PERU	The variability of El Nino/Southern Oscillation (ENSO) during the Holocene epoch, in particular on millennial timescales, is poorly understood. Palaeoclimate studies have documented ENSO variability for selected intervals in the Holocene, but most records are either too short or insufficiently resolved to investigate variability on millennial scales(1-3). Here we present a record of sedimentation in Laguna Pallcacocha, southern Ecuador, which is strongly influenced by ENSO variability, and covers the past 12,000 years continuously. We find that changes on a timescale of 2-8 years, which we attribute to warm ENSO events, become more frequent over the Holocene until about 1,200 years ago, and then decline towards the present. Periods of relatively high and low ENSO activity, alternating at a timescale of about 2,000 years, are superimposed on this long-term trend. We attribute the long-term trend to orbitally induced changes in insolation, and suggest internal ENSO dynamics as a possible cause of the millennial variability. However, the millennial oscillation will need to be confirmed in other ENSO proxy records.	Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA; Union Coll, Dept Geol, Schenectady, NY 12308 USA; Univ Colorado, NOAA, Paleoclimatol Program, Boulder, CO 80305 USA; Univ Colorado, INSTAAR, Boulder, CO 80305 USA	Syracuse University; Union College; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Moy, CM (corresponding author), Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA.		anderson, david/E-6416-2011	Moy, Christopher/0000-0002-2177-5265				Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; Clement AC, 1999, GEOPH MONOG SERIES, V112, P363; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cole J, 2001, SCIENCE, V291, P1496, DOI 10.1126/science.1059111; GILMAN DL, 1963, J ATMOS SCI, V20, P182, DOI 10.1175/1520-0469(1963)020<0182:OTPSON>2.0.CO;2; HANSEN BCS, IN PRESS PALEOGEOGR; MARTIN L, 1993, QUATERNARY RES, V39, P338, DOI 10.1006/qres.1993.1040; Moy C.M., 2000, THESIS SYRACUSE U; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Rodbell DT, 2002, QUATERNARY RES, V57, P343, DOI 10.1006/qres.2002.2324; RODBELL DT, 1993, GEOL SOC AM BULL, V105, P923, DOI 10.1130/0016-7606(1993)105<0923:TTOTLD>2.3.CO;2; Sandweiss DH, 2001, GEOLOGY, V29, P603, DOI 10.1130/0091-7613(2001)029<0603:VIHENO>2.0.CO;2; STUIVER M, 1991, QUATERNARY RES, V35, P1, DOI 10.1016/0033-5894(91)90091-I; THOMPSON LG, 1992, EL NINO HIST PALEOCL, P295; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Villalba, 2000, EL NINO SO OSCILLATI, P297; Vuille M, 2000, J CLIMATE, V13, P2520, DOI 10.1175/1520-0442(2000)013<2520:CVITAO>2.0.CO;2	18	1144	1211	6	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					162	165		10.1038/nature01194	http://dx.doi.org/10.1038/nature01194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432388				2022-12-24	WOS:000179200900041
J	Neuberger, JS; Gesell, TF				Neuberger, JS; Gesell, TF			Childhood cancers, radon, and gamma radiation	LANCET			English	Editorial Material									Univ Kansas, Sch Med, Dept Prevent Med & Publ Hlth, Kansas City, KS 66160 USA; Idaho State Univ, Dept Phys, Pocatello, ID 83209 USA	University of Kansas; University of Kansas Medical Center; Idaho; Idaho State University	Neuberger, JS (corresponding author), Univ Kansas, Sch Med, Dept Prevent Med & Publ Hlth, Kansas City, KS 66160 USA.							Boulton A, 2000, BRIT J CANCER, V82, P1073; Cartwright RA, 2002, BRIT J CANCER, V86, P1721, DOI 10.1038/sj.bjc.6600276; Cartwright RA, 2002, BRIT J CANCER, V86, P1727, DOI 10.1038/sj.bjc.6600277; Neuberger JS, 2002, HEALTH PHYS, V83, P1, DOI 10.1097/00004032-200207000-00001	4	9	9	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 9	2002	360	9344					1437	1438		10.1016/S0140-6736(02)11488-7	http://dx.doi.org/10.1016/S0140-6736(02)11488-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JV	12433506				2022-12-24	WOS:000179186000003
J	Madsen, KM; Hviid, A; Vestergaard, M; Schendel, D; Wohlfahrt, J; Thorsen, P; Olsen, J; Melbye, M				Madsen, KM; Hviid, A; Vestergaard, M; Schendel, D; Wohlfahrt, J; Thorsen, P; Olsen, J; Melbye, M			A population-based study of measles, mumps, and rubella vaccination and autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MMR IMMUNIZATION; FOLLOW-UP; DISORDERS; PREVALENCE; DIAGNOSIS; REGISTER	Background: It has been suggested that vaccination against measles, mumps, and rubella (MMR) is a cause of autism. Methods: We conducted a retrospective cohort study of all children born in Denmark from January 1991 through December 1998. The cohort was selected on the basis of data from the Danish Civil Registration System, which assigns a unique identification number to every live-born infant and new resident in Denmark. MMR-vaccination status was obtained from the Danish National Board of Health. Information on the children's autism status was obtained from the Danish Psychiatric Central Register, which contains information on all diagnoses received by patients in psychiatric hospitals and outpatient clinics in Denmark. We obtained information on potential confounders from the Danish Medical Birth Registry, the National Hospital Registry, and Statistics Denmark. Results: Of the 537,303 children in the cohort (representing 2,129,864 person-years), 440,655 (82.0 percent) had received the MMR vaccine. We identified 316 children with a diagnosis of autistic disorder and 422 with a diagnosis of other autistic-spectrum disorders. After adjustment for potential confounders, the relative risk of autistic disorder in the group of vaccinated children, as compared with the unvaccinated group, was 0.92 (95 percent confidence interval, 0.68 to 1.24), and the relative risk of another autistic-spectrum disorder was 0.83 (95 percent confidence interval, 0.65 to 1.07). There was no association between the age at the time of vaccination, the time since vaccination, or the date of vaccination and the development of autistic disorder. Conclusions: This study provides strong evidence against the hypothesis that MMR vaccination causes autism.	Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabilities, Atlanta, GA USA	Aarhus University; Aarhus University; Statens Serum Institut; Centers for Disease Control & Prevention - USA	Madsen, KM (corresponding author), Danish Epidemiol Sci Ctr, Dept Epidemiol & Social Med, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.	kmm@dadlnet.dk	Hviid, Anders/AAH-4319-2020; Vestergaard, Mogens/M-9333-2014	Hviid, Anders/0000-0002-7509-9127; Vestergaard, Mogens/0000-0001-8830-2174; Schendel, Diana/0000-0002-8588-1227; melbye, mads/0000-0001-8264-6785				Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P85; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; BURD L, 1987, J AM ACAD CHILD PSY, V26, P700, DOI 10.1097/00004583-198709000-00014; *CDCP, 2002, EP PREV VACC PREV DI; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; *DEP DEV SERV, 1999, CHANG POP PERS AUT P; Edwardes M, 2001, JAMA-J AM MED ASSOC, V285, P2852, DOI 10.1001/jama.285.22.2852; Filipek PA, 2000, J AUTISM DEV DISORD, V30, P81; Filipek PA, 1999, J AUTISM DEV DISORD, V29, P439, DOI 10.1023/A:1021943802493; Fombonne E, 1997, J AM ACAD CHILD PSY, V36, P1561, DOI 10.1016/S0890-8567(09)66566-7; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; GRIFFIN DE, 1989, NEW ENGL J MED, V320, P1667, DOI 10.1056/NEJM198906223202506; Hill A, 2001, PSYCHOPATHOLOGY, V34, P187, DOI 10.1159/000049305; Hills, 1993, STAT MODELS EPIDEMIO; JOHNSON RT, 1984, NEW ENGL J MED, V310, P137, DOI 10.1056/NEJM198401193100301; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Knudsen LB, 1998, DAN MED BULL, V45, P320; MALIG C, 1996, 66 IIVRS; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Peltola H, 1998, LANCET, V351, P1327, DOI 10.1016/S0140-6736(98)24018-9; Singh VK, 2002, J BIOMED SCI, V9, P359, DOI 10.1007/BF02256592; Smeeth L, 2001, BRIT MED J, V323, P163, DOI 10.1136/bmj.323.7305.163; Stratton K, 2001, IMMUNIZATION SAFETY; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Vellinga A, 2002, ACTA PAEDIATR, V91, P599, DOI 10.1080/080352502753711759; VOLKMAR FR, 1994, AM J PSYCHIAT, V151, P1361; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield Andrew J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P265; WHO, 2012, ICD 10 CLASS MENT BE; 2000, US HOUS REPR 106 C 2; 2000, LANCET, V355, P1379	37	403	417	1	316	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2002	347	19					1477	1482		10.1056/NEJMoa021134	http://dx.doi.org/10.1056/NEJMoa021134			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611XG	12421889				2022-12-24	WOS:000179042700002
J	Carter, RC				Carter, RC			The impact of public schools on childhood obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Carter, RC (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.							Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Cullen KW, 2000, J AM DIET ASSOC, V100, P1482, DOI 10.1016/S0002-8223(00)00414-4; Dwyer JT, 1996, PREV MED, V25, P413, DOI 10.1006/pmed.1996.0073; Edmunds L, 2001, BMJ-BRIT MED J, V323, P916, DOI 10.1136/bmj.323.7318.916; *FOOD NUTR SERV, 2002, NUTR PROGR FACTS NAT; Munoz KA, 1997, PEDIATRICS, V100, P323, DOI 10.1542/peds.100.3.323; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; 1995, FED REG, V60, P31188	11	37	38	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2180	2180		10.1001/jama.288.17.2180	http://dx.doi.org/10.1001/jama.288.17.2180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413386	Green Published, hybrid			2022-12-24	WOS:000179048100036
J	Fried, EJ; Nestle, M				Fried, EJ; Nestle, M			The growing political movement against soft drinks in schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD		NYU, Dept Nutr & Food Studies, New York, NY 10011 USA	New York University	Fried, EJ (corresponding author), NYU, Dept Nutr & Food Studies, New York, NY 10011 USA.							Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; *BRUN COMM, 2002, ADV PROM KIDS; Cullen KW, 2000, J AM DIET ASSOC, V100, P1482, DOI 10.1016/S0002-8223(00)00414-4; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Munoz KA, 1997, PEDIATRICS, V100, P323, DOI 10.1542/peds.100.3.323; NESTLE M, 2013, FOOD POLITICS FOOD I; SEVERSON K, 2002, SAN FRANCISCO C 0828, pA1; STARKE AM, 2001, OREGONIAN       0911, pFD1	8	40	40	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2181	2181		10.1001/jama.288.17.2181	http://dx.doi.org/10.1001/jama.288.17.2181			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413387	hybrid			2022-12-24	WOS:000179048100037
J	Martianov, I; Viville, S; Davidson, I				Martianov, I; Viville, S; Davidson, I			RNA polymerase II transcription in murine cells lacking the TATA binding protein	SCIENCE			English	Article							TBP-LIKE FACTOR; GENE; MITOSIS; UBF	Inactivation of the murine TATA binding protein (TBP) gene by homologous recombination leads to growth arrest and apoptosis at the embryonic blastocyst stage. However, after loss of TBP, RNA polymerase II (pol II) remains in a transcriptionally active phosphorylation state, and in situ run-on experiments showed high levels of pol II transcription comparable to those of wild-type cells. In contrast, pol I and pol III transcription was arrested. Our results show a differential dependency of the RNA polymerases on TBP and provide evidence for TBP-independent pol II transcriptional mechanisms that allow reinitiation and maintenance of gene transcription in vivo.	IGBMC, CNRS, INSERM, ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Davidson, I (corresponding author), IGBMC, CNRS, INSERM, ULP, BP 163, F-67404 Illkirch Graffenstaden, France.			Davidson, Irwin/0000-0001-5533-1171; Viville, Stephane/0000-0002-5088-3003; Martiyanov, Igor/0000-0001-6108-2036				BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; GebraneYounes J, 1997, J CELL SCI, V110, P2429; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; MARTIANOV I, UNPUB; Masson C, 1996, EXP CELL RES, V226, P114, DOI 10.1006/excr.1996.0209; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Um M, 2001, MOL CELL BIOL, V21, P2435, DOI 10.1128/MCB.21.7.2435-2448.2001; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307	16	96	101	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					1036	1039		10.1126/science.1076327	http://dx.doi.org/10.1126/science.1076327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411709				2022-12-24	WOS:000178932000060
J	Reznick, DN; Mateos, M; Springer, MS				Reznick, DN; Mateos, M; Springer, MS			Independent origins and rapid evolution of the placenta in the fish genus Poeciliopsis	SCIENCE			English	Article							LIFE-HISTORY; POECILIIDAE	The evolution of complex organs is a source of controversy because they require the contributions of many adaptations to function properly. We argue that placentas are complex, that they have evolved multiple times in Poeciliopsis, and that there are closely related sister taxa that have either no placentas or intermediate stages in the evolution of a placenta. Furthermore, placentas can evolve in 750,000 years or less, on the same time scale as suggested by theoretical calculations for the evolution of complex eyes. Independent origins of such complexity, accompanied by sister taxa that either lack or have intermediate stages in the evolution of the trait, present an opportunity to study the evolution of novelty and complexity from a comparative, evolutionary perspective.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Monterey Bay Aquarium Research Institute	Reznick, DN (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.		Mateos, Mariana/B-5235-2008	Mateos, Mariana/0000-0001-5738-0145; reznick, david/0000-0002-1144-0568				Arias AL, 2000, COPEIA, P792, DOI 10.1643/0045-8511(2000)000[0792:LHOPCA]2.0.CO;2; BLACKBURN DG, 1999, ENCY REPROD, V3, P840; Darwin C., 1859, ORIGIN SPECIES MEANS; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HANDWERGER S, 1999, ENCY REPROD, V3, P855; HAYNES JL, 1995, COPEIA, P147; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Mateos M, 2002, EVOLUTION, V56, P972; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Randall D.J., 1988, FISH PHYSIOL, P2; Reznick D.N., 1989, P125; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sadler TW, 1995, LANGMANS MED EMBRYOL; Schultz R.J., 1989, P69; Sokal R. R, 1981, BIOMETRY; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Turner CL, 1940, J MORPHOL, V67, P59, DOI 10.1002/jmor.1050670103; VRIJENHOEK RC, 1993, J HERED, V84, P388, DOI 10.1093/oxfordjournals.jhered.a111359; WETHERINGTON D, 1989, ECOLOGY EVOLUTION LI, P259	22	161	164	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					1018	1020		10.1126/science.1076018	http://dx.doi.org/10.1126/science.1076018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411703				2022-12-24	WOS:000178932000054
J	Grimes, DA				Grimes, DA			Uncertainty	LANCET			English	Editorial Material									Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.								0	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1242	1242		10.1016/S0140-6736(02)11275-X	http://dx.doi.org/10.1016/S0140-6736(02)11275-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401269				2022-12-24	WOS:000178708100031
J	Pecina, A; Smith, KN; Mezard, C; Murakami, H; Ohta, K; Nicolas, A				Pecina, A; Smith, KN; Mezard, C; Murakami, H; Ohta, K; Nicolas, A			Targeted stimulation of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; DNA-REPLICATION; HOT-SPOT; CHROMATIN-STRUCTURE; HIS4 LOCUS; WILD-TYPE; GENE; SITES; CHROMOSOMES; INITIATION	Meiotic recombination in Saccharomyces cerevisiae is initiated by programmed DNA double-strand breaks (DSBs), a process that requires the Spo11 protein. DSBs usually occur in intergenic regions that display open chromatin accessibility, but other determinants that control their frequencies and non-random chromosomal distribution remain obscure. We report that a Spo11 construct bearing the Ga14 DNA binding domain not only rescues spo11Delta spore inviability and catalyzes DSb formation at natural sites but also strongly stimulates DSb formation near Ga14 binding sites. At GAL2, a naturally DSb-cold locus, GaL4bd-Spo11 creates a recombinational hotspot that depends on all the other DSB gene functions, showing that the targeting of Spo11 to a specific site is sufficient to stimulate meiotic recombination that is under normal physiological control.	Inst Curie, Sect Rech, CNRS, UMR 144, F-75248 Paris 05, France; Saitama Univ, Grad Sch Sci & Engn, Urawa, Saitama 3388570, Japan; RIKEN, Inst Phys & Chem Res, Genet Dynam Res Unit Lab, Wako, Saitama 35101, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Saitama University; RIKEN	Nicolas, A (corresponding author), Inst Curie, Sect Rech, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.	alain.nicolas@curie.fr		Pecina, Ana/0000-0002-6243-9313; Murakami, Hajime/0000-0002-7022-6887				ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; [Anonymous], 1997, NATURE, V387, pS; ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bateson W., 1905, REPORTS EVOLUTION CO, V2, P80; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Baudat F, 2001, CURR BIOL, V11, pR45, DOI 10.1016/S0960-9822(01)00013-6; Beretta GL, 1999, CANCER RES, V59, P3689; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 1999, MOL CELL BIOL, V19, P4832; Bullard SA, 1996, P NATL ACAD SCI USA, V93, P13054, DOI 10.1073/pnas.93.23.13054; Cha RS, 2000, GENE DEV, V14, P493; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DEVRIES H, 1903, FERTILIZATION HYBRID, P217; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Forsburg SL, 2002, MOL CELL, V9, P703, DOI 10.1016/S1097-2765(02)00508-7; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; HUIBREGTSE JM, 1993, J BIOL CHEM, V268, P22219; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim YG, 1998, BIOL CHEM, V379, P489, DOI 10.1515/bchm.1998.379.4-5.489; KLAPHOLZ S, 1985, GENETICS, V110, P187; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Malkova A, 2000, P NATL ACAD SCI USA, V97, P14500, DOI 10.1073/pnas.97.26.14500; Moore CS, 1999, GENOMICS, V59, P1, DOI 10.1006/geno.1999.5812; Morgan TH, 1912, J EXP ZOOL, V13, P79, DOI 10.1002/jez.1400130105; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Neale MJ, 2002, MOL CELL, V9, P835, DOI 10.1016/S1097-2765(02)00498-7; Noor MAF, 2001, GENETICS, V159, P581; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Ohta K, 1999, NUCLEIC ACIDS RES, V27, P2175, DOI 10.1093/nar/27.10.2175; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith KN, 1998, CURR OPIN GENET DEV, V8, P200, DOI 10.1016/S0959-437X(98)80142-1; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Vedel M, 1999, GENETICS, V151, P1245; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WHITEHOUSE HLK, 1982, UNDERSTANDING MECH; WU TC, 1995, GENETICS, V140, P55; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Xu F, 1996, GENETICS, V143, P1115; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; ZENVIRTH D, 1992, EMBO J, V11, P3441, DOI 10.1002/j.1460-2075.1992.tb05423.x; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	58	78	83	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2002	111	2					173	184		10.1016/S0092-8674(02)01002-4	http://dx.doi.org/10.1016/S0092-8674(02)01002-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408862	Bronze			2022-12-24	WOS:000178753500007
J	Smothers, JF; Henikoff, S; Carter, P				Smothers, JF; Henikoff, S; Carter, P			Affinity selection from biological libraries	SCIENCE			English	Article							PHAGE DISPLAY; ANTIBODY; LIGANDS		Amgen Inc, Dept Antibody Technol, Seattle, WA 98101 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Amgen; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Smothers, JF (corresponding author), Amgen Inc, Dept Antibody Technol, Seattle, WA 98101 USA.	SmotherJ@amgen.com; steveh@fhcrc.org; CarterP@amgen.com		Henikoff, Steven/0000-0002-7621-8685				Adda CG, 2002, COMB CHEM HIGH T SCR, V5, P1; Amstutz P, 2001, CURR OPIN BIOTECH, V12, P400, DOI 10.1016/S0958-1669(00)00234-2; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Crameri R, 2002, Methods Mol Biol, V185, P461; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Manoutcharian K., 2001, Current Pharmaceutical Biotechnology, V2, P217; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; QUAN MP, 2002, ANTIIGE ALLERGIC DIS, V164, P427; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smothers JF, 2001, COMB CHEM HIGH T SCR, V4, P585; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626	19	57	66	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2002	298	5593					621	622		10.1126/science.298.5593.621	http://dx.doi.org/10.1126/science.298.5593.621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12386335				2022-12-24	WOS:000178634800046
J	Lichtenegger, HC; Schoberl, T; Bartl, MH; Waite, H; Stucky, GD				Lichtenegger, HC; Schoberl, T; Bartl, MH; Waite, H; Stucky, GD			High abrasion resistance with sparse mineralization: Copper biomineral in worm jaws	SCIENCE			English	Article							MECHANICAL-PROPERTIES; CRYSTALS; SUBUNITS; TISSUES; DENTIN; DAMAGE	Biominerals are widely exploited to harden or stiffen tissues in living organisms, with calcium-, silicon-, and iron-based minerals being most common. In notable contrast, the jaws of the marine bloodworm Glycera dibranchiata contain the copper-based biomineral atacamite [Cu-2(OH)(3)Cl]. Polycrystalline fibers are oriented with the outer contour of the jaw. Using nanoindentation, we show that the mineral has a structural role and enhances hardness and stiffness. Despite the low degree of mineralization, bloodworm jaws exhibit an extraordinary resistance to abrasion, significantly exceeding that of vertebrate dentin and approaching that of tooth enamel.	Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; Austrian Acad Sci, Erich Schmid Inst Mat Sci, A-8700 Leoben, Austria; Univ Leoben, A-8700 Leoben, Austria; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Austrian Academy of Sciences; University of Leoben; University of California System; University of California Santa Barbara	Lichtenegger, HC (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.			Lichtenegger, Helga/0000-0002-6624-1419				Addadi L, 2001, NATURE, V411, P753, DOI 10.1038/35081227; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Bandy MC, 1938, AM MINERAL, V23, P669; BAO G, 1991, ACTA METALL MATER, V39, P1871, DOI 10.1016/0956-7151(91)90156-U; Bhushan B., 1999, PRINCIPLES APPL TRIB; BRYAN GW, 1980, J MAR BIOL ASSOC UK, V60, P641, DOI 10.1017/S0025315400040339; BRYAN GW, 1979, J MAR BIOL ASSOC UK, V59, P969, DOI 10.1017/S0025315400036961; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; CHISHOLM JE, 1987, MINERAL MAG, V51, P715, DOI 10.1180/minmag.1987.051.363.12; Currey JD, 1999, J EXP BIOL, V202, P3285; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2; FRATZL P, 1994, J STAT PHYS, V77, P125, DOI 10.1007/BF02186835; GIBBS PE, 1980, J MAR BIOL ASSOC UK, V60, P205, DOI 10.1017/S0025315400024267; HANNINGTON MD, 1993, CAN MINERAL, V31, P945; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Jones R.M., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; KRAMER R, 1993, P NATL ACAD SCI USA, V90, P5394, DOI 10.1073/pnas.90.12.5394; Landis WJ, 1996, CONNECT TISSUE RES, V35, P1; LOWENSTAM HA, 1967, SCIENCE, V156, P1373, DOI 10.1126/science.156.3780.1373; Lowenstam HA, 1989, BIOMINERALIZATION; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; MICHEL C, 1973, Bulletin Biologique de la France et de la Belgique, V107, P301; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; *PDF, 25269 PDF; Roberts W. L., 1990, ENCY MINERALS; Shiraishi N, 2002, FEBS LETT, V511, P118, DOI 10.1016/S0014-5793(01)03324-5; Suresh S, 1999, ACTA MATER, V47, P3915, DOI 10.1016/S1359-6454(99)00205-0; Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716; Tesch W, 2001, CALCIFIED TISSUE INT, V69, P147, DOI 10.1007/s00223-001-2012-z; THIEFFRY M, 1982, J PHYSIOL-PARIS, V78, P343; Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514; Vincent J, 1990, STRUCTURAL BIOMATERI; Waters N E, 1980, Symp Soc Exp Biol, V34, P99; [No title captured]	36	175	180	6	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					389	392		10.1126/science.1075433	http://dx.doi.org/10.1126/science.1075433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376695				2022-12-24	WOS:000178510400041
J	Ha, T; Rasnik, I; Cheng, W; Babcock, HP; Gauss, GH; Lohman, TM; Chu, S				Ha, T; Rasnik, I; Cheng, W; Babcock, HP; Gauss, GH; Lohman, TM; Chu, S			Initiation and re-initiation of DNA unwinding by the Escherichia coli Rep helicase	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE; TRANSLOCATION; MECHANISM; HYDROLYSIS; MONOMER; PROTEIN	Helicases are motor proteins that couple conformational changes induced by ATP binding and hydrolysis with unwinding of duplex nucleic acid(1-3), and are involved in several human diseases. Some function as hexameric rings(4), but the functional form of non-hexameric helicases has been debated(5-10). Here we use a combination of a surface immobilization scheme and single-molecule fluorescence assays-which do not interfere with biological activity-to probe DNA unwinding by the Escherichia coli Rep helicase. Our studies indicate that a Rep monomer uses ATP hydrolysis to move toward the junction between single-stranded and double-stranded DNA but then displays conformational fluctuations that do not lead to DNA unwinding. DNA unwinding initiates only if a functional helicase is formed via additional protein binding. Partial dissociation of the functional complex during unwinding results in interruptions ('stalls') that lead either to duplex rewinding upon complete dissociation of the complex, or to re-initiation of unwinding upon re-formation of the functional helicase. These results suggest that the low unwinding processivity observed in vitro for Rep is due to the relative instability of the functional complex. We expect that these techniques will be useful for dynamic studies of other helicases and protein-DNA interactions.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63110 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Stanford University	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@uiuc.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Babcock, Hazen/0000-0003-4835-3692	NIGMS NIH HHS [R01 GM045948, R01 GM065367] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM045948] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; BJORNSON KP, 1994, BIOCHEMISTRY-US, V33, P14306, DOI 10.1021/bi00251a044; CHAO KL, 1991, J MOL BIOL, V221, P1165, DOI 10.1016/0022-2836(91)80119-F; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14550, DOI 10.1021/bi00252a023; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; Wong I, 1997, BIOCHEMISTRY-US, V36, P3115, DOI 10.1021/bi9621977; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	24	376	387	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2002	419	6907					638	641		10.1038/nature01083	http://dx.doi.org/10.1038/nature01083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374984				2022-12-24	WOS:000178483100050
J	Debnath, J; Mills, KR; Collins, NL; Reginato, MJ; Muthuswamy, SK; Brugge, JS				Debnath, J; Mills, KR; Collins, NL; Reginato, MJ; Muthuswamy, SK; Brugge, JS			The role of apoptosis in creating and maintaining luminal space with normal and oncogene-expressing mammary acini	CELL			English	Article							PROGRAMMED CELL-DEATH; BREAST EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; SURVIVAL; DIFFERENTIATION; PROTEIN; CANCER; GROWTH; LINE	We have utilized in vitro three-dimensional epithelial cell cultures to analyze the role of apoptosis in the formation and maintenance of a hollow glandular architecture. Lumen formation is associated with the selective apoptosis of centrally located cells; this apoptosis follows apicobasal polarization and precedes proliferative suppression during acinar development. Notably, either inhibiting apoptosis (by exogenously expressing antiapoptotic Bcl family proteins) or enhancing proliferation (via Cyclin D1 or HPV E7 overexpression) does not result in luminal filling, suggesting glandular architecture is resistant to such isolated oncogenic insults. However, the lumen is filled when oncogenes that enhance proliferation are coexpressed with those that inhibit apoptosis, or when ErbB2, which induces both activities, is activated by homodimerization. Hence, apoptosis can counteract increased proliferation to maintain luminal space, suggesting that tumor cells must restrain apoptosis to populate the lumen.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Reginato, Mauricio/I-6155-2013; Muthuswamy, Senthil K/AGY-2834-2022	Reginato, Mauricio/0000-0002-7541-4094; Muthuswamy, Senthil K/0000-0001-6564-9634; Debnath, Jayanta/0000-0002-8745-4069	NATIONAL CANCER INSTITUTE [P01CA080111, P50CA089393] Funding Source: NIH RePORTER; NCI NIH HHS [CA89393, CA80111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blatchford DR, 1999, J CELL PHYSIOL, V181, P304, DOI 10.1002/(SICI)1097-4652(199911)181:2<304::AID-JCP12>3.0.CO;2-5; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Boyer SN, 1996, CANCER RES, V56, P4620; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Furth PA, 1999, ONCOGENE, V18, P6589, DOI 10.1038/sj.onc.1203073; GILLETT C, 1994, CANCER RES, V54, P1812; Gudjonsson T, 2002, J CELL SCI, V115, P39; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Harris J, 1999, DIS BREAST; Hoffman MP, 1996, J CELL SCI, V109, P2013; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; LAMMIE GA, 1991, ONCOGENE, V6, P439; Lee CY, 2001, DEVELOPMENT, V128, P1443; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Moreno A, 2001, Breast J, V7, P245, DOI 10.1046/j.1524-4741.2001.98116.x; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Murphy KL, 1999, ONCOGENE, V18, P6597, DOI 10.1038/sj.onc.1203099; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ojakian GK, 1997, J CELL SCI, V110, P2781; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SCHUURING E, 1992, ONCOGENE, V7, P355; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SOULE HD, 1990, CANCER RES, V50, P6075; Spancake KM, 1999, CANCER RES, V59, P6042; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; STREULI CH, 1990, J CELL BIOL, V110, P1405; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3	49	604	616	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 4	2002	111	1					29	40		10.1016/S0092-8674(02)01001-2	http://dx.doi.org/10.1016/S0092-8674(02)01001-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372298	Bronze			2022-12-24	WOS:000178461900006
J	Lasonder, E; Ishihama, Y; Andersen, JS; Vermunt, AMW; Pain, A; Sauerwein, RW; Eling, WMC; Hall, N; Waters, AP; Stunnenberg, HG; Mann, M				Lasonder, E; Ishihama, Y; Andersen, JS; Vermunt, AMW; Pain, A; Sauerwein, RW; Eling, WMC; Hall, N; Waters, AP; Stunnenberg, HG; Mann, M			Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry	NATURE			English	Article							PROTEINS; IDENTIFICATION; SEQUENCE; ANTIGEN; EXPRESSION; CLONING	The annotated genomes of organisms define a 'blueprint' of their possible gene products. Post-genome analyses attempt to confirm and modify the annotation and impose a sense of the spatial, temporal and developmental usage of genetic information by the organism. Here we describe a large-scale, high-accuracy (average deviation less than 0.02 Da at 1,000 Da) mass spectrometric proteome analysis(1-3) of selected stages of the human malaria parasite Plasmodium falciparum. The analysis revealed 1,289 proteins of which 714 proteins were identified in asexual blood stages, 931 in gametocytes and 645 in gametes. The last two groups provide insights into the biology of the sexual stages of the parasite, and include conserved, stage-specific, secreted and membrane-associated proteins. A subset of these proteins contain domains that indicate a role in cell-cell interactions, and therefore can be evaluated as potential components of a malaria vaccine formulation. We also report a set of peptides with significant matches in the parasite genome but not in the protein set predicted by computational methods.	Univ Nijmegen, Dept Mol Biol, NCMLS, NL-6525 GA Nijmegen, Netherlands; Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Med Ctr, Dept Med Microbiol, NCMLS, NL-6500 HB Nijmegen, Netherlands; Leiden Univ, Leiden Malaria Res Grp, Med Ctr, Dept Parasitol, Ctr Infect Dis, NL-2333 ZA Leiden, Netherlands	Radboud University Nijmegen; University of Southern Denmark; Wellcome Trust Sanger Institute; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Stunnenberg, HG (corresponding author), Univ Nijmegen, Dept Mol Biol, NCMLS, Geert Grooteplein 26, NL-6525 GA Nijmegen, Netherlands.	h.stunnenberg@ncmls.kun.nl; mann@bmb.sdu.dk	Ishihama, Yasushi/B-3101-2016; Hall, Neil/A-8717-2013; Stunnenberg, Hendrik G./D-6875-2012; Waters, Andy P/C-9377-2009; Mann, Matthias/A-3454-2013; Sauerwein, Robert/C-8519-2013; Pain, Arnab/L-5766-2015; Andersen, Jens S/L-2100-2015	Ishihama, Yasushi/0000-0001-7714-203X; Hall, Neil/0000-0002-7995-3810; Stunnenberg, Hendrik G./0000-0002-0066-1576; Waters, Andy P/0000-0001-8900-2982; Mann, Matthias/0000-0003-1292-4799; Pain, Arnab/0000-0002-1755-2819; Andersen, Jens S/0000-0002-6091-140X; Lasonder, Edwin/0000-0003-2582-3444				Alano P, 1995, MOL BIOCHEM PARASIT, V74, P143, DOI 10.1016/0166-6851(95)02491-3; Brooks SR, 2000, MOL BIOCHEM PARASIT, V106, P77, DOI 10.1016/S0166-6851(99)00201-7; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Cowman AF, 2000, FEBS LETT, V476, P84, DOI 10.1016/S0014-5793(00)01703-8; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Fowler RE, 2001, MOL BIOCHEM PARASIT, V117, P187, DOI 10.1016/S0166-6851(01)00351-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Griffin TJ, 2001, J BIOL CHEM, V276, P45497, DOI 10.1074/jbc.R100014200; KOCKEN CHM, 1993, MOL BIOCHEM PARASIT, V61, P59, DOI 10.1016/0166-6851(93)90158-T; Kuster B, 2001, PROTEOMICS, V1, P641; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rahlfs S, 2001, J BIOL CHEM, V276, P37133, DOI 10.1074/jbc.M105524200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Templeton TJ, 1998, J EXP MED, V187, P1599, DOI 10.1084/jem.187.10.1599; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	22	517	544	4	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					537	542		10.1038/nature01111	http://dx.doi.org/10.1038/nature01111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368870				2022-12-24	WOS:000178348400051
J	Luo, RF				Luo, RF			Understanding the threat of HIV/AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Luo, RF (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.							De Cock KM, 2002, JAMA-J AM MED ASSOC, V288, P236, DOI 10.1001/jama.288.2.236; HSU L, 2001, HIV SUBVERTS NATL SE; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; PIOT P, 2001, COMMUNICATION   0902; PIOT P, 2002, 14 INT AIDS C JUL 7; *UN POP DIV JOINT, 1998, TECHN M NOV 10 NEW Y; *US GOV NAT INT CO, 2000, GLOB INF DIS THREAT; 2000, NATURE, V405, P9	8	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1649	1649		10.1001/jama.288.13.1649	http://dx.doi.org/10.1001/jama.288.13.1649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350199	hybrid			2022-12-24	WOS:000178314000028
J	Regev, A; Shapiro, E				Regev, A; Shapiro, E			Cellular abstractions: Cells as computation	NATURE			English	Editorial Material									Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Regev, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.				European Research Council [233047] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Fontana W, 1996, BOUNDARIES BARRIERS, P55; Milner R., 2000, COMMUNICATING MOBILE	2	195	199	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					343	343		10.1038/419343a	http://dx.doi.org/10.1038/419343a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353013	Green Accepted			2022-12-24	WOS:000178195400023
J	Teklehaimanot, A; Snow, RW				Teklehaimanot, A; Snow, RW			Will the Global Fund help roll back malaria in Africa?	LANCET			English	Editorial Material									Columbia Univ, Ctr Global Hlth & Econ Dev, New York, NY 10002 USA; KEMRI Wellcome Trust Collaborat Program, Nairobi, Kenya; Univ Oxford, Ctr Trop Med, Oxford OX1 2JD, England	Columbia University; University of Oxford	Teklehaimanot, A (corresponding author), Columbia Univ, Ctr Global Hlth & Econ Dev, New York, NY 10002 USA.		Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088				[Anonymous], 2000, GLOB PARTN ROLL BACK; *COMM MACR HLTH, 2002, IMPR HLTH OUTC POOR; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Deichmann U, 1996, AFRICAN POPULATION D; *GLOB FUND FIGHT A, 2002, TUB MAL; Ramsay S, 2002, LANCET, V359, P1581, DOI 10.1016/S0140-6736(02)08531-8; *UN POP DIV, 2002, WORLD POP PROSP POP	7	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 21	2002	360	9337					888	889		10.1016/S0140-6736(02)11069-5	http://dx.doi.org/10.1016/S0140-6736(02)11069-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AU	12354467				2022-12-24	WOS:000178142200004
J	Nguyen, KB; Watford, WT; Salomon, R; Hofmann, SR; Pien, GC; Morinobu, A; Gadina, M; O'Shea, JJ; Biron, CA				Nguyen, KB; Watford, WT; Salomon, R; Hofmann, SR; Pien, GC; Morinobu, A; Gadina, M; O'Shea, JJ; Biron, CA			Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection	SCIENCE			English	Article							IFN-GAMMA; T-CELLS; NATURAL-KILLER; ANTIVIRAL DEFENSE; GENE-EXPRESSION; I IFNS; ALPHA/BETA; IL-12; INTERLEUKIN-12; REQUIREMENT	Interferons (IFNs) are essential for host defense. Although the antiviral effects of the type 1 IFNs IFN-alpha and IFN-beta (IFN-alpha/beta) have been established, their immunoregulatory functions, especially their ability to regulate IFN-gamma production, are poorly understood. Here we show that IFN-alpha/beta activate STAT4 directly (STAT, signal transducers and activators of transcription) and that this is required for IFN-gamma production during viral infections of mice, in concert with T cell receptor derived signals. In contrast, STAT1 appears to negatively regulate IFN-alpha/beta induction of IFN-gamma. Thus, type 1 IFNs, in addition to interleukin-12, provide pathways for innate regulation of adaptive immunity, and their immunoregulatory functions are controlled by modulating the activity of individual STATs.	Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA; NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Biron, CA (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA.		Gadina, Massimo/R-4195-2019		NATIONAL CANCER INSTITUTE [R01CA041268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, ZIAAR041106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020760] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA41268] Funding Source: Medline; NIGMS NIH HHS [F31-GM20760-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Byrnes AA, 2001, EUR J IMMUNOL, V31, P2026, DOI 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.3.CO;2-L; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Kuroda E, 2002, J IMMUNOL, V168, P5477, DOI 10.4049/jimmunol.168.11.5477; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; McRae BL, 1998, J IMMUNOL, V160, P4298; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Orange JS, 1996, J IMMUNOL, V156, P1138; PIEN GC, UNPUB; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Rogge L, 1998, J IMMUNOL, V161, P6567; Sareneva T, 1998, J IMMUNOL, V160, P6032; Su HC, 1998, J IMMUNOL, V160, P5007; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Wenner CA, 1996, J IMMUNOL, V156, P1442; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794	30	395	406	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2063	2066		10.1126/science.1074900	http://dx.doi.org/10.1126/science.1074900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242445				2022-12-24	WOS:000178078500050
J	Xu, X; Cheng, YN; Wang, XL; Chang, CH; Chang, H				Xu, X; Cheng, YN; Wang, XL; Chang, CH; Chang, H			An unusual oviraptorosaurian dinosaur from China	NATURE			English	Article							EVOLUTION; SKELETON	Oviraptorosaurians are an unusual group of theropod dinosaurs, with highly specialized skulls(1-6). Here we report a new oviraptorosaurian, Incisivosaurus gauthieri, gen. et sp. nov., from the lowest part of the Lower Cretaceous Yixian Formation of China. This oviraptorosaurian displays a number of characters closer to more typical theropods, such as a low skull and toothed jaws, thus greatly reducing the morphological gap between oviraptorosaurs and other theropods(4-11). Incisivosaurus has a pair of premaxillary teeth resembling rodent incisors and small, lanceolate cheek teeth with large wear facets. These dental features were previously unknown among theropods and suggest a herbivorous diet. The new discovery provides a case of convergent evolution and demonstrates that non-avian theropods were much more diverse ecologically than previously suspected.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Natl Museum Nat Sci, Div Geol, Taichung, Taiwan	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xing_xu@sina.com						[Anonymous], 1981, T JOINT SOVIET MONGO; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barsbold, 1983, SOVMESTNAIA SOVETSKO, V19, P1; Barsbold R., 1990, P249; BARSBOLD R, 1976, DOKL AKAD NAUK SSSR+, V226, P685; Barsbold R., 1997, ENCY DINOSAURS, P505; Benton MJ, 1997, VERTEBRATE PALEONTOL; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Elzanowski A, 1999, SM C PALEOB, P311; Holtz Jr T. R., 2000, GAIA, V15, P5; HOLTZ TR, 2000, GAIA, V15, P159; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; OSMOLSKA H, 1976, NATURE, V262, P683, DOI 10.1038/262683a0; Paul G.S., 1988, HUNTERIA, V2, P1; Russell DA., 1997, ENCY DINOSAURS, P729; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SUES HD, 1997, J VERT PALEONTOL, V17, P498; Swisher C.C., 2001, CHINESE SCI BULL, V46, P2009; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	29	107	119	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					291	293		10.1038/nature00966	http://dx.doi.org/10.1038/nature00966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239565				2022-12-24	WOS:000178056300043
J	Yanovsky, MJ; Kay, SA				Yanovsky, MJ; Kay, SA			Molecular basis of seasonal time measurement in Arabidopsis	NATURE			English	Article							CIRCADIAN CLOCK; FLOWERING-TIME; THALIANA; GENES; INDUCTION; GIGANTEA; MUTANTS; RHYTHMS; SYSTEM; PLANTS	Several organisms have evolved the ability to measure daylength, or photoperiod, allowing them to adjust their development in anticipation of annual seasonal changes. Daylength measurement requires the integration of temporal information, provided by the circadian system, with light/dark discrimination, initiated by specific photoreceptors. Here we demonstrate that in Arabidopsis this integration takes place at the level of CONSTANS (CO)(1) function. CO is a transcriptional activator that accelerates flowering time in long days, at least in part by inducing the expression of FLOWERING LOCUS T (FT)(2-5). First, we show that precise clock control of the timing of CO expression, such that it is high during daytime only in long days, is critical for daylength discrimination. We then provide evidence that CO activation of FT expression requires the presence of light perceived through cryptochrome 2 (cry2) or phytochrome A (phyA). We conclude that an external coincidence mechanism, based on the endogenous circadian control of CO messenger RNA levels, and the modulation of CO function by light, constitutes the molecular basis for the regulation of flowering time by daylength in Arabidopsis.	Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ARAKI T, 1993, PLANT J, V3, P231, DOI 10.1046/j.1365-313X.1993.t01-15-00999.x; B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	25	495	534	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					308	312		10.1038/nature00996	http://dx.doi.org/10.1038/nature00996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239570				2022-12-24	WOS:000178056300048
J	Brooks, JI; Rud, EW; Pilon, RG; Smith, JM; Switzer, WM; Sandstrom, PA				Brooks, JI; Rud, EW; Pilon, RG; Smith, JM; Switzer, WM; Sandstrom, PA			Cross-species retroviral transmission from macaques to human beings	LANCET			English	Article							FOAMY; INFECTION	Cross-species transmission of simian foamy virus (SFV) to human beings from chimpanzees, baboons, and African green monkeys has been described. Although macaques are the non-human primate most often handled in research, human infection with SFV from macaques has not been reported. Two of 46 primate-facility workers tested positive for antibodies that reacted with an immunoblot that contained macaque foamy virus antigens. Phylogenetic assessment of a 96-bp fragment of amplified proviral DNA isolated from peripheral-blood mononuclear cells from one infected individual was consistent with SFV infection of macaque origin. Frequent use of macaques in biomedical research, and identification of persistent retroviral infection from macaques to human beings, could have implications for public-health policy and occupational health and safety.	Hlth Canada, Bur HIV AIDS STD & TB, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada; Hlth Canada, Anim Resource Div, Ottawa, ON K1A 0L2, Canada; CDC, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA	Health Canada; Health Canada; Centers for Disease Control & Prevention - USA	Sandstrom, PA (corresponding author), Hlth Canada, Bur HIV AIDS STD & TB, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada.		Rud, Erling/P-5359-2016	Rud, Erling/0000-0001-8615-0277; Pilon, Richard/0000-0003-0100-6917				HAHN H, 1994, J GEN VIROL, V75, P2635, DOI 10.1099/0022-1317-75-10-2635; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; MACK D, 1982, ILAR NEWS, V25, P10; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7	5	62	63	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					387	388		10.1016/S0140-6736(02)09597-1	http://dx.doi.org/10.1016/S0140-6736(02)09597-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241782				2022-12-24	WOS:000177255600015
J	Milad, MR; Quirk, GJ				Milad, MR; Quirk, GJ			Neurons in medial prefrontal cortex signal memory for fear extinction	NATURE			English	Article							CONDITIONED FEAR; POTENTIATED STARTLE; FRONTAL-CORTEX; AMYGDALA; RAT; STIMULATION; BRAIN; PROJECTIONS; ACQUISITION	Conditioned fear responses to a tone previously paired with a shock diminish if the tone is repeatedly presented without the shock, a process known as extinction. Since Pavlov(1) it has been hypothesized that extinction does not erase conditioning, but forms a new memory. Destruction of the ventral medial prefrontal cortex, which consists of infralimbic and prelimbic cortices, blocks recall of fear extinction(2,3), indicating that medial prefrontal cortex might store long-term extinction memory. Here we show that infralimbic neurons recorded during fear conditioning and extinction fire to the tone only when rats are recalling extinction on the following day. Rats that froze the least showed the greatest increase in infralimbic tone responses. We also show that conditioned tones paired with brief electrical stimulation of infralimbic cortex elicit low freezing in rats that had not been extinguished. Thus, stimulation resembling extinction-induced infralimbic tone responses is able to simulate extinction memory. We suggest that consolidation of extinction learning potentiates infralimbic activity, which inhibits fear during subsequent encounters with fear stimuli.	Ponce Sch Med, Dept Physiol, Ponce, PR 00732 USA		Quirk, GJ (corresponding author), Ponce Sch Med, Dept Physiol, Ponce, PR 00732 USA.		Milad, Mohammed R/O-4553-2018; anand, amit/A-7222-2009					ALMASKATI HA, 1989, J AUTONOM NERV SYST, V28, P117, DOI 10.1016/0165-1838(89)90084-2; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; Eschweiler GW, 2000, PSYCHIAT RES-NEUROIM, V99, P161, DOI 10.1016/S0925-4927(00)00062-7; FALLS WA, 1992, J NEUROSCI, V12, P854; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Gewirtz JC, 1997, BEHAV NEUROSCI, V111, P712, DOI 10.1037/0735-7044.111.4.712; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 1999, J NEUROPHYSIOL, V82, P2827, DOI 10.1152/jn.1999.82.5.2827; Konorski J., 1967, INTEGRATIVE ACTIVITY; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu KT, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0005.2001; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morrow BA, 1999, NEUROSCIENCE, V92, P553, DOI 10.1016/S0306-4522(99)00014-7; Pavlov I.P., 1927, CONDITIONED REFLEXES; PEREZJARANAY JM, 1991, BRAIN RES, V564, P97, DOI 10.1016/0006-8993(91)91357-7; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; ROBERTSON A, 1982, PHYSIOL BEHAV, V28, P869, DOI 10.1016/0031-9384(82)90206-2; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2000, J NEUROSCI, V20, P9034; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Semple WE, 2000, PSYCHIATRY, V63, P65, DOI 10.1080/00332747.2000.11024895; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X	30	1294	1324	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					70	74		10.1038/nature01138	http://dx.doi.org/10.1038/nature01138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422216				2022-12-24	WOS:000179068100038
J	Roth, M; Johnson, PRA; Rudiger, JJ; King, GG; Ge, Q; Burgess, JK; Anderson, G; Tamm, M; Black, JL				Roth, M; Johnson, PRA; Rudiger, JJ; King, GG; Ge, Q; Burgess, JK; Anderson, G; Tamm, M; Black, JL			Interaction between glucocorticoids and beta(2) agonists on bronchial airway smooth muscle cells through synchronised cellular signalling	LANCET			English	Article							RAT HEPATOMA-CELLS; BINDING PROTEIN; RECEPTOR; ASTHMA; PROLIFERATION; SALMETEROL; BUDESONIDE; FORMOTEROL; GENE; BETA(2)-ADRENOCEPTOR	Background Increased airway smooth muscle bulk is a pathological feature of asthma. Asthma is well controlled by the combined inhalation of glucocorticoids and beta(2)-adrenoceptor agonists. The basic molecular mechanism of the interaction of the two drugs on proliferation of airway smooth muscle cells is yet to be identified. Our aim was to elucidate how glucocorticoids and beta(2) agonists affect the growth of human bronchial airway smooth muscle cells. Methods We assessed the effect of formoterol and budesonide on the activation and function of transcription factors by immunohistochemistry, western blotting, DNA mobility shift assay, and a luciferase reporter gene assay. The effect of the drugs and the involvement of specific transcription factors on cell proliferation was ascertained by direct cell count and confirmed by thymidine incorporation. Findings Both classes of drugs (10(-8) mol/L) activated C/EBP-alpha and the glucocorticoid receptor with different kinetic profiles, and inhibited proliferation. The combination of lower doses of drugs (10(-12) to 10(-9) mol/L) resulted in a synchronised activation of the transcription factors and an enhanced antiproliferative effect. The action of the drugs alone or in combination on transcription-factor activity and proliferation was suppressed by either depletion of C/EBP-alpha or in the presence of a glucocorticoid-receptor blocker. Interpretation Our findings could provide one explanation for the interaction of beta(2)-agonists and glucocorticoids at a molecular level, and indicate that the concentration of inhaled glucocorticoids can be reduced when combined with beta(2) agonists, minimising the side-effects of the drugs.	Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Pulm Cell Res, CH-4031 Basel, Switzerland; Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Basel; University of Basel; University of Melbourne	Roth, M (corresponding author), Woolcock Inst Med Res, POB M77, Camperdown, NSW 2050, Australia.		Ge, Qi/D-3988-2013; Roth, Michael/H-8657-2019; Black, Judith L/C-6559-2008; Burgess, Janette/M-7117-2019; Burgess, Janette K/A-3597-2010	Roth, Michael/0000-0002-8139-2821; Anderson, Gary/0000-0001-6580-3398; Burgess, Janette/0000-0001-9868-9966				Adamson DL, 2000, J MOL CELL CARDIOL, V32, P1353, DOI 10.1006/jmcc.2000.1171; ANDERSON GP, 1994, EUR RESPIR J, V7, P569, DOI 10.1183/09031936.94.07030569; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; Cram EJ, 1998, J BIOL CHEM, V273, P2008, DOI 10.1074/jbc.273.4.2008; DEMOLY P, 1994, AM J RESP CRIT CARE, V150, P214, DOI 10.1164/ajrccm.150.1.7912988; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Esmailpour N, 1997, EUR RESPIR J, V10, P1496, DOI 10.1183/09031936.97.10071496; Fernandes D, 1999, AM J RESP CELL MOL, V21, P77, DOI 10.1165/ajrcmb.21.1.3396; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kips JC, 2000, AM J RESP CRIT CARE, V161, P996, DOI 10.1164/ajrccm.161.3.9812056; Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301; Koukouritaki SB, 1996, J CELL BIOCHEM, V62, P251, DOI 10.1002/(SICI)1097-4644(199608)62:2<251::AID-JCB13>3.0.CO;2-O; Pang LH, 2001, FASEB J, V15, P261, DOI 10.1096/fj.00-0103com; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Ramos RA, 1999, FASEB J, V13, P169, DOI 10.1096/fasebj.13.1.169; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Spoelstra FM, 2002, THORAX, V57, P237, DOI 10.1136/thorax.57.3.237; Stewart AG, 1995, BRIT J PHARMACOL, V116, P3219, DOI 10.1111/j.1476-5381.1995.tb15127.x; Stewart AG, 1997, BRIT J PHARMACOL, V121, P361, DOI 10.1038/sj.bjp.0701128; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; TOMLINSON PR, 1995, BIOCHEM PHARMACOL, V49, P1809, DOI 10.1016/0006-2952(94)00532-Q; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; van der Velden VHJ, 1998, MEDIAT INFLAMM, V7, P229, DOI 10.1080/09629359890910; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607	33	218	226	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 26	2002	360	9342					1293	1299		10.1016/S0140-6736(02)11319-5	http://dx.doi.org/10.1016/S0140-6736(02)11319-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CH	12414205				2022-12-24	WOS:000178827200012
J	Noren, AJ; Bierman, PR; Steig, EJ; Lini, A; Southon, J				Noren, AJ; Bierman, PR; Steig, EJ; Lini, A; Southon, J			Millennial-scale storminess variability in the northeastern United States during the Holocene epoch	NATURE			English	Article							NORTH-ATLANTIC; YR RECORD; CLIMATE; ICE; CIRCULATION; SEDIMENTS; EROSION; EVENTS; NORWAY; CORES		Univ Vermont, Dept Geol, Burlington, VT 05405 USA; Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Noren, AJ (corresponding author), Univ Vermont, Dept Geol, Burlington, VT 05405 USA.		Steig, Eric J/G-9088-2015; Bierman, Paul/AAA-9466-2020; Lini, Andrea/F-9020-2016	Steig, Eric J/0000-0002-8191-5549; Bierman, Paul/0000-0001-9627-4601; Noren, Anders/0000-0002-5604-1085; Lini, Andrea/0000-0002-2920-570X				Bierman P., 1997, GSA TODAY, V7, P1; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; BOSLEY AC, 2001, GEOL SOC AM ABSTR, V33, P15; BOULTON GS, 1997, GLACIER FLUCTUATIONS, P5; Brown P, 1999, PALEOCEANOGRAPHY, V14, P498, DOI 10.1029/1999PA900017; Brown SL, 2000, GEOLOGY, V28, P335, DOI 10.1130/0091-7613(2000)28<335:YROEHE>2.0.CO;2; CONLAN A, 2001, VERMONT GEOLOGICAL S; Eden DN, 1998, PALAEOGEOGR PALAEOCL, V139, P37, DOI 10.1016/S0031-0182(97)00136-3; Fischer H, 2001, J GEOPHYS RES-ATMOS, V106, P23977, DOI 10.1029/2000JD000175; Grove JM, 1988, LITTLE ICE AGE; Hormes A, 2001, HOLOCENE, V11, P255, DOI 10.1191/095968301675275728; Houghton J. T., 2001, CLIMATE CHANGE 2001; JENNINGS KL, IN PRESS GEOL SOC AM; Karlen W, 1996, HOLOCENE, V6, P359, DOI 10.1177/095968369600600311; Knox JC, 2000, QUATERNARY SCI REV, V19, P439, DOI 10.1016/S0277-3791(99)00074-8; LAMB HH, 1979, QUATERNARY RES, V11, P1, DOI 10.1016/0033-5894(79)90067-X; Lamoureux S, 2000, WATER RESOUR RES, V36, P309, DOI 10.1029/1999WR900271; Liu KB, 2000, QUATERNARY RES, V54, P238, DOI 10.1006/qres.2000.2166; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Matthews JA, 2000, QUATERNARY SCI REV, V19, P1625, DOI 10.1016/S0277-3791(00)00008-1; MAYEWSKI PA, 1994, SCIENCE, V263, P1747, DOI 10.1126/science.263.5154.1747; Nesje A, 2001, J PALEOLIMNOL, V25, P329, DOI 10.1023/A:1011197507174; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Thorndycraft V, 1998, HOLOCENE, V8, P741, DOI 10.1191/095968398668590504; Zong YQ, 1999, QUATERN INT, V55, P43, DOI 10.1016/S1040-6182(98)00022-6	30	139	149	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 24	2002	419	6909					821	824		10.1038/nature01132	http://dx.doi.org/10.1038/nature01132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397353				2022-12-24	WOS:000178769800041
J	Zhang, J; Huang, WD; Chua, SS; Wei, P; Moore, DD				Zhang, J; Huang, WD; Chua, SS; Wei, P; Moore, DD			Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR	SCIENCE			English	Article							NUCLEAR TRANSLOCATION; MEDIATED INCREASES; MOUSE-LIVER; CYP2B GENE; MICE; POTENTIATION; GLUTATHIONE; ACTIVATION; INDUCTION; TOXICITY	We have identified the xenobiotic receptor CAR (constitutive androstane receptor) as a key regulator of acetaminophen metabolism and hepatotoxicity. Known CAR activators as well as high doses of acetaminophen induced expression of three acetaminophen-metabolizing enzymes in wild-type but not in CAR null mice, and the CAR null mice were resistant to acetaminophen toxicity. Inhibition of CAR activity by administration of the inverse agonist ligand androstanol 1 hour after acetaminophen treatment blocked hepatotoxicity in wild type but not in CAR null mice. These results suggest an innovative therapeutic approach for treating the adverse effects of acetaminophen and potentially other hepatotoxic agents.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046546] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK46546] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNAIZ SL, 1995, FREE RADICAL BIO MED, V19, P303, DOI 10.1016/0891-5849(95)00023-Q; BURK RF, 1990, RES COMMUN CHEM PATH, V69, P115; COLES B, 1988, ARCH BIOCHEM BIOPHYS, V264, P253, DOI 10.1016/0003-9861(88)90592-9; CORCORAN GB, 1985, J PHARMACOL EXP THER, V232, P864; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Gill RQ, 2001, J CLIN GASTROENTEROL, V33, P191, DOI 10.1097/00004836-200109000-00005; Henderson CJ, 2000, P NATL ACAD SCI USA, V97, P12741, DOI 10.1073/pnas.220176997; HINSON JA, 1990, LANCET, V335, P732, DOI 10.1016/0140-6736(90)90851-U; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kostrubsky VE, 1997, TOXICOL APPL PHARM, V143, P315, DOI 10.1006/taap.1996.8081; MINTON NA, 1988, HUM TOXICOL, V7, P33, DOI 10.1177/096032718800700106; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; PIROTTE JH, 1984, ANN INTERN MED, V101, P403, DOI 10.7326/0003-4819-101-3-403_1; PRESCOTT LF, 1983, DRUGS, V25, P290, DOI 10.2165/00003495-198325030-00002; PRESCOTT LF, 1983, ANNU REV PHARMACOL, V23, P87, DOI 10.1146/annurev.pa.23.040183.000511; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Rogers LK, 1997, CHEM RES TOXICOL, V10, P470, DOI 10.1021/tx960159i; Sinclair J, 1998, BIOCHEM PHARMACOL, V55, P1557; SNAWDER JE, 1994, BIOCHEM BIOPH RES CO, V203, P532, DOI 10.1006/bbrc.1994.2215; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; WILSON JT, 1978, AM J DIS CHILD, V132, P466, DOI 10.1001/archpedi.1978.02120300026004; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	29	253	266	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					422	424		10.1126/science.1073502	http://dx.doi.org/10.1126/science.1073502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376703				2022-12-24	WOS:000178510400051
J	Small, KM; Wagoner, LE; Levin, AM; Kardia, SLR; Liggett, SB				Small, KM; Wagoner, LE; Levin, AM; Kardia, SLR; Liggett, SB			Synergistic polymorphisms of beta(1)- and alpha(2C)-adrenergic receptors and the risk of congestive heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUPPRESSING SYMPATHETIC ACTIVATION; HUMAN BETA(1)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTORS; VENTRICULAR ARRHYTHMIAS; TRANSGENIC MICE; CLONIDINE; HYPERTROPHY; BLOCKERS	Background: Sustained cardiac adrenergic stimulation has been implicated in the development and progression of heart failure. Release of norepinephrine is controlled by negative feedback from presynaptic (alpha)(sub 2)-adrenergic receptors, and the targets of the released norepinephrine on myocytes are (beta)(sub 1)-adrenergic receptors. In transfected cells, a polymorphic (alpha)(sub 2C)-adrenergic receptor ((alpha)(sub 2C)Del322-325) has decreased function, and a variant of the (beta)(sub 1)-adrenergic receptor ((beta)(sub 1)Arg389) has increased function. We hypothesized that this combination of receptor variants, which results in increased synaptic norepinephrine release and enhanced receptor function at the myocyte, would predispose persons to heart failure. Methods: Genotyping at these loci was performed in 159 patients with heart failure and 189 controls. Logistic-regression methods were used to determine the potential effect of each genotype and the interaction between them on the risk of heart failure. Results: Among black subjects, the adjusted odds ratio for heart failure among persons who were homozygous for (alpha)(sub 2C)Del322-325 as compared with those with the other (alpha)(sub 2C)-adrenergic receptor genotypes was 5.65 (95 percent confidence interval, 2.67 to 11.95; P<0.001). There was no increase in risk with (beta)(sub 1)Arg389 alone. However, there was a marked increase in the risk of heart failure among persons who were homozygous for both variants (adjusted odds ratio, 10.11; 95 percent confidence interval, 2.11 to 48.53; P=0.004). The patients with heart failure did not differ from the controls in the frequencies of nine short tandem-repeat alleles. Among white subjects, there were too few who were homozygous for both polymorphisms to allow an adequate assessment of risk. Conclusions: The (alpha)(sub 2C)Del322-325 and (beta)(sub 1)Arg389 receptors act synergistically to increase the risk of heart failure in blacks. Genotyping at these two loci may be a useful approach for identification of persons at risk for heart failure or its progression, who may be candidates for early preventive measures.	Univ Cincinnati, Coll Med, Div Pulm Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Div Cardiol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan	Liggett, SB (corresponding author), Univ Cincinnati, Coll Med, Div Pulm Med, 231 Albert Sabin Way,ML 0564, Cincinnati, OH 45267 USA.		liggett, stephen b/E-7453-2012	Liggett, Stephen B./0000-0002-0128-3669	NHGRI NIH HHS [HG-00040] Funding Source: Medline; NHLBI NIH HHS [HL-22619, HL-52318] Funding Source: Medline; NIEHS NIH HHS [ES-06096] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052318, P01HL022619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aggarwal A, 2001, J AM COLL CARDIOL, V37, P1246, DOI 10.1016/S0735-1097(01)01121-4; Bisognano JD, 2000, J MOL CELL CARDIOL, V32, P817, DOI 10.1006/jmcc.2000.1123; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bristow MR, 1998, LANCET, V352, P8; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; Bristow MR, 2000, J CARD FAIL, V6, P8; COHN JN, 1993, CIRCULATION, V87, P5; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; GILES TD, 1981, CLIN PHARMACOL THER, V30, P724, DOI 10.1038/clpt.1981.229; Grassi G, 2001, HYPERTENSION, V38, P286, DOI 10.1161/01.HYP.38.2.286; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; HERMILLER JB, 1983, AM J CARDIOL, V51, P791, DOI 10.1016/S0002-9149(83)80135-0; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Liggett SB, 1999, AM J RESP CELL MOL, V21, P564, DOI 10.1165/ajrcmb.21.5.f175; Liggett SB, 2001, J CLIN INVEST, V107, P947, DOI 10.1172/JCI12774; LIGGETT SB, 1989, AM J PHYSIOL, V256, pE600, DOI 10.1152/ajpendo.1989.256.5.E600; MANOLIS AJ, 1995, HYPERTENSION, V26, P719, DOI 10.1161/01.HYP.26.5.719; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; MINATOGUCHI S, 1995, AM HEART J, V130, P516, DOI 10.1016/0002-8703(95)90360-7; Moore MM, 1999, MUTAGENESIS, V14, P271, DOI 10.1093/mutage/14.3.271; Packer M, 1998, EUR HEART J, V19, pB40; PARKER JD, 1995, CIRCULATION, V92, P1793, DOI 10.1161/01.CIR.92.7.1793; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Sacchetti L, 1999, CLIN CHEM, V45, P178; Small KM, 2000, J BIOL CHEM, V275, P23059, DOI 10.1074/jbc.M000796200; Small KM, 2002, METHOD ENZYMOL, V343, P459; van Campen LCMC, 1998, J CARDIOVASC PHARM, V32, pS31, DOI 10.1097/00005344-199806321-00006; Zhang YH, 1998, INT J CARDIOL, V65, P233, DOI 10.1016/S0167-5273(98)00127-2	29	403	422	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2002	347	15					1135	1142		10.1056/NEJMoa020803	http://dx.doi.org/10.1056/NEJMoa020803			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601TW	12374873	Bronze			2022-12-24	WOS:000178465100003
J	Bidartondo, MI; Redecker, D; Hijri, I; Wiemken, A; Bruns, TD; Dominguez, L; Sersic, A; Leake, JR; Read, DJ				Bidartondo, MI; Redecker, D; Hijri, I; Wiemken, A; Bruns, TD; Dominguez, L; Sersic, A; Leake, JR; Read, DJ			Epiparasitic plants specialized on arbuscular mycorrhizal fungi	NATURE			English	Article							CARBON TRANSFER; SPECIFICITY; DIVERSITY; IDENTIFICATION; ASSOCIATIONS; VARIABILITY; MUTUALISM; PRIMERS; GLOMUS; ROOTS	Over 400 non-photosynthetic species from 10 families of vascular plants obtain their carbon from fungi and are thus defined as myco-heterotrophs(1). Many of these plants are epiparasitic on green plants from which they obtain carbon by 'cheating' shared mycorrhizal fungi(2-7). Epiparasitic plants examined to date depend on ectomycorrhizal fungi for carbon transfer and exhibit exceptional specificity for these fungi(3-7), but for most mycoheterotrophs neither the identity of the fungi nor the sources of their carbon are known. Because many myco-heterotrophs grow in forests dominated by plants associated with arbuscular mycorrhizal fungi (AMF; phylum Glomeromycota), we proposed that epiparasitism would occur also between plants linked by AMF. On a global scale AMF form the most widespread mycorrhizae, thus the ability of plants to cheat this symbiosis would be highly significant. We analysed mycorrhizae from three populations of Arachnitis uniflora (Corsiaceae, Monocotyledonae), five Voyria species and one Voyriella species (Gentianaceae, Dicotyledonae), and neighbouring green plants. Here we show that non-photosynthetic plants associate with AMF and can display the characteristic specificity of epiparasites. This suggests that AMF mediate significant inter-plant carbon transfer in nature.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; Inst Multidisciplinario Biol Vegetal, RA-5000 Cordoba, Argentina; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of California System; University of California Berkeley; University of Basel; University of Sheffield	Bidartondo, MI (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.		Bidartondo, Martin/AAC-9454-2021; Read, David/C-2454-2013	Leake, Jonathan/0000-0001-8364-7616				Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bidartondo MI, 2002, MOL ECOL, V11, P557, DOI 10.1046/j.0962-1083.2001.01443.x; Bidartondo MI, 2001, MOL ECOL, V10, P2285, DOI 10.1046/j.1365-294X.2001.01358.x; BJORKMAN E, 1960, PHYSIOL PLANTARUM, V13, P308, DOI 10.1111/j.1399-3054.1960.tb08034.x; Cullings KW, 1996, NATURE, V379, P63, DOI 10.1038/379063a0; Fitter AH, 1998, FUNCT ECOL, V12, P406, DOI 10.1046/j.1365-2435.1998.00206.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 1999, MOL ECOL, V8, P659, DOI 10.1046/j.1365-294x.1999.00604.x; Imhof S, 1997, BOT ACTA, V110, P298, DOI 10.1111/j.1438-8677.1997.tb00643.x; JOHNSON NC, 1992, ECOLOGY, V73, P2034, DOI 10.2307/1941453; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Lanfranco L, 1999, MOL ECOL, V8, P37, DOI 10.1046/j.1365-294X.1999.00535.x; LEAKE JR, 1994, NEW PHYTOL, V127, P171, DOI 10.1111/j.1469-8137.1994.tb04272.x; MCGONIGLE TP, 1990, MYCOL RES, V94, P120, DOI 10.1016/S0953-7562(09)81272-0; McKendrick SL, 2000, NEW PHYTOL, V145, P539, DOI 10.1046/j.1469-8137.2000.00592.x; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Price P.W., 1980, EVOLUTIONARY BIOL PA; Redecker D, 2000, MYCORRHIZA, V10, P73, DOI 10.1007/s005720000061; Redecker D, 2000, MYCOLOGIA, V92, P282, DOI 10.2307/3761561; Robinson D, 1999, J EXP BOT, V50, P9, DOI 10.1093/jexbot/50.330.9; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; SMIT LS, 1996, GROW FACT CYTOK  A&B, V1, P43; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; SWOFFORD DL, 2002, PAUP ASTERISQUE PHYL; Taylor DL, 1997, P NATL ACAD SCI USA, V94, P4510, DOI 10.1073/pnas.94.9.4510; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yamato M, 2001, MYCORRHIZA, V11, P83, DOI 10.1007/s005720100099	30	187	212	4	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					389	392		10.1038/nature01054	http://dx.doi.org/10.1038/nature01054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353033	Green Accepted			2022-12-24	WOS:000178195400044
J	Monnier, PP; Sierra, A; Macchi, P; Deitinghoff, L; Andersen, JS; Mann, M; Flad, M; Hornberger, MR; Stahl, B; Bonhoeffer, F; Mueller, BK				Monnier, PP; Sierra, A; Macchi, P; Deitinghoff, L; Andersen, JS; Mann, M; Flad, M; Hornberger, MR; Stahl, B; Bonhoeffer, F; Mueller, BK			RGM is a repulsive guidance molecule for retinal axons	NATURE			English	Article							CHICK VISUAL-SYSTEM; RECOGNITION; GRADIENTS; MEMBRANES; SEQUENCES; PROTEIN	Axons rely on guidance cues to reach remote targets during nervous system development(1). A well-studied model system for axon guidance is the retinotectal projection. The retina can be divided into halves; the nasal half, next to the nose, and the temporal half. A subset of retinal axons, those from the temporal half, is guided by repulsive cues expressed in a graded fashion in the optic tectum(2,3), part of the midbrain. Here we report the cloning and functional characterization of a membrane-associated glycoprotein, which we call RGM (repulsive guidance molecule). This molecule shares no sequence homology with known guidance cues, and its messenger RNA is distributed in a gradient with increasing concentration from the anterior to posterior pole of the embryonic tectum. Recombinant RGM at low nanomolar concentration induces collapse of temporal but not of nasal growth cones and guides temporal retinal axons in vitro, demonstrating its repulsive and axon-specific guiding activity.	Migragen AG, D-72076 Tubingen, Germany; Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Develogen AG, D-37079 Gottingen, Germany	Max Planck Society; University of Southern Denmark	Mueller, BK (corresponding author), Migragen AG, Spemannstr 34, D-72076 Tubingen, Germany.		Sierra, Ana/U-5997-2019; Andersen, Jens S/L-2100-2015; Mann, Matthias/A-3454-2013	Andersen, Jens S/0000-0002-6091-140X; Mann, Matthias/0000-0003-1292-4799; monnier, philippe/0000-0002-6221-4130				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	14	243	263	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					392	395		10.1038/nature01041	http://dx.doi.org/10.1038/nature01041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353034				2022-12-24	WOS:000178195400045
J	Hilton, DA; Ghani, AC; Conyers, L; Edwards, P; McCardle, L; Penney, M; Ritchie, D; Ironside, JW				Hilton, DA; Ghani, AC; Conyers, L; Edwards, P; McCardle, L; Penney, M; Ritchie, D; Ironside, JW			Accumulation of prion protein in tonsil and appendix: review of tissue samples	BRITISH MEDICAL JOURNAL			English	Article							CREUTZFELDT-JAKOB-DISEASE		Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; Univ Edinburgh, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Derriford Hospital; Imperial College London; University of Edinburgh	Hilton, DA (corresponding author), Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England.		Ghani, Azra/B-8560-2009	Ghani, Azra/0000-0002-0007-4910; Ironside, James/0000-0001-5869-2108				Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Schreuder BEC, 1996, NATURE, V381, P563, DOI 10.1038/381563a0	5	109	115	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 21	2002	325	7365					633	634		10.1136/bmj.325.7365.633	http://dx.doi.org/10.1136/bmj.325.7365.633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597WM	12242174	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-24	WOS:000178243800027
J	Gruber, SB; Ellis, NA; Rennert, G; Offit, K				Gruber, SB; Ellis, NA; Rennert, G; Offit, K			BLM heterozygosity and the risk of colorectal cancer	SCIENCE			English	Article							FREQUENCY; MUTATION; JEWS		Carmel Hosp, Clalit Hlth Serv Natl Canc Control Ctr, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Mem Sloan Kettering Canc Ctr, Dept Med Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol, New York, NY 10021 USA; Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; N Shore Long Island Jewish Res Inst, Manhasset, NY 11030 USA; Columbia Univ, Dept Med Informat, New York, NY 10032 USA; NCI, Bethesda, MD 20892 USA	Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University System of Ohio; University of Cincinnati; Northwell Health; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rennert, G (corresponding author), Carmel Hosp, Clalit Hlth Serv Natl Canc Control Ctr, Haifa, Israel.			Rennert, Gad/0000-0002-8512-068X; Kirchhoff, Tomas/0000-0002-9055-2364; Shia, Jinru/0000-0002-4351-2511	NATIONAL CANCER INSTITUTE [R01CA081488] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA81488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Li L, 1998, MOL GENET METAB, V64, P286, DOI 10.1006/mgme.1998.2733; Oddoux C, 1999, AM J HUM GENET, V64, P1241, DOI 10.1086/302312; Peleg L, 2002, ISRAEL MED ASSOC J, V4, P95; Shahrabani-Gargir L, 1998, GENET TEST, V2, P293, DOI 10.1089/gte.1998.2.293	7	146	150	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2013	2013		10.1126/science.1074399	http://dx.doi.org/10.1126/science.1074399			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242432				2022-12-24	WOS:000178078500035
J	Huxley, R; Neil, A; Collins, R				Huxley, R; Neil, A; Collins, R			Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure?	LANCET			English	Article							ISCHEMIC-HEART-DISEASE; PRENATAL EXPOSURE; EARLY NUTRITION; ADULT DISEASE; IN-UTERO; HYPERTENSION; MORTALITY; INFANTS; TWINS; SIZE	Background The association between birthweight and subsequent blood pressure levels has been considered to provide some of the strongest, and most consistent, support for the "fetal origins" hypothesis of adult disease. It had been estimated that a 1 kg higher birthweight is typically associated with a 2-4 mm Hg lower systolic blood pressure. Methods 55 studies that had reported regression coefficients of systolic blood pressure on birthweight (with 48 further studies that reported only the direction of this association), and seven such studies within twin pairs, were identified. Each study was weighted according to the inverse of the variance of the regression coefficient (ie, "statistical size"), and combined using a "fixed effects" approach. Findings Among the 55 studies that reported regression coefficients, there was a clear trend (p<0.0001) towards weaker associations in the larger studies: -1.9 mm Hg/kg in those with less than about 1000 participants; -1.5 mm Hg/kg with about 1000-3000 participants; and -0.6 mm Hg/kg with more than 3000 participants. By contrast with the inverse associations reported in 52 of these 55 studies, only 25 of the 48 studies that did not report regression coefficients found an inverse association (p<0.0001 for heterogeneity). Almost all of these regression coefficients had been adjusted for current weight (whereas few were adjusted for potential confounding factors), and removal of this adjustment in the larger studies reduced the estimated association to -0.4 mm Hg/kg. For studies within monozygotic twin pairs, the combined estimate was -0.6 mm Hg/kg with adjustment for current weight, and was also reduced without this adjustment. Interpretation Claims of a strong inverse association between birthweight and subsequent blood pressure may chiefly reflect the impact of random error, selective emphasis of particular results, and inappropriate adjustment for current weight and for confounding factors. These findings suggest that birthweight is of little relevance to blood pressure levels in later life.	Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Hlth Care, Oxford, England; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Huxley, R (corresponding author), Inst Int Hlth, 144 Burren St, Sydney, NSW 2042, Australia.	rhuxley@iih.usyd.edu.au	Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616				[Anonymous], 2001, LANCET, V357, P405; BARKER DJP, 1986, LANCET, V1, P1077; Campbell DM, 1996, BRIT J OBSTET GYNAEC, V103, P273, DOI 10.1111/j.1471-0528.1996.tb09718.x; CHRISTENSEN K, 1995, BRIT MED J, V310, P432, DOI 10.1136/bmj.310.6977.432; Christensen K, 2001, J EPIDEMIOL COMMUN H, V55, P583, DOI 10.1136/jech.55.8.583; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; *COLL GRP HORM FAC, 2001, LANCET, V350, P1047; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; EIFORD J, 1991, INT J EPIDEMIOL, V20, P833; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Law CM, 1996, J HYPERTENS, V14, P935; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Leon DA, 1999, BMJ-BRIT MED J, V319, P1313, DOI 10.1136/bmj.319.7221.1313; LEON DA, IN PRESS FETALORIGIN; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; LUCAS A, 1994, BRIT MED J, V309, P304, DOI 10.1136/bmj.309.6950.304; Lumey LH, 2001, LANCET, V357, P472, DOI 10.1016/S0140-6736(00)04003-4; PANETH N, 1995, BRIT MED J, V310, P411, DOI 10.1136/bmj.310.6977.411; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pietilainen KH, 2001, AM J EPIDEMIOL, V154, P21, DOI 10.1093/aje/154.1.21; Robinson R, 2001, BRIT MED J, V322, P375, DOI 10.1136/bmj.322.7283.375; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; Roseboom TJ, 1999, J HYPERTENS, V17, P325, DOI 10.1097/00004872-199917030-00004; Said MH, 1998, REV EPIDEMIOL SANTE, V46, P351; SHADISH WR, 1984, HDB RES SYNTHESIS; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; VAGERO D, 1994, LANCET, V343, P260, DOI 10.1016/S0140-6736(94)91112-6; Walker BR, 1998, BRIT MED J, V316, P834, DOI 10.1136/bmj.316.7134.834; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195	35	496	511	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2002	360	9334					659	665		10.1016/S0140-6736(02)09834-3	http://dx.doi.org/10.1016/S0140-6736(02)09834-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241871				2022-12-24	WOS:000177795100006
J	Talal, A				Talal, A			Opportunistic infections in HIV-infected individuals: hepatitis C virus	LANCET			English	Editorial Material							LIVER FIBROSIS PROGRESSION; INTERFERON-ALPHA; COINFECTION; RIBAVIRIN; RESPONSES; DISEASE		Cornell Univ, Ctr Study Hepatitis C, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Dept Med, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Talal, A (corresponding author), Cornell Univ, Ctr Study Hepatitis C, Weill Med Coll, New York, NY 10021 USA.	aht2002@med.cornell.edu						Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; CHUNG R, 2002, 9 C RETR OPP INF SEA; DIENSTAG JL, 2002, NIH CONS DEV C MAN H, P81; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; FRIED M, 2001, GASTROENTEROLOG SA55, V120; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; PESCE A, 1993, LANCET, V341, P1597, DOI 10.1016/0140-6736(93)90736-Z; Puoti M, 2001, J INFECT DIS, V183, P134, DOI 10.1086/317644; Soriano V, 1996, CLIN INFECT DIS, V23, P585, DOI 10.1093/clinids/23.3.585; Soriano V, 2002, AIDS, V16, P813, DOI 10.1097/00002030-200204120-00001; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; TELFER P, 1994, BRIT J HAEMATOL, V87, P555, DOI 10.1111/j.1365-2141.1994.tb08312.x; Zhang ZX, 1997, J INFECT DIS, V175, P1294, DOI 10.1086/516459	17	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2002	360	9333					584	586		10.1016/S0140-6736(02)09811-2	http://dx.doi.org/10.1016/S0140-6736(02)09811-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241926				2022-12-24	WOS:000177600400004
J	White, RE; Abnet, CC; Mungatana, CK; Dawsey, SM				White, RE; Abnet, CC; Mungatana, CK; Dawsey, SM			Oesophageal cancer: a common malignancy in young people of Bomet District, Kenya	LANCET			English	Article								Oesophageal cancer is a common cancer with uneven geographical distribution. We reviewed all malignancies diagnosed at Tenwek Hospital (Bomet District, Kenya) between 1989 and 1998. Oesophageal cancer was the most common malignancy; 274 cases accounted for 19% of 1459 malignancies diagnosed, and for a steady rise in total cancer cases during this period. A striking feature of our study was the presence of a subset of very young patients. 26 (11%) patients were aged 30 years or less at diagnosis, and the youngest patient was 14 years old. This area of West Kenya seems to be a high-risk region for oesophageal cancer.	Tenwek Hosp, Bomet, Kenya; NCI, Canc Prevent Studies Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	White, RE (corresponding author), Tenwek Hosp, POB 39, Bomet, Kenya.	rwhite@maf.or.ke	Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843				AHMED N, 1969, BRIT J CANCER, V23, P302, DOI 10.1038/bjc.1969.40; GATEI DG, 1978, CANCER RES, V38, P303; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; *SURV EP END RES S, 2002, PROGR PUBL US DAT 19; ZHANG ZX, 1990, SHI GUAN AI FANG ZHI, V1, P1	5	27	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					462	463		10.1016/S0140-6736(02)09639-3	http://dx.doi.org/10.1016/S0140-6736(02)09639-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241722				2022-12-24	WOS:000177342900016
J	Dayan, CM; Saravanan, P; Bayly, G				Dayan, CM; Saravanan, P; Bayly, G			Whose normal thyroid function is better - yours or mine?	LANCET			English	Editorial Material							SUBCLINICAL HYPOTHYROIDISM; SERUM-CHOLESTEROL; BLOOD-PRESSURE; SENSITIVITY; THYROXINE		Univ Bristol, Bristol Royal Infirm, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England; Bristol Royal Infirm & Gen Hosp, Dept Chem Pathol, Bristol, Avon, England	Bristol Royal Infirmary; University of Bristol; Bristol Royal Infirmary	Dayan, CM (corresponding author), Univ Bristol, Bristol Royal Infirm, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England.		Saravanan, P/M-6142-2016; Dayan, Colin/AAH-6242-2019	Saravanan, P/0000-0002-9566-2626; Dayan, Colin/0000-0002-6557-3462				Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Bjoro T, 2000, EUR J ENDOCRINOL, V143, P639, DOI 10.1530/eje.0.1430639; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; DAYAN CM, 1996, P R COLL PHYSICIANS, V26, P419; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hearing SD, 1999, J CLIN ENDOCR METAB, V84, P4149, DOI 10.1210/jc.84.11.4149; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P47, DOI 10.1210/jc.83.1.47; MARTIN MJ, 1986, LANCET, V2, P933; Michalopoulou G, 1998, EUR J ENDOCRINOL, V138, P141, DOI 10.1530/eje.0.1380141; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; SARAVANAN P, IN PRESS CLIN ENDOCR; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x	13	38	39	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					353	354		10.1016/S0140-6736(02)09602-2	http://dx.doi.org/10.1016/S0140-6736(02)09602-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241772				2022-12-24	WOS:000177255600005
J	Sharp, D				Sharp, D			Lightning strikes	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Carte AE, 2002, ANN EMERG MED, V39, P665, DOI 10.1067/mem.2002.124438; Cherington M, 1998, LANCET, V351, P1788, DOI 10.1016/S0140-6736(05)78750-X; Cooper MA, 2002, ACAD EMERG MED, V9, P172, DOI 10.1197/aemj.9.2.172; CURRAN EB, LIGHTNING FATALITIES; Makdissi M, 2002, MED J AUSTRALIA, V177, P35, DOI 10.5694/j.1326-5377.2002.tb04633.x; Muehlberger T, 2001, BURNS, V27, P829, DOI 10.1016/S0305-4179(01)00029-8; Zimmermann C, 2002, ANN EMERG MED, V39, P660, DOI 10.1067/mem.2002.124439; 1998, MMWR MORB MORTAL WKL, V47, P391	8	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					354	354		10.1016/S0140-6736(02)09604-6	http://dx.doi.org/10.1016/S0140-6736(02)09604-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241773				2022-12-24	WOS:000177255600006
J	Tappin, D; Brooke, H; Ecob, R; Gibson, A				Tappin, D; Brooke, H; Ecob, R; Gibson, A			Used infant mattresses and sudden infant death syndrome in Scotland: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To examine the proposition that a used infant mattress is associated with an increased risk of sudden infant death syndrome. Design Case-control study. Setting Scotland (population 5.1 million, with about 53000 births a year). Participants 131 infants who died of sudden infant death syndrome between I January 1996 and 31 May 2000 and 278 age, season, and obstetric unit matched control infants. Main outcome measures Routine use of an infant mattress previously used by another child and place of last sleep. Results Routine use of an infant mattress previously used by another child was significantly associated with an increased risk of sudden infant death syndrome (multivariate odds ratio 3.07,95% confidence interval 1.51 to 6.22). Use of a used infant mattress for last sleep was also associated with increased risk (6.10, 2.31 to 16.12). The association was significantly stronger if the mattress was from another home (4.78, 2.08 to 11.0) than if it was from the same home (1.64, 0.64 to 4.2). Conclusion A valid significant association exists between use of a used infant mattress and an increased risk of sudden infant death syndrome, particularly if the mattress is from another home. Insufficient evidence is available to judge whether this relation is cause and effect.	Royal Hosp Sick Children, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow G3 8SJ, Lanark, Scotland; Royal Hosp Sick Children, Scottish Cot Death Trust, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow; University of Glasgow	Tappin, D (corresponding author), Royal Hosp Sick Children, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow G3 8SJ, Lanark, Scotland.	goda11@udcf.gla.ac.uk						BLACKWELL CC, 1992, J CLIN PATHOL, V45, P20; BLACKWELL CC, 1999, FEMS IMMUNOL MED MIC, V25, P199; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; Carstairs V., 1991, DEPRIVATION HLTH SCO; FLEMING P, 2000, SUDDEN UNEXPECTED DE, P50; GIBSON AAM, 1994, 3 SIDS INT C STAV NO; JENKINS R, 2002, P SCOTT COT DEATH TR; *STATA, 2001, STATA7 US GUID	8	65	65	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2002	325	7371					1007	1009		10.1136/bmj.325.7371.1007	http://dx.doi.org/10.1136/bmj.325.7371.1007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JU	12411359	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000179415600021
J	Biragyn, A; Ruffini, PA; Leifer, CA; Klyushnenkova, E; Shakhov, A; Chertov, O; Shirakawa, AK; Farber, JM; Segal, DM; Oppenheim, JJ; Kwak, LW				Biragyn, A; Ruffini, PA; Leifer, CA; Klyushnenkova, E; Shakhov, A; Chertov, O; Shirakawa, AK; Farber, JM; Segal, DM; Oppenheim, JJ; Kwak, LW			Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2	SCIENCE			English	Article							INNATE IMMUNITY; BETA-DEFENSINS; LIPOPOLYSACCHARIDE; COMPLEXES; CD14	beta-Defensins are small antimicrobial peptides of the innate immune system produced in response to microbial infection of mucosal tissue and skin. We demonstrate that murine beta-defensin 2 (mDF2beta) acts directly on immature dendritic cells as an endogenous ligand for Toll-like receptor 4 (TLR-4), inducing up-regulation of costimulatory molecules and dendritic cell maturation. These events, in turn, trigger robust, type 1 polarized adaptive immune responses in vivo, suggesting that mDF2beta may play an important role in immunosurveillance against pathogens and, possibly, self antigens or tumor antigens.	NCI, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA; NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; Sci Applicat Int Corp, Intramural Res Support Program, Frederick, MD 21702 USA; Sci Applicat Int Corp, Prot Chem Lab, Frederick, MD 21702 USA; NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; NCI, Mol Immunoregulat Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Biragyn, A (corresponding author), NCI, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA.	arya@mail.ncifcrf.gov	Ruffini, Pier Adelchi/GLU-1933-2022	Kwak, Larry/0000-0002-1884-5349	NCI NIH HHS [N0L-CO-12400] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000725, ZIAAI000725] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; BIRAGYN A, UNPUB; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Jarvis BW, 1997, INFECT IMMUN, V65, P3011, DOI 10.1128/IAI.65.8.3011-3016.1997; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wiese A, 1998, J MEMBRANE BIOL, V162, P127, DOI 10.1007/s002329900350; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	20	735	810	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2002	298	5595					1025	1029		10.1126/science.1075565	http://dx.doi.org/10.1126/science.1075565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411706				2022-12-24	WOS:000178932000057
J	Thwaites, GE; Chau, TTH; Stepniewska, K; Phu, NH; Chuong, LV; Sinh, DX; White, NJ; Parry, CM; Farrar, JJ				Thwaites, GE; Chau, TTH; Stepniewska, K; Phu, NH; Chuong, LV; Sinh, DX; White, NJ; Parry, CM; Farrar, JJ			Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features	LANCET			English	Article							INFECTION; COUNTRIES; PROGNOSIS; CHILDREN	Background The diagnosis of tuberculous meningitis is difficult. Discrimination of cases from those of bacterial meningitis by clinical features alone is often impossible, and current laboratory methods remain inadequate or inaccessible in developing countries. We aimed to create a simple diagnostic aid for tuberculous meningitis in adults on the basis of clinical and basic laboratory features. Methods We compared the clinical and laboratory features on admission of 251 adults at an infectious disease hospital in Vietnam who satisfied diagnostic criteria for tuberculous (n=143) or bacterial (n=108) meningitis. Features independently predictive of tuberculous meningitis were modelled by multivariate logistic regression to create a diagnostic rule, and by a classification-tree method. The performance of both diagnostic aids was assessed by resubstitution and prospective test data methods. Findings Five features were predictive of a diagnosis of tuberculous meningitis: age, length of history, white-blood-cell count, total cerebrospinal fluid white-cell count, and cerebrospinal fluid neutrophil proportion. A diagnostic rule developed from these features was 97% sensitive and 91% specific by resubstitution, and 86% sensitive and 79% specific when applied prospectively to a further 42 adults with tuberculous meningitis, and 33 with bacterial meningitis. The corresponding values for the classification tree were 99% and 93% by resubstitution, and 88% and 70% with prospective test data. Interpretation This study suggests that simple, clinical and laboratory data can help in the diagnosis of adults with tuberculous meningitis. Although the usefulness of the diagnostic rule will vary depending on the prevalence of tuberculosis and HIV-1 infection, we suggest it be applied to adults with meningitis and a low cerebrospinal fluid glucose, particularly in settings with limited microbiological resources.	Univ Oxford, Wellcome Trust Clin Res Unit, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Dis, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Thwaites, GE (corresponding author), Univ Oxford, Wellcome Trust Clin Res Unit, Ctr Trop Dis, 190 Ben Ham Tu, Ho Chi Minh City, Vietnam.	gthwaites@hcm.vnn.vn	Farrar, Jeremy J./HGA-7610-2022; White, Nicholas J/I-4629-2012; Thwaites, Guy E/R-4993-2019; White, Nick/AAC-6527-2019	Thwaites, Guy E/0000-0002-2858-2087; White, Nick/0000-0002-1897-1978; Stepniewska, Kasia/0000-0002-1713-6209; Farrar, Jeremy/0000-0002-2700-623X				AHUJA GK, 1994, TUBERCLE LUNG DIS, V75, P149, DOI 10.1016/0962-8479(94)90045-0; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; FALLON RJ, 1981, J INFECTION, V3, P39, DOI 10.1016/S0163-4453(81)80007-2; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Hosoglu S, 1998, INT J TUBERC LUNG D, V2, P553; HUMPHRIES MJ, 1990, TUBERCLE, V71, P161, DOI 10.1016/0041-3879(90)90069-K; Kalita J, 1999, INT J TUBERC LUNG D, V3, P261; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; KAY R, 1995, QJM-INT J MED, V88, P39; KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264; Kumar R, 1999, ARCH DIS CHILD, V81, P221, DOI 10.1136/adc.81.3.221; LINCOLN EM, 1960, J PEDIATR-US, V57, P807, DOI 10.1016/S0022-3476(60)80132-1; Misra UK, 1996, J NEUROL SCI, V137, P57, DOI 10.1016/0022-510X(95)00334-X; NGUYEN TH, 1999, J ACQ IMMUN DEF SYND, V21, P338; Pfyffer GE, 1999, J INFECTION, V39, P21, DOI 10.1016/S0163-4453(99)90097-X; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Verdon R, 1996, CLIN INFECT DIS, V22, P982, DOI 10.1093/clinids/22.6.982; Wilson SM, 1998, T ROY SOC TROP MED H, V92, P241, DOI 10.1016/S0035-9203(98)90996-8; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	20	267	299	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2002	360	9342					1287	1292		10.1016/S0140-6736(02)11318-3	http://dx.doi.org/10.1016/S0140-6736(02)11318-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CH	12414204				2022-12-24	WOS:000178827200011
J	Milo, R; Shen-Orr, S; Itzkovitz, S; Kashtan, N; Chklovskii, D; Alon, U				Milo, R; Shen-Orr, S; Itzkovitz, S; Kashtan, N; Chklovskii, D; Alon, U			Network motifs: Simple building blocks of complex networks	SCIENCE			English	Article							SMALL-WORLD; TRANSCRIPTIONAL REGULATION; DYNAMICS	Complex networks are studied across many fields of science. To uncover their structural design principles, we defined network motifs, patterns of interconnections occurring in complex networks at numbers that are significantly higher than those in randomized networks. We found such motifs in networks from biochemistry, neurobiology, ecology, and engineering. The motifs shared by ecological food webs were distinct from the motifs shared by the genetic networks of Escherichia coli and Saccharomyces cerevisiae or from those found in the World Wide Web. Similar motifs were found in networks that perform information processing, even though they describe elements as different as biomolecules within a cell and synaptic connections between neurons in Caenorhabditis elegans. Motifs may thus define universal classes of networks. This approach may uncover the basic building blocks of most networks.	Weizmann Inst Sci, Dept Phys, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Complex Syst, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Cold Spring Harbor Laboratory	Alon, U (corresponding author), Weizmann Inst Sci, Dept Phys, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Yang, Chen/G-1379-2010	Kashtan, Nadav/0000-0002-7475-1363; Shen-Orr, Shai/0000-0002-6991-7736; Milo, Ron/0000-0003-1641-2299				Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B., 2001, RANDOM GRAPHS, V2nd edn; BRGLEZ F, 1989, 1989 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-3, P1929, DOI 10.1109/ISCAS.1989.100747; Callaway DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041902; Cancho RFI, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046119; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Cohen JE, 1990, COMMUNITY FOOD WEBS; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; HOLLAND PW, 1975, SOCIOL METHODOL, P1, DOI DOI 10.2307/270703; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Wasserman S., 1994, SOCIAL NETWORK ANAL, V8, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	24	4413	4572	39	796	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					824	827		10.1126/science.298.5594.824	http://dx.doi.org/10.1126/science.298.5594.824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399590				2022-12-24	WOS:000178791200058
J	Blum, R; Kafitz, KW; Konnerth, A				Blum, R; Kafitz, KW; Konnerth, A			Neurotrophin-evoked depolarization requires the sodium channel Na(V)1.9	NATURE			English	Article							HIGH-FREQUENCY STIMULATION; LONG-TERM POTENTIATION; RETINOIC ACID; BDNF; TRKB; HIPPOCAMPUS; EXPRESSION; SAXITOXIN; RECEPTORS; INDUCTION	Brain-derived neurotrophic factor (BDNF) and other neurotrophins are essential for normal brain function. Many types of neurons in the central nervous system are excited by BDNF or neurotrophin-4/5, an action that has recently been implicated in synaptic plasticity. The mechanisms involved in this transmitter-like action of neurotrophins remains unclear. Here, by screening candidate genes with an antisense messenger RNA expression approach and by co-expressing the receptor tyrosine kinase TrkB and various sodium channels, we demonstrate that the tetrodotoxin-insensitive sodium channel Na(V)1.9 underlies the neurotrophin-evoked excitation. These results establish the molecular basis of neurotrophin-evoked depolarization and reveal a mechanism of ligand-mediated sodium channel activation.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Konnerth, A (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.	konnerth@lrz.uni-muenchen.de	Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854				BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Coward K, 2000, PAIN, V85, P41, DOI 10.1016/S0304-3959(99)00251-1; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; FAVRE I, 1995, J GEN PHYSIOL, V106, P203, DOI 10.1085/jgp.106.2.203; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jeong SY, 2000, BIOCHEM BIOPH RES CO, V267, P262, DOI 10.1006/bbrc.1999.1916; Kafitz K. W., 2001, Pfluegers Archiv European Journal of Physiology, V441, pR125; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Kossel AH, 2001, P NATL ACAD SCI USA, V98, P14702, DOI 10.1073/pnas.251326998; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Penzotti JL, 1998, BIOPHYS J, V75, P2647, DOI 10.1016/S0006-3495(98)77710-0; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yiangou Y, 2000, FEBS LETT, V467, P249, DOI 10.1016/S0014-5793(00)01166-2	45	205	215	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2002	419	6908					687	693		10.1038/nature01085	http://dx.doi.org/10.1038/nature01085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384689				2022-12-24	WOS:000178615200031
J	Manns, BJ; Lee, H; Doig, CJ; Johnson, D; Donaldson, C				Manns, BJ; Lee, H; Doig, CJ; Johnson, D; Donaldson, C			An economic evaluation of activated protein C treatment for severe sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; INTENSIVE-CARE; SEPTIC SHOCK; COSTS; HEALTH; UNCERTAINTY; SURVIVORS	Background: Recombinant human activated protein C was shown in the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study to reduce mortality among patients with severe sepsis. A post hoc reanalysis by the Food and Drug Administration (FDA) of data from this study suggested that the reduction in mortality was restricted to patients with Acute Physiology and Chronic Health Evaluation (APACHE II) scores of 25 or more. Methods: We estimated the cost effectiveness of activated protein C as compared with conventional care for patients with severe sepsis. We performed an economic analysis involving all patients, as well as analyses of subgroups defined according to age and severity of illness. The probabilities of transition between clinical states and the estimates of resource use were derived from a population-based cohort of patients with severe sepsis. We used data on the effectiveness of activated protein C from the PROWESS study and analyses by the FDA. Results: The cost per life-year gained by treating all patients with activated protein C was $27,936. It was more cost effective to treat patients with an APACHE II score of 25 or more ($24,484 per life-year gained) than those with a lower APACHE II score ($35,632 per life-year gained). The cost effectiveness of treating patients with an APACHE II score of 24 or less increased to $575,054 per life-year gained when the FDA's estimates of effectiveness were considered. For patients with an APACHE II score of 25 or more, the cost per life-year gained increased with age ($16,309 for patients less than 40 years of age; $28,100 for those 80 years of age or older). Conclusions: Activated protein C is relatively cost effective when targeted to patients with severe sepsis, greater severity of illness (an APACHE II score of 25 or more), and a reasonable life expectancy if they survive the episode of sepsis. Further research is needed to determine the cost effectiveness of activated protein C for patients with sepsis and less severe illness.	Inst Hlth Econ, Edmonton, AB, Canada; Univ Calgary, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada; Alberta Ctr Hlth Serv Utilizat Res, Edmonton, AB, Canada; Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta	Manns, BJ (corresponding author), Foothills Med Ctr, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	manns@calgaryhealthregion.ca	Doig, Christopher/AAC-7949-2020; Manns, Braden J/I-8942-2012	Doig, Christopher/0000-0002-8576-9139; Donaldson, Cam/0000-0003-4670-5340				*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; *CAN I HLTH INF, 1999, GUID MAN INF SYST CA; CRITCHFIELD GC, 1986, MED DECIS MAKING, V6, P85, DOI 10.1177/0272989X8600600205; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Edbrooke DL, 1997, INTENS CARE MED, V23, P645, DOI 10.1007/s001340050388; Edbrooke DL, 1999, CRIT CARE MED, V27, P1760, DOI 10.1097/00003246-199909000-00010; *FDA, XIGR DROTR ALF ACT P; Gold MR, 1996, COST EFFECTIVENESS H; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KONOPAD E, 1995, CRIT CARE MED, V23, P1653, DOI 10.1097/00003246-199510000-00008; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; MCKILLOP I, 1995, RES PROJECT EXAMINE; MCKILLOP I, 2001, FINANC MANAGE, P83; Montuclard L, 2000, CRIT CARE MED, V28, P3389, DOI 10.1097/00003246-200010000-00002; MUNN J, 1995, ANAESTHESIA, V50, P1017, DOI 10.1111/j.1365-2044.1995.tb05942.x; OBrien B, 1996, MED CARE, V34, pDS99; PITTET D, 1995, INTENS CARE MED, V21, P302, DOI 10.1007/BF01705408; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; *STAT CAN, 1992, 62553 STAT CAN; *STAT CAN, 1998, 13F0016XPB STAT CAN; The World Bank, 2001, WORLD DEV IND 2000; 1997, GUIDELINES EC EVALUA; [No title captured]	32	166	169	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2002	347	13					993	1000		10.1056/NEJMsa020969	http://dx.doi.org/10.1056/NEJMsa020969			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596RD	12324556				2022-12-24	WOS:000178178400006
J	Spurdle, AB; Hopper, JL; Chen, XQ; McCredie, MRE; Giles, GG; Newman, B; Chenevix-Trench, G				Spurdle, AB; Hopper, JL; Chen, XQ; McCredie, MRE; Giles, GG; Newman, B; Chenevix-Trench, G			Prohibitin 3 ' untranslated region polymorphism and breast cancer risk in Australian women	LANCET			English	Article							3'-UNTRANSLATED REGION	A C to T transition within the 3' untranslated region of the prohibitin gene alters mRNA function, and an association between the T allele and an increased risk of breast cancer has been reported in North American women, specifically in those aged under 50 years with a first-degree family history of breast cancer. We did a population-based case-control study to assess whether this association existed in Australian women. We did not note such an association in our sample of 1446 patients and 786 controls (odds ratio 0.96, 95% Cl 0.80-1.16; p=0.7), or in subgroups defined by age or family history, or both. Hence, our results do not lend support to the hypothesis that this polymorphism contributes to risk of breast cancer.	Queensland Inst Med Res, Joint Expt Oncol Programme, Canc & Cell Biol Div, Brisbane, Qld 4006, Australia; Univ Queensland, Brisbane, Qld, Australia; Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic 3053, Australia; New S Wales Canc Council, Kings Cross, NSW, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Anticanc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Melbourne; Cancer Council New South Wales; University of Otago; Queensland University of Technology (QUT); University of Queensland	Spurdle, AB (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Canc & Cell Biol Div, Melbourne, Vic 4029, Australia.		Chenevix-Trench, Georgia/AAV-2014-2020; Spurdle, Amanda B/A-4978-2011	Chenevix-Trench, Georgia/0000-0002-1878-2587; Spurdle, Amanda B/0000-0003-1337-7897; Giles, Graham/0000-0003-4946-9099				Hopper J L, 1999, J Natl Cancer Inst Monogr, P95; Jupe ER, 2001, LANCET, V357, P1588, DOI 10.1016/S0140-6736(00)04747-4; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Spurdle AB, 2000, J NATL CANCER I, V92, P1674, DOI 10.1093/jnci/92.20.1674; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684	5	23	29	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 21	2002	360	9337					925	926		10.1016/S0140-6736(02)11043-9	http://dx.doi.org/10.1016/S0140-6736(02)11043-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AU	12354477				2022-12-24	WOS:000178142200014
J	Cohn, RD; Henry, MD; Michele, DE; Barresi, R; Saito, F; Moore, SA; Flanagan, JD; Skwarchuk, MW; Robbins, ME; Mendell, JR; Williamson, RA; Campbell, KP				Cohn, RD; Henry, MD; Michele, DE; Barresi, R; Saito, F; Moore, SA; Flanagan, JD; Skwarchuk, MW; Robbins, ME; Mendell, JR; Williamson, RA; Campbell, KP			Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration	CELL			English	Article							MYOGENIC STEM-CELL; MUSCULAR-DYSTROPHY; MICE; GENE; EXPRESSION; MEMBRANE; DEFICIENCY; MYOTUBES; COMPLEX	Striated muscle-specific disruption of the dystroglycan (DAG1) gene results in loss of the dystrophin-glycoprotein complex in differentiated muscle and a remarkably mild muscular dystrophy with hypertrophy and without tissue fibrosis. We find that satellite cells, expressing dystroglycan, support continued efficient regeneration of skeletal muscle along with transient expression of dystroglycan in regenerating muscle fibers. We demonstrate a similar phenomenon of reexpression of functional dystroglycan in regenerating muscle fibers in a mild form of human muscular dystrophy caused by disruption of posttranslational dystroglycan processing. Thus, maintenance of regenerative capacity by satellite cells expressing dystroglycan is likely responsible for mild disease progression in mice and possibly humans. Therefore, inadequate repair of skeletal muscle by satellite cells represents an important mechanism affecting the pathogenesis of muscular dystrophy.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Ohio State Univ Hosp, Dept Neurol, Columbus, OH 43210 USA; Holden Comprehens Canc Ctr, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University System of Ohio; Ohio State University	Campbell, KP (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Barresi, Rita/AAB-9569-2022; Cohn, Ronald/AAC-5835-2021	Barresi, Rita/0000-0001-7351-959X; Moore, Steven/0000-0002-6353-7900; Campbell, Kevin/0000-0003-2066-5889; Henry, Michael/0000-0002-7871-245X	NHLBI NIH HHS [HL07121] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bushby K, 2000, DEV MED CHILD NEUROL, V42, P780, DOI 10.1017/S0012162200001444; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cossu G, 2000, J CLIN INVEST, V105, P1669, DOI 10.1172/JCI10376; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Heslop L, 2000, J CELL SCI, V113, P2299; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kong JM, 2001, MUSCLE NERVE, V24, P77, DOI 10.1002/1097-4598(200101)24:1<77::AID-MUS9>3.0.CO;2-Q; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mussini I, 1995, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, VOL 100 - SUPPLEMENT N.1 - 1995, P155; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Winder SJ, 1997, J MUSCLE RES CELL M, V18, P617, DOI 10.1023/A:1018627705273	28	206	217	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					639	648		10.1016/S0092-8674(02)00907-8	http://dx.doi.org/10.1016/S0092-8674(02)00907-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230980	Bronze			2022-12-24	WOS:000177943700010
J	Ibarra, RU; Edwards, JS; Palsson, BO				Ibarra, RU; Edwards, JS; Palsson, BO			Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth	NATURE			English	Article							IN-SILICO; METABOLIC NETWORKS; GENOME SEQUENCE; RECONSTRUCTION; CAPABILITIES; DEFINITION	Annotated genome sequences(1,2) can be used to reconstruct whole-cell metabolic networks(3-6). These metabolic networks can be modelled and analysed (computed) to study complex biological functions(7-11). In particular, constraints-based in silico models(12) have been used to calculate optimal growth rates on common carbon substrates, and the results were found to be consistent with experimental data under many but not all conditions(13,14). Optimal biological functions are acquired through an evolutionary process. Thus, incorrect predictions of in silico models based on optimal performance criteria may be due to incomplete adaptive evolution under the conditions examined. Escherichia coli K-12 MG1655 grows sub-optimally on glycerol as the sole carbon source. Here we show that when placed under growth selection pressure, the growth rate of E. coli on glycerol reproducibly evolved over 40 days, or about 700 generations, from a sub-optimal value to the optimal growth rate predicted from a whole-cell in silico model. These results open the possibility of using adaptive evolution of entire metabolic networks to realize metabolic states that have been determined a priori based on in silico analysis.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA	University of California System; University of California San Diego; University of Delaware	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Palsson, Bernhard/0000-0003-2357-6785				Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonarius HPJ, 1997, TRENDS BIOTECHNOL, V15, P308, DOI 10.1016/S0167-7799(97)01067-6; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Drell Daniel, 2002, OMICS A Journal of Integrative Biology, V6, P3, DOI 10.1089/15362310252780799; Edwards J., 1999, METABOLIC ENG; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; FELL D, 1996, UNDERSTANDING CONTRO; Gombert AK, 2000, CURR OPIN BIOTECH, V11, P180, DOI 10.1016/S0958-1669(00)00079-3; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Palsson B, 2000, NAT BIOTECHNOL, V18, P1147, DOI 10.1038/81125; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Selkov E, 1997, GENE, V197, pGC11, DOI 10.1016/S0378-1119(97)00307-7; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Weikert C, 1997, MICROBIOL-UK, V143, P1567, DOI 10.1099/00221287-143-5-1567; Wiechert W, 2002, J BIOTECHNOL, V94, P37, DOI 10.1016/S0168-1656(01)00418-7	22	607	658	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					186	189		10.1038/nature01149	http://dx.doi.org/10.1038/nature01149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432395				2022-12-24	WOS:000179200900048
J	Rabkin, M; El-Sadr, W; Katzenstein, DA; Mukherjee, J; Masur, H; Mugyenyi, P; Munderi, P; Darbyshire, J				Rabkin, M; El-Sadr, W; Katzenstein, DA; Mukherjee, J; Masur, H; Mugyenyi, P; Munderi, P; Darbyshire, J			Antiretroviral treatment in resource-poor settings: clinical research priorities	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS INFECTION; CD4 CELL COUNT; VIRAL LOAD; DISEASE PROGRESSION; CONTROLLED TRIAL; THERAPY; ADHERENCE; INDINAVIR; AIDS		Columbia Univ, Dept Med, New York, NY 10027 USA; Columbia Univ, Harlem Hosp, Mailman Sch Publ Hlth, New York, NY USA; Columbia Univ, Harlem Hosp, Div Infect Dis, New York, NY USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; Joint Clin Res Ctr, Kampala, Uganda; WHO, Dept Essential Drugs & Med, CH-1211 Geneva, Switzerland; Med Res Ctr, Clin Trials Unit, London, England	Columbia University; Columbia University; Columbia University; Stanford University; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; Joint Clinic Research Center - United Arab Emirates; World Health Organization; Medical Research Council Clinical Trials Unit	Rabkin, M (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.			katzenstein, david/0000-0002-8593-4560				Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; BEDELL R, 2001, 1 IAS C HIV PATH TRE; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; CHAPMAN K, 2001, UNAIDS0193E; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; DIDER JM, 2001, J ACQ IMMUN DEF SYND, V26, P193; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Henry K, 2000, ANN INTERN MED, V132, P306, DOI 10.7326/0003-4819-132-4-200002150-00009; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Janossy G, 2000, BRIT J HAEMATOL, V111, P1198, DOI 10.1046/j.1365-2141.2000.02433.x; KITYO C, 2002, 14 INT AIDS C BARC; LAURENT C, 2002, 9 C RETR OPP INF SEA; Ledergerber B, 2000, J INFECT DIS, V181, P1280, DOI 10.1086/315366; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Post FA, 1996, QJM-MON J ASSOC PHYS, V89, P505; SCHECHTER M, 1994, J ACQ IMMUN DEF SYND, V7, P163; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; *US DEP HHS HJ KAI, 2002, GUID US ANT AG HIV 1; *WHO, 2002, SCAL ANT THER RES LI; Zwerner RK, 1997, J ACQ IMMUN DEF SYND, V14, P31, DOI 10.1097/00042560-199701010-00006	26	38	39	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 9	2002	360	9344					1503	1505		10.1016/S0140-6736(02)11478-4	http://dx.doi.org/10.1016/S0140-6736(02)11478-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JV	12433534				2022-12-24	WOS:000179186000031
J	Chuck, G; Muszynski, M; Kellogg, E; Hake, S; Schmidt, RJ				Chuck, G; Muszynski, M; Kellogg, E; Hake, S; Schmidt, RJ			The control of spikelet meristem identity by the branched silkless1 gene in maize	SCIENCE			English	Article							FLOWER DEVELOPMENT; ARABIDOPSIS; INITIATION; FIMBRIATA; TASSEL; FAMILY	Most of the world's food supply is derived from cereal grains that are borne in a unique structure called the spikelet, the fundamental unit of inflorescence architecture in all grasses. branched silkless1 ( bd1) is a maize mutation that alters the identity of the spikelet meristem, causing indeterminate branches to form in place of spikelets. We show that bd1 encodes a putative ERF transcription factor that is conserved in different grasses and is expressed in a distinct domain of the spikelet meristem. Its expression pattern suggests that signaling pathways regulate meristem identity from lateral domains of the spikelet meristem.	ARS, Ctr Plant Gene Express, USDA, Albany, CA 94710 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA; Univ Missouri, St Louis, MO 63121 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	United States Department of Agriculture (USDA); DuPont; University of Missouri System; University of Missouri Saint Louis; University of California System; University of California San Diego	Chuck, G (corresponding author), ARS, Ctr Plant Gene Express, USDA, 800 Buchanan St, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu	Kellogg, Elizabeth/M-2845-2013; Muszynski, Michael G./L-2843-2016	Kellogg, Elizabeth/0000-0003-1671-7447; Muszynski, Michael G./0000-0002-0817-7594				Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; BARKAN A, 1991, P NATL ACAD SCI USA, V88, P3502, DOI 10.1073/pnas.88.8.3502; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; CHUCK G, UNPUB; Clayton WD., 1990, REPROD VERSATILITY G, P32; Colombo L, 1998, PLANT J, V16, P355, DOI 10.1046/j.1365-313x.1998.00300.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; HELENTJARIS T, 1988, GENETICS, V118, P353; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; Kempton JH, 1934, J HERED, V25, P29, DOI 10.1093/oxfordjournals.jhered.a103835; Laudencia-Chingcuanco D, 2002, DEVELOPMENT, V129, P2629; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; LEVIN JZ, 1995, PLANT CELL, V7, P529, DOI 10.1105/tpc.7.5.529; Mathews S, 2002, INT J PLANT SCI, V163, P441, DOI 10.1086/339155; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; Mena M, 1996, SCIENCE, V274, P1537, DOI 10.1126/science.274.5292.1537; Mena M, 1995, PLANT J, V8, P845, DOI 10.1046/j.1365-313X.1995.8060845.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; SIMON R, 1994, CELL, V78, P99, DOI 10.1016/0092-8674(94)90576-2; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659	23	210	237	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1238	1241		10.1126/science.1076920	http://dx.doi.org/10.1126/science.1076920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424380				2022-12-24	WOS:000179080400052
J	Joint, I; Tait, K; Callow, ME; Callow, JA; Milton, D; Williams, P; Camara, M				Joint, I; Tait, K; Callow, ME; Callow, JA; Milton, D; Williams, P; Camara, M			Cell-to-cell communication across the prokaryote-eukaryote boundary	SCIENCE			English	Article							LACTONE		Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; Univ Nottingham, Sch Pharmaceut Sci, Inst Infect & Immun, Nottingham NG7 2RD, England	Plymouth Marine Laboratory; University of Birmingham; Umea University; University of Nottingham	Joint, I (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth PL1 3DH, Devon, England.		Williams, Paul/A-5629-2011; Williams, Paul/P-5224-2019	Williams, Paul/0000-0002-1920-5036; Tait, Karen/0000-0001-8137-6998				Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Joint I, 2000, BIOFOULING, V16, P151, DOI 10.1080/08927010009378440; Milton DL, 1997, J BACTERIOL, V179, P3004, DOI 10.1128/jb.179.9.3004-3012.1997; Milton DL, 2001, J BACTERIOL, V183, P3537, DOI 10.1128/JB.183.12.3537-3547.2001; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3; Withers H, 2001, CURR OPIN MICROBIOL, V4, P186, DOI 10.1016/S1369-5274(00)00187-9	6	208	218	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 8	2002	298	5596					1207	1207		10.1126/science.1077075	http://dx.doi.org/10.1126/science.1077075			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424372				2022-12-24	WOS:000179080400041
J	Shin, CS; Manley, JL				Shin, CS; Manley, JL			The SR protein SRp38 represses splicing in M phase cells	CELL			English	Article							PRE-MESSENGER-RNA; PREMESSENGER RNA; POLYMERASE-II; DEPENDENT TRANSCRIPTION; SITE SELECTION; FACTOR ASF/SF2; PHOSPHORYLATION; INHIBITION; DEPHOSPHORYLATION; LOCALIZATION	SR proteins constitute a family of pre-mRNA splicing factors that play important roles in both constitutive and regulated splicing. Here, we describe one member of the family, which we call SRp38, with unexpected properties. Unlike other SR proteins, SRp38 cannot activate splicing and is essentially inactive in splicing assays. However, dephosphorylation converts SRp38 to a potent, general repressor that inhibits splicing at an early step. To investigate the cellular function of SRp38, we examined its possible role in cell cycle control. We show first that splicing, like other steps in gene expression, is inhibited in extracts of mitotic cells. Strikingly, SRp38 was found to be dephosphorylated specifically in mitotic cells, and we show that dephosphorylated SRp38 is required for the observed splicing repression.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Manley, James/0000-0002-8341-1459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048259] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM48259] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; Barnard DC, 2000, MOL CELL BIOL, V20, P3049, DOI 10.1128/MCB.20.9.3049-3057.2000; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hanamura A, 1998, RNA, V4, P430; Harlow E, 1988, ANTIBODIES LAB MANUA; Hertel KJ, 1999, P NATL ACAD SCI USA, V96, P2651, DOI 10.1073/pnas.96.6.2651; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Hirose Y, 2000, GENE DEV, V14, P1415; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Komatsu M, 1999, GENES CELLS, V4, P593, DOI 10.1046/j.1365-2443.1999.00286.x; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Labourier E, 1999, GENE DEV, V13, P740, DOI 10.1101/gad.13.6.740; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Okamoto K, 1996, MOL CELL BIOL, V16, P6593; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Van Hooser A, 1998, J CELL SCI, V111, P3497; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	53	159	163	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					407	417		10.1016/S0092-8674(02)01038-3	http://dx.doi.org/10.1016/S0092-8674(02)01038-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419250	Bronze			2022-12-24	WOS:000179010100012
J	Coates, JC; de Bono, M				Coates, JC; de Bono, M			Antagonistic pathways in neurons exposed to body fluid regulate social feeding in Caenorhabditis elegans	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; NEUROPEPTIDE-Y RECEPTOR; C-ELEGANS; NATURAL VARIATION; NERVOUS-SYSTEM; BEHAVIOR; FAMILY; EXPRESSION; ENCODES; PROTEIN	Wild isolates of Caenorhabditis elegans can feed either alone or in groups(1,2). This natural variation in behaviour is associated with a single residue difference in NPR-1, a predicted G-protein-coupled neuropeptide receptor related to Neuropeptide Y receptors(2). Here we show that the NPR-1 isoform associated with solitary feeding acts in neurons exposed to the body fluid to inhibit social feeding. Furthermore, suppressing the activity of these neurons, called AQR, PQR and URX, using an activated K+ channel, inhibits social feeding. NPR-1 activity in AQR, PQR and URX neurons seems to suppress social feeding by antagonizing signalling through a cyclic GMP-gated ion channel encoded by tax-2 and tax-4. We show that mutations in tax-2 or tax-4 disrupt social feeding, and that tax-4 is required in several neurons for social feeding, including one or more of AQR, PQR and URX. The AQR, PQR and URX neurons are unusual in C. elegans because they are directly exposed to the pseudocoelomic body fluid(3). Our data suggest a model in which these neurons integrate antagonistic signals to control the choice between social and solitary feeding behaviour.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Coates, Juliet C/A-3608-2013	Coates, Juliet C/0000-0002-2381-0298; de Bono, Mario/0000-0001-8347-0443				Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; CLARK SG, 1994, GENETICS, V137, P987; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Hodgkin J, 1997, GENETICS, V146, P149; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lee DL, 1976, PHYSL NEMATODES; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Marsh DJ, 1999, P NATL ACAD SCI USA, V96, P13518, DOI 10.1073/pnas.96.23.13518; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Robinson GE, 1997, BIOESSAYS, V19, P1099, DOI 10.1002/bies.950191209; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Sulston J, 1988, NEMATODE CAENORHABDI, P587; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; Weinshenker D, 1999, J NEUROSCI, V19, P9831; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; [No title captured]	28	146	155	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					925	929		10.1038/nature01170	http://dx.doi.org/10.1038/nature01170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410311				2022-12-24	WOS:000178909700044
J	Barberger-Gateau, P; Letenneur, L; Deschamps, V; Peres, K; Dartigues, JF; Renaud, S				Barberger-Gateau, P; Letenneur, L; Deschamps, V; Peres, K; Dartigues, JF; Renaud, S			Fish, meat, and risk of dementia: cohort study	BRITISH MEDICAL JOURNAL			English	Article									Univ Bordeaux 2, INSERM, U330, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Barberger-Gateau, P (corresponding author), Univ Bordeaux 2, INSERM, U330, 2 Case 11,146 Rue Leo Saignat, F-33076 Bordeaux, France.		PERES, Karine/T-4128-2019; Robles-Sardin, Alma E/M-7714-2015; DARTIGUES, Jean François/T-4513-2019; LETENNEUR, Luc/T-4424-2019	PERES, Karine/0000-0002-0720-0684; Robles-Sardin, Alma E/0000-0003-2044-7793; LETENNEUR, Luc/0000-0002-3274-937X				Barberger-Gateau P, 1999, J AM GERIATR SOC, V47, P456, DOI 10.1111/j.1532-5415.1999.tb07239.x; Grant W B, 1999, J Alzheimers Dis, V1, P197; Kalmijn S, 2000, J Nutr Health Aging, V4, P202; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177	5	361	377	0	34	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2002	325	7370					932	+		10.1136/bmj.325.7370.932	http://dx.doi.org/10.1136/bmj.325.7370.932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610XB	12399342	Bronze, Green Published			2022-12-24	WOS:000178986300015
J	Meissner, M; Schluter, D; Soldati, D				Meissner, M; Schluter, D; Soldati, D			Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion	SCIENCE			English	Article							MAMMALIAN-CELLS; EXPRESSION; MOTILITY; EGRESS; SYSTEM	Obligate intracellular apicomplexan parasites rely on gliding motion powered by their actomyosin system to disperse throughout tissues and to penetrate host cells. Toxoplasma gondii myosin A has been implicated in this process, but direct proof has been lacking. We designed a genetic screen to generate a tetracycline-inducible transactivator system in T. gondii. The MyoA gene was disrupted in the presence of a second regulatable copy of MyoA. Conditional removal of this myosin caused severe impairment in host cell invasion and parasite spreading in cultured cells, and unambiguously established the pathogenic function of this motor in an animal model.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Heidelberg Univ, Klinikum Mannheim, Inst Med Mikrobiol & Hyg, D-68167 Mannheim, Germany	Imperial College London; Ruprecht Karls University Heidelberg	Soldati, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Imperial Coll Rd, London SW7 2AZ, England.	d.soldati@ic.ac.uk	Soldati-Favre, Dominique/A-2999-2009	Meissner, Markus/0000-0002-5341-5969; Soldati-Favre, Dominique/0000-0003-4156-2109				Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Hoff EF, 2002, TRENDS PARASITOL, V18, P251, DOI 10.1016/S1471-4922(02)02240-7; Meissner M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e115; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Sibley LD, 1998, CURR BIOL, V8, pR12, DOI 10.1016/S0960-9822(98)70008-9; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	17	356	377	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					837	840		10.1126/science.1074553	http://dx.doi.org/10.1126/science.1074553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399593	Green Accepted			2022-12-24	WOS:000178791200062
J	Sabeti, PC; Reich, DE; Higgins, JM; Levine, HZP; Richter, DJ; Schaffner, SF; Gabriel, SB; Platko, JV; Patterson, NJ; McDonald, GJ; Ackerman, HC; Campbell, SJ; Altshuler, D; Cooper, R; Kwiatkowski, D; Ward, R; Lander, ES				Sabeti, PC; Reich, DE; Higgins, JM; Levine, HZP; Richter, DJ; Schaffner, SF; Gabriel, SB; Platko, JV; Patterson, NJ; McDonald, GJ; Ackerman, HC; Campbell, SJ; Altshuler, D; Cooper, R; Kwiatkowski, D; Ward, R; Lander, ES			Detecting recent positive selection in the human genome from haplotype structure	NATURE			English	Article							LINKAGE DISEQUILIBRIUM; EVOLUTION; DIVERSITY; ALLELE; ORIGIN	The ability to detect recent natural selection in the human population would have profound implications for the study of human history and for medicine. Here, we introduce a framework for detecting the genetic imprint of recent positive selection by analysing long-range haplotypes in human populations. We first identify haplotypes at a locus of interest (core haplotypes). We then assess the age of each core haplotype by the decay of its association to alleles at various distances from the locus, as measured by extended haplotype homozygosity (EHH). Core haplotypes that have unusually high EHH and a high population frequency indicate the presence of a mutation that rose to prominence in the human gene pool faster than expected under neutral evolution. We applied this approach to investigate selection at two genes carrying common variants implicated in resistance to malaria: G6PD(1) and CD40 ligand(2). At both loci, the core haplotypes carrying the proposed protective mutation stand out and show significant evidence of selection. More generally, the method could be used to scan the entire genome for evidence of recent positive selection.	Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02142 USA; Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Loyola Univ, Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60143 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Loyola University Chicago; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lander, ES (corresponding author), Whitehead Inst MIT Ctr Genome Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lander@genome.wi.mit.edu	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022; Altshuler, David M/A-4476-2009; Ackerman, Hans/U-9621-2019	Altshuler, David M/0000-0002-7250-4107; Ackerman, Hans/0000-0003-4940-3305; Kwiatkowski, Dominic/0000-0002-5023-0176; Schaffner, Stephen/0000-0001-6699-3568; Richter, Daniel/0000-0002-9238-5571; Pickett, Sarah/0000-0002-1242-2927				Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Kimura M, 1985, NEUTRAL THEORY MOL E; LEWONTIN RC, 1964, GENETICS, V49, P49; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nei M, 1987, MOL EVOLUTIONARY GEN; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; REICH DE, 1999, MICROSATELLITES EVOL, P128; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAJIMA F, 1989, GENETICS, V123, P585; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Vulliamy T J, 1991, Gene Geogr, V5, P13; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; [No title captured]	26	1354	1399	9	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					832	837		10.1038/nature01140	http://dx.doi.org/10.1038/nature01140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397357				2022-12-24	WOS:000178769800045
J	Brenner, H				Brenner, H			Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis	LANCET			English	Article							RECENT TRENDS; CHILDHOOD-CANCER; UNITED-STATES; MORTALITY; SAARLAND; GERMANY	Background Long-term survival rates for many types of cancer have substantially improved in past decades because of advances in early detection and treatment. However, much of this improvement is only seen many years later with traditional cohort-based methods of survival analysis. I aimed to assess achievements in cancer patients' survival by an alternative method of survival analysis, known as period analysis, which provides more up-to-date estimates of long-term survival rates than do conventional methods. Methods The 1973-98 database of the Surveillance, Epidemiology, and End Results (SEER) programme of the US National Cancer Institute was analysed by period analysis. Findings Estimates of 5-year, 10-year, 15-year, and 20-year relative survival rates for all types of cancer were 63%, 57%, 53%, and 51%, respectively, by period analysis. These estimates were 1%, 7%, 11%, and 11% higher, respectively, than corresponding estimates by cohort-based survival analysis. By period analysis, 20-year relative survival rates were close to 90% for thyroid and testis cancer, exceeded 80% for melanomas and prostate cancer, were about 80% for endometrial cancer, and almost 70% for bladder cancer and Hodgkin's disease. A 20-year relative survival rate of 65% was estimated for breast cancer, of 60% for cervical cancer, and of about 50% for colorectal, ovarian, and renal cancer. Interpretation Timely detection of improvements in long-term survival rates might help to prevent clinicians and their patients from undue discouragement or depression by outdated and often overly pessimistic survival expectations. It also adds to the value of cancer surveillance as a basis for appropriate public-health decisions.	German Ctr Res Ageing, Dept Epidemiol, D-69115 Heidelberg, Germany		Brenner, H (corresponding author), German Ctr Res Ageing, Dept Epidemiol, Bergheimer Str 20, D-69115 Heidelberg, Germany.	brenner@dzfa.uni-heidelberg.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572				Berrino F, 1995, IARC SCI PUBLICATION, V132; Berrino F, 1999, IARC SCI PUBLICATION, V151; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Brandt L, 2001, ACTA ONCOL, V40, P185, DOI 10.1080/02841860151116240; Brenner H, 2002, INT J EPIDEMIOL, V31, P456, DOI 10.1093/ije/31.2.456; Brenner H, 2002, J CLIN ONCOL, V20, P826, DOI 10.1200/JCO.20.3.826; Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5; Brenner H, 2001, CANCER, V92, P1977, DOI 10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W; Brenner H, 2001, BRIT J CANCER, V85, P367, DOI 10.1054/bjoc.2001.1905; Brenner H, 1997, J CLIN EPIDEMIOL, V50, P211, DOI 10.1016/S0895-4356(97)00280-1; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; Brenner H, 2001, METHOD INFORM MED, V40, P248; Brenner H, 1998, BRIT J CANCER, V78, P694, DOI 10.1038/bjc.1998.562; Brenner H, 1999, J CANCER RES CLIN, V125, P109, DOI 10.1007/s004320050250; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; Coleman MP, 2001, CANCER, V91, P208, DOI 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E; Cox D. R., 1984, ANAL SURVIVAL DATA; CUTLER SJ, 1958, J CHRON DIS, V8, P699; Dennis LK, 2000, PROSTATE, V42, P247; Dickman PW, 1999, ACTA ONCOL, V38, P1; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Gatta G, 2000, CANCER-AM CANCER SOC, V89, P893, DOI 10.1002/1097-0142(20000815)89:4<893::AID-CNCR24>3.3.CO;2-0; Greenwood M., 1926, REPORT NATURAL DURAT; HAKULINEN T, 1982, BIOMETRICS, V38, P933, DOI 10.2307/2529873; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; *NCI DCCPS CANC SU, 2001, SURV EP END RES SEER; ROBERTSON CM, 1994, BRIT MED J, V309, P162, DOI 10.1136/bmj.309.6948.162; Sankaranarayanan R, 1996, CANCER-AM CANCER SOC, V78, P2461, DOI 10.1002/(SICI)1097-0142(19961215)78:12<2461::AID-CNCR2>3.0.CO;2-N; Wingo PA, 1998, CANCER EPIDEM BIOMAR, V7, P271	30	384	399	3	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2002	360	9340					1131	1135		10.1016/S0140-6736(02)11199-8	http://dx.doi.org/10.1016/S0140-6736(02)11199-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604QF	12387961				2022-12-24	WOS:000178632000013
J	Volkman, SK; Hartl, DL; Wirth, DF; Nielsen, KM; Choi, M; Batalov, S; Zhou, YY; Plouffe, D; Le Roch, KG; Abagyan, R; Winzeler, EA				Volkman, SK; Hartl, DL; Wirth, DF; Nielsen, KM; Choi, M; Batalov, S; Zhou, YY; Plouffe, D; Le Roch, KG; Abagyan, R; Winzeler, EA			Excess Polymorphisms in genes for membrane proteins in Plasmodium falciparum	SCIENCE			English	Article							RECOMBINATION; SEQUENCE; ARRAYS; SIZE	The detection of single-nucleotide polymorphisms in pathogenic microorganisms has normally been carried out by trial and error. Here we show that DNA hybridization with high-density oligonucleotide arrays provides rapid and convenient detection of single-nucleotide polymorphisms in Plasmodium falciparum, despite its exceptionally high adenine-thymine (AT) content (82%). A disproportionate number of polymorphisms are found in genes encoding proteins associated with the cell membrane. These genes are targets for only 22% of the oligonucleotide probes but account for 69% of the polymorphisms. Genetic variation is also enriched in subtelomeric regions, which account for 22% of the chromosome but 76% of the polymorphisms.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Tromso, Dept Pharm, N-9037 Tromso, Norway	Novartis; Scripps Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; UiT The Arctic University of Tromso	Winzeler, EA (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.		Nielsen, Kaare Magne/G-8107-2018; Winzeler, Elizabeth/AAP-6752-2020	Nielsen, Kaare Magne/0000-0002-7217-2114; Winzeler, Elizabeth/0000-0002-4049-2113; Batalov, Sergey/0000-0002-0925-0554	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061351] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61351] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clark AG, 2002, NATURE, V418, P283, DOI 10.1038/418283a; CORCORAN LM, 1988, CELL, V53, P807, DOI 10.1016/0092-8674(88)90097-9; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	11	76	79	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2002	298	5591					216	218		10.1126/science.1075642	http://dx.doi.org/10.1126/science.1075642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364807				2022-12-24	WOS:000178370500064
J	Hyman, RW; Fung, E; Conway, A; Kurdi, O; Mao, J; Miranda, M; Nakao, B; Rowley, D; Tamaki, T; Wang, F; Davis, RW				Hyman, RW; Fung, E; Conway, A; Kurdi, O; Mao, J; Miranda, M; Nakao, B; Rowley, D; Tamaki, T; Wang, F; Davis, RW			Sequence of Plasmodium falciparum chromosome 12	NATURE			English	Article							PROTEINS; SITES; TOOL	The human malaria parasite Plasmodium falciparum is responsible for the death of more than a million people every year(1). To stimulate basic research on the disease, and to promote the development of effective drugs and vaccines against the parasite, the complete genome of P. falciparum clone 3D7 has been sequenced, using a chromosome-by-chromosome shotgun strategy(2-4). Here we report the nucleotide sequence of the third largest of the parasite's 14 chromosomes, chromosome 12, which comprises about 10% of the 23-megabase genome. As the most (A + T)-rich (80.6%) genome sequenced to date, the P. falciparum genome presented severe problems during the assembly of primary sequence reads. We discuss the methodology that yielded a finished and fully contiguous sequence for chromosome 12. The biological implications of the sequence data are more thoroughly discussed in an accompanying Article (ref. 3).	Stanford Univ, Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Dept Biochem, Coll Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Coll Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Hyman, RW (corresponding author), Stanford Univ, Genome Technol Ctr, 855 Calif Ave, Palo Alto, CA 94304 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Jing JP, 1999, GENOME RES, V9, P175; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oefner PJ, 1996, NUCLEIC ACIDS RES, V24, P3879, DOI 10.1093/nar/24.20.3879; Rubio JP, 1996, EMBO J, V15, P4069, DOI 10.1002/j.1460-2075.1996.tb00780.x; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Su XZ, 1999, EXP PARASITOL, V91, P367, DOI 10.1006/expr.1998.4390	24	50	52	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					534	537		10.1038/nature01102	http://dx.doi.org/10.1038/nature01102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368869				2022-12-24	WOS:000178348400050
J	Ma, JY; Lindquist, S				Ma, JY; Lindquist, S			Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol	SCIENCE			English	Article							PRION PROTEIN; CELLS	A rare conformation of the prion protein, PrPSc, is found only in mammals with transmissible prion diseases and represents either the infectious agent itself or a major component of it. The mechanism for initiating PrPSc formation is unknown. We report that PrP retrogradely transported out of the endoplasmic reticulum produced both amorphous aggregates and a PrPSc-like conformation in the cytosol. The distribution between these forms correlated with the rate of appearance in the cytosol. Once conversion to the PrPSc-like conformation occurred, it was sustained. Thus, PrP has an inherent capacity to promote its own conformational conversion in mammalian cells. These observations might explain the origin of PrPSc.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Chicago	Lindquist, S (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			Ma, Jiyan/0000-0001-7150-1898	NIGMS NIH HHS [GMS 25874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DICKINSON AG, 1988, CIBA F SYMP, V135, P63; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; KIMBERLIN RH, 1982, NATURE, V297, P107, DOI 10.1038/297107a0; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; KOPITO RR, 1999, PHYSIOL REV, V79, P167; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 1999, NAT CELL BIOL, V1, P358, DOI 10.1038/14053; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Wigley WC, 1999, J CELL BIOL, V145, P481; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383	22	228	240	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1785	1788		10.1126/science.1073619	http://dx.doi.org/10.1126/science.1073619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12386336				2022-12-24	WOS:000179494800044
J	Osrin, D; Tumbahangphe, KM; Shrestha, D; Mesko, N; Shtestha, BP; Manandhar, MK; Standing, H; Manandhar, DS; Costello, AMD				Osrin, D; Tumbahangphe, KM; Shrestha, D; Mesko, N; Shtestha, BP; Manandhar, MK; Standing, H; Manandhar, DS; Costello, AMD			Cross sectional, community based study of care of newborn infants in Nepal	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPOTHERMIA; DELIVERY; INDIA	Objective To determine home based newborn care practices in rural Nepal in order to inform strategies to improve neonatal outcome. Design Cross sectional, retrospective study using structured interviews. Setting Makwanpur district, Nepal. Participants 5411 married women aged 15 to 49 years who had given birth to a live baby in the past year. Main outcome measures Attendance at delivery, hygiene, thermal care, and early feeding practices. Results 4893 (90%) women gave birth at home. Attendance at delivery by skilled government health workers was low (334, 6%), as was attendance by traditional birth attendants (267, 5%). Only 461 (8%) women had used a clean home delivery kit, and about half of attendants had washed their,hands. Only 3482 (64%) newborn infants had been wrapped within half an hour of birth, and 4992 (92%) had been bathed within the first hour. 99% (5362) of babies were breast fed, 91% (4939) within six hours of birth. Practices with respect to colostrum and prelacteals were not a cause for anxiety. Conclusions Health promotion interventions most likely to improve newborn health in this setting include increasing attendance at delivery by skilled service providers, improving information for families about basic perinatal care, promotion of clean delivery practices, early cord cutting and wrapping of the baby, and avoidance of early bathing.	UCL, Inst Child Hlth, Int Perinatal Care Unit, London WC1N 1EH, England; Mother Infant Res Act, Kathmandu, Nepal; Nepal Adm Staff Coll, Ctr Local Governance, Kathmandu, Nepal; Univ Sussex, Inst Dev Studies, Hlth & Social Change Unit, Brighton BN1 9RH, E Sussex, England	University of London; University College London; University of Sussex	Costello, AMD (corresponding author), UCL, Inst Child Hlth, Int Perinatal Care Unit, London WC1N 1EH, England.	ipu@ich.ucl.ac.uk		Osrin, David/0000-0001-9691-9684				[Anonymous], 2002, WORLD DEV REP 2002; Bang A T, 2001, Indian Pediatr, V38, P952; BHAVE S A, 1989, Indian Pediatrics, V26, P1094; *CENTR BUR STAT, 2001, STAT YB NEP 2001; Claeson M, 2000, B WORLD HEALTH ORGAN, V78, P1192; *DEP HLTH SERV, 2001, 205657 DEP HLTH SERV; Ellis M, 1996, ARCH DIS CHILD-FETAL, V75, pF42, DOI 10.1136/fn.75.1.F42; *FAM HLTH DIV, 1998, CONTR TRAIN TBAS NEP; GOODBURN EA, 1995, STUD FAMILY PLANN, V26, P22, DOI 10.2307/2138048; IYENGAR SD, 1991, TROP GEOGR MED, V43, P293; JUSTICE J, 1983, SOC SCI MED, V17, P967, DOI 10.1016/0277-9536(83)90223-X; MANANDHAR M, 1999, BIRTHING PRACTICES S; *NAT PLANN COMM SE, 1998, FURTH AN REP AN DEL; *NAT PLANN COMM SE, 1998, FURTH AN REP ANT DEL; *NAT PLANN COMM SE, 1998, CAR PREGN DEL IMPL P; *NEP S AS CTR, 1998, NEP HUM DEV REP 1998; NICHTER M, 1983, HUM ORGAN, V42, P235, DOI 10.17730/humo.42.3.43081445235366lk; Pradhan A., 1997, NEPAL FAMILY HLTH SU; Pradhan A, 1997, NEP FAM HLTH SURV 19; Tamang S, 2001, CONTRIBUTIONS NEPALE, V28, P10; Thapa N, 2000, SOC SCI MED, V51, P1447, DOI 10.1016/S0277-9536(00)00045-9; TRAVERSO HP, 1989, LANCET, V1, P486; *UN CHILDR FUND, 1999, TRENDS CHILDH MORT D; *UN FUND POP ACT, 2000, STAT WORLDS POP 2000; *WHO, 1993, THERM CONTR NEWB PRA; World Bank, 2002, WORLD DEV REP; World Health Organization, 1996, ESS NEWB CAR REP TEC	27	84	84	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2002	325	7372					1063	1066		10.1136/bmj.325.7372.1063	http://dx.doi.org/10.1136/bmj.325.7372.1063			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JV	12424164	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000179415700017
J	van Dam, RM; Feskens, EJM				van Dam, RM; Feskens, EJM			Coffee consumption and risk of type 2 diabetes mellitus	LANCET			English	Article							GLUCOSE; INSULIN	Coffee is a major source of caffeine, which has been shown to acutely reduce sensitivity to insulin, but also has potentially beneficial effects. We prospectively investigated the association between coffee consumption and risk of clinical type 2 diabetes in a population-based cohort of 17 111 Dutch men and women aged 30-60 years. During 125 774 person years of follow-up, 306 new cases of type 2 diabetes were reported. After adjustment for potential confounders, individuals who drank at least seven cups of coffee a day were 0-50 (95% CI 0.35-0.72, p=0.0002) times as likely as those who drank two cups or fewer a day to develop type 2 diabetes. Coffee consumption was associated with a substantially lower risk of clinical type 2 diabetes.	Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	van Dam, RM (corresponding author), Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands.		Feskens, Edith JM/A-3757-2012; Feskens, Edith/ABI-1446-2020; van Dam, Rob M/F-9674-2010	Feskens, Edith/0000-0001-5819-2488; van Dam, Rob M/0000-0002-7354-8734				Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T]; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364; NAISMITH DJ, 1970, NUTR METAB, V12, P144; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472	5	328	341	2	42	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 9	2002	360	9344					1477	1478		10.1016/S0140-6736(02)11436-X	http://dx.doi.org/10.1016/S0140-6736(02)11436-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JV	12433517				2022-12-24	WOS:000179186000014
J	Pizzorusso, T; Medini, P; Berardi, N; Chierzi, S; Fawcett, JW; Maffei, L				Pizzorusso, T; Medini, P; Berardi, N; Chierzi, S; Fawcett, JW; Maffei, L			Reactivation of ocular dominance plasticity in the adult visual cortex	SCIENCE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; EXPERIENCE-DEPENDENT PLASTICITY; EXTRACELLULAR-MATRIX; RAT-BRAIN; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; PERINEURONAL NETS; AXON GROWTH; IN-VIVO; REGENERATION	In young animals, monocular deprivation leads to an ocular dominance shift, whereas in adults after the critical period there is no such shift. Chondroitin sulphate proteoglycans ( CSPGs) are components of the extracellular matrix (ECM) inhibitory for axonal sprouting. We tested whether the developmental maturation of the ECM is inhibitory for experience-dependent plasticity in the visual cortex. The organization of CSPGs into perineuronal nets coincided with the end of the critical period and was delayed by dark rearing. After CSPG degradation with chondroitinase-ABC in adult rats, monocular deprivation caused an ocular dominance shift toward the nondeprived eye. The mature ECM is thus inhibitory for experience-dependent plasticity, and degradation of CSPGs reactivates cortical plasticity.	Scuola Normale Super Pisa, I-56100 Pisa, Italy; CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England; Univ Florence, Dipartimento Psicol, I-50123 Florence, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Cambridge; University of Florence	Pizzorusso, T (corresponding author), Scuola Normale Super Pisa, I-56100 Pisa, Italy.		Medini, Paolo/R-7504-2018; Medini, Paolo/GWC-1936-2022; Pizzorusso, Tommaso/D-1399-2013	Fawcett, James/0000-0002-7990-4568; Pizzorusso, Tommaso/0000-0001-5614-0668				Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Grumet M, 1996, PERSPECT DEV NEUROBI, V3, P319; HARAUZOV A, 2001, SOC NEUR ABSTR, V27, P10; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kind PC, 2002, NATURE, V416, P430, DOI 10.1038/416430a; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Koppe G, 1997, CELL TISSUE RES, V288, P33, DOI 10.1007/s004410050790; Lander C, 1997, J NEUROSCI, V17, P1928; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Matsui F, 1998, BRAIN RES, V790, P45, DOI 10.1016/S0006-8993(98)00009-2; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	25	1164	1195	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 8	2002	298	5596					1248	1251		10.1126/science.1072699	http://dx.doi.org/10.1126/science.1072699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424383				2022-12-24	WOS:000179080400055
J	Castellani, F; van Rossum, B; Diehl, A; Schubert, M; Rehbein, K; Oschkinat, H				Castellani, F; van Rossum, B; Diehl, A; Schubert, M; Rehbein, K; Oschkinat, H			Structure of a protein determined by solid-state magic-angle-spinning NMR spectroscopy	NATURE			English	Article							SPECTRIN SH3 DOMAIN; DISTANCE MEASUREMENTS; RHODOBACTER-SPHAEROIDES; MEMBRANE-PROTEINS; REACTION CENTERS; ROTATING SOLIDS; C-13; ASSIGNMENT; RESONANCE; ENVIRONMENT	The determination of a representative set of protein structures is a chief aim in structural genomics. Solid-state NMR may have a crucial role in structural investigations of those proteins that do not easily form crystals or are not accessible to solution NMR, such as amyloid systems 1 or membrane proteins(2-4). Here we present a protein structure determined by solid-state magic-angle-spinning (MAS) NMR. Almost complete C-13 and N-15 resonance assignments for a micro-crystalline preparation of the alpha-spectrin Src-homology 3 (SH3) domain(5) formed the basis for the extraction of a set of distance restraints. These restraints were derived from proton-driven spin diffusion (PDSD) spectra of biosynthetically site-directed, labelled samples obtained from bacteria grown using [1,3- C-13] glycerol or [2-C-13] glycerol as carbon sources. This allowed the observation of long-range distance correlations up to similar to7 Angstrom. The calculated global fold of the alpha-spectrin SH3 domain is based on 286 inter-residue C-13-C-13 and six N-15-N-15 restraints, all self-consistently obtained by solid-state MAS NMR. This MAS NMR procedure should be widely applicable to small membrane proteins that can be expressed in bacteria.	Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany; Free Univ Berlin, D-14195 Berlin, Germany	Free University of Berlin	Oschkinat, H (corresponding author), Forschungsinst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.		Schubert, Mario/B-3972-2008	Schubert, Mario/0000-0003-0278-4091; Oschkinat, Hartmut/0000-0002-4384-9544; Diehl, Anne/0000-0001-7295-9972				BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Brown SP, 2001, CHEM REV, V101, P4125, DOI 10.1021/cr990132e; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costa PR, 1997, J AM CHEM SOC, V119, P10821, DOI 10.1021/ja964313z; de Groot HJM, 2000, CURR OPIN STRUC BIOL, V10, P593, DOI 10.1016/S0959-440X(00)00136-6; EgorovaZachernyuk TA, 1997, BIOCHEMISTRY-US, V36, P7513, DOI 10.1021/bi962770m; Griffin RG, 1998, NAT STRUCT BIOL, V5, P508, DOI 10.1038/749; GRIFFITHS JM, 1994, J AM CHEM SOC, V116, P10178, DOI 10.1021/ja00101a042; Hodgkinson P, 1999, J MAGN RESON, V139, P46, DOI 10.1006/jmre.1999.1759; Hong M, 1999, J MAGN RESON, V139, P389, DOI 10.1006/jmre.1999.1805; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Ketchem RR, 1996, J BIOMOL NMR, V8, P1; Kiihne S, 1998, J PHYS CHEM A, V102, P2274, DOI 10.1021/jp9721412; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; NIELSEN NC, 1994, J CHEM PHYS, V101, P1805, DOI 10.1063/1.467759; Opella SJ, 1997, NAT STRUCT BIOL, V4, P845; Pauli J, 2000, J MAGN RESON, V143, P411, DOI 10.1006/jmre.2000.2029; Pauli J, 2001, CHEMBIOCHEM, V2, P272, DOI 10.1002/1439-7633(20010401)2:4<272::AID-CBIC272>3.3.CO;2-U; Reif B, 2001, J MAGN RESON, V151, P320, DOI 10.1006/jmre.2001.2354; SHOCHAT S, 1995, SPECTROCHIM ACTA A, V51, P135, DOI 10.1016/0584-8539(94)00207-R; Straus SK, 1998, J BIOMOL NMR, V12, P39, DOI 10.1023/A:1008280716360; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tycko R, 2001, ANNU REV PHYS CHEM, V52, P575, DOI 10.1146/annurev.physchem.52.1.575; van Rossum BJ, 2001, CHEMBIOCHEM, V2, P906, DOI 10.1002/1439-7633(20011203)2:12<906::AID-CBIC906>3.0.CO;2-M; Verhoeven MA, 2001, BIOCHEMISTRY-US, V40, P3282, DOI 10.1021/bi0023798; Wuthrich K., 1986, NMR PROTEINS NUCL AC	28	748	759	4	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					98	102		10.1038/nature01070	http://dx.doi.org/10.1038/nature01070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422222				2022-12-24	WOS:000179068100044
J	Youssef, S; Stuve, O; Patarroyo, JC; Ruiz, PJ; Radosevich, JL; Hur, EM; Bravo, M; Mitchell, DJ; Sobel, RA; Steinman, L; Zamvil, SS				Youssef, S; Stuve, O; Patarroyo, JC; Ruiz, PJ; Radosevich, JL; Hur, EM; Bravo, M; Mitchell, DJ; Sobel, RA; Steinman, L; Zamvil, SS			The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease	NATURE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; II TRANSACTIVATOR GENE; T-CELLS; MULTIPLE-SCLEROSIS; EXPRESSION; STATINS; ASTROCYTES; CD4(+); LOVASTATIN; MICROGLIA	Statins, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, which are approved for cholesterol reduction, may also be beneficial in the treatment of inflammatory diseases(1-3). Atorvastatin (Lipitor) was tested in chronic and relapsing experimental autoimmune encephalomyelitis, a CD4+ Th1-mediated central nervous system (CNS) demyelinating disease model of multiple sclerosis(4,5). Here we show that oral atorvastatin prevented or reversed chronic and relapsing paralysis. Atorvastatin induced STAT6 phosphorylation and secretion of Th2 cytokines (interleukin (IL)-4, IL-5 and IL-10) and transforming growth factor (TGF)-beta. Conversely, STAT4 phosphorylation was inhibited and secretion of Th1 cytokines (IL-2, IL-12, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha) was suppressed. Atorvastatin promoted differentiation of Th0 cells into Th2 cells. In adoptive transfer, these Th2 cells protected recipient mice from EAE induction. Atorvastatin reduced CNS infiltration and major histocompatibility complex (MHC) class II expression. Treatment of microglia inhibited IFN-gamma-inducible transcription at multiple MHC class II transactivator (CIITA) promoters and suppressed class II upregulation. Atorvastatin suppressed IFN-gamma-inducible expression of CD40, CD80 and CD86 co-stimulatory molecules. L-Mevalonate, the product of HMG-CoA reductase, reversed atorvastatin's effects on antigen-presenting cells (APC) and T cells. Atorvastatin treatment of either APC or T cells suppressed antigen-specific T-cell activation. Thus, atorvastatin has pleiotropic immunomodulatory effects involving both APC and T-cell compartments. Statins may be beneficial for multiple sclerosis and other Th1-mediated autoimmune diseases.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Stanford Univ, Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol Neuropathol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; Stanford University	Zamvil, SS (corresponding author), Univ Calif San Francisco, Dept Neurol, 521 Parnassus Ave, San Francisco, CA 94143 USA.			Steinman, Lawrence/0000-0002-2437-2250; Sobel, Raymond/0000-0002-0477-9002				Aloisi F, 1999, EUR J IMMUNOL, V29, P2705, DOI 10.1002/(SICI)1521-4141(199909)29:09<2705::AID-IMMU2705>3.0.CO;2-1; Bernini F, 2001, CARDIOVASC DRUG THER, V15, P211, DOI 10.1023/A:1011908004965; BOTTAZZO GF, 1983, LANCET, V2, P1115; Cilla DD, 1996, CLIN PHARMACOL THER, V60, P687, DOI 10.1016/S0009-9236(96)90218-0; CUTHBERT JA, 1981, J IMMUNOL, V126, P2093; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dostal LA, 1996, FUND APPL TOXICOL, V32, P285, DOI 10.1006/faat.1996.0132; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Maeda A, 1996, J NEUROPATH EXP NEUR, V55, P300, DOI 10.1097/00005072-199603000-00005; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Romano M, 2000, LAB INVEST, V80, P1095, DOI 10.1038/labinvest.3780115; Rudick RA, 2001, J NEURO-OPHTHALMOL, V21, P284, DOI 10.1097/00041327-200112000-00012; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; Soos JM, 1998, J IMMUNOL, V161, P5959; Soos JM, 2001, GLIA, V36, P391, DOI 10.1002/glia.1125; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stanislaus R, 1999, NEUROSCI LETT, V269, P71, DOI 10.1016/S0304-3940(99)00414-0; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; STEINMAN L, 1981, P NATL ACAD SCI-BIOL, V78, P7111, DOI 10.1073/pnas.78.11.7111; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Walker WS, 1995, J NEUROIMMUNOL, V63, P163, DOI 10.1016/0165-5728(95)00146-8; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wong BM, 2001, J LEUKOCYTE BIOL, V69, P959; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	30	905	952	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					78	84		10.1038/nature01158	http://dx.doi.org/10.1038/nature01158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422218				2022-12-24	WOS:000179068100040
J	Kitzman, DW; Little, WC; Brubaker, PH; Anderson, RT; Hundley, WG; Marburger, CT; Brosnihan, B; Morgan, TM; Stewart, KP				Kitzman, DW; Little, WC; Brubaker, PH; Anderson, RT; Hundley, WG; Marburger, CT; Brosnihan, B; Morgan, TM; Stewart, KP			Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRAIN NATRIURETIC PEPTIDE; PATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARS; PLASMA NOREPINEPHRINE; EJECTION FRACTION; ELDERLY-PATIENTS; EXERCISE; DYSFUNCTION; MINNESOTA; QUESTIONNAIRE; PREVALENCE	Context Many older patients with symptoms of congestive heart failure have a preserved left ventricular ejection fraction (LVEF). However, the pathophysiology of this disorder, presumptively termed diastolic heart failure (DHF), is not well characterized and it is unknown whether it represents true heart failure. Objective To assess the 4 key pathophysiological domains that characterize classic heart failure by systematically performing measurements in older patients with presumed DHF and comparing these results with those from age-matched healthy volunteers and patients with classic systolic heart failure (SHF). Design and Setting Observational clinical investigation conducted in 1998 in a general community and teaching hospital in Winston-Salem, NC. Participants A total of 147 subjects aged at least 60 years. Fifty-nine had isolated DHF defined as clinically presumed heart failure, LVEF of at least 50%, and no evidence of significant coronary, valvular, or pulmonary disease. Sixty had typical SHF (LVEF :less than or equal to35%). Twenty-eight were age-matched healthy volunteer controls. Main Outcome Measures Left ventricular structure and function, exercise capacity, neuroendocrine function, and quality of life. Results By echocardiography, mean (SE) LVEF was 60% (2%) inpatients with DHF vs 31% (2%) in those with SHF and 54% (2%) in controls. Mean (SE) LV mass-volume ratio was markedly increased in patients with DHF (2.12 [0.14] g/mL) vs those with SHF (1.22 [0.14] g/mL) (P<.001) and vs controls (1.49 [0.17] g/mL) (P=.002). Peak oxygen consumption by expired gas analysis during cycle ergometry was similar in the DHF and SHF groups (14.2 [0.5] and 13.1 [0.5] mL/kg per minute, respectively; P=.40) and in both was markedly reduced compared with healthy controls (19.9 [0.7] mL/kg per minute) (P=.001 for both). Ventilatory anaerobic threshold was similar in the DHF and SHF groups (9.1 [0.3] and 8.7 [0.3] mL/kg per minute, respectively; P<.001) and in both was reduced compared with healthy controls (11.5 [0.4] mL/kg per minute) (P<.001). Norepinephrine levels were similar in the DHF (306 [64] pg/mL) and SHF (287 [62] pg/mL) groups (P=.56) and in both were markedly increased vs healthy controls (169 [80] pg/mL) (P=.007 and .03, respectively). Brain natriuretic peptide was substantially increased in both the DHF (56 [30] pg/mL) and the SHF (154 [28] pg/mL) groups compared with healthy controls (3 [38] pg/mL) (P=.02 and .001, respectively). Quality-of-life decrement score as assessed by the Minnesota Living with Heart Failure Questionnaire was substantially increased from the benchmark score of 10 in both groups (SHF: 43.8 [3.9]; DHF: 24.8 [4.4]). Conclusion Patients with isolated DHF have similar though not as severe pathophysiologic characteristics compared with patients with typical SHF, including severely reduced exercise capacity, neuroendocrine activation, and impaired quality of life.	Wake Forest Univ, Bowman Gray Sch Med, Cardiol Sect, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Sect Gerontol, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Div Surg, Winston Salem, NC 27157 USA; Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Kitzman, DW (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Cardiol Sect, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	dkitzman@wfubmc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018915, P60AG010484, R01AG012257, R37AG018915, P30AG021332] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR07122] Funding Source: Medline; NIA NIH HHS [P60AG10484, P30 AG021332, AG18915, AG12257] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Banerjee P, 2002, J AM COLL CARDIOL, V39, P138, DOI 10.1016/S0735-1097(01)01704-1; Benedict CR, 1996, CIRCULATION, V94, P690, DOI 10.1161/01.CIR.94.4.690; Bettencourt P, 2000, CARDIOLOGY, V93, P19, DOI 10.1159/000006997; BRAUNWALD E, 1991, NEW ENGL J MED, V325, P351, DOI 10.1056/NEJM199108013250508; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Chen CH, 1998, J AM COLL CARDIOL, V32, P1221, DOI 10.1016/S0735-1097(98)00374-X; Clarkson PBM, 1996, CIRCULATION, V93, P2037, DOI 10.1161/01.CIR.93.11.2037; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; EISENACH JC, 1992, ANESTHESIOLOGY, V77, P522, DOI 10.1097/00000542-199209000-00018; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Grossman W, 2000, CIRCULATION, V101, P2020, DOI 10.1161/01.CIR.101.17.2020; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Kaminsky LA, 2000, AM J CARDIOL, V85, P1385, DOI 10.1016/S0002-9149(00)00778-5; KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; Kitzman DW, 2000, CLIN GERIATR MED, V16, P489, DOI 10.1016/S0749-0690(05)70025-2; LANG CC, 1994, AM HEART J, V127, P1635, DOI 10.1016/0002-8703(94)90401-4; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Marburger CT, 1998, AM J CARDIOL, V82, P905, DOI 10.1016/S0002-9149(98)00502-5; Mars F, 1998, CAH PSYCHOL COGN, V17, P1064; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Rector TS, 1987, HEART FAIL, V3, P198; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; ROSS RD, 1987, AM J CARDIOL, V60, P1411, DOI 10.1016/0002-9149(87)90635-7; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Warner JG, 1999, J AM COLL CARDIOL, V33, P1567, DOI 10.1016/S0735-1097(99)00048-0; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	39	609	640	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2144	2150		10.1001/jama.288.17.2144	http://dx.doi.org/10.1001/jama.288.17.2144			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413374	Bronze			2022-12-24	WOS:000179048100025
J	Looker, AC; Cogswell, ME; Gunter, EW				Looker, AC; Cogswell, ME; Gunter, EW		CDC	Iron deficiency - United States, 1999-2000 (Reprinted from MMWR, vol 51, pg 897-899, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									CDC, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Atlanta, GA 30333 USA; CDC, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; CDC, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Looker, AC (corresponding author), CDC, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Atlanta, GA 30333 USA.							Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897	1	25	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2114	2116						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12425310				2022-12-24	WOS:000179048100012
J	Jartti, T; van den Hoogen, B; Garofalo, RP; Osterhaus, ADME; Ruuskanen, O				Jartti, T; van den Hoogen, B; Garofalo, RP; Osterhaus, ADME; Ruuskanen, O			Metapneumovirus and acute wheezing in children	LANCET			English	Article								A new respiratory virus, human metapneumovirus, was recently identified. We detected this virus by PCR in ten (8%) of 132 consecutive children admitted to Turku Hospital, Finland, for acute expiratory wheezing (median age 7 months, range 4-25). The mean duration of hospital stay was 2.5 days (SD 1-6) and mean duration of respiratory symptoms was 19 days (8). The white blood cell count, C-reactive protein, and regulated upon activation, normal T-cell-expressed and T-cell-secreted (RANTES) concentrations in nasal secretion remained low, whereas interleukin 8 concentrations in nasal secretion were high. Human metapneumovirus is a clinically important causative agent of acute wheezing in young children.	Turku Univ Hosp, Dept Paediat, Turku 20521, Finland; Univ Texas, Med Branch, Childrens Hosp, Galveston, TX 77550 USA; Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands	University of Turku; University of Texas System; University of Texas Medical Branch Galveston; Erasmus University Rotterdam; Erasmus MC	Jartti, T (corresponding author), Turku Univ Hosp, Dept Paediat, PL 52, Turku 20521, Finland.		Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022; van den Hoogen, Bernadette/J-5461-2013	Osterhaus, Albert/0000-0002-6074-1172	NIAID NIH HHS [AI 15939, P01 AI 46004] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015939, P01AI046004] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Ruuskanen O, 1993, Curr Probl Pediatr, V23, P50, DOI 10.1016/0045-9380(93)90003-U; Saito T, 1997, J INFECT DIS, V175, P497, DOI 10.1093/infdis/175.3.497; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098	5	217	237	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 2	2002	360	9343					1393	1394		10.1016/S0140-6736(02)11391-2	http://dx.doi.org/10.1016/S0140-6736(02)11391-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	612ND	12423987	Green Published, Bronze			2022-12-24	WOS:000179081600014
J	Sorensen, HT; Norgard, B; Pedersen, L; Larsen, H; Johnsen, SP				Sorensen, HT; Norgard, B; Pedersen, L; Larsen, H; Johnsen, SP			Maternal smoking and risk of hypertrophic infantile pyloric stenosis: 10-year population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Aalborg Hosp, Dept Obstet & Gynaecol, DK-9000 Aalborg, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark.	hts@soci.au.dk	Nørgård, Bente M/F-9563-2013; Sorensen, Henrik Toft/Z-6181-2019; Johnsen, Søren P/K-1724-2013	Nørgård, Bente M/0000-0002-9514-3033; Sorensen, Henrik Toft/0000-0003-4299-7040; 				APPLEGATE MS, 1995, ARCH PEDIAT ADOL MED, V149, P1123, DOI 10.1001/archpedi.1995.02170230077011; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; Nielsen JP, 2000, DAN MED BULL, V47, P223; Persson S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e70; Wisborg K, 1998, ACTA OBSTET GYN SCAN, V77, P836	5	38	40	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2002	325	7371					1011	1012		10.1136/bmj.325.7371.1011	http://dx.doi.org/10.1136/bmj.325.7371.1011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JU	12411361	Bronze, Green Published			2022-12-24	WOS:000179415600023
J	Cremer, S; Sledge, MF; Heinze, J				Cremer, S; Sledge, MF; Heinze, J			Chemical mimicry - Male ants disguised by the queen's bouquet	NATURE			English	Article							HYDROCARBONS; RECOGNITION		Univ Regensburg, D-93040 Regensburg, Germany; Univ Florence, Dept Anim Biol & Genet, I-50125 Florence, Italy	University of Regensburg; University of Florence	Cremer, S (corresponding author), Univ Copenhagen, Inst Zool, Dept Populat Ecol, DK-2100 Copenhagen, Denmark.	sylvia.cremer@biologie.uni-regensburg.de	Cremer, Sylvia/B-2199-2013	Cremer, Sylvia/0000-0002-2193-3868				ANDERSON C, IN PRESS BEHAV ECOL; Andersson Malte, 1994; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Heinze J, 1998, BEHAV ECOL SOCIOBIOL, V42, P239, DOI 10.1007/s002650050435; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; Holldobler B, 1985, EXPT BEHAV ECOLOGY S, P167; KINOMURA K, 1987, J ETHOL, V5, P75, DOI 10.1007/BF02347897; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; PESCHKE K, 1987, J CHEM ECOL, V13, P1993, DOI 10.1007/BF01041727; Shine R, 2000, ANIM BEHAV, V59, P349, DOI 10.1006/anbe.1999.1321; Singer TL, 1998, AM ZOOL, V38, P394; Turillazzi S., 2002, Insect Social Life, V4, P169	13	47	47	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					897	897		10.1038/419897a	http://dx.doi.org/10.1038/419897a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410300				2022-12-24	WOS:000178909700032
J	Levy, D; Kenchaiah, S; Larson, MG; Benjamin, EJ; Kupka, MJ; Ho, KKL; Murabito, JM; Vasan, RS				Levy, D; Kenchaiah, S; Larson, MG; Benjamin, EJ; Kupka, MJ; Ho, KKL; Murabito, JM; Vasan, RS			Long-term trends in the incidence of and survival with heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CASE-FATALITY; MORTALITY; HYPERTENSION; PREVALENCE; MORBIDITY; PROGNOSIS; COMMUNITY; THERAPY; DISEASE	Background: Heart failure is a major public health problem. Long-term trends in the incidence of heart failure and survival after its onset in the community have not been characterized. Methods: We used statistical models to assess temporal trends in the incidence of heart failure and Cox proportional-hazards regression to evaluate survival after the onset of heart failure among subjects in the Framingham Heart Study. Cases of heart failure were classified according to the date of onset: 1950 through 1969 (223 cases), 1970 through 1979 (222), 1980 through 1989 (307), and 1990 through 1999 (323). We also calculated 30-day, 1-year, and 5-year age-adjusted mortality rates for each period. Results: Heart failure occurred in 1075 subjects (51 percent of whom were women). As compared with the rate for the period from 1950 through 1969, the incidence of heart failure remained virtually unchanged among men in the three subsequent periods but declined by 31 to 40 percent among women (rate ratio for the period from 1990 through 1999, 0.69; 95 percent confidence interval, 0.51 to 0.93). The 30-day, 1-year, and 5-year age-adjusted mortality rates among men declined from 12 percent, 30 percent, and 70 percent, respectively, in the period from 1950 through 1969 to 11 percent, 28 percent, and 59 percent, respectively, in the period from 1990 through 1999. The corresponding rates among women were 18 percent, 28 percent, and 57 percent for the period from 1950 through 1969 and 10 percent, 24 percent, and 45 percent for the period from 1990 through 1999. Overall, there was an improvement in the survival rate after the onset of heart failure of 12 percent per decade (P=0.01 for men and P=0.02 for women). Conclusions: Over the past 50 years, the incidence of heart failure has declined among women but not among men, whereas survival after the onset of heart failure has improved in both sexes. Factors contributing to these trends need further clarification.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Clin Res Inst, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levy, D (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA 01702 USA.		Kenchaiah, Satish/A-1519-2016; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Kenchaiah, Satish/0000-0002-8731-8702; Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Rocha, Evangelista Casimiro/0000-0002-8716-5259; Ho, Kalon/0000-0001-5946-6428; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336; Murabito, Joanne/0000-0002-0192-7516	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195, 1K24 HL04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2001, 2002 HEART STROK STA; [Anonymous], 1991, JAMA, V265, P3255; BAKER DW, 1994, JAMA-J AM MED ASSOC, V272, P1528, DOI 10.1001/jama.272.19.1528; Black HR, 1998, ARCH INTERN MED, V158, P573; BROPHY JM, 1992, CAN J CARDIOL, V8, P495; Burt VL, 1996, HYPERTENSION, V27, P1192; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COX DR, 1972, J R STAT SOC B, V34, P187; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DILENARDA A, 1994, BRIT HEART J, V72, pS46; Hjalmarson A, 1999, LANCET, V353, P2001; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; KANNEL WB, 1994, BRIT HEART J, V72, P3; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION; Lechat P, 1999, LANCET, V353, P9; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MORRISON AS, 1982, INT J EPIDEMIOL, V11, P261, DOI 10.1093/ije/11.3.261; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Murdoch DR, 1998, EUR HEART J, V19, P1829, DOI 10.1053/euhj.1998.1269; *NAT HEART LUNG BL, 2002, FACT BOOK FISC YEAR; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Philbin EF, 1998, CLIN CARDIOL, V21, P103, DOI 10.1002/clc.4960210208; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RodriguezArtalejo F, 1997, EUR HEART J, V18, P1771; SAS Institute, 1997, SAS STAT SOFTW CHANG; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; SHURTLEFF D, 1974, SOME CHARACTERISTICS, P7; SIMBORG DW, 1981, NEW ENGL J MED, V304, P1602, DOI 10.1056/NEJM198106253042611; STEVENSON R, 1993, BMJ-BRIT MED J, V307, P349, DOI 10.1136/bmj.307.6900.349; STEVENSON R, 1993, BRIT MED J, V307, P909; STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P1417, DOI 10.1016/0735-1097(95)00341-X; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; 1997, ARCH INTERN MED, V157, P2413	43	1480	1557	3	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2002	347	18					1397	1402		10.1056/NEJMoa020265	http://dx.doi.org/10.1056/NEJMoa020265			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609DM	12409541	Bronze			2022-12-24	WOS:000178888400002
J	Liston, C; Kagan, J				Liston, C; Kagan, J			Brain development - Memory enhancement in early childhood	NATURE			English	Article							HUMAN PREFRONTAL CORTEX; BEHAVIORAL-DEVELOPMENT; NEUROBIOLOGICAL BASES; RETRIEVAL; EXPLICIT; INFANCY		Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Liston, C (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	cliston@post.harvard.edu	, Conor Liston/GQH-8931-2022					BACHEVALIER J, 1993, NEUROREPORT, V4, P77, DOI 10.1097/00001756-199301000-00020; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Carver LJ, 2001, J EXP PSYCHOL GEN, V130, P726, DOI 10.1037//0096-3445.130.4.726; Herschkowitz N, 1997, NEUROPEDIATRICS, V28, P296, DOI 10.1055/s-2007-973720; Herschkowitz N, 1999, NEUROPEDIATRICS, V30, P221, DOI 10.1055/s-2007-973495; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; KOENDERINK MJT, 1994, BRAIN RES, V653, P173, DOI 10.1016/0006-8993(94)90387-5; MRZLJAK L, 1990, PROG BRAIN RES, V85, P185; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; Piaget Jean, 1952, ORIGINS INTELLIGENCE; SERESS L, 1992, HIPPOCAMPUS, V2, P127, DOI 10.1002/hipo.450020205; Van Buren JM, 1972, VARIATIONS CONNECTIO	13	25	25	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					896	896		10.1038/419896a	http://dx.doi.org/10.1038/419896a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410299				2022-12-24	WOS:000178909700031
J	Chenn, A				Chenn, A			Eppendorf & Science Prize - Making a bigger brain by regulating cell cycle exit	SCIENCE			English	Editorial Material							BETA-CATENIN; MICE LACKING; MAMMALIAN BRAINS; EMBRYOGENESIS; EVOLUTION; HYPERPLASIA; HIPPOCAMPUS; EXPRESSION; CASPASE-9; P27(KIP1)		Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Chenn, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.							Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Brault V, 2001, DEVELOPMENT, V128, P1253; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cho EA, 1998, MECH DEVELOP, V77, P9; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; ELIAS H, 1969, SCIENCE, V166, P111, DOI 10.1126/science.166.3901.111; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Galceran J, 2000, DEVELOPMENT, V127, P469; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lee SMK, 2000, DEVELOPMENT, V127, P457; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; PARR BA, 1993, DEVELOPMENT, V119, P247; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Zurawel RH, 1998, CANCER RES, V58, P896	28	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 25	2002	298	5594					766	767		10.1126/science.1079328	http://dx.doi.org/10.1126/science.1079328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399574				2022-12-24	WOS:000178791200042
J	Lee, TI; Rinaldi, NJ; Robert, F; Odom, DT; Bar-Joseph, Z; Gerber, GK; Hannett, NM; Harbison, CT; Thompson, CM; Simon, I; Zeitlinger, J; Jennings, EG; Murray, HL; Gordon, DB; Ren, B; Wyrick, JJ; Tagne, JB; Volkert, TL; Fraenkel, E; Gifford, DK; Young, RA				Lee, TI; Rinaldi, NJ; Robert, F; Odom, DT; Bar-Joseph, Z; Gerber, GK; Hannett, NM; Harbison, CT; Thompson, CM; Simon, I; Zeitlinger, J; Jennings, EG; Murray, HL; Gordon, DB; Ren, B; Wyrick, JJ; Tagne, JB; Volkert, TL; Fraenkel, E; Gifford, DK; Young, RA			Transcriptional regulatory networks in Saccharomyces cerevisiae	SCIENCE			English	Article							YEAST-CELL-CYCLE; GENE-EXPRESSION; BUDDING YEAST; ENVIRONMENTAL-CHANGES; PROTEINS; BINDING; BIOSYNTHESIS; ASSOCIATION; PROFILES; PROGRAM	We have determined how most of the transcriptional regulators encoded in the eukaryote Saccharomyces cerevisiae associate with genes across the genome in living cells. Just as maps of metabolic networks describe the potential pathways that may be used by a cell to accomplish metabolic processes, this network of regulator-gene interactions describes potential pathways yeast cells can use to regulate global gene expression programs. We use this information to identify network motifs, the simplest units of network architecture, and demonstrate that an automated process can use motifs to assemble a transcriptional regulatory network structure. Our results reveal that eukaryotic cellular functions are highly connected through networks of transcriptional regulators that regulate other transcriptional regulators.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Comp Sci Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Robert, Francois/D-2316-2012; Yang, Chen/G-1379-2010; Young, Richard A/F-6495-2012; Rinaldi, Nicola J/J-5858-2017; Pillay, Nischalan/F-9536-2012; Bar-Joseph, Ziv/GWN-2754-2022	Young, Richard A/0000-0001-8855-8647; Rinaldi, Nicola J/0000-0002-0358-0747; Bar-Joseph, Ziv/0000-0003-3430-6051; Tagne, Jean-Bosco/0000-0003-1830-9156; Fraenkel, Ernest/0000-0001-9249-8181; Simon, Itamar/0000-0002-8517-1903; Odom, Duncan/0000-0001-6201-5599				BARJOSEPH Z, 2002, 6 ANN INT C RES COMP, P39; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bouquin N, 1999, MOL BIOL CELL, V10, P3389, DOI 10.1091/mbc.10.10.3389; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Devaux F, 2002, FEBS LETT, V515, P25, DOI 10.1016/S0014-5793(02)02387-6; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Ho W, 1999, MOL CELL BIOL, V19, P5267; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; KAWASAKI Y, 1990, J BACTERIOL, V172, P6145, DOI 10.1128/jb.172.10.6145-6147.1990; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lopez MC, 2000, J BACTERIOL, V182, P4970, DOI 10.1128/JB.182.17.4970-4978.2000; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; MORGAN BA, 1995, EMBO J, V14, P5679, DOI 10.1002/j.1460-2075.1995.tb00255.x; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; NISHIMURA H, 1992, FEBS LETT, V297, P155, DOI 10.1016/0014-5793(92)80349-L; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Ptashne M., 2002, GENES SIGNALS; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101	45	2191	2295	4	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					799	804		10.1126/science.1075090	http://dx.doi.org/10.1126/science.1075090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399584				2022-12-24	WOS:000178791200051
J	Kivimaki, M; Leino-Arjas, P; Luukkonen, R; Riihimaki, H; Vahtera, J; Kirjonen, J				Kivimaki, M; Leino-Arjas, P; Luukkonen, R; Riihimaki, H; Vahtera, J; Kirjonen, J			Work stress and risk of cardiovascular mortality: prospective cohort study of industrial employees	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; JOB STRAIN; DECISION LATITUDE; SWEDISH MEN; INEQUALITIES; WOMEN	Objective To examine the association between work stress, according to the job strain model and the effort-reward imbalance model, and the risk of death from cardiovascular disease. Design Prospective cohort study. Baseline examination in 1973 determined cases of cardiovascular disease, behavioural and biological risks, and stressful characteristics of work. Biological risks were measured at 5 year and 10 year follow up. Setting Staff of a company in the metal industry in Finland. Participants 812 employees (545 men, 267 women) who were free from cardiovascular diseases at baseline. Main outcome measure Cardiovascular mortality 1973-2001 from the national mortality register. Results Mean length of follow up was 25.6 years. After adjustment for age and sex, employees with high job strain, a combination of high demands at work and low job control, had a 2.2-fold (95% confidence interval 1.2 to 4.2) cardiovascular mortality risk compared with their colleagues with low job strain. The corresponding risk ratio for employees with effort-reward imbalance (low salary, lack of social approval, and few career opportunities relative to efforts required at work) was 2.4 (1.3 to 4.4). These ratios remained significant after additional adjustment for occupational group and biological and behavioural risks at baseline. High job strain was associated with increased serum total cholesterol at the 5-year follow up. Effort-reward imbalance predicted increased body mass index at the 10 year follow up. Conclusions High job strain and effort-reward imbalance seem to increase the risk of cardiovascular mortality. The evidence froth industrial employees suggests that attention should be paid to the prevention of work stress.	Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland; Univ Jyvaskyla, Dept Educ Phys, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla	Kivimaki, M (corresponding author), Univ Helsinki, Dept Psychol, POB 13, FIN-00014 Helsinki, Finland.		Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012	Kivimaki, Mika/0000-0002-4699-5627; Leino-Arjas, Paivi/0000-0001-9534-7071				ALTERMAN T, 1994, AM J EPIDEMIOL, V139, P620, DOI 10.1093/oxfordjournals.aje.a117051; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Karasek R, 1990, STRESS PRODUCTIVITY; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Lynch J, 1997, AM J PUBLIC HEALTH, V87, P617, DOI 10.2105/AJPH.87.4.617; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; *METELI, 1975, 9 METELL RES I PHYS; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; REED DM, 1989, AM J EPIDEMIOL, V129, P495, DOI 10.1093/oxfordjournals.aje.a115160; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Steenland K, 1997, AM J IND MED, V31, P256, DOI 10.1002/(SICI)1097-0274(199702)31:2<256::AID-AJIM16>3.0.CO;2-0; SUADICANI P, 1993, ATHEROSCLEROSIS, V101, P165, DOI 10.1016/0021-9150(93)90113-9; Theorell T, 1996, J Occup Health Psychol, V1, P9, DOI 10.1037/1076-8998.1.1.9; Theorell T, 1998, AM J PUBLIC HEALTH, V88, P382, DOI 10.2105/AJPH.88.3.382; Vrijkotte TGM, 1999, PSYCHOSOM MED, V61, P796, DOI 10.1097/00006842-199911000-00012; Vrijkotte TGM, 2000, HYPERTENSION, V35, P880, DOI 10.1161/01.HYP.35.4.880	19	546	571	0	49	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2002	325	7369					857	860		10.1136/bmj.325.7369.857	http://dx.doi.org/10.1136/bmj.325.7369.857			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	607LL	12386034	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000178793000016
J	Doukov, TI; Iverson, TM; Seravalli, J; Ragsdale, SW; Drennan, CL				Doukov, TI; Iverson, TM; Seravalli, J; Ragsdale, SW; Drennan, CL			A Ni-Fe-Cu center in a bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase	SCIENCE			English	Article							IRON-SULFUR PROTEIN; ACETYL-COENZYME-A; CLOSTRIDIUM-THERMOACETICUM; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; ACTIVE-SITE; CRYSTALLOGRAPHY; MECHANISM; COORDINATION; METHYLATION	A metallocofactor containing iron, sulfur, copper, and nickel has been discovered in the enzyme carbon monoxide dehydrogenase/acetyl-CoA ( coenzyme A) synthase from Moorella thermoacetica (f. Clostridium thermoaceticum). Our structure at 2.2 angstrom resolution reveals that the cofactor responsible for the assembly of acetyl-CoA contains a [Fe4S4] cubane bridged to a copper-nickel binuclear site. The presence of these three metals together in one cluster was unanticipated and suggests a newly discovered role for copper in biology. The different active sites of this bifunctional enzyme complex are connected via a channel, 138 angstroms long, that provides a conduit for carbon monoxide generated at the C-cluster on one subunit to be incorporated into acetyl-CoA at the A-cluster on the other subunit.	MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Nebraska, Beadle Ctr, Dept Biochem, Lincoln, NE 68588 USA	Massachusetts Institute of Technology (MIT); University of Nebraska System; University of Nebraska Lincoln	Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.			Doukov, Tzanko/0000-0001-8625-2572	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039451] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM39451] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREESE.JR, 1973, J BACTERIOL, V114, P743, DOI 10.1128/JB.114.2.743-751.1973; Barondeau DP, 1997, J AM CHEM SOC, V119, P3959, DOI 10.1021/ja963597k; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHRISTOPHER JA, 1998, THESIS TEXASS A M U; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; HU SI, 1982, J BACTERIOL, V149, P440, DOI 10.1128/JB.149.2.440-448.1982; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; Jaron S, 1999, BIOCHEMISTRY-US, V38, P15086, DOI 10.1021/bi991341w; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KUMAR M, 1992, J AM CHEM SOC, V114, P8713, DOI 10.1021/ja00048a062; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindahl PA, 2002, BIOCHEMISTRY-US, V41, P2097, DOI 10.1021/bi015932+; Maynard EL, 1999, J AM CHEM SOC, V121, P9221, DOI 10.1021/ja992120g; Maynard EL, 2001, J AM CHEM SOC, V123, P4697, DOI 10.1021/ja004017t; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Menon S, 1999, J BIOL CHEM, V274, P11513, DOI 10.1074/jbc.274.17.11513; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; RAGSDALE SW, 2000, ENZYME CATALYZED ELE, V35, P487; Russell WK, 1998, J AM CHEM SOC, V120, P7502, DOI 10.1021/ja981165z; Seravalli J, 2000, BIOCHEMISTRY-US, V39, P1274, DOI 10.1021/bi991812e; Seravalli J, 2002, BIOCHEMISTRY-US, V41, P1807, DOI 10.1021/bi011687i; SHANMUGASUNDARAM T, 1992, J BIOL CHEM, V267, P897; SHANMUGASUNDARAM T, 1988, BIOCHEMISTRY-US, V27, P6499, DOI 10.1021/bi00417a045; Strop P, 2001, BIOCHEMISTRY-US, V40, P651, DOI 10.1021/bi0016467; Szulc A, 1998, INORG CHIM ACTA, V270, P440, DOI 10.1016/S0020-1693(97)06001-5; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; VOLBEDA A, 1999, ECOLES PHYSIQUE CHIM, V1, P47; YOUNGBLOOD MP, 1980, INORG CHEM, V19, P3068, DOI 10.1021/ic50212a048	45	422	431	12	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					567	572		10.1126/science.1075843	http://dx.doi.org/10.1126/science.1075843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12386327				2022-12-24	WOS:000178634800032
J	Keimer, B; Sackmann, E; Withers, PJ				Keimer, B; Sackmann, E; Withers, PJ			Neutron scattering - The case for neutron sources	SCIENCE			English	Editorial Material									Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; Tech Univ Munich, Dept Phys, D-85747 Garching, Germany; Univ Manchester, Manchester Mat Sci Ctr, Manchester M1 7HS, Lancs, England	Max Planck Society; Technical University of Munich; University of Manchester	Keimer, B (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.		Withers, Phil/A-6760-2009	Withers, Phil/0000-0002-1946-5647				Birgeneau RJ, 2000, SCIENCE, V288, P437, DOI 10.1126/science.288.5465.437; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43	2	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					543	543		10.1126/science.1077970	http://dx.doi.org/10.1126/science.1077970			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12386318				2022-12-24	WOS:000178634800021
J	Kroger, N; Lorenz, S; Brunner, E; Sumper, M				Kroger, N; Lorenz, S; Brunner, E; Sumper, M			Self-assembly of highly phosphorylated silaffins and their function in biosilica morphogenesis	SCIENCE			English	Article							DIATOM BIOSILICA; SILICA; DEPOSITION; PROTEINS; PEPTIDES	Silaffins are uniquely modified peptides that have been implicated in the biogenesis of diatom biosilica. A method that avoids the harsh anhydrous hydrogen fluoride treatment commonly used to dissolve biosilica allows the extraction of silaffins in their native state. The native silaffins carry further posttranslational modifications in addition to their polyamine moieties. Each serine residue was phosphorylated, and this high level of phosphorylation is essential for biological activity. The zwitterionic structure of native silaffins enables the formation of supramolecular assemblies. Time-resolved analysis of silica morphogenesis in vitro detected a plastic silaffin-silica phase, which may represent a building material for diatom biosilica.	Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany; Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Sumper, M (corresponding author), Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany.		Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381				Bencini A, 1999, COORDIN CHEM REV, V188, P97, DOI 10.1016/S0010-8545(98)00243-4; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHIAPPINO ML, 1977, PROTOPLASMA, V93, P205, DOI 10.1007/BF01275654; Crawford CG, 2001, J AM WATER RESOUR AS, V37, P1, DOI 10.1111/j.1752-1688.2001.tb05470.x; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; NAKAJIMA T, 1970, BIOCHEM BIOPH RES CO, V39, P28, DOI 10.1016/0006-291X(70)90752-7; Noll F, 2002, NANO LETT, V2, P91, DOI 10.1021/nl015581k; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Pickett-Heaps J., 1990, PROGR PHYCOLOGICAL R, V7, P1; Round F.E., 1990, DIATOMS; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; SWIFT DM, 1992, J PHYCOL, V28, P202, DOI 10.1111/j.0022-3646.1992.00202.x; Vrieling EG, 1999, J PHYCOL, V35, P548, DOI 10.1046/j.1529-8817.1999.3530548.x	20	612	641	9	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					584	586		10.1126/science.1076221	http://dx.doi.org/10.1126/science.1076221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12386330				2022-12-24	WOS:000178634800036
J	Groh, V; Wu, J; Yee, C; Spies, T				Groh, V; Wu, J; Yee, C; Spies, T			Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation	NATURE			English	Article							RECEPTOR; RECOGNITION; ENGAGEMENT; PEPTIDE	Engagement of the NKG2D receptor by tumour-associated ligands may promote tumour rejection by stimulating innate and adaptive lymphocyte responses(1-5). In humans, NKG2D is expressed on most natural killer cells, gammadelta T cells and CD8alphabeta T cells(1). Ligands of NKG2D include the major histocompatibility complex class I homologues MICA and MICB, which function as signals of cellular stress(6,7). These molecules are absent from most cells and tissues but can be induced by viral and bacterial infections and are frequently expressed in epithelial tumours(8-11). MIC engagement of NKG2D triggers natural killer cells and costimulates antigen-specific effector T cells(1,10). Here we show that binding of MIC induces endocytosis and degradation of NKG2D. Expression of NKG2D is reduced markedly on large numbers of tumour-infiltrating and matched peripheral blood T cells from individuals with cancer. This systemic deficiency is associated with circulating tumour-derived soluble MICA, causing the downregulation of NKG2D and in turn severe impairment of the responsiveness of tumour-antigen-specific effector T cells. This mode of T-cell silencing may promote tumour immune evasion and, by inference, compromise host resistance to infections.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Groh, V (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N, Seattle, WA 98109 USA.	vgroh@fhcrc.org						Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Huard B, 2000, NATURE, V403, P325, DOI 10.1038/35002105; KNAPPIK A, 1994, BIOTECHNIQUES, V17, P754; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; Long EO, 2002, SEMIN CANCER BIOL, V12, P57, DOI 10.1006/scbi.2001.0398; Pardoll DM, 2001, SCIENCE, V294, P534, DOI 10.1126/science.1066284; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yee C, 1999, J IMMUNOL, V162, P2227	20	1181	1271	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2002	419	6908					734	738		10.1038/nature01112	http://dx.doi.org/10.1038/nature01112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384702				2022-12-24	WOS:000178615200044
J	Gottdiener, JS; McClelland, RL; Marshall, R; Shemanski, L; Furberg, CD; Kitzman, DW; Cushman, M; Polak, J; Gardin, JM; Gersh, BJ; Aurigemma, GP; Manolio, TA				Gottdiener, JS; McClelland, RL; Marshall, R; Shemanski, L; Furberg, CD; Kitzman, DW; Cushman, M; Polak, J; Gardin, JM; Gersh, BJ; Aurigemma, GP; Manolio, TA			Outcome of congestive heart failure in elderly persons: Influence of left ventricular systolic function - The cardiovascular health study	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM PROGNOSIS; EJECTION FRACTION; MYOCARDIAL-INFARCTION; PULMONARY-EDEMA; MORTALITY; PREVALENCE; DYSFUNCTION; MASS; AGE; HYPERTENSION	Background: Most persons with congestive heart failure are elderly, and many elderly persons with congestive heart failure have normal left ventricular systolic function. Objective: To evaluate the relationship between left ventricular systolic function and outcome of congestive heart failure in elderly persons. Design: Population-based longitudinal study of coronary heart disease and stroke. Setting: Four U.S. sites: Forsyth County, North Carolina; Sacramento County, California; Allegheny County, Pennsylvania; and Washington County, Maryland. Participants: 5888 persons who were at least 65 years of age and were recruited from the community. Measurements: Total mortality and cardiovascular morbidity and mortality. Results: Of 5532 participants, 269 (4.9%) had congestive heart failure. Among these, left ventricular function was normal in 63%, borderline decreased in 15%, and overtly impaired in 22%. The mortality rate was 25 deaths per 1000 person-years in the reference group (no congestive heart failure and normal left ventricular function at baseline); 154 deaths per 1000 person-years in participants with congestive heart failure and impaired left ventricular systolic function; 87 and 115 deaths per 1000 person-years in participants with congestive heart failure and normal or borderline systolic function, respectively; and 89 deaths per 1000 person-years in persons with impaired left ventricular function but no congestive heart failure. Although the risk for death from congestive heart failure was lower in persons with normal systolic function than in those with impaired function, more deaths were associated with normal systolic function because more persons with heart failure fall into this category. Conclusions: Community-dwelling elderly persons, especially those with impaired left ventricular function, have a substantial risk for death from congestive heart failure. However, more deaths occur from heart failure in persons with normal systolic function because left ventricular function is more often normal than impaired in elderly persons with heart failure.	St Francis Hosp, Div Cardiol, Roslyn, NY 11576 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Georgetown Univ Hosp, Washington, DC 20007 USA; Univ Washington, Seattle, WA 98195 USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Univ Vermont, Burlington, VT USA; Tufts Univ New England Med Ctr, Boston, MA USA; St John Hosp & Med Ctr, Detroit, MI USA; Univ Massachusetts, Med Ctr, Worcester, MA USA; NHLBI, Bethesda, MD 20892 USA	Mayo Clinic; Georgetown University; University of Washington; University of Washington Seattle; Wake Forest University; University of Vermont; Tufts Medical Center; St. John Hospital & Medical Center; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gottdiener, JS (corresponding author), St Francis Hosp, Div Cardiol, 100 Port Washington Blvd, Roslyn, NY 11576 USA.	gottdien@ziplink.net			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085085, N01HC085083, N01HC085080, N01HC085081, N01HC085079, N01HC085086, N01HC085084, N01HC085082, N01HC015103] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-85086, N01-HC-15103, N01-HC-85079-85086, N01-HC-85085, N01-HC-85084, N01-HC-85083, N01-HC-85082, N01-HC-85081, N01-HC-85080] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON B, 1993, AM HEART J, V126, P632, DOI 10.1016/0002-8703(93)90414-5; Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; BONOW RO, 1992, ANN INTERN MED, V117, P502, DOI 10.7326/0003-4819-117-6-502; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; BRAUNWALD E, 1992, HEART DISEASE, P1179; Carson P, 1996, J AM COLL CARDIOL, V27, P642, DOI 10.1016/0735-1097(95)00503-X; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; COHN JN, 1990, CIRCULATION, V81, P48; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GAASCH WH, 1994, JAMA-J AM MED ASSOC, V271, P1276; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Gardin J M, 1992, J Am Soc Echocardiogr, V5, P63; Gardin JM, 1997, HYPERTENSION, V29, P1095, DOI 10.1161/01.HYP.29.5.1095; GARDIN JM, 1995, CIRCULATION, V91, P1739, DOI 10.1161/01.CIR.91.6.1739; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; GRADMAN A, 1989, J AM COLL CARDIOL, V14, P564, DOI 10.1016/0735-1097(89)90093-4; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; KAMBARA H, 1993, CLIN CARDIOL, V16, P872, DOI 10.1002/clc.4960161207; KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; Kitzman OW, 1994, DIASTOLIC RELAXATION, P295; Kramer K, 2000, AM HEART J, V140, P451, DOI 10.1067/mhj.2000.108828; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; LILIENFELD AM, 1980, F EPIDEMIOLOGY, P217; MITTELMARK MB, 1993, AM J EPIDEMIOL, V137, P311, DOI 10.1093/oxfordjournals.aje.a116678; *MMWR, 1994, MMWR-MORBID MORTAL W, V43, P77; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Opasich C, 2000, AM J CARDIOL, V86, P353, DOI 10.1016/S0002-9149(00)00934-6; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pernenkil R, 1997, AM J CARDIOL, V79, P216, DOI 10.1016/S0002-9149(96)00719-9; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; POWELL AC, 1993, CIRCULATION, V88, P1083, DOI 10.1161/01.CIR.88.3.1083; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Rautaharju PM, 1996, HYPERTENSION, V28, P8, DOI 10.1161/01.HYP.28.1.8; Rich MW, 1997, J AM GERIATR SOC, V45, P968, DOI 10.1111/j.1532-5415.1997.tb02968.x; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 1997, MAYO CLIN PROC, V72, P453, DOI 10.4065/72.5.453; SETARO JF, 1992, AM J CARDIOL, V69, P1212, DOI 10.1016/0002-9149(92)90938-U; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; WEI JY, 1992, NEW ENGL J MED, V327, P1735, DOI 10.1056/NEJM199212103272408; WILBER DJ, 1988, NEW ENGL J MED, V318, P19, DOI 10.1056/NEJM198801073180105; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	53	346	358	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2002	137	8					631	639		10.7326/0003-4819-137-8-200210150-00006	http://dx.doi.org/10.7326/0003-4819-137-8-200210150-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604WL	12379062				2022-12-24	WOS:000178644000001
J	Joyce, GF; Escarce, JJ; Solomon, MD; Goldman, DP				Joyce, GF; Escarce, JJ; Solomon, MD; Goldman, DP			Employer drug benefit plans and spending on prescription drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH MAINTENANCE ORGANIZATION; COST-CONTAINMENT; MEDICAID; PAYMENT; FORMULARY; MEMBERS; IMPACT	Context With drug spending rising rapidly for working-aged adults, many employers and health insurance providers have changed benefits packages to encourage use of fewer or less expensive drugs. It is unknown how these initiatives affect drug costs. Objective To examine how innovations in benefits packages, such as those that include multitier formularies and mandatory generic substitution, affect total cost to insurance providers for generic and brand drugs and out-of-pocket payments to beneficiaries. Design and Participants Retrospective study from 1997 to 1999 linking claims data of 420786 primary beneficiaries aged 18 through 64 years who worked at large firms (n = 25) with health insurance benefits that included outpatient drugs. Main Outcome Measures Overall drug costs; generic, single-source brand, and multisource brand costs; and drug expenditures by health insurance providers and out-of-pocket costs for beneficiaries. Results For a 1-tier plan with a $5 co-payment for all drugs,,the average annual spending was $725 per member. Doubling co-payments to $10 for all drugs reduced the annual average drug cost from $725 to $563 per member (22.3%, P<.001). Doubling co-payments in a 2-tier plan from $5 for generics and $10 for brand drugs to $10 for generics and $20 for brand drugs reduced costs from $678 to $455 (32.9%, P<.001). Adding an additional co-payment of $30 for nonpreferred brand drugs to a 2-tier plan ($10 generics; $20 brand) lowered overall drug spending by 4% (P<.001). Requiring mandatory generic substitution in a 2-tier plan reduced drug spending by 8% (P<.001). Doubling co-payments in a 2-tier plan increased the fraction beneficiaries' paid out-of-pocket from 17.6% to 25.6%. Conclusions Adding an additional level of co-payment, increasing existing co-, payments or coinsurance rates, and requiring mandatory generic substitution all reduced plan payments and overall drug spending among working-age enrollees with employer-provided drug coverage. The reduction in drug spending largely benefited health insurance plans because the percentage of drug expenses beneficiaries paid out-of-pocket rose significantly.	RAND Hlth, Santa Monica, CA 90407 USA	RAND Corporation	Joyce, GF (corresponding author), RAND Hlth, 1700 Main St, Santa Monica, CA 90407 USA.		Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396				Berndt ER, 2001, HEALTH AFFAIR, V20, P100, DOI 10.1377/hlthaff.20.2.100; BYMARK L, 2002, PRESCRIPTION DRUG US; *CA HEALTHC FDN FO, 2002, PRESCR DRUG COV FORM; DUAN N, 1983, J EC BUSINESS STATIS, V1, P115, DOI DOI 10.2307/1391852; Dubois RW, 2000, HEALTH AFFAIR, V19, P231, DOI 10.1377/hlthaff.19.2.231; Ernst ME, 2000, ARCH FAM MED, V9, P1002, DOI 10.1001/archfami.9.10.1002; Goldman DP, 1998, J AM STAT ASSOC, V93, P54, DOI 10.2307/2669602; HARRIS BL, 1990, MED CARE, V28, P907, DOI 10.1097/00005650-199010000-00005; HILLMAN AL, 1999, HLTH AFF MILLWOOD, V18, P188; Horn SD, 1998, AM J MANAG CARE, V4, P1105; Johnson RE, 1997, HEALTH SERV RES, V32, P103; Johnson RE, 1997, MED CARE, V35, P1119, DOI 10.1097/00005650-199711000-00004; LEIBOWITZ A, 1985, SOC SCI MED, V21, P1063, DOI 10.1016/0277-9536(85)90161-3; Levit K, 2000, HEALTH AFFAIR, V19, P124, DOI 10.1377/hlthaff.19.1.124; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Motheral B, 2001, MED CARE, V39, P1293, DOI 10.1097/00005650-200112000-00005; Motheral BR, 1999, INQUIRY-J HEALTH CAR, V36, P481; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; *NIH CAR MAN FDN, 2001, PRESCR DRUG EXP 2000; PENNA P, 2000, J MANAGE CARE PHARM, V6, P351; REEDER CE, 1985, INQUIRY-J HEALTH CAR, V22, P396; REISSMAN D, 2001, DRUG BENEFIT TRENDS, V13, P24; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; SMITH DG, 1993, INQUIRY-J HEALTH CAR, V30, P189; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; Stuart B, 1999, HEALTH AFFAIR, V18, P201, DOI 10.1377/hlthaff.18.2.201; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Walser BL, 1996, HEALTH AFFAIR, V15, P95, DOI 10.1377/hlthaff.15.3.95	30	183	184	1	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2002	288	14					1733	1739		10.1001/jama.288.14.1733	http://dx.doi.org/10.1001/jama.288.14.1733			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	602BJ	12365957	Bronze			2022-12-24	WOS:000178484700026
J	Hemingway, J; Field, L; Vontas, J				Hemingway, J; Field, L; Vontas, J			An overview of insecticide resistance	SCIENCE			English	Editorial Material							ANOPHELES-GAMBIAE; MALARIA VECTOR; EXPRESSION; GENES; DDT		Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Rothamsted, Harpenden AL5 2JQ, Herts, England; Inst Mol Biol & Biotechnol, Crete, NE USA	Liverpool School of Tropical Medicine; University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Hemingway, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.		Vontas, John/X-5112-2018	Vontas, John/0000-0002-8704-2574; Hemingway, Janet/0000-0002-3200-7173				Blackman RL, 1999, HEREDITY, V82, P180, DOI 10.1038/sj.hdy.6884580; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Curtis CF, 1998, PHILOS T ROY SOC B, V353, P1769, DOI 10.1098/rstb.1998.0329; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Grauso M, 1998, FEBS LETT, V424, P279, DOI 10.1016/S0014-5793(98)00191-4; Huang Y, 2000, NEUROSCI LETT, V284, P116, DOI 10.1016/S0304-3940(00)00969-1; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Paton MG, 2000, BIOCHEM J, V346, P17, DOI 10.1042/0264-6021:3460017; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2002, INSECT MOL BIOL, V11, P409, DOI 10.1046/j.1365-2583.2002.00350.x	13	239	266	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					96	97		10.1126/science.1078052	http://dx.doi.org/10.1126/science.1078052			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364782				2022-12-24	WOS:000178370500039
J	Serwold, T; Gonzalez, F; Kim, J; Jacob, R; Shastri, N				Serwold, T; Gonzalez, F; Kim, J; Jacob, R; Shastri, N			ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum	NATURE			English	Article							CELLS; AMINOPEPTIDASE; PROTEASOME; GENERATION; RESPONSES; CLEAVAGE; COMPLEX; MOTIFS; MICE; ER	The ability of killer T cells carrying the CD8 antigen to detect tumours or intracellular pathogens requires an extensive display of antigenic peptides by major histocompatibility complex (MHC) class I molecules on the surface of potential target cells(1). These peptides are derived from almost all intracellular proteins and reveal the presence of foreign pathogens and mutations. How cells produce thousands of distinct peptides cleaved to the precise lengths required for binding different MHC class I molecules remains unknown(2,3). The peptides are cleaved from endogenously synthesized proteins by the proteasome in the cytoplasm(4,5) and then trimmed by an unknown aminopeptidase in the endoplasmic reticulum (ER)(6-8). Here we identify ERAAP, the aminopeptidase associated with antigen processing in the ER. ERAAP has a broad substrate specificity, and its expression is strongly upregulated by interferon-gamma. Reducing the expression of ERAAP through RNA interference prevents the trimming of peptides for MHC class I molecules in the ER and greatly reduces the expression of MHC class I molecules on the cell surface. Thus, ERAAP is the missing link between the products of cytosolic processing and the final peptides presented by MHC class I molecules on the cell surface.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.			Jacob, Richard/0000-0003-0910-5282				ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; HELEN I, 2001, PROTEOMICS, V2, P36; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Medzihradszky KF, 2000, ANAL CHEM, V72, P552, DOI 10.1021/ac990809y; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1	26	466	472	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					480	483		10.1038/nature01074	http://dx.doi.org/10.1038/nature01074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368856				2022-12-24	WOS:000178348400037
J	Zignego, AL; Ferri, C; Giannelli, F; Giannini, C; Caini, P; Monti, M; Marrocchi, ME; Di Pietro, E; La Villa, G; Laffi, G; Gentilini, P				Zignego, AL; Ferri, C; Giannelli, F; Giannini, C; Caini, P; Monti, M; Marrocchi, ME; Di Pietro, E; La Villa, G; Laffi, G; Gentilini, P			Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas	ANNALS OF INTERNAL MEDICINE			English	Article							NON-HODGKINS-LYMPHOMA; IMMUNOGLOBULIN GENE REARRANGEMENT; POLYMERASE-CHAIN-REACTION; GRADE MALIGNANT-LYMPHOMA; FOLLICULAR LYMPHOMA; CHROMOSOMAL TRANSLOCATION; T(14-18) TRANSLOCATION; HELICOBACTER-PYLORI; INFECTION; BLOOD	Background: Hepatitis C virus (HCV) infection is strictly associated with mixed cryoglobulinemia, a benign B-cell lymphoproliferative disorder that may evolve to lymphoma. An increased prevalence of bcl-2 rearrangement (the t(14;18) translocation) has been shown in patients infected with HCV. Objective: To evaluate the prevalence of bcl-2 rearrangement in patients with HCV-related mixed cryoglobulinemia and patients with chronic hepatitis but no cryoglobulinemia. Design: Prospective study. Setting: Two university hospitals. Patients: 37 consecutively recruited patients with HCV-related mixed cryoglobulinemia and 101 patients with chronic HCV infection but without mixed cryoglobulinemia. Measurements: Clinical and serologic characteristics; liver biopsy; bcl-2 rearrangement, Bcl-2 expression, and the ratio of Bcl-2 to Bax in total peripheral blood mononuclear cells and cell subgroups; and sequence analysis of the junction of bcl-2 and IgH joining segments in positive samples. Results: Rearrangement of bcl-2 was observed in 28 of 37 (75.7%) patients with mixed cryoglobulinemia (65% of those with type III disease and 85% of those with type 11 disease, including 3 of 4 patients with lymphoma) and in 38 of 101 (37.6%) patients with chronic HCV infection but not mixed cryoglobulinemia (P < 0.001). Overexpression of Bcl-2 protein and a high ratio of Bcl-2 to Bax were observed in samples from patients with bcl-2 rearrangement. In 2 patients followed over time, peripheral blood cells bearing the t(14;18) translocation disappeared after antiviral therapy. Conclusions: Rearrangement of bcl-2 was found with increased frequency in patients with chronic HCV infection and mixed cryoglobulinemia. The frequency was greatest in patients with type 11 mixed cryoglobulinemia. The high ratio of Bcl-2 to Bax in patients with bcl-2 rearrangement and disappearance of the rearrangement with antiviral therapy suggest that the translocation is associated with the antiapoptotic function of Bcl-2 and that HCV infection is linked to inhibition of B-cell apoptosis.	Univ Florence, Sch Med, Dept Internal Med, I-50134 Florence, Italy; Univ Pisa, Sch Med, I-56100 Pisa, Italy	University of Florence; University of Pisa	Zignego, AL (corresponding author), Univ Florence, Sch Med, Dept Internal Med, Viale Morgagni,85, I-50134 Florence, Italy.	a.zignego@dmi.unifi.it	Zignego, Anna Linda/AAL-8205-2021	Laffi, Giacomo/0000-0001-6916-1134				ABEL G, 1993, ARTHRITIS RHEUM, V36, P1341, DOI 10.1002/art.1780361003; Aiello A, 1999, BLOOD, V94, P2247, DOI 10.1182/blood.V94.7.2247.419k12_2247_2251; Andreone P, 1998, ANN INTERN MED, V129, P294, DOI 10.7326/0003-4819-129-4-199808150-00005; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Carlson SJ, 1996, JAMA-J AM MED ASSOC, V275, P937; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Cory S, 1999, CANCER RES, V59, p1685S; Dolken G, 1996, J CLIN ONCOL, V14, P1333; Ferri C, 2000, INFEC DIS S, P349; FRANZIN F, 1995, BRIT J HAEMATOL, V90, P548, DOI 10.1111/j.1365-2141.1995.tb05582.x; Fuscoe JC, 1996, CARCINOGENESIS, V17, P1013, DOI 10.1093/carcin/17.5.1013; Giannini C, 1999, J LAB CLIN MED, V134, P68, DOI 10.1016/S0022-2143(99)90055-0; GOREVIC PD, 1991, SEMIN HEMATOL, V28, P79; HARRIS NL, 1994, BLOOD, V84, P1361; Ivanovski M, 1998, BLOOD, V91, P2433, DOI 10.1182/blood.V91.7.2433.2433_2433_2442; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Johnson PWM, 1999, ANN ONCOL, V10, P1349, DOI 10.1023/A:1008385924543; Kitay-Cohen Y, 2000, BLOOD, V96, P2910; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; KORSMEYER SJ, 1992, BLOOD, V80, P879; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; LIMPENS J, 1991, ONCOGENE, V6, P2271; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; Lopez-Guillermo A, 1999, BLOOD, V93, P3081, DOI 10.1182/blood.V93.9.3081; Magalini AR, 1998, J PATHOL, V185, P86; Mazzaro C, 1996, CANCER, V77, P2604, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MEIJERINK JPP, 1995, BRIT J HAEMATOL, V91, P630, DOI 10.1111/j.1365-2141.1995.tb05359.x; Monteverde A, 1997, SPRINGER SEMIN IMMUN, V19, P99, DOI 10.1007/BF00945028; MONTEVERDE A, 1988, ACTA HAEMATOL-BASEL, V79, P20, DOI 10.1159/000205684; Monteverde A, 1995, CLIN EXP RHEUMATOL, V13, pS141; MONTI G, 1995, QJM-MON J ASSOC PHYS, V88, P115; MUSSET L, 1992, CLIN CHEM, V38, P798; NGAN BY, 1989, BLOOD, V73, P1759; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Otter I, 1998, J BIOL CHEM, V273, P6110, DOI 10.1074/jbc.273.11.6110; Poetsch M, 1996, J CLIN ONCOL, V14, P963, DOI 10.1200/JCO.1996.14.3.963; Rasul I, 1999, HEPATOLOGY, V29, P543, DOI 10.1002/hep.510290224; RIVAS C, 1992, LEUKEMIA LYMPHOMA, V8, P87, DOI 10.3109/10428199209049822; ROBLEDO M, 1991, Sangre (Saragossa), V36, P295; Silvestri F, 1998, ANN ONCOL, V9, P499, DOI 10.1023/A:1008265804550; STOLTE M, 1992, LANCET, V339, P745, DOI 10.1016/0140-6736(92)90645-J; TISSOT JD, 1994, J IMMUNOL METHODS, V173, P63, DOI 10.1016/0022-1759(94)90284-4; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; WINFIELD JB, 1983, HUM PATHOL, V14, P350, DOI 10.1016/S0046-8177(83)80121-X; Zignego AL, 1999, J HEPATOL, V31, P369, DOI 10.1016/S0168-8278(99)80239-6; Zignego AL, 1996, ANN INTERN MED, V124, P31, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00006; ZIGNEGO AL, 1992, J HEPATOL, V15, P382, DOI 10.1016/0168-8278(92)90073-X; Zignego AL, 1997, CLIN EXP RHEUMATOL, V15, P711; Zignego AL, 2000, HEPATOLOGY, V31, P474, DOI 10.1002/hep.510310230; Zuckerman E, 2001, BLOOD, V97, P1555, DOI 10.1182/blood.V97.6.1555; Zuckerman E, 2001, BRIT J HAEMATOL, V112, P364, DOI 10.1046/j.1365-2141.2001.02573.x	55	152	163	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2002	137	7					571	580		10.7326/0003-4819-137-7-200210010-00008	http://dx.doi.org/10.7326/0003-4819-137-7-200210010-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599VD	12353944				2022-12-24	WOS:000178355100003
J	Santos-Rosa, H; Schneider, R; Bannister, AJ; Sherriff, J; Bernstein, BE; Emre, NCT; Schreiber, SL; Mellor, J; Kouzarides, T				Santos-Rosa, H; Schneider, R; Bannister, AJ; Sherriff, J; Bernstein, BE; Emre, NCT; Schreiber, SL; Mellor, J; Kouzarides, T			Active genes are tri-methylated at K4 of histone H3	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; LYSINE 9; SET1; EXPRESSION; CHROMATIN; INCLUDES; HOMOLOG; COMPLEX	Lysine methylation of histones in vivo occurs in three states: mono-, di- and tri-methyl(1). Histone H3 has been found to be dimethylated at lysine 4 (K4) in active euchromatic regions but not in silent heterochromatic sites(2). Here we show that the Saccharomyces cerevisiae Set1 protein can catalyse di- and tri- methylation of K4 and stimulate the activity of many genes. Using antibodies that discriminate between the di- and tri- methylated state of K4 we show that di- methylation occurs at both inactive and active euchromatic genes, whereas tri- methylation is present exclusively at active genes. It is therefore the presence of a trimethylated K4 that defines an active state of gene expression. These findings establish the concept of methyl status as a determinant for gene activity and thus extend considerably the complexity of histone modifications.	Wellcome Trust Canc Res UK Inst, Cambridge CG2 1QR, England; Dept Pathol, Cambridge CG2 1QR, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Wilstar Inst, Philadelphia, PA 19104 USA	University of Oxford; Harvard University	Kouzarides, T (corresponding author), Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CG2 1QR, England.	tk106@mole.bio.cam.ac.uk	Emre, Tolga/A-1787-2016	Emre, Tolga/0000-0001-8021-5228; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Carroll AS, 2001, P NATL ACAD SCI USA, V98, P12578, DOI 10.1073/pnas.211195798; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967	20	1532	1586	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2002	419	6905					407	411		10.1038/nature01080	http://dx.doi.org/10.1038/nature01080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353038				2022-12-24	WOS:000178195400049
J	Warren, HS; Suffredini, AF; Eichacker, PQ; Munford, RS				Warren, HS; Suffredini, AF; Eichacker, PQ; Munford, RS			Risks and benefits of activated protein C treatment for severe sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							APACHE-II; VARIABILITY		Massachusetts Gen Hosp, Boston, MA 02114 USA; NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Warren, HS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018188, R56AI018188, R37AI018188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059694] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18188] Funding Source: Medline; NIGMS NIH HHS [R01-GM59694-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*ANT ADV COMM, 2002, FDA BRIEF DOC DROTR; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; *FDA DOCK MAN BRAN, 2001, CDER 2001 M DOC ROCK; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Natanson C, 1998, CRIT CARE MED, V26, P1927, DOI 10.1097/00003246-199812000-00001; Polderman KH, 2001, INTENS CARE MED, V27, P1550, DOI 10.1007/s001340101033; Polderman KH, 2001, INTENS CARE MED, V27, P1365, DOI 10.1007/s001340101012; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; 2002, CBER BIOL LICENSE AP; 2001, CHIRON ANNOUNCES RES	14	179	186	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2002	347	13					1027	1030		10.1056/NEJMsb020574	http://dx.doi.org/10.1056/NEJMsb020574			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596RD	12324562				2022-12-24	WOS:000178178400012
J	Lyketsos, CG; Lopez, O; Jones, B; Fitzpatrick, AL; Breitner, J; DeKosky, S				Lyketsos, CG; Lopez, O; Jones, B; Fitzpatrick, AL; Breitner, J; DeKosky, S			Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment - Results from the Cardiovascular Health Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; ALZHEIMERS-DISEASE; DOUBLE-BLIND; PSYCHIATRIC PHENOMENA; BEHAVIORAL DISTURBANCES; DEPRESSED-PATIENTS; AGGRESSION; DISORDERS; PSYCHOSIS; CARE	Context Mild cognitive impairment (MCI) may be a precursor to dementia, at least in some cases. Dementia and MCI are associated with neuropsychiatric symptoms in clinical samples. Only 2 population-based studies exist of the prevalence of these symptoms in dementia, and none exist for MCI. Objective To estimate the prevalence of neuropsychiatric symptoms in dementia and MCI in a population-based study. Design Cross-sectional study derived from the Cardiovascular Health Study, a longitudinal cohort study. Setting and Participants A total of 3608 participants were cognitively evaluated using data collected longitudinally over 10 years and additional data collected in 19992000 in 4 US counties. Dementia and MCI were classified using clinical criteria and adjudicated by committee review by expert neurologists and psychiatrists. A total of 824 individuals completed the Neuropsychiatric Inventory (NPI); 362 were classified as having dementia, 320 as having MCI; and 142 did not meet criteria for MCI or dementia. Main Outcome Measure Prevalence of neuropsychiatric symptoms, based on ratings on the NPI in the previous month and from the onset of cognitive symptoms. Results Of the 682 individuals with dementia or MCI, 43% of MCI participants (n = 138) exhibited neuropsychiatric symptoms in the previous month (29% rated as clinically significant) with depression (20%), apathy (15%), and irritability (15%) being most common. Among the dementia participants, 75% (n=270) had exhibited a neuropsychiatric symptom in the past month (62% were clinically significant); 55% (n=199) reported 2 or more and 44% (n=159) 3 or more disturbances in the past month. In participants with dementia, the most frequent disturbances were apathy (36%), depression (32%), and agitation/aggression (30%). Eighty percent of dementia participants (n=233) and 50% of MCI participants (n=139) exhibited at least 1 NPI symptom from the onset of cognitive symptoms. There were no differences in prevalence of neuropsychiatric symptoms between participants with Alzheimer-type dementia and those with other dementias, with the exception of aberrant motor behavior, which was more frequent in Alzheimer-type dementia (5.4% vs 1 %; P=.02). Conclusions Neuropsychiatric symptoms occur in the majority of persons with dementia over the course of the disease. These are the first population-based estimates for neuropsychiatric symptoms in MCI, indicating a high prevalence associated with this condition as well. These symptoms have serious adverse consequences and should be inquired about and treated as necessary. Study of neuropsychiatric symptoms in the context of dementia may improve our understanding of brain-behavior relationships.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Psychiat, Winston Salem, NC USA; Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; Dept Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest Baptist Medical Center; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle	Lyketsos, CG (corresponding author), Johns Hopkins Univ Hosp, Osler 320,600 N Wolfe St, Baltimore, MD 21287 USA.			DeKosky, Steven/0000-0003-3743-2758	NHLBI NIH HHS [N01-HC-85086, N01-HC-85079, N01-HC-35129, N01-HC-15103] Funding Source: Medline; NIA NIH HHS [R01-AG11380, 5 R01 AG15928-02] Funding Source: Medline; NIMH NIH HHS [R01-MH56511] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085079, N01HC085086, N01HC035129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011380, R01AG015928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; BRYANT J, 2001, HEALTH TECHNOL ASSES, V5, P1; BURNS A, 1990, BRIT J PSYCHIAT, V157, P81, DOI 10.1192/bjp.157.1.81; BURNS A, 1990, BRIT J PSYCHIAT, V157, P72, DOI 10.1192/bjp.157.1.72; BURNS A, 1990, BRIT J PSYCHIAT, V157, P86, DOI 10.1192/bjp.157.1.86; BURNS A, 1990, BRIT J PSYCHIAT, V157, P76, DOI 10.1192/bjp.157.1.76; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; Devanand DP, 1998, AM J PSYCHIAT, V155, P1512, DOI 10.1176/ajp.155.11.1512; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; FORSTL H, 1992, PSYCHOL MED, V22, P877, DOI 10.1017/S0033291700038459; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gonzalez-Salvador MT, 1999, INT J GERIATR PSYCH, V14, P701, DOI 10.1002/(SICI)1099-1166(199909)14:9<701::AID-GPS5>3.0.CO;2-#; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Grutzendler J, 2001, DRUGS, V61, P41, DOI 10.2165/00003495-200161010-00005; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jeste DV, 2000, AM J GERIAT PSYCHIAT, V8, P29, DOI 10.1097/00019442-200002000-00004; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Klein DA, 1999, INT J GERIATR PSYCH, V14, P272, DOI 10.1002/(SICI)1099-1166(199904)14:4<272::AID-GPS896>3.0.CO;2-P; LOPEZ OL, IN PRESS NEUROEPIDEM; LOPEZ OL, IN PRESS NEUROLOGY; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lyketsos CG, 1997, J NEUROPSYCH CLIN N, V9, P556; LYKETSOS CG, 1995, J NEUROPSYCH CLIN N, V7, P350; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1037, DOI 10.1002/gps.440; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P1686, DOI 10.1176/appi.ajp.157.10.1686; LYKETSOS CG, 2000, BEHAV MEASURES COGNI, P393; LYKETSOS CG, 1999, REICHELS CARE ELDERL, P214; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; NYTH AL, 1992, ACTA PSYCHIAT SCAND, V86, P138, DOI 10.1111/j.1600-0447.1992.tb03242.x; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petracca G, 1996, J NEUROPSYCH CLIN N, V8, P270; Porsteinsson AP, 2001, AM J GERIAT PSYCHIAT, V9, P58, DOI 10.1176/appi.ajgp.9.1.58; PROCTER AW, 1992, NEUROCHEM RES, V17, P917, DOI 10.1007/BF00993268; Rabins P, 1997, AM J PSYCHIAT, V154, P1; RABINS PV, 1999, PRACTICAL DEMENTIA C; Roth M., 1996, British Journal of Psychiatry, V168, P149, DOI 10.1192/bjp.168.2.149; Schneider LS, 2001, AM J GERIAT PSYCHIAT, V9, P346, DOI 10.1176/appi.ajgp.9.4.346; Shankle WR, 1995, ALZ DIS ASSOC DIS, V9, P233, DOI 10.1097/00002093-199509040-00010; STARKSTEIN SE, 1994, NEUROLOGY, V44, P2055, DOI 10.1212/WNL.44.11.2055; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Sweet RA, 1998, ARCH NEUROL-CHICAGO, V55, P1335, DOI 10.1001/archneur.55.10.1335; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; TERI L, 1997, J GERONTOL B-PSYCHOL, V52, P159, DOI DOI 10.1093/GER0NB/52B.4.P159; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Victoroff J, 1996, ARCH NEUROL-CHICAGO, V53, P428, DOI 10.1001/archneur.1996.00550050058024; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; ZUBENKO GS, 1990, ARCH NEUROL-CHICAGO, V47, P209, DOI 10.1001/archneur.1990.00530020117023; ZWEIG RM, 1988, ANN NEUROL, V24, P233, DOI 10.1002/ana.410240210	61	1337	1390	2	78	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2002	288	12					1475	1483		10.1001/jama.288.12.1475	http://dx.doi.org/10.1001/jama.288.12.1475			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	596AT	12243634	Bronze			2022-12-24	WOS:000178142000018
J	Laxminarayana, D; Khan, IU; Kammer, GM				Laxminarayana, D; Khan, IU; Kammer, GM			Transcript mutations of the a regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes	LANCET			English	Article							RI-ALPHA; ADENOSINE DEAMINASES; SIGNAL-TRANSDUCTION; MESSENGER-RNA; ACT; SELECTION	Background Systemic lupus erythematosus (SLE) is an autoimmune disorder characterised by diverse dysfunctions of immune effector cells, including proliferation and cytotoxicity. In T cells from patients with SLE, activity of type 1 protein kinase A isozymes is greatly reduced because of decreased expression of the alpha and beta regulatory subunits (RIalpha and RIP). We aimed to identify a molecular mechanism or mechanisms for this isozyme deficiency by assessing occurrence of mutations in transcripts of the RIalpha Subunit in patients with SLE. Methods We cloned and sequenced cIDNA of RIalpha and corresponding genomic DNA of the coding region to detect sequence changes from eight patients with SLE and six healthy controls. Because transcript editing is regulated by adenosine deaminases that act on RNA (ADAR), we quantified expression of ADAR1 transcripts in SLE and control T cells by competitive PCR. Findings Sequence analyses of cDNA showed heterogeneous transcript mutations, including deletions, transitions, and transversions. We identified 1.22X10(-3)/bp transcript mutations in SLE T cells-a frequency 7.5 times higher than that in control T cells. By contrast, we identified no genomic mutations. Two hotspots were identified in the RIalpha subunit transcripts from SLE T cells, one located adjacent to a pseudosubstrate site of the RIalpha subunit and the other a component of the cAMP binding A domain. ADAR1 mRNA content was 3.5 times higher in SLE cells than in control T cells (p=0.001). Interpretation An RNA-editing enzyme could be converting adenosine to inosine within double-stranded regions of RNA, resulting in transcript mutations. This process could be one mechanism resulting in mutations in the RIalpha subunit of type 1 protein kinase A.	Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Rheumatol & Clin Immunol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Laxminarayana, D (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Rheumatol & Clin Immunol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	diaxmina@wfubmc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR046385, R01AR039501] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR07122] Funding Source: Medline; NIAID NIH HHS [R01-AI46526] Funding Source: Medline; NIAMS NIH HHS [R01-AR39501, R03-AR46385] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Davidson NO, 2002, J CLIN INVEST, V109, P291, DOI 10.1172/JCI14979; GMELIGMEYLING F, 1992, J EXP MED, V175, P297, DOI 10.1084/jem.175.1.297; HASLER P, 1990, P NATL ACAD SCI USA, V87, P1978, DOI 10.1073/pnas.87.5.1978; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Jacob AM, 2001, AUTOIMMUNITY, V33, P61, DOI 10.3109/08916930108994110; Kammer Gary M, 2002, Curr Dir Autoimmun, V5, P131; Kammer GM, 1999, ARTHRITIS RHEUM, V42, P1458, DOI 10.1002/1529-0131(199907)42:7<1458::AID-ANR20>3.0.CO;2-P; Kammer GM, 1996, J IMMUNOL, V157, P2690; Kammer GM, 2002, ARTHRITIS RHEUM-US, V46, P1139, DOI 10.1002/art.10192; KAMMER GM, 1994, J CLIN INVEST, V94, P422, DOI 10.1172/JCI117340; KHAN IU, 1999, LUPUS MOL CELLULAR P, P257; Laxminarayana D, 1999, J IMMUNOL, V162, P5639; Laxminarayana D, 2000, INT IMMUNOL, V12, P1521, DOI 10.1093/intimm/12.11.1521; Lee JS, 2000, J IMMUNOL, V165, P6322, DOI 10.4049/jimmunol.165.11.6322; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.3.CO;2-S; MANDLER R, 1982, P NATL ACAD SCI-BIOL, V79, P7542, DOI 10.1073/pnas.79.23.7542; Mishra N, 2000, J IMMUNOL, V165, P2830, DOI 10.4049/jimmunol.165.5.2830; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Nambiar MP, 2001, J AUTOIMMUN, V16, P133, DOI 10.1006/jaut.2000.0475; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; SOLBERG R, 1993, GENOMICS, V15, P591, DOI 10.1006/geno.1993.1112; Solberg R, 1997, ENDOCRINOLOGY, V138, P169, DOI 10.1210/en.138.1.169; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Leeuwen FW, 1998, TRENDS NEUROSCI, V21, P331, DOI 10.1016/S0166-2236(98)01280-6; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	30	35	35	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2002	360	9336					842	849		10.1016/S0140-6736(02)09966-X	http://dx.doi.org/10.1016/S0140-6736(02)09966-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594MC	12243919				2022-12-24	WOS:000178053500010
J	Masuda, S; Bauer, CE				Masuda, S; Bauer, CE			AppA is a blue light photoreceptor that antirepresses photosynthesis gene expression in Rhodobacter sphaeroides	CELL			English	Article							DISULFIDE BOND FORMATION; PHOTOSYSTEM FORMATION; REDOX; BACTERIOCHLOROPHYLL; FLAVOPROTEIN; REPRESSOR; PPSR; CRTJ; CRYPTOCHROME; THIOREDOXIN	Photosynthetic bacteria regulate photosystem synthesis in response to alterations in oxygen tension and light intensity. In this study we show that the PpsR repressor from Rhodobacter sphaeroides binds to DNA in a redox-dependent manner through the formation/breakage of an intramolecular disulfide bond. We also demonstrate that PpsR is antagonized by the flavin-containing antirepressor, AppA, that is capable of breaking the disulfide bond in oxidized PpsR as well as forming a stable AppA-PpsR(2) antirepressor-repressor complex. Blue light excitation of AppA induces a photocycle that is characterized by a long-lived red-shifted absorbance of the flavin. Light-excited AppA was found to be incapable of forming the AppA-PpsR(2) antirepressor complex. These results establish AppA as a transcription factor that controls both redox and blue light repression of photosystem gene expression by mediating DNA binding activity of PpsR.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Bauer, CE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cbauer@bio.indiana.edu	Masuda, Shinji/A-2703-2014	Masuda, Shinji/0000-0002-5349-4927	NIGMS NIH HHS [R01 GM040941, R37 GM040941, GM53940] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040941, R37GM040941, R01GM053940] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Aslund F, 1999, J BACTERIOL, V181, P1375; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bauer CE, 2001, ADV PHOTOSYNTH, V11, P67; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Debarbieux L, 1999, CELL, V99, P117, DOI 10.1016/S0092-8674(00)81642-6; Elsen S, 1998, J BIOL CHEM, V273, P30762, DOI 10.1074/jbc.273.46.30762; GOMELSKY M, 1995, J BACTERIOL, V177, P4609, DOI 10.1128/jb.177.16.4609-4618.1995; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; GOMELSKY M, 1995, J BACTERIOL, V177, P1634, DOI 10.1128/jb.177.6.1634-1637.1995; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; Gregor J, 1999, FEMS MICROBIOL LETT, V179, P1; Hitomi K, 2000, NUCLEIC ACIDS RES, V28, P2353, DOI 10.1093/nar/28.12.2353; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Jiang ZY, 1997, J BACTERIOL, V179, P5720, DOI 10.1128/jb.179.18.5720-5727.1997; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Link G, 2001, ADV PHOTOSYNTH, V11, P85; Malakhov M, 2001, ADV PHOTOSYNTH, V11, P51; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; Pellett JD, 2001, BIOCHEMISTRY-US, V40, P7720, DOI 10.1021/bi010206s; PENFOLD RJ, 1994, J BACTERIOL, V176, P2869, DOI 10.1128/JB.176.10.2869-2876.1994; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; PONNAMPALAM SN, 1995, J BACTERIOL, V177, P2990, DOI 10.1128/jb.177.11.2990-2997.1995; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Ponnampalam SN, 1998, J BIOL CHEM, V273, P30757, DOI 10.1074/jbc.273.46.30757; SHIMADA H, 1992, PLANT CELL PHYSIOL, V33, P471; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Swem DL, 2002, J BACTERIOL, V184, P2815, DOI 10.1128/JB.184.10.2815-2820.2002; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WEAVER KE, 1983, J BACTERIOL, V156, P507, DOI 10.1128/JB.156.2.507-515.1983; Zeilstra-Ryalls J, 1998, J BACTERIOL, V180, P2801, DOI 10.1128/JB.180.11.2801-2809.1998	37	334	345	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					613	623		10.1016/S0092-8674(02)00876-0	http://dx.doi.org/10.1016/S0092-8674(02)00876-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230978	Bronze			2022-12-24	WOS:000177943700008
J	Ronkainen, J; Nuutinen, M; Koskimies, O				Ronkainen, J; Nuutinen, M; Koskimies, O			The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study	LANCET			English	Article							LONG-TERM PROGNOSIS; NEPHRITIS; CHILDREN; HYPERTENSION; MANAGEMENT; POPULATION	Background Henoch-Schonlein purpura arising in childhood could cause renal impairment or even an end-stage renal disease later in life. We aimed to assess long-term outcome of childhood Henoch-Schonlein purpura after 24 years. Methods We studied a cohort of 26 boys and 26 girls who were treated for Henoch-Schonlein purpura at Helsinki University Hospital during 1964-83. Mean follow-up was 24.1 years (SD 6.0; 16.4-36.5). All participants were asked about their state of health in a questionnaire, and 47 (90%) were examined by a doctor. Patients' medical history data were obtained from health-care centres and regional hospitals. Findings Seven (35%) of 20 adults who had severe Henoch-Schonlein purpura and glomerulonephritis at onset had renal impairment as adults, compared with two (7%) of 27 with mild or no renal symptoms at onset (relative risk 4.7, 95% Cl 1.3-18.7). Relative risk for a poor outcome was 5.0 in women (1.1-32.5) and 2.0 in men (0.2-17.5). All patients with no renal symptoms at onset had a good outcome after 24 years of follow-up. Severity of first kidney biopsy finding did not correlate with risk of a poor outcome. 16 (70%) of 23 pregnancies had been complicated by hypertension, proteinuria, or both. Five (56%) of the nine women with complicated pregnancies had a poor renal outcome. Interpretation Long-term follow-up of all patients who had Henoch-Schonlein purpura with severe renal symptoms at onset is needed during adulthood. All women who had even mild renal symptoms at onset of Henoch-Schonlein purpura should be carefully observed during and after pregnancy.	Oulu Univ Hosp, Dept Paediat & Adolescence, FIN-90029 Oulu, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	University of Oulu; University of Helsinki	Nuutinen, M (corresponding author), Oulu Univ Hosp, Dept Paediat & Adolescence, POB 23, FIN-90029 Oulu, Finland.							Balmelli C, 1996, SCHWEIZ MED WSCHR, V126, P293; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277; COUNAHAN R, 1977, BRIT MED J, V2, P11, DOI 10.1136/bmj.2.6078.11; GOLDSTEIN AR, 1992, LANCET, V339, P280, DOI 10.1016/0140-6736(92)91341-5; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Kaku Y, 1998, KIDNEY INT, V53, P1755, DOI 10.1046/j.1523-1755.1998.00915.x; KOSKIMIES O, 1981, ARCH DIS CHILD, V56, P482, DOI 10.1136/adc.56.6.482; Magee LA, 1999, BMJ-BRIT MED J, V318, P1332, DOI 10.1136/bmj.318.7194.1332; Niaudet P, 1993, Adv Nephrol Necker Hosp, V22, P121; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Scharer K, 1999, PEDIATR NEPHROL, V13, P816, DOI 10.1007/s004670050707; STEWART M, 1988, EUR J PEDIATR, V147, P113, DOI 10.1007/BF00442205; Szer Ilona S., 1994, Current Opinion in Rheumatology, V6, P25, DOI 10.1097/00002281-199401000-00005; Tizard EJ, 1999, ARCH DIS CHILD, V80, P380, DOI 10.1136/adc.80.4.380; WHITE RHR, 1994, NEPHRON, V68, P1, DOI 10.1159/000188216	17	175	192	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 31	2002	360	9334					666	670		10.1016/S0140-6736(02)09835-5	http://dx.doi.org/10.1016/S0140-6736(02)09835-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241872				2022-12-24	WOS:000177795100007
J	Watson, A; Al Ozairi, O; Fraser, A; Loudon, M; O'Kelly, T				Watson, A; Al Ozairi, O; Fraser, A; Loudon, M; O'Kelly, T			Nicorandil associated anal ulceration	LANCET			English	Article							MAJOR APHTHOUS ULCERS	Nicorandil is a vasodilator used to control angina. It has been associated with oral ulceration and stomatitis that resolves upon withdrawal of the drug. We report a series of five patients with non-specific anal ulceration, all of whom received nicorandil for symptomatic control of ischaemic heart disease. Histological appearances were similar and the ulcers healed on withdrawal of the drug. Our results suggest that nicorandil might be a cause of anal ulceration.	Aberdeen Royal Infirm, Dept Gastroenterol, Aberdeen AB25 2ZD, Scotland; Aberdeen Royal Infirm, Dept Surg, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Watson, A (corresponding author), Aberdeen Royal Infirm, Dept Gastroenterol, Aberdeen AB25 2ZD, Scotland.							Agbo-Godeau S, 1998, LANCET, V352, P1598, DOI 10.1016/S0140-6736(05)61045-8; Gupta A, 2000, AGE AGEING, V29, P372, DOI 10.1093/ageing/29.4.372; Reichert S, 1997, EUR J DERMATOL, V7, P132	3	69	71	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					546	547		10.1016/S0140-6736(02)09710-6	http://dx.doi.org/10.1016/S0140-6736(02)09710-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241662				2022-12-24	WOS:000177512800016
J	Morahan, G; Huang, DX; Wu, M; Holt, BJ; White, GP; Kendall, GE; Sly, PD; Holt, PG				Morahan, G; Huang, DX; Wu, M; Holt, BJ; White, GP; Kendall, GE; Sly, PD; Holt, PG			Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children	LANCET			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INDUCED AIRWAY HYPERRESPONSIVENESS; BLOOD MONONUCLEAR-CELLS; INTERFERON-GAMMA; EARLY-LIFE; INTERLEUKIN-12; INFECTIONS; IL-12; RISK; GENE	Background Severe asthma is a frequent cause of hospital admission, especially among children. The main environmental triggers of airway inflammation in asthma are viruses and aeroallergens. These agents elicit reciprocal immune responses, characterised by production of T helper 1 and T helper 2 cytokines, respectively. There is no genetic explanation for how hyper-responsiveness to these disparate environmental stimuli develops among individuals with asthma. Our aim was to assess relation between an IL12B promoter polymorphism and asthma. Methods We did a cohort study in which we initially genotyped 411 6-year olds for the IL12B promoter polymorphism. We then assessed the relation between this polymorphism and asthma severity: A further 85 asthmatic children in an additional sample of 433 children from the same cohort were then assessed to confirm these findings. We also examined in-vitro interleukin-12 responses in a subgroup of individuals. Findings Heterozygosity for the IL12B promoter polymorphism was observed in 76% (16) of atopic and non-atopic individuals with severe asthma in the initial sample. By comparison, heterozygotes comprised only 31% (17) of the moderate asthma group, and 48% (20) of individuals with mild asthma were heterozygous, as were unaffected controls. These findings were confirmed in the second sample (overall p < 0.0001). Our data suggest that IL12B promoter heterozygosity contributes to asthma severity rather than susceptibility per se. The severity-predisposing genotype was associated with reduced interleukin 12 p40 gene transcription and decreased interleukin 12 p70 secretion. Interpretation Interleukin 12 plays a key part in antagonism of T helper 2 differentiation, and in induction of antiviral host defense. Genetically determined attenuation of interleukin-12 response capacity would, therefore, provide a plausible common immunological pathway to disease severity for the two major forms of asthma.	Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6872, Australia; Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6872, Australia; PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Holt, PG (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, POB 855, Perth, WA 6872, Australia.	patrick@ichr.uwa.edu.au	Holt, Patrick G/H-1548-2011; Sly, Peter D/F-1486-2010; Study, Raine/K-4517-2013; Morahan, Grant/T-7501-2019; White, Gregory P/C-8932-2012	Holt, Patrick G/0000-0003-1193-0935; Sly, Peter D/0000-0001-6305-2201; White, Gregory P/0000-0001-9532-0856				Aberle JH, 1999, AM J RESP CRIT CARE, V160, P1263, DOI 10.1164/ajrccm.160.4.9812025; Anderson GG, 1999, MOL MED TODAY, V5, P264, DOI 10.1016/S1357-4310(99)01479-3; BURKE CM, 1995, ALLERGY IMMUNOL LIFE, V14, P75; Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; Davoodi-Semiromi A, 2002, DIABETES, V51, P2334, DOI 10.2337/diabetes.51.7.2334; Ehlenfield DR, 2000, PEDIATRICS, V105, P79, DOI 10.1542/peds.105.1.79; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Gaga M, 2000, CLIN EXP ALLERGY, V30, P663; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Gonzalez J, 1999, CHASQUI, V28, P175, DOI 10.2307/29741560; Haby MM, 2001, THORAX, V56, P589, DOI 10.1136/thorax.56.8.589; HENRY RL, 1993, J PAEDIATR CHILD H, V29, P101; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; HOTL PG, 2002, EUROP RESP J, V19, P1; Huang D, 2000, GENES IMMUN, V1, P515, DOI 10.1038/sj.gene.6363720; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; ISLES AF, 1993, MED J AUSTRALIA, V158, P761, DOI 10.5694/j.1326-5377.1993.tb121958.x; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Joyner JL, 2000, J INFECT DIS, V182, P974, DOI 10.1086/315796; Keane-Myers A, 1998, J IMMUNOL, V161, P919; Lee SM, 1996, BLOOD, V88, P945; Leech SC, 2000, ALLERGY, V55, P74, DOI 10.1034/j.1398-9995.2000.00222.x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Noguchi E, 2001, GENES IMMUN, V2, P401, DOI 10.1038/sj.gene.6363790; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Renzi PM, 1999, AM J RESP CRIT CARE, V159, P1417, DOI 10.1164/ajrccm.159.5.9805080; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; TRINCHIERI G, 1994, IMMUNOL TODAY, V15, P460, DOI 10.1016/0167-5699(94)90189-9; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; von Mutius E, 2001, THORAX, V56, P153, DOI 10.1136/thorax.56.2.153; Weir TD, 1998, AM J RESP CRIT CARE, V158, P787, DOI 10.1164/ajrccm.158.3.9801035; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201	39	162	164	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					455	459		10.1016/S0140-6736(02)09676-9	http://dx.doi.org/10.1016/S0140-6736(02)09676-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241719				2022-12-24	WOS:000177342900013
J	Atkinson, L; Milligan, CJ; Buckley, NJ; Deuchars, J				Atkinson, L; Milligan, CJ; Buckley, NJ; Deuchars, J			Purinergic receptors - An ATP-gated ion channel at the cell nucleus	NATURE			English	Article							P2X(7) RECEPTOR; PERMEABILITY; INTERNEURONS; HIPPOCAMPUS		Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England; Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Atkinson, L (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England.		Buckley, Noel J/B-9675-2012; Deuchars, Jim/L-3740-2019	Buckley, Noel J/0000-0003-1152-0653; Deuchars, Jim/0000-0002-4445-654X				Assandri R, 1997, J MEMBRANE BIOL, V157, P301, DOI 10.1007/s002329900237; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Du J, 1996, J NEUROSCI, V16, P506; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Kim M, 2001, J BIOL CHEM, V276, P23262, DOI 10.1074/jbc.M102253200; MAZZANTI M, 1994, FASEB J, V8, P231, DOI 10.1096/fasebj.8.2.7509760; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735	10	45	46	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					42	42		10.1038/420042a	http://dx.doi.org/10.1038/420042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422208				2022-12-24	WOS:000179068100030
J	Blumenthal, SJ; Hendi, JM; Marsillo, L				Blumenthal, SJ; Hendi, JM; Marsillo, L			A public health approach to decreasing obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									US Dept HHS, Washington, DC 20201 USA		Blumenthal, SJ (corresponding author), US Dept HHS, Washington, DC 20201 USA.							Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Division of Adult and Community Health National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention, 2002, BEH RISK FACT SURV S; LEE T, 2002, KSG FACULTY RES WORK; *NAT CTR CHRON DIS, 2002, YOUTH RISK BEH SURV; *NAT I DIAB DIG KI, 2002, CHOOS SAF SUCC WEIGH; Putnam J., 2000, FoodReview, V23, P2; SPAKE A, 2002, US NEWS WORLD RE AUG; *US DHHS, 2001, SURG GEN CALL ACT PR; Variyam J. N., 2002, FoodReview, V25, P13	9	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2178	2178		10.1001/jama.288.17.2178	http://dx.doi.org/10.1001/jama.288.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413384	hybrid			2022-12-24	WOS:000179048100034
J	Zandi, PP; Carlson, MC; Plassman, BL; Welsh-Bohmer, KA; Mayer, LS; Steffens, DC; Breitner, JCS				Zandi, PP; Carlson, MC; Plassman, BL; Welsh-Bohmer, KA; Mayer, LS; Steffens, DC; Breitner, JCS		Cache County Memory Study Investig	Hormone replacement therapy and incidence of Alzheimer disease in older women - The Cache County Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE DECLINE; CONTROLLED TRIAL; ESTROGEN; RISK; DEMENTIA; AD; POPULATION; PREVALENCE; AGE	Context Previous studies have shown a sex-specific increased risk of Alzheimer disease (AD) in women older than 80 years. Basic neuroscience findings suggest that hormone replacement therapy (HRT) could reduce a woman's risk of AD. Epidemiologic findings on AD and HRT are mixed. Objective To examine the relationship between use of HRT and risk of AD among elderly women. Design, Setting, and Participants Prospective study of incident dementia among 1357 men (mean age, 73.2 years) and 1889 women (mean age, 74.5 years) residing in a single county in Utah. Participants were first assessed in 1995-1997, with follow-up conducted in 1998-2000. History of women's current and former use of HRT, as well as of calcium and multivitamin supplements, was ascertained at the initial contact. Main Outcome Measure Diagnosis of incident AD. Results Thirty-five men (2.6%) and 88 women (4.7%) developed AD between the initial interview and time of the follow-up Q years). Incidence among women increased after age 80 years and exceeded the risk among men of similar age (adjusted hazard ratio [HR], 2.11.; 95% confidence interval [CI], 1.22-3.86). Women who used HRT had a reduced risk of AD (26 cases among 1066 women) compared with non-HRT users (58 cases among 800 women) (adjusted HR, 0.59; 95% CI, 0.36-0.96). Risk varied with duration of HRT use, so that a woman's sex-specific increase in risk disappeared entirely with more than 10 years of treatment Q cases among 427 women). Adjusted HRs were 0.41 (95% CI, 0.17-0.86) for HRT users compared with non users and 0.77 (95% CI, 0.31-1.67) compared with men. No similar effect was seen with calcium or multivitamin use. Almost all of the HRT-related reduction in incidence reflected former use of HRT (9 cases among 490 women; adjusted HR, 0.33 [95% CI, 0.15-0.65]). There was no effect with current HRT use (17 cases among 576 women; adjusted HR, 1.08 [95% CI, 0.59-1.91]) unless duration of treatment exceeded 10 years (6 cases among 344 women; adjusted HR, 0.55 [95% CI, 0.21-1.23]). Conclusions Prior HRT use is associated with reduced risk of AD, but there is no apparent benefit with current HRT use unless such use has exceeded 10 years.	VA Puget Sound Hlth Care Syst, GRECC S182, Seattle, WA 98108 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Ment Hyg, Baltimore, MD USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; Banner Hlth Syst, Phoenix, AZ USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Johns Hopkins University; Duke University; Duke University; Banner Research; Banner Health; University of Washington; University of Washington Seattle	Breitner, JCS (corresponding author), VA Puget Sound Hlth Care Syst, GRECC S182, 1660 S Columbian Way, Seattle, WA 98108 USA.	jcsb@u.washington.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020; Plassman, Brenda L/K-2620-2015		NATIONAL INSTITUTE ON AGING [R01AG011380] Funding Source: NIH RePORTER; NIA NIH HHS [R01-AG-11380] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison P.D., 1984, EVENT HIST ANAL REGR; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Baldereschi M, 1998, NEUROLOGY, V50, P996, DOI 10.1212/WNL.50.4.996; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; BRENNER DE, 1994, AM J EPIDEMIOL, V140, P262, DOI 10.1093/oxfordjournals.aje.a117245; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; HENDERSON VW, 1994, ARCH NEUROL-CHICAGO, V51, P896, DOI 10.1001/archneur.1994.00540210068014; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; Lerner A, 1997, LANCET, V349, P403, DOI 10.1016/S0140-6736(97)80025-6; Marder K, 2000, NEUROLOGY, V54, P2035, DOI 10.1212/WNL.54.11.2035; Matthews K, 1999, J AM GERIATR SOC, V47, P518, DOI 10.1111/j.1532-5415.1999.tb02563.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; MORTEL KF, 1995, J NEUROPSYCH CLIN N, V7, P334; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; RINCH CE, 2000, CHANCE DEV AGING; Seshadri S, 2001, ARCH NEUROL-CHICAGO, V58, P435, DOI 10.1001/archneur.58.3.435; Shumaker SA, 1998, CONTROL CLIN TRIALS, V19, P604, DOI 10.1016/S0197-2456(98)00038-5; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; Skoog I, 1999, J Epidemiol Biostat, V4, P227; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965	32	693	709	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2123	2129		10.1001/jama.288.17.2123	http://dx.doi.org/10.1001/jama.288.17.2123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413371	Bronze			2022-12-24	WOS:000179048100022
J	Xu, WH; Liu, YG; Wang, S; McDonald, T; Van Eyk, JE; Sidor, A; O'Rourke, B				Xu, WH; Liu, YG; Wang, S; McDonald, T; Van Eyk, JE; Sidor, A; O'Rourke, B			Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane	SCIENCE			English	Article							RAT-LIVER; POSSIBLE MECHANISM; MATRIX VOLUME; POTASSIUM; DIAZOXIDE; RECONSTITUTION; TRANSPORT; PURIFICATION; INHIBITION; ISCHEMIA	Ion channels on the mitochondrial inner membrane influence cell function in specific ways that can be detrimental or beneficial to cell survival. At least one type of potassium (K+) channel, the mitochondrial adenosine triphosphate sensitive K+ channel (mitoK(ATP)), is an important effector of protection against necrotic and apoptotic cell injury after ischemia. Here another channel with properties similar to the surface membrane calcium-activated K+ channel was found on the mitochondrial inner membrane (mitoK(Ca)) of guinea pig ventricular cells. MitoK(Ca) significantly contributed to mitochondrial K+ uptake of the myocyte, and an opener of mitoK(Ca) protected hearts against infarction.	Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, Baltimore, MD 21205 USA; Otsuka Maryland Res Inst, Maryland Res Labs, Rockville, MD 20850 USA; Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Johns Hopkins University; Queens University - Canada	O'Rourke, B (corresponding author), Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, Baltimore, MD 21205 USA.	bor@jhmi.edu		O'Rourke, Brian/0000-0002-5548-4853	NHLBI NIH HHS [NIHR01HL54598] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; DIWAN JJ, 1988, BIOCHEM BIOPH RES CO, V153, P224, DOI 10.1016/S0006-291X(88)81212-9; DIWAN JJ, 1985, J MEMBRANE BIOL, V84, P165, DOI 10.1007/BF01872214; Forbes RA, 2001, CIRC RES, V88, P802, DOI 10.1161/hh0801.089342; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 1996, BBA-BIOENERGETICS, V1275, P123, DOI 10.1016/0005-2728(96)00061-8; GIANGIACOMO KM, 1993, BIOCHEMISTRY-US, V32, P2363, DOI 10.1021/bi00060a030; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Grimmsmann T, 1998, BRIT J PHARMACOL, V123, P781, DOI 10.1038/sj.bjp.0701663; HALESTRAP AP, 1986, BIOCHEM J, V236, P779, DOI 10.1042/bj2360779; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; HANSFORD RG, 1972, BIOCHEM J, V126, P689, DOI 10.1042/bj1260689; JUNG DW, 1977, ARCH BIOCHEM BIOPHYS, V183, P452, DOI 10.1016/0003-9861(77)90380-0; KIMMICH GA, 1967, BIOCHIM BIOPHYS ACTA, V131, P413, DOI 10.1016/0005-2728(67)90001-1; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; LIU Y, 1998, CIRCULATION, V97, P2413; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Miura T, 2000, J AM COLL CARDIOL, V35, P238, DOI 10.1016/S0735-1097(99)00493-3; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; Pain T, 2000, CIRC RES, V87, P460; PALIWAL R, 1992, BIOCHEMISTRY-US, V31, P2223, DOI 10.1021/bi00123a003; PAUCEK P, 1992, J BIOL CHEM, V267, P26062; PEREZ G, 1994, BIOPHYS J, V66, P1022, DOI 10.1016/S0006-3495(94)80883-5; Ransom CB, 2001, J NEUROPHYSIOL, V85, P790, DOI 10.1152/jn.2001.85.2.790; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; Shake JG, 2001, ANN THORAC SURG, V72, P1849, DOI 10.1016/S0003-4975(01)03192-7; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Wang LG, 2001, AM J PHYSIOL-HEART C, V280, pH2321, DOI 10.1152/ajpheart.2001.280.5.H2321; Yao ZH, 1999, AM J PHYSIOL-HEART C, V277, pH2504	29	385	401	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2002	298	5595					1029	1033		10.1126/science.1074360	http://dx.doi.org/10.1126/science.1074360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411707				2022-12-24	WOS:000178932000058
J	Lee, FJS; Xue, S; Pei, L; Vukusic, B; Chery, N; Wang, YS; Wang, YT; Niznik, HB; Yu, XM; Liu, F				Lee, FJS; Xue, S; Pei, L; Vukusic, B; Chery, N; Wang, YS; Wang, YT; Niznik, HB; Yu, XM; Liu, F			Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor	CELL			English	Article							CALMODULIN; CALCIUM; KINASE; NEUROTOXICITY; APOPTOSIS; EXCITOTOXICITY; PHOSPHATASE-1; MITOCHONDRIA; NEOSTRIATUM; INHIBITION	Dopamine D1-like receptors, composed of D1 and D5 receptors, have been documented to modulate glutamate-mediated fast excitatory synaptic neurotransmission. Here, we report that dopamine D1 receptors modulate NMDA glutamate receptor-mediated functions through direct protein-protein interactions. Two regions in the D1 receptor carboxyl tail can directly and selectively couple to NMDA glutamate receptor subunits NR1-1a and NR2A. While one interaction is involved in the inhibition of NMDA receptor-gated currents, the other is implicated in the attenuation of NMDA receptor-mediated excitotoxicity through a PI-3 kinase-dependent pathway.	Univ Toronto, Ctr Addict & Mental Hlth, Dept Neurosci, Clarke Div, Toronto, ON M5T 1R8, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; Univ Toronto, Fac Dent, Toronto, ON M5T 1R8, Canada; Univ British Columbia, Vancouver, BC V6T 1Z3, Canada; Vancouver Gen Hosp, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; Vancouver Gen Hosp, Dept Med, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of British Columbia; University of British Columbia; University of British Columbia	Liu, F (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Dept Neurosci, Clarke Div, 100 Coll St, Toronto, ON M5T 1R8, Canada.		Wang, Yu Tian/A-4729-2008; Lee, Frank J.S./D-5899-2017; Wang, Yu Tian/J-8255-2015; Shin, Jung Hoon/C-9566-2012	Lee, Frank J.S./0000-0002-5768-3776; 				Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRORSON JR, 1995, STROKE, V26, P1259, DOI 10.1161/01.STR.26.7.1259; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; FELDMAN DS, 2002, J BIOL CHEM, V29, P29; Fischer R, 1998, FEBS LETT, V425, P175, DOI 10.1016/S0014-5793(98)00225-7; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harvey J, 1997, J NEUROSCI, V17, P5271; HAWES BE, 1994, J BIOL CHEM, V269, P15776; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lamey M, 2002, J BIOL CHEM, V277, P9415, DOI 10.1074/jbc.M111811200; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Levine MS, 1996, J NEUROSCI, V16, P5870; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lipton SA, 1998, CELL CALCIUM, V23, P165, DOI 10.1016/S0143-4160(98)90115-4; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Snyder GL, 1998, J NEUROSCI, V18, P10297; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; ZEEVALK GD, 1993, J NEUROCHEM, V61, P386, DOI 10.1111/j.1471-4159.1993.tb03585.x	47	393	416	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 18	2002	111	2					219	230		10.1016/S0092-8674(02)00962-5	http://dx.doi.org/10.1016/S0092-8674(02)00962-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408866	Bronze			2022-12-24	WOS:000178753500011
J	Ikeda, M; Matsunaga, T; Irabu, N; Yoshida, S				Ikeda, M; Matsunaga, T; Irabu, N; Yoshida, S			Using vital signs to diagnose impaired consciousness: cross sectional observational study	BRITISH MEDICAL JOURNAL			English	Article							LIKELIHOOD RATIOS; CURVES; COMA	Objectives To determine whether any vital signs can be used to quickly identify brain lesions in patients with impaired consciousness. Design Cross sectional observational study. Setting Emergency department of m urban hospital, Japan. Participants 529 consecutive patients (mean age 65 years) presenting with impaired consciousness (score < 15 on the Glasgow coma scale) during 2000. Main outcome measures The receiver operating characteristic curve was used to quantify the relation between the vital signs on arrival and the final diagnosis of a brain lesion. Stratum specific likelihood ratios were calculated to define strata with optimal discriminating power. Results 312 (59%) had a brain lesion which accounted for the impaired consciousness. The area under the receiver operating curve for systolic blood pressure was 0.90 (SE 0.01), indicating significantly higher accuracy (P < 0.01) in the identification of a brain lesion than using diastolic pressure 0.82 (0.02) or pulse rate 0.63 (0.03). Likelihood ratios for systolic blood pressure lower than 90 mm Hg were less than 0.04, and those for systolic pressure higher than 170 mm Hg were greater than 6.09. Conclusions Systolic blood pressure is useful for diagnosing brain lesions in patients with impaired consciousness.	Natl Saigata Hosp, Dept Clin Res, Ohgata, Niigata 9493193, Japan; Asahi Gen Hosp, Dept Neurol, Chiba, Japan; Asahi Gen Hosp, Dept Emergency Med, Chiba, Japan; Asahi Gen Hosp, Dept Med, Chiba, Japan		Ikeda, M (corresponding author), Natl Saigata Hosp, Dept Clin Res, Ohgata, Niigata 9493193, Japan.							BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; Furukawa TA, 2001, PSYCHOL MED, V31, P519, DOI 10.1017/S0033291701003713; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; Guyton AC, 1996, TXB MED PHYSL, P209; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; LEVY LL, 1976, STROKE, V7, P147, DOI 10.1161/01.STR.7.2.147; LEVY LL, 1977, STROKE, V8, P189, DOI 10.1161/01.STR.8.2.189; MILLS ML, 1986, ANN EMERG MED, V15, P1167, DOI 10.1016/S0196-0644(86)80859-9; PEIRCE JC, 1993, MED DECIS MAKING, V13, P141, DOI 10.1177/0272989X9301300208; Plum F, 1980, DIAGNOSIS STUPOR COM, Vthird; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TEASDALE G, 1974, LANCET, V2, P81; VICTOR M, 2001, ADAMS VICTORS PRINCI, P366; WALLACE JD, 1981, JAMA-J AM MED ASSOC, V246, P2177, DOI 10.1001/jama.246.19.2177; Yamashiro Seiji, 1994, Fukuoka Acta Medica, V85, P353	15	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2002	325	7368					800	U5		10.1136/bmj.325.7368.800	http://dx.doi.org/10.1136/bmj.325.7368.800			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604YM	12376438	Bronze, Green Published			2022-12-24	WOS:000178648700015
J	Irigoien, X; Harris, RP; Verheye, HM; Joly, P; Runge, J; Starr, M; Pond, D; Campbell, R; Shreeve, R; Ward, P; Smith, AN; Dam, HG; Peterson, W; Tirelli, V; Koski, M; Smith, T; Harbour, D; Davidson, R				Irigoien, X; Harris, RP; Verheye, HM; Joly, P; Runge, J; Starr, M; Pond, D; Campbell, R; Shreeve, R; Ward, P; Smith, AN; Dam, HG; Peterson, W; Tirelli, V; Koski, M; Smith, T; Harbour, D; Davidson, R			Copepod hatching success in marine ecosystems with high diatom concentrations	NATURE			English	Article							CALANUS-HELGOLANDICUS; ORGANIC-CARBON; EGG-PRODUCTION; PHYTOPLANKTON; FISHERIES	Diatoms dominate spring bloom phytoplankton assemblages in temperate waters and coastal upwelling regions of the global ocean. Copepods usually dominate the zooplankton in these regions and are the prey of many larval fish species. Recent laboratory studies suggest that diatoms may have a deleterious effect on the success of copepod egg hatching(1-4). These findings challenge the classical view of marine food-web energy flow from diatoms to fish by means of copepods(5-7). Egg mortality is an important factor in copepod population dynamics(8), thus, if diatoms have a deleterious in situ effect, paradoxically, high diatom abundance could limit secondary production. Therefore, the current understanding of energy transfer from primary production to fisheries in some of the most productive and economically important marine ecosystems(9) may be seriously flawed(1,10). Here we present in situ estimates of copepod egg hatching success from twelve globally distributed areas, where diatoms dominate the phytoplankton assemblage. We did not observe a negative relationship between copepod egg hatching success and either diatom biomass or dominance in the microplankton in any of these regions. The classical model for diatom-dominated system remains valid.	AZTI, Pasaia 20110, Spain; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Marine & Coastal Management, ZA-8012 Cape Town, Cape Town, South Africa; Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; British Antarctic Survey, Cambridge CB3 0ET, England; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; Natl Marine Fisheries Serv, Newport, OR 97365 USA; Univ Trieste, Dept Biol, Trieste, Italy; LBM, Trieste, Italy; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	AZTI; Plymouth Marine Laboratory; University of Cape Town; Fisheries & Oceans Canada; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Victoria; University of Connecticut; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Trieste; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); NERC National Oceanography Centre; University of Southampton	Irigoien, X (corresponding author), AZTI, Herrera Kaia Portualdea S-G, Pasaia 20110, Spain.	xirigoien@pas.azti.es	Dam, Hans G/A-9723-2015; Irigoien, Xabier/B-8171-2009; Tirelli, Valentina/GPG-4131-2022	Dam, Hans G/0000-0001-6121-5038; Irigoien, Xabier/0000-0002-5411-6741; Tirelli, Valentina/0000-0002-5152-2891; Koski, Marja/0000-0002-1860-9768				Ban SH, 1997, MAR ECOL PROG SER, V157, P287, DOI 10.3354/meps157287; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; HOLLIGAN PM, 1977, J MAR BIOL ASSOC UK, V57, P1075, DOI 10.1017/S002531540002614X; Ianora A, 1999, MAR ECOL PROG SER, V177, P305; Ianora A, 1996, MAR BIOL, V125, P279, DOI 10.1007/BF00346308; Irigoien X, 2000, LIMNOL OCEANOGR, V45, P44, DOI 10.4319/lo.2000.45.1.0044; Irigoien X, 2000, LIMNOL OCEANOGR, V45, P1433, DOI 10.4319/lo.2000.45.6.1433; Jonasdottir SH, 1998, MAR ECOL PROG SER, V172, P305, DOI 10.3354/meps172305; LEGENDRE L, 1990, J PLANKTON RES, V12, P681, DOI 10.1093/plankt/12.4.681; LESSARD EJ, 1986, J PLANKTON RES, V8, P1209, DOI 10.1093/plankt/8.6.1209; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; OHMAN MD, 1994, LIMNOL OCEANOGR, V39, P21, DOI 10.4319/lo.1994.39.1.0021; Ohman MD, 2001, NATURE, V412, P638, DOI 10.1038/35088068; Paffenhofer GA, 2002, MAR ECOL PROG SER, V227, P305, DOI 10.3354/meps227305; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Peterson WT, 2001, HYDROBIOLOGIA, V453, P91, DOI 10.1023/A:1013111832700; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; POULET SA, 1994, MAR ECOL PROG SER, V111, P79, DOI 10.3354/meps111079; Runge J.A., 2000, P401, DOI 10.1016/B978-012327645-2/50010-4; RUNGE JA, 1988, HYDROBIOLOGIA, V167, P61, DOI 10.1007/BF00026294; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Uye S, 1996, MAR ECOL PROG SER, V133, P89, DOI 10.3354/meps133089	22	181	211	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2002	419	6905					387	389		10.1038/nature01055	http://dx.doi.org/10.1038/nature01055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353032				2022-12-24	WOS:000178195400043
J	Kops, GJPL; Dansen, TB; Polderman, PE; Saarloos, I; Wirtz, KWA; Coffer, PJ; Huang, TT; Bos, JL; Medema, RH; Burgering, BMT				Kops, GJPL; Dansen, TB; Polderman, PE; Saarloos, I; Wirtz, KWA; Coffer, PJ; Huang, TT; Bos, JL; Medema, RH; Burgering, BMT			Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GLUCOSE DEPRIVATION; GENE-EXPRESSION; KINASE; CYTOTOXICITY; ACTIVATION; AKT/PKB; SIGNALS	Reactive oxygen species are required for cell proliferation but can also induce apoptosis(1). In proliferating cells this paradox is solved by the activation of protein kinase B (PKB; also known as c-Akt), which protects cells from apoptosis(2). By contrast, it is unknown how quiescent cells that lack PKB activity are protected against cell death induced by reactive oxygen species. Here we show that the PKB-regulated Forkhead transcription factor FOXO3a (also known as FKHR-L1) protects quiescent cells from oxidative stress by directly increasing their quantities of manganese superoxide dismutase (MnSOD) messenger RNA and protein. This increase in protection from reactive oxygen species antagonizes apoptosis caused by glucose deprivation. In quiescent cells that lack the protective mechanism of PKB-mediated signalling, an alternative mechanism is induced as a consequence of PKB inactivity. This mechanism entails the activation of Forkhead transcription factors, the transcriptional activation of MnSOD and the subsequent reduction of reactive oxygen species. Increased resistance to oxidative stress is associated with longevity. The model of Forkhead involvement in regulating longevity stems from genetic analysis in Caenorhabditis elegans(3-6), and we conclude that this model also extends to mammalian systems.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, Dept Biochem Lipids, NL-3584 CH Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Pulm Dis, NL-3584 CX Utrecht, Netherlands; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; Netherlands Cancer Institute	Burgering, BMT (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands.		Coffer, Paul J/A-5769-2009; Coffer, Paul/AAF-7970-2020; Medema, Rene H/E-2981-2013; Medema, Rene H/G-5415-2011	Medema, Rene/0000-0002-6754-0381; Kops, Geert/0000-0003-3555-5295				Aulwurm UR, 2000, EUR J BIOCHEM, V267, P5693, DOI 10.1046/j.1432-1327.2000.01576.x; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pap EHW, 1999, FEBS LETT, V453, P278, DOI 10.1016/S0014-5793(99)00696-1; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712	27	1222	1259	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					316	321		10.1038/nature01036	http://dx.doi.org/10.1038/nature01036			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239572	Green Published			2022-12-24	WOS:000178056300050
J	Liberman, MC; Gao, JG; He, DZZ; Wu, XD; Jia, SP; Zuo, J				Liberman, MC; Gao, JG; He, DZZ; Wu, XD; Jia, SP; Zuo, J			Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier	NATURE			English	Article							BASILAR-MEMBRANE; MOTOR PROTEIN; RESPONSES; ADAPTATION	Hearing sensitivity in mammals is enhanced by more than 40 dB (that is, 100-fold) by mechanical amplification thought to be generated by one class of cochlear sensory cells, the outer hair cells(1-4). In addition to the mechano-electrical transduction required for auditory sensation, mammalian outer hair cells also perform electromechanical transduction, whereby transmembrane voltage drives cellular length changes at audio frequencies in vitro(5-7). This electromotility is thought to arise through voltage-gated conformational changes in a membrane protein 8,9, and prestin has been proposed as this molecular motor(10-12). Here we show that targeted deletion of prestin in mice results in loss of outer hair cell electromotility in vitro and a 40-60 dB loss of cochlear sensitivity in vivo, without disruption of mechano-electrical transduction in outer hair cells. In heterozygotes, electromotility is halved and there is a twofold (about 6 dB) increase in cochlear thresholds. These results suggest that prestin is indeed the motor protein, that there is a simple and direct coupling between electromotility and cochlear amplification, and that there is no need to invoke additional active processes to explain cochlear sensitivity in the mammalian ear.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Boys Town National Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	NIDCD NIH HHS [R01 DC004696] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J. F., 1989, COCHLEAR MECH, P107; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOHNE BA, 1983, HEARING RES, V11, P41, DOI 10.1016/0378-5955(83)90044-8; BROWN MC, 1983, SCIENCE, V222, P69, DOI 10.1126/science.6623058; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; DALLOS P, 1974, AUDIOLOGY, V13, P277; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; Ehret G, 1983, AUDITORY PSYCHOBIOLO, P169; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; JOHNSTONE BM, 1986, HEARING RES, V22, P147, DOI 10.1016/0378-5955(86)90090-0; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KIANG NYS, 1974, J ACOUST SOC AM, V55, P620, DOI 10.1121/1.1914572; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; RUGGERO MA, 1991, HEARING RES, V51, P215, DOI 10.1016/0378-5955(91)90038-B; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	29	630	671	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					300	304		10.1038/nature01059	http://dx.doi.org/10.1038/nature01059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239568				2022-12-24	WOS:000178056300046
J	Vinogradova, O; Velyvis, A; Velyviene, A; Hu, B; Haas, TA; Plow, EF; Qin, J				Vinogradova, O; Velyvis, A; Velyviene, A; Hu, B; Haas, TA; Plow, EF; Qin, J			A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face	CELL			English	Article							MEMBRANE-PROXIMAL REGION; GLYCOPROTEIN IIB-IIIA; LIGAND-BINDING; GPIIB-IIIA; SIGNAL-TRANSDUCTION; TALIN-BINDING; DOMAIN; PROTEIN; NMR; MODULATION	Activation of the ligand binding function of integrin heterodimers requires transmission of an "inside-out" signal from their small intracellular segments to their large extracellular domains. The structure of the cytoplasmic domain of a prototypic integrin alpha(IIb)beta(3) has been solved by NMR and reveals multiple hydrophobic and electrostatic contacts within the membrane-proximal helices of its alpha and the beta cytoplasmic tails. The interface interactions are disrupted by point mutations or the cytoskeletal protein talin that are known to activate the receptor. These results provide a structural mechanism by which a handshake between the alpha and the beta cytoplasmic tails restrains the integrin in a resting state and unclasping of this interaction triggers the inside-out conformational signal that leads to receptor activation.	Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Struct Biol Program, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Plow, EF (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org	Vinogradova, Olga/ABE-8367-2020; Qin, Jun/D-5559-2009	Vinogradova, Olga/0000-0001-5101-7361; Qin, Jun/0000-0002-2647-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010259] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL010259-01, F32 HL010259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874; BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caen J. P., 1996, AM J MED, V41, P2; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Eigenthaler R, 1997, J BIOL CHEM, V272, P7693, DOI 10.1074/jbc.272.12.7693; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; FITZGERALD LA, 1985, ANAL BIOCHEM, V151, P169, DOI 10.1016/0003-2697(85)90067-3; FRACHET P, 1992, BIOCHEMISTRY-US, V31, P2408, DOI 10.1021/bi00123a028; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Haas TA, 1997, PROTEIN ENG, V10, P1395, DOI 10.1093/protein/10.12.1395; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Peterson JA, 1998, BLOOD, V92, P2053, DOI 10.1182/blood.V92.6.2053.418k14_2053_2063; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Plow EF, 1999, CORONARY ARTERY DIS, V10, P547, DOI 10.1097/00019501-199912000-00002; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Woodside DG, 2001, THROMB HAEMOSTASIS, V86, P316, DOI 10.1055/s-0037-1616229; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	59	422	436	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					587	597		10.1016/S0092-8674(02)00906-6	http://dx.doi.org/10.1016/S0092-8674(02)00906-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230976	Bronze			2022-12-24	WOS:000177943700006
J	Ribeiro, ALP; dos Reis, AM; Barros, MVL; de Sousa, MR; Rocha, ALL; Perez, AA; Pereira, JB; Machado, FS; Rocha, MOC				Ribeiro, ALP; dos Reis, AM; Barros, MVL; de Sousa, MR; Rocha, ALL; Perez, AA; Pereira, JB; Machado, FS; Rocha, MOC			Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease	LANCET			English	Article							CONGESTIVE-HEART-FAILURE	Left ventricular dysfunction in Chagas' disease is common but can be difficult to detect. We investigated whether measurement of plasma brain natriuretic peptide (BNP) could identify patients with left ventricular dysfunction who need further investigation or treatment. Among patients with an abnormal electrocardiogram or chest radiograph, a BNP concentration of 60.7 pmol/L or higher has a sensitivity and positive predictive value of 80%, and specificity and negative predictive value of 97%. Measurement of plasma BNP concentration could be a useful method to screen patients with Chagas' disease.	Univ Fed Minas Gerais, Sch Med, Postgrad Course Trop Med, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Hosp Clin, Serv Cardiol, Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; Ecoar Med Diagnost, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Ribeiro, ALP (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Course Trop Med, Belo Horizonte, MG, Brazil.		Rocha, Ana L/B-1645-2014; Reis, Adelina/C-8162-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Rocha, Manoel Otávio C/H-4776-2013; Barros, Marcio/GXF-3499-2022; Ribeiro, Antonio L/C-2707-2009	Rocha, Ana L/0000-0002-4717-9541; Reis, Adelina/0000-0003-0138-9612; Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042				Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; GUTKOWSKA J, 1987, ENDOCRIN METAB CLIN, V16, P183, DOI 10.1016/S0889-8529(18)30500-0; Hjalmarson A, 1999, LANCET, V353, P2001; MADY C, 1994, CIRCULATION, V90, P3098, DOI 10.1161/01.CIR.90.6.3098; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1	5	57	63	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					461	462		10.1016/S0140-6736(02)09638-1	http://dx.doi.org/10.1016/S0140-6736(02)09638-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241721				2022-12-24	WOS:000177342900015
J	Post, E; Forchhammer, MC				Post, E; Forchhammer, MC			Synchronization of animal population dynamics by large-scale climate	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; DENSITY; FLUCTUATIONS; PHENOLOGY; ECOLOGY; TRENDS; CANADA; SHEEP	The hypothesis that animal population dynamics may be synchronized by climate(1) is highly relevant in the context of climate change because it suggests that several populations might respond simultaneously to climatic trends if their dynamics are entrained by environmental correlation. The dynamics of many species throughout the Northern Hemisphere are influenced by a single large-scale climate system, the North Atlantic Oscillation (NAO)(2,3), which exerts highly correlated regional effects on local weather(4). But efforts to attribute synchronous fluctuations of contiguous populations to large-scale climate are confounded by the synchronizing influences of dispersal or trophic interactions(5). Here we report that the dynamics of caribou and musk oxen on opposite coasts of Greenland show spatial synchrony among populations of both species that correlates with the NAO index. Our analysis shows that the NAO has an influence in the high degree of cross-species synchrony between pairs of caribou and musk oxen populations separated by a minimum of 1,000 km of inland ice. The vast distances, and complete physical and ecological separation of these species, rule out spatial coupling by dispersal or interaction. These results indicate that animal populations of different species may respond synchronously to global climate change over large regions.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Univ Copenhagen, Inst Zool, Dept Populat Ecol, DK-2100 Copenhagen, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Copenhagen	Post, E (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.		Forchhammer, Mads/I-7474-2013					Blasius B, 2000, NATURE, V406, P846, DOI 10.1038/35022646; Born ErikW., 2001, ECOLOGY GREENLAND; FORCHHAMMER M, 1993, ECOGRAPHY, V16, P299, DOI 10.1111/j.1600-0587.1993.tb00219.x; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Haydon DT, 2001, P NATL ACAD SCI USA, V98, P13149, DOI 10.1073/pnas.221275198; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Klein David R., 1999, Ecological Bulletins, V47, P96; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Lodwick G. D., 1970, Australian Computer Journal, V2, P104; Marshall J, 2001, INT J CLIMATOL, V21, P1863, DOI 10.1002/joc.693; Meldgaard M., 1986, Meddelelser om Gronland Bioscience, V20, P1; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2001, EVOLUTION, V55, P830, DOI 10.1554/0014-3820(2001)055[0830:RAIWED]2.0.CO;2; Post E, 1999, J WILDLIFE MANAGE, V63, P335, DOI 10.2307/3802517; POST E, IN PRESS ECOLOGY; Ranta E, 1999, P ROY SOC B-BIOL SCI, V266, P1851, DOI 10.1098/rspb.1999.0856; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Skogland T, 1989, COMP SOCIAL ORG WILD; *SPSS INC, 1998, SYSTAT WIND VERS 8 0; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	31	233	241	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					168	171		10.1038/nature01064	http://dx.doi.org/10.1038/nature01064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432390				2022-12-24	WOS:000179200900043
J	Blackman, MB; Sorkin, JD; Munzer, T; Bellantoni, MF; Busby-Whitehead, J; Stevens, TE; Jayme, J; O'Connor, KG; Christmas, C; Tobin, JD; Stewart, KJ; Cottrell, E; St Clair, C; Pabst, KM; Harman, SM				Blackman, MB; Sorkin, JD; Munzer, T; Bellantoni, MF; Busby-Whitehead, J; Stevens, TE; Jayme, J; O'Connor, KG; Christmas, C; Tobin, JD; Stewart, KJ; Cottrell, E; St Clair, C; Pabst, KM; Harman, SM			Growth hormone and sex steroid administration in healthy aged women and men - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; MUSCLE STRENGTH; FACTOR-I; TESTOSTERONE REPLACEMENT; BODY-COMPOSITION; HYPOGONADAL MEN; OLDER MEN; ESTROGEN REPLACEMENT; RESISTANCE EXERCISE	Context Hormone administration to elderly individuals can increase lean body mass (LBM) and decrease fat, but interactive effects of growth hormone (GH) and sex steroids and their influence on strength and endurance are unknown. Objective To evaluate the effects of recombinant human GH and/or sex steroids on body composition, strength, endurance, and adverse outcomes in aged persons. Design, Setting, and Participants A 26-week randomized, double-blind, placebo-controlled parallel-group trial in healthy, ambulatory, community-dwelling US women (n=57) and men (n=74) aged 65 to 88 years recruited between June 1992 and July 1998. Interventions Participants were randomized to receive GH (starting dose, 30 mug/kg reduced to 20 mug/kg, subcutaneously 3 times/wk) + sex steroids (women: transdermal estradiol,100 mug/d, plus oral medroxyprogesterone acetate, 10 mg/d, during the last 10 days of each 28-day cycle [HRT]; men: testosterone enanthate, biweekly intramuscular injections of 100 mg) (n=35); GH + placebo sex steroid (n=30); sex steroid + placebo GH (n=35); or placebo GH + placebo sex steroid (n=31) in a 2 x 2 factorial design. Main Outcome Measures Lean body mass, fat mass, muscle strength, maximum oxygen uptake ((V) over doto(2)max) during treadmill test, and adverse effects. Results In women, LBM increased by 0.4 kg with placebo, 1.2 kg with HRT (P=.09), 1.0 kg with GH (P=.001), and 2.1 kg with GH+HRT (P<.001). Fat mass decreased significantly in the GH and GH+HRT groups. In men, LBM increased by 0.1 kg with placebo, 1.4 kg with testosterone (P=.06), 3.1 kg with GH (P<.001), and 4.3 kg with GH+testosterone (P<.001). Fat mass decreased significantly with GH and GH+testosterone. Women's strength decreased in the placebo group and increased's strength nonsignificantly with HRT (P=.09), GH (P=.29), and GH+HRT (P=.14). Men also did not increase significantly except for a marginally significant increase of 13.5 kg with GH+testosterone (P=.05). Women's (V) over dot o(2)max declined by 0.4 mL/min/kg in the placebo and HRT groups but increased with GH (P=.07) and GH+HRT (P=.06). 3 Men's (V) over dot o(2)max declined by 1.2 mL/min/kg with placebo and by 0.4 mL/min/kg with testosterone (P=.49) but increased with GH (P=.11) and with GH+testosterone (P<.001). Changes in strength (r=0.355; P<.001) and in (V) over dot o(2)max (r=0.320; P=.002) were directly related to changes in LBM. Edema was significantly more common in women taking GH (39% vs 0%) and GH+HRT (38% vs 0%). Carpal tunnel symptoms were more common in men taking GH+testosterone (32% vs 0%) and arthralgias were more common in men taking GH (41% vs 0%). Diabetes or glucose intolerance occurred in 18 GH-treated men vs 7 not receiving GH (P=.006). Conclusions In this study, GH with or without sex steroids in healthy, aged women and men increased LBM and decreased fat mass. Sex steroid + GH increased muscle strength marginally and (V) over dot o(2)max in men, but women had no significant change in strength or cardiovascular endurance. Because adverse effects were frequent (importantly, diabetes and glucose intolerance), GH interventions; in the elderly should be confined to controlled studies.	Natl Ctr Complementary & Alternat Med, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA; NIA, Endocrine Sect, NIH, Lab Clin Invest,Intramural Res Program, Bethesda, MD 20892 USA; NIA, Metab Sect, NIH, Lab Clin Invest,Intramural Res Program, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; Burgerspital, St Gallen, Switzerland; Univ N Carolina, Sch Med, Div Geriatr Med, Chapel Hill, NC USA; Univ S Alabama, Sch Med, Div Geriatr Med, Mobile, AL USA; Louth Hosp, Louth, Ireland; Kronos Res Inst, Phoenix, AZ USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of South Alabama	Blackman, MB (corresponding author), Natl Ctr Complementary & Alternat Med, NIH, 8 West Dr,Bldg 15 B-1, Bethesda, MD 20892 USA.			Bellantoni, Michele/0000-0001-8525-2247	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719] Funding Source: NIH RePORTER; NCRR NIH HHS [M0-1-RR-02719] Funding Source: Medline; NIA NIH HHS [R0-1 AG11005] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BELLANTONI MF, 1991, J CLIN ENDOCR METAB, V72, P172, DOI 10.1210/jcem-72-1-172; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; BLACKMAN MR, 1999, SEX STEROID INTERACT, P44; BLACKMAN MR, 1995, ENDOCRINOLOGY, P2702; BRUCE RA, 1966, AM HEART J, V71, P455, DOI 10.1016/0002-8703(66)90210-9; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; CAULEY JA, 1987, J CHRON DIS, V40, P115, DOI 10.1016/0021-9681(87)90062-2; Cefalu WT, 1998, METABOLISM, V47, P401, DOI 10.1016/S0026-0495(98)90050-6; Christmas C, 2002, J GERONTOL A-BIOL, V57, pM12, DOI 10.1093/gerona/57.1.M12; COHN L, 1993, CLIN ENDOCRINOL, V39, P417, DOI 10.1111/j.1365-2265.1993.tb02388.x; CUNEO RC, 1991, J APPL PHYSIOL, V70, P688, DOI 10.1152/jappl.1991.70.2.688; Cuttica CM, 1997, AGING CLIN EXP RES, V9, P193, DOI 10.1007/BF03340149; DAWSONHUGHES B, 1986, J CLIN ENDOCR METAB, V63, P424, DOI 10.1210/jcem-63-2-424; Dobs AS, 2002, J CLIN ENDOCR METAB, V87, P1509, DOI 10.1210/jc.87.4.1509; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Friend KE, 1996, J CLIN ENDOCR METAB, V81, P2250, DOI 10.1210/jc.81.6.2250; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gentili A, 2002, J CLIN ENDOCR METAB, V87, P825, DOI 10.1210/jc.87.2.825; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; Hajjar RR, 1997, J CLIN ENDOCR METAB, V82, P3793, DOI 10.1210/jc.82.11.3793; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hayes VY, 2001, J CLIN ENDOCR METAB, V86, P2211, DOI 10.1210/jc.86.5.2211; Ho Ken K. Y., 1996, Endocrine Journal, V43, pS57; HULKA BS, 1980, JAMA-J AM MED ASSOC, V244, P2419; Johnston D. G., 1999, Journal of Endocrinological Investigation, V22, P37; KLATZ R, 1997, GROW YOUNG HGH AMAZI; KRITZSILVERSTEIN D, 1994, J BONE MINER RES, V9, P45, DOI 10.1002/jbmr.5650090107; Lasco A, 2000, DIABETES CARE, V23, P422, DOI 10.2337/diacare.23.3.422; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; MALOZOWSKI S, 1993, NEW ENGL J MED, V329, P665, DOI 10.1056/NEJM199308263290917; MARDH G, 1994, ENDOCRINOLOGY MET SA, V1, P43; Marin P, 1992, Eur J Med, V1, P329; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Miller MM, 1999, EXP GERONTOL, V34, P587, DOI 10.1016/S0531-5565(99)00032-7; Munzer T, 2001, J CLIN ENDOCR METAB, V86, P3604, DOI 10.1210/jc.86.8.3604; O'Connor KG, 1998, J GERONTOL A-BIOL, V53, pM176, DOI 10.1093/gerona/53A.3.M176; O'Sullivan AJ, 1998, J CLIN INVEST, V102, P1035, DOI 10.1172/JCI2773; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; Rosenfalck AM, 1999, GROWTH HORM IGF RES, V9, P96, DOI 10.1054/ghir.1999.0091; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roy TA, 2002, AM J PHYSIOL-ENDOC M, V283, pE284, DOI 10.1152/ajpendo.00334.2001; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; Savine R, 2000, HORM RES, V53, P37, DOI 10.1159/000023531; SHIMOKATA H, 1989, INT J OBESITY, V13, P455; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Sorensen MB, 2001, OBES RES, V9, P622, DOI 10.1038/oby.2001.81; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208, DOI 10.1111/j.1532-5415.1999.tb05201.x; TAAFFE DR, 1994, J CLIN ENDOCR METAB, V79, P1361, DOI 10.1210/jc.79.5.1361; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM149, DOI 10.1093/gerona/52A.3.M149; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	62	325	351	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2002	288	18					2282	2292		10.1001/jama.288.18.2282	http://dx.doi.org/10.1001/jama.288.18.2282			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JZ	12425705	Bronze			2022-12-24	WOS:000179186400027
J	Grizzard, T				Grizzard, T			Undertreatment of obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Grizzard, T (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							*CDCP, 2000, MMWR-MORBID MORTAL W, V49, P797; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P854; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; KUSHNER RF, 1995, PREV MED, V24, P546, DOI 10.1006/pmed.1995.1087; Miller LA, 2002, J PEDIATR-US, V141, P121, DOI 10.1067/mpd.2002.124382; OCKENE JK, 1988, ARCH INTERN MED, V148, P1039, DOI 10.1001/archinte.148.5.1039; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; ORLEANS CT, 1985, PREV MED, V14, P636, DOI 10.1016/0091-7435(85)90083-0; Stafford RS, 2000, ARCH FAM MED, V9, P631, DOI 10.1001/archfami.9.7.631; Tershakovec AM, 1999, J PEDIATR-US, V134, P573, DOI 10.1016/S0022-3476(99)70243-X; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586	11	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2177	2177		10.1001/jama.288.17.2177	http://dx.doi.org/10.1001/jama.288.17.2177			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413383	hybrid			2022-12-24	WOS:000179048100033
J	Chinnery, PF; Samuels, DC; Elson, J; Turnbull, DM				Chinnery, PF; Samuels, DC; Elson, J; Turnbull, DM			Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism?	LANCET			English	Article							MTDNA; REPLICATION; INCREASE; MUSCLE; TUMORS; MOUSE	In man, cells accumulate somatic mutations of mitochondrial DNA (mtDNA) as part of normal ageing. Although the overall concentration of mutant mtDNA is low in tissue as a whole, very high numbers of various mtDNA mutations develop in individual cells within the same person, which causes age-associated mitochondrial dysfunction. Some tumours contain high numbers of mtDNA mutations that are not present in healthy tissues from the same individual. The proportion of mutant mtDNA also rises in patients with progressive neurological disease due to inherited mtDNA mutations. This increase parallels the relentless clinical progression seen in these disorders. Mathematical models suggest that the same basic cellular mechanisms are responsible for the amplification of mutant mtDNA in ageing, in tumours, and in mtDNA disease. The accumulation of cells that contain high levels of mutant mtDNA may be an inevitable result of the normal mechanisms that maintain cellular concentrations of mtDNA.	Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Dept Math, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Samuels, David/AHC-8381-2022; Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008	Samuels, David/0000-0003-3529-7791; Samuels, David C/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617; /0000-0002-3551-5624				Augenlicht LH, 2001, NAT GENET, V28, P104, DOI 10.1038/88800; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI G, 1990, NUCLEIC ACIDS RES, V275, P169; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; MORGANHUGHES JA, 1994, MYOLOGY, P1610; Nakayama T, 2000, IPAP CONFERENCE SER, V1, P7, DOI 10.1109/ROMAN.2000.892461; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Turnbull DM, 1998, NAT GENET, V18, P199, DOI 10.1038/ng0398-199; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Weber K, 1997, AM J HUM GENET, V60, P373	23	165	180	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2002	360	9342					1323	1325		10.1016/S0140-6736(02)11310-9	http://dx.doi.org/10.1016/S0140-6736(02)11310-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CH	12414225				2022-12-24	WOS:000178827200031
J	Honma, S; Kawamoto, T; Takagi, Y; Fujimoto, K; Sato, F; Noshiro, M; Kato, Y; Honma, K				Honma, S; Kawamoto, T; Takagi, Y; Fujimoto, K; Sato, F; Noshiro, M; Kato, Y; Honma, K			Dec1 and Dec2 are regulators of the mammalian molecular clock	NATURE			English	Article							CIRCADIAN CLOCK; LOOP; TRANSCRIPTION; PROTEINS; RHYTHM; GENE; PATHWAYS; PERIOD; BMAL1; MOUSE	The circadian rhythms in mammals are regulated by a pacemaker located in the suprachiasmatic nucleus of the hypothalamus(1,2). Four clock-gene families have been found to be involved in a transcription-translation feedback loop that generates the circadian rhythm at the intracellular level(3). The proteins Clock and Bmal1 form a heterodimer which activates the transcription of the Per gene from the E-box elements in its promoter region(4,5). Protein products of Per act together with Cry proteins to inhibit Per transcription(6,7), thus closing the autoregulatory feedback loop. We found that Dec1 and Dec2, basic helix-loop-helix transcription factors, repressed Clock/Bmal1-induced transactivation of the mouse Per1 promoter through direct protein-protein interactions with Bmal1 and/or competition for E-box elements. Dec1 and Dec2 are expressed in the suprachiasmic nucleus in a circadian fashion, with a peak in the subjective day. A brief light pulse induced Dec1 but not Dec2 expression in the suprachiasmic nucleus in a phase-dependent manner. Dec1 and Dec2 are regulators of the mammalian molecular clock, and form a fifth clock-gene family.	Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent & Med Biochem, Hiroshima 7348553, Japan	Hokkaido University; Hiroshima University	Honma, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan.	sathonma@med.hokudai.ac.jp	, 河本健/D-7938-2015	, 河本健/0000-0003-3337-1775				Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dear TN, 1997, ONCOGENE, V14, P891, DOI 10.1038/sj.onc.1200912; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; HONMA K, 1985, JPN J PHYSIOL, V35, P643, DOI 10.2170/jjphysiol.35.643; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; MOORE RY, 1985, ANN NY ACAD SCI, V453, P123, DOI 10.1111/j.1749-6632.1985.tb11805.x; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stephan F.K., 1972, P NATL ACAD SCI USA, V54, P1521; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Teramoto M, 2001, J BIOCHEM-TOKYO, V129, P391, DOI 10.1093/oxfordjournals.jbchem.a002869; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Yagita K, 2000, GENE DEV, V14, P1353; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	29	485	507	1	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					841	+		10.1038/nature01123	http://dx.doi.org/10.1038/nature01123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397359				2022-12-24	WOS:000178769800047
J	Koskinen, MT; Haugen, TO; Primmer, CR				Koskinen, MT; Haugen, TO; Primmer, CR			Contemporary fisherian life-history evolution in small salmonid populations	NATURE			English	Article							NATURAL-SELECTION; DIFFERENTIATION; DIVERGENCE; THYMALLUS; GENETICS; LOCI	The relative importance of natural selection(1) and random drift(2) in phenotypic evolution has been discussed since the introduction of the first population genetic models(3-5). The empirical evidence used to evaluate the evolutionary theories of Fisher(1) and Wright(2) remains obscure because formal tests for neutral divergence(6-8) or sensitive attempts to separate the effects of selection and drift are scarce, subject to error, and have not been interpreted in the light of well-known population demography. We combined quantitative genetic and microsatellite DNA analyses to investigate the determinants of contemporary life-history evolution in isolated populations of grayling (Thymallus thymallus, Salmonidae) that originated from a common source 80-120 years ago. Here we show that natural selection was the dominant diversifying agent in the evolution of the quantitative traits. However, the populations were founded by a small number of individuals, exhibit very low microsatellite-based effective sizes and show genetic imprints of severe 'bottlenecks'; which are conditions often suggested to constrain selection and favour drift(6,8,9). This study demonstrates a very clear case of fisherian evolution in small natural populations across a contemporary timescale.	Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, FIN-00014 Helsinki, Finland; Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway	University of Helsinki; University of Oslo	Koskinen, MT (corresponding author), Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, POB 65,Viikinkaari 1, FIN-00014 Helsinki, Finland.	mtkoskin@cc.helsinki.fi	Primmer, Craig R/B-8179-2008; Peng, Bo/A-6920-2009	Primmer, Craig R/0000-0002-3687-8435; Peng, Bo/0000-0001-8225-2284				BAKER AJ, 1992, EVOLUTION, V46, P1784, DOI 10.1111/j.1558-5646.1992.tb01169.x; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Beaumont MA, 1999, GENETICS, V153, P2013; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; FRY JD, 1992, EVOLUTION, V46, P540, DOI [10.2307/2409870, 10.1111/j.1558-5646.1992.tb02057.x]; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Haugen TO, 2001, GENETICA, V112, P475, DOI 10.1023/A:1013315116795; Haugen TO, 2000, J EVOLUTION BIOL, V13, P897, DOI 10.1046/j.1420-9101.2000.00242.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hendry AP, 2001, GENETICA, V112, P515, DOI 10.1023/A:1013367100865; Kimura M, 1985, NEUTRAL THEORY MOL E; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Koskinen MT, 2001, CONSERV GENET, V2, P173, DOI 10.1023/A:1011886412830; Koskinen MT, 2002, HEREDITY, V88, P391, DOI 10.1038/sj.hdy.6800072; LANDE R, 1976, EVOLUTION, V30, P314, DOI [10.2307/2407703, 10.1111/j.1558-5646.1976.tb00911.x]; LANDE R, 1977, EVOLUTION, V31, P442, DOI 10.1111/j.1558-5646.1977.tb01025.x; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; LYNCH M, 1998, GENETICS ANAL QUANTI, P328; Majerus MEN, 1998, MELANISM EVOLUTION A; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; O'Ryan C, 1998, ANIM CONSERV, V1, P85, DOI 10.1111/j.1469-1795.1998.tb00015.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323	30	212	217	1	78	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					826	830		10.1038/nature01029	http://dx.doi.org/10.1038/nature01029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397355				2022-12-24	WOS:000178769800043
J	Zacchi, P; Gostissa, M; Uchida, T; Salvagno, C; Avolio, F; Volinia, S; Ronai, Z; Blandino, G; Schneider, C; Del Sal, G				Zacchi, P; Gostissa, M; Uchida, T; Salvagno, C; Avolio, F; Volinia, S; Ronai, Z; Blandino, G; Schneider, C; Del Sal, G			The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults	NATURE			English	Article							CYCLIN-DEPENDENT KINASES; BETA-CATENIN; APOPTOSIS; PHOSPHORYLATION; DEATH; ACCUMULATION; MITOSIS; DOMAINS; BINDING; AGENTS	The tumour suppressor p53 is important in the cell decision to either arrest cell cycle progression or induce apoptosis in response to a variety of stimuli. p53 post-translational modifications and association with other proteins have been implicated in the regulation of its stability and transcriptional activities(1,2). Here we report that, on DNA damage, p53 interacts with Pin1, a peptidyl-prolyl isomerase 3, which regulates the function of many proteins involved in cell cycle control and apoptosis(4-6). The interaction is strictly dependent on p53 phosphorylation, and requires Ser 33, Thr 81 and Ser 315. On binding, Pin1 generates conformational changes in p53, enhancing its transactivation activity. Stabilization of p53 is impaired in UV-treated Pin1(-/-) cells owing to its inability to efficiently dissociate from Mdm2. As a consequence, a reduced p53-dependent response was detected in Pin1(-/-) cells, and this correlates with a diminished transcriptional activation of some p53-regulated genes. Our results suggest that, following stress-induced phosphorylation, p53 needs to form a complex with Pin1 and to undergo a conformational change to fulfil its biological roles.	Lab Nazl CIB, I-34012 Trieste, Italy; Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34100 Trieste, Italy; Tohoku Univ, Inst Dev Aging & Canc, Dept Pathol, Sendai, Miyagi 9808575, Japan; Univ Ferrara, Sez Istol & Embriol, Dipartimento Morfol & Embriol, I-44100 Ferrara, Italy; CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA; Regina Elena Inst Canc Res, Mol Oncogenesis Lab, I-00158 Rome, Italy; Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	University of Trieste; Tohoku University; University of Ferrara; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Del Sal, G (corresponding author), Lab Nazl CIB, AREA Sci Pk,Padriciano 99, I-34012 Trieste, Italy.		Volinia, Stefano/A-3029-2010; Blandino, Giovanni/B-1137-2013; Volinia, Stefano/AAA-9264-2019	Volinia, Stefano/0000-0003-0910-3893; Blandino, Giovanni/0000-0002-6970-2241; Volinia, Stefano/0000-0003-0910-3893; Avolio, Fabio/0000-0003-2067-5315; DEL SAL, GIANNINO/0000-0003-2185-6003; RONAI, ZEEV/0000-0002-3859-0400; Uchida, Takafumi/0000-0003-3665-4906				Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; KWONSEOP K, 2000, MOL BIOL CELL, V11, P3509; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Pathan N, 2001, NEOPLASIA, V3, P70, DOI 10.1038/sj.neo.7900131; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459	28	357	367	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 24	2002	419	6909					853	857		10.1038/nature01120	http://dx.doi.org/10.1038/nature01120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397362				2022-12-24	WOS:000178769800050
J	Seoane, J; Le, HV; Massague, J				Seoane, J; Le, HV; Massague, J			Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage	NATURE			English	Article							HUMAN CANCER-CELLS; TGF-BETA; C-MYC; CYCLE ARREST; G(1) ARREST; GROWTH; EXPRESSION; TRANSCRIPTION; P15(INK4B); MIZ-1	Activation of the tumour suppressor p53 by DNA damage induces either cell cycle arrest or apoptotic cell death(1). The cytostatic effect of p53 is mediated by transcriptional activation of the cyclin-dependent kinase (CDK) inhibitor p21(Cip1), whereas the apoptotic effect is mediated by transcriptional activation of mediators including PUMA and PIG3 (ref. 2). What determines the choice between cytostasis and apoptosis is not clear(3). Here we show that the transcription factor Myc is a principal determinant of this choice. Myc is directly recruited to the p21(Cip1) promoter by the DNA-binding protein Miz-1. This interaction blocks p21(Cip1) induction by p53 and other activators. As a result Myc switches, from cytostatic to apoptotic, the p53-dependent response of colon cancer cells to DNA damage. Myc does not modify the ability of p53 to bind to the p21(Cip1) or PUMA promoters, but selectively inhibits bound p53 from activating p21(Cip1) transcription. By inhibiting p21(Cip1) expression Myc favours the initiation of apoptosis, thereby influencing the outcome of a p53 response in favour of cell death.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.		Seoane, Joan/AAG-9173-2019	Seoane, Joan/0000-0002-6541-5974; Massague, Joan/0000-0001-9324-8408				ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Lane D, 2001, NATURE, V414, P25, DOI 10.1038/35102132; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WALDMAN T, 1995, CANCER RES, V55, P5187; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zeng YX, 1996, ONCOGENE, V12, P1557; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	30	534	559	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					729	734		10.1038/nature01119	http://dx.doi.org/10.1038/nature01119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384701				2022-12-24	WOS:000178615200043
J	Nelson, MR; Reid, CM; Krum, H; Muir, T; Ryan, P; McNeil, JJ				Nelson, MR; Reid, CM; Krum, H; Muir, T; Ryan, P; McNeil, JJ			Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSION; THERAPY; TRIAL	Objectives To identify simple long term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in elderly patients in general practice. Design Prospective cohort study. Setting 169 general practices in Victoria, Australia. Participants 503 patients aged 65-84 with treated hypertension who were withdrawn from all antihypertensive drugs and remained drug free and normotensive for an initial two week period; all were followed for a further 12 months. Main outcome measures Relative likelihood of maintaining normotension 12 months after drug withdrawal; relative likelihood of early return to hypertension after drug withdrawal. Results The likelihood of remaining normotensive at 12 months was greater among younger patients (65-74 years), patients with lower "on-treatment" systolic blood pressure, patients on single agent treatment, and patients with a greater waist:hip ratio. The likelihood of return to hypertension was greatest for patients with higher "on-treatment" systolic blood pressure. Conclusions Age, blood pressure control, and the number of antihypertensive drugs are important factors in the clinical decision to withdraw drug treatment. Because of consistent rates of return to antihypertensive treatment, all patients from whom such treatment is withdrawn should be monitored indefinitely to detect a recurrence of hypertension.	Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia; Alfred Hosp, Baker Heart Res Inst, Cardiovasc Dis Prevent Unit, Melbourne, Vic, Australia; Univ Adelaide, Fac Hlth Sci, Dept Publ Hlth, Adelaide, SA 5005, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; University of Adelaide	Nelson, MR (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia.	niark.nelson@med.monash.edu.au	Reid, Christopher M/AAP-8135-2021; McNeil, John/L-6440-2019	McNeil, John/0000-0002-1049-5129; Reid, Christopher/0000-0001-9173-3944				ALDERMAN MH, 1986, ARCH INTERN MED, V146, P1309, DOI 10.1001/archinte.146.7.1309; [Anonymous], 1975, CIRCULATION, V51, P1107; BLAUFOX MD, 1984, J HYPERTENS       S3, V2, P179; FOTHERBY MD, 1992, BMJ-BRIT MED J, V305, P750, DOI 10.1136/bmj.305.6856.750; GREENBERG G, 1986, BRIT MED J, V293, P988; HOWES L, 1988, CURR THERAPEUTIC NOV, P15; Jennings G L, 1995, Blood Press Suppl, V2, P99; LEE J, 1994, INT J EPIDEMIOL, V23, P201, DOI 10.1093/ije/23.1.201; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MITCHELL A, 1989, J GEN INTERN MED, V4, P221, DOI 10.1007/BF02599527; Myers MG, 1996, AM J HYPERTENS, V9, P419, DOI 10.1016/0895-7061(96)00030-1; Nelson M, 2001, AM J HYPERTENS, V14, P98, DOI 10.1016/S0895-7061(00)01246-2; STAMLER R, 1984, J HYPERTENSION S3, V2, P167; TAKATA Y, 1992, AM HEART J, V124, P1574, DOI 10.1016/0002-8703(92)90075-7; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Wing LMH, 1997, CLIN EXP HYPERTENS, V19, P779, DOI 10.3109/10641969709083186; Yusuf S, 2000, NEW ENGL J MED, V342, P145	17	29	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2002	325	7368					815	817		10.1136/bmj.325.7368.815	http://dx.doi.org/10.1136/bmj.325.7368.815			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604YM	12376444	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000178648700021
J	Smetacek, V				Smetacek, V			Microbial food webs: The ocean's veil	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							ENCHEL T, 2002, SCIENCE, V296, P1068; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; MATZ C, 2002, MECH GAZING RESISTAN; OOPLEY J, 2002, NATURE, V415, P572; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903	5	21	23	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	2002	419	6907					565	565		10.1038/419565a	http://dx.doi.org/10.1038/419565a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374956	Bronze			2022-12-24	WOS:000178483100020
J	Hoffman, KL; McNaughton, BL				Hoffman, KL; McNaughton, BL			Coordinated reactivation of distributed memory traces in primate neocortex	SCIENCE			English	Article							PREFRONTAL CORTEX; SLEEP; HIPPOCAMPUS; REPLAY; EXPERIENCE; ACTIVATION	Conversion of new memories into a lasting form may involve the gradual refinement and linking together of neural representations stored widely throughout neocortex. This consolidation process may require coordinated reactivation of distributed components of memory traces while the cortex is "offline", i.e., not engaged in processing external stimuli. Simultaneous neural ensemble recordings from four sites in the macaque neocortex revealed such coordinated reactivation. In motor, somatosensory, and parietal cortex (but not prefrontal cortex), the behaviorally induced correlation structure and temporal patterning of neural ensembles within and between regions were preserved, confirming a major tenet of the trace-reactivation theory of memory consolidation.	Univ Arizona, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	University of Arizona	McNaughton, BL (corresponding author), Univ Arizona, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA.		Hoffman, Kari L/I-3062-2012	Hoffman, Kari L/0000-0003-0560-8157	NIMH NIH HHS [MH01565] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MacLeod AK, 1998, NEUROIMAGE, V7, P41, DOI 10.1006/nimg.1997.0308; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Qin YL, 1997, PHILOS T R SOC B, V352, P1525, DOI 10.1098/rstb.1997.0139; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	14	297	303	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2070	2073		10.1126/science.1073538	http://dx.doi.org/10.1126/science.1073538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242447				2022-12-24	WOS:000178078500052
J	Eyber, C; Ager, A				Eyber, C; Ager, A			Conselho: psychological healing in displaced communities in Angola	LANCET			English	Editorial Material									Queen Margaret Univ Coll, Ctr Int Hlth Studies, Edinburgh EH12 8TS, Midlothian, Scotland	Queen Margaret University	Eyber, C (corresponding author), Queen Margaret Univ Coll, Ctr Int Hlth Studies, Edinburgh EH12 8TS, Midlothian, Scotland.			Ager, Alastair/0000-0002-9474-3563					0	17	17	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 14	2002	360	9336					871	871		10.1016/S0140-6736(02)09961-0	http://dx.doi.org/10.1016/S0140-6736(02)09961-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594MC	12243936				2022-12-24	WOS:000178053500026
J	Heron, SE; Crossland, KM; Andermann, E; Phillips, HA; Hall, AJ; Bleasel, A; Shevell, M; Mercho, S; Seni, MH; Guiot, MC; Mulley, JC; Berkovic, SF; Scheffer, IE				Heron, SE; Crossland, KM; Andermann, E; Phillips, HA; Hall, AJ; Bleasel, A; Shevell, M; Mercho, S; Seni, MH; Guiot, MC; Mulley, JC; Berkovic, SF; Scheffer, IE			Sodium-channel defects in benign familial neonatal-infantile seizures	LANCET			English	Article								Ion-channel gene defects are associated with a range of paroxysmal disorders, including several monogenic epilepsy syndromes. Two autosomal dominant disorders present in the first year of life: benign familial neonatal seizures, which is associated with potassium-channel gene defects; and benign familial infantile seizures, for which no genes have been identified. Here, we describe a clinically intermediate variant, benign familial neonatal-infantile seizures, with mutations in the sodium-channel subunit gene SCN2A. This clinico-molecular correlation defines a new benign familial epilepsy syndrome beginning in early infancy, an age at which seizure disorders frequently have a sombre prognosis.	Womens & Childrens Hosp, Dept Lab Genet, Adelaide, SA, Australia; Univ Melbourne, Dept Med Neurol, Heidelberg, Vic, Australia; AUstin & Repatriat Med Ctr, Heidelberg, Vic, Australia; Westmead Hosp, Royal Alexandra Hosp Children, Dept Neurol, Westmead, NSW 2145, Australia; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Paediat, Montreal, PQ H3A 2T5, Canada; Montreal Neurol Hosp & Inst, Neurogenet Unit, Montreal, PQ H3A 2B4, Canada	Womens & Childrens Hospital Australia; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Sydney; McGill University; McGill University; McGill University; McGill University	Heron, SE (corresponding author), Bion Res Facil, 31 Dalgleish St, Thebarton 5031, Australia.		Heron, Sarah/F-4222-2013; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; Bleasel, Andrew/W-6205-2019	Heron, Sarah/0000-0001-8759-6748; Scheffer, Ingrid E/0000-0002-2311-2174; Bleasel, Andrew/0000-0002-1843-3619; Berkovic, Samuel/0000-0003-4580-841X					0	260	279	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 14	2002	360	9336					851	852		10.1016/S0140-6736(02)09968-3	http://dx.doi.org/10.1016/S0140-6736(02)09968-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594MC	12243921				2022-12-24	WOS:000178053500012
J	Kahn, R; Herwald, H; Muller-Esterl, W; Schmitt, R; Sjogren, AC; Truedsson, L; Karpman, D				Kahn, R; Herwald, H; Muller-Esterl, W; Schmitt, R; Sjogren, AC; Truedsson, L; Karpman, D			Contact-system activation in children with vasculitis	LANCET			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MOLECULAR-WEIGHT KININOGEN; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; SCHONLEIN PURPURA NEPHRITIS; HUMAN-PLASMA; HUMAN-NEUTROPHILS; ACE GENE; BRADYKININ; POLYMORPHISM; KALLIKREIN	Background The contact system triggers the kallikrein-kinin cascade, liberating bradykinin from high-molecular-weight kininogen. Effectors of the contact system have proinflammatory and vasoactive properties. Vasculitis is a condition characterised by inflammation around vessel walls, leading to secondary tissue damage for which the underlying molecular mechanisms are poorly understood. Our aim was to investigate contact-system activation in children with vasculitis. Methods We compared 17 children, aged 4-19 years, with vasculitis, engaging the skin, joints, intestines, or kidneys, with 21 controls, aged 2-18 years. We analysed proteolysis of high-molecular-weight kininogen by immunoblotting. Plasma bradykinin concentrations were quantified by ELISA. Kidney and skin biopsies were stained in situ for kinins. Concentrations of heparin binding protein (HBP) were quantified by ELISA. Findings We noted extensive proteolysis of high-molecular-weight kininogen in the plasma of 13 of 17 patients, but in only one of 21 controls (p<0.0001). Bradykinin concentrations were higher in the patients' plasma (median 320 ng/L, range <1-19 680) than in plasma from controls (11 ng/L, <1-304; p=0.0004). Patients had local release of kinins at sites of inflammation in kidney and skin biopsies. HBP values were raised in patients (17.4 mu g/L, 5.4-237.6) compared with controls (6 mu g/L, 2.5-43.4; p=0.008). Interpretation Activation of the contact system could play a part in the pathogenesis of vasculitis, and explain the inflammation, pain, vasodilatation, and oedema seen in patients.	Lund Univ, Dept Paediat, Lund, Sweden; Lund Univ, Dept Cell & Mol Biol, Lund, Sweden; Lund Univ, Dept Lab Med, Lund, Sweden; Univ Hosp, Inst Biochem 2, Frankfurt, Germany	Lund University; Lund University; Lund University; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Karpman, D (corresponding author), Lund Univ, Dept Paediat, Lund, Sweden.	diana.karpman@pedi.lu.se	Herwald, Heiko/AAN-3708-2021	Herwald, Heiko/0000-0002-8111-2842; Karpman, Diana/0000-0001-7220-7658; Schmitt, Roland/0000-0003-4294-6526; Aradottir, Sigridur Sunna/0000-0002-6898-3256				Bank U, 2001, J LEUKOCYTE BIOL, V69, P197; Bergamaschini L, 1998, ALZ DIS ASSOC DIS, V12, P102, DOI 10.1097/00002093-199806000-00008; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bjartell A, 1999, HISTOCHEM J, V31, P45, DOI 10.1023/A:1003504115690; BUTTERY JE, 1993, CLIN CHEM, V39, P312; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Dudley J, 2000, PEDIATR NEPHROL, V14, P218, DOI 10.1007/s004670050045; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; GUSTAFSON EJ, 1989, J CLIN INVEST, V84, P28, DOI 10.1172/JCI114151; HASAN AAK, 1995, J BIOL CHEM, V270, P19256, DOI 10.1074/jbc.270.33.19256; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; JENNETTE JC, 1990, AM J KIDNEY DIS, V15, P517, DOI 10.1016/S0272-6386(12)80521-X; KAPLAN AP, 1972, J EXP MED, V135, P81, DOI 10.1084/jem.135.1.81; KAUFMANN J, 1993, J BIOL CHEM, V268, P9079; Mahabeer R, 2000, PHARMACOL THERAPEUT, V88, P77, DOI 10.1016/S0163-7258(00)00080-2; Mattsson E, 2001, INFECT IMMUN, V69, P3877, DOI 10.1128/IAI.69.6.3877-3882.2001; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLERESTERL W, 1988, METHOD ENZYMOL, V163, P240; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; PIXLEY RA, 1997, HDB IMMUNOPHARMACOLO, P173; Pullmann R, 1999, CLIN EXP RHEUMATOL, V17, P593; REDDIGARI S, 1995, INT ARCH ALLERGY IMM, V107, P93, DOI 10.1159/000236941; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Savige J, 2000, KIDNEY INT, V57, P846, DOI 10.1046/j.1523-1755.2000.057003846.x; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; Stadnicki A, 1997, DIGEST DIS SCI, V42, P2356, DOI 10.1023/A:1018891323205; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; VANDERGRAAF F, 1982, BLOOD, V59, P1225; VERPY E, 1995, J CLIN INVEST, V95, P350, DOI 10.1172/JCI117663; Volpe AR, 1999, IMMUNOPHARMACOLOGY, V44, P87, DOI 10.1016/S0162-3109(99)00140-X; WACHTFOGEL YT, 1989, BLOOD, V73, P468; WACHTFOGEL YT, 1983, J CLIN INVEST, V72, P1672, DOI 10.1172/JCI111126; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; Yoshioka T, 1998, ARCH DIS CHILD, V79, P394, DOI 10.1136/adc.79.5.394; Zhao MH, 1996, CLIN EXP IMMUNOL, V103, P397	36	33	37	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					535	541		10.1016/S0140-6736(02)09743-X	http://dx.doi.org/10.1016/S0140-6736(02)09743-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241658				2022-12-24	WOS:000177512800012
J	Labarrere, CA; Lee, JB; Nelson, DR; Al-Hassani, M; Miller, SJ; Pitts, DE				Labarrere, CA; Lee, JB; Nelson, DR; Al-Hassani, M; Miller, SJ; Pitts, DE			C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study	LANCET			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; APPARENTLY HEALTHY-MEN; UNSTABLE ANGINA; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATION; ELEVATED LEVELS; HEART-DISEASE; GRAFT FAILURE; RISK-FACTORS	Background Arterial endothelial expression and raised serum concentrations of the soluble form of intercellular adhesion molecule-1 (ICAM-1) are implicated in development of transplant coronary artery disease. We investigated whether C-reactive protein, known to stimulate ICAM-1, was associated with increased ICAM-1 concentration and subsequent development of coronary artery disease. Methods With sandwich ELISAs, we measured C-reactive protein and soluble ICAM-1 in serial serum samples obtained during the first 3 months after transplantation in 109 heart-transplant patients. Matching endomyocardial biopsy samples were screened immunohistochemically for arterial endothelial ICAM-1. Serial coronary angiograms were assessed for development, severity, and progression of coronary artery disease. Findings We showed a significant correlation (p=0.001) between raised concentrations of C-reactive protein and arterial endothelial ICAM-1 expression in endomyocardial biopsy samples. We also noted a significant relation between C-reactive protein and soluble CAM-1 concentrations soon after transplantation (p=0.003). Early raised C-reactive protein concentrations were associated with development (p=0.004), increased severity (p=0.02), and enhanced rate of progression (p=0.01) of coronary artery disease, and with heightened frequency of ischaemic events (p=0.049) and graft failure (p=0.04). Interpretation C-reactive protein concentration can be used to identify heart-transplant patients at increased risk of coronary artery disease and graft failure. Treatments directed at reduction of C-reactive protein concentration could improve patients' outcome.	Methodist Indiana Univ, Riley Hosp, Clarian Hlth Partners, Methodist Res Inst, Indianapolis, IN USA; Methodist Indiana Univ, Riley Hosp, Clarian Hlth Partners, Dept Transplantat, Indianapolis, IN USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Indiana University System; James Whitcomb Riley Hospital Children; Indiana University System; James Whitcomb Riley Hospital Children; Cleveland Clinic Foundation	Labarrere, CA (corresponding author), Methodist Res Inst Clarian Hlth, 1701 N Senate Blvd, Indianapolis, IN 46202 USA.	clabarrere@clarian.org		Nelson, David/0000-0002-3240-0725				Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Costanzo MR, 1998, J HEART LUNG TRANSPL, V17, P744; Eisenberg MS, 2000, CIRCULATION, V102, P2100, DOI 10.1161/01.CIR.102.17.2100; Gag SZ, 1996, J AM COLL CARDIOL, V28, P673, DOI 10.1016/0735-1097(96)00201-X; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; JACKSON E, 2001, HEMOSTASIS THROMBOSI, P1179; JOHNSON DE, 1989, J HEART TRANSPLANT, V8, P349; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Labarrere CA, 2000, CIRCULATION, V102, P1549, DOI 10.1161/01.CIR.102.13.1549; Labarrere CA, 2000, JAMA-J AM MED ASSOC, V284, P457, DOI 10.1001/jama.284.4.457; LABARRERE CA, 1995, NEW ENGL J MED, V333, P1111, DOI 10.1056/NEJM199510263331704; Labarrere CA, 1997, JAMA-J AM MED ASSOC, V278, P1169, DOI 10.1001/jama.278.14.1169; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Liuzzo G, 1996, CIRCULATION, V94, P2373, DOI 10.1161/01.CIR.94.10.2373; Mueck AO, 2001, EXP CLIN ENDOCR DIAB, V109, P181, DOI 10.1055/s-2001-14843; Pasceri V, 2000, CIRCULATION, V102, P2165; Rebuzzi AG, 1998, AM J CARDIOL, V82, P715, DOI 10.1016/S0002-9149(98)00458-5; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Shah PK, 2000, CIRCULATION, V101, P1758, DOI 10.1161/01.CIR.101.15.1758; Zhu JH, 1999, J AM COLL CARDIOL, V34, P1738, DOI 10.1016/S0735-1097(99)00410-6	30	94	96	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2002	360	9344					1462	1467		10.1016/S0140-6736(02)11473-5	http://dx.doi.org/10.1016/S0140-6736(02)11473-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JV	12433514				2022-12-24	WOS:000179186000011
J	Lens, L; Van Dongen, S; Norris, K; Githiru, M; Matthysen, E				Lens, L; Van Dongen, S; Norris, K; Githiru, M; Matthysen, E			Avian persistence in fragmented rainforest	SCIENCE			English	Article							FLUCTUATING ASYMMETRY; CONSERVATION; FITNESS	What factors determine the persistence of species in fragmented habitats? To address this question, we studied the relative impacts of forest deterioration and fragmentation on bird species in 12 rainforest fragments in Kenya, combining 6 years of individual capture-recapture data with measurements of current captures and museum specimens. Species mobility, as estimated from species-specific dispersal rates, and tolerance to habitat deterioration, as estimated from change in fluctuating asymmetry with increasing habitat disturbance, explained 88% of the variation in patch occupancy among eight forest bird species. Occupancy increased with mobility and with tolerance to deterioration, where both variables contributed equally to this relationship. We conclude that individual-level study, such as of dispersal behavior and phenotypic development, can predict patterns of persistence at the species level. More generally, for conservation tactics to stand a high chance of success, they should include action both within sites, to minimize habitat deterioration, and across landscapes, to maximize dispersal.	Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; Natl Museums Kenya, Dept Ornithol, Nairobi, Kenya; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Antwerp; University of Reading; University of Oxford	Lens, L (corresponding author), Univ Ghent, Dept Biol, Lab Terr Ecol, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	luc.lens@rug.ac.be	Rodewald, Amanda D/I-6308-2016	Rodewald, Amanda D/0000-0002-6719-6306; Lens, Luc/0000-0002-0241-2215				Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Congdon P., 2001, BAYESIAN STAT MODELL; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Etienne RS, 2001, AM NAT, V158, P389, DOI 10.1086/321986; GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1241, DOI 10.1098/rspb.1999.0769; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2002, CONSERV BIOL, V16, P479, DOI 10.1046/j.1523-1739.2002.00516.x; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; VANVALEN L, 1962, EVOLUTION, V16, P125; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	16	142	153	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1236	1238		10.1126/science.1075664	http://dx.doi.org/10.1126/science.1075664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424379				2022-12-24	WOS:000179080400051
J	Miller, GT; Pitnick, S				Miller, GT; Pitnick, S			Sperm-female coevolution in Drosophila	SCIENCE			English	Article							RAPID EVOLUTION; REPRODUCTIVE PROTEINS; BODY-SIZE; COMPETITION; COST	Rapid evolution of reproductive traits has been attributed to sexual selection arising from interaction between the sexes. However, little is known about the nature of selection driving the evolution of interacting sex-specific phenotypes. Using populations of Drosophila melanogaster selected for divergent sperm length or female sperm-storage organ length, we experimentally show that male fertilization success is determined by an interaction between sperm and female morphology. In addition, sperm length evolution occurred as a correlated response to selection on the female reproductive tract. Giant sperm tails are the cellular equivalent of the peacock's tail, having evolved because females evolved reproductive tracts that selectively bias paternity in favor of males with longer sperm.	Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Pitnick, S (corresponding author), Syracuse Univ, Dept Biol, 108 Coll Pl, Syracuse, NY 13244 USA.	sspitnic@syr.edu						Andersson Malte, 1994; Arnqvist G, 2002, EVOLUTION, V56, P936; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Birkhead TR, 2000, EVOLUTION, V54, P1057; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; Eady PE, 2001, J ZOOL, V253, P47, DOI 10.1017/S095283690100005X; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Gage MJG, 1998, P ROY SOC B-BIOL SCI, V265, P97, DOI 10.1098/rspb.1998.0269; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Jamieson B.G., 1987, ULTRASTRUCTURE PHYLO; Karr TL, 1996, NATURE, V379, P405, DOI 10.1038/379405a0; LaMunyon CW, 2002, P ROY SOC B-BIOL SCI, V269, P1125, DOI 10.1098/rspb.2002.1996; Miller GT, 2001, HEREDITY, V87, P25, DOI 10.1046/j.1365-2540.2001.00903.x; MILLER GT, IN PRESS J EVOL BIOL; Morrow EH, 2001, P ROY SOC B-BIOL SCI, V268, P2281, DOI 10.1098/rspb.2001.1807; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; Pitnick S, 2001, P ROY SOC B-BIOL SCI, V268, P1071, DOI 10.1098/rspb.2001.1621; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI 10.1111/j.1558-5646.1999.tb04564.x; Pitnick S, 2002, P ROY SOC B-BIOL SCI, V269, P1821, DOI 10.1098/rspb.2002.2090; PITNICK S, UNPUB; Rakitin A, 1999, CAN J FISH AQUAT SCI, V56, P2315, DOI 10.1139/cjfas-56-12-2315; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; SIMMONS LW, 2001, SPERM CONPETITION IT; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	33	348	350	0	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1230	1233		10.1126/science.1076968	http://dx.doi.org/10.1126/science.1076968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424377				2022-12-24	WOS:000179080400049
J	Dinsmore, AD; Hsu, MF; Nikolaides, MG; Marquez, M; Bausch, AR; Weitz, DA				Dinsmore, AD; Hsu, MF; Nikolaides, MG; Marquez, M; Bausch, AR; Weitz, DA			Colloidosomes: Selectively permeable capsules composed of colloidal particles	SCIENCE			English	Article							EMULSION DROPLETS; LATEX-PARTICLES; ENCAPSULATION; TEMPLATES; CELLS; MICROENCAPSULATION; ENDOSTATIN; INTERFACES	We present an approach to fabricate solid capsules with precise control of size, permeability, mechanical strength, and compatibility. The capsules are fabricated by the self-assembly of colloidal particles onto the interface of emulsion droplets. After the particles are locked together to form elastic shells, the emulsion droplets are transferred to a fresh continuous-phase fluid that is the same as that inside the droplets. The resultant structures, which we call "colloidosomes", are hollow, elastic shells whose permeability and elasticity can be precisely controlled. The generality and robustness of these structures and their potential for cellular immunoisolation are demonstrated by the use of a variety of solvents, particles, and contents.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, DEAS, Cambridge, MA 02138 USA; Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; Kraft Foods R&D, Nanotechnol Lab, Glenview, IL 60025 USA	Harvard University; Harvard University; United States Department of Energy (DOE); Los Alamos National Laboratory; Kraft Heinz	Dinsmore, AD (corresponding author), Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA.	dinsmore@physics.umass.edu; abausch@ph.atum.de; weitz@deas.harvard.edu						BAUSCH AR, UNPUB; Berg, 2018, RANDOM WALKS BIOL; Binks BP, 2002, LANGMUIR, V18, P1270, DOI 10.1021/la011420k; Bowick MJ, 2000, PHYS REV B, V62, P8738, DOI 10.1103/PhysRevB.62.8738; Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Chaikof EL, 1999, ANNU REV BIOMED ENG, V1, P103, DOI 10.1146/annurev.bioeng.1.1.103; Cohen I, 2001, SCIENCE, V292, P265, DOI 10.1126/science.1059175; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0; Ganan-Calvo AM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.274501; Gibbs BF, 1999, INT J FOOD SCI NUTR, V50, P213, DOI 10.1080/096374899101256; GORDON V, UNPUB; HURD AJ, 1985, J PHYS A-MATH GEN, V18, P1055; Joki T, 2001, NAT BIOTECHNOL, V19, P35, DOI 10.1038/83481; Kralchevsky PA, 2000, ADV COLLOID INTERFAC, V85, P145, DOI 10.1016/S0001-8686(99)00016-0; Lanza R.P., 2000, PRINCIPLES TISSUE EN; Leoni L, 2001, IEEE T BIO-MED ENG, V48, P1335, DOI 10.1109/10.959329; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lin Y. P., UNPUB; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Lowe KC, 1999, ARTIF CELL BLOOD SUB, V27, P255, DOI 10.3109/10731199909117698; Marinakos SM, 1999, J AM CHEM SOC, V121, P8518, DOI 10.1021/ja990945k; NIKOLAIDES MG, IN PRESS NATURE; ONODA GY, 1985, PHYS REV LETT, V55, P226, DOI 10.1103/PhysRevLett.55.226; Park JK, 2000, BIOTECHNOL ADV, V18, P303, DOI 10.1016/S0734-9750(00)00040-9; PIERANSKI P, 1980, PHYS REV LETT, V45, P569, DOI 10.1103/PhysRevLett.45.569; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471; RODRIGUEZ BE, 1994, MACROMOLECULES, V27, P6642, DOI 10.1021/ma00100a058; Sukhorukov GB, 1999, J PHYS CHEM B, V103, P6434, DOI 10.1021/jp990095v; Tiarks F, 2001, LANGMUIR, V17, P908, DOI 10.1021/la001276n; Umbanhowar PB, 2000, LANGMUIR, V16, P347, DOI 10.1021/la990101e; Velev OD, 2000, SCIENCE, V287, P2240, DOI 10.1126/science.287.5461.2240; Velev OD, 1996, LANGMUIR, V12, P2385, DOI 10.1021/la950679y; Velev OD, 1996, LANGMUIR, V12, P2374, DOI 10.1021/la9506786; Velev OD, 1997, LANGMUIR, V13, P1856, DOI 10.1021/la960652u; Willaert RG, 1996, REV CHEM ENG, V12, P5	38	1759	1864	22	912	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2002	298	5595					1006	1009		10.1126/science.1074868	http://dx.doi.org/10.1126/science.1074868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411700	Green Submitted			2022-12-24	WOS:000178932000050
J	Ganesan, S; Silver, DP; Greenberg, RA; Avni, D; Drapkin, R; Miron, A; Mok, SC; Randrianarison, V; Brodie, S; Salstrom, J; Rasmussen, TP; Klimke, A; Marrese, C; Marahrens, Y; Deng, CX; Feunteun, J; Livingston, DM				Ganesan, S; Silver, DP; Greenberg, RA; Avni, D; Drapkin, R; Miron, A; Mok, SC; Randrianarison, V; Brodie, S; Salstrom, J; Rasmussen, TP; Klimke, A; Marrese, C; Marahrens, Y; Deng, CX; Feunteun, J; Livingston, DM			BRCA1 supports XIST RNA concentration on the inactive X chromosome	CELL			English	Article							MEIOTIC CELLS; BREAST-CANCER; ESTROGEN-RECEPTOR; DNA-REPAIR; TRANSCRIPTION; MUTATION; ASSOCIATION; PROTEINS; COMPLEX; CHROMATIN	BRCA1, a breast and ovarian tumor suppressor, colocalizes with markers of the inactive X chromosome (Xi) on Xi in female somatic cells and associates with XIST RNA, as detected by chromatin immunoprecipitation. Breast and ovarian carcinoma cells lacking BRCA1 show evidence of defects in Xi chromatin structure. Reconstitution of BRCA1-deficient cells with wt BRCA1 led to the appearance of focal XIST RNA staining without altering XIST abundance. Inhibiting BRCA1 synthesis in a suitable reporter line led to increased expression of an otherwise silenced Xi-located GFP transgene. These observations suggest that loss of BRCA1 in female cells may lead to Xi perturbation and destabilization of its silenced state.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Lab Gynecol Oncol, Boston, MA 02115 USA; Inst Gustave Roussy, Lab Genet Oncol, Lab Vectorol & Transfert Genes, F-94805 Villejuif, France; NIDDKD, Genet Dev & Dis Branch 10 9N105, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Human Genet, Gonda Ctr, Los Angeles, CA 90095 USA; Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; UNICANCER; Gustave Roussy; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California Los Angeles; University of Connecticut; University of Connecticut	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Avni, Dror/GRE-8325-2022; deng, chuxia/N-6713-2016; Feunteun, Jean/AAZ-1267-2020; Silver, Daniel/P-3443-2019; Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; Feunteun, Jean/0000-0003-1212-9189; Rasmussen, Theodore/0000-0001-9450-3394; Avni, Dror/0000-0002-8738-1840	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, Z01DK056001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayoub N, 1997, CHROMOSOMA, V106, P1, DOI 10.1007/s004120050218; Bieche I, 1999, CLIN CHEM, V45, P1148; Blackshear PE, 1998, ONCOGENE, V16, P61, DOI 10.1038/sj.onc.1201506; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Brodie S G, 2001, Trends Genet, V17, pS18, DOI 10.1016/S0168-9525(01)02451-9; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Buller RE, 1999, JNCI-J NATL CANCER I, V91, P339, DOI 10.1093/jnci/91.4.339; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Deng CX, 2000, BIOESSAYS, V22, P728; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gilbert SL, 2000, J BIOL CHEM, V275, P36491, DOI 10.1074/jbc.C000409200; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; HANDEL MA, 1992, BIOESSAYS, V14, P817, DOI 10.1002/bies.950141205; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; Jazaeri AA, 2002, JNCI-J NATL CANCER I, V94, P990, DOI 10.1093/jnci/94.13.990; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; KIMMEL VM, 1957, CANCER, V10, P922; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MOORE R, 1957, BRIT J CANCER, V11, P384; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; PERRY M, 1972, BRIT J SURG, V59, P731, DOI 10.1002/bjs.1800590912; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; Richler C, 2000, CYTOGENET CELL GENET, V89, P118, DOI 10.1159/000015589; SAVINO A, 1971, ACTA CYTOL, V15, P372; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Squire JA, 2000, GENOMICS, V65, P234, DOI 10.1006/geno.2000.6155; Tomlinson GE, 1998, CANCER RES, V58, P3237; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang Y, 2000, GENE DEV, V14, P927; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	52	232	239	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					393	405		10.1016/S0092-8674(02)01052-8	http://dx.doi.org/10.1016/S0092-8674(02)01052-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419249	Bronze			2022-12-24	WOS:000179010100011
J	Yifrach, O; MacKinnon, R				Yifrach, O; MacKinnon, R			Energetics of pore opening in a voltage-gated K+ channel	CELL			English	Article							SHAKER POTASSIUM CHANNELS; ION CHANNELS; GATING CHARGE; WILD-TYPE; ACTIVATION; MOVEMENT; S4; SELECTIVITY; TRANSITIONS; SENSOR	Voltage-dependent gating in K+ channels results from the mechanical coupling of voltage sensor movements to pore opening. We used single and double mutations in the pore of the Shaker K+ channel to analyze a late concerted pore opening transition and interpreted the results in the context of known K+ channel structures. Gating sensitive mutations are located at mechanistically informative regions of the pore and are coupled energetically across distances up to 15 Angstrom. We propose that the pore is intrinsically more stable when closed, and that to open the pore the voltage sensors must exert positive work by applying an outward lateral force near the inner helix bundle.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.		YIFRACH, Ofer/F-1480-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047400] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47400] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	249	254	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 18	2002	111	2					231	239		10.1016/S0092-8674(02)01013-9	http://dx.doi.org/10.1016/S0092-8674(02)01013-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408867	Bronze			2022-12-24	WOS:000178753500012
J	Whelton, PK; He, J; Appel, LJ; Cutler, JA; Havas, S; Kotchen, TA; Roccella, EJ; Stout, R; Vallbona, C; Winston, MC; Karimbakas, J				Whelton, PK; He, J; Appel, LJ; Cutler, JA; Havas, S; Kotchen, TA; Roccella, EJ; Stout, R; Vallbona, C; Winston, MC; Karimbakas, J		Natl High Blood Pressure Educ Prog	Primary prevention of hypertension - Clinical and public health advisory from the National High Blood Pressure Education Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCED DIETARY-SODIUM; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; ADULT-POPULATION; UNITED-STATES; RISK-FACTOR; METAANALYSIS; REDUCTION; MORTALITY; MEN	The National High Blood Pressure Education Program Coordinating Committee published its first statement on the primary prevention of hypertension in 1993. This article updates the 1993 report, using new and further evidence from the scientific literature. Current recommendations for primary prevention of hypertension involve a population-based approach and an intensive targeted strategy focused on individuals at high risk for hypertension. These 2 strategies are complementary and emphasize 6 approaches with proven efficacy for prevention of hypertension: engage in moderate physical activity; maintain normal body weight; limit alcohol consumption; reduce sodium intake; maintain adequate intake of potassium; and consume a diet rich in fruits, vegetables, and low-fat dairy products and reduced in saturated and total fat. Applying these approaches to the general population as a component of public health and clinical practice can help prevent blood pressure from increasing and can help decrease elevated blood pressure levels for those with high normal blood pressure or hypertension.	NHLBI, Natl High Blood Pressure Educ Program, Off Prevent Educ & Control, NIH, Bethesda, MD 20892 USA; Tulane Univ, Hlth Sci Ctr, Dept Epidemiol & Med, New Orleans, LA 70118 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; Johns Hopkins Med Inst, Dept Internal Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Int Hlth, Baltimore, MD 21205 USA; NHLBI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA; Procter & Gamble Co, Hlth Care Res Ctr, Mason, OH USA; Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA; Amer Heart Assoc, Dallas, TX USA; Amer Inst Res Hlth Program, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tulane University; Tulane University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland Baltimore; Medical College of Wisconsin; Procter & Gamble; Baylor College of Medicine; American Institutes for Research	Roccella, EJ (corresponding author), NHLBI, Natl High Blood Pressure Educ Program, Off Prevent Educ & Control, NIH, 31 Ctr Dr,MSC 2480, Bethesda, MD 20892 USA.	roccella@nih.gov	Appel, Larry/GLT-2608-2022					[Anonymous], 1997, ARCH INTERN MED, V157, P2413; APPEL LJ, 1993, ARCH INTERN MED, V153, P1429, DOI 10.1001/archinte.153.12.1429; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; DEHMER GJ, 1988, NEW ENGL J MED, V319, P733, DOI 10.1056/NEJM198809223191201; Falkner B, 1996, PEDIATRICS, V98, P649; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Griffith LE, 1999, AM J HYPERTENS, V12, P84, DOI 10.1016/S0895-7061(98)00224-6; He J, 1999, J HYPERTENS, V17, pS7; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; *I MED, 1997, DIET REF INT CALC PH, P106; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; LAST JM, 1995, DICT EPIDEMIOLOGY; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; STAMLER R, 1991, HYPERTENSION, V17, pI16, DOI 10.1161/01.HYP.17.1_Suppl.I16; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; *US DEPT HHS, 1996, PHYS ACT HLTH REP SU, V28; *US DEPT HHS, 2002, HEARTS N PARKS; *US DEPT HHS, 2002, YOUR GUID LOW HIGH B; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Wolz M, 2000, AM J HYPERTENS, V13, P103, DOI 10.1016/S0895-7061(99)00241-1; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	45	1000	1042	2	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2002	288	15					1882	1888		10.1001/jama.288.15.1882	http://dx.doi.org/10.1001/jama.288.15.1882			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604EU	12377087				2022-12-24	WOS:000178604200027
J	Bodenheimer, T; Wagner, EH; Grumbach, K				Bodenheimer, T; Wagner, EH; Grumbach, K			Improving primary care for patients with chronic illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY	The chronic care model is a guide to higher-quality chronic illness management within primary care. The model predicts that improvement in its 6 interrelated components-self-management support, clinical information systems, delivery system redesign, decision support, health care organization, and community resources-can produce system reform in which informed, activated patients interact with prepared, proactive practice teams. Case studies are provided describing how components of the chronic care model have been implemented in the primary care practices of 4 health care organizations.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, MacColl Inst Healthcare Innovat, Seattle, WA USA	University of California System; University of California San Francisco; Group Health Cooperative	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Ward 83,1001 Potrero Ave, San Francisco, CA 94110 USA.	tbodie@earthlink.net	Tao, Youyou/D-2367-2014; Young, Alexander/A-1523-2009; Grumbach, Kevin/L-9222-2016	Young, Alexander/0000-0002-9367-9213; 				[Anonymous], 1997, ARCH INTERN MED, V157, P2413; BYRNES J, 1998, DIS MANAG, V1, P39; Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Institute of Medicine, 2001, CROSSING QUALITY CHA; Legorreta AP, 2000, AM J MANAG CARE, V6, P445; Lorig K, 1993, GENERATIONS, V3, P11; McBride P, 1998, ARCH INTERN MED, V158, P1238, DOI 10.1001/archinte.158.11.1238; Ni HY, 1998, ARCH INTERN MED, V158, P1231, DOI 10.1001/archinte.158.11.1231; Perez-Stable EJ, 1998, WESTERN J MED, V169, P23; *RW JOHNS FDN, 2002, IMPR CHRON ILLN CAR; Samsa GP, 2000, ARCH INTERN MED, V160, P967, DOI 10.1001/archinte.160.7.967; Sperl-Hillen J, 2000, Jt Comm J Qual Improv, V26, P615; Stuart M E, 1991, HMO Pract, V5, P198; *US DEP HHS, 2000, HLTH US 2000; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2001, BMJ-BRIT MED J, V323, P945, DOI 10.1136/bmj.323.7319.945; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	24	1840	1861	8	143	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2002	288	14					1775	1779		10.1001/jama.288.14.1775	http://dx.doi.org/10.1001/jama.288.14.1775			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	602BJ	12365965				2022-12-24	WOS:000178484700034
J	Carlton, JM; Angiuoli, SV; Suh, BB; Kooij, TW; Pertea, M; Silva, JC; Ermolaeva, MD; Allen, JE; Selengut, JD; Koo, HL; Peterson, JD; Pop, M; Kosack, DS; Shumway, MF; Bidwell, SL; Shallom, SJ; van Aken, SE; Riedmuller, SB; Feldblyum, TV; Cho, JK; Quackenbush, J; Sedegah, M; Shoaibi, A; Cummings, LM; Florens, L; Yates, JR; Raine, JD; Sinden, RE; Harris, MA; Cunningham, DA; Preiser, PR; Bergman, LW; Vaidya, AB; Van Lin, LH; Janse, CJ; Waters, AP; Smith, HO; White, OR; Salzberg, SL; Venter, JC; Fraser, CM; Hoffman, SL; Gardner, MJ; Carucci, DJ				Carlton, JM; Angiuoli, SV; Suh, BB; Kooij, TW; Pertea, M; Silva, JC; Ermolaeva, MD; Allen, JE; Selengut, JD; Koo, HL; Peterson, JD; Pop, M; Kosack, DS; Shumway, MF; Bidwell, SL; Shallom, SJ; van Aken, SE; Riedmuller, SB; Feldblyum, TV; Cho, JK; Quackenbush, J; Sedegah, M; Shoaibi, A; Cummings, LM; Florens, L; Yates, JR; Raine, JD; Sinden, RE; Harris, MA; Cunningham, DA; Preiser, PR; Bergman, LW; Vaidya, AB; Van Lin, LH; Janse, CJ; Waters, AP; Smith, HO; White, OR; Salzberg, SL; Venter, JC; Fraser, CM; Hoffman, SL; Gardner, MJ; Carucci, DJ			Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii	NATURE			English	Article							RESTRICTION MAP; PROTEIN FAMILY; MARKOV-MODELS; BLOOD STAGES; FALCIPARUM; BERGHEI; GENES; DNA; IDENTIFICATION; CHABAUDI	Species of malaria parasite that infect rodents have long been used as models for malaria disease research. Here we report the whole-genome shotgun sequence of one species, Plasmodium yoelii yoelii, and comparative studies with the genome of the human malaria parasite Plasmodium falciparum clone 3D7. A synteny map of 2,212 P. y. yoelii contiguous DNA sequences (contigs) aligned to 14 P. falciparum chromosomes reveals marked conservation of gene synteny within the body of each chromosome. Of about 5,300 P. falciparum genes, more than 3,300 P. y. yoelii orthologues of predominantly metabolic function were identified. Over 800 copies of a variant antigen gene located in subtelomeric regions were found. This is the first genome sequence of a model eukaryotic parasite, and it provides insight into the use of such systems in the modelling of Plasmodium biology and disease.	Inst Genom Res, Rockville, MD 20850 USA; Ctr Advancement Genom, Rockville, MD 20850 USA; Leiden Univ, Dept Parasitol, Med Ctr, NL-2300 RC Leiden, Netherlands; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ London Imperial Coll Sci Technol & Med, Infect & Immun Sect, Dept Biol Sci, London SW7 2AZ, England; Celara Genom, Rockville, MD 20850 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Drexel Univ, Div Mol Parasitol, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19129 USA	J. Craig Venter Institute; J. Craig Venter Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; United States Department of Defense; United States Navy; Scripps Research Institute; Imperial College London; MRC National Institute for Medical Research; Drexel University	Carlton, JM (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	carlton@tigr.org	Salzberg, Steven L/F-6162-2011; Angiuoli, Samuel V/H-7340-2014; Waters, Andy P/C-9377-2009; Silva, Joana/GYQ-9526-2022; Pertea, Mihaela/AAT-2705-2021; Salzberg, Steven/Q-6514-2019; Silva, Joana/GVT-6441-2022; Preiser, Peter R/A-2201-2011; Kooij, Taco W.A./L-5623-2015; Pop, Mihai/A-7987-2013	Salzberg, Steven L/0000-0002-8859-7432; Waters, Andy P/0000-0001-8900-2982; Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven/0000-0002-8859-7432; Kooij, Taco W.A./0000-0002-8547-7523; Pop, Mihai/0000-0001-9617-5304; Angiuoli, Samuel/0000-0001-9525-4350; Quackenbush, John/0000-0002-2702-5879; Janse, Chris J/0000-0002-6410-6205; Allen, Jonathan/0000-0002-4359-8263; Fraser, Claire/0000-0003-1462-2428; Florens, Laurence/0000-0002-9310-6650; Harris, Michael/0000-0001-8789-0912; , Peter/0000-0003-4331-7000	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI028398] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M, 2001, GENOME RES, V11, P1425; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Black CG, 1999, INFECT IMMUN, V67, P2075, DOI 10.1128/IAI.67.5.2075-2081.1999; Carlton Jane M., 2002, Trends in Parasitology, V18, P100, DOI 10.1016/S1471-4922(01)02229-2; Carlton JMR, 1999, MOL BIOCHEM PARASIT, V101, P23, DOI 10.1016/S0166-6851(99)00045-6; Carlton JMR, 2001, CURR OPIN MICROBIOL, V4, P415, DOI 10.1016/S1369-5274(00)00228-9; Carlton JMR, 1998, MOL BIOCHEM PARASIT, V93, P285, DOI 10.1016/S0166-6851(98)00043-7; Carter R., 1977, P359; Cawley SE, 2001, MOL BIOCHEM PARASIT, V118, P167, DOI 10.1016/S0166-6851(01)00363-2; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Daly TM, 2001, MOL BIOCHEM PARASIT, V117, P27, DOI 10.1016/S0166-6851(01)00329-2; DAME JB, 1983, J BIOL CHEM, V258, P6984; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; FAVALORO JM, 1993, MOL BIOCHEM PARASIT, V62, P263, DOI 10.1016/0166-6851(93)90115-E; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Galinski MR, 2000, MOL BIOCHEM PARASIT, V108, P257, DOI 10.1016/S0166-6851(00)00219-X; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garnham P.C.C., 1966, MALARIA PARASITES OT; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; JANSE CJ, 1993, PARASITOL TODAY, V9, P19, DOI 10.1016/0169-4758(93)90158-C; JANSE CJ, 1994, MOL BIOCHEM PARASIT, V68, P285, DOI 10.1016/0166-6851(94)90173-2; JANSE CJ, 1992, EXP PARASITOL, V74, P1, DOI 10.1016/0014-4894(92)90133-U; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; LANDAU I, 1965, CR HEBD ACAD SCI, V261, P230; LANDER E S, 1988, Genomics, V2, P231; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; MCCUTCHAN TF, 1984, SCIENCE, V225, P808, DOI 10.1126/science.6382604; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NEI M, 1986, MOL BIOL EVOL, V3, P418; OGURTSOV AY, IN PRESS BIOINFORMAT; Ohkanda J, 2001, BIOORG MED CHEM LETT, V11, P761, DOI 10.1016/S0960-894X(01)00055-5; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Shabalina SA, 2001, TRENDS GENET, V17, P373, DOI 10.1016/S0168-9525(01)02344-7; Spielmann T, 2000, MOL BIOCHEM PARASIT, V111, P453, DOI 10.1016/S0166-6851(00)00333-9; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tchavtchitch M, 2001, MOL BIOCHEM PARASIT, V118, P211, DOI 10.1016/S0166-6851(01)00380-2; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Lin LHM, 2001, NUCLEIC ACIDS RES, V29, P2059, DOI 10.1093/nar/29.10.2059; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; vanLin LHM, 1997, MOL BIOCHEM PARASIT, V86, P111, DOI 10.1016/S0166-6851(97)90012-8; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140; WEINBAUM FI, 1976, J IMMUNOL, V116, P1280; Wiser MF, 1997, EXP PARASITOL, V85, P43, DOI 10.1006/expr.1996.4126	62	587	650	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					512	519		10.1038/nature01099	http://dx.doi.org/10.1038/nature01099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368865	hybrid			2022-12-24	WOS:000178348400046
J	Gill, TM; Baker, DI; Gottschalk, M; Peduzzi, PN; Allore, H; Byers, A				Gill, TM; Baker, DI; Gottschalk, M; Peduzzi, PN; Allore, H; Byers, A			A program to prevent functional decline in physically frail, elderly persons who live at home	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OLDER PERSONS; CARE; DISABILITY; DEPENDENCE; STRATEGIES; EXERCISE; PEOPLE; ADULTS; RISK; AGE	Background: Functional decline in physically frail, elderly persons is associated with substantial morbidity. It is uncertain whether such functional decline can be prevented. Methods: We randomly assigned 188 persons 75 years of age or older who were physically frail and living at home to undergo a six-month, home-based intervention program that included physical therapy and that focused primarily on improving underlying impairments in physical abilities, including balance, muscle strength, ability to transfer from one position to another, and mobility, or to undergo an educational program (as a control). The primary outcome was the change between base line and 3, 7, and 12 months in the score on a disability scale based on eight activities of daily living: walking, bathing, upper- and lower-body dressing, transferring from a chair, using the toilet, eating, and grooming. Scores on the scale ranged from 0 to 16, with higher scores indicating more severe disability. Results: Participants in the intervention group had less functional decline over time, according to their disability scores, than participants in the control group. The disability scores in the intervention and control groups were 2.3 and 2.8, respectively, at base line; 2.0 and 3.6 at 7 months (P=0.008 for the comparison between the groups in the change from base line); and 2.7 and 4.2 at 12 months (P=0.02). The benefit of the intervention was observed among participants with moderate frailty but not those with severe frailty. The frequency of admission to a nursing home did not differ significantly between the intervention group and the control group (14 percent and 19 percent, respectively; P=0.37). Conclusions: A home-based program targeting underlying impairments in physical abilities can reduce the progression of functional decline among physically frail, elderly persons who live at home.	Yale Univ, Sch Med, Dorothy Adler Geriatr Assessment Ctr, Dept Internal Med, New Haven, CT 06504 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Dept Rehabil Serv, New Haven, CT 06504 USA; Connecticut Healthcare Syst, Dept Vet Affairs, West Haven, CT USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Gill, TM (corresponding author), Yale Univ, Sch Med, Dorothy Adler Geriatr Assessment Ctr, Dept Internal Med, TMP 17B,20 York St, New Haven, CT 06504 USA.	gill@ynhh.org	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	NATIONAL INSTITUTE ON AGING [P60AG010469, K23AG000759] Funding Source: NIH RePORTER; NIA NIH HHS [P60AG10469, K23AG00759] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; COUGHLIN TA, 1992, HEALTH SERV RES, V27, P453; *DEP HLTH HUM SERV, 1990, DHHS PUBL; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; Gill TM, 2001, J AM GERIATR SOC, V49, P1039, DOI 10.1046/j.1532-5415.2001.49206.x; GILL TM, IN PRESS ARCH PHYS M; GILL TM, IN PRESS ARCH INTERN; GILL TM, 1995, J GERONTOL MED SCI, V50, pM325; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 2002, AM J PUBLIC HEALTH, V92, P1244, DOI 10.2105/AJPH.92.8.1244; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Jette AM, 1999, AM J PUBLIC HEALTH, V89, P66, DOI 10.2105/AJPH.89.1.66; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; KEMPER P, 1992, HEALTH SERV RES, V27, P421; KING AC, 1988, AM J CARDIOL, V61, P628, DOI 10.1016/0002-9149(88)90778-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levine C, 1999, NEW ENGL J MED, V340, P1587, DOI 10.1056/NEJM199905203402013; MANTON KG, 1988, J GERONTOL, V43, pS153, DOI 10.1093/geronj/43.5.S153; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; MCCULLAGH P., 1991, GEN LINEAR MODELS; MCKINLAY JB, 1995, J AGING HEALTH, V7, P497, DOI 10.1177/089826439500700403; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002	31	557	567	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2002	347	14					1068	1074		10.1056/NEJMoa020423	http://dx.doi.org/10.1056/NEJMoa020423			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	599KD	12362007				2022-12-24	WOS:000178332900003
J	Arbeitman, MN; Furlong, EEM; Imam, F; Johnson, E; Null, BH; Baker, BS; Krasnow, MA; Scott, MP; Davis, RW; White, KP				Arbeitman, MN; Furlong, EEM; Imam, F; Johnson, E; Null, BH; Baker, BS; Krasnow, MA; Scott, MP; Davis, RW; White, KP			Gene expression during the life cycle of Drosophila melanogaster	SCIENCE			English	Article							PATTERNS; MICROARRAY; PRESENILIN; SEQUENCE; COMPLEX; NOTCH; DNA	Molecular genetic studies of Drosophila melanogaster have led to profound advances in understanding the regulation of development. Here we report gene expression patterns for nearly one-third of all Drosophila genes during a complete time course of development. Mutations that eliminate eye or germline tissue were used to further analyze tissue-specific gene expression programs. These studies de ne major characteristics of the transcriptional programs that underlie the life cycle, compare development in males and females, and show that large-scale gene expression data collected from whole animals can be used to identify genes expressed in particular tissues and organs or genes involved in specific biological and biochemical processes.	Stanford Univ, Genome Technol Ctr, Palo Alto, CA 94306 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; European Mol Biol Lab, Dev Biol Program, D-69117 Heidelberg, Germany; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Stanford University; Yale University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; European Molecular Biology Laboratory (EMBL); University of Oregon	White, KP (corresponding author), Stanford Univ, Genome Technol Ctr, 855 Calif Ave, Palo Alto, CA 94306 USA.			Furlong, Eileen/0000-0002-9544-8339	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [F32 GM019760] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AKAM M, 1987, DEVELOPMENT, V101, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; BARNETT T, 1980, CELL, V21, P729, DOI 10.1016/0092-8674(80)90436-5; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Bertram MJ, 1996, INSECT BIOCHEM MOLEC, V26, P971, DOI 10.1016/S0965-1748(96)00064-1; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gateff E, 1982, Prog Clin Biol Res, V85 Pt B, P621; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HAZELRIGG T, 1990, GENETICS, V126, P607; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; LEVY LS, 1981, DEV BIOL, V85, P141, DOI 10.1016/0012-1606(81)90243-8; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P00225, DOI DOI 10.1111/J.1601-5223.1952.TB02915.X; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Spradling Allan C., 1993, P1; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	28	686	710	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2270	2275		10.1126/science.1072152	http://dx.doi.org/10.1126/science.1072152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12351791				2022-12-24	WOS:000178222000050
J	Maldonado, AM; Doerner, P; Dixon, RA; Lamb, CJ; Cameron, RK				Maldonado, AM; Doerner, P; Dixon, RA; Lamb, CJ; Cameron, RK			A putative lipid transfer protein involved in systemic resistance signalling in Arabidopsis	NATURE			English	Article							INDUCED DISEASE RESISTANCE; SYRINGAE PV. TOMATO; SALICYLIC-ACID; ACQUIRED-RESISTANCE; GENE; THALIANA; PLANTS; ACCUMULATION; TRANSDUCTION; PATHOGENS	Localized attack by a necrotizing pathogen induces systemic acquired resistance (SAR) to subsequent attack by a broad range of normally virulent pathogens. Salicylic acid accumulation is required for activation of local defenses, such as pathogenesis-related protein accumulation, at the initial site of attack, and for subsequent expression of SAR upon secondary, distant challenge(1,2). Although salicylic acid moves through the plant, it is apparently not an essential mobile signal(2). We screened Agrobacterium tumefaciens transfer DNA (tDNA) tagged lines of Arabidopsis thaliana for mutants specifically compromized in SAR. Here we show that Defective in induced resistance 1-1 (dir1-1) exhibits wild-type local resistance to avirulent and virulent Pseudomonas syringae, but that pathogenesis-related gene expression is abolished in uninoculated distant leaves and dir1-1 fails to develop SAR to virulent Pseudomonas or Peronospora parasitica. Petiole exudate experiments indicate that dir1-1 is defective in the production or transmission from the inoculated leaf of an essential mobile signal. DIR1 encodes a putative apoplastic lipid transfer protein and we propose that DIR1 interacts with a lipid-derived molecule to promote long distance signalling.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Noble Fdn Inc, Ardmore, OK 73401 USA	Salk Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Toronto; Noble Research Institute	Cameron, RK (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Mary, Ana/AAA-2822-2019	Mary, Ana/0000-0002-9357-012X; Doerner, Peter/0000-0001-7218-8469				Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; Cameron RK, 1999, PHYSIOL MOL PLANT P, V55, P121, DOI 10.1006/pmpp.1999.0214; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; DALESSIO JM, 1992, FOCUS, V14, P76; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Feldmann K. A., 1992, Methods in Arabidopsis research., P274; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Garcia-Olmedo Francisco, 1995, Trends in Microbiology, V3, P72, DOI 10.1016/S0966-842X(00)88879-4; Gomar J, 1998, PROTEINS, V31, P160, DOI 10.1002/(SICI)1097-0134(19980501)31:2<160::AID-PROT6>3.0.CO;2-Q; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Kader JC, 1997, TRENDS PLANT SCI, V2, P66, DOI 10.1016/S1360-1385(97)82565-4; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mauch-Mani B, 1998, ANN BOT-LONDON, V82, P535, DOI 10.1006/anbo.1998.0726; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; THOMA S, 1993, PLANT J, V3, P427, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; VERNOOIJ B, 1995, MOL PLANT MICROBE IN, V8, P228, DOI 10.1094/MPMI-8-0228; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353; Wolfe J, 2000, PHYSIOL MOL PLANT P, V56, P253, DOI 10.1006/pmpp.2000.0270; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021	31	550	614	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					399	403		10.1038/nature00962	http://dx.doi.org/10.1038/nature00962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353036				2022-12-24	WOS:000178195400047
J	Johansson, J; Mandin, P; Renzoni, A; Chiaruttini, C; Springer, M; Cossart, P				Johansson, J; Mandin, P; Renzoni, A; Chiaruttini, C; Springer, M; Cossart, P			An RNA thermosensor controls expression of virulence genes in Listeria monocytogenes	CELL			English	Article							ESCHERICHIA-COLI; PLEIOTROPIC ACTIVATOR; MAMMALIAN-CELLS; PRFA; PROTEIN; TRANSLATION; INTERNALIN; REGULATOR; PROMOTER; CLONING	In Listeria monocytogenes, virulence genes are maximally expressed at 37degreesC, almost silent at 30degreesC and controlled by PrfA, a transcriptional activator whose expression is thermoregulated. Here, we show that the untranslated mRNA (UTR) preceding prfA, forms a secondary structure, which masks the ribosome binding region. Mutations predicted to destabilize this structure led to virulence gene expression and invasion of mammalian cells at 30degreesC. Chemical probing, native gel electrophoresis, in vitro translation, and "compensatory" and "increased stability" mutations demonstrated that the UTR switches between a structure active at high temperatures, and another inactive at low temperatures. Strikingly, when the DNA corresponding to the UTR was fused to gfp in E. coli, bacteria became fluorescent at 37degreesC, but not at 30degreesC. This mechanism of posttranscriptional thermoregulation may have important applications.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75724 Paris 15, France; Inst Biol Physicochim, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, 28 Rue Dr Roux, F-75724 Paris 15, France.		Taylor, Graham/A-4027-2012	Renzoni, Adriana/0000-0002-4897-5208; Mandin, Pierre/0000-0002-4870-941X				BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BHATTACHARYYA A, 1990, NATURE, V343, P484, DOI 10.1038/343484a0; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; GAILLARD JL, 1994, METHOD ENZYMOL, V236, P551; GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; PHILIPPE C, 1993, P NATL ACAD SCI USA, V90, P4394, DOI 10.1073/pnas.90.10.4394; Renzoni A, 1997, INFECT IMMUN, V65, P1515, DOI 10.1128/IAI.65.4.1515-1518.1997; SHEEHAN B, 1995, J BACTERIOL, V177, P6469, DOI 10.1128/jb.177.22.6469-6476.1995; Sheehan B, 1996, MOL MICROBIOL, V20, P785, DOI 10.1111/j.1365-2958.1996.tb02517.x; VICENTE MF, 1985, FEMS MICROBIOL LETT, V30, P77; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	24	470	494	2	56	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					551	561		10.1016/S0092-8674(02)00905-4	http://dx.doi.org/10.1016/S0092-8674(02)00905-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230973	Bronze			2022-12-24	WOS:000177943700003
J	Agalioti, T; Chen, GY; Thanos, D				Agalioti, T; Chen, GY; Thanos, D			Deciphering the transcriptional histone acetylation code for a human gene	CELL			English	Article							IFN-BETA ENHANCEOSOME; H3 PHOSPHORYLATION; IN-VITRO; COACTIVATORS; HETEROCHROMATIN; DEACETYLATION; REQUIREMENTS; RECRUITMENT; ACTIVATION; EXPRESSION	We report the results of experiments designed to test the histone code hypothesis. We found that only a small subset of lysines in histories H4 and H3 are acetylated in vivo by the GCN5 acetyltransferase during activation of the IFN-beta gene. Reconstitution of recombinant nucleosomes bearing mutations in these lysine residues revealed the cascade of gene activation via a point-by-point interpretation of the histone code through the ordered recruitment of bromodomain-containing transcription complexes. Acetylation of histone H4 K8 mediates recruitment of the SWI/SNF complex whereas acetylation of K9 and K14 in histone H3 is critical for the recruitment of TFIID. Thus, the information contained in the DNA address of the enhancer is transferred to the histone N termini by generating novel adhesive surfaces required for the recruitment of transcription complexes.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Biomed Sci Res Ctr Al Fleming, Inst Mol Biol & Genet, Athens 16672, Greece	Columbia University; Alexander Fleming Biomedical Sciences Research Center	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	dt73@columbia.edu	Thanos, Dimitris/AAE-5720-2019	Agalioti, Theodora/0000-0002-5898-2751	NIGMS NIH HHS [GM54605] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054605] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Featherstone M, 2002, CURR OPIN GENET DEV, V12, P149, DOI 10.1016/S0959-437X(02)00280-0; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Loyola A, 2001, GENE DEV, V15, P2837; Luger K, 1999, METH MOL B, V119, P1; Marmorstein R, 2001, GENE, V272, P1, DOI 10.1016/S0378-1119(01)00519-4; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Peterson CL, 2002, CURR BIOL, V12, pR245, DOI 10.1016/S0960-9822(02)00782-0; Ptashne M., 2002, GENES SIGNALS; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108	40	500	516	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2002	111	3					381	392		10.1016/S0092-8674(02)01077-2	http://dx.doi.org/10.1016/S0092-8674(02)01077-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419248	Bronze			2022-12-24	WOS:000179010100010
J	Heussler, VT; Rottenberg, S; Schwab, R; Kuenzi, P; Fernandez, PC; McKellar, S; Shiels, B; Chen, ZJJ; Orth, K; Wallach, D; Dobbelaere, DAE				Heussler, VT; Rottenberg, S; Schwab, R; Kuenzi, P; Fernandez, PC; McKellar, S; Shiels, B; Chen, ZJJ; Orth, K; Wallach, D; Dobbelaere, DAE			Hijacking of host cell IKK signalosomes by the transforming parasite Theileria	SCIENCE			English	Article							NF-KAPPA-B; BOVINE LYMPHOCYTES; SIGNALING PATHWAYS; PARVA INFECTION; KINASE IKK; T-CELLS; ACTIVATION; RIP; OLIGOMERIZATION; LEUKOCYTES	Parasites have evolved a plethora of mechanisms to ensure their propagation and evade antagonistic host responses. The intracellular protozoan parasite Theileria is the only eukaryote known to induce uncontrolled host cell proliferation. Survival of Theileria-transformed leukocytes depends strictly on constitutive nuclear factor kappa B (NF-kappaB) activity. We found that this was mediated by recruitment of the multisubunit IkappaB kinase (IKK) into large, activated foci on the parasite surface. IKK signalosome assembly was specific for the transforming schizont stage of the parasite and was down-regulated upon differentiation into the nontransforming merozoite stage. Our findings provide insights into IKK activation and how pathogens subvert host-cell signaling pathways.	Univ Bern, Inst Anim Pathol, Div Mol Pathol, CH-3012 Bern, Switzerland; Univ Glasgow, Dept Vet Parasitol, Glasgow G61 1QH, Lanark, Scotland; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Bern; University of Glasgow; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Weizmann Institute of Science	Dobbelaere, DAE (corresponding author), Univ Bern, Inst Anim Pathol, Div Mol Pathol, CH-3012 Bern, Switzerland.		Heussler, Volker/H-9322-2019; Dobbelaere, Dirk/A-3885-2013; Orth, Kim/AAV-4421-2021; Chen, Zhijian/C-6039-2012	Heussler, Volker/0000-0001-8028-9825; Dobbelaere, Dirk/0000-0003-0672-8468; Orth, Kim/0000-0002-0678-7620; Chen, Zhijian/0000-0002-8475-8251; Rottenberg, Sven/0000-0003-2044-9844; Fernandez, Paula Carolina/0000-0003-3237-6283; Shiels, Brian/0000-0001-7595-2514	NIGMS NIH HHS [GM63692] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; DOBBELAERE DAE, 1988, P NATL ACAD SCI USA, V85, P4730, DOI 10.1073/pnas.85.13.4730; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GIRARDIN SE, 2001, EMBO REP, V19, P19; Heussler VT, 2001, CELL MICROBIOL, V3, P537, DOI 10.1046/j.1462-5822.2001.00134.x; Heussler VT, 1999, P NATL ACAD SCI USA, V96, P7312, DOI 10.1073/pnas.96.13.7312; HUDSON AT, 1985, PARASITOLOGY, V90, P45, DOI 10.1017/S0031182000049003; Inohara N, 2000, J BIOL CHEM, V275, P27823; IVANOV V, 1989, MOL CELL BIOL, V9, P4677, DOI 10.1128/MCB.9.11.4677; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; KUENZI P, UNPUB; Machado J, 2000, MICROBES INFECT, V2, P1311, DOI 10.1016/S1286-4579(00)01284-3; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Palmer GH, 1997, P NATL ACAD SCI USA, V94, P12527, DOI 10.1073/pnas.94.23.12527; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Shaw MK, 1997, INT J PARASITOL, V27, P457, DOI 10.1016/S0020-7519(97)00015-5; SHIELS B, 1992, J CELL SCI, V101, P99; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	28	106	116	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					1033	1036		10.1126/science.1075462	http://dx.doi.org/10.1126/science.1075462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411708				2022-12-24	WOS:000178932000059
J	Packard, M; Koo, ES; Gorczyca, M; Sharpe, J; Cumberledge, S; Budnik, V				Packard, M; Koo, ES; Gorczyca, M; Sharpe, J; Cumberledge, S; Budnik, V			The drosophila wnt, wingless, provides an essential signal for pre- and postsynaptic differentiation	CELL			English	Article							TUMOR-SUPPRESSOR GENE; LARVAL NEUROMUSCULAR-JUNCTION; PRESYNAPTIC ACTIVE ZONES; SYNAPTIC GROWTH; PROTEIN; LOCALIZATION; TRANSDUCTION; PLASTICITY; SYNAPSES; DYNAMIN	At vertebrate neuromuscular junctions (NMJs), Agrin plays pivotal roles in synapse development, but molecules that activate synapse formation at central synapses are largely unknown. Members of the Wnt family are well established as morphogens, yet recently they have also been implicated in synapse maturation. Here we demonstrate that the Drosophila Wnt, Wingless (Wg), is essential for synapse development. We show that Wg and its receptor are expressed at glutamatergic NMJs, and that Wg is secreted by synaptic boutons. Loss of Wg leads to dramatic reductions in target-dependent synapse formation, and new boutons either fail to develop active zones and postsynaptic specializations or these are strikingly aberrant. We suggest that Wg signals the coordinated development of pre- and postsynaptic compartments.	Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Biochem & Mol Biol, Cell Mol & Dev Biol Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Budnik, V (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037061, R01NS042629] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 36000, R01 HD036000] Funding Source: Medline; NIMH NIH HHS [R01 MH070000] Funding Source: Medline; NINDS NIH HHS [R01 NS 42629, R01 NS 3700, R01 NS 37061] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Binari RC, 1997, DEVELOPMENT, V124, P2623; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; CHULAGRAFF Q, 1993, SCIENCE, V261, P1594, DOI 10.1126/science.8372355; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 2000, NEURON, V26, P551, DOI 10.1016/S0896-6273(00)81190-3; Day SJ, 2000, DEVELOPMENT, V127, P2977; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Estes PS, 1996, J NEUROSCI, V16, P5443; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Goold RG, 1999, J CELL SCI, V112, P3373; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Koh YH, 2002, J NEUROSCI, V22, P2496, DOI 10.1523/JNEUROSCI.22-07-02496.2002; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Lucas FR, 1998, J CELL SCI, V111, P1351; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Moline MM, 1999, DEVELOPMENT, V126, P4375; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Salinas P C, 1999, Bipolar Disord, V1, P87, DOI 10.1034/j.1399-5618.1999.010205.x; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SchultzEhrenburg U, 1996, PHLEBOLOGY, V11, P17; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Torroja L, 1999, J NEUROSCI, V19, P7793; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	57	323	329	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					319	330		10.1016/S0092-8674(02)01047-4	http://dx.doi.org/10.1016/S0092-8674(02)01047-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419243	Green Accepted, Bronze			2022-12-24	WOS:000179010100005
J	Blackmore, S				Blackmore, S			Environment - Biodiversity update - Progress in taxonomy	SCIENCE			English	Editorial Material									Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland		Blackmore, S (corresponding author), Royal Bot Garden Edinburgh, Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland.							*AM SOC PLANT TAX, 1994, SYST AG 2000; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Cronk QCB, 2001, NAT REV GENET, V2, P607, DOI 10.1038/35084556; Environment Australia, 1998, DARW DECL; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Pennisi E, 2001, SCIENCE, V293, P1979, DOI 10.1126/science.293.5537.1979; Smith AT, 2000, SCIENCE, V290, P2073; Stork Nigel E., 1997, P41; Wilson EO, 2000, SCIENCE, V289, P2279; 2002, WHAT EARTH THREAT SC	10	17	22	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					365	365		10.1126/science.1075026	http://dx.doi.org/10.1126/science.1075026			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376687				2022-12-24	WOS:000178510400029
J	Winer, S; Astsaturov, I; Cheung, R; Tsui, H; Song, AH; Gaedigk, R; Winer, D; Sampson, A; McKerlie, C; Bookman, A; Dosch, HM				Winer, S; Astsaturov, I; Cheung, R; Tsui, H; Song, AH; Gaedigk, R; Winer, D; Sampson, A; McKerlie, C; Bookman, A; Dosch, HM			Primary Sjogren's syndrome and deficiency of ICA69	LANCET			English	Article							NONOBESE DIABETIC MICE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALPHA-FODRIN; ANIMAL-MODEL; NOD MOUSE; AUTOANTIGEN; AUTOANTIBODIES; LYMPHOCYTES; EXPRESSION; SECONDARY	Background Sjogren's syndrome is a common (about 1% of the population) autoimmune disease of salivary and lacrimal glands. Its cause and pathogenesis are poorly understood, and treatments are mostly for symptoms of the disease. ICA69 is a self-antigen expressed in brain, pancreas, salivary, and lacrimal glands. NOD-strain mice are an animal model of spontaneous Sjogren's syndrome. We aimed to assess the role of ICA69 in autoimmunity against Sjogren's syndrome. Methods We inactivated the genomic ICA69 locus, generated NOD congenic mice that were deficient in ICA69, and assessed development of Sjogren's syndrome. ICA69 autoimmunity was investigated in controls and in patients with primary Sjogren's syndrome or systemic lupus erythematosus, and in various NOD mice, some of which were given an ICA69-directed prototype peptide vaccine. Findings Disruption of the ICA69 locus prevented lacrimal gland disease and greatly reduced salivary gland disease in NOD mice. In healthy NOD mice, ICA69-specific T cells accumulated in lymph nodes that drain salivary tissue. T-cell and B-cell autoreactivity against ICA69 was much the same in patients with primary Sjogren's syndrome, but not in those with systemic lupus erythematosus or in healthy controls. Immunotherapy with a high-affinity mimicry peptide targeting ICA69-specific T-cells reduced established Sjogren's syndrome in wild-type NOD mice in the long term. Interpretation ICA69 is a new autoantigen in primary Sjogren's syndrome that has an important role in progression of disease and could be of diagnostic value. Immunotherapy of primary Sjogren's syndrome is promising, since autoimmunity in NOD mice with Sjogren's syndrome seems to be uniquely susceptible to such treatment even late in disease.	Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Immunol, Toronto, ON, Canada; Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Clin Studies Resource Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Dosch, HM (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hmdosch@sickkids.ca	ASTSATUROV, Igor/AAG-4099-2021	Astsaturov, Igor/0000-0002-8613-1890; McKerlie, Colin/0000-0002-2232-0967; Gaedigk, Roger/0000-0001-5942-1609				ANDONOPOULOS AP, 1990, BRIT J RHEUMATOL, V29, P21; Billaut-Mulot O, 2001, J CLIN INVEST, V108, P861, DOI 10.1172/JCI13469; Brayer JB, 2001, ARCH IMMUNOL THER EX, V49, P353; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; CHUSED TM, 1977, NEW ENGL J MED, V296, P895, DOI 10.1056/NEJM197704212961602; Dosch HM, 1999, J IMMUNOL, V163, P6933; Dosch HM, 2000, DIABETOLOGIA, V43, P386; FOSTER H, 1993, ARTHRITIS RHEUM-US, V36, P473; Fox R I, 1999, Curr Opin Rheumatol, V11, P364, DOI 10.1097/00002281-199909000-00007; Fox RI, 2000, CURR OPIN RHEUMATOL, V12, P391, DOI 10.1097/00002281-200009000-00007; GOILLOT E, 1991, CLIN IMMUNOL IMMUNOP, V59, P462, DOI 10.1016/0090-1229(91)90041-8; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; HANEJI N, 1994, J IMMUNOL, V153, P2769; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; HOFFMAN RW, 1984, ARTHRITIS RHEUM, V27, P157, DOI 10.1002/art.1780270206; HUMPHREYSBEHER MG, 1994, ADV EXP MED BIOL, V350, P631; Hunger RE, 1998, J CLIN INVEST, V101, P1300, DOI 10.1172/JCI1230; James JA, 2001, CURR OPIN RHEUMATOL, V13, P370, DOI 10.1097/00002281-200109000-00005; Karges W, 1997, DIABETES, V46, P1548, DOI 10.2337/diabetes.46.10.1548; Karges W, 1996, DIABETES, V45, P513, DOI 10.2337/diabetes.45.4.513; Kuwana M, 2001, J IMMUNOL, V167, P5449, DOI 10.4049/jimmunol.167.9.5449; Lafitte C, 2001, J NEUROL, V248, P577, DOI 10.1007/s004150170135; MALINOW K, 1986, ANN NEUROL, V20, P535, DOI 10.1002/ana.410200416; Masago R, 2001, ARTHRITIS RHEUM, V44, P693, DOI 10.1002/1529-0131(200103)44:3<693::AID-ANR119>3.0.CO;2-7; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Robinson CP, 1998, P NATL ACAD SCI USA, V95, P7538, DOI 10.1073/pnas.95.13.7538; Robinson CP, 1996, CLIN IMMUNOL IMMUNOP, V79, P50, DOI 10.1006/clin.1996.0050; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2002, J IMMUNOL, V168, P475, DOI 10.4049/jimmunol.168.1.475; Winer S, 2000, J IMMUNOL, V165, P4086, DOI 10.4049/jimmunol.165.7.4086; Yanagi K, 1998, EUR J IMMUNOL, V28, P3336, DOI 10.1002/(SICI)1521-4141(199810)28:10<3336::AID-IMMU3336>3.3.CO;2-I	34	49	53	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2002	360	9339					1063	1069		10.1016/S0140-6736(02)11144-5	http://dx.doi.org/10.1016/S0140-6736(02)11144-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	602BN	12383988				2022-12-24	WOS:000178485200013
J	Crawford, LM				Crawford, LM			Advisory on clinical holds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1579	1579		10.1001/jama.288.13.1579-c	http://dx.doi.org/10.1001/jama.288.13.1579-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350176				2022-12-24	WOS:000178314000007
J	Kanabar, D; Volans, G				Kanabar, D; Volans, G			Accidental superwarfarin poisoning in children - less treatment is better	LANCET			English	Editorial Material									Guys & St Thomas NHS Trust UK, Med Toxicol Unit, London SW1 9RT, England		Kanabar, D (corresponding author), Guys & St Thomas NHS Trust UK, Med Toxicol Unit, London SW1 9RT, England.	dkanabar@doctors.org.uk						*EUR ASS POIS CTR, 1997, CLIN TOXICOL, V35, P721; *EUR ASS POIS CTR, 1997, CLIN TOXICOL, V35, P711; *EUR ASS POIS CTR, 1997, CLIN TOXICOL, V35, P699; HENRY J, 1984, BRIT MED J, V289, P94, DOI 10.1136/bmj.289.6437.94; Ingels M, 2002, ANN EMERG MED, V40, P75, DOI 10.1067/mem.2002.125449; JONES EC, 1984, JAMA-J AM MED ASSOC, V252, P3005, DOI 10.1001/jama.252.21.3005; Mullins ME, 2000, PEDIATRICS, V105, P402, DOI 10.1542/peds.105.2.402; SMOLINSKE SC, 1989, PEDIATRICS, V84, P490	8	12	12	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2002	360	9338					963	963		10.1016/S0140-6736(02)11120-2	http://dx.doi.org/10.1016/S0140-6736(02)11120-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597YU	12383662				2022-12-24	WOS:000178249000005
J	Wang, LT; Eckmann, CR; Kadyk, LC; Wickens, M; Kimble, J				Wang, LT; Eckmann, CR; Kadyk, LC; Wickens, M; Kimble, J			A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans	NATURE			English	Article							MESSENGER-RNAS; IDENTIFICATION; FAMILIES; HOMOLOGY; COMPLEX	Messenger RNA regulation is a critical mode of controlling gene expression. Regulation of mRNA stability and translation is linked to controls of poly(A) tail length(1,2). Poly(A) lengthening can stabilize and translationally activate mRNAs, whereas poly(A) removal can trigger degradation and translational repression. Germline granules (for example, polar granules in flies, P granules in worms) are ribonucleoprotein particles implicated in translational control(3). Here we report that the Caenorhabditis elegans gene gld-2, a regulator of mitosis/meiosis decision and other germline events(4), encodes the catalytic moiety of a cytoplasmic poly(A) polymerase (PAP) that is associated with P granules in early embryos. Importantly, the GLD-2 protein sequence has diverged substantially from that of conventional eukaryotic PAPs, and lacks a recognizable RRM (RNA recognition motif)-like domain. GLD-2 has little PAP activity on its own, but is stimulated in vitro by GLD-3. GLD-3 is also a developmental regulator, and belongs to the Bicaudal-C family of RNA binding proteins(5). We suggest that GLD-2 is the prototype for a class of regulatory cytoplasmic PAPs that are recruited to specific mRNAs by a binding partner, thereby targeting those mRNAs for polyadenylation and increased expression.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	jekimble@facstaff.wisc.edu	Kadyk, Lisa/W-5243-2019					Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; CRITTENDEN SL, 1998, CELL LAB MANUAL; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; ECKMANN C, IN PRESS DEV CELL; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Kadyk LC, 1998, DEVELOPMENT, V125, P1803; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200; LINGNER J, 1991, J BIOL CHEM, V266, P8741; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Praitis V, 2001, GENETICS, V157, P1217; READ RL, IN PRESS P NATL ACAD; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Sambrook JFE, 1989, MOL CLONING LAB MANU; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295	31	227	238	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					312	316		10.1038/nature01039	http://dx.doi.org/10.1038/nature01039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239571				2022-12-24	WOS:000178056300049
J	Rea, TD; Heckbert, SR; Kaplan, RC; Smith, NL; Lemaitre, RN; Psaty, BM				Rea, TD; Heckbert, SR; Kaplan, RC; Smith, NL; Lemaitre, RN; Psaty, BM			Smoking status and risk for recurrent coronary events after myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM PROGNOSIS; CIGARETTE-SMOKING; THROMBOLYTIC THERAPY; SECONDARY PREVENTION; STOPPING SMOKING; CESSATION; MORTALITY; ARTERY; WOMEN; NICOTINE	Background: Questions remain about the importance of smoking and smoking cessation after incident myocardial infarction. Objective: To assess the association between smoking status and risk for recurrent coronary events. Design: Retrospective, population-based, inception cohort study. Setting: Health maintenance organization from 1986 to 1996. Patients: 2619 persons who survived to hospital discharge after a first myocardial infarction. Measurements: Relative risk (RR), assessed by using Cox proportional hazards regression analysis, for recurrent coronary events in nonsmokers (persons with no history of smoking), former smokers (persons who had stopped smoking before infarction), quitters (persons who stopped smoking after infarction), and active smokers (persons who continued smoking after infarction). Results: At the time of incident infarction, 33.6% of patients were nonsmokers, 35.5% were former smokers, and 30.9% were active smokers. Of the 808 persons who were active smokers at the time of incident infarction, 449 quit smoking during hospitalization or after discharge. With nonsmokers as the reference group, the multivariable RR for recurrent coronary events (n = 433) was 1.17 (95% CI, 0.93 to 1.43) for former smokers and 1.51 (CI, 1.10 to 2.07) for active smokers. Among quitters, the RR decreased as duration of cessation increased: With nonsmokers as the reference group, the RR for quitters was 1.62 (CI, 1.02 to 2.61) if the duration of cessation was 0 to less than 6 months, 1.60 (CI, 0.97 to 2.60) if the duration was 6 to less than 18 months, 1.48 (CI, 0.76 to 2.51) if the duration was 18 to less than 36 months, and 1.02 (CI, 0.54 to 1.86) if the duration was 36 months or more (P = 0.01 for trend). Conclusion: After incident myocardial infarction, smoking was associated with an elevated risk for recurrent coronary events. In persons who quit smoking after infarction, the risk declined to equal that of nonsmokers by 3 years after cessation.	Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle	Rea, TD (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Metropolitan Pk,E Tower,1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	rea123@u.washington.edu	Kaplan, Robert/A-2526-2011		NHLBI NIH HHS [HL40628, HL43201, HL53375] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043201, R01HL040628, R29HL040628, R01HL053375] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERG A, 1983, BRIT HEART J, V49, P416, DOI 10.1136/hrt.49.5.416; [Anonymous], 1997, Eur Heart J, V18, P1569; BARBASH GI, 1995, J AM COLL CARDIOL, V26, P1222, DOI 10.1016/0735-1097(95)00299-5; BURR ML, 1992, EUR HEART J, V13, P166, DOI 10.1093/oxfordjournals.eurheartj.a060141; deChillou C, 1996, J AM COLL CARDIOL, V27, P1662, DOI 10.1016/0735-1097(96)00091-5; Goldstein MG, 2000, MED CLIN N AM, V84, P63, DOI 10.1016/S0025-7125(05)70207-8; Gottlieb S, 1996, J AM COLL CARDIOL, V28, P1506, DOI 10.1016/S0735-1097(96)00334-8; Greenwood DC, 1995, J EPIDEMIOL COMMUN H, V49, P583, DOI 10.1136/jech.49.6.583; GRINES CL, 1995, CIRCULATION, V91, P298, DOI 10.1161/01.CIR.91.2.298; Hasdai D, 1997, NEW ENGL J MED, V336, P755, DOI 10.1056/NEJM199703133361103; HEDBACK B, 1993, EUR HEART J, V14, P831, DOI 10.1093/eurheartj/14.6.831; HERLITZ J, 1995, CARDIOLOGY, V86, P496, DOI 10.1159/000176929; HERMANSON B, 1988, NEW ENGL J MED, V319, P1365, DOI 10.1056/NEJM198811243192101; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Ishihara M, 1997, AM HEART J, V134, P955, DOI 10.1016/S0002-8703(97)80020-8; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; JAFRI SM, 1990, AM J CARDIOL, V65, P271, DOI 10.1016/0002-9149(90)90286-A; JOHANSSON S, 1985, AM J EPIDEMIOL, V121, P823, DOI 10.1093/oxfordjournals.aje.a114053; Jorgensen S, 1999, J CARDIOVASC RISK, V6, P23; Joseph AM, 1996, NEW ENGL J MED, V335, P1792, DOI 10.1056/NEJM199612123352402; KELLY TL, 1985, AM HEART J, V110, P535; Maggioni A P, 1998, G Ital Cardiol, V28, P970; Mahmarian JJ, 1997, J AM COLL CARDIOL, V30, P125, DOI 10.1016/S0735-1097(97)00128-9; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MOLSTAD P, 1991, EUR HEART J, V12, P753, DOI 10.1093/eurheartj/12.7.753; MULCAHY R, 1977, AM HEART J, V93, P556, DOI 10.1016/S0002-8703(77)80003-3; Nitenberg A, 1999, J CARDIOVASC PHARM, V34, P694, DOI 10.1097/00005344-199911000-00011; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; PERKINS J, 1985, POSTGRAD MED J, V61, P295, DOI 10.1136/pgmj.61.714.295; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; Qureshi AI, 2001, ARCH INTERN MED, V161, P1621, DOI 10.1001/archinte.161.13.1621; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; ROSENBERG L, 1985, NEW ENGL J MED, V313, P1511, DOI 10.1056/NEJM198512123132404; SALONEN JT, 1980, BRIT HEART J, V43, P463, DOI 10.1136/hrt.43.4.463; SIEGEL D, 1988, ANN INTERN MED, V109, P213, DOI 10.7326/0003-4819-109-3-213; SPARROW D, 1978, J CHRON DIS, V31, P425, DOI 10.1016/0021-9681(78)90006-1; TOFLER GH, 1993, AM J CARDIOL, V71, P1031, DOI 10.1016/0002-9149(93)90568-W; *US DEP HHS, 1988, DHHS PUB; van Domburg RT, 2000, J AM COLL CARDIOL, V36, P878, DOI 10.1016/S0735-1097(00)00810-X; Vogel RA, 1997, CLIN CARDIOL, V20, P426, DOI 10.1002/clc.4960200505; Wilhelmsen L, 1998, J Cardiovasc Risk, V5, P173, DOI 10.1097/00043798-199806000-00006; WILHELMSSON C, 1975, LANCET, V1, P416; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; ZHU BQ, 1995, AM HEART J, V130, P1270, DOI 10.1016/0002-8703(95)90154-X	46	131	133	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					494	500		10.7326/0003-4819-137-6-200209170-00009	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230350				2022-12-24	WOS:000178069100003
J	Richards, AM; Nicholls, MG; Lainchbury, JG; Fisher, S; Yandle, TG				Richards, AM; Nicholls, MG; Lainchbury, JG; Fisher, S; Yandle, TG			Plasma urotensin II in heart failure	LANCET			English	Article							ARTERIES	Urotensin II has vasoconstrictive and negative inotropic effects, suggesting a possible role in circulatory regulation and pathophysiology of heart failure. We developed a sensitive specific RIA and measured plasma urotensin II in patients with heart failure and in controls. Plasma urotensin II was higher in heart failure patients (mean 3.9 pmol/L [SD 1.4]; than in controls (1.9 pmol/L [0.9]; p<0.0001). The role of urotensin II in heart failure, however, has yet to be defined.	Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	University of Otago	Richards, AM (corresponding author), Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, POB 4345, Christchurch, New Zealand.							Affolter J, 2001, LANCET, V358, P774, DOI 10.1016/S0140-6736(01)06005-6; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Hillier C, 2001, CIRCULATION, V103, P1378, DOI 10.1161/01.CIR.103.10.1378; Stirrat A, 2001, AM J PHYSIOL-HEART C, V280, pH925, DOI 10.1152/ajpheart.2001.280.2.H925; Totsune K, 2001, LANCET, V358, P810, DOI 10.1016/S0140-6736(01)06002-0	5	149	156	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					545	546						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241661				2022-12-24	WOS:000177512800015
J	Lunyak, VV; Burgess, R; Prefontaine, GG; Nelson, C; Sze, SH; Chenoweth, J; Schwartz, P; Pevzner, PA; Glass, C; Mandel, G; Rosenfeld, MG				Lunyak, VV; Burgess, R; Prefontaine, GG; Nelson, C; Sze, SH; Chenoweth, J; Schwartz, P; Pevzner, PA; Glass, C; Mandel, G; Rosenfeld, MG			Corepressor-dependent silencing of chromosomal regions encoding neuronal genes	SCIENCE			English	Article							ACETYLCHOLINE-RECEPTOR GENE; NEURAL-SPECIFIC EXPRESSION; HISTONE H3; DNA METHYLATION; LYSINE 9; PROTEIN; TRANSCRIPTION; COMPLEX; ELEMENT; COREST	The molecular mechanisms by which central nervous system-specific genes are expressed only in the nervous system and repressed in other tissues remain a central issue in developmental and regulatory biology. Here, we report that the zinc-finger gene-specific repressor element RE-1 silencing transcription factor/neuronal restricted silencing factor (REST/NRSF) can mediate extra-neuronal restriction by imposing either active repression via histone deacetylase recruitment or long-term gene silencing using a distinct functional complex. Silencing of neuronal-specific genes requires the recruitment of an associated corepressor, CoREST, that serves as a functional molecular beacon for the recruitment of molecular machinery that imposes silencing across a chromosomal interval, including transcriptional units that do not themselves contain REST/NRSF response elements.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; SUNY Stony Brook, Dept Neurobiol, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; Affin BioReagents Inc, Golden, CO 80401 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	lunyak, victoria/R-3765-2017	lunyak, victoria/0000-0001-9093-2714				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; LUNYAK VV, UNPUB; MECHTLER K, 2000, NATURE, V406, P593; Mieda M, 1997, J BIOL CHEM, V272, P5854, DOI 10.1074/jbc.272.9.5854; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; RAZIN A, 1989, BIOCHIM BIOPHYS ACTA, V782, P331; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	40	377	392	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1747	1752		10.1126/science.1076469	http://dx.doi.org/10.1126/science.1076469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12399542				2022-12-24	WOS:000179494800033
J	Reik, W; Dean, W				Reik, W; Dean, W			Back to the beginning	NATURE			English	Editorial Material									Babraham Inst, Dev Genet Programme, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Reik, W (corresponding author), Babraham Inst, Dev Genet Programme, Cambridge CB2 4AT, England.		Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Dean, Wendy/0000-0001-9441-5044				Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; Waddington C. H, 1940, ORG AND GENES	5	15	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					127	127		10.1038/420127a	http://dx.doi.org/10.1038/420127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432368				2022-12-24	WOS:000179200900022
J	McClellan, MB				McClellan, MB			New drug for hepatitis B	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2112	2112		10.1001/jama.288.17.2112	http://dx.doi.org/10.1001/jama.288.17.2112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413360				2022-12-24	WOS:000179048100008
J	Tilzey, AJ; Banatvala, JE				Tilzey, AJ; Banatvala, JE			Protection from HIV on electives: questionnaire survey of UK medical schools	BRITISH MEDICAL JOURNAL			English	Article							STUDENTS; PROVISION; OVERSEAS		Guys Kings & St Thomass Sch Med & Dent, Dept Infect Virol, London SE1 7EH, England	University of London; King's College London	Tilzey, AJ (corresponding author), Guys Kings & St Thomass Sch Med & Dent, Dept Infect Virol, London SE1 7EH, England.							Franklin GF, 2001, J INFECTION, V43, P191, DOI 10.1053/jinf.2001.0903; Gamester CF, 1999, BRIT MED J, V318, P158, DOI 10.1136/bmj.318.7177.158; Karstaedt AS, 2001, S AFR MED J, V91, P57; Moss PJ, 1999, BRIT MED J, V318, P161, DOI 10.1136/bmj.318.7177.161; *UK HLTH DEP, 2000, HIV POST EXP PROPH G	5	12	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2002	325	7371					1010	1011		10.1136/bmj.325.7371.1010	http://dx.doi.org/10.1136/bmj.325.7371.1010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JU	12411360	Green Published, Bronze			2022-12-24	WOS:000179415600022
J	Hassan, AH; Prochasson, P; Neely, KE; Galasinski, SC; Chandy, M; Carrozza, MJ; Workman, JL				Hassan, AH; Prochasson, P; Neely, KE; Galasinski, SC; Chandy, M; Carrozza, MJ; Workman, JL			Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes	CELL			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; TRANSCRIPTION IN-VIVO; SACCHAROMYCES-CEREVISIAE; REMODELING COMPLEX; ORDERED RECRUITMENT; ACTIVATION DOMAIN; GCN5 BROMODOMAIN; SWI/SNF COMPLEX; SAGA COMPLEX; YEAST	The functions of the SAGA and SWI/SNF complexes are interrelated and can form stable "epigenetic marks" on promoters in vivo. Here we show that stable promoter occupancy by SWI/SNF and SAGA in the absence of transcription activators requires the bromodomains of the Swi2/Snf2 and Gcn5 subunits, respectively, and nucleosome acetylation. This acetylation can be brought about by either the SAGA or NuA4 HAT complexes. The bromodomain in the Spt7 subunit of SAGA is dispensable for this activity but will anchor SAGA if it is swapped into Gcn5, indicating that specificity of bromodomain function is determined in part by the subunit it occupies. Thus, bromodomains within the catalytic subunits of SAGA and SWI/SNF anchor these complexes to acetylated promoter nucleosomes.	Penn State Univ, Dept Biochem & Mol Biol, Howard Hughes Med Inst, Althouse Lab 306, University Pk, PA 16802 USA; Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Workman, JL (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Howard Hughes Med Inst, Althouse Lab 306, University Pk, PA 16802 USA.		Chandy, Mark Joseph Koonthanam/GLT-9682-2022; Hassan, Ahmed/AAB-7241-2019	Chandy, Mark Joseph Koonthanam/0000-0002-6741-2822; Al-Marzouqi, Ahmed/0000-0003-4586-5676				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Carrozza MJ, 2002, J BIOL CHEM, V277, P24648, DOI 10.1074/jbc.M201965200; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Elfring LK, 1998, GENETICS, V148, P251; GANSHEROFF LJ, 1995, GENETICS, V139, P523; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jia MH, 2000, PHYSIOL GENOMICS, V3, P83, DOI 10.1152/physiolgenomics.2000.3.2.83; KANAZAWA S, 1988, MOL CELL BIOL, V8, P664, DOI 10.1128/MCB.8.2.664; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; LAURENT BC, 1991, P NATL ACAD SCI USA, V88, P2687, DOI 10.1073/pnas.88.7.2687; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Matangkasombut O, 2000, GENE DEV, V14, P951; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; NEIGEBORN L, 1984, GENETICS, V108, P845; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Roberts SM, 1997, GENETICS, V147, P451; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	49	397	406	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					369	379		10.1016/S0092-8674(02)01005-X	http://dx.doi.org/10.1016/S0092-8674(02)01005-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419247	Bronze			2022-12-24	WOS:000179010100009
J	Kajikawa, M; Okada, N				Kajikawa, M; Okada, N			LINEs mobilize SINEs in the eel through a shared 3 ' sequence	CELL			English	Article							LTR RETROTRANSPOSABLE ELEMENTS; HIV-1 REVERSE-TRANSCRIPTASE; TRANSFER-RNA; L1 RETROTRANSPOSITION; SECONDARY STRUCTURE; MAMMALIAN-CELLS; TELOMERASE; ORIGIN; GENOME; ENDS	We characterized members of the LINE (UnaL2) and SINE (UnaSINE1) families from the eel genome and found that these LINE/SINE partners share similar 3' tails. A retrotransposition assay in HeLa cells demonstrated that the 3' conserved tail of UnaL2 is necessary for its retrotransposition. This 3' tail is recognized in trans by the UnaL2 reverse transcriptase at a surprisingly high rate, and that of UnaSINE1 can also be recognized, thus providing experimental evidence that a SINE can be mobilized by the retrotransposition machinery of a partner LINE. We also demonstrated that short repeats at the 3' end of UnaL2 are required for retrotransposition suggesting that UnaL2 retrotransposes in a manner reminiscent of the reverse transcriptase activity of telomerases.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Tokyo, Japan	Tokyo Institute of Technology	Okada, N (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Tokyo, Japan.	nokada@bio.titech.ac.jp		Okada, Norihiro/0000-0002-3655-8060				BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Boeke JD, 1998, CELL, V93, P1087, DOI 10.1016/S0092-8674(00)81450-6; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Chaboissier MC, 2000, NUCLEIC ACIDS RES, V28, P2467, DOI 10.1093/nar/28.13.2467; DEININGER PL, 1993, EVOL BIOL, V27, P157; Eickbush TH, 1997, SCIENCE, V277, P911, DOI 10.1126/science.277.5328.911; EICKBUSH TH, 1992, NEW BIOL, V4, P430; ENDOH H, 1986, P NATL ACAD SCI USA, V83, P251, DOI 10.1073/pnas.83.2.251; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P46; Gilbert N, 1999, P NATL ACAD SCI USA, V96, P2869, DOI 10.1073/pnas.96.6.2869; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; HATTORI M, 1986, NATURE, V321, P625, DOI 10.1038/321625a0; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kajikawa M, 1997, MOL BIOL EVOL, V14, P1206, DOI 10.1093/oxfordjournals.molbev.a025730; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIU CT, 1993, HIGH TEMPERATURE ORD, V5, P3; Lovsin N, 2001, MOL BIOL EVOL, V18, P2213, DOI 10.1093/oxfordjournals.molbev.a003768; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Mathews DH, 1997, RNA, V3, P1; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Ogiwara I, 1999, MOL BIOL EVOL, V16, P1238, DOI 10.1093/oxfordjournals.molbev.a026214; Ogiwara I, 2002, GENOME RES, V12, P316, DOI 10.1101/gr.212302; Ohshima K, 1996, MOL CELL BIOL, V16, P3756; Okada N, 1997, J MOL EVOL, V44, pS52, DOI 10.1007/PL00000058; Okada N, 1997, GENE, V205, P229, DOI 10.1016/S0378-1119(97)00409-5; OKADA N, 1991, TRENDS ECOL EVOL, V6, P358, DOI 10.1016/0169-5347(91)90226-N; Okada N., 1995, IMPACT SHORT INTERSP, P61; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Schmid C, 1992, CURR OPIN GENET DEV, V2, P874, DOI 10.1016/S0959-437X(05)80110-8; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Terai Y, 1998, MOL BIOL EVOL, V15, P1460, DOI 10.1093/oxfordjournals.molbev.a025873; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weiner AM, 2000, NAT GENET, V24, P332, DOI 10.1038/74135; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; YU GL, 1991, CELL, V67, P823, DOI 10.1016/0092-8674(91)90077-C; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	54	242	256	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					433	444		10.1016/S0092-8674(02)01041-3	http://dx.doi.org/10.1016/S0092-8674(02)01041-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419252	Bronze			2022-12-24	WOS:000179010100014
J	Kulesa, PM; Fraser, SE				Kulesa, PM; Fraser, SE			Cell dynamics during somite boundary formation revealed by time-lapse analysis	SCIENCE			English	Article							SEGMENTATION CLOCK; LUNATIC FRINGE; CHICK-EMBRYO; SOMITOGENESIS; MODEL; MORPHOGENESIS; EXPRESSION; OSCILLATOR; ZEBRAFISH; MESODERM	We follow somite segmentation in living chick embryos and find that the shaping process is not simple periodic slicing of tissue blocks but much more carefully choreographed separation in which the somite pulls apart from the segmental plate. Cells move across the presumptive somite boundary and violate gene expression boundaries thought to correlate with the site of the somite boundary. Similarly, cells do not appear to be preassigned to given somite as they leave the node. The results offer detailed picture of somite shaping and provide spatiotemporal framework for linking gene expression with cell movements.	CALTECH, Beckman Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Fraser, SE (corresponding author), CALTECH, Beckman Inst, Div Biol, Pasadena, CA 91125 USA.		Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; BELLAIRS R., 1980, B ZOOL, V47, P245; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Collier JR, 2000, J THEOR BIOL, V207, P305, DOI 10.1006/jtbi.2000.2172; Cooke J, 1998, TRENDS GENET, V14, P85, DOI 10.1016/S0168-9525(98)01396-1; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Henry CA, 2000, CURR BIOL, V10, P1063, DOI 10.1016/S0960-9822(00)00677-1; JACOBSON AG, 1986, SOMITES DEV EMBRYOS, P1; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Keller R, 2000, CURR TOP DEV BIOL, V47, P183; Kerszberg M, 2000, J THEOR BIOL, V205, P505, DOI 10.1006/jtbi.2000.2085; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; PRIMMETT DRN, 1989, DEVELOPMENT, V105, P119; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sakamoto K, 1997, BIOCHEM BIOPH RES CO, V234, P754, DOI 10.1006/bbrc.1997.6652; Schmidt C, 2001, DEV DYNAM, V220, P377, DOI 10.1002/dvdy.1117; Schnell S, 2000, DEV DYNAM, V217, P415, DOI 10.1002/(SICI)1097-0177(200004)217:4<415::AID-DVDY8>3.0.CO;2-3; STERN CD, 1988, DEVELOPMENT, V104, P231; Stickney HL, 2000, DEV DYNAM, V219, P287; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; TAM PPL, 1994, ANAT EMBRYOL, V189, P275; WOOD A, 1994, DEV DYNAM, V201, P151, DOI 10.1002/aja.1002010206; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	28	100	104	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					991	995		10.1126/science.1075544	http://dx.doi.org/10.1126/science.1075544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411697				2022-12-24	WOS:000178932000046
J	Bishop, JKB; Davis, RE; Sherman, JT				Bishop, JKB; Davis, RE; Sherman, JT			Robotic observations of dust storm enhancement of carbon biomass in the North Pacific	SCIENCE			English	Article							SUB-ARCTIC PACIFIC; PHYTOPLANKTON DYNAMICS; TEMPORAL VARIABILITY; ATLANTIC OCEAN; IRON; SENSORS; BLOOM; FLUX	Two autonomous robotic pro ling oats deployed in the subarctic North Pacific on 10 April 2001 provided direct records of carbon biomass variability from surface to 1000 meters below surface at daily and diurnal time scales. Eight months of real-time data documented the marine biological response to natural events, including hydrographic changes, multiple storms, and the April 2001 dust event. High-frequency observations of upper ocean particulate organic carbon variability show a near doubling of biomass in the mixed layer over a 2-week period after the passage of a cloud of Gobi desert dust. The temporal evolution of particulate organic carbon enhancement and an increase in chlorophyll use efficiency after the dust storm suggest a biotic response to a natural iron fertilization by the dust.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Diego; Scripps Institution of Oceanography	Bishop, JKB (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, 1 Cyclotron Rd,MS 90-1116, Berkeley, CA 94720 USA.	JKBishop@lbl.gov		Davis, Russ/0000-0003-1903-6313; Bishop, James/0000-0002-8036-3017				Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Bishop JKB, 1999, DEEP-SEA RES PT I, V46, P353, DOI 10.1016/S0967-0637(98)00069-7; BISHOP JKB, 1991, J GEOPHYS RES-OCEANS, V96, P16839, DOI 10.1029/91JC01754; Bishop JKB, 1999, DEEP-SEA RES PT II, V46, P2699; Boyd P, 1999, DEEP-SEA RES PT II, V46, P2405, DOI 10.1016/S0967-0645(99)00069-7; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 1999, DEEP-SEA RES PT II, V46, P2761, DOI 10.1016/S0967-0645(99)00083-1; Boyd PW, 1998, GLOBAL BIOGEOCHEM CY, V12, P429, DOI 10.1029/98GB00745; Davis RE, 1998, J GEOPHYS RES-OCEANS, V103, P24619, DOI 10.1029/98JC01913; Davis RE, 2001, J ATMOS OCEAN TECH, V18, P982, DOI 10.1175/1520-0426(2001)018<0982:PAAOAI>2.0.CO;2; DICKEY T, 1991, J GEOPHYS RES-OCEANS, V96, P8643, DOI 10.1029/91JC00413; DICKEY T, 1994, J GEOPHYS RES-OCEANS, V99, P22541, DOI 10.1029/94JC01221; DITULLIO GR, 1991, DEEP-SEA RES, V38, P1305, DOI 10.1016/0198-0149(91)90029-F; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foley DG, 1997, DEEP-SEA RES PT II, V44, P1801, DOI 10.1016/S0967-0645(97)00080-5; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; *INT UND ASS LOND, 1999, 2 UK BOD INJ AW STUD, P1; Kinkade CS, 1999, DEEP-SEA RES PT II, V46, P1813, DOI 10.1016/S0967-0645(99)00045-4; Lenes JM, 2001, LIMNOL OCEANOGR, V46, P1261, DOI 10.4319/lo.2001.46.6.1261; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; MARRA J, 1992, J GEOPHYS RES-OCEANS, V97, P7399, DOI 10.1029/92JC00408; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; MILLER CB, 1993, PROG OCEANOGR, V32, P1, DOI 10.1016/0079-6611(93)90007-Z; OREILLY JE, SEAWIFS POSTLAUNCH 3, P1; SIEGEL DA, 1989, DEEP-SEA RES, V36, P211, DOI 10.1016/0198-0149(89)90134-9; SMITH RC, 1978, LIMNOL OCEANOGR, V23, P247, DOI 10.4319/lo.1978.23.2.0247; STRAMSKA M, 1995, J GEOPHYS RES-OCEANS, V100, P6621, DOI 10.1029/94JC01447; Thibault D, 1999, DEEP-SEA RES PT II, V46, P2669, DOI 10.1016/S0967-0645(99)00080-6; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; Whitney FA, 1999, DEEP-SEA RES PT II, V46, P2351, DOI 10.1016/S0967-0645(99)00067-3; Young RW, 1991, GLOBAL BIOGEOCHEM CY, V5, P119, DOI 10.1029/91GB00927	35	305	357	7	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					817	821		10.1126/science.1074961	http://dx.doi.org/10.1126/science.1074961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399588	Green Published			2022-12-24	WOS:000178791200056
J	Miller, M; Iliff, P; Stoltzfus, RJ; Humphrey, J				Miller, M; Iliff, P; Stoltzfus, RJ; Humphrey, J			Breastmilk erythropoietin and mother-to-child HIV transmission through breastmilk	LANCET			English	Article							HUMAN-MILK; DEFICIENCY; INFANTS; ANEMIA	A third to a half the 1.5 million HIV-positive children in the world today acquired their infection via breastfeeding. However, what protects the 85% of breastfed babies of HIV-infected mothers who do not become infected? We postulate that erythropoietin (EPO), a hormone in human milk, has a role in the prevention of HIV transmission during breastfeeding. EPO might maintain mammary epithelium integrity, thereby reducing viral loads in milk, or maintain intestinal epithelial integrity in the breastfed neonate, and thus preventing ingested milk-borne virus being infective. This hypothesis could be tested by administration of recombinant human EPO parenterally to HIV-infected mothers or enterally to breastfed babies, or both, and assessment of the effect on mammary permeability, viral load in milk, and intestinal permeability in babies. If our hypothesis is correct, EPO treatment for mother or baby, or both might help prevent transmission of HIV.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA; ZVITAMBO Project, Harare, Zimbabwe; Univ Zimbabwe, Sch Med, Dept Paediat & Child Hlth, Harare, Zimbabwe	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zimbabwe	Stoltzfus, RJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA.							Ballin A, 1999, LANCET, V353, P1849, DOI 10.1016/S0140-6736(99)01222-2; BOYD HK, 1991, EUR J HAEMATOL, V46, P198; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Filteau SM, 1999, AM J CLIN NUTR, V69, P953; Goldman AS, 1996, J MAMMARY GLAND BIOL, V1, P251, DOI 10.1007/BF02018078; Henry DH, 1998, SEMIN ONCOL, V25, P64; Humphrey J, 2001, NUTR REV, V59, P119, DOI 10.1111/j.1753-4887.2001.tb06999.x; ITO K, 1991, RES GASTROINTEST BLO, V7, P57; Juul SE, 2000, PEDIATR RES, V48, P660, DOI 10.1203/00006450-200011000-00018; Juul SE, 1999, PEDIATR RES, V46, P263, DOI 10.1203/00006450-199909000-00003; Juul SE, 2001, GUT, V49, P182, DOI 10.1136/gut.49.2.182; Kling PJ, 1998, PEDIATR RES, V43, P216, DOI 10.1203/00006450-199802000-00010; Krafft A, 1999, LANCET, V354, P778, DOI 10.1016/S0140-6736(05)76022-0; Ledbetter DJ, 2000, J PEDIATR SURG, V35, P178, DOI 10.1016/S0022-3468(00)90006-X; MAHMOOD T, 1977, BLOOD, V50, P449; NEVILLE MC, 1984, AM J CLIN NUTR, V40, P635, DOI 10.1093/ajcn/40.3.635; Okada A, 1996, DIGESTION, V57, P328, DOI 10.1159/000201353; Semba R D, 1999, J Hum Lact, V15, P301, DOI 10.1177/089033449901500407; SPIVAK JL, 1989, JAMA-J AM MED ASSOC, V261, P3104, DOI 10.1001/jama.261.21.3104	19	12	13	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1246	1248		10.1016/S0140-6736(02)11277-3	http://dx.doi.org/10.1016/S0140-6736(02)11277-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401271				2022-12-24	WOS:000178708100033
J	Meegaskumbura, M; Bossuyt, F; Pethiyagoda, R; Manamendra-Arachchi, K; Bahir, M; Milinkovitch, MC; Schneider, CJ				Meegaskumbura, M; Bossuyt, F; Pethiyagoda, R; Manamendra-Arachchi, K; Bahir, M; Milinkovitch, MC; Schneider, CJ			Sri Lanka: An amphibian hot spot	SCIENCE			English	Article									Boston Univ, Dept Biol, Boston, MA 02215 USA; Wildlife Heritage Trust, Colombo 8, Sri Lanka; Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, B-1050 Brussels, Belgium; Inst Mol BIol & Med, Unit Evolut Genet, B-6041 Gosselies, Belgium	Boston University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Schneider, CJ (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	cschneid@bu.edu	Meegaskumbura, Madhava/F-8782-2013; Pethiyagoda, Rohan/C-2307-2009	Meegaskumbura, Madhava/0000-0002-4599-6724; Bossuyt, Franky/0000-0001-6804-9271; Milinkovitch, Michel/0000-0002-2553-0724; Pethiyagoda, Rohan/0000-0001-7215-9617				Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F., 2001, ZEYLANICA, V6, P1; Dutta S. K., 1996, AMPHIBIAN FAUNA SRI; Glaw Frank, 1998, Herpetological Review, V29, P11; Inger RF, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P445; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Pethiyagoda R, 1998, OCC PAP WILDL HERITA, V2, P1	7	165	182	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2002	298	5592					379	379		10.1126/science.298.5592.379	http://dx.doi.org/10.1126/science.298.5592.379			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376694	Green Submitted			2022-12-24	WOS:000178510400038
J	Kumanogoh, A; Marukawa, S; Suzuki, K; Takegahara, N; Watanabe, C; Ch'ng, ES; Ishida, I; Fujimura, H; Sakoda, S; Yoshida, K; Kikutani, H				Kumanogoh, A; Marukawa, S; Suzuki, K; Takegahara, N; Watanabe, C; Ch'ng, ES; Ishida, I; Fujimura, H; Sakoda, S; Yoshida, K; Kikutani, H			Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2	NATURE			English	Article							B-CELL; NONREDUNDANT ROLES; IMMUNE-RESPONSES; MICE REVEAL; GENE FAMILY; CD100; RECEPTOR; GUIDANCE; CD72; IDENTIFICATION	Semaphorins are a family of phylogenetically conserved soluble and transmembrane proteins(1,2). Although many soluble semaphorins deliver guidance cues to migrating axons during neuronal development(3-5), some members are involved in immune responses(6-9). For example, CD100 (also known as Sema4D), a class IV transmembrane semaphorin, signals through CD72 to effect nonredundant roles in immune responses(7,10-13) in a ligand-receptor system that is distinct from any seen previously in the nervous system(14,15). Here we report that the class IV semaphorin Sema4A, which is expressed in dendritic cells and B cells, enhances the in vitro activation and differentiation of T cells and the in vivo generation of antigen-specific T cells. Treating mice with monoclonal antibodies against Sema4A blocks the development of an experimental autoimmune encephalomyelitis that is induced by an antigenic peptide derived from myelin oligodendrocyte glycoprotein. In addition, expression cloning shows that the Sema4A receptor is Tim-2, a member of the family of T-cell immunoglobulin domain and mucin domain (Tim) proteins that is expressed on activated T cells.	Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kikutani, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.		Suzuki, Kazuhiro/B-3886-2012; Kikutani, Hitoshi/C-9525-2009; Takegahara, Noriko/AAP-1694-2021; Kumanogoh, Atsushi/C-7354-2009; Ch'ng, Ewe Seng/F-2630-2010	Ch'ng, Ewe Seng/0000-0001-8831-8678; Suzuki, Kazuhiro/0000-0002-9081-538X				Adachi T, 1998, J IMMUNOL, V160, P4662; ALEXANDER BH, 2000, IMMUNITY, V13, P345; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	27	244	283	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	2002	419	6907					629	633		10.1038/nature01037	http://dx.doi.org/10.1038/nature01037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374982				2022-12-24	WOS:000178483100048
J	Kaufman, TC; Severson, DW; Robinson, GE				Kaufman, TC; Severson, DW; Robinson, GE			The Anopheles genome and comparative insect genomics	SCIENCE			English	Editorial Material							HOX GENES; DROSOPHILA; MOSQUITO; PROBOSCIPEDIA; SEQUENCE; TRANSFORMATION; EVOLUTION; VECTORS; DIPTERA		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Notre Dame, Dept Biol Sci, Ctr Trop Dis Res & Training, Notre Dame, IN 46556 USA; Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	Indiana University System; Indiana University Bloomington; University of Notre Dame; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kaufman, TC (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.			Severson, David/0000-0002-5798-3365				Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Abzhanov A, 2001, DEVELOPMENT, V128, P2803; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Anderson JR, 2001, MOL PHYLOGENET EVOL, V20, P316, DOI 10.1006/mpev.2001.0964; Aultman KS, 2001, TRENDS PARASITOL, V17, P507, DOI 10.1016/S1471-4922(01)02094-3; Beaty BJ, 2000, P NATL ACAD SCI USA, V97, P10295, DOI 10.1073/pnas.97.19.10295; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Brown S, 1999, DEV GENES EVOL, V209, P389, DOI 10.1007/s004270050269; BRUSCA RC, 1990, INVEREBRATES; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; DeCamillis MA, 2001, GENETICS, V159, P1643; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Pennisi E, 2002, SCIENCE, V296, P1589; Rai KS, 1999, ADV GENET, V41, P1, DOI 10.1016/S0065-2660(08)60149-2; Robinson GE, 2002, SCIENCE, V297, P204, DOI 10.1126/science.1074493; Robinson GE, 1999, TRENDS ECOL EVOL, V14, P202, DOI 10.1016/S0169-5347(98)01536-5; Rogers BT, 2002, EVOL DEV, V4, P96, DOI 10.1046/j.1525-142X.2002.01065.x; Rusch DB, 2000, GENETICS, V156, P183; Severson DW, 2001, ANNU REV ENTOMOL, V46, P183, DOI 10.1146/annurev.ento.46.1.183; SEVERSON DW, COMMUNICATION; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; World Health Organization, 2000, HLTH SYST IMPR PERF; ZBODNOV EM, 2002, SCIENCE, V298, P149	32	17	19	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					97	+		10.1126/science.1077901	http://dx.doi.org/10.1126/science.1077901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364783				2022-12-24	WOS:000178370500040
J	Chun, HJ; Zheng, LX; Ahmad, M; Wang, J; Speirs, CK; Siegel, RM; Dale, MK; Puck, J; Davis, J; Hall, CG; Skoda-Smith, S; Atkinson, TP; Straus, SE; Lenardo, MJ				Chun, HJ; Zheng, LX; Ahmad, M; Wang, J; Speirs, CK; Siegel, RM; Dale, MK; Puck, J; Davis, J; Hall, CG; Skoda-Smith, S; Atkinson, TP; Straus, SE; Lenardo, MJ			Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency	NATURE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; NATURAL-KILLER-CELLS; FAS GENE-MUTATIONS; T-CELLS; APOPTOSIS; INITIATION; CLEAVAGE; DISORDER; SIGNAL	Apoptosis is a form of programmed cell death that is controlled by aspartate-specific cysteine proteases called caspases. In the immune system, apoptosis counters the proliferation of lymphocytes to achieve a homeostatic balance, which allows potent responses to pathogens but avoids autoimmunity(1,2). The CD95 (Fas, Apo-1) receptor triggers lymphocyte apoptosis by recruiting Fas-associated death domain (FADD), caspase-8 and caspase-10 proteins into a death-inducing signalling complex(3,4). Heterozygous mutations in CD95, CD95 ligand or caspase-10 underlie most cases of autoimmune lymphoproliferative syndrome (ALPS), a human disorder that is characterized by defective lymphocyte apoptosis, lymphadenopathy, splenomegaly and autoimmunity(5-14). Mutations in caspase-8 have not been described in ALPS, and homozygous caspase-8 deficiency causes embryonic lethality in mice. Here we describe a human kindred with an inherited genetic deficiency of caspase-8. Homozygous individuals manifest defective lymphocyte apoptosis and homeostasis but, unlike individuals affected with ALPS, also have defects in their activation of T lymphocytes, B lymphocytes and natural killer cells, which leads to immunodeficiency. Thus, caspase-8 deficiency in humans is compatible with normal development and shows that caspase-8 has a postnatal role in immune activation of naive lymphocytes.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Univ Alabama, Sch Med, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alabama System; University of Alabama Birmingham	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.		Siegel, Richard/C-7592-2009; chun, hyung/AAE-1463-2020; Chun, Hyung/K-1859-2013	Siegel, Richard/0000-0001-5953-9893; Chun, Hyung/0000-0003-3508-2678; Wang, Jin/0000-0002-3116-0838	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000034, Z01HG000116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718, ZIAAI000769, Z01AI000718, Z01AI000769, ZIAAI000732, Z01AI000732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041133, ZIAAR041133] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Chinnasamy D, 2000, BLOOD, V96, P1309, DOI 10.1182/blood.V96.4.1309.h8001309_1309_1316; Chun HJ, 2001, ADV EXP MED BIOL, V490, P49; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FINER MH, 1994, BLOOD, V83, P43; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kasahara Y, 1998, INT IMMUNOL, V10, P195, DOI 10.1093/intimm/10.2.195; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; PETRAK D, 1994, J IMMUNOL, V153, P2046; Posmantur R, 1998, EXP CELL RES, V244, P302, DOI 10.1006/excr.1998.4214; RAGERZISMAN B, 1987, J IMMUNOL, V138, P884; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; STAHLS A, 1994, EUR J IMMUNOL, V24, P2491, DOI 10.1002/eji.1830241035; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	26	518	541	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					395	399		10.1038/nature01063	http://dx.doi.org/10.1038/nature01063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353035	Green Published			2022-12-24	WOS:000178195400046
J	Yao, TT; Cohen, RE				Yao, TT; Cohen, RE			A cryptic protease couples deubiquitination and degradation by the proteasome	NATURE			English	Article							REGULATORY PARTICLE; SACCHAROMYCES-CEREVISIAE; UBIQUITIN; ENZYMES; DOMAIN; GENE; THERMODYNAMICS; SIGNAL; ATP	The 26S proteasome is responsible for most intracellular proteolysis in eukaryotes(1,2). Efficient substrate recognition relies on conjugation of substrates with multiple ubiquitin molecules and recognition of the polyubiquitin moiety by the 19S regulatory complex-a multisubunit assembly that is bound to either end of the cylindrical 20S proteasome core. Only unfolded proteins can pass through narrow axial channels into the central proteolytic chamber of the 20S core, so the attached polyubiquitin chain must be released to allow full translocation of the substrate polypeptide. Whereas unfolding is rate-limiting for the degradation of some substrates and appears to involve chaperone-like activities associated with the proteasome(3-5), the importance and mechanism of degradation-associated deubiquitination has remained unclear. Here we report that the POH1 (also known as Rpn11 in yeast) subunit of the 19S complex is responsible for substrate deubiquitination during proteasomal degradation. The inability to remove ubiquitin can be rate-limiting for degradation in vitro and is lethal to yeast. Unlike all other known deubiquitinating enzymes (DUBs) that are cysteine proteases(6,7), POH1 appears to be a Zn2+-dependent protease.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Cohen, RE (corresponding author), Univ Iowa, Dept Biochem, 51 Newton Rd, Iowa City, IA 52242 USA.							Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; BEERS EP, 1993, J BIOL CHEM, V268, P21645; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; DeKoster GT, 1997, BIOCHEMISTRY-US, V36, P2323, DOI 10.1021/bi962580b; EYTAN E, 1993, J BIOL CHEM, V268, P4668; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; LEGGETT DL, IN PRESS MOL CELL; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; THICK J, 1994, LEUKEMIA, V8, P564; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; WINTRODE PL, 1994, PROTEINS, V18, P246, DOI 10.1002/prot.340180305; Zwickl P, 2000, CURR OPIN STRUC BIOL, V10, P242, DOI 10.1016/S0959-440X(00)00075-0	30	556	573	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					403	407		10.1038/nature01071	http://dx.doi.org/10.1038/nature01071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353037				2022-12-24	WOS:000178195400048
J	McFadden, P				McFadden, P			Broadband biodetection: Holmes on a chip	SCIENCE			English	Editorial Material							BIOSENSORS; CELLS		Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Rainwater Res Inc, Albany, OR 97330 USA	Oregon State University	McFadden, P (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.							Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e; Danosky TR, 1997, BIOSENS BIOELECTRON, V12, P925, DOI 10.1016/S0956-5663(97)00028-6; DOYLE AC, 1993, STUDY SCARLET, P32; Karlsson AM, 2002, BIOSENS BIOELECTRON, V17, P331, DOI 10.1016/S0956-5663(01)00284-6; Preston RR, 2001, BIOSENS BIOELECTRON, V16, P447, DOI 10.1016/S0956-5663(01)00159-2; Sohn H, 2001, ANGEW CHEM INT EDIT, V40, P2104, DOI 10.1002/1521-3773(20010601)40:11<2104::AID-ANIE2104>3.0.CO;2-#; Stenger DA, 2001, TRENDS BIOTECHNOL, V19, P304, DOI 10.1016/S0167-7799(01)01690-0; Turner A. P. F., 1996, BIOSENSORS PRESENT F; Turner APF, 2001, BIOSENS BIOELECTRON, V16, P609, DOI 10.1016/S0956-5663(01)00184-1	9	36	39	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2075	2076		10.1126/science.297.5589.2075	http://dx.doi.org/10.1126/science.297.5589.2075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242448				2022-12-24	WOS:000178078500053
J	Bertheau, P; Plassa, F; Espie, M; Turpin, E; de Roquancourt, A; Marty, M; Lerebours, F; Beuzard, Y; Janin, A; de The, H				Bertheau, P; Plassa, F; Espie, M; Turpin, E; de Roquancourt, A; Marty, M; Lerebours, F; Beuzard, Y; Janin, A; de The, H			Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy	LANCET			English	Article							P53	TP53 activation by genotoxic drugs can induce apoptosis or cell-cycle arrest. Thus, whether the gene is mutated or wild type could affect the response of a tumour to chemotherapy. Clinical data are unclear, possibly as a result of heterogeneity of tumours, drugs, methods of assessing response, or TP53 status. We studied 50 non-inflammatory, locally advanced breast cancers that had been treated with high doses of a combination of epirubicin and cyclophosphamide. We noted eight complete responses, which all occurred in the 14 patients with tumours containing mutated TP53 (p<0.0001). In high-grade, advanced breast cancers, inactivation of the TP53 pathway could greatly improve the response to this chemotherapy regimen.	Hop St Louis, Serv Biochim B, F-75475 Paris 10, France; Hop St Louis, CNRS, UPR 9051, F-75475 Paris, France; Hop St Louis, INSERM, ERM 0220, F-75475 Paris 10, France; Hop St Louis, Serv Pathol, F-75475 Paris 10, France; Hop St Louis, Serv Oncol, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	de The, H (corresponding author), Hop St Louis, Serv Biochim B, 1 Ave C Vellefaux, F-75475 Paris 10, France.							Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Lavarino C, 2000, J CLIN ONCOL, V18, P3936, DOI 10.1200/JCO.2000.18.23.3936; MAKRIS A, 1995, LANCET, V345, P1181, DOI 10.1016/S0140-6736(95)91014-X; McGill G, 1999, J CLIN INVEST, V104, P223, DOI 10.1172/JCI7861	5	114	119	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 14	2002	360	9336					852	854		10.1016/S0140-6736(02)09969-5	http://dx.doi.org/10.1016/S0140-6736(02)09969-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594MC	12243922				2022-12-24	WOS:000178053500013
J	Garlanda, C; Hirsch, E; Bozza, S; Salustri, A; De Acetis, M; Nota, R; Maccagno, A; Riva, F; Bottazzi, B; Peri, G; Doni, A; Vago, L; Botto, M; De Santis, R; Carminati, P; Siracusa, G; Altruda, F; Vecchi, A; Romani, L; Mantovani, A				Garlanda, C; Hirsch, E; Bozza, S; Salustri, A; De Acetis, M; Nota, R; Maccagno, A; Riva, F; Bottazzi, B; Peri, G; Doni, A; Vago, L; Botto, M; De Santis, R; Carminati, P; Siracusa, G; Altruda, F; Vecchi, A; Romani, L; Mantovani, A			Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response	NATURE			English	Article							AMYLOID-P COMPONENT; C-REACTIVE PROTEIN; ACUTE-PHASE PROTEINS; INVASIVE ASPERGILLOSIS; A-PROTEIN; FAMILY; INFECTION; MEMBER; MONONUCLEAR; EXPRESSION	Pentraxins are a superfamily of conserved proteins that are characterized by a cyclic multimeric structure(1). The classical short pentraxins, C-reactive protein (CRP) and serum amyloid P component (SAP), are acute-phase proteins produced in the liver in response to inflammatory mediators(2-4). Short pentraxins regulate innate resistance to microbes and the scavenging of cellular debris and extracellular matrix components(2-5). In contrast, long pentraxins have an unrelated, long amino-terminal domain coupled to the carboxy-terminal pentraxin domain, and differ, with respect to short pentraxins, in their gene organization, chromosomal localization, cellular source, and in their stimuli-inducing and ligand-recognition ability(6). To investigate the in vivo function of the long pentraxin PTX3, we generated mice deficient in Ptx3 by homologous recombination. Ptx3-null mice were susceptible to invasive pulmonary aspergillosis. Ptx3 binds selected microbial agents, including conidia of Aspergillus fumigatus, and we found that susceptibility of Ptx3-null mice was associated with defective recognition of conidia by alveolar macrophages and dendritic cells, as well as inappropriate induction of an adaptive type 2 response. Thus, the long pentraxin Ptx3 is a secreted pattern-recognition receptor that has a non-redundant role in resistance to selected microbial agents, in particular to the opportunistic fungal pathogen Aspergillus fumigatus.	Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, I-20157 Milan, Italy; Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; Univ Milan, Osped Luigi Sacco, Inst Pathol, Milan, Italy; Imperial Coll Sch Med, Hammersmith Hosp, Div Med, Rheumatol Sect, London, England; SigmaTau SpA, Rome, Italy; Univ Milan, Inst Gen Pathol, Ctr IDET, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Turin; University of Perugia; University of Rome Tor Vergata; University of Milan; Luigi Sacco Hospital; Imperial College London; University of Milan	Mantovani, A (corresponding author), Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, Via Eritrea 62, I-20157 Milan, Italy.		Garlanda, Cecilia/K-4601-2016; Riva, Federica/B-9287-2013; Romani, Luigina/O-9987-2018; Mantovani, Alberto/HCI-7449-2022; bottazzi, barbara/ABH-9274-2020; Hirsch, Emilio/F-4848-2013	Garlanda, Cecilia/0000-0002-1510-7703; Riva, Federica/0000-0002-1270-1627; Mantovani, Alberto/0000-0001-5578-236X; bottazzi, barbara/0000-0002-1930-9257; Hirsch, Emilio/0000-0002-9073-6024; Romani, Luigina/0000-0002-1356-525X; DE SANTIS, Rita/0000-0002-5037-0611; Doni, Andrea/0000-0001-9203-5814; SALUSTRI, ANTONIETTA/0000-0002-8731-1041				ALLES VV, 1994, BLOOD, V84, P3483; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Cenci E, 1997, INFECT IMMUN, V65, P564, DOI 10.1128/IAI.65.2.564-570.1997; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Introna M, 1996, BLOOD, V87, P1862; LEE GW, 1994, J IMMUNOL, V153, P3700; LEE GW, 1993, J IMMUNOL, V150, P1804; Mantovani A., 2002, CYTOKINE REFERENCE; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mencacci A., 2000, Current Pharmaceutical Biotechnology, V1, P235, DOI 10.2174/1389201003378924; Mencacci A, 2001, BLOOD, V97, P1483, DOI 10.1182/blood.V97.5.1483; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Romani L, 1997, CURR OPIN IMMUNOL, V9, P484, DOI 10.1016/S0952-7915(97)80099-4; Rovere P, 2000, BLOOD, V96, P4300; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Szalai AJ, 1997, IMMUNOL RES, V16, P127, DOI 10.1007/BF02786357; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; WATANABE Y, 1986, INFECT IMMUN, V52, P730, DOI 10.1128/IAI.52.3.730-735.1986	27	531	553	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					182	186		10.1038/nature01195	http://dx.doi.org/10.1038/nature01195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432394				2022-12-24	WOS:000179200900047
J	Keyomarsi, K; Tucker, SL; Buchholz, TA; Callister, M; Ding, Y; Hortobagyi, GN; Bedrosian, I; Knickerbocker, C; Toyofuku, W; Lowe, M; Herliczek, TW; Bacus, SS				Keyomarsi, K; Tucker, SL; Buchholz, TA; Callister, M; Ding, Y; Hortobagyi, GN; Bedrosian, I; Knickerbocker, C; Toyofuku, W; Lowe, M; Herliczek, TW; Bacus, SS			Cyclin E and survival in patients with breast cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							E OVEREXPRESSION; IMAGE-ANALYSIS; ESTROGEN-RECEPTOR; PROGNOSTIC MARKER; REDUNDANT CYCLIN; PHASE-TRANSITION; EXPRESSION; CELLS; CARCINOMA; AMPLIFICATION	Background: Cyclin E, a regulator of the cell cycle, affects the behavior of breast-cancer cells. We investigated whether levels of cyclin E in the tumor correlated with survival among patients with breast cancer. Methods: Tumor tissue from 395 patients with breast cancer was assayed for cyclin E, cyclin D1, cyclin D3, and the HER-2/neu oncogene with the use of Western blot analysis. Full-length, low-molecular-weight, and total cyclin E were measured. Immunohistochemical assessments of cyclin E were also made of 256 tumors. We sought correlations between levels of these molecular markers and disease-specific and overall survival. Results: The median follow-up was 6.4 years. A high level of the low-molecular-weight isoforms of cyclin E, as detected by Western blotting, correlated strongly with disease-specific survival whether axillary lymph nodes were negative or positive for metastases (P<0.001). Among 114 patients with stage I breast cancer, none of the 102 patients with low levels of cyclin E in the tumor had died of breast cancer by five years after diagnosis, whereas all 12 patients with a high level of low-molecular-weight cyclin E had died of breast cancer within that period. In multivariate analysis, a high total cyclin E level or high levels of the low-molecular-weight forms of cyclin E were significantly correlated with poor outcome. The hazard ratio for death from breast cancer for patients with high total cyclin E levels as compared with those with low total cyclin E levels was 13.3 -- about eight times as high as the hazard ratios associated with other independent clinical and pathological risk factors. Conclusions: Levels of total cyclin E and low-molecular-weight cyclin E in tumor tissue, as measured by Western blot assay, correlate strongly with survival in patients with breast cancer.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Breast Canc Res Program, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; Wadsworth Ctr, Div Mol Med, Albany, NY USA; Quantitat Diagnost Labs, Elmhurst, NY USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Wadsworth Center	Keyomarsi, K (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd,Box 66, Houston, TX 77030 USA.		Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849	NCI NIH HHS [R29-CA666062, R01-CA87548, T32CA77050, CA16672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087548, T32CA077050, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 1998, LANCET, V352, P930; BACUS S, 1988, AM J CLIN PATHOL, V90, P233, DOI 10.1093/ajcp/90.3.233; BACUS SS, 1989, AM J PATHOL, V135, P783; BACUS SS, 1993, PATHOL ANNU, V28, P179; BERCHUCK A, 1992, GYNECOL ONCOL, V44, P61, DOI 10.1016/0090-8258(92)90013-9; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Clarke M, 1998, LANCET, V351, P1451; COX DR, 1972, J R STAT SOC B, V34, P187; Donnellan R, 2001, HUM PATHOL, V32, P89, DOI 10.1053/hupa.2001.21141; Dou QP, 1996, NAT MED, V2, P254, DOI 10.1038/nm0396-254a; DOU QP, 1993, CANCER RES, V53, P1493; GrayBablin J, 1996, P NATL ACAD SCI USA, V93, P15215, DOI 10.1073/pnas.93.26.15215; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; Harwell RM, 2000, CANCER RES, V60, P481; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; KEYOMARSI K, 1995, ONCOGENE, V11, P941; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Nielsen NH, 1996, BRIT J CANCER, V74, P874, DOI 10.1038/bjc.1996.451; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Scuderi R, 1996, BLOOD, V87, P3360, DOI 10.1182/blood.V87.8.3360.bloodjournal8783360; SCUDERI R, 1996, BLOOD, V88, P1083; Sgambato A, 1997, CELL GROWTH DIFFER, V8, P393; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; TAYLOR SR, 1989, CYTOMETRY, V10, P382, DOI 10.1002/cyto.990100404; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Wang A, 1996, J CANCER RES CLIN, V122, P122, DOI 10.1007/BF01226270; YAMASHITA JI, 1994, BRIT J CANCER, V69, P72, DOI 10.1038/bjc.1994.11	35	456	484	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2002	347	20					1566	1575		10.1056/NEJMoa021153	http://dx.doi.org/10.1056/NEJMoa021153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614KL	12432043	Bronze			2022-12-24	WOS:000179187800004
J	Hennessy, S; Bilker, WB; Knauss, JS; Margolis, DJ; Kimmel, SE; Reynolds, RF; Glasser, DB; Morrison, MF; Strom, BL				Hennessy, S; Bilker, WB; Knauss, JS; Margolis, DJ; Kimmel, SE; Reynolds, RF; Glasser, DB; Morrison, MF; Strom, BL			Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data	BRITISH MEDICAL JOURNAL			English	Article							DEATH; RISK; PROLONGATION; EXPERIENCE; PSORIASIS	Objective To examine the rates of cardiac arrest and ventricular arrhythmia in patients with treated schizophrenia and in non-schizophrenic controls. Design Cohort study of outpatients using administrative data. Setting 3 US Medicaid programmes. Participants Patients with schizophrenia treated with clozapine, haloperidol, risperidone, or thioridazine; a control group of patients with glaucoma; and a control group of patients with psoriasis. Main outcome measure Diagnosis of cardiac arrest or ventricular arrhythmia. Results Patients with treated schizophrenia had higher rates of cardiac arrest and ventricular arrhythmia than controls, with rate ratios ranging from 1.7 to 3.2. Overall, thioridazine was not associated with an increased risk compared with haloperidol (rate ratio 0.9, 95% confidence interval 0.7 to 1.2). However, thioridazine showed an increased risk of events at doses greater than or equal to600 mg (2.6, 1.0 to 6.6; P=0.049) and a linear dose-response relation (P=0.038). Conclusions The increased risk of cardiac arrest and ventricular arrhythmia in patients with treated schizophrenia could be due to the disease or its treatment. Overall, the risk with thioridazine was no worse than that with haloperidol. Thioridazine may, however, have a higher risk at high doses, although this finding could be due to chance. To reduce cardiac risk, thioridazine should be prescribed at the lowest dose needed to obtain an optimal therapeutic effect.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Pfizer, Epidemiol, New York, NY 10017 USA; Pfizer, Sexual Hlth, New York, NY 10017 USA; Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Pfizer; Pfizer; University of Pennsylvania	Hennessy, S (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.		Bilker, Warren/AAS-3515-2021		NIA NIH HHS [1K23AG000987, K23 AG000987] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG000987] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bhana N, 2000, DRUG AGING, V16, P451, DOI 10.2165/00002512-200016060-00005; *BRIT MED ASS, 2001, BRIT NATL FORM, V172; *BRIT MED ASS, 2001, BRIT NAT FORM, V172; BUCKLEY NA, 1995, J TOXICOL-CLIN TOXIC, V33, P199, DOI 10.3109/15563659509017984; Cavero I, 2000, Expert Opin Pharmacother, V1, P947, DOI 10.1517/14656566.1.5.947; *COMM PROPR MED PR, 1997, 12171997 COMM PROPR; De Ponti F, 2000, EUR J CLIN PHARMACOL, V56, P1, DOI 10.1007/s002280050714; De Ponti F, 2001, EUR J CLIN PHARMACOL, V57, P185, DOI 10.1007/s002280100290; DEMAILLY P, 1984, OPHTHALMOLOGICA, V188, P65, DOI 10.1159/000309344; *FED DRUGS ADM, 2000, BRIEF DOC ZELD CAPS; *FED DRUGS ADM PSY, 2000, BRIEF DOC ZELD CAPS; Leuraud K, 2001, STAT MED, V20, P3335, DOI 10.1002/sim.959; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Margolis D, 2001, ARCH DERMATOL, V137, P778; National Center for Health Statistics, AMB CAR DRUG DAT SYS; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Sesso HD, 2000, AM J EPIDEMIOL, V152, P107, DOI 10.1093/aje/152.2.107; Staffa JA, 1995, CLIN THER, V17, P1062, DOI 10.1016/0149-2918(95)80085-9; STERN RS, 1988, J INVEST DERMATOL, V91, P197, DOI 10.1111/1523-1747.ep12464847; Zarate CA, 2001, ARCH GEN PSYCHIAT, V58, P1168, DOI 10.1001/archpsyc.58.12.1168	21	191	194	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 9	2002	325	7372					1070	1072A		10.1136/bmj.325.7372.1070	http://dx.doi.org/10.1136/bmj.325.7372.1070			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JV	12424166	Green Published, Bronze			2022-12-24	WOS:000179415700019
J	McClellan, MB				McClellan, MB			Request for grant applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2112	2112		10.1001/jama.288.17.2112	http://dx.doi.org/10.1001/jama.288.17.2112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413360				2022-12-24	WOS:000179048100010
J	Sun, BL; Griffin, BM; Ayala-del-Rio, HL; Hashsham, SA; Tiedje, JM				Sun, BL; Griffin, BM; Ayala-del-Rio, HL; Hashsham, SA; Tiedje, JM			Microbial dehalorespiration with 1,1,1-trichloroethane	SCIENCE			English	Article							REDUCTIVELY DECHLORINATES TETRACHLOROETHENE; CHLORINATED ALIPHATIC-HYDROCARBONS; DESULFOMONILE-TIEDJEI; MIXED CULTURE; DEGRADATION; BACTERIUM; ACETATE; DEHALOGENATION; COMETABOLISM; MIXTURES	1,1,1-Trichloroethane (TCA) is a ubiquitous environmental pollutant because of its widespread use as an industrial solvent, its improper disposal, and its substantial emission to the atmosphere. We report the isolation of an anaerobic bacterium, strain TCA1, that reductively dechlorinates TCA to 1,1-dichloroethane and chloroethane. Strain TCA1 required H 2 as an electron donor and TCA as an electron acceptor for growth, indicating that dechlorination is a respiratory process. Phylogenetic analysis indicated that strain TCA1 is related to gram-positive bacteria with low DNA G + C content and that its closest relative is Dehalobacter restrictus, an obligate H-2-oxidizing, chloroethene-respiring bacterium.	Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Tiedje, JM (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	tiedjej@msu.edu	Sun, Baolin/C-8354-2014	Sun, Baolin/0000-0002-2896-3015; Hashsham, Syed/0000-0003-2398-7453				Adamson DT, 1999, WATER RES, V33, P1482, DOI 10.1016/S0043-1354(98)00344-3; Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; *AG TOX SUBST DIS, 1996, TAXF 1 1 1 TRICHL; Aziz CE, 1999, BIOTECHNOL BIOENG, V65, P100, DOI 10.1002/(SICI)1097-0290(19991005)65:1<100::AID-BIT12>3.0.CO;2-1; deBest JH, 1997, APPL MICROBIOL BIOT, V48, P417, DOI 10.1007/s002530051073; Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577; Kim Y, 2000, J ENVIRON ENG-ASCE, V126, P934, DOI 10.1061/(ASCE)0733-9372(2000)126:10(934); Lee MD, 1998, ANNU REV MICROBIOL, V52, P423, DOI 10.1146/annurev.micro.52.1.423; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; MCNAB WW, 1994, ENVIRON SCI TECHNOL, V28, P769, DOI 10.1021/es00054a005; MOHN WW, 1991, ARCH MICROBIOL, V157, P1; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; OLDENHUIS R, 1989, APPL ENVIRON MICROB, V55, P2819, DOI 10.1128/AEM.55.11.2819-2826.1989; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Schlotelburg C, 2000, INT J SYST EVOL MICR, V50, P1505, DOI 10.1099/00207713-50-4-1505; SCHOLTZ R, 1987, J GEN MICROBIOL, V133, P267; STRUNK O, 1998, SOFTWARE ENV SEQUENC; Sun BL, 2000, APPL ENVIRON MICROB, V66, P2408, DOI 10.1128/AEM.66.6.2408-2413.2000; Townsend GT, 1997, APPL ENVIRON MICROB, V63, P3594, DOI 10.1128/AEM.63.9.3594-3599.1997; U.S. EPA (Environmental Protection Agency), 1989, FED REG, V54, P22062; *UN ENV PROGR, 1999, PROD CONS OZ DEPL SU; VOGEL TM, 1987, ENVIRON SCI TECHNOL, V21, P722, DOI 10.1021/es00162a001; von Wintzingerode F, 1999, APPL ENVIRON MICROB, V65, P283; WESTRICK JJ, 1984, J AM WATER WORKS ASS, V76, P52; Wild A, 1997, BIODEGRADATION, V7, P507, DOI 10.1007/BF00115297	26	92	101	8	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2002	298	5595					1023	1025		10.1126/science.1074675	http://dx.doi.org/10.1126/science.1074675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411705				2022-12-24	WOS:000178932000056
J	Aarts, M; Liu, YT; Liu, LD; Besshoh, S; Arundine, M; Gurd, JW; Wang, YT; Salter, MW; Tymianski, M				Aarts, M; Liu, YT; Liu, LD; Besshoh, S; Arundine, M; Gurd, JW; Wang, YT; Salter, MW; Tymianski, M			Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions	SCIENCE			English	Article							CEREBRAL-ARTERY OCCLUSION; NITRIC-OXIDE; NEUROTOXICITY; ANTAGONIST; PSD-95; MODEL; RAT; SELFOTEL; STROKE	N-methyl-D-aspartate receptors (NMDARs) mediate ischemic brain damage but also mediate essential neuronal excitation. To treat stroke without blocking NMDARs, we transduced neurons with peptides that disrupted the interaction of NMDARs with the postsynaptic density protein PSD-95. This procedure dissociated NMDARs from downstream neurotoxic signaling without blocking synaptic activity or calcium influx. The peptides, when applied either before or 1 hour after an insult, protected cultured neurons from excitotoxicity, reduced focal ischemic brain damage in rats, and improved their neurological function. This approach circumvents the negative consequences associated with blocking NMDARs and may constitute a practical stroke therapy.	Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; Hosp Sick Children, Div Lab Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Pathobiol, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Med, Vancouver, BC V6T 1Z3, Canada; Univ Toronto Scarborough, Ctr Neurobiol Stress, Div Life Sci, Toronto, ON M1C 1A3, Canada; Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of British Columbia; University of Toronto; University Toronto Scarborough; University of Toronto; University of Toronto	Salter, MW (corresponding author), Hosp Sick Children, Programme Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008; Aarts, Michelle/C-5766-2008	Aarts, Michelle/0000-0002-9171-0571; Tymianski, Mike/0000-0002-6311-9565; Liu, Lidong/0000-0002-7026-690X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 39060] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256	20	770	865	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 25	2002	298	5594					846	850		10.1126/science.1072873	http://dx.doi.org/10.1126/science.1072873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399596				2022-12-24	WOS:000178791200065
J	Dillin, A; Crawford, DK; Kenyon, C				Dillin, A; Crawford, DK; Kenyon, C			Timing requirements for insulin/IGF-1 signaling in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; LONGEVITY; REPRODUCTION; INTERFERENCE; EXTENSION; MUTANT; DAF-2; GENES	The insulin/IGF-1 (where IGF-1 is insulin-like growth factor 1) signaling pathway influences longevity, reproduction, and diapause in many organisms. Because of the fundamental importance of this system in animal physiology, we asked when during the animal's life it is required to regulate these different processes. We find that in Caenorhabditis elegans, the pathway acts during adulthood, to relatively advanced ages, to influence aging. In contrast, it regulates diapause during development. In addition, the pathway controls longevity and reproduction independently of one another. Together our findings show that life-span regulation can be dissociated temporally from phenotypes that might seem to decrease the quality of life.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [5RO1AG11816] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011816] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartke A, 2000, RES PRO CEL, V29, P181; BERMAN J, UNPUB; CHNG Q, UNPUB; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DILLIN A, UNPUB; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; LARSEN PL, 1995, GENETICS, V139, P1567; Lithgow GJ, 2000, RES PRO CEL, V29, P131; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; RIDDLE DL, 1977, STADLER GENET S, V9, P101; Sun JT, 2002, GENETICS, V161, P661; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tissenbaum HA, 1998, GENETICS, V148, P703; 5RO1AG11816 NIH; DRG1525 D RUNY FDN F	25	330	342	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 25	2002	298	5594					830	834		10.1126/science.1074240	http://dx.doi.org/10.1126/science.1074240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399591				2022-12-24	WOS:000178791200060
J	Fodde, R; Smits, R				Fodde, R; Smits, R			A matter of dosage	SCIENCE			English	Editorial Material							HAPLO-INSUFFICIENT; TUMOR SUPPRESSION; CANCER; MICE; HAPLOINSUFFICIENCY; MUTATIONS; P53		Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Fodde, R (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands.		Fodde, Riccardo/AAW-9394-2021	Fodde, Riccardo/0000-0001-9839-4324				Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Miyoshi H, 2002, CANCER RES, V62, P2261; Smits R, 2000, GASTROENTEROLOGY, V119, P1045, DOI 10.1053/gast.2000.18162; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Wetmore C, 2000, CANCER RES, V60, P2239; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zurawel RH, 2000, GENE CHROMOSOME CANC, V28, P77, DOI 10.1002/(SICI)1098-2264(200005)28:1<77::AID-GCC9>3.0.CO;2-Y	18	100	104	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 25	2002	298	5594					761	763		10.1126/science.1077707	http://dx.doi.org/10.1126/science.1077707			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399571				2022-12-24	WOS:000178791200039
J	Damste, JSS; Strous, M; Rijpstra, WIC; Hopmans, EC; Geenevasen, JAJ; van Duin, ACT; van Niftrik, LA; Jetten, MSM				Damste, JSS; Strous, M; Rijpstra, WIC; Hopmans, EC; Geenevasen, JAJ; van Duin, ACT; van Niftrik, LA; Jetten, MSM			Linearly concatenated cyclobutane lipids form a dense bacterial membrane	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; GLYCEROL DIETHERS; NITRATE; GENUS	Lipid membranes are essential to the functioning of cells, enabling the existence of concentration gradients of ions and metabolites. Microbial membrane lipids can contain three-, five-, six- and even seven-membered aliphatic rings(1-3), but four-membered aliphatic cyclobutane rings have never been observed. Here we report the discovery of cyclobutane rings in the dominant membrane lipids of two anaerobic ammonium-oxidizing (anammox) bacteria. These lipids contain up to five linearly fused cyclobutane moieties with cis ring junctions. Such 'ladderane' molecules are unprecedented in nature but are known as promising building blocks in optoelectronics(4). The ladderane lipids occur in the membrane of the anammoxosome, the dedicated intracytoplasmic compartment where anammox catabolism takes place. They give rise to an exceptionally dense membrane, a tight barrier against diffusion. We propose that such a membrane is required to maintain concentration gradients during the exceptionally slow anammox metabolism and to protect the remainder of the cell from the toxic anammox intermediates. Our results further illustrate that microbial membrane lipid structures are far more diverse than previously recognized(5-7).	Royal Netherlands Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Univ Nijmegen, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; Univ Amsterdam, Inst Mol Chem, NL-1018 WS Amsterdam, Netherlands; Newcastle Univ, Dept Fossil Fuels & Environm Geochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Radboud University Nijmegen; University of Amsterdam; Newcastle University - UK; Delft University of Technology	Damste, JSS (corresponding author), Royal Netherlands Sea Res, Dept Marine Biogeochem & Toxicol, POB 59, NL-1790 AB Den Burg, Netherlands.	damste@nioz.nl	Damste, Jaap S Sinninghe/F-6128-2011; van Niftrik, Laura/AAQ-7724-2020; van Niftrik, Laura/C-3269-2011; Jetten, Mike/B-8834-2011; Strous, Marc/B-4064-2017	Damste, Jaap S Sinninghe/0000-0002-8683-1854; van Niftrik, Laura/0000-0002-7011-7234; Jetten, Mike/0000-0002-4691-7039; Strous, Marc/0000-0001-9600-3828				BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Damste JSS, 2000, CHEM COMMUN, P1683, DOI 10.1039/b004517i; DEROSA M, 1989, FEMS SYMP, V49, P167; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; Egli K, 2001, ARCH MICROBIOL, V175, P198, DOI 10.1007/s002030100255; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Huber R, 1996, SYST APPL MICROBIOL, V19, P40, DOI 10.1016/S0723-2020(96)80007-5; LANGWORTHY TA, 1986, SYST APPL MICROBIOL, V7, P253; LANGWORTHY TA, 1983, SYST APPL MICROBIOL, V4, P1, DOI 10.1016/S0723-2020(83)80029-0; Li WJ, 1996, J AM CHEM SOC, V118, P11752, DOI 10.1021/ja961647f; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; MEHTA G, 1992, ANGEW CHEM INT EDIT, V31, P1488, DOI 10.1002/anie.199214881; MILLER MA, 1988, J MOL STRUC-THEOCHEM, V40, P133, DOI 10.1016/0166-1280(88)80385-3; Olsen GJ, 1999, NATURE, V400, P403, DOI 10.1038/22643; Pancost RD, 2001, ORG GEOCHEM, V32, P695, DOI 10.1016/S0146-6380(01)00015-8; Rutters H, 2001, ARCH MICROBIOL, V176, P435, DOI 10.1007/s002030100343; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schouten S, 2000, P NATL ACAD SCI USA, V97, P14421, DOI 10.1073/pnas.97.26.14421; SITTIG M, 1993, SYST APPL MICROBIOL, V16, P92; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Van De Graaf Astrid A., 1996, Microbiology (Reading), V142, P2187; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; VANDUIN ACT, 2001, GEOCHEM T, V6; WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263, DOI 10.1099/00207713-42-2-263	29	317	340	18	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2002	419	6908					708	712		10.1038/nature01128	http://dx.doi.org/10.1038/nature01128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	604JF	12384695				2022-12-24	WOS:000178615200037
J	Trievel, RC; Beach, BM; Dirk, LMA; Houtz, RL; Hurley, JH				Trievel, RC; Beach, BM; Dirk, LMA; Houtz, RL; Hurley, JH			Structure and catalytic mechanism of a SET domain protein methyltransferase	CELL			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; MULTIPLE ISOMORPHOUS REPLACEMENT; HISTONE H3 METHYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; ARGININE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; PARTIAL-PURIFICATION; CRYSTAL-STRUCTURE; DNA METHYLATION; LYSINE 9	Protein lysine methylation by SET domain enzymes regulates chromatin structure, gene silencing, transcriptional activation, plant metabolism, and other processes. The 2.6 Angstrom resolution structure of Rubisco large subunit methyltransferase in a pseudo-bisubstrate complex with S-adenosylhomocysteine and a HEPES ion reveals an all-beta architecture for the SET domain embedded within a larger alpha-helical enzyme fold. Conserved regions of the SET domain bind S-adenosylmethionine and substrate lysine at two sites connected by a pore. We propose that methyl transfer is catalyzed by a conserved Tyr at a narrow pore connecting the sites. The cofactor enters by a "back door" on the opposite side of the enzyme from substrate, promoting highly specific protein recognition and allowing addition of multiple methyl groups.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Kentucky, Dept Hort, Plant Physiol Biochem Mol Biol Program, Lexington, KY 40546 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Kentucky	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	jh8e@nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DURBAN E, 1978, J BIOL CHEM, V253, P1427; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; HOUTZ RL, 1991, PLANT PHYSIOL, V97, P913, DOI 10.1104/pp.97.3.913; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; MCCURRY SD, 1982, METHOD ENZYMOL, V90, P515; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; ROWE PM, 1986, J BIOL CHEM, V261, P7060; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; SCHNEIDER G, 1992, ANNU REV BIOPH BIOM, V21, P119, DOI 10.1146/annurev.bb.21.060192.001003; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Soltis SM, 1997, J APPL CRYSTALLOGR, V30, P190, DOI 10.1107/S0021889896012939; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; WANG P, 1995, PROTEIN EXPRES PURIF, V6, P528, DOI 10.1006/prep.1995.1070; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Ying ZT, 1999, J BIOL CHEM, V274, P36750, DOI 10.1074/jbc.274.51.36750; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936	60	201	210	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2002	111	1					91	103		10.1016/S0092-8674(02)01000-0	http://dx.doi.org/10.1016/S0092-8674(02)01000-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372303	Bronze			2022-12-24	WOS:000178461900011
J	Tomishige, M; Klopfenstein, DR; Vale, RD				Tomishige, M; Klopfenstein, DR; Vale, RD			Conversion of Unc104/KIF1A kinesin into a processive motor after dimerization	SCIENCE			English	Article							SUPERFAMILY PROTEIN KIF1A; AXONAL-TRANSPORT; K-LOOP; SINGLE; MECHANISM; ELEGANS; UNC-104; FAMILY	Unc104/KIF1A belongs to a class of monomeric kinesin motors that have been thought to possess an unusual motility mechanism. Unlike the unidirectional motion driven by the coordinated actions of the two heads in conventional kinesins, single-headed KIF1A was reported to undergo biased diffusional motion along microtubules. Here, we show that Unc104/KIF1A can dimerize and move unidirectionally and processively with rapid velocities characteristic of transport in living cells. These results suggest that Unc104/KIF1A operates in vivo by a mechanism similar to conventional kinesin and that regulation of motor dimerization may be used to control transport by this class of kinesins.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.				NIAMS NIH HHS [AR42895] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bloom GS, 2001, CURR OPIN CELL BIOL, V13, P36, DOI 10.1016/S0955-0674(00)00171-X; Dorner C, 1999, J BIOL CHEM, V274, P33654, DOI 10.1074/jbc.274.47.33654; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Pierce DW, 1999, BIOCHEMISTRY-US, V38, P5412, DOI 10.1021/bi9830009; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	17	200	204	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2263	2267		10.1126/science.1073386	http://dx.doi.org/10.1126/science.1073386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12351789				2022-12-24	WOS:000178222000048
J	Bi, XP; Corpina, RA; Goldberg, J				Bi, XP; Corpina, RA; Goldberg, J			Structure of the Sec23/24-Sar1 pre-budding complex of the COPII vesicle coat	NATURE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; ADP-RIBOSYLATION FACTOR; ENDOPLASMIC-RETICULUM; MEMBRANE PHOSPHOLIPIDS; PROTEIN-TRANSPORT; GTP; BINDING; ER; ACTIVATION; DOMAIN	COPII-coated vesicles form on the endoplasmic reticulum by the stepwise recruitment of three cytosolic components: Sar1-GTP to initiate coat formation, Sec23/24 heterodimer to select SNARE and cargo molecules, and Sec13/31 to induce coat polymerization and membrane deformation. Crystallographic analysis of the Saccharomyces cerevisiae Sec23/24-Sar1 complex reveals a bow-tie-shaped structure, 15 nm long, with a membrane-proximal surface that is concave and positively charged to conform to the size and acidic-phospholipid composition of the COPII vesicle. Sec23 and Sar1 form a continuous surface stabilized by a non-hydrolysable GTP analogue, and Sar1 has rearranged from the GDP conformation to expose amino-terminal residues that will probably embed in the bilayer. The GTPase-activating protein (GAP) activity of Sec23 involves an arginine side chain inserted into the Sar1 active site. These observations establish the structural basis for GTP-dependent recruitment of a vesicular coat complex, and for uncoating through coat-controlled GTP hydrolysis.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *COLL COMP PROJ, 1984, ACTA CRYSTALLOGR D, V50, P760; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; FRANCO M, 1993, J BIOL CHEM, V268, P24531; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grabowski R, 1997, FEBS LETT, V411, P169, DOI 10.1016/S0014-5793(97)00720-5; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Huang MD, 2002, ACTA CRYSTALLOGR D, V58, P700, DOI 10.1107/S090744490200238X; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Peng RW, 1999, P NATL ACAD SCI USA, V96, P3751, DOI 10.1073/pnas.96.7.3751; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	50	337	349	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					271	277		10.1038/nature01040	http://dx.doi.org/10.1038/nature01040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239560				2022-12-24	WOS:000178056300038
J	Fischbach, W; Goebeler-Kolve, M; Starostik, P; Greiner, A; Muller-Hermelink, HK				Fischbach, W; Goebeler-Kolve, M; Starostik, P; Greiner, A; Muller-Hermelink, HK			Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori	LANCET			English	Article							B-CELL LYMPHOMA; TISSUE-TYPE	Helicobacter pylori eradication is the initial treatment of choice in localised low-grade gastric MALT (mucosa-associated lymphoid-tissue)-type lymphoma. We describe the natural course of seven patients who refused further oncological treatment for persistent lymphoma after successful eradication of H pylori. Despite persistent clonality, neither lymphoma progression nor high-grade transformation arose during a mean observation period of 34 (range 22-44) months. In view of the favourable course of these patients, a watch-and-wait strategy could be a valid approach to management of this disease.	Klin Aschaffenburg, Dept Internal Med 2, D-63739 Aschaffenburg, Germany; Univ Wurzburg, Med Poliklin, D-8700 Wurzburg, Germany; Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Fischbach, W (corresponding author), Klin Aschaffenburg, Dept Internal Med 2, D-63739 Aschaffenburg, Germany.							Fischbach W, 2000, GASTROENTEROLOGY, V119, P1191, DOI 10.1053/gast.2000.19579; Liu HX, 2001, LANCET, V357, P39, DOI 10.1016/S0140-6736(00)03571-6; QIN YF, 1995, BLOOD, V86, P3528, DOI 10.1182/blood.V86.9.3528.bloodjournal8693528; Starostik P, 2002, BLOOD, V99, P3, DOI 10.1182/blood.V99.1.3; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F	5	58	61	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 17	2002	360	9332					547	548		10.1016/S0140-6736(02)09711-8	http://dx.doi.org/10.1016/S0140-6736(02)09711-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241663				2022-12-24	WOS:000177512800017
J	Murphy, C; Schubert, CR; Cruickshanks, KJ; Klein, BEK; Klein, R; Nondahl, DM				Murphy, C; Schubert, CR; Cruickshanks, KJ; Klein, BEK; Klein, R; Nondahl, DM			Prevalence of olfactory impairment in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EVENT-RELATED POTENTIALS; CHEMOSENSORY PERCEPTION; SMELL IDENTIFICATION; MITRAL CELLS; BEAVER-DAM; TASTE; AGE; DISEASE; BULB; DYSFUNCTION	Context Older adults represent the fastest-growing segment of the US population, and prevalences of vision and hearing impairment have been extensively evaluated. However, despite the importance of sense of smell for nutrition and safety, the prevalence of olfactory impairment in older US adults has not been studied. Objective To determine the prevalence of olfactory impairment in older adults. Design, Setting, and Participants A total of 2491 Beaver Dam, Wis, residents aged 53 to 97 years participating in the 5-year follow-up examination (1998-2000) for the Epidemiology of Hearing Loss Study, a population-based, cross-sectional study. Main Outcome Measures Olfactory impairment, assessed by the San Diego Odor Identification Test and self-report.. Results The mean (SD) prevalence of impaired olfaction was 24.5% (1.7%). The prevalence increased with age; 62.5% (95% confidence interval [CI], 57.4%-67.7%) of 80- to 97-year-olds had olfactory impairment. Olfactory impairment was more prevalent among men (adjusted prevalence ratio, 1.92; 95% CI, 1.65-2.19). Current smoking, stroke, epilepsy, and nasal congestion or upper respiratory tract infection were also associated with increased prevalence of olfactory impairment. Self-reported olfactory impairment was low (9.5%) and this measure became less accurate with age. In the oldest group, aged 80 to 97 years, sensitivity of self-report was 12% for women and 18% for men. Conclusions This study demonstrates that prevalence of olfactory impairment among older adults is high and increases with age. Self-report significantly underestimated prevalence rates obtained by olfaction testing. Physicians and caregivers should be particularly alert to the potential for olfactory impairment in the elderly population.	San Diego State Univ, Sch Med, Joint Doctoral Program, San Diego, CA 92120 USA; Univ Calif San Diego, Sch Med, San Diego, CA USA; Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA	California State University System; San Diego State University; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Murphy, C (corresponding author), San Diego State Univ, Sch Med, Joint Doctoral Program, 6363 Alvarado Ct,Suite 101, San Diego, CA 92120 USA.	cmurphy@sciences.sdsu.edu		Klein, Ronald/0000-0002-4428-6237	NATIONAL INSTITUTE ON AGING [R37AG004085, R37AG011099, R01AG004085, R01AG011099] Funding Source: NIH RePORTER; NEI NIH HHS [EY06594] Funding Source: Medline; NIA NIH HHS [AG04085, R01 AG004085, AG11099] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; CHALKE HD, 1957, BRIT MED J, V2, P915, DOI 10.1136/bmj.2.5050.915; DAVIDSON TM, 1995, POSTGRAD MED, V98, P107, DOI 10.1080/00325481.1995.11946020; DAVIDSON TM, 1987, WESTERN J MED, V146, P434; DAVIES L, 1992, NESTLE NUTR WORKS SE, V29, P203; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Doty RL., 1991, SMELL TASTE HLTH DIS, P449; Drewnowski A, 2001, J GERONTOL A-BIOL, V56, P89, DOI 10.1093/gerona/56.suppl_2.89; EKMAN G, 1967, SCAND J PSYCHOL, V8, P177, DOI 10.1111/j.1467-9450.1967.tb01392.x; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; FELDMAN JI, 1986, AM J OTOLARYNG, V7, P431, DOI 10.1016/S0196-0709(86)80019-9; HALL JR, 1997, PATTERNS FIRE CASUAL, V2, P14; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jones N, 1998, J LARYNGOL OTOL, V112, P11, DOI 10.1017/S0022215100139829; KENDALL M, 1979, ADV THEORY STAT, V2, P580; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Kunihara KSN, 1994, OLFACTION TASTE, P609; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meisami E, 1998, ANN NY ACAD SCI, V855, P708, DOI 10.1111/j.1749-6632.1998.tb10649.x; Morgan CD, 1997, EVOKED POTENTIAL, V104, P351, DOI 10.1016/S0168-5597(97)00020-8; MORGAN CD, 1995, J CLIN EXP NEUROPSYC, V17, P793, DOI 10.1080/01688639508405168; MURPHY C, 1993, CRIT REV FOOD SCI, V33, P3, DOI 10.1080/10408399309527607; Murphy C, 2000, INT J PSYCHOPHYSIOL, V36, P133, DOI 10.1016/S0167-8760(99)00107-5; MURPHY C, 1992, NESTLE NUTR WORKS SE, V29, P79; MURPHY C, 1989, ANN NY ACAD SCI, V561, P251; MURPHY C, 1994, CHEM SENSES, V19, P47, DOI 10.1093/chemse/19.1.47; MURPHY C, 2002, HDB OLFACTION GUSTAT, P461; NAKASHIMA T, 1984, ARCH OTOLARYNGOL, V110, P641; NAKASHIMA T, 1985, LARYNGOSCOPE, V95, P391; *NIH, NIH PUBL; NORDIN S, 1995, J GERONTOL B-PSYCHOL, V50, pP187, DOI 10.1093/geronb/50B.4.P187; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schiffman S., 1991, SMELL TASTE HLTH DIS, P845; SCHIFFMAN SS, 1993, CRIT REV FOOD SCI, V33, P17, DOI 10.1080/10408399309527608; Schiffman SS, 1999, PHYSIOL BEHAV, V66, P183, DOI 10.1016/S0031-9384(98)00263-7; Schiffman SS, 1999, NUTRITION, V15, P767, DOI 10.1016/S0899-9007(99)00152-5; SCHIFFMAN SS, 1993, PHYSIOL BEHAV, V53, P395, DOI 10.1016/0031-9384(93)90224-4; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1337; SCHIFFMAN SS, 1986, CLIN MEASUREMENT TAS, P326; Schiffman SS., 1992, SCIENCE OLFACTION, P500, DOI 10.1007/978-1-4612-2836-3_18; Settle R., 1991, SMELL TASTE HLTH DIS, P829; SHIP JA, 1993, J GERONTOL, V48, pM26, DOI 10.1093/geronj/48.1.M26; Ship JA, 1996, J GERONTOL A-BIOL, V51, pM86, DOI 10.1093/gerona/51A.2.M86; Smith CG, 1941, ARCHIV OTOLARYNGOL, V34, P533; Stevens MH, 2001, LARYNGOSCOPE, V111, P200, DOI 10.1097/00005537-200102000-00002; *US BUR CENS, CENS 2000 SUMM FIL 1; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VELLAS B, 1992, NESTLE NUTR WORKS SE, V29, P75; Wakimoto P, 2001, J GERONTOL A-BIOL, V56, P65, DOI 10.1093/gerona/56.suppl_2.65; WYSOCKI CJ, 1989, ANN NY ACAD SCI, V561, P12, DOI 10.1111/j.1749-6632.1989.tb20966.x; Yousem DM, 1999, AM J NEURORADIOL, V20, P600; Zervakis J, 2000, PHYSIOL BEHAV, V68, P405, DOI 10.1016/S0031-9384(99)00208-5; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; [No title captured]	59	701	722	3	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2002	288	18					2307	2312		10.1001/jama.288.18.2307	http://dx.doi.org/10.1001/jama.288.18.2307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JZ	12425708	Bronze			2022-12-24	WOS:000179186400030
J	Cosgaya, JM; Chan, JR; Shooter, EM				Cosgaya, JM; Chan, JR; Shooter, EM			The neurotrophin receptor p75(NTR) as a positive modulator of myelination	SCIENCE			English	Article							NERVE GROWTH-FACTOR; SCIATIC-NERVE; MESSENGER-RNA; SCHWANN-CELLS; PERIPHERAL-NERVE; SYSTEM; NGF; EXPRESSION; ROLES	Schwann cells in developing and regenerating peripheral nerves express elevated levels of the neurotrophin receptor p75(NTR). Neurotrophins are key mediators of peripheral nervous system myelination. Our results show that myelin formation is inhibited in the absence of functional p75(NTR) and enhanced by blocking TrkC activity. Moreover, the enhancement of myelin formation by endogenous brain-derived neurotrophic factor is mediated by the p75(NTR) receptor, whereas TrkC receptors are responsible for neurotrophin-3 inhibition. Thus p75(NTR) and TrkC receptors have opposite effects on myelination.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Shooter, EM (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, 299 Campus Dr,Fairchild Bldg, Stanford, CA 94305 USA.	eshooter@cmgm.stanford.edu	Cosgaya, Jose M/B-4936-2008	Cosgaya, Jose Miguel/0000-0002-6005-2916	NINDS NIH HHS [NS04270] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Meier C, 1999, J NEUROSCI, V19, P3847; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	21	261	283	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1245	1248		10.1126/science.1076595	http://dx.doi.org/10.1126/science.1076595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424382				2022-12-24	WOS:000179080400054
J	Hirata, H; Yoshiura, S; Ohtsuka, T; Bessho, Y; Harada, T; Yoshikawa, K; Kageyama, R				Hirata, H; Yoshiura, S; Ohtsuka, T; Bessho, Y; Harada, T; Yoshikawa, K; Kageyama, R			Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop	SCIENCE			English	Article							SOMITE SEGMENTATION; PRESOMITIC MESODERM; NEURONAL DIFFERENTIATION; VERTEBRATE SEGMENTATION; DYNAMIC EXPRESSION; GENE-EXPRESSION; NOTCH; CLOCK; SOMITOGENESIS; HAIRY	Transcription of messenger RNAs (mRNAs) for Notch signaling molecules oscillates with 2-hour cycles, and this oscillation is important for coordinated somite segmentation. However, the molecular mechanism of such oscillation remains to be determined. Here, we show that serum treatment of cultured cells induces cyclic expression of both mRNA and protein of the Notch effector Hes1, a basic helix-loop-helix (bHLH) factor, with 2-hour periodicity. Cycling is cell-autonomous and depends on negative autoregulation of hes1 transcription and ubiquitin-proteasome mediated degradation of Hes1 protein. Because Hes1 oscillation can be seen in many cell types, this clock may regulate timing in many biological systems.	Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; CREST, Kyoto 6068502, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	rkageyam@virus.kyoto-u.ac.jp	Yoshikawa, Kenichi/L-4774-2016; Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136; Hirata, Hiromi/0000-0002-3769-7441				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; DALE JK, IN PRESS NATURE; Davis RL, 2001, DEV CELL, V1, P553, DOI 10.1016/S1534-5807(01)00054-5; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sawada A, 2000, DEVELOPMENT, V127, P1691; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150	27	565	578	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					840	843		10.1126/science.1074560	http://dx.doi.org/10.1126/science.1074560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399594				2022-12-24	WOS:000178791200063
J	Check, E				Check, E			Malta provides loophole for breast-cancer screen	NATURE			English	News Item																		Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					767	767		10.1038/419767b	http://dx.doi.org/10.1038/419767b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397316	Bronze			2022-12-24	WOS:000178769800006
J	Batlle, E; Henderson, JT; Beghtel, H; van den Born, MMW; Sancho, E; Huls, G; Meeldijk, J; Robertson, J; van de Wetering, M; Pawson, T; Clevers, H				Batlle, E; Henderson, JT; Beghtel, H; van den Born, MMW; Sancho, E; Huls, G; Meeldijk, J; Robertson, J; van de Wetering, M; Pawson, T; Clevers, H			beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB	CELL			English	Article							RECEPTOR TYROSINE KINASE; FOCAL-ADHESION-KINASE; EPH RECEPTORS; COLORECTAL-CANCER; COMMISSURAL AXONS; EPHRINS; LIGANDS; MICE; MIGRATION; DYNAMICS	In the small intestine, the progeny of stem cells migrate in precise patterns. Absorptive, enteroendocrine, and goblet cells migrate toward the villus while Paneth cells occupy the bottom of the crypts. We show here that beta-catenin and TCF inversely control the expression of the EphB2/EphB3 receptors and their ligand ephrin-B1 in colorectal cancer and along the crypt-villus axis. Disruption of EphB2 and EphB3 genes reveals that their gene products restrict cell intermingling and allocate cell populations within the intestinal epithelium. In EphB2/EphB3 null mice, the proliferative and differentiated populations intermingle. In adult EphB3(-/-) mice, Paneth cells do not follow their downward migratory path, but scatter along crypt and villus. We conclude that in the intestinal epithelium beta-catenin and TCF couple proliferation and differentiation to the sorting of cell populations through the EphB/ephrin-B system.	Univ Med Ctr, Dept Immunol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr, Ctr Biomed Genet, NL-3584 CX Utrecht, Netherlands; Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 262, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@azu.nl	Eckhardt, Erik/G-1567-2010; Sancho, Elena/ABH-4867-2020; Huls, G.A./L-4398-2015; Pawson, Tony J/E-4578-2013; Batlle, Eduard/K-8080-2014	Sancho, Elena/0000-0002-8182-513X; Batlle, Eduard/0000-0003-2422-0326				Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Brambilla R, 1996, MOL CELL NEUROSCI, V8, P199, DOI 10.1006/mcne.1996.0057; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; FLANAGAN JG, 2001, NAT REV CANC, V1, P55; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holder N, 1999, DEVELOPMENT, V126, P2033; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Oshima H, 1997, CANCER RES, V57, P1644; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Polakis P, 2000, GENE DEV, V14, P1837; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Robinson V, 1997, CELL TISSUE RES, V290, P265, DOI 10.1007/s004410050931; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wilkinson DG, 2000, CURR BIOL, V10, pR447, DOI 10.1016/S0960-9822(00)00530-3; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Xu QL, 1995, DEVELOPMENT, V121, P4005	37	874	909	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2002	111	2					251	263		10.1016/S0092-8674(02)01015-2	http://dx.doi.org/10.1016/S0092-8674(02)01015-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408869	Bronze			2022-12-24	WOS:000178753500014
J	Gaba, DM; Howard, SK				Gaba, DM; Howard, SK			Patient safety: Fatigue among clinicians and the safety of patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SLEEP-DEPRIVATION; WORK HOURS; PERFORMANCE; RESIDENTS; DECREMENTS; ALCOHOL; DOCTORS; RISK; NAPS; NEED		Vet Affairs Palo Alto Hlth Care Syst, Patient Safety Ctr Inquiry, Palo Alto, CA USA; Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Gaba, DM (corresponding author), Anesthesiol Serv, 112A,3801 Miranda Ave, Palo Alto, CA 94304 USA.	gaba@stanford.edu	Gaba, David M/D-5229-2009	Gaba, David M/0000-0002-0657-5396; Howard, Steven/0000-0001-6475-1792				*ACCR COUNC GRAD M, 2001, ACGME RESP PAT PHYS; *ACCR COUNC GRAD M, 2002, PROGR REQ IND SPEC R; *ACCR COUNC GRAD M, 2001, PERC PROGR CIT WORK; *ACCR COUNC GRAD M, 2002, ACGME APPR NEW PROP; Arnedt JT, 2001, ACCIDENT ANAL PREV, V33, P337, DOI 10.1016/S0001-4575(00)00047-6; ASKEN MJ, 1983, J MED EDUC, V58, P382; *ASS AM MED COLL, 2001, AAMC POL GUID GRAD M; *AUSTR MED ASS, 1998, OV EXP REG HOURS WOR; Batejat DM, 1999, AVIAT SPACE ENVIR MD, V70, P493; Clark PA, 2001, ACAD MED, V76, P419, DOI 10.1097/00001888-200105000-00008; Collier VU, 2002, ANN INTERN MED, V136, P384, DOI 10.7326/0003-4819-136-5-200203050-00011; Cooper J B, 1989, J Clin Anesth, V1, P228, DOI 10.1016/0952-8180(89)90047-0; Coulehan J, 2001, ACAD MED, V76, P598, DOI 10.1097/00001888-200106000-00008; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1996, 110404 NASA AM RES C; DUNCAN D, 1996, RESIDENTS; FRIEDMAN FC, 1973, J MED EDUC, V48, P436; GABA DM, 1994, ANESTHESIOLOGY, V81, P488, DOI 10.1097/00000542-199408000-00028; GLICKMAN RM, 1988, NEW ENGL J MED, V318, P780, DOI 10.1056/NEJM198803243181212; Heins A, 2002, ANN EMERG MED, V39, P444, DOI 10.1067/mem.2002.122773; Holzman IR, 2000, MT SINAI J MED, V67, P136; Hopkins GE, 1971, AIRLINE PILOTS STUDY, P116; Howard SK, 2002, ACAD MED, V77, P1019, DOI 10.1097/00001888-200210000-00015; HOWARD SK, IN PRESS ANESTHESIOL; JHA AK, 2001, AHRQ PUBLICATION, P519; Kapur N, 1998, MED EDUC, V32, P432, DOI 10.1046/j.1365-2923.1998.00238.x; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Leach DC, 2000, ACAD MED, V75, P1156, DOI 10.1097/00001888-200012000-00005; LEUNG L, 1992, J OCCUP ENVIRON MED, V34, P1153; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; MCKEE M, 1993, J PUBLIC HEALTH MED, V15, P16, DOI 10.1093/oxfordjournals.pubmed.a042815; Mizrahi T., 1986, GETTING RID PATIENTS; *NY STAT DEP HLTH, 1998, ASS HOSP COMPL RES W; Office of Technology Assessment, 1991, OTABA463; Owens J A, 2001, Curr Opin Pulm Med, V7, P411, DOI 10.1097/00063198-200111000-00009; PANKRATZ H, 1995, DENVER POST     0915, pA1; Patton D V, 2001, J Health Law, V34, P377; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pickersgill T, 2001, BRIT MED J, V323, P1266, DOI 10.1136/bmj.323.7324.1266; *PUBL CIT HLTH RES, 2002, HRG PUBL, V1570; Reid K, 2001, OCCUP ENVIRON MED, V58, P58, DOI 10.1136/oem.58.1.58; Robins NS, 1995, GIRL WHO DIED TWICE; Rosekind MR, 1995, J SLEEP RES, V4, P62, DOI 10.1111/j.1365-2869.1995.tb00229.x; Rosekind MR, 1996, BEHAV MED, V21, P166, DOI 10.1080/08964289.1996.9933754; ROSEKIND MR, 1994, NTSBAAR9404; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; SCHWARTZ RJ, 1992, ARCH SURG-CHICAGO, V127, P778; Shine KI, 2002, ACAD MED, V77, P92, DOI 10.1097/00001888-200201000-00021; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; STODDARD JJ, 1994, JAMA-J AM MED ASSOC, V272, P1256; STODDARD JJ, 1994, JAMA-J AM MED ASSOC, V272, P53, DOI 10.1001/jama.272.1.53; Stone MD, 2000, SURGERY, V128, P465, DOI 10.1067/msy.2000.108048; Taffinder N, 1999, J ROY SOC MED, V92, P329, DOI 10.1177/014107689909200701; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Torkington J, 2000, ANN ROY COLL SURG, V82, P88; Van Dongen HP., 2000, PRINCIPLE PRACT SLEE, V20, P391; Wallack MK, 2001, ARCH SURG-CHICAGO, V136, P1426, DOI 10.1001/archsurg.136.12.1426; Weinger MB, 2002, JAMA-J AM MED ASSOC, V287, P955, DOI 10.1001/jama.287.8.955; 1999, NEW YORK POST   0207, P1; 2002, NY TIMES        0507, pA1; 2002, NY TIMES        0509, pB6	64	459	466	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2002	347	16					1249	1255		10.1056/NEJMsa020846	http://dx.doi.org/10.1056/NEJMsa020846			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604CP	12393823	Bronze			2022-12-24	WOS:000178598300007
J	Enquist, BJ; Haskell, JP; Tiffney, BH				Enquist, BJ; Haskell, JP; Tiffney, BH			General patterns of taxonomic and biomass partitioning in extant and fossil plant communities	NATURE			English	Article							LIMITING SIMILARITY; DIVERSITY; RECRUITMENT	A central goal of evolutionary ecology is to identify the general features maintaining the diversity of species assemblages(1-3). Understanding the taxonomic and ecological characteristics of ecological communities provides a means to develop and test theories about the processes that regulate species coexistence and diversity. Here, using data from woody plant communities from different biogeographic regions, continents and geologic time periods, we show that the number of higher taxa is a general power-function of species richness that is significantly different from randomized assemblages. In general, we find that local communities are characterized by fewer higher taxa than would be expected by chance. The degree of taxonomic diversity is influenced by modes of dispersal and potential biotic interactions. Further, changes in local diversity are accompanied by regular changes in the partitioning of community biomass between taxa that are also described by a power function. Our results indicate that local and regional processes(2) have consistently regulated community diversity and biomass partitioning for millions of years.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Conservat Int, Ctr Appl Biodivers Res, Washington, DC 20036 USA; Utah State Univ, Dept Fisheries & Wildlife, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; Univ Calif Santa Barbara, Dept Geol, Santa Barbara, CA 93106 USA	University of Arizona; Conservation International; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of California System; University of California Santa Barbara	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	benquist@u.arizona.edu	Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				Darwin C., 1859, ORIGIN SPECIES FACSI; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; GENTRY AH, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P500; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Karr J.R., 1975, P258; Kinzig AP, 1999, AM NAT, V153, P371, DOI 10.1086/303182; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; Manly B. F. J, 1997, RANDOMIZATION BOOTST; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; RICKLEFS RE, 1975, EVOLUTION, V29, P313, DOI 10.1111/j.1558-5646.1975.tb00211.x; Ricklefs Robert E., 1993, P350; Robeck HE, 2000, PALEOBIOLOGY, V26, P171, DOI 10.1666/0094-8373(2000)026<0171:TATDP>2.0.CO;2; Roy K, 1996, PHILOS T R SOC B, V351, P1605, DOI 10.1098/rstb.1996.0144; SEPKOSKI JJ, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P210; SIMBERLOFF DS, 1970, EVOLUTION, V24, P23, DOI 10.1111/j.1558-5646.1970.tb01738.x; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; VALENTINE J W, 1970, Journal of Paleontology, V44, P410; Vazquez JA, 1998, J ECOL, V86, P999, DOI 10.1046/j.1365-2745.1998.00325.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Williams C. B., 1964, PATTERNS BALANCE NAT; WILLIAMS PH, 1994, P ROY SOC B-BIOL SCI, V256, P67, DOI 10.1098/rspb.1994.0050	28	79	84	2	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 10	2002	419	6907					610	613		10.1038/nature01069	http://dx.doi.org/10.1038/nature01069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374977				2022-12-24	WOS:000178483100043
J	Scott, TW; Takken, W; Knols, BGJ; Boete, C				Scott, TW; Takken, W; Knols, BGJ; Boete, C			The ecology of genetically modified mosquitoes	SCIENCE			English	Editorial Material							POPULATION-SIZE; AFRICA		Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; Univ Paris 06, Lab Parasitol Evolut, Paris 5, France	University of California System; University of California Davis; Wageningen University & Research; UDICE-French Research Universities; Sorbonne Universite	Scott, TW (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	twscott@ucdavis.edu	BOETE, Christophe/A-7926-2010; Knols, Bart/C-5765-2017	BOETE, Christophe/0000-0001-9043-8652; 				Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Boete C, 2002, PARASITOLOGY, V125, P93, DOI 10.1017/S0031182002001944; BOETE C, IN PRESS TRENDS PARA; Boete Christopher, 2002, Malaria Journal, V1, pUnpaginated; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Donnelly MJ, 2002, TRENDS PARASITOL, V18, P75, DOI 10.1016/S1471-4922(01)02198-5; Enserink M, 2002, SCIENCE, V297, P30; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2000, INSECT TRANSGENESIS, P319, DOI 10.1201/9781420039399.ch18; Kiszewski AE, 2002, J MED ENTOMOL, V39, P847, DOI 10.1603/0022-2585-39.6.847; LORIMER N, 1976, J ECON ENTOMOL, V69, P405, DOI 10.1093/jee/69.3.405; MAXWELL CA, IN PRESS TROP MED IN; MORRISON AC, UNPUB; Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635; Okanda F.M., 2002, Malaria Journal, pUnpaginated, DOI 10.1186/1475-2875-1-10; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; TAKKEN W, IN PRESS TROP MED IN; TAYLOR CE, 1993, MED VET ENTOMOL, V7, P351, DOI 10.1111/j.1365-2915.1993.tb00704.x; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X	28	147	151	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					117	119		10.1126/science.298.5591.117	http://dx.doi.org/10.1126/science.298.5591.117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364785				2022-12-24	WOS:000178370500042
J	Mottram, DS; Wedzicha, BL; Dodson, AT				Mottram, DS; Wedzicha, BL; Dodson, AT			Acrylamide is formed in the Maillard reaction	NATURE			English	Article									Univ Reading, Sch Food Biosci, Reading RG6 6AP, Berks, England; Univ Leeds, Procter Dept Food Sci, Leeds LS2 9JT, W Yorkshire, England	University of Reading; University of Leeds	Mottram, DS (corresponding author), Univ Reading, Sch Food Biosci, Reading RG6 6AP, Berks, England.	d.s.mottram@reading.ac.uk						Belitz H -D, 1999, FOOD CHEM; CASTLE L, 1993, J AGR FOOD CHEM, V41, P1261, DOI 10.1021/jf00032a019; DEMBINSKI E, 1991, J PLANT PHYSIOL, V138, P494, DOI 10.1016/S0176-1617(11)80529-8; Martin FL, 2001, J AGR FOOD CHEM, V49, P3885, DOI 10.1021/jf010310g; Rosen J, 2002, ANALYST, V127, P880, DOI 10.1039/b204938d; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; WHO INT AGCY RES CANC, 1994, IARC MONOG EVAL CARC, V60, P389	7	1561	1729	29	524	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					448	449		10.1038/419448a	http://dx.doi.org/10.1038/419448a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368844				2022-12-24	WOS:000178348400025
J	Shlipak, MG; Heidenreich, PA; Noguchi, H; Chertow, GM; Browner, WS; McClellan, MB				Shlipak, MG; Heidenreich, PA; Noguchi, H; Chertow, GM; Browner, WS; McClellan, MB			Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; CARDIOVASCULAR-DISEASE; MEDICARE PATIENTS; TERM MORTALITY; BETA-BLOCKERS; RISK; EVENTS; PREDICTION; INHIBITORS; SURVIVAL	Background: Patients with end-stage renal disease are known to have decreased survival after myocardial infarction, but the association of less severe renal dysfunction with survival after myocardial infarction is unknown. Objectives: To determine how patients with renal insufficiency are treated during hospitalization for myocardial infarction and to determine the association of renal insufficiency with survival after myocardial infarction. Design: Cohort study. Setting: All nongovernment hospitals in the United States. Patients: 130 099 elderly patients with myocardial infarction hospitalized between April 1994 and July 1995. Measurements: Patients were categorized according to initial serum creatinine level: no renal insufficiency (creatinine level < 1.5 mg/dL [<132 mumol/L];. n = 82 455), mild renal insufficiency (creatinine level, 1.5 to 2.4 mg/dL [132 to 212 mumol/L]; n = 36 756), or moderate renal insufficiency (creatinine level, 2.5 to 3.9 mg/dL (221 to 345 mumol/L); n = 10 888). Vital status up to 1 year after discharge was obtained from Social Security records. Results: Compared with patients with no renal insufficiency, patients with moderate renal insufficiency were less likely to receive aspirin, beta-blockers, thrombolytic therapy, angiography, and angioplasty during hospitalization. One-year mortality was 24% in patients with no renal insufficiency, 46% in patients with mild renal insufficiency, and 66% in patients with moderate renal insufficiency (P < 0.001). After adjustment for patient and treatment characteristics, mild (hazard ratio, 1.68 [95% CI, 1.63 to 1.73]) and moderate (hazard ratio, 2.35 [CI 2.26 to 2.45]) renal insufficiency were associated with substantially elevated risk for death during the first month of follow-up. This increased mortality risk continued until 6 months after myocardial infarction. Conclusions: Renal insufficiency was an independent risk factor for death in elderly patients after myocardial infarction. Targeted interventions may be needed to improve treatment for this high-risk population.	Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Palo Alto Vet Affairs Med Ctr, Palo Alto, CA USA; Stanford Univ, Palo Alto, CA 94304 USA; Toyo Eiwa Univ, Kanagawa, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Stanford University	Shlipak, MG (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	shlip@itsa.ucsf.edu	Noguchi, Haruko/ABF-3059-2020; Heidenreich, Paul/AAU-6864-2021	Noguchi, Haruko/0000-0002-4437-8238; Heidenreich, Paul/0000-0001-7730-8490; Chertow, Glenn/0000-0002-7599-0534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL068099] Funding Source: NIH RePORTER; NHLBI NIH HHS [R03 HL68099-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1998, Am J Kidney Dis, V32, pS1; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cox D. R., 1984, ANAL SURVIVAL DATA; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Fitzmaurice GM, 1997, BIOMETRICS, V53, P110, DOI 10.2307/2533101; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Frances CD, 2000, ARCH INTERN MED, V160, P2645, DOI 10.1001/archinte.160.17.2645; Herlitz J, 1998, CARDIOLOGY, V90, P110, DOI 10.1159/000006828; Herzog CA, 1999, KIDNEY INT, V56, pS130, DOI 10.1046/j.1523-1755.1999.07132.x; Herzog CA, 1999, KIDNEY INT, V56, P324, DOI 10.1046/j.1523-1755.1999.00540.x; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Hjalmarson A, 1999, LANCET, V353, P2001; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lechat P, 1999, LANCET, V353, P9; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Meng X L, 1997, Stat Methods Med Res, V6, P3, DOI 10.1191/096228097675663031; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Samuels LE, 1996, J CARDIAC SURG, V11, P128, DOI 10.1111/j.1540-8191.1996.tb00026.x; Samuels LE, 1996, J CARDIOVASC SURG, V11, P134; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Shlipak MG, 2001, AM J MED, V110, P425, DOI 10.1016/S0002-9343(01)00652-0; SIEGEL D, 1988, ANN INTERN MED, V109, P213, DOI 10.7326/0003-4819-109-3-213; Wheeler DC, 1996, LANCET, V348, P1673, DOI 10.1016/S0140-6736(05)65816-3; Yusuf S, 2000, NEW ENGL J MED, V342, P145	30	435	461	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2002	137	7					555	562		10.7326/0003-4819-137-7-200210010-00006	http://dx.doi.org/10.7326/0003-4819-137-7-200210010-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599VD	12353942				2022-12-24	WOS:000178355100001
J	Chapin, DM; Cohen, KP; Davis, WK; Kintner, EE; Koch, LJ; Landis, JW; Levenson, M; Mandil, IH; Pate, ZT; Rockwell, T; Schriesheim, A; Simpson, JW; Squire, A; Starr, C; Stone, HE; Taylor, JJ; Todreas, NE; Wolfe, B; Zebroski, EL				Chapin, DM; Cohen, KP; Davis, WK; Kintner, EE; Koch, LJ; Landis, JW; Levenson, M; Mandil, IH; Pate, ZT; Rockwell, T; Schriesheim, A; Simpson, JW; Squire, A; Starr, C; Stone, HE; Taylor, JJ; Todreas, NE; Wolfe, B; Zebroski, EL			Nuclear safety - Nuclear power plants and their fuel as terrorist targets	SCIENCE			English	Editorial Material							BIOLOGIC RESPONSES; IONIZING-RADIATION; DOSE RESPONSES; DETRIMENT		MPR Associates Inc, Alexandria, VA 22314 USA; GE Co, Nucl Energy Grp, Schenectady, NY 12301 USA; Publ Safety Stand Grp, Weston, MA 02198 USA; WANO, Atlanta, GA 30339 USA; Argonne Natl Lab, Argonne, IL 60439 USA; Westinghouse Elect Corp, Pittsburgh, PA 15222 USA; Elect Power Res Inst, Palo Alto, CA 94393 USA; MIT, Cambridge, MA 02139 USA	General Electric; United States Department of Energy (DOE); Argonne National Laboratory; Paramount Global; Electric Power Research Institute (EPRI); Massachusetts Institute of Technology (MIT)	Rockwell, T (corresponding author), MPR Associates Inc, Alexandria, VA 22314 USA.	tedrock@cpcug.org						BRUES AM, 1958, SCIENCE, V128, P693, DOI 10.1126/science.128.3326.693; COLE N, 1985, TMI 2 LEARNING EXPER; DIAZ N, 2002, AM NUCL SOC C HOLL F; *DOE EIS, 2002, DOEEIS0250; Feinendegen LE, 2001, J NUCL MED, V42, p17N; Gerber LM, 1999, Q REV BIOL, V74, P273, DOI 10.1086/393162; HENDERSON B, 2001, SAN FRANCISCO C 1005, pA6; HENRY HF, 1961, JAMA-J AM MED ASSOC, V176, P671, DOI 10.1001/jama.1961.63040210001004; Jaworowski Z, 1999, PHYS TODAY, V52, P24, DOI 10.1063/1.882810; Jaworowski Z, 2001, SCIENCE, V293, P605; Kemeny J., 1979, NEED CHANGE LEGACY T; Luckey TD, 1991, RAD HORMESIS; Luckey TD, 1980, HORMESIS IONIZING RA; MUCKERHEIDE J, 1998, LOW LEV RAD HLTH EFF; *NCRP, 94 NCRP; NELSON D, 2001, ONEWORLD UK; *ORG EC COOP DEV, 1993, 3 MIL ISL REACT PRES; Pollycove M, 2001, J NUCL MED, V42, p26N; Service RF, 2001, SCIENCE, V291, P426, DOI 10.1126/science.291.5503.426; SMITH BC, 2002, TECH            0501; SPRUNG JL, 2000, NUREGCR6672 SAND NAT; *UN SCI COMM EFF A, CHERN ACC, V2; *UN SCI COMM EFF A, CHERN ACC, V1, P13; UNICEF, 2002, HUMAN CONSEQUENCES C; United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation, 2000, SOURC EFF ION RAD UN; US Environmental Protection Agency, 2000, FED REG         1207, V65, P76708; WALINDER G, 1995, HAS RAD PROTECTION H; Williams D, 2002, NAT REV CANCER, V2, P543, DOI 10.1038/nrc845; YALOW RS, 1988, SCIENTIST, V2, P11; 2002, ASS PRESS       0805; 2000, FED REG         0421, V65, P21576	31	9	9	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					1997	+		10.1126/science.1077855	http://dx.doi.org/10.1126/science.1077855			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242425				2022-12-24	WOS:000178078500026
J	Zhang, QM; Li, HF; Poh, M; Xia, F; Cheng, ZY; Xu, HS; Huang, C				Zhang, QM; Li, HF; Poh, M; Xia, F; Cheng, ZY; Xu, HS; Huang, C			An all-organic composite actuator material with a high dielectric constant	NATURE			English	Article							THIN-FILMS; ELECTROSTRICTION; ELASTOMERS; POLYMER; FIELD	Electroactive polymers (EAPs) can behave as actuators, changing their shape in response to electrical stimulation. EAPs that are controlled by external electric fields-referred to here as field-type EAPs-include ferroelectric polymers, electrostrictive polymers, dielectric elastomers and liquid crystal polymers(1-6). Field-type EAPs can exhibit fast response speeds, low hysteresis(1-8) and strain levels far above those of traditional piezoelectric materials(4-6,9,10), with elastic energy densities even higher than those of piezoceramics(4,5,9-11). However, these polymers also require a high field (>70 V mum(-1)) to generate such high elastic energy densities (>0.1 J cm(-3); refs 4, 5, 9, 10). Here we report a new class of all-organic field-type EAP composites, which can exhibit high elastic energy densities induced by an electric field of only 13 V mum(-1). The composites are fabricated from an organic filler material possessing very high dielectric constant dispersed in an electrostrictive polymer matrix. The composites can exhibit high net dielectric constants while retaining the flexibility of the matrix. These all-organic actuators could find applications as artificial muscles, 'smart skins' for drag reduction, and in microfluidic systems for drug delivery(1-3,12).	Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, QM (corresponding author), Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.	qxz1@psu.edu	Cheng, Zhongyang (Z.-Y.)/A-9841-2008; Li, Hengfeng/B-4767-2010	Cheng, Zhongyang (Z.-Y.)/0000-0001-7209-7380; Li, Hengfeng/0000-0002-3406-9335				ACHAR BN, 1982, J POLYM SCI POL CHEM, V20, P1785, DOI 10.1002/pol.1982.170200711; AIALIAK H, 1998, J APPL PHYS, V64, P6477; Bao ZN, 1997, ADV MATER, V9, P42, DOI 10.1002/adma.19970090108; BARCOHEN Y, 2001, ELECTROACTIVE POLYM; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Cheng ZY, 2001, SENSOR ACTUAT A-PHYS, V90, P138, DOI 10.1016/S0924-4247(01)00496-4; Cross LE, 1996, CERAM T, V68, P15; Damjanovic D, 1997, PHYS REV B, V55, pR649, DOI 10.1103/PhysRevB.55.R649; Dario P, 2000, J MICROMECH MICROENG, V10, P235, DOI 10.1088/0960-1317/10/2/322; Gould RD, 1996, COORDIN CHEM REV, V156, P237, DOI 10.1016/S0010-8545(96)01238-6; Hayashi K, 1997, APPL PHYS LETT, V70, P1384, DOI 10.1063/1.118584; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Lehmann W, 2001, NATURE, V410, P447, DOI 10.1038/35068522; Lifshitz E.M., 1970, ELECTRODYNAMICS CONT; McCrum NG, 1967, ANELASTIC DIELECTRIC; MOULSON A, 1995, ELECTROCERAMICS; Nalwa H S, 1995, FERROELECTRIC POLYM; NALWA HS, 1985, EUR POLYM J, V21, P943, DOI 10.1016/0014-3057(85)90180-6; Newnham RE, 1998, CERAM TRANS, V88, P15; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; PHOUGAT N, 1999, HDB LOW HIGH EIELECT, pCH8; Su J, 1998, REV SCI INSTRUM, V69, P2480, DOI 10.1063/1.1148947; Su J, 1997, APPL PHYS LETT, V71, P386, DOI 10.1063/1.119545; Tominaga T, 1997, APPL PHYS LETT, V70, P762, DOI 10.1063/1.118252; VIJAYAKUMAR PS, 1984, J POLYM SCI POL PHYS, V22, P1439, DOI 10.1002/pol.1984.180220808; Xu HS, 2001, APPL PHYS LETT, V78, P2360, DOI 10.1063/1.1358847; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZHANG QM, 1999, MRS S P, V600; [No title captured]	30	901	949	22	1045	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					284	287		10.1038/nature01021	http://dx.doi.org/10.1038/nature01021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239563				2022-12-24	WOS:000178056300041
J	Bull, SA; Hu, XH; Hunkeler, EM; Lee, JY; Ming, EE; Markson, LE; Fireman, B				Bull, SA; Hu, XH; Hunkeler, EM; Lee, JY; Ming, EE; Markson, LE; Fireman, B			Discontinuation of use and switching of antidepressants - Influence of patient-physician communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; TREATMENT GUIDELINES; DEPRESSION; ADHERENCE; NONCOMPLIANCE; METAANALYSIS; MEDICATION	Context Although current depression treatment guidelines recommend continuing antidepressant therapy for at least 4 to 9 months, many patients discontinue treatment prematurely, within 3 months. Objectives To investigate the relationship between patient-physician communication and the continuation of treatment with antidepressants and to explore the demographics, adverse effects, therapeutic response, and frequency of follow-up visits. Design, Setting, and Patients A total of 401 telephone interviews of depressed patients being treated with selective serotonin reuptake inhibitor (SSRI) therapy between December 15,1999, and May 31, 2000, were conducted and 137 prescribing physicians completed written surveys from Northern California Kaiser Permanente health maintenance organization outpatient clinics. Main Outcome Measures Patient-physician communication about therapy duration and about adverse effects; therapy discontinuation or medication switching within 3 months after start of SSRI therapy. Results Ninety-nine physicians (72%) reported that they usually ask patients to continue using antidepressants for at least 6 months, but 137 patients (34%) reported that their physicians asked them to continue using antidepressants for this duration and 228 (56%) reported receiving no instructions. Patients who said they were told to take their medication for less than 6 months were 3 times more likely to discontinue therapy (odds ratio [OR], 3.12; 95% confidence interval [CI], 1.21-8.07) compared with patients who said they were told to continue therapy longer. Patients who discussed adverse effects with their physicians were less likely to discontinue therapy than patients who did not discuss them (OR, 0.49; 95% CI, 0.25-0.95). Patients who reported discussing adverse effects with their physicians were more likely to switch medications (OR, 5.60; 95% CI, 2.31-13.60). Fewer than 3 follow-up visits for depression, adverse effects, and lack of therapeutic response to medication were also associated with patients' discontinuing therapy. Conclusions Discrepancies exist between instructions that physicians report they communicate to patients and what patients remember being told. Explicit instructions about expected duration of therapy and discussions about medication adverse effects throughout treatment may reduce discontinuation of SSRI use. Our finding that patients with 3 or more follow-up visits were more likely to continue using the initially prescribed antidepressant medication suggests that frequent patient-physician contact may increase the probability that patients will continue therapy.	Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94612 USA; Merck & Co Inc, Outcomes Res & Management Dept, West Point, PA USA	Kaiser Permanente; Merck & Company	Bull, SA (corresponding author), Kaiser Permanente Med Care Program, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	scott.bull@alza.com	Ming, Eileen/L-9349-2019					*AM PSYCH ASS WORK, 2001, PRACT GUID TREATM PA; BECK AT, 2001, BDI FASTSCREEN MED P; BLACKWELL B, 1982, J CLIN PSYCHIAT, V43, P14; BROWN WA, 1995, J CLIN PSYCHIAT, V56, P30; *DEPR GUID PAN, DEPR PRIM CAR, V2; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; FRANK E, 1985, PSYCHOPHARMACOL BULL, V21, P37; Hotopf M, 1997, BRIT J PSYCHIAT, V170, P120, DOI 10.1192/bjp.170.2.120; JOHNSON DAW, 1981, ACTA PSYCHIAT SCAND, V63, P447, DOI 10.1111/j.1600-0447.1981.tb00751.x; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; Linden M, 2000, J CLIN PSYCHOPHARM, V20, P523, DOI 10.1097/00004714-200010000-00005; Melfi CA, 1998, ARCH GEN PSYCHIAT, V55, P1128, DOI 10.1001/archpsyc.55.12.1128; Miller N H, 1997, Am J Med, V102, P43; MYERS ED, 1992, BRIT J PSYCHIAT, V160, P83, DOI 10.1192/bjp.160.1.83; *NAT COMM QUAL ASS, 1999, HEDIS 2000 TECHN SPE, V2, P105; Sarrel PM, 1999, AM J OBSTET GYNECOL, V180, pS337, DOI 10.1016/S0002-9378(99)70732-5; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; URQUHART J, 2001, CLIN RES, V1, P26; Venturini F, 1999, J MANAGE CARE PHARM, V5, P243	24	276	279	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1403	1409		10.1001/jama.288.11.1403	http://dx.doi.org/10.1001/jama.288.11.1403			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12234237	Bronze			2022-12-24	WOS:000178008300025
J	Nelson, HD; Helfand, M; Woolf, SH; Allan, JD				Nelson, HD; Helfand, M; Woolf, SH; Allan, JD			Screening for postmenopausal osteoporosis: A review of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; BAND ULTRASOUND ATTENUATION; DIFFERENT SKELETAL SITES; QUANTITATIVE COMPUTED-TOMOGRAPHY; PREDICT HIP FRACTURE; RISK-FACTORS; ELDERLY-WOMEN; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL	Background: Although osteoporotic fractures present an enormous health burden, it is not clear whether screening to identify high-risk persons is appropriate. Purpose: To examine evidence on the benefits and harms of screening postmenopausal women for osteoporosis. Data Sources: MEDLINE (1966 to May 2001), HealthSTAR (1975 to May 2001), and Cochrane databases; reference lists; and experts. Study Selection: English-language abstracts that included original data about postmenopausal women and osteoporosis and addressed the effectiveness of risk factor assessment, bone density tests, or treatment were included. Data Extraction: Selected information about patient population, interventions, clinical end points, and study design were extracted, and a set of criteria was applied to evaluate study quality. Data Synthesis: No trials of the effectiveness of screening have been published. Instruments developed to assess clinical risk factors for low bone density or fractures have moderate to high sensitivity and low specificity. Among different bone density tests measured at various sites, bone density measured at the femoral neck by dual-energy x-ray absorptiometry is the best predictor of hip fracture. Women with low bone density have approximately a 40% to 50% reduction in fracture risk when treated with bisphosphonates. Conclusions: Population screening would be based on evidence that the risk for osteoporosis and fractures increases with age, that the short-term risk for fracture can be estimated by bone density tests and risk factors, and that fracture risk can be reduced with treatment. The role of risk factor assessment and different bone density techniques, frequency of screening, and identification of subgroups for which screening is most effective remain unclear.	Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Virginia Commonwealth Univ, Fairfax, VA USA; Univ Maryland, Baltimore, MD 21201 USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Virginia Commonwealth University; University System of Maryland; University of Maryland Baltimore	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.				PHS HHS [290-97-0018] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADAMI S, 1995, BONE, V17, P383, DOI 10.1016/S8756-3282(95)00262-6; AGREN M, 1991, CALCIFIED TISSUE INT, V48, P240, DOI 10.1007/BF02556374; Ahmed AIH, 1997, OSTEOPOROSIS INT, V7, P432, DOI 10.1007/s001980050029; Alenfeld FE, 1998, OSTEOPOROSIS INT, V8, P393, DOI 10.1007/s001980050081; [Anonymous], 1997, J Intern Med Suppl, V739, P1; Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Ballard PA, 1998, OSTEOPOROSIS INT, V8, P535, DOI 10.1007/s001980050095; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; BLACK DM, 1992, J BONE MINER RES, V7, P633; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Blake GM, 1998, ENDOCRIN METAB CLIN, V27, P267, DOI 10.1016/S0889-8529(05)70005-0; Blake GM, 1997, BRIT J RADIOL, V70, pS177, DOI 10.1259/bjr.1997.0022; *BLUE CROSS BLUE S, 1999, ULTR HEEL DIAGN OST; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; BONNICK S, 1998, BONE, V23, P5476; Burger H, 1999, BONE, V25, P369, DOI 10.1016/S8756-3282(99)00173-8; Cadarette SM, 2000, CAN MED ASSOC J, V162, P1289; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Chen Z, 1998, OSTEOPOROSIS INT, V8, P423, DOI 10.1007/s001980050086; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; CHRISTIANSEN C, 1991, AM J MED, V90, P107; COOPER C, 1991, OSTEOPOROSIS INT, V2, P48, DOI 10.1007/BF01627079; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cunningham JL, 1996, BRIT J RADIOL, V69, P25, DOI 10.1259/0007-1285-69-817-25; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Duboeuf F, 1997, J BONE MINER RES, V12, P1895, DOI 10.1359/jbmr.1997.12.11.1895; ELLIOT JR, 1993, AUST NZ J MED, V23, P458, DOI 10.1111/j.1445-5994.1993.tb01830.x; Ettinger B, 1998, AM J MANAG CARE, V4, P1377; FALCH JA, 1992, BONE, V13, P337, DOI 10.1016/8756-3282(92)90080-G; FAULKNER KG, 1994, OSTEOPOROSIS INT, V4, P42, DOI 10.1007/BF02352260; Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343; Formica CA, 1998, OSTEOPOROSIS INT, V8, P460, DOI 10.1007/s001980050092; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Garnero P, 1998, OSTEOPOROSIS INT, V8, P563, DOI 10.1007/s001980050100; Genant HK, 1996, J BONE MINER RES, V11, P707; Goemaere S, 1999, CALCIFIED TISSUE INT, V65, P354, DOI 10.1007/s002239900712; Graafmans WC, 1996, BONE, V19, P97, DOI 10.1016/8756-3282(96)00134-2; Grampp S, 1996, AM J ROENTGENOL, V167, P133, DOI 10.2214/ajr.167.1.8659357; Grampp S, 1999, AM J ROENTGENOL, V173, P329, DOI 10.2214/ajr.173.2.10430129; GREEN CJ, 1997, 972T BRIT COL OFF HL; Greenspan SL, 1998, J BONE MINER RES, V13, P1431, DOI 10.1359/jbmr.1998.13.9.1431; Greenspan SL, 1997, J BONE MINER RES, V12, P1303, DOI 10.1359/jbmr.1997.12.8.1303; HAILEY D, 1996, INAHTA PROJECT EFFEC; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Heaney RP, 1998, ANN INTERN MED, V128, P313, DOI 10.7326/0003-4819-128-4-199802150-00014; *HLTH CAR FIN ADM, 2000, NAT PHYS FEE SCHED P; HOMIK J, 1999, HLTH TECHNOLOGY BRIE, V4; Homik J., 1998, QUANTITATIVE ULTRASO; Honkanen R, 1998, OSTEOPOROSIS INT, V8, P25, DOI 10.1007/s001980050044; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Jergas M, 1997, CALCIFIED TISSUE INT, V61, P351, DOI 10.1007/s002239900347; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; JOHNELL O, 1995, J BONE MINER RES, V10, P1802, DOI 10.1002/jbmr.5650101125; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KLEEREKOPER M, 1989, BONE MINER, V7, P171, DOI 10.1016/0169-6009(89)90074-3; KREIGER N, 1982, AM J EPIDEMIOL, V116, P141, DOI 10.1093/oxfordjournals.aje.a113388; Kroger H, 1999, CALCIFIED TISSUE INT, V64, P191; Langton CM, 1997, CLIN RHEUMATOL, V16, P117, DOI 10.1007/BF02238781; LASKEY MA, 1992, BRIT J RADIOL, V65, P1124, DOI 10.1259/0007-1285-65-780-1124; LAVALJEANTET AM, 1995, CALCIFIED TISSUE INT, V56, P14, DOI 10.1007/BF00298738; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lunt M, 1997, J BONE MINER RES, V12, P1883, DOI 10.1359/jbmr.1997.12.11.1883; Lydick E, 1998, AM J MANAG CARE, V4, P37; LYLES KW, 1993, AM J MED, V94, P595, DOI 10.1016/0002-9343(93)90210-G; MALLMIN H, 1994, OSTEOPOROSIS INT, V4, P298, DOI 10.1007/BF01622186; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martin JC, 1996, BRIT J RADIOL, V69, P234, DOI 10.1259/0007-1285-69-819-234; MASSIE A, 1993, OSTEOPOROSIS INT, V3, P107, DOI 10.1007/BF01623382; McClung M, 1998, ANN INTERN MED, V128, P253, DOI 10.7326/0003-4819-128-4-199802150-00001; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MELTON LJ, 1995, J BONE MINER RES, V10, P175; MELTON LJ, 1993, J BONE MINER RES, V8, P1227; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1997, SPINE, V22, p2S, DOI 10.1097/00007632-199712151-00002; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; Michaelsson K, 1996, OSTEOPOROSIS INT, V6, P120, DOI 10.1007/BF01623934; Naganathan V, 1999, MED J AUSTRALIA, V171, P297, DOI 10.5694/j.1326-5377.1999.tb123659.x; *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, pS7; National Osteoporosis Foundation, 1999, PHYS GUID PREV TREAT; NELSON H, 2002, OSTEOPOROSIS POSTMEN; Nelson HD, 2002, SCREENING POSTMENOPA; Nelson HD, 2002, HORMONE REPLACEMENT; NEVITT MC, 1994, OSTEOPOROSIS INT, V4, P325, DOI 10.1007/BF01622192; PECK WA, 1993, AM J MED, V94, P646; Petley GW, 1996, BRIT J RADIOL, V69, P655, DOI 10.1259/0007-1285-69-823-655; Pocock NA, 1996, MED J AUSTRALIA, V164, P367, DOI 10.5694/j.1326-5377.1996.tb122057.x; Pols HAP, 1999, OSTEOPOROSIS INT, V9, P461, DOI 10.1007/PL00004171; Ranstam J, 1996, AGE AGEING, V25, P439, DOI 10.1093/ageing/25.6.439; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; RIBOT C, 1992, CLIN ENDOCRINOL, V36, P225, DOI 10.1111/j.1365-2265.1992.tb01436.x; Rimes KA, 1999, PSYCHOL HEALTH, V14, P585, DOI 10.1080/08870449908410752; ROSENTHALL L, 1995, EUR J NUCL MED, V22, P402, DOI 10.1007/BF00839053; ROUX C, 1993, REV RHUM, V60, P897; *ROYAL COLL PHYS L, 1999, OST CLIN GUID PREV T; SALAMONE LM, 1994, CALCIFIED TISSUE INT, V54, P87, DOI 10.1007/BF00296056; Schott AM, 1998, OSTEOPOROSIS INT, V8, P247, DOI 10.1007/s001980050061; SCHOTT AM, 1995, J BONE MINER RES, V10, P243; Siebzehner MI, 2000, ISRAEL MED ASSOC J, V2, P397; SIMMONS A, 1995, BRIT J RADIOL, V68, P903, DOI 10.1259/0007-1285-68-812-903; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; SLEMENDA CW, 1990, ANN INTERN MED, V112, P96, DOI 10.7326/0003-4819-112-2-96; Stock JL, 1998, ANN INTERN MED, V128, P996, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00006; Torgerson DJ, 1996, J BONE MINER RES, V11, P293; Tromp AM, 1998, J BONE MINER RES, V13, P1932, DOI 10.1359/jbmr.1998.13.12.1932; Tromp AM, 1999, OSTEOPOROSIS INT, V9, P230, DOI 10.1007/s001980050142; TUPPURAINEN M, 1995, ACTA OBSTET GYN SCAN, V74, P624, DOI 10.3109/00016349509013475; TURNER CH, 1995, OSTEOPOROSIS INT, V5, P130, DOI 10.1007/BF01623314; *US DEP HHS, 1995, AHRQ PUBL; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANHEMERT AM, 1990, AM J EPIDEMIOL, V132, P123, DOI 10.1093/oxfordjournals.aje.a115624; Varney LF, 1999, J CLIN DENSITOM, V2, P275, DOI 10.1385/JCD:2:3:275; Verhaar HJJ, 1998, OSTEOPOROSIS INT, V8, P174, DOI 10.1007/BF02672515; Weinstein L, 2000, AM J OBSTET GYNECOL, V183, P547, DOI 10.1067/mob.2000.106594; Weinstein L, 1999, OBSTET GYNECOL, V93, P757, DOI 10.1016/S0029-7844(98)00549-3; WHITE BL, 1987, J BONE JOINT SURG AM, V69A, P1335; WOLINSKY FD, 1994, J GERONTOL, V49, pS165, DOI 10.1093/geronj/49.4.S165; World Health Organization, 1994, WHO TECHN REP SER, V843; YOUNG H, 1993, OSTEOPOROSIS INT, V3, P160, DOI 10.1007/BF01623278	125	232	242	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					529	541		10.7326/0003-4819-137-6-200209170-00015	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00015			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230356				2022-12-24	WOS:000178069100009
J	Wentworth, P; McDunn, JE; Wentworth, AD; Takeuchi, C; Nieva, J; Jones, T; Bautista, C; Ruedi, JM; Gutierrez, A; Janda, KD; Babior, BM; Eschenmoser, A; Lerner, RA				Wentworth, P; McDunn, JE; Wentworth, AD; Takeuchi, C; Nieva, J; Jones, T; Bautista, C; Ruedi, JM; Gutierrez, A; Janda, KD; Babior, BM; Eschenmoser, A; Lerner, RA			Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation	SCIENCE			English	Article							MOLECULAR-OXYGEN; SINGLET OXYGEN; NEUTROPHILS; INDIGO-5,5'-DISULFONATE; PARTICLES	Recently, we showed that antibodies catalyze the generation of hydrogen peroxide (H2O2) from singlet molecular oxygen (O-1(2)*) and water. Here, we show that this process can lead to efficient killing of bacteria, regardless of the antigen specificity of the antibody. H2O2 production by antibodies alone was found to be not sufficient for bacterial killing. Our studies suggested that the antibody-catalyzed water-oxidation pathway produced an additional molecular species with a chemical signature similar to that of ozone. This species is also generated during the oxidative burst of activated human neutrophils and during inflammation. These observations suggest that alternative pathways may exist for biological killing of bacteria that are mediated by potent oxidants previously unknown to biology.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; ETH Honggerberg, Organ Chem Lab, CH-8093 Zurich, Switzerland	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		McDunn, Jonathan/A-6816-2009	McDunn, Jonathan/0000-0001-8792-828X	NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043858, R29GM043858] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA27489] Funding Source: Medline; NIAID NIH HHS [5T32AI07606] Funding Source: Medline; NIGMS NIH HHS [GM43858] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER EL, 1978, J IMMUNOL METHODS, V22, P263, DOI 10.1016/0022-1759(78)90034-0; BERTHIAUME F, 1994, BIO-TECHNOL, V12, P703, DOI 10.1038/nbt0794-703; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; GLAZE WH, 1987, OZONE-SCI ENG, V9, P335; GORMAN AA, 1981, CHEM SOC REV, V10, P205, DOI 10.1039/cs9811000205; Hofman P, 2000, INFECT IMMUN, V68, P449, DOI 10.1128/IAI.68.2.449-455.2000; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Klebanoff SJ, 1998, ENCY IMMUNOLOGY, P1713, DOI [10.1006/rwei.1999.0435, DOI 10.1006/RWEI.1999.0435]; Kohl J, 1999, MOL IMMUNOL, V36, P893, DOI 10.1016/S0161-5890(99)00111-X; Kuo CH, 1999, CAN J CHEM ENG, V77, P473, DOI 10.1002/cjce.5450770306; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; SIM RB, 1991, IMMUNOL TODAY, V12, P307, DOI 10.1016/0167-5699(91)90004-D; STEINBECK MJ, 1992, J BIOL CHEM, V267, P13425; STEINBECK MJ, 1993, J BIOL CHEM, V268, P15649; TAKEUCHI K, 1990, ANAL CHIM ACTA, V230, P183, DOI 10.1016/S0003-2670(00)82779-8; TAKEUCHI K, 1989, ANAL CHEM, V61, P619, DOI 10.1021/ac00181a025; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2002, SCIENCE, V296, P2247, DOI 10.1126/science.296.5576.2247; WILKINSON F, 1993, J PHYS CHEM REF DATA, V22, P113, DOI 10.1063/1.555934; Xu X, 2002, P NATL ACAD SCI USA, V99, P3376, DOI 10.1073/pnas.052710099	21	283	310	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2195	2199		10.1126/science.1077642	http://dx.doi.org/10.1126/science.1077642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12434011				2022-12-24	WOS:000179773700049
J	Perry, SJ; Baillie, GS; Kohout, TA; McPhee, I; Magiera, MM; Ang, KL; Miller, WE; McLean, AJ; Conti, M; Houslay, MD; Lefkowitz, RJ				Perry, SJ; Baillie, GS; Kohout, TA; McPhee, I; Magiera, MM; Ang, KL; Miller, WE; McLean, AJ; Conti, M; Houslay, MD; Lefkowitz, RJ			Targeting of cyclic AMP degradation to beta(2)-adrenergic receptors by beta-arrestins	SCIENCE			English	Article							CAMP; PROTEIN; INTERACTS; KINASES	Catecholamines signal through the beta(2)-adrenergic receptor by promoting production of the second messenger adenosine 3'-5'-monophosphate (cAMP). The magnitude of this signal is restricted by desensitization of the receptors through their binding to beta-arrestins and by cAMP degradation by phosphodiesterase (PDE) enzymes. We show that arrestins coordinate both processes by recruiting PDEs to activated beta(2)-adrenergic receptors in the plasma membrane of mammalian cells. In doing so, the beta-arrestins limit activation of membrane-associated cAMP-activated protein kinase by simultaneously slowing the rate of cAMP production through receptor desensitization and increasing the rate of its degradation at the membrane.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; University of Glasgow; Stanford University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Magiera, Maria M./Y-8754-2019; Lefkowitz, Robert/AAW-2649-2021; Houslay, Miles/AAM-5281-2020; Houslay, Miles D/A-6825-2011	Magiera, Maria M./0000-0003-4847-3053; Houslay, Miles/0000-0002-3826-8091; Baillie, George/0000-0003-2469-6316	NHLBI NIH HHS [HL16037] Funding Source: Medline; NICHD NIH HHS [HD20788] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bolger GB, 1997, BIOCHEM J, V328, P539; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz RJ, 1996, NAT BIOTECHNOL, V14, P283, DOI 10.1038/nbt0396-283; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; McPhee I, 1999, J BIOL CHEM, V274, P11796, DOI 10.1074/jbc.274.17.11796; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; SETTE C, 1994, J BIOL CHEM, V269, P18271; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	18	381	407	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					834	836		10.1126/science.1074683	http://dx.doi.org/10.1126/science.1074683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399592				2022-12-24	WOS:000178791200061
J	Muller, J; Hart, CM; Francis, NJ; Vargas, ML; Sengupta, A; Wild, B; Miller, EL; O'Connor, MB; Kingston, RE; Simon, JA				Muller, J; Hart, CM; Francis, NJ; Vargas, ML; Sengupta, A; Wild, B; Miller, EL; O'Connor, MB; Kingston, RE; Simon, JA			Histone methyltransferase activity of a Drosophila polycomb group repressor complex	CELL			English	Article							GROUP GENE ENHANCER; GROUP PROTEIN; HOMEOTIC GENE; CAENORHABDITIS-ELEGANS; DEACETYLASE RPD3; CHROMATIN STRUCTURE; LYSINE 9; ZESTE; TRITHORAX; ARABIDOPSIS	Polycomb group (PcG) proteins maintain transcriptional repression during development, likely by creating repressive chromatin states. The Extra Sex Combs (ESC) and Enhancer of Zeste [E(Z)] proteins are partners in an essential PcG complex, but its full composition and biochemical activities are not known. A SET domain in E(Z) suggests this complex might methylate histones. We purified an ESC-E(Z) complex from Drosophila embryos and found four major subunits: ESC, E(Z), NURF-55, and the PcG repressor, SU(Z)12. A recombinant complex reconstituted from these four subunits methylates lysine-27 of histone H3. Mutations in the E(Z) SET domain disrupt methyltransferase activity in vitro and HOX gene repression in vivo. These results identify E(Z) as a PcG protein with enzymatic activity and implicate histone methylation in PcG-mediated silencing.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	European Molecular Biology Laboratory (EMBL); Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Muller, J (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Hart, Craig/B-4832-2016; O'Connor, Michael B/C-9977-2014	Hart, Craig/0000-0002-9870-991X; O'Connor, Michael B/0000-0002-3067-5506				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Beuchle D, 2001, DEVELOPMENT, V128, P993; Birve A, 2001, DEVELOPMENT, V128, P3371; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chang YL, 2001, P NATL ACAD SCI USA, V98, P9730, DOI 10.1073/pnas.171325498; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; DeRubertis F, 1996, NATURE, V384, P589; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jones CA, 1998, MOL CELL BIOL, V18, P2825, DOI 10.1128/MCB.18.5.2825; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; JONES RS, 1990, GENETICS, V126, P185; Kal AJ, 2000, GENE DEV, V14, P1058; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; SIMON J, 1995, MECH DEVELOP, V53, P197, DOI 10.1016/0925-4773(95)00434-3; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Spillane C, 2000, CURR BIOL, V10, P1535, DOI 10.1016/S0960-9822(00)00839-3; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tie F, 2001, DEVELOPMENT, V128, P275; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Xu L, 2001, P NATL ACAD SCI USA, V98, P5061, DOI 10.1073/pnas.081016198; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	61	1197	1242	2	49	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 18	2002	111	2					197	208		10.1016/S0092-8674(02)00976-5	http://dx.doi.org/10.1016/S0092-8674(02)00976-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408864	Bronze, Green Published			2022-12-24	WOS:000178753500009
J	Yasui, D; Miyano, M; Cai, ST; Varga-WEisz, P; Kohwi-Shigematsu, T				Yasui, D; Miyano, M; Cai, ST; Varga-WEisz, P; Kohwi-Shigematsu, T			SATB1 targets chromatin remodelling to regulate genes over long distances	NATURE			English	Article							CELL-SPECIFIC DEMETHYLATION; DNA-BINDING PROTEIN; NUCLEAR-MATRIX; HISTONE DEACETYLASE; IN-VIVO; COMPLEX; ENHANCER; REGION; ACETYLATION; EXPRESSION	Eukaryotic chromosomes are organized inside the nucleus in such a way that only a subset of the genome is expressed in any given cell type, but the details of this organization are largely unknown(1-3). SATB1 ('special AT-rich sequence binding 1'), a protein found predominantly in thymocytes(4), regulates genes by folding chromatin into loop domains, tethering specialized DNA elements to an SATB1 network structure(5). Ablation of SATB1 by gene targeting results in temporal and spatial mis-expression of numerous genes and arrested T-cell development, suggesting that SATB1 is a cell-type specific global gene regulator(6). Here we show that SATB1 targets chromatin remodelling to the IL-2Ralpha ('interleukin-2 receptor alpha') gene, which is ectopically transcribed in SATB1 null thymocytes. SATB1 recruits the histone deacetylase contained in the NURD chromatin remodelling complex to a SATB1-bound site in the IL-2Ralpha locus, and mediates the specific deacetylation of histones in a large domain within the locus. SATB1 also targets ACF1 and ISWI, subunits of CHRAC and ACF nucleosome mobilizing complexes, to this specific site and regulates nucleosome positioning over seven kilobases. SATB1 defines a class of transcriptional regulators that function as a 'landing platform' for several chromatin remodelling enzymes and hence regulate large chromatin domains.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Marie Curie Res Inst, Surrey RH8 OTL, England	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	terumiks@lbl.gov	Yasui, Dag/ABL-3626-2022; MIYANO, MASARU/I-1353-2015	Varga-Weisz, Patrick/0000-0001-7409-8686	NIA NIH HHS [AG00266] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alvarez JD, 2000, GENE DEV, V14, P521; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; CAI S, UNPUB CELL; COLLINS N, IN PRESS NATURE GENE; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; Forrester WC, 1999, GENE DEV, V13, P3003, DOI 10.1101/gad.13.22.3003; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Langst G, 2001, J CELL SCI, V114, P2561; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SOLDAINI E, 1995, J BIOL CHEM, V270, P10733, DOI 10.1074/jbc.270.18.10733; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Travers A, 1999, CELL, V96, P311, DOI 10.1016/S0092-8674(00)80543-7; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	30	383	405	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2002	419	6907					641	645		10.1038/nature01084	http://dx.doi.org/10.1038/nature01084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374985	Green Submitted			2022-12-24	WOS:000178483100051
J	Siegel, JP				Siegel, JP			Assessing the use of activated protein c in the treatment of severe sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Siegel, JP (corresponding author), Ctr Biol Evaluat & Res, Rockville, MD 20852 USA.							*ANT ADV COMM, 2001, FDA BRIEF DOC DROTR; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; *FDA, 2001, ANT DRUGS ADV COMM M; *FDA, IN PRESS FDA CLIN RE; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Warren HS, 2002, NEW ENGL J MED, V347, P1027, DOI 10.1056/NEJMsb020574	6	99	107	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2002	347	13					1030	1034		10.1056/NEJMsb021512	http://dx.doi.org/10.1056/NEJMsb021512			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596RD	12324563				2022-12-24	WOS:000178178400013
J	Tzedakis, PC; Lawson, IT; Frogley, MR; Hewitt, GM; Preece, RC				Tzedakis, PC; Lawson, IT; Frogley, MR; Hewitt, GM; Preece, RC			Buffered tree population changes in a quaternary refugium: Evolutionary implications	SCIENCE			English	Article							NORTHWEST GREECE; ICE AGES; VARIABILITY; SPECIATION; CALIBRATION; SCALE	A high-resolution pollen record from western Greece shows that the amplitude of millennial-scale oscillations in tree abundance during the last glacial period was subdued, with temperate tree populations surviving throughout the interval. This provides evidence for the existence of an area of relative ecological stability, reflecting the influence of continued moisture availability and varied topography. Long-term buffering of populations from climatic extremes, together with genetic isolation at such refugial sites, may have allowed lineage divergence to proceed through the Quaternary. Such ecologically stable areas may be critical not only for the long-term survival of species, but also for the emergence of new ones.	Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; Univ Cambridge, Dept Geog, Godwin Inst Quaternary Res, Cambridge CB2 3EN, England; Univ Sussex, Environm Res Ctr, Sch Chem Phys & Environm Sci, Brighton BN1 9QJ, E Sussex, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ Cambridge, Dept Zool, Godwin Inst Quaternary Res, Cambridge CB2 3EJ, England	University of Leeds; University of Cambridge; University of Sussex; University of East Anglia; University of Cambridge	Tzedakis, PC (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.		Frogley, Michael R/H-2956-2016; Tzedakis, Polychronis/J-1894-2012	Frogley, Michael R/0000-0003-4273-0901; Tzedakis, Polychronis/0000-0001-6072-1166; Lawson, Ian Thomas/0000-0002-3547-2425				Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; [Anonymous], 1999, BIOL WILDLIFE MEDITE; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; BARRON EJ, IN PRESS QUAT RES; BENNETT KD, 1997, EVOLUTION ECOLOGY; DELTSHEV C, IN PRESS BALKAN BIOD; FJELDSA J, 1997, BIODIVERS CONSERV, V6, P323; Follieri M, 1998, QUATERN INT, V47-8, P3, DOI 10.1016/S1040-6182(97)00065-7; Frogley MR, 2001, J BIOGEOGR, V28, P745, DOI 10.1046/j.1365-2699.2001.00582.x; Frogley MR, 1999, SCIENCE, V285, P1886, DOI 10.1126/science.285.5435.1886; GRIFFITHS HI, IN PRESS BALKAN BIOD; Griffiths SJ, 2002, SEDIMENT GEOL, V148, P79, DOI 10.1016/S0037-0738(01)00211-1; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Magri D, 2000, QUATERN INT, V73-4, P69, DOI 10.1016/S1040-6182(00)00065-3; MARGARI V, 2000, THESISU CAMBRIDGE; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Roucoux KH, 2001, QUATERNARY RES, V56, P128, DOI 10.1006/qres.2001.2218; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; Roy MS, 1997, P ROY SOC B-BIOL SCI, V264, P1337, DOI 10.1098/rspb.1997.0185; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Shackleton NJ, 2002, QUATERNARY RES, V58, P14, DOI 10.1006/qres.2001.2312; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TZEDAKIS PC, 1993, NATURE, V364, P437, DOI 10.1038/364437a0; Tzedakis PC, 2002, QUATERNARY RES, V58, P53, DOI 10.1006/qres.2002.2328; Tzedakis PC, 1999, J GEOL SOC LONDON, V156, P425, DOI 10.1144/gsjgs.156.2.0425; WIJMSTRA TA, 1969, ACTA BOT NEERL, V18, P511, DOI 10.1111/j.1438-8677.1969.tb00591.x; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Zohary M, 1973, GEOBOTANICAL FDN MID	36	419	438	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2044	2047		10.1126/science.1073083	http://dx.doi.org/10.1126/science.1073083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242441				2022-12-24	WOS:000178078500044
J	William, J; Euler, C; Christensen, S; Shlomchik, MJ				William, J; Euler, C; Christensen, S; Shlomchik, MJ			Evolution of autoantibody responses via somatic hypermutation outside of germinal centers	SCIENCE			English	Article							AFFINITY MATURATION; CLONAL SELECTION; B-CELLS; MOUSE; FAS; MUTATION; ANTIGEN; GENES; MICE	Somatically mutated high-affinity autoantibodies are hallmark of some autoimmune diseases, including systemic lupus erythematosus. It has long been presumed that germinal centers (GCs) are critical in autoantibody production, because they are the only sites currently believed to sustain high rate of somatic hypermutation. Contrary to this idea, we found that splenic autoreactive B cells in autoimmune MRL.Fas(lpr) mice proliferated and underwent active somatic hypermutation at the T zone red pulp border rather than in GCs. Our results implicate this region as an important site for hypermutation and the loss of B cell self-tolerance.	Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Yale University; Yale University	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, Box 208035, New Haven, CT 06520 USA.		Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959	PHS HHS [P01-A36529] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; HAN SH, 1995, J IMMUNOL, V155, P556; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Kallberg E, 1996, SCIENCE, V271, P1285, DOI 10.1126/science.271.5253.1285; KLEINSTEIN S, UNPUB; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; PULENDRAN B, 1995, J IMMUNOL, V155, P1141; Schroder AE, 1996, P NATL ACAD SCI USA, V93, P221, DOI 10.1073/pnas.93.1.221; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; Watanabe D, 1995, INT IMMUNOL, V7, P1949, DOI 10.1093/intimm/7.12.1949; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; WILLIAM J, UNPUB	22	386	390	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2066	2070		10.1126/science.1073924	http://dx.doi.org/10.1126/science.1073924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242446				2022-12-24	WOS:000178078500051
J	MacKie, RM; Bray, CA; Hole, DJ; Morris, A; Nicolson, M; Evans, A; Doherty, V; Vestey, J				MacKie, RM; Bray, CA; Hole, DJ; Morris, A; Nicolson, M; Evans, A; Doherty, V; Vestey, J		Scottish Melanoma Grp	Incidence of and survival from malignant melanoma in Scotland: an epidemiological study	LANCET			English	Article							AMERICAN JOINT COMMITTEE; CUTANEOUS MELANOMA; STAGING SYSTEM; TRENDS; MORTALITY	Background We aimed to assess the incidence and survival for all patients with invasive primary cutaneous malignant melanoma diagnosed in Scotland, UK, during 1979-98. Methods The Scottish Melanoma Group obtained data for 8830 patients (3301 male and 5529 female) first diagnosed with invasive cutaneous malignant melanoma. Findings Age-standardised incidence rose from 3.5 in 1979 to 10.6 per 10(5) population in 1998 for men, and from 7.0 to 13.1 for women, a rise of 303% and 187%, respectively. After 1995, the rate of increase levelled in women younger than 65 years at diagnosis. Melanoma incidence increased most in men on the trunk, head, and neck and in women on the leg. 5-year survival rose from 58% to 80% for men diagnosed in 1979 and 1993, respectively, and from 74% to 85% for women; improvements of 38% (p<0.001) and 15% (p<0.001), respectively. Most improvement was attributable to a higher proportion of thinner tumours. Male mortality from melanoma was 1-9/10(5) population per year at the start and end of the study, whereas mortality for men younger than 65 years at diagnosis rose from 1.2 to 1.35 (p=0.24). For all women, mortality fell slightly from 1.9 to 1.85/10(5) population per year (p=0.61), whereas for women younger than 65 years at diagnosis, mortality fell from 1.3 to 1.15 (p=0.62). Interpretation Interventions aimed at both primary and secondary prevention of melanoma are justified. Specialist tumour registers for entire countries can be used to plan and monitor public health interventions.	Univ Glasgow, Dept Dermatol, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8QQ, Lanark, Scotland; Ninewells Hosp, Dept Plast Surg, Dundee DD1 9SY, Scotland; Ninewells Hosp, Dept Pathol, Dundee DD1 9SY, Scotland; Foresterhill Hosp, Dept Oncol, Aberdeen, Scotland; Royal Infirm, Dept Dermatol, Edinburgh, Midlothian, Scotland; Raigmore Hosp, Dept Dermatol, Inverness, Scotland	University of Glasgow; University of Glasgow; University of Dundee; University of Dundee; Royal Infirmary of Edinburgh	MacKie, RM (corresponding author), Univ Glasgow, Dept Dermatol, Glasgow G12 8QQ, Lanark, Scotland.		Kelly, Caroline/AAZ-4146-2021	Kelly, Caroline/0000-0002-5330-7888				Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Cohn-Cedermark G, 2000, CANCER-AM CANCER SOC, V89, P348, DOI 10.1002/1097-0142(20000715)89:2<348::AID-CNCR20>3.0.CO;2-X; Helliwell T, 2001, BRIT MED J, V322, P730; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; MACKIE R, 1992, LANCET, V339, P971, DOI 10.1016/0140-6736(92)91539-K; MACKIE RM, 1985, LANCET, V2, P859; MacKie RM, 1997, BRIT MED J, V315, P1117, DOI 10.1136/bmj.315.7116.1117; Marrett LD, 2001, INT J CANCER, V92, P457, DOI 10.1002/ijc.1203	9	166	171	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 24	2002	360	9333					587	591		10.1016/S0140-6736(02)09779-9	http://dx.doi.org/10.1016/S0140-6736(02)09779-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241928				2022-12-24	WOS:000177600400006
J	Pfeifer, M; Boncristiano, S; Bondolfi, L; Stalder, A; Deller, T; Staufenbiel, M; Mathews, PM; Jucker, M				Pfeifer, M; Boncristiano, S; Bondolfi, L; Stalder, A; Deller, T; Staufenbiel, M; Mathews, PM; Jucker, M			Cerebral hemorrhage after passive anti-A beta immunotherapy	SCIENCE			English	Article							AMYLOID ANGIOPATHY; DISEASE		Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland; Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; Novartis Pharma, CH-4002 Basel, Switzerland; NYU, Sch Med, Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	University of Basel; Goethe University Frankfurt; Novartis; Nathan Kline Institute for Psychiatric Research; New York University	Jucker, M (corresponding author), Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland.		Pfeifer, Matthias/GRJ-4579-2022	Mathews, Paul/0000-0003-1742-7687				Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Greenberg SM, 1998, NEUROLOGY, V51, P690, DOI 10.1212/WNL.51.3.690; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; MAEDA A, 1993, STROKE, V24, P1857, DOI 10.1161/01.STR.24.12.1857; Paris D, 2000, NEUROBIOL AGING, V21, P183, DOI 10.1016/S0197-4580(99)00111-6; Poduslo JF, 2001, NEUROREPORT, V12, P3197, DOI 10.1097/00001756-200110290-00011; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	9	418	480	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1379	1379		10.1126/science.1078259	http://dx.doi.org/10.1126/science.1078259			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434053				2022-12-24	WOS:000179223100041
J	Kmita, M; Fraudeau, N; Herault, Y; Duboule, D				Kmita, M; Fraudeau, N; Herault, Y; Duboule, D			Serial deletions and duplications suggest a mechanism for the collinearity of Hoxd genes in limbs	NATURE			English	Article							REGULATORY CONTROLS; BETA-GLOBIN; COMPLEX; EXPRESSION; COLINEARITY; MICE; MOUSE; MORPHOGENESIS; TRANSCRIPTION; HIERARCHY	Hox genes, located at one end of the HoxD cluster, are essential for the development of the extremities of our limbs; that is, the digits. This 'collinear' correspondence is accompanied by a gradual decrease in the transcriptional efficiency of the genes. To decipher the underlying regulatory mechanisms, and thus to understand better how digits develop, we engineered a series of deletions and duplications in vivo. We find that HoxD genes compete for a remote enhancer that recognizes the locus in a polar fashion, with a preference for the 5' extremity. Modifications in either the number or topography of Hoxd loci induced regulatory reallocations affecting both the number and morphology of digits. These results demonstrate why genes located at the extremity of the cluster are expressed at the distal end of the limbs, following a gradual reduction in transcriptional efficiency, and thus highlight the mechanistic nature of collinearity in limbs.	Univ Geneva, Dept Zool & Anim Biol, NCCR Frontiers Genet, CH-1211 Geneva 4, Switzerland	University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, NCCR Frontiers Genet, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.		kmita, marie/AAU-9620-2020; Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; duboule, denis/0000-0001-9961-2960; Kmita, Marie/0000-0003-4021-0478				Davis AP, 1996, DEVELOPMENT, V122, P1175; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1994, SCIENCE, V266, P575, DOI 10.1126/science.7939709; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Duboule D, 1991, CURR OPIN GENET DEV, V1, P211, DOI 10.1016/S0959-437X(05)80072-3; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Goff DJ, 1997, DEVELOPMENT, V124, P627; Herault Y, 1997, DEVELOPMENT, V124, P3493; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Herault Y, 1996, EMBO J, V15, P6727, DOI 10.1002/j.1460-2075.1996.tb01062.x; Herault Y, 1998, DEVELOPMENT, V125, P1669; INOUYE M, 1976, Congenital Anomalies, V16, P171; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2000, GENE DEV, V14, P198; KMITA M, 1976, DEVELOPMENT, V129, P5521; Kondo T, 1998, MOL CELL, V1, P289, DOI 10.1016/S1097-2765(00)80029-5; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695	35	177	179	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					145	150		10.1038/nature01189	http://dx.doi.org/10.1038/nature01189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432383				2022-12-24	WOS:000179200900036
J	DeLuca, TH; Zackrisson, O; Nilsson, MC; Sellstedt, A				DeLuca, TH; Zackrisson, O; Nilsson, MC; Sellstedt, A			Quantifying nitrogen-fixation in feather moss carpets of boreal forests	NATURE			English	Article							COMMUNITIES; ECOSYSTEM; PATTERNS	Biological nitrogen (N) fixation is the primary source of N within natural ecosystems(1), yet the origin of boreal forest N has remained elusive. The boreal forests of Eurasia and North America lack any significant, widespread symbiotic N-fixing plants(1-6). With the exception of scattered stands of alder in early primary successional forests(7), N-fixation in boreal forests is considered to be extremely limited. Nitrogen-fixation in northern European boreal forests has been estimated(2) at only 0.5 kg Nha(-1) yr(-1); however, organic N is accumulated in these ecosystems at a rate of 3 kg N ha(-1) yr(-1) (ref. 8). Our limited understanding of the origin of boreal N is unacceptable given the extent of the boreal forest region, but predictable given our imperfect knowledge of N-fixation(1,9). Herein we report on a N-fixing symbiosis between a cyanobacterium (Nostoc sp.) and the ubiquitous feather moss, Pleurozium schreberi (Bird) Mitt. that alone fixes between 1.5 and 2.0 kg N ha(-1) yr(-1) in mid- to late-successional forests of northern Scandinavia and Finland. Previous efforts have probably underestimated N-fixation potential in boreal forests.	Univ Montana, Sch Forestry, Missoula, MT 59812 USA; Swedish Univ Agr Sci, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden	University of Montana System; University of Montana; Swedish University of Agricultural Sciences; Umea University	DeLuca, TH (corresponding author), Univ Montana, Sch Forestry, Missoula, MT 59812 USA.		Hegethorn, Marie-Charlotte Nilsson/B-1802-2017; DeLuca, Thomas Henry/B-4547-2012; DeLuca, Thomas/GYU-3468-2022	Hegethorn, Marie-Charlotte Nilsson/0000-0002-9254-2223; DeLuca, Thomas Henry/0000-0003-1561-9597; Sellstedt, Anita/0000-0002-0536-903X				Alexander V., 1986, FOREST ECOSYSETMS AL, P112; Binkley D, 2000, ECOSYSTEMS, V3, P321, DOI 10.1007/s100210000029; CHAPIN DM, 1991, CAN J BOT, V69, P2744, DOI 10.1139/b91-345; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHRISTIE P, 1987, J ECOL, V75, P73, DOI 10.2307/2260537; Cleve K. Van, 1981, Ecological Bulletins, P375; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; DELUCA TH, 2002, OECOLOGIA ADV O 0828; FOSTER DR, 1985, J ECOL, V73, P517, DOI 10.2307/2260491; GRANHALL U, 1973, OIKOS, V24, P8, DOI 10.2307/3543247; Hagglund B., 1977, Studia Forestalia Suecica; Kuc M, 1997, CAN FIELD NAT, V111, P630; Longton Royce E., 1992, P32; Mattsson U, 2000, CAN J MICROBIOL, V46, P1091, DOI 10.1139/cjm-46-12-1091; MELKONEN E, 1974, COMM I FOR FENN, V84, P1; Oechel W, 1986, FOREST ECOSYSTEMS AL, P121; PANDEY KD, 1992, ISRAEL J BOT, V41, P187; Rai AN, 2000, NEW PHYTOL, V147, P449, DOI 10.1046/j.1469-8137.2000.00720.x; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; REDDY GB, 1981, SOIL BIOL BIOCHEM, V13, P537, DOI 10.1016/0038-0717(81)90047-X; ROSEN K, 1980, HOLARCTIC ECOL, V3, P137; SHUGART R, 1992, SYSTEM ANAL GLOBAL B, P565; Tamm C.O., 1991, NITROGEN TERRESTRIAL, P34, DOI DOI 10.1007/978-3-642-75168-4_3; Vitousek PM, 2000, ECOLOGY, V81, P2366, DOI 10.1890/0012-9658(2000)081[2366:HNFIDL]2.0.CO;2; Vogel JG, 1998, ECOSYSTEMS, V1, P386, DOI 10.1007/s100219900032; Walter H, 1989, ECOLOGICAL SYSTEMS G, DOI DOI 10.1007/978-3-642-70160-3; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; WEAVER RW, 1994, METHODS SOIL ANAL 2, P985; Whitehead D, 2001, TREE PHYSIOL, V21, P925, DOI 10.1093/treephys/21.12-13.925	29	389	405	4	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					917	920		10.1038/nature01051	http://dx.doi.org/10.1038/nature01051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410308				2022-12-24	WOS:000178909700041
J	Goldacre, MJ; Roberts, SE; Yeates, D				Goldacre, MJ; Roberts, SE; Yeates, D			Mortality after admission to hospital with fractured neck of femur: database study	BRITISH MEDICAL JOURNAL			English	Article							HIP-FRACTURES		Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.							BOEREBOOM FTJ, 1992, NETH J MED, V41, P4; GOLDACRE MJ, 1993, J EPIDEMIOL COMMUN H, V47, P491, DOI 10.1136/jech.47.6.491; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; NHS Executive, 1999, QUAL PERF NHS CLIN I, P30; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904	5	133	134	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2002	325	7369					868	869		10.1136/bmj.325.7369.868	http://dx.doi.org/10.1136/bmj.325.7369.868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607LL	12386038	Bronze, Green Published			2022-12-24	WOS:000178793000020
J	Vermund, SH; Wilson, CM				Vermund, SH; Wilson, CM			Barriers to HIV testing - where next?	LANCET			English	Editorial Material							ADOLESCENTS; ACCESS; WOMEN; CARE; CITY		Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wilson, CM (corresponding author), Univ Alabama, Div Geog Med, Birmingham, AL 35294 USA.		Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Wilson, Craig/0000-0001-6869-1053				Allen S., 1999, PREVENTING HIV DEV C, P87; Coovadia HM, 2000, ANN NY ACAD SCI, V918, P57; Futterman DC, 2001, J ADOLESCENT HEALTH, V29, P19, DOI 10.1016/S1054-139X(01)00290-7; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Inungu JN, 2002, AIDS PATIENT CARE ST, V16, P293, DOI 10.1089/10872910260066723; Jemmott JB, 1998, JAMA-J AM MED ASSOC, V279, P1529, DOI 10.1001/jama.279.19.1529; Kawichai S, 2002, J ACQ IMMUN DEF SYND, V30, P493, DOI 10.1097/00126334-200208150-00005; Kopelman LM, 2002, J MED PHILOS, V27, P231, DOI 10.1076/jmep.27.2.231.2987; Murphy DA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e36; NICHOLS SA, IN PRESS AM J MED SC; Royce RA, 2001, AM J PUBLIC HEALTH, V91, P727, DOI 10.2105/AJPH.91.5.727; SCHOENBAUM EE, 1993, AM J PUBLIC HEALTH, V83, P363, DOI 10.2105/AJPH.83.3.363; STOTO MA, 1998, REDUCING ODDS PREVEN; Stringer EM, 2001, OBSTET GYNECOL, V98, P1104, DOI 10.1016/S0029-7844(01)01631-3; Stringer JSA, 1999, J ACQ IMMUN DEF SYND, V21, P217, DOI 10.1097/00126334-199907010-00006; Webber MP, 2001, AM J PERINAT, V18, P49, DOI 10.1055/s-2001-12941	16	55	57	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1186	1187		10.1016/S0140-6736(02)11291-8	http://dx.doi.org/10.1016/S0140-6736(02)11291-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	605ZZ	12401241				2022-12-24	WOS:000178708100004
J	Lawlor, DA; Ebrahim, S; Smith, GD				Lawlor, DA; Ebrahim, S; Smith, GD			Socioeconomic position in childhood and adulthood and insulin resistance: cross sectional survey using data from British women's heart and health study	BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; RISK-FACTORS; MORTALITY; CIRCUMSTANCES; LIFE	Objective To assess the associations between childhood and adulthood social class and insulin resistance. Design Cross sectional survey. Setting 23 towns across England, Scotland, and Wales. Participants 4286 women aged 60-79 years. Main outcome measures Insulin resistance and other cardiovascular disease risk factors. Results Belonging to manual social classes in childhood and in adulthood was independently associated with increased insulin resistance, dyslipidaemia, and general obesity. The association between childhood social class and insulin resistance was stronger than that for adult social class. The effect, on insulin resistance and other risk factors, of belonging to a manual social class at either stage in the life course was cumulative, with no evidence of an interaction between childhood and adult social class. Women who were in manual social classes in childhood remained at increased risk of insulin resistance, dyslipidaemia, and obesity-even if they moved into non-manual social classes in adulthood-compared with women who were in non-manual social classes at both stages. Conclusions Adverse social circumstances in childhood, as well as adulthood, arc strongly and independently associated with increased risk of insulin resistance and other metabolic risk factors.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				BAO WH, 1994, ARCH INTERN MED, V154, P1842; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; Brunner E, 1999, J EPIDEMIOL COMMUN H, V53, P757, DOI 10.1136/jech.53.12.757; ERENS B, 1999, HLTH SURVEY ENGLAND; Ernster V, 2000, B WORLD HEALTH ORGAN, V78, P891; GRAHAM H, 1998, HLTH B, V56, P757; Heslop P, 2001, SOC SCI MED, V53, P477, DOI 10.1016/S0277-9536(00)00350-6; KAPLAN GA, 1990, BRIT MED J, V301, P1121, DOI 10.1136/bmj.301.6761.1121; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; LAWLOR DA, IN PRESS J EPIDEMIOL; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Office of Population Censuses and Surveys, 1980, CLASS OCC COD IND; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Rose D, 1995, SOCIAL RES UPDAT JUL, P1; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P20; Smith GD, 1997, LANCET, V349, P284, DOI 10.1016/S0140-6736(05)64894-5; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P340, DOI 10.1136/jech.55.5.340; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Wamala SP, 2001, INT J EPIDEMIOL, V30, P275, DOI 10.1093/ije/30.2.275; Wannamethee SG, 1996, LANCET, V348, P1259, DOI 10.1016/S0140-6736(96)02465-8	24	141	141	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2002	325	7368					805	807		10.1136/bmj.325.7368.805	http://dx.doi.org/10.1136/bmj.325.7368.805			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604YM	12376440	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000178648700017
J	Levin, M; Thorlin, T; Robinson, KR; Nogi, T; Mercola, M				Levin, M; Thorlin, T; Robinson, KR; Nogi, T; Mercola, M			Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning	CELL			English	Article							MESSENGER-RNA LOCALIZATION; RIGHT AXIS FORMATION; CHICK-EMBRYO; DROSOPHILA OOCYTES; INTRACELLULAR PH; PRIMITIVE STREAK; XENOPUS EMBRYOS; BUDDING YEAST; GAP-JUNCTIONS; ALPHA-SUBUNIT	A pharmacological screen identified the H+ and K+ ATPase transporter as obligatory for normal orientation of the left-right body axis in Xenopus. Maternal H+/K+-ATPase mRNA is symmetrically expressed in the 1-cell Xenopus embryo but becomes localized during the first two cell divisions, demonstrating that asymmetry is generated within two hours postfertilization. Although H+/K+-ATPase subunit mRNAs are symmetrically localized in chick embryos, an endogenous H+/K+-ATPase-dependent difference in membrane voltage potential exists between the left and right sides of the primitive streak. In both species, pharmacologic or genetic perturbation of endogenous H+/K+-ATPase randomized the sided pattern of asymmetrically expressed genes and induced organ heterotaxia. Thus, LR asymmetry determination depends on a very early differential ion flux created by H+/K+-ATPase activity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Forsyth Inst, Cytokine Biol Dept, Boston, MA 02115 USA; Sahlgrens Univ Hosp, Inst Clin Neurosci, SE-41345 Gothenburg, Sweden; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Harvard University; Forsyth Institute; Sahlgrenska University Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mercola, M (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Nogi, Taisaku/C-7657-2009; Levin, Michael/A-5918-2011; Nogi, Taisaku/F-4675-2017	Levin, Michael/0000-0001-7292-8084; 	NHLBI NIH HHS [R01 HL63271] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063271] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altizer AM, 2001, DEV DYNAM, V221, P391, DOI 10.1002/dvdy.1158; Bashirullah A, 1999, EMBO J, V18, P2610, DOI 10.1093/emboj/18.9.2610; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; BORGENS RB, 1995, DEV DYNAM, V203, P456, DOI 10.1002/aja.1002030408; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Brink P, 2000, J GEN PHYSIOL, V116, P11, DOI 10.1085/jgp.116.1.11; BROWN NA, 1990, DEVELOPMENT, V109, P1; Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Casey B, 2000, CURR OPIN GENET DEV, V10, P257, DOI 10.1016/S0959-437X(00)00085-X; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; COOPER MS, 1989, DEV BIOL, V132, P179, DOI 10.1016/0012-1606(89)90216-9; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x; DANOS MC, 1995, DEVELOPMENT, V121, P1467; DIEHLJONES W, 1993, DEV BIOL, V158, P301, DOI 10.1006/dbio.1993.1190; ELINSON RP, 1975, DEV BIOL, V47, P257, DOI 10.1016/0012-1606(75)90281-X; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; GERHART J, 1981, NATURE, V292, P511, DOI 10.1038/292511a0; GOTTARDI CJ, 1993, J CELL BIOL, V121, P283, DOI 10.1083/jcb.121.2.283; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HARLAND RM, 1991, XENOPUS LAEVIS PRACT, P685; Harris C, 1999, INT J MOL MED, V3, P315; HOTARY KB, 1992, DEVELOPMENT, V114, P985; HOTARY KB, 1994, DEV BIOL, V166, P789, DOI 10.1006/dbio.1994.1357; Hyatt BA, 1998, CELL, V93, P37, DOI 10.1016/S0092-8674(00)81144-7; Ikuma M, 1998, J MEMBRANE BIOL, V166, P205; JAFFE LF, 1981, PHILOS T ROY SOC B, V295, P553, DOI 10.1098/rstb.1981.0160; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; LANGE CS, 1978, DIFFERENTIATION, V11, P1, DOI 10.1111/j.1432-0436.1978.tb00965.x; Levin M, 1998, SEMIN CELL DEV BIOL, V9, P67, DOI 10.1006/scdb.1997.0192; Levin M, 1999, DEVELOPMENT, V126, P4703; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Linask KK, 2001, DEV DYNAM, V221, P249, DOI 10.1002/dvdy.1131; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Lohr JL, 1997, DEVELOPMENT, V124, P1465; MARINOS E, 1986, CELL DIFFER DEV, V18, P163, DOI 10.1016/0045-6039(86)90082-5; MATHEWS PM, 1995, AM J PHYSIOL-CELL PH, V268, pC1207, DOI 10.1152/ajpcell.1995.268.5.C1207; Mathur S, 1997, ANESTHESIOLOGY, V87, P1460, DOI 10.1097/00000542-199712000-00025; Meneton P, 1998, J CLIN INVEST, V101, P536, DOI 10.1172/JCI1720; Meneton P, 1999, SEMIN NEPHROL, V19, P438; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; MIZUNASHI K, 1993, CALCIFIED TISSUE INT, V53, P21, DOI 10.1007/BF01352010; Morley GE, 1997, J CARDIOVASC ELECTR, V8, P939, DOI 10.1111/j.1540-8167.1997.tb00856.x; Munchow S, 1999, J CELL SCI, V112, P1511; Munson KB, 2000, BIOCHEMISTRY-US, V39, P2997, DOI 10.1021/bi991837d; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Ohuchi H, 2000, MECH DEVELOP, V95, P55, DOI 10.1016/S0925-4773(00)00331-2; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; Psychoyos D, 1996, DEVELOPMENT, V122, P3263; ROBINSON K, 1996, NERVE GROWTH GUIDANC; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; ROSE SM, 1970, AM ZOOL, V10, P91; SACHS G, 1995, ANNU REV PHARMACOL, V35, P277, DOI 10.1146/annurev.pa.35.040195.001425; SANDERS SW, 1992, ALIMENT PHARM THERAP, V6, P359; SCHARF SR, 1980, DEV BIOL, V79, P181, DOI 10.1016/0012-1606(80)90082-2; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; SHI R, 1994, DEV BIOL, V165, P105, DOI 10.1006/dbio.1994.1238; SHI RY, 1995, DEV DYNAM, V202, P101, DOI 10.1002/aja.1002020202; Spemann H., 1938, EMBRYONIC DEV INDUCT; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; TURIN L, 1980, J PHYSIOL-LONDON, V300, P489, DOI 10.1113/jphysiol.1980.sp013174; Waddington CH, 1937, J EXP BIOL, V14, P229; Weber J, 1998, J BIOL CHEM, V273, P33210, DOI 10.1074/jbc.273.50.33210; WHITE TW, 1994, NATURE, V371, P208, DOI 10.1038/371208a0; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; WOODRUFF RI, 1980, NATURE, V286, P84, DOI 10.1038/286084a0; WOODRUFF RI, 1988, ROUX ARCH DEV BIOL, V197, P231, DOI 10.1007/BF02439430; Yost HJ, 2001, INT REV CYTOL, V203, P357; YU HY, 1994, BBA-BIOMEMBRANES, V1190, P189, DOI 10.1016/0005-2736(94)90052-3; Yuan SP, 1998, DEVELOPMENT, V125, P201; Zhu L, 1999, CURR BIOL, V9, P931, DOI 10.1016/S0960-9822(99)80419-9	85	320	327	2	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 4	2002	111	1					77	89		10.1016/S0092-8674(02)00939-X	http://dx.doi.org/10.1016/S0092-8674(02)00939-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372302	Bronze			2022-12-24	WOS:000178461900010
J	Ma, Y; Erkner, A; Gong, RY; Yao, SQ; Taipale, J; Basler, K; Beachy, PA				Ma, Y; Erkner, A; Gong, RY; Yao, SQ; Taipale, J; Basler, K; Beachy, PA			Hedgehog-mediated patterning of the mammalian embryo requires transporter-like function of dispatched	CELL			English	Article							TERMINAL CLEAVAGE PRODUCT; STEROL-SENSING DOMAIN; HUMAN SONIC HEDGEHOG; CHOLESTEROL MODIFICATION; SCLEROTOME INDUCTION; DROSOPHILA SEGMENT; ANIMAL DEVELOPMENT; SIGNALING PATHWAY; MEMBRANE-PROTEIN; NODAL EXPRESSION	The dispatched (disp) gene is required for long-range Hedgehog (Hh) signaling in Drosophila. Here, we demonstrate that one of two murine homologs, rnDispA, can rescue disp function in Drosophila and is essential for all Hh patterning activities examined in the early mouse embryo. Embryonic fibroblasts lacking mDispA respond normally to exogenously provided Sonic hedgehog (Shh) signal, but are impaired in stimulation of other responding cells when expressing Shh. We have developed a biochemical assay that directly measures the activity of Disp proteins in release of soluble Hh proteins. This activity is disrupted by alteration of residues functionally conserved in Patched and in a related family of bacterial transmembrane transporters, thus suggesting similar mechanisms of action for all of these proteins.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; Johns Hopkins University; University of Zurich	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.			Basler, Konrad/0000-0003-3534-1529				Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Borycki AG, 1999, DEVELOPMENT, V126, P4053; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Dudley AT, 2000, CURR OPIN GENET DEV, V10, P387, DOI 10.1016/S0959-437X(00)00101-5; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Hogan B, 1994, MANIPULATING MOUSE E; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Liu JX, 1999, GENE, V237, P153, DOI 10.1016/S0378-1119(99)00314-5; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEVELOPMENT, V122, P1225; MUENKE M, 2001, METABOLIC MOL BASES, P6203; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; NIES DH, 1995, J BACTERIOL, V177, P2707, DOI 10.1128/jb.177.10.2707-2712.1995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sasaki H, 1997, DEVELOPMENT, V124, P1313; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	62	230	246	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 4	2002	111	1					63	75		10.1016/S0092-8674(02)00977-7	http://dx.doi.org/10.1016/S0092-8674(02)00977-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372301	Bronze, Green Accepted			2022-12-24	WOS:000178461900009
J	Malhotra, V; Emr, SD				Malhotra, V; Emr, SD			Rothman and Schekman SNAREd by Lasker for trafficking	CELL			English	Article								This year, the recipients of the Lasker Award for Basic Medical Research are James Rothman and Randy Schekman. This highly anticipated honor highlights their unique contributions to our understanding of the mechanisms of membrane traffic.	Univ Calif San Diego, Dept Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Dept Cell & Dev Biol, La Jolla, CA 92093 USA.		Malhotra, Vivek/O-9811-2014	Malhotra, Vivek/0000-0001-6198-7943					0	5	5	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 4	2002	111	1					1	3		10.1016/S0092-8674(02)01008-5	http://dx.doi.org/10.1016/S0092-8674(02)01008-5			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372293	Bronze			2022-12-24	WOS:000178461900001
J	Ludwig, A; Debus, L; Lieckfeldt, D; Wirgin, I; Benecke, N; Jenneckens, I; Williot, P; Waldman, JR; Pitra, C				Ludwig, A; Debus, L; Lieckfeldt, D; Wirgin, I; Benecke, N; Jenneckens, I; Williot, P; Waldman, JR; Pitra, C			When the American sea sturgeon swam east - A colder Baltic Sea greeted this fish from across the Atantic Ocean in the Middle Ages	NATURE			English	Article							CONTROL REGION; ACIPENSER		Inst Zoo & Wildlife Res, Dept Evolutionary Genet, D-10252 Berlin, Germany; Univ Rostock, Inst Zool, D-18051 Rostock, Germany; NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA; German Archaeol Inst, D-14195 Berlin, Germany; Univ Gottingen, Inst Genet & Anim Breeding, D-37075 Gottingen, Germany; Cemagref, Inland Living Aquat Resources Res Unit, F-33612 Cestas, France; Hudson River Fdn Sci & Environm Res, New York, NY 10011 USA	Leibniz Institut fur Zoo und Wildtierforschung; University of Rostock; New York University; University of Gottingen; INRAE	Ludwig, A (corresponding author), Inst Zoo & Wildlife Res, Dept Evolutionary Genet, D-10252 Berlin, Germany.			Lieckfeldt, Dietmar/0000-0002-8040-8588				Artyukhin E, 1999, J APPL ICHTHYOL, V15, P35, DOI 10.1111/j.1439-0426.1999.tb00202.x; BROWN JR, 1993, MOL BIOL EVOL, V10, P326; ISORODIN N, 1925, T AM FISH SOC, V55, P184; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Ludwig A, 2000, GENETICS, V156, P1933; MAGNIN ETIENNE, 1964, NATUR CAN, V91, P5; Quantz H., 1903, MITTEILUNGEN DTSCH S, V19, P176	7	92	100	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					447	448		10.1038/419447a	http://dx.doi.org/10.1038/419447a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368843				2022-12-24	WOS:000178348400024
J	Chintu, C; Mudenda, V; Lucas, S; Nunn, A; Lishimpi, K; Maswahu, D; Kasolo, F; Mwaba, P; Bhat, G; Terunuma, H; Zumla, A				Chintu, C; Mudenda, V; Lucas, S; Nunn, A; Lishimpi, K; Maswahu, D; Kasolo, F; Mwaba, P; Bhat, G; Terunuma, H; Zumla, A		UNZA-UCLMS Project Paediat Post-Mo	Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study	LANCET			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-INFECTION; CLINICAL PRESENTATION; IMPACT; TUBERCULOSIS; ABIDJAN	Background Accurate information about specific causes of death in African children dying of respiratory illnesses is scarce, and can only be obtained by autopsy. We undertook a study of children who died from respiratory diseases at University Teaching Hospital, Lusaka, Zambia. Methods 137 boys (93 HIV-1-positive, 44 HIV-1-negative), and 127 girls (87 HIV-1-positive, 40 HIV-1-negative) aged between 1 month and younger than 16 years underwent autopsy restricted to the chest cavity. Outcome measures were specific lung diseases, stratified by age and HIV-1 status. Findings The presence of multiple diseases was common. Acute pyogenic pneumonia (population-adjusted prevalence 39.1%, 116/264), Pneumocystis carinii pneumonia (27.5%, 58/264), tuberculosis (18.8%, 54/264), and cytomegalovirus infection (CMV, 20.2%, 43/264) were the four most common findings overall. The three most frequent findings in the HIV-1-negative group were acute pyogenic pneumonia (50%), tuberculosis (26%), and interstitial pneumonitis (18%); and in the HIV-1-positive group were acute pyogenic pneumonia (41%), P carinii pneumonia (29%), and CMV (22%). HIV-1-positive children more frequently had P carinii pneumonia (odds ratio 5.28, 95% CI 2.12-15.68, p=0.0001), CMV (7.71, 2.33-40.0, p=0.0002), and shock lung (4-15, 1.20-22.10, p=0.03) than did HIV-1-negative children. 51/58 (88%) cases of P carinii pneumonia were in children younger than 12 months, and five in children aged over 24 months. Tuberculosis was common in all age groups, irrespective of HIV-1 status. Interpretation Most children dying from respiratory diseases have preventable or treatable infectious illnesses. The presence of multiple diseases might make diagnosis difficult. WHO recommendations should therefore be updated with mention of HIV-1-positive children. Improved diagnostic tests for bacterial pathogens, tuberculosis, and P carinii pneumonia are urgently needed.	Univ Zambia, Univ Coll London, Sch Med, Res & Training Project,Univ Teaching Hosp, Lusaka, Zambia; Univ Teaching Hosp, Dept Pathol, Lusaka, Zambia; Univ Teaching Hosp, Dept Paediat & Child Hlth, Lusaka, Zambia; Guys Kings & St Thomass Hosp, Sch Med, Dept Histopathol, London, England; Univ Teaching Hosp, JICA Project, Lusaka, Zambia; MRC, Clin Trials Unit, London, England; Royal Free & UCL, Sch Med, Ctr Infect Dis & Int Hlth, Dept Med, London W1T 4JF, England	University of Zambia; University of Zambia; University of Zambia; University of London; King's College London; University of Zambia; Medical Research Council Clinical Trials Unit; University of London; University College London; UCL Medical School	Zumla, A (corresponding author), UCL Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, Room G41,46 Cleveland St, London W1T 4JF, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020; Mwaba, Peter/V-6017-2019	ZUMLA, Alimuddin/0000-0002-5111-5735; Nunn, Andrew/0000-0002-9158-4595				ABOUYA YL, 1992, AM REV RESPIR DIS, V145, P617, DOI 10.1164/ajrccm/145.3.617; Abrams EJ, 2001, PEDIATR INFECT DIS J, V20, P511, DOI 10.1097/00006454-200105000-00008; ANSARI NA, 1999, INT J TUBERC LUNG S1, V3, pS201; Beyers N, 1997, INT J TUBERC LUNG D, V1, P38; CARME B, 1991, T ROY SOC TROP MED H, V85, P80, DOI 10.1016/0035-9203(91)90167-W; Chintu C, 1995, J TROP PEDIATRICS, V41, P348, DOI 10.1093/tropej/41.6.348; CHINTU C, 1993, PEDIATR INFECT DIS J, V12, P499, DOI 10.1097/00006454-199306000-00008; CORNFIELD J, 1996, P 3 BERK S BERK, V4, P135; Dray-Spira R, 2000, AIDS, V14, P1091, DOI 10.1097/00002030-200006160-00005; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; Kamiya Y, 1997, ANN TROP PAEDIATR, V17, P121, DOI 10.1080/02724936.1997.11747874; Kiwanuka J, 2001, ANN TROP PAEDIATR, V21, P5, DOI 10.1080/02724930020028849; Lishimpi K, 2001, ARCH DIS CHILD, V84, P463, DOI 10.1136/adc.84.6.463; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; MUGANGA N, 1991, PEDIATRIE, V46, P825; Mukadi YD, 1997, AIDS, V11, P1151, DOI 10.1097/00002030-199709000-00011; Nathoo KJ, 2001, T ROY SOC TROP MED H, V95, P37, DOI 10.1016/S0035-9203(01)90325-6; Pillay K, 2001, ARCH DIS CHILD, V85, P50, DOI 10.1136/adc.85.1.50; SASSANMOROKRO M, 1994, T ROY SOC TROP MED H, V88, P178, DOI 10.1016/0035-9203(94)90285-2; Smyth A, 1997, ARCH DIS CHILD, V77, P227, DOI 10.1136/adc.77.3.227; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; THIJS A, 1963, Trop Geogr Med, V15, P158; *UNAIDS, US COTR PROPH AD CHI; *UNAIDS WHO, AIDS EP UPD 2001; Vetter KM, 1996, PEDIATR INFECT DIS J, V15, P438, DOI 10.1097/00006454-199605000-00011; *WHO UNICEF, 1999, WHOCHSCAH98IDREV1 WH; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163	32	240	247	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2002	360	9338					985	990		10.1016/S0140-6736(02)11082-8	http://dx.doi.org/10.1016/S0140-6736(02)11082-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597YU	12383668				2022-12-24	WOS:000178249000011
J	Nishtar, S				Nishtar, S			Prevention of coronary heart disease in south Asia	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; CENTRAL OBESITY; ARTERY-DISEASE; PREVALENCE; POPULATIONS; TOBACCO; MALES; MEN	The great increase in rates of cardiovascular disease in developing countries will probably have grave implications for south Asia, which houses nearly a quarter of the world's population. Several factors might contribute to this effect, such as increased susceptibility of south Asian people to cardiovascular disease, unrecognised targets for preventive interventions, and restricted access to high-cost tertiary cardiovascular care for economically disadvantaged communities. Furthermore, prevention and control of cardiovascular disease does not feature prominently in the health care agendas of south Asian countries. To address these issues, therefore, a multifaceted approach is needed, which should include epidemiological studies to fill in the gaps in knowledge. Additionally, political, social, cultural, and economic issues need to be considered in prevention and control of these diseases, to identify and address key limitations and opportunities specific to the region. A set of recommendations outlining the approach is crucial.	Heartfile Pakistan, Islamabad, Pakistan		Nishtar, S (corresponding author), Heartfile Pakistan, 1 Pk Rd, Islamabad, Pakistan.	sania@heartfile.org						BHATNAGAR D, 1995, LANCET, V345, P405; Bhopal R, 2000, J PUBLIC HEALTH MED, V22, P375, DOI 10.1093/pubmed/22.3.375; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; FERNANDES VL, 2001, CORONARY ARTERY DIS, P147; Gupta Rajeev, 2002, Indian Heart J, V54, P59; HAQ MU, 1999, HUM DEV S ASIA CRISI; Hoogeveen RC, 2001, J LIPID RES, V42, P631; KLATSKY AL, 1994, AM J PUBLIC HEALTH, V84, P1672, DOI 10.2105/AJPH.84.10.1672; KRISHNASWAMI S, 1989, INT J CARDIOL, V24, P337, DOI 10.1016/0167-5273(89)90013-2; Lee J, 2001, INT J EPIDEMIOL, V30, P983, DOI 10.1093/ije/30.5.983; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1988, BRIT MED J, V297, P903, DOI 10.1136/bmj.297.6653.903; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MENDIS S, 1994, INT J CARDIOL, V46, P135, DOI 10.1016/0167-5273(94)90034-5; Ministry of Health, 1994, PAK NAT PLAN PREV BL; Mohan V, 2001, J AM COLL CARDIOL, V38, P682, DOI 10.1016/S0735-1097(01)01415-2; NISHTAR S, PREVENTING CORONARY; PANDEY MR, 1988, INT J EPIDEMIOL, V17, P535, DOI 10.1093/ije/17.3.535; PUSKA P, 1995, N KARELIA PROJECT 20; Ramachandran A, 2001, AM J CARDIOL, V87, P267, DOI 10.1016/S0002-9149(00)01356-4; Reddy KB., 1996, APOPTOSIS, V1, P33, DOI [10.1007/BF00142076, DOI 10.1007/BF00142076]; Riste L, 2001, DIABETES CARE, V24, P1377, DOI 10.2337/diacare.24.8.1377; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Singh R B, 1996, J Cardiovasc Risk, V3, P489, DOI 10.1097/00043798-199612000-00002; Singh RB, 1997, EUR HEART J, V18, P1728; SQUIRES WG, 1984, PREV MED, V13, P195, DOI 10.1016/0091-7435(84)90051-3; Tinker H., 1974, NEW SYSTEM SLAVERY E; *WORLD BANK, 2001, WORLD BANK REP 2001; World Health Organisation, 2001, MENT DIS AFF ON 4 PE; Zaman MM, 2001, J CARDIOVASC RISK, V8, P103, DOI 10.1097/00043798-200104000-00007; Zoratti R, 2000, METABOLISM, V49, P245, DOI 10.1016/S0026-0495(00)91507-5	34	84	86	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2002	360	9338					1015	1018		10.1016/S0140-6736(02)11088-9	http://dx.doi.org/10.1016/S0140-6736(02)11088-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597YU	12383683				2022-12-24	WOS:000178249000026
J	Bourgeois, C; Rocha, B; Tanchot, C				Bourgeois, C; Rocha, B; Tanchot, C			A role for CD40 expression on CD8(+) T cells in the generation of CD8(+) T cell memory	SCIENCE			English	Article							IN-VIVO; MICE; RESPONSES; LIGAND; IMMUNITY; HELP; INDUCTION; TOLERANCE; DIFFERENTIATION; COSTIMULATION	The delivery of CD4 help to CD8(+) T cell responses requires interactions between CD40 and CD40 ligand and is thought to occur through antigen-presenting cell (APC) activation. Here we show that generation of memory CD8(+) T cells displaying an enhanced capacity for cell division and cytokine secretion required CD4 help but not CD40 expression by the APCs. Activated CD4(+) and CD8(+) T cells expressed CD40; and in the absence of this protein, CD8(+) T cells were unable to differentiate into memory cells or receive CD4 help. These results suggest that, like B cells, CD8(+) T cells receive CD4 help directly through CD40 and that this interaction is fundamental for CD8(+) T cell memory generation.	Inst Necker, INSERM, U345, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tanchot, C (corresponding author), Inst Necker, INSERM, U345, 156 Rue Vaugirard, F-75730 Paris 15, France.		Bourgeois, Christine/ABA-1432-2021; Bourgeois, Christine/L-5944-2018	Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Tanchot, Corinne/0000-0002-2913-1755				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BODMER H, 1993, EUR J IMMUNOL, V23, P1649, DOI 10.1002/eji.1830230738; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Gray D, 1994, Semin Immunol, V6, P303, DOI 10.1006/smim.1994.1039; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HERMANN P, 1995, EUR J IMMUNOL, V25, P2972, DOI 10.1002/eji.1830251039; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Livingstone AM, 1999, EUR J IMMUNOL, V29, P2826, DOI 10.1002/(SICI)1521-4141(199909)29:09<2826::AID-IMMU2826>3.0.CO;2-M; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; Ozaki ME, 1999, J IMMUNOL, V163, P5250; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shepherd DM, 1999, J IMMUNOL, V163, P2470; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TANCHOT C, UNPUB; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Whitmire JK, 1999, J IMMUNOL, V163, P3194	35	515	542	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2060	2063		10.1126/science.1072615	http://dx.doi.org/10.1126/science.1072615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242444				2022-12-24	WOS:000178078500049
J	Klein, CA; Blankenstein, TJF; Schmidt-Kittler, O; Petronio, M; Polzer, B; Stoecklein, NH; Riethmuller, G				Klein, CA; Blankenstein, TJF; Schmidt-Kittler, O; Petronio, M; Polzer, B; Stoecklein, NH; Riethmuller, G			Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer	LANCET			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN PROSTATE-CANCER; BONE-MARROW; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; CYTOGENETIC ANALYSIS; ESOPHAGEAL CANCER; P53 MUTATIONS; LYMPH-NODES; LUNG-CANCER	Background Because cancer patients with small tumours often relapse despite local and systemic treatment, we investigated the genetic variation of the precursors of distant metastasis at the stage of minimal residual disease. Disseminated tumour cells can be detected by epithelial markers in mesenchymal tissues and represent targets for adjuvant therapies. Methods We screened 525 bone-marrow, blood, and lymphnode samples from 474 patients with breast, prostate, and gastrointestinal cancers for single disseminated cancer cells by immunocytochemistry with epithelial-specific markers. 71 (14%) of the samples contained two or more tumour cells whose genomic organisation we studied by single cell genomic hybridisation. In addition, we tested whether TP53 was mutated. Hierarchical clustering algorithms were used to determine the degree of clonal relatedness of sister cells that were isolated from individual patients. Findings Irrespective of cancer type, we saw an unexpectedly high genetic divergence in minimal residual cancer, particularly at the level of chromosomal imbalances. Although few disseminated cells harboured TP53 mutations at this stage of disease, we also saw microheterogeneity of the TP53 genotype. The genetic heterogeneity was strikingly reduced with the emergence of clinically evident metastasis. Interpretation Although the heterogeneity of primary tumours has long been known, we show here that early disseminated cancer cells are genomically very unstable as well. Selection of clonally expanding cells leading to metastasis, seems to occur after dissemination has taken place. Therefore, adjuvant therapies are confronted with an extremely large reservoir of variant cells from which resistant tumour cells can be selected.	Univ Munich, Inst Immunol, D-80336 Munich, Germany; Univ Hamburg, Klinikum Eppendorf, Chirurg Klin, Hamburg, Germany	University of Munich; University of Hamburg	Klein, CA (corresponding author), Univ Munich, Inst Immunol, D-80336 Munich, Germany.	christoph.klein@ifi.med.uni-muenchen.de	Califano, Andrea/F-7239-2012	Klein, Christoph A./0000-0001-7128-1725				Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Braun S, 2000, J CLIN ONCOL, V18, P80, DOI 10.1200/JCO.2000.18.1.80; Chay C, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.20744; Edwards BK, 2002, CANCER-AM CANCER SOC, V94, P2766, DOI 10.1002/cncr.10593; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fujii H, 1996, CANCER RES, V56, P1493; Gianni L, 2001, SEMIN ONCOL, V28, P13, DOI 10.1053/sonc.2001.20747; Gorunova L, 1998, GENE CHROMOSOME CANC, V23, P81, DOI 10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Harris DT, 2001, SEMIN ONCOL, V28, P1; Heim S, 1997, CANCER GENET CYTOGEN, V95, P16, DOI 10.1016/S0165-4608(96)00322-6; Izbicki JR, 1997, NEW ENGL J MED, V337, P1188, DOI 10.1056/NEJM199710233371702; Jauch KW, 1996, J CLIN ONCOL, V14, P1810, DOI 10.1200/JCO.1996.14.6.1810; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Klein CA, 2000, TRENDS CELL BIOL, V10, P489, DOI 10.1016/S0962-8924(00)01846-8; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LINDEMANN F, 1992, LANCET, V340, P685, DOI 10.1016/0140-6736(92)92230-D; Loeb LA, 2001, CANCER RES, V61, P3230; Macdonald JS, 2001, SEMIN ONCOL, V28, P30, DOI 10.1053/sonc.2001.20750; Macintosh CA, 1998, CANCER RES, V58, P23; MIRCHANDANI D, 1995, AM J PATHOL, V147, P92; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pandis N, 1998, GENE CHROMOSOME CANC, V22, P122, DOI 10.1002/(SICI)1098-2264(199806)22:2<122::AID-GCC6>3.0.CO;2-Z; Pantel K, 1999, JNCI-J NATL CANCER I, V91, P1113, DOI 10.1093/jnci/91.13.1113; Pantel K, 1996, LANCET, V347, P649, DOI 10.1016/S0140-6736(96)91203-9; PASSLICK B, 1994, J CLIN ONCOL, V12, P1827, DOI 10.1200/JCO.1994.12.9.1827; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Stapleton AMF, 1997, CLIN CANCER RES, V3, P1389; Thorban S, 2000, BRIT J CANCER, V83, P35; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6	33	391	401	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2002	360	9334					683	689		10.1016/S0140-6736(02)09838-0	http://dx.doi.org/10.1016/S0140-6736(02)09838-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241875				2022-12-24	WOS:000177795100010
J	Thomas, SL; Wheeler, JG; Hall, AJ				Thomas, SL; Wheeler, JG; Hall, AJ			Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study	LANCET			English	Article							VIRUS-DNA; GANGLIA; CHICKENPOX	Background Whether exogenous exposure to varicella-zoster-virus protects individuals with latent varicella-zoster virus infection against herpes zoster by boosting immunity is not known. To test the hypothesis that contacts with children increase exposure to varicella-zoster virus and protect latently infected adults against zoster, we did a case-control study in south London, UK. Methods From 22 general practices, we identified patients with recently diagnosed zoster, and control individuals with no history of zoster, matched to patients by age, sex, and practice. Participants were asked about contacts with people with varicella or zoster in the past 10 years, and social and occupational contacts with children as proxies for varicella contacts. Odds ratios were estimated with conditional logistic regression. Findings Data from 244 patients and 485 controls were analysed. On multivariable analysis, protection associated with contacts with a few children in the household or via childcare seemed to be largely mediated by increased access to children outside the household. Social contacts with many children outside the household and occupational contacts with ill children were associated with graded protection against zoster, with less than a fifth the risk in the most heavily exposed groups compared with the least exposed. The strength of protection diminished after controlling for known varicella contacts; the latter remained significantly protective (odds ratio 0.29 [95% CI 0.10-0.84] for those with five contacts or more). Interpretation Re-exposure to varicella-zoster virus via contact with children seems to protect latently infected individuals against zoster. Reduction of childhood varicella by vaccination might lead to increased incidence of adult zoster. Vaccination of the elderly (if effective) should be considered in countries with childhood varicella vaccination programmes.	Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Thomas, SL (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.							ARVIN AM, 1992, J INFECT DIS, V166, pS35, DOI 10.1093/infdis/166.Supplement_1.S35; ARVIN AM, 1983, J INFECT DIS, V148, P200, DOI 10.1093/infdis/148.2.200; BERGER R, 1981, INFECT IMMUN, V32, P24, DOI 10.1128/IAI.32.1.24-27.1981; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; BURKE BL, 1982, ARCH INTERN MED, V142, P291, DOI 10.1001/archinte.142.2.291; Fairley CK, 1996, J INFECT DIS, V174, pS314, DOI 10.1093/infdis/174.Supplement_3.S314; FURUTA Y, 1992, J INFECT DIS, V166, P1157, DOI 10.1093/infdis/166.5.1157; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Gershon AA, 1996, J INFECT DIS, V173, P450, DOI 10.1093/infdis/173.2.450; GILDEN DH, 1983, NATURE, V306, P478, DOI 10.1038/306478a0; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; HOPESIMPSON RE, 1964, P ROY SOC MED, V58, P9; Kennedy PGE, 1998, P NATL ACAD SCI USA, V95, P4658, DOI 10.1073/pnas.95.8.4658; KRAUSE PR, 1995, J PEDIATR-US, V127, P518, DOI 10.1016/S0022-3476(95)70106-0; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; NAHASS GT, 1992, JAMA-J AM MED ASSOC, V268, P2541, DOI 10.1001/jama.268.18.2541; OXMAN MN, 1995, NEUROLOGY S8, V45, P41; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Schmader K, 1998, J AM GERIATR SOC, V46, P973, DOI 10.1111/j.1532-5415.1998.tb02751.x; Solomon BA, 1998, J AM ACAD DERMATOL, V38, P763, DOI 10.1016/S0190-9622(98)70207-5; *UNL AN SURV STEER, 2000, PREV HIV HEP INF UK; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Weller TH, 1997, VIRAL INFECT HUMANS, P866	23	201	211	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 31	2002	360	9334					678	682		10.1016/S0140-6736(02)09837-9	http://dx.doi.org/10.1016/S0140-6736(02)09837-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241874				2022-12-24	WOS:000177795100009
J	Horton, R				Horton, R			The case for a Global Development Organisation	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Calomiris Charles, 2002, GLOBALIST MANIFESTO; Horton R, 2001, LANCET, V358, P2141, DOI 10.1016/S0140-6736(01)07221-X; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Human Development Report, 2002, HUMAN DEV REPORT 200; Lal D, 2002, POVERTY DEV EC; Stiglitz J, 2002, GLOBALISATION ITS DI; Subramanian SV, 2002, ANNU REV PUBL HEALTH, V23, P287, DOI 10.1146/annurev.publhealth.23.100901.140540; 2002, LANCET, V360, P181	9	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2002	360	9333					582	583		10.1016/S0140-6736(02)09809-4	http://dx.doi.org/10.1016/S0140-6736(02)09809-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241924				2022-12-24	WOS:000177600400002
J	Pombo, DJ; Lawrence, G; Hirunpetcharat, C; Rzepczyk, C; Bryden, M; Cloonan, N; Anderson, K; Mahakunkijcharoen, Y; Martin, LB; Wilson, D; Elliott, S; Elliott, S; Eisen, DP; Weinberg, JB; Saul, A; Good, MF				Pombo, DJ; Lawrence, G; Hirunpetcharat, C; Rzepczyk, C; Bryden, M; Cloonan, N; Anderson, K; Mahakunkijcharoen, Y; Martin, LB; Wilson, D; Elliott, S; Elliott, S; Eisen, DP; Weinberg, JB; Saul, A; Good, MF			Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum	LANCET			English	Article							GROWTH IN-VITRO; CD4(+) T-CELLS; ANTIMICROBIAL ACTIVITY; MEDIATED-IMMUNITY; MICE; ANTIGENS; IMMUNOSUPPRESSION; ERYTHROCYTES; PARASITEMIA; MECHANISMS	Background The ability of T cells, acting independently of antibodies, to control malaria parasite growth in people has not been defined. If such cell-mediated immunity was shown to be effective, an additional vaccine strategy could be pursued. Our aim was to ascertain whether or not development of cell-mediated immunity to Plasmodium falciparum blood-stage infection could be induced in human beings by exposure to malaria parasites in very low density. Methods We enrolled five volunteers from the staff at our research institute who had never had malaria. We used a cryopreserved inoculum of red cells infected with P falciparum strain 3D7 to give them repeated subclinical infections of malaria that we then cured early with drugs, to induce cell-mediated immune responses. We tested for development of immunity by measurement of parasite concentrations in the blood of volunteers by PCR of the multicopy gene STEVOR and by following up the volunteers clinically, and by measuring antibody and cellular immune responses to the parasite. Findings After challenge and a extended period without drug cure, volunteers were protected against malaria as indicated by absence of parasites or parasite DNA in the blood, and absence of clinical symptoms. Immunity was characterised by absence of detectable antibodies that bind the parasite or infected red cells, but by the presence of a proliferative T-cell response, involving CD4+ and CD8+ T cells, a cytokine response, consisting of interferon gamma but not interleukin 4 or interleukin 10, induction of high concentrations of nitric oxide synthase activity in peripheral blood mononuclear cells, and a drop in the number of peripheral natural killer T cells. Interpretation People can be protected against the erythrocytic stage of malaria by a strong cell-mediated immune response, in the absence of detectable parasite-specific antibodies, suggesting an additional strategy for development of a malaria vaccine.	Queensland Inst Med Res, Australian Ctr Int & Trop Hlth & Nutr, Brisbane, Qld 4029, Australia; Cooperat Res Inst Vaccine Technol, Brisbane, Qld, Australia; LDS Hosp, Div Infect Dis, Salt Lake City, UT USA; Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; Mahidol Univ, Dept Microbiol & Immunol, Fac Trop Med, Bangkok 10700, Thailand; Vet Affairs Med Ctr, Div Hematol Oncol, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Utah, Salt Lake City, UT USA	QIMR Berghofer Medical Research Institute; Chiang Mai University; Mahidol University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Utah System of Higher Education; University of Utah	Good, MF (corresponding author), Queensland Inst Med Res, Australian Ctr Int & Trop Hlth & Nutr, PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.	michaelG@qimr.edu.au	Cloonan, Nicole/B-5272-2008; Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013; Martin, Laura/N-1789-2013; Wilson, Danny W/E-6186-2019; eisen, damon/AAC-7433-2019	Cloonan, Nicole/0000-0001-7802-6647; Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; Martin, Laura/0000-0002-4431-4381; Wilson, Danny W/0000-0002-5073-1405; Eisen, Damon/0000-0002-8987-4358				Amante FH, 1997, PARASITE IMMUNOL, V19, P111, DOI 10.1046/j.1365-3024.1997.d01-187.x; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BUTCHER GA, 1992, PARASITOL TODAY, V8, P307, DOI 10.1016/0169-4758(92)90104-A; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; COOMBS RRA, 1945, BRIT J EXP PATHOL, V26, P255; CURRIER J, 1992, INT IMMUNOL, V4, P985, DOI 10.1093/intimm/4.9.985; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FELL AH, 1994, PARASITE IMMUNOL, V16, P579, DOI 10.1111/j.1365-3024.1994.tb00313.x; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Good MF, 2001, NAT REV IMMUNOL, V1, P117, DOI 10.1038/35100540; GYAN B, 1994, PARASITE IMMUNOL, V16, P371, DOI 10.1111/j.1365-3024.1994.tb00362.x; Hirunpetcharat C, 1998, P NATL ACAD SCI USA, V95, P1715, DOI 10.1073/pnas.95.4.1715; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Mohan K, 1997, J IMMUNOL, V159, P4990; Newbold CI, 1999, CURR OPIN MICROBIOL, V2, P420, DOI 10.1016/S1369-5274(99)80074-5; PARISH CR, 1972, TRANSPLANT REV-DENMA, V13, P35; Piper KP, 1999, INFECT IMMUN, V67, P6369; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Seixas EMG, 1999, J IMMUNOL, V162, P2837; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; TAYLORROBINSON AW, 1993, SCIENCE, V260, P1931, DOI 10.1126/science.8100366; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; WEINBERG JB, 1995, BLOOD, V86, P1184; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174	32	329	352	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2002	360	9333					610	617		10.1016/S0140-6736(02)09784-2	http://dx.doi.org/10.1016/S0140-6736(02)09784-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241933				2022-12-24	WOS:000177600400011
J	Anderson, MS; Venanzi, ES; Klein, L; Chen, ZB; Berzins, SP; Turley, SJ; von Boehmer, H; Bronson, R; Dierich, A; Benoist, C; Mathis, D				Anderson, MS; Venanzi, ES; Klein, L; Chen, ZB; Berzins, SP; Turley, SJ; von Boehmer, H; Bronson, R; Dierich, A; Benoist, C; Mathis, D			Projection of an immunological self shadow within the thymus by the aire protein	SCIENCE			English	Article							CANDIDIASIS-ECTODERMAL DYSTROPHY; T-CELL TOLERANCE; AUTOIMMUNE REGULATOR AIRE; EPITHELIAL-CELLS; SUBCELLULAR LOCATION; IMMUNE TOLERANCE; GENE-EXPRESSION; BINDING PROTEIN; STROMAL CELLS; ANTIGEN	Humans expressing a defective form of the transcription factor AIRE (autoimmune regulator) develop multiorgan autoimmune disease. We used aire-deficient mice to test the hypothesis that this transcription factor regulates autoimmunity by promoting the ectopic expression of peripheral tissue restricted antigens in medullary epithelial cells of the thymus. This hypothesis proved correct. The mutant animals exhibited a defined pro. le of autoimmune diseases that depended on the absence of aire in stromal cells of the thymus. Aire-deficient thymic medullary epithelial cells showed a specific reduction in ectopic transcription of genes encoding peripheral antigens. These findings highlight the importance of thymically imposed "central" tolerance in controlling autoimmunity.	Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellualire, F-67404 Strasbourg, France	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Benoist, C (corresponding author), Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02115 USA.		Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X; Venanzi, Emily/0000-0002-4185-0381	NCI NIH HHS [T32CA70083-05] Funding Source: Medline; NIDDK NIH HHS [2 P30 DK36836-16, 2T32 DK07260-26, R01 DK60027-01, KO8-DK59958-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260, K08DK059958, P30DK036836, R01DK060027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; ANTONIA SJ, 1995, INT IMMUNOL, V7, P715, DOI 10.1093/intimm/7.5.715; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Garza K M, 2000, Rev Immunogenet, V2, P2; Gylling M, 2000, J CLIN ENDOCR METAB, V85, P4434, DOI 10.1210/jc.85.12.4434; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Halonen M, 2001, J HISTOCHEM CYTOCHEM, V49, P197, DOI 10.1177/002215540104900207; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; HOFFMANN MW, 1995, P NATL ACAD SCI USA, V92, P9851, DOI 10.1073/pnas.92.21.9851; HOFFMANN MW, 1992, P NATL ACAD SCI USA, V89, P2526, DOI 10.1073/pnas.89.7.2526; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Kishimoto H, 2000, CLIN IMMUNOL, V95, pS3, DOI 10.1006/clim.1999.4818; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; NAGAMINE K, 1997, NAT GENET, V17, P399; Naquet P, 1999, SEMIN IMMUNOL, V11, P47, DOI 10.1006/smim.1998.0149; Oukka M, 1996, J IMMUNOL, V156, P968; Oukka M, 1996, IMMUNITY, V4, P545, DOI 10.1016/S1074-7613(00)80481-1; Peterson P, 1998, IMMUNOL TODAY, V19, P384, DOI 10.1016/S0167-5699(98)01293-6; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rosatelli MC, 1998, HUM GENET, V103, P428, DOI 10.1007/s004390050846; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; SPONAAS AM, 1994, INT IMMUNOL, V6, P277, DOI 10.1093/intimm/6.2.277; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	37	1693	1744	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1395	1401		10.1126/science.1075958	http://dx.doi.org/10.1126/science.1075958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12376594				2022-12-24	WOS:000179223100044
J	Yin, YW; Steitz, TA				Yin, YW; Steitz, TA			Structural basis for the transition from initiation to elongation transcription in T7 RNA polymerase	SCIENCE			English	Article							DNA BUBBLE DUPLEXES; ANGSTROM RESOLUTION; COMPLEX; BACTERIOPHAGE-T7; PROMOTER; MECHANISM; LYSOZYME; DISPLACEMENT; STABILITY; CRYSTAL	To make messenger RNA transcripts, bacteriophage T7 RNA polymerase (T7 RNAP) undergoes a transition from an initiation phase, which only makes short RNA fragments, to a stable elongation phase. We have determined at 2.1 angstrom resolution the crystal structure of a T7 RNAP elongation complex with 30 base pairs of duplex DNA containing a "transcription bubble" interacting with a 17-nucleotide RNA transcript. The transition from an initiation to an elongation complex is accompanied by a major refolding of the amino-terminal 300 residues. This results in loss of the promoter binding site, facilitating promoter clearance, and creates a tunnel that surrounds the RNA transcript after it peels off a seven-base pair heteroduplex. Formation of the exit tunnel explains the enhanced processivity of the elongation complex. Downstream duplex DNA binds to the fingers domain, and its orientation relative to upstream DNA in the initiation complex implies an unwinding that could facilitate formation of the open promoter complex.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	eatherton@csb.yale.edu			NIGMS NIH HHS [GM57510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brieba LG, 2001, BIOCHEMISTRY-US, V40, P3882, DOI 10.1021/bi002716c; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DAUBE SS, 1994, BIOCHEMISTRY-US, V33, P340, DOI 10.1021/bi00167a044; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Diaz GA, 1996, BIOCHEMISTRY-US, V35, P10837, DOI 10.1021/bi960488+; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; GUNDERSON SI, 1987, BIOCHEMISTRY-US, V26, P1539, DOI 10.1021/bi00380a007; He B, 1997, J MOL BIOL, V265, P275, DOI 10.1006/jmbi.1996.0741; Huang JB, 1999, J MOL BIOL, V293, P457, DOI 10.1006/jmbi.1999.3135; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1987, J BIOL CHEM, V262, P3790; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kornberg A., 1991, DNA REPLICATION; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Kumar A, 1997, BIOCHEMISTRY-US, V36, P13954, DOI 10.1021/bi971432y; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LING ML, 1989, NUCLEIC ACIDS RES, V17, P1605, DOI 10.1093/nar/17.4.1605; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; MULLER DK, 1988, BIOCHEMISTRY-US, V27, P5763, DOI 10.1021/bi00415a055; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Navarro M, 1999, EMBO J, V18, P2265, DOI 10.1093/emboj/18.8.2265; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Stano NM, 2002, J MOL BIOL, V315, P1009, DOI 10.1006/jmbi.2001.5313; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Urs UK, 1999, ACTA CRYSTALLOGR D, V55, P1971; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133; Yin Y.G., UNPUB; Zhang X, 1997, J MOL BIOL, V269, P10, DOI 10.1006/jmbi.1997.1016; [No title captured]	57	265	275	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2002	298	5597					1387	1395		10.1126/science.1077464	http://dx.doi.org/10.1126/science.1077464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12242451				2022-12-24	WOS:000179223100043
J	Grima, B; Lamouroux, A; Chelot, E; Papin, C; Limbourg-Bouchon, B; Rouyer, F				Grima, B; Lamouroux, A; Chelot, E; Papin, C; Limbourg-Bouchon, B; Rouyer, F			The F-box protein Slimb controls the levels of clock proteins Period and Timeless	NATURE			English	Article							DROSOPHILA CIRCADIAN CLOCK; UBIQUITIN-LIGASE COMPLEX; KINASE-I-EPSILON; KAPPA-B-ALPHA; BETA-TRCP; GENE; LIGHT; WINGLESS; RHYTHMS; PHOSPHORYLATION	The Drosophila circadian clock is driven by daily fluctuations of the proteins Period and Timeless, which associate in a complex and negatively regulate the transcription of their own genes(1,2). Protein phosphorylation has a central role in this feedback loop, by controlling Per stability in both cytoplasmic and nuclear compartments(3-6) as well as Per/Tim nuclear transfer(7,8). However, the pathways regulating degradation of phosphorylated Per and Tim are unknown. Here we show that the product of the slimb (slmb) gene(9)-a member of the F-box/WD40 protein family of the ubiquitin ligase SCF complex that targets phosphorylated proteins for degradation(10-13)-is an essential component of the Drosophila circadian clock. slmb mutants are behaviourally arrhythmic, and can be rescued by targeted expression of Slmb in the clock neurons. In constant darkness, highly phosphorylated forms of the Per and Tim proteins are constitutively present in the mutants, indicating that the control of their cyclic degradation is impaired. Because levels of Per and Tim oscillate in slmb mutants maintained in light: dark conditions, light- and clock-controlled degradation of Per and Tim do not rely on the same mechanisms.	CNRS, Inst Neurobiol Alfred Fessard, NGI, UPR 2216, F-91198 Gif Sur Yvette, France; CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rouyer, F (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, NGI, UPR 2216, Av Terrasse, F-91198 Gif Sur Yvette, France.		Rouyer, François/L-9043-2018	Rouyer, François/0000-0001-5641-397X				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Miletich I, 2000, MECH DEVELOP, V93, P15, DOI 10.1016/S0925-4773(00)00256-2; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Pai LM, 1997, DEVELOPMENT, V124, P2255; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stanewsky R, 1997, J NEUROSCI, V17, P676; Suri V, 2000, J NEUROSCI, V20, P7547; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	30	218	222	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					178	182		10.1038/nature01122	http://dx.doi.org/10.1038/nature01122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432393				2022-12-24	WOS:000179200900046
J	Jinks, RN; Markley, TL; Taylor, EE; Perovich, G; Dittel, AI; Epifanio, CE; Cronin, TW				Jinks, RN; Markley, TL; Taylor, EE; Perovich, G; Dittel, AI; Epifanio, CE; Cronin, TW			Adaptive visual metamorphosis in a deep-sea hydrothermal vent crab	NATURE			English	Article							SHRIMPS; MORPHOLOGY; DISPERSAL; BEHAVIOR; SULFIDE; LARVAE; EYES	Hydrothermal vents along the mid-ocean ridges host ephemeral ecosystems of diverse endemic fauna including several crustacean species(1-4), some of which undergo planktonic development as larvae up to 1,000 m above and 100 km away from the vents(5,6). Little is known about the role of vision in the life history of vent fauna. Here we report that planktonic zoea larvae of the vent crab Bythograea thermydron possess image-forming compound eyes with a visual pigment sensitive to the blue light of mesopelagic waters. As they metamorphose and begin to descend to and settle at the vents, they lose their image-forming optics and develop high-sensitivity naked-retina eyes. The spectral absorbance of the visual pigment in these eyes shifts towards longer wavelengths from larva to postlarva to adult. This progressive visual metamorphosis trades imaging for increased sensitivity, and changes spectral sensitivity from the blue wavelengths of the larval environment towards the dim, longer wavelengths(7) produced in the deeper bathypelagic vent environment of the adults. As hydrothermal vents produce light(7), vision may supplement thermal and chemical senses to orient postlarval settlement at vent sites.	Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; Univ Delaware, Grad Coll Marine Studies, Lewes, DE 19958 USA; Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	Franklin & Marshall College; University of Delaware; University System of Maryland; University of Maryland Baltimore County	Jinks, RN (corresponding author), Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA.	rjinks@fandm.edu			NATIONAL EYE INSTITUTE [R15EY013196] Funding Source: NIH RePORTER; NEI NIH HHS [R15 EY013196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENNETT JT, 1984, LIMNOL OCEANOGR, V29, P1088, DOI 10.4319/lo.1984.29.5.1088; Cronin TW, 2001, AM ZOOL, V41, P1098, DOI 10.1668/0003-1569(2001)041[1098:OOVIMC]2.0.CO;2; Cronin TW, 1995, MAR FRESHW BEHAV PHY, V26, P219, DOI 10.1080/10236249509378941; Epifanio CE, 1999, MAR ECOL PROG SER, V185, P147, DOI 10.3354/meps185147; FRANK TM, 1988, BIOL BULL, V175, P261, DOI 10.2307/1541567; Gaten E, 1998, BIOL BULL, V194, P267, DOI 10.2307/1543097; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Herring PJ, 1999, NATURE, V398, P116, DOI 10.1038/18142; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Jinks RN, 1998, CAH BIOL MAR, V39, P309; LAND MF, 1989, NATURE, V337, P404, DOI 10.1038/337404a0; ONEILL PJ, 1995, VISUAL NEUROSCI, V12, P861, DOI 10.1017/S0952523800009421; Pond D, 1997, MAR ECOL PROG SER, V146, P289, DOI 10.3354/meps146289; RENNINGER GH, 1995, BIOL BULL, V189, P69, DOI 10.2307/1542456; RONA PA, 1986, NATURE, V321, P33, DOI 10.1038/321033a0; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Tapley DW, 1999, BIOL BULL, V196, P52, DOI 10.2307/1543166; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; VanDover CL, 1996, GEOPHYS RES LETT, V23, P2049, DOI 10.1029/96GL02151; VANDOVER CL, 1989, NATURE, V337, P458, DOI 10.1038/337458a0; VANDOVER CL, 1995, SPECIAL PUBLICATION, V87, P257; White SN, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000015; WILLIAMS A B, 1980, Proceedings of the Biological Society of Washington, V93, P443	23	42	42	3	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2002	420	6911					68	70		10.1038/nature01144	http://dx.doi.org/10.1038/nature01144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422215				2022-12-24	WOS:000179068100037
J	McClellan, MB				McClellan, MB			Adjuvant breast cancer treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2112	2112		10.1001/jama.288.17.2112	http://dx.doi.org/10.1001/jama.288.17.2112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413360				2022-12-24	WOS:000179048100009
J	Hayes, T; Haston, K; Tsui, M; Hoang, A; Haeffele, C; Vonk, A				Hayes, T; Haston, K; Tsui, M; Hoang, A; Haeffele, C; Vonk, A			Herbicides: Feminization of male frogs in the wild	NATURE			English	Article									Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Lab Integrat Studies Amphibian Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Hayes, T (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Lab Integrat Studies Amphibian Biol, Berkeley, CA 94720 USA.	tyrone@socrates.berkeley.edu						Akingbemi BT, 2001, ANN MED, V33, P391, DOI 10.3109/07853890108995952; BATTAGLIN WA, 1995, 944176 US GEOL SURV; Conant R, 1998, FIELD GUIDE REPTILES; Crain DA, 1997, ENVIRON HEALTH PERSP, V105, P528, DOI 10.2307/3433582; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; KIMBROUGH RA, 1995, PESTICIDES SURFACE W; Reeder AL, 1998, ENVIRON HEALTH PERSP, V106, P261, DOI 10.2307/3434013; Sanderson JT, 2000, TOXICOL SCI, V54, P121, DOI 10.1093/toxsci/54.1.121; Sanderson JT, 2001, ENVIRON HEALTH PERSP, V109, P1027, DOI 10.2307/3454957; Stebbins, 1985, FIELD GUIDE W REPTIL; Tavera-Mendoza L, 2002, ENVIRON TOXICOL CHEM, V21, P527, DOI 10.1897/1551-5028(2002)021&lt;0527:ROTATX&gt;2.0.CO;2; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; 1994, FEDERAL REGISTER, V59, P60412	13	293	341	12	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					895	896		10.1038/419895a	http://dx.doi.org/10.1038/419895a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410298				2022-12-24	WOS:000178909700030
J	Clancy, L; Goodman, P; Sinclair, H; Dockery, DW				Clancy, L; Goodman, P; Sinclair, H; Dockery, DW			Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study	LANCET			English	Article							DAILY MORTALITY; CITIES; PROJECT	Background Particulate air pollution episodes have been associated with increased daily death. However, there is little direct evidence that diminished particulate air pollution concentrations would lead to reductions in death rates. We assessed the effect of air pollution controls-ie, the ban on coal sales-on particulate air pollution and death rates in Dublin. Methods Concentrations of air pollution and directly-standardised non-trauma, respiratory, and cardiovascular death rates were compared for 72 months before and after the ban of coal sales in Dublin. The effect of the ban on age-standardised death rates was estimated with an interrupted time-series analysis, adjusting for weather, respiratory epidemics, and death rates in the rest of Ireland. Findings Average black smoke concentrations in Dublin declined by 35.6 mug/ml(3) (70%) after the ban on coal sales. Adjusted non-trauma death rates decreased by 5.7% (95% CI 4.7, p<0.0001), respiratory deaths by 15.5% (12-19, p<0.0001), and cardiovascular deaths by 10.3% (8-13, p<0.0001). Respiratory and cardiovascular standardised death rates fell coincident with the ban on coal sales. About 116 fewer respiratory deaths and 243 fewer cardiovascular deaths were seen per year in Dublin after the ban. Interpretation Reductions in respiratory and cardiovascular death rates in Dublin suggest that control of particulate air pollution could substantially diminish daily death. The net benefit of the reduced death rate was greater than predicted from results of previous time-series studies.	Harvard Univ, Sch Publ Hlth, Environm Epidemiol Program, Boston, MA 02115 USA; St James Hosp, Dublin 8, Ireland; Dublin Inst Technol, Dept Phys, Dublin, Ireland; Trinity Coll Dublin, Dublin, Ireland	Harvard University; Harvard T.H. Chan School of Public Health; Trinity College Dublin; Technological University Dublin; Trinity College Dublin	Dockery, DW (corresponding author), Harvard Univ, Sch Publ Hlth, Environm Epidemiol Program, 665 Huntington Ave, Boston, MA 02115 USA.		clancy, luke/ABA-1826-2020; , dwdockery/AAO-7272-2021; Clancy, Luke/O-6597-2019	Clancy, Luke/0000-0003-2407-2263; Dockery, Douglas/0000-0002-6052-4880; Goodman, Patrick/0000-0001-9509-131X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES-00002] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		DEAN G, 1982, IRISH MED J, V75, P338; DEAN G, 1984, IRISH MED J, V77, P98; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; ELLIS FP, 1972, ENVIRON RES, V5, P1, DOI 10.1016/0013-9351(72)90019-9; Eng H, 1998, J Cardiovasc Risk, V5, P89, DOI 10.1097/00043798-199804000-00004; Flanagan P. J., 1986, AIR QUALITY IRELAND; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; KALKSTEIN LS, 1993, LANCET, V342, P1397, DOI 10.1016/0140-6736(93)92757-K; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; KELLY I, 1984, IRISH MED J, V77, P322; La Vecchia C, 1998, EUR J EPIDEMIOL, V14, P1, DOI 10.1023/A:1007440201137; MCMAHON G, 1986, IRISH MED J, V79, P130; McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450; POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P211, DOI 10.1080/00039896.1992.9938351; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SHELLEY E, 1991, IRISH J MED SCI, V160, P5, DOI 10.1007/BF02950435; SHELLEY E, 1995, EUR HEART J, V16, P752, DOI 10.1093/oxfordjournals.eurheartj.a060993; SHELLEY E, 1996, IRAN MED J, V89, P183; SINCLAIR H, 1995, IRISH J MED SCI, V164, P163; Webster DW, 2002, AM J EPIDEMIOL, V155, P406, DOI 10.1093/aje/155.5.406	20	439	458	3	69	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1210	1214		10.1016/S0140-6736(02)11281-5	http://dx.doi.org/10.1016/S0140-6736(02)11281-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401247				2022-12-24	WOS:000178708100010
J	Dernburg, AF; Karpen, GH				Dernburg, AF; Karpen, GH			A chromosome RNAissance	CELL			English	Review							PROTEIN	In RNA-mediated interference (RNAI), double-stranded RNAs (dsRNAs) target complementary mRNAs for degradation. New work demonstrates that essential chromosomal functions are mediated through RNAi protein components and short RNAs, which alter chromosome function at specific DNA loci via histone modification.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Salk Inst Biol Studies, MCBL, La Jolla, CA 92037 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Salk Institute	Dernburg, AF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.			Dernburg, Abby/0000-0001-8037-1079	NIGMS NIH HHS [R01 GM054549-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054549] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; MUCHARDT C, 2002, EMBO REP; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yao MC, 2002, MOBILE DNA, P730; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	17	40	48	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 18	2002	111	2					159	162		10.1016/S0092-8674(02)01039-5	http://dx.doi.org/10.1016/S0092-8674(02)01039-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408860	Bronze			2022-12-24	WOS:000178753500005
J	Capelluto, DGS; Kutateladze, TG; Habas, R; Finkielstein, CV; He, X; Overduin, M				Capelluto, DGS; Kutateladze, TG; Habas, R; Finkielstein, CV; He, X; Overduin, M			The DIX domain targets dishevelled to actin stress fibres and vesicular membranes	NATURE			English	Article							PLANAR CELL POLARITY; INTRACELLULAR-LOCALIZATION; PROTEIN INTERACTIONS; CORTICAL ROTATION; WNT PATHWAY; XENOPUS; AXIN; PHOSPHORYLATION; EMBRYOGENESIS; GASTRULATION	Colorectal cancer results from mutations in components of the Wnt pathway that regulate beta-catenin levels(1). Dishevelled (Dvl or Dsh) signals downstream of Wnt receptors and stabilizes beta-catenin during cell proliferation(1) and embryonic axis formation(2). Moreover, Dvl contributes to cytoskeletal reorganization during gastrulation(3-5) and mitotic spindle orientation during asymmetric cell division(6). Dvl belongs to a family of eukaryotic signalling proteins that contain a conserved 85-residue module of unknown structure and biological function called the DIX domain(7). Here we show that the DIX domain mediates targeting to actin stress fibres and cytoplasmic vesicles in vivo. Neighbouring interaction sites for actin and phospholipid are identified between two helices by nuclear magnetic resonance spectroscopy (NMR). Mutation of the actin-binding motif abolishes the cytoskeletal localization of Dvl, but enhances Wnt/beta-catenin signalling and axis induction in Xenopus. By contrast, mutation of the phospholipid interaction site disrupts vesicular association of Dvl, Dvl phosphorylation, and Wnt/beta-catenin pathway activation. We propose that partitioning of Dvl into cytoskeletal and vesicular pools by the DIX domain represents a point of divergence in Wnt signalling.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; NICHHD, Genet Mol Lab, Bethesda, MD 20892 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Overduin, M (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave, Denver, CO 80262 USA.		Overduin, Michael/AAG-3632-2020	Overduin, Michael/0000-0002-3114-6585; Kutateladze, Tatiana/0000-0001-7375-6990; finkielstein, carla/0000-0002-8417-4643				ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Anderson T., 1973, Acta Informatica, V2, P12, DOI 10.1007/BF00571461; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Dahmen RP, 2001, CANCER RES, V61, P7039; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Kato Y, 1999, J NEUROSCI, V19, P9364; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Tada M, 2000, DEVELOPMENT, V127, P2227; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; VANCOMPERNOLLE K, 1991, J BIOL CHEM, V266, P15427; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200	30	159	161	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					726	729		10.1038/nature01056	http://dx.doi.org/10.1038/nature01056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384700				2022-12-24	WOS:000178615200042
J	Bates, DW; Black, DM; Cummings, SR				Bates, DW; Black, DM; Cummings, SR			Clinical use of bone densitometry - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OSTEOPOROSIS; FRACTURE	Osteoporosis represents a difficult problem for physicians because, although many diagnostic tests are available, interpreting their results is not straightforward. As a result, many patients, even those with clear indications such as long-term steroid therapy or vertebral fractures on radiography, do not get screened or treated. Current evidence-based guidelines recommend screening for all white women older than 65 years and not already receiving an osteoporosis treatment and for many nonwhite women. For postmenopausal women who are younger than 65 years and have strong risk factors for osteoporosis, screening may also be beneficial. The optimal testing strategy depends on what is available locally. The best role for follow-up testing is still being defined, and interpretation of such testing is tricky. Reports of results can be hard to understand; a randomized controlled trial of clearer reports increased testing and decreased confusion about the meaning of test results. Densitometry might be more effectively used in practice if strategies such as having patients fill out a short questionnaire to assess for risk factors or creating a nurse-based system were used to identify patients. Clinicians need better approaches for identifying patients most likely to benefit from screening, systems that facilitate their application, and test results that are easy to interpret.	Brigham & Womens Hosp, Div Gen Med & Primary Care, Dept Med, Boston, MA 02115 USA; Partners Healthcare Syst, Ctr Appl Med Informat Syst Res, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calif San Francisco, UCSF Coordinating Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Med & Primary Care, Dept Med, 75 Francis St, Boston, MA 02115 USA.							*AG FDN, OST SCREEN FORM; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Gallagher JC, 2002, MENOPAUSE, V9, P84; Gehlbach SH, 2000, OSTEOPOROSIS INT, V11, P577, DOI 10.1007/s001980070078; Mudano A, 2001, J RHEUMATOL, V28, P1298; *NAT OST FDN, 2000, PHYS GUID PREV TREAT; Papa LJ, 1997, J GEN INTERN MED, V12, P781, DOI 10.1046/j.1525-1497.1997.07165.x; RUBIN SM, 1992, ANN INTERN MED, V116, P990, DOI 10.7326/0003-4819-116-12-990; *SEN PHYS THER I, OST RISK ASS; Stock JL, 1998, ANN INTERN MED, V128, P996, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00006; *US PREV SERV TAST, 1996, GUID CLIN PREV SERV	12	59	62	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2002	288	15					1898	1900		10.1001/jama.288.15.1898	http://dx.doi.org/10.1001/jama.288.15.1898			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604EU	12377089	Bronze			2022-12-24	WOS:000178604200029
J	Wells, AW; Mounter, PJ; Chapman, CE; Stainsby, D; Wallis, JP				Wells, AW; Mounter, PJ; Chapman, CE; Stainsby, D; Wallis, JP			Where does blood go? Prospective observational study of red cell transfusion in north England	BRITISH MEDICAL JOURNAL			English	Article							HOSPITALS	Objective To collect population based information on transfusion of red blood cells. Design Prospective observational study over 28 days. Setting Hospital blood banks in the north of England (population 2.9 million). Main outcome measures Indications for transfusion, number of units given, and the age and sex of transfusion recipients. Participants All patients who received a red cell transfusion during the study period. Data completed by hospital blood bank staff. Results The destination of 9848 units was recorded (97% of expected blood use). In total 9774 units were transfused: 5047 (51.6%) units were given to medical patients, 3982 (40.7%) to surgical patients, and 612 (6.3%) to obstetric and gynaecology patients. Nearly half (49.3%) of all blood is given to female recipients, and the mean age of recipients of individual units was 62.7 years. The most common surgical indications for transfusion were total hip replacement (4.6% of all blood transfused) and coronary artery bypass grafting (4.1%). Haematological disorders accounted for 15.5% of use. Overall use was 4274 units per 100 000 population per year. Conclusion In the north east of England more than half of red cell units are transfused for medical indications. Demand for red cell transfusion increases with age. With anticipated changes in the age structure of the population the demand for blood will increase by 4.9% by 2008.	Freeman Rd Hosp, Newcastle Tyne Hosp NHS Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Newcastle Ctr, Natl Blood Serv, Newcastle Upon Tyne NE2 4NQ, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Wallis, JP (corresponding author), Freeman Rd Hosp, Newcastle Tyne Hosp NHS Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.							Barrett-Lee PJ, 2000, BRIT J CANCER, V82, P93, DOI 10.1054/bjoc.1999.0883; Chapman J., 2001, British Journal of Haematology, V113, P58; Charlton BG, 1997, QJM-MON J ASSOC PHYS, V90, P147, DOI 10.1093/qjmed/90.2.147; Chiavetta JA, 1996, TRANSFUSION, V36, P699, DOI 10.1046/j.1537-2995.1996.36896374373.x; COOK SS, 1991, TRANSFUSION, V31, P355, DOI 10.1046/j.1537-2995.1991.31491213303.x; Mathoulin-Pelissier S, 2000, TRANSFUSION, V40, P1140, DOI 10.1046/j.1537-2995.2000.40091140.x; *NHS EX, 1998, 1998224 NHS EX HSC; SIRCHIA G, 1994, TRANSFUSION MED, V4, P251; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; VAMVAKAS EC, 1994, TRANSFUSION, V34, P471, DOI 10.1046/j.1537-2995.1994.34694295060.x; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Wallace EL, 1998, TRANSFUSION, V38, P625, DOI 10.1046/j.1537-2995.1998.38798346630.x; WALLIS JP, 2000, TRANSFUSION MED, V10, P15	13	164	168	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2002	325	7368					803	U7		10.1136/bmj.325.7368.803	http://dx.doi.org/10.1136/bmj.325.7368.803			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604YM	12376439	Bronze, Green Published			2022-12-24	WOS:000178648700016
J	Hakala, P; Rimpela, A; Salminen, JJ; Virtanen, SM; Rimpela, M				Hakala, P; Rimpela, A; Salminen, JJ; Virtanen, SM; Rimpela, M			Back, neck, and shoulder pain in Finnish adolescents: national cross sectional surveys	BRITISH MEDICAL JOURNAL			English	Article							SCHOOL-CHILDREN; SCHOOLCHILDREN; PREVALENCE	Objectives To study changes in pain of the back and neck in adolescents between 1985 and 2001 and pain of the neck, shoulder, and lower back between 1991 and 2001. Design Biennial nationwide postal surveys, 1985-2001, and annual classroom surveys, 1996-2001. Setting Finland. Participants 62 677 12, 14, 16, and 18 year olds and 127 217 14-16 year olds. Main outcome measures Pain in the back and neck, neck and shoulder, or lower back, at least weekly. Results Prevalence of pain in the back and neck was greater in the 1990s than in the 1980s and increased steadily from 1993 to 1997. Pain of the neck and shoulder and pain of the lower back was much more common in 1999 than in 1991 and in 2001 than in 1999. Pain was more common among girls and older groups: pain of the neck and shoulder affected 24% of girls and 12% of boys in 14 year olds, 38% of girls and 16% of boys in 16 year olds, and 45% of girls mid 19% of boys in 18 year olds; pain in the lower back affected 8% of girls and 7% of boys in 14 year olds, 14% of girls and 11% of boys in 16 year olds, and 17% of boys and 13% of girls in 18 year olds. Conclusion Pain in the neck, shoulder, and lower back is becoming more common in Finnish adolescents. This pain suggests a new disease burden of degenerative musculoskeletal disorders in future adults.	Univ Tampere, Tampere Sch Publ Hlth, FIN-33014 Tampere, Finland; Turku Univ Hosp, Dept Phys Med & Rehabil, FIN-20520 Turku, Finland; Natl Res & Dev Ctr Welf & Hlth, FIN-00531 Helsinki, Finland	Tampere University; University of Turku	Hakala, P (corresponding author), Univ Tampere, Tampere Sch Publ Hlth, FIN-33014 Tampere, Finland.		Rimpela, Arja/J-3910-2014	Virtanen, Suvi/0000-0001-8928-0878; Rimpela, Arja/0000-0003-3273-6226				BALAGUE F, 1988, SCAND J REHABIL MED, V20, P175; BALAGUE F, 1994, J SPINAL DISORD, V7, P374; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; BERNTSSON I, 2000, HLTH WELL BEING CHIL, P8; BERNTSSON L, 2000, HLTH WELL BEING CHIL, P8; BRATTBERG G, 1994, QUAL LIFE RES, V3, pS27, DOI 10.1007/BF00433372; CURRIE C, 2002, 1997836 HBSC; CURRIE G, 2002, 1997836 HBSC; FAIRBANK JCT, 1984, SPINE, V9, P461, DOI 10.1097/00007632-198407000-00007; Jensen C, 1998, SCAND J WORK ENV HEA, V24, P418, DOI 10.5271/sjweh.364; Kautiainen S, 2002, INT J OBESITY, V26, P544, DOI 10.1038/sj.ijo.0801928; KING A, 1996, WHO REG PUBL EUR SER, V69, P68; KING A, 1996, HLTH YOUTH CROSS NAT, P68; LEINO PI, 1994, SCAND J RHEUMATOL, V23, P269, DOI 10.3109/03009749409103728; MAKELA M, 1993, J CLIN EPIDEMIOL, V46, P549, DOI 10.1016/0895-4356(93)90128-N; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Mikkelsson M, 1997, PAIN, V73, P29, DOI 10.1016/S0304-3959(97)00073-0; OLSEN TL, 1992, AM J PUBLIC HEALTH, V82, P606, DOI 10.2105/AJPH.82.4.606; Palmer KT, 2000, BRIT MED J, V320, P1577, DOI 10.1136/bmj.320.7249.1577; RIMPELA M, 1997, SUOM LAAKARILEHTI, V52, P2705; SALMINEN JJ, 1992, ACTA PAEDIATR, V81, P1035, DOI 10.1111/j.1651-2227.1992.tb12170.x; Salminen JJ, 1999, SPINE, V24, P1316, DOI 10.1097/00007632-199907010-00008; Salminen JJ, 1984, ACTA PAEDIAT SCAND, V315, P8; *STAT FINL, 2001, ROAD FINN INF SOC, V3; TROUSSIER B, 1994, SCAND J REHABIL MED, V26, P143; Vikat A, 2000, SCAND J PUBLIC HEALT, V28, P164, DOI 10.1177/14034948000280030401	26	213	226	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 5	2002	325	7367					743	745		10.1136/bmj.325.7367.743	http://dx.doi.org/10.1136/bmj.325.7367.743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603AU	12364301	Bronze, Green Published			2022-12-24	WOS:000178537300015
J	Niare, O; Markianos, K; Volz, J; Oduol, F; Toure, A; Bagayoko, M; Sangare, D; Traore, SF; Wang, R; Blass, C; Dolo, G; Bouare, M; Kafatos, FC; Kruglyak, L; Toure, YT; Vernick, KD				Niare, O; Markianos, K; Volz, J; Oduol, F; Toure, A; Bagayoko, M; Sangare, D; Traore, SF; Wang, R; Blass, C; Dolo, G; Bouare, M; Kafatos, FC; Kruglyak, L; Toure, YT; Vernick, KD			Genetic loci affecting resistance to human malaria parasites in a West African mosquito vector population	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSE; EXPRESSION; INFECTIONS; VIRULENCE; MECHANISM	Successful propagation of the malaria parasite Plasmodium falciparum within a susceptible mosquito vector is prerequisite for the transmission of malaria. A field-based genetic analysis of the major human malaria vector, Anopheles gambiae, has revealed natural factors that reduce the transmission of P. falciparum. Differences in P. falciparum oocyst numbers between mosquito isofemale families fed on the same infected blood indicated large genetic component affecting resistance to the parasite, and genome-wide scanning in pedigrees of wild mosquitoes detected segregating resistance alleles. The apparently high natural frequency of resistance alleles suggests that malaria parasites (or similar pathogen) exert significant selective pressure on vector populations.	NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA; Fac Med Pharm & Odontostomatol, Dept Epidemiol Affectat Parasitaires, Bamako, Mali; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	New York University; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL)	Vernick, KD (corresponding author), NYU, Sch Med, Dept Med & Mol Parasitol, 341 E 25th St, New York, NY 10010 USA.		Wang-Sattler, Rui/B-5354-2014	Wang-Sattler, Rui/0000-0002-8794-8229; Markianos, Kyriacos/0000-0003-0214-6014				Anderson RA, 2000, PARASITOLOGY, V120, P329, DOI 10.1017/S0031182099005570; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; BILLINGSLEY PF, 1994, AM J TROP MED HYG, V51, P260, DOI 10.4269/ajtmh.1994.51.260; Bonnet S, 2001, CELL MICROBIOL, V3, P449, DOI 10.1046/j.1462-5822.2001.00128.x; CHURCHILL GA, 1994, GENETICS, V138, P963; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Deitsch KW, 1997, MICROBIOL MOL BIOL R, V61, P281, DOI 10.1128/.61.3.281-293.1997; Ferguson HM, 2002, P ROY SOC B-BIOL SCI, V269, P1217, DOI 10.1098/rspb.2002.2023; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hopwood JA, 2001, J EXP BIOL, V204, P2773; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Pichon G, 1996, PARASITE, V3, P161, DOI 10.1051/parasite/1996032161; POLOGE LG, 1994, MOL BIOCHEM PARASIT, V68, P35, DOI 10.1016/0166-6851(94)00142-1; PRINGLE G, 1966, T ROY SOC TROP MED H, V60, P626, DOI 10.1016/0035-9203(66)90009-5; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; SCHIEFER BA, 1977, EXP PARASITOL, V41, P397, DOI 10.1016/0014-4894(77)90111-4; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Zheng LB, 1996, GENETICS, V143, P941; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	27	107	108	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2002	298	5591					213	216		10.1126/science.1073420	http://dx.doi.org/10.1126/science.1073420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364806				2022-12-24	WOS:000178370500063
J	Hall, N; Pain, A; Berriman, M; Churcher, C; Harris, B; Harris, D; Mungall, K; Bowman, S; Atkin, R; Baker, S; Barron, A; Brooks, K; Buckee, CO; Burrows, C; Cherevach, I; Chillingworth, C; Chillingworth, T; Christodoulou, Z; Clark, L; Clark, R; Corton, C; Cronin, A; Davies, R; Davis, P; Dear, P; Dearden, F; Doggett, J; Feltwell, T; Goble, A; Goodhead, I; Gwilliam, R; Hamlin, N; Hance, Z; Harper, D; Hauser, H; Hornsby, T; Holroyd, S; Horrocks, P; Humphray, S; Jagels, K; James, KD; Johnson, D; Kerhornou, A; Knights, A; Konfortov, B; Kyes, S; Larke, N; Lawson, D; Lennard, N; Line, A; Maddison, M; McLean, J; Mooney, P; Moule, S; Murphy, L; Oliver, K; Ormond, D; Price, C; Quail, MA; Rabbinowitsch, E; Rajandream, MA; Rutter, S; Rutherford, KM; Sanders, M; Simmonds, M; Seeger, K; Sharp, S; Smith, R; Squares, R; Squares, S; Stevens, K; Taylor, K; Tivey, A; Unwin, L; Whitehead, S; Woodward, J; Sulston, JE; Craig, A; Newbold, C; Barrell, BG				Hall, N; Pain, A; Berriman, M; Churcher, C; Harris, B; Harris, D; Mungall, K; Bowman, S; Atkin, R; Baker, S; Barron, A; Brooks, K; Buckee, CO; Burrows, C; Cherevach, I; Chillingworth, C; Chillingworth, T; Christodoulou, Z; Clark, L; Clark, R; Corton, C; Cronin, A; Davies, R; Davis, P; Dear, P; Dearden, F; Doggett, J; Feltwell, T; Goble, A; Goodhead, I; Gwilliam, R; Hamlin, N; Hance, Z; Harper, D; Hauser, H; Hornsby, T; Holroyd, S; Horrocks, P; Humphray, S; Jagels, K; James, KD; Johnson, D; Kerhornou, A; Knights, A; Konfortov, B; Kyes, S; Larke, N; Lawson, D; Lennard, N; Line, A; Maddison, M; McLean, J; Mooney, P; Moule, S; Murphy, L; Oliver, K; Ormond, D; Price, C; Quail, MA; Rabbinowitsch, E; Rajandream, MA; Rutter, S; Rutherford, KM; Sanders, M; Simmonds, M; Seeger, K; Sharp, S; Smith, R; Squares, R; Squares, S; Stevens, K; Taylor, K; Tivey, A; Unwin, L; Whitehead, S; Woodward, J; Sulston, JE; Craig, A; Newbold, C; Barrell, BG			Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13	NATURE			English	Article							PROTEIN FAMILIES; HAPPY MAP; MALARIA; EXPRESSION; ELEMENTS; SURFACE; CLONING; RICH	Since the sequencing of the first two chromosomes of the malaria parasite, Plasmodium falciparum(1,2), there has been a concerted effort to sequence and assemble the entire genome of this organism. Here we report the sequence of chromosomes 1, 3-9 and 13 of P. falciparum clone 3D7-these chromosomes account for approximately 55% of the total genome. We describe the methods used to map, sequence and annotate these chromosomes. By comparing our assemblies with the optical map, we indicate the completeness of the resulting sequence. During annotation, we assign Gene Ontology terms to the predicted gene products, and observe clustering of some malaria-specific terms to specific chromosomes. We identify a highly conserved sequence element found in the intergenic region of internal var genes that is not associated with their telomeric counterparts.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Wellcome Trust Sanger Institute; University of Oxford; MRC Laboratory Molecular Biology; Liverpool School of Tropical Medicine; University of Liverpool	Hamlin, N (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	nh1@sanger.ac.uk	Berriman, Matthew/A-7618-2011; Dear, Paul H/A-1162-2012; Rutherford, Kim/Y-7995-2018; Pain, Arnab/L-5766-2015; Hall, Neil/A-8717-2013; Goodhead, Ian/ABC-9200-2020; Quail, michael/ABE-6131-2020; Horrocks, Paul/C-2615-2009	Berriman, Matthew/0000-0002-9581-0377; Rutherford, Kim/0000-0001-6277-726X; Pain, Arnab/0000-0002-1755-2819; Hall, Neil/0000-0002-7995-3810; Horrocks, Paul/0000-0003-3981-0732; Goodhead, Ian/0000-0002-3110-9442; Hall, Neil/0000-0003-2808-0009; Lawson, Daniel/0000-0001-7765-983X; Kerhornou, Arnaud/0000-0002-2890-295X; Craig, Alister/0000-0003-0914-6164; Murphy, Lee/0000-0001-6467-7449; Davies, Robert/0000-0002-9983-1378; Baker, Stephen/0000-0003-1308-5755; Davis, Paul/0000-0001-5545-0824; Newbold, Chris/0000-0002-9274-3789				ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.genet.23.1.227; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berriman M, 2001, TRENDS PARASITOL, V17, P463, DOI 10.1016/S1471-4922(01)02083-9; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Cawley SE, 2001, MOL BIOCHEM PARASIT, V118, P167, DOI 10.1016/S0166-6851(01)00363-2; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DEBRUIN D, 1992, GENOMICS, V14, P332, DOI 10.1016/S0888-7543(05)80223-X; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Hapgood JP, 2001, CELL BIOL INT, V25, P17, DOI 10.1006/cbir.2000.0674; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai ZW, 1999, NAT GENET, V23, P309, DOI 10.1038/15484; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Piper MB, 1998, GENOME RES, V8, P1299, DOI 10.1101/gr.8.12.1299; Quail MA, 2001, DNA SEQUENCE, V12, P355, DOI 10.3109/10425170109084459; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Vazquez-Macias A, 2002, MOL MICROBIOL, V45, P155, DOI 10.1046/j.1365-2958.2002.02999.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	33	136	268	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					527	531		10.1038/nature01095	http://dx.doi.org/10.1038/nature01095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368867	Green Accepted			2022-12-24	WOS:000178348400048
J	Sin, WC; Haas, K; Ruthazer, ES; Cline, HT				Sin, WC; Haas, K; Ruthazer, ES; Cline, HT			Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases	NATURE			English	Article							CALCIUM CURRENT; IN-VIVO; INHIBITION; PLASTICITY; INTERACTS; PROTEINS; SYNGAP; FAMILY; DOMAIN; RAC	Previous studies suggest that neuronal activity may guide the development of synaptic connections in the central nervous system through mechanisms involving glutamate receptors and GTPase-dependent modulation of the actin cytoskeleton(1-7). Here we demonstrate by in vivo time-lapse imaging of optic tectal cells in Xenopus laevis tadpoles that enhanced visual activity driven by a light stimulus promotes dendritic arbor growth. The stimulus-induced dendritic arbor growth requires glutamate-receptor-mediated synaptic transmission, decreased RhoA activity and increased Rac and Cdc42 activity. The results delineate a role for Rho GTPases in the structural plasticity driven by visual stimulation in vivo.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	cline@cshl.org	Jansen, Heiko T./A-5770-2008; Haas, Kurt/B-3812-2009; Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014	Jansen, Heiko T./0000-0003-0178-396X; Haas, Kurt/0000-0003-4754-1560; Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151	NATIONAL EYE INSTITUTE [F32EY006963, R01EY012102] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY006963-03, R01 EY012102] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Djouder N, 2000, J BIOL CHEM, V275, P18732, DOI 10.1074/jbc.M001425200; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Lawler S, 1999, CURR BIOL, V9, pR800, DOI 10.1016/S0960-9822(99)80493-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Rajan I, 1998, J NEUROSCI, V18, P7836; Ruthazer ES, 2002, REAL-TIME IMAGING, V8, P175, DOI 10.1006/rtim.2002.0284; VAN AL, 1997, GENE DEV, V11, P2295; WilkBlaszczak MA, 1997, J NEUROSCI, V17, P4094; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 1999, J NEUROSCI, V19, P4472; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Zhang DF, 1999, SPECTROSC SPECT ANAL, V19, P108; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	30	346	350	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					475	480		10.1038/nature00987	http://dx.doi.org/10.1038/nature00987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368855				2022-12-24	WOS:000178348400036
J	Bekoff, M				Bekoff, M			Awareness: Animal reflections	NATURE			English	Article									Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bekoff, M (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.							Bekoff M., 2002, MINDING ANIMALS AWAR, DOI 10.5860/choice.40-1522; Gallup G.G., 2002, THE COGNITIVE ANIMAL, P335; Mitchell RW, 2003, HANDBOOK OF SELF AND IDENTITY, P567; Reiss D, 2002, NATURE, V418, P369, DOI 10.1038/418369a; Rilling J, 2000, AM J PHYS ANTHROPOL, P263; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2001, BIOL PSYCHIAT, V49, P146, DOI 10.1016/S0006-3223(00)00977-X	7	20	20	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					255	255		10.1038/419255a	http://dx.doi.org/10.1038/419255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239547	Bronze			2022-12-24	WOS:000178056300026
J	Braun-Fahrlander, C; Riedler, J; Herz, U; Eder, W; Waser, M; Grize, L; Maisch, S; Carr, D; Gerlach, F; Bufe, A; Lauener, RP; Schierl, R; Renz, H; Nowak, D; von Mutius, E				Braun-Fahrlander, C; Riedler, J; Herz, U; Eder, W; Waser, M; Grize, L; Maisch, S; Carr, D; Gerlach, F; Bufe, A; Lauener, RP; Schierl, R; Renz, H; Nowak, D; von Mutius, E		Allergy Endotoxin Study Team	Environmental exposure to endotoxin and its relation to asthma in school-age children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOUSE-DUST ENDOTOXIN; AIRBORNE ENDOTOXIN; IMMUNE-RESPONSE; CHILDHOOD; LIFE; RISK; SENSITIZATION; ALLERGY	Background: In early life, the innate immune system can recognize both viable and nonviable parts of microorganisms. Immune activation may direct the immune response, thus conferring tolerance to allergens such as animal dander or tree and grass pollen. Methods: Parents of children who were 6 to 13 years of age and were living in rural areas of Germany, Austria, or Switzerland where there were both farming and nonfarming households completed a standardized questionnaire on asthma and hay fever. Blood samples were obtained from the children and tested for atopic sensitization; peripheral-blood leukocytes were also harvested from the samples for testing. The levels of endotoxin in the bedding used by these children were examined in relation to clinical findings and to the cytokine-production profiles of peripheral-blood leukocytes that had been stimulated with lipopolysaccharide and staphylococcal enterotoxin B. Complete data were available for 812 children. Results: Endotoxin levels in samples of dust from the child's mattress were inversely related to the occurrence of hay fever, atopic asthma, and atopic sensitization. Nonatopic wheeze was not significantly associated with the endotoxin level. Cytokine production by leukocytes (production of tumor necrosis factor (alpha), interferon-(gamma), interleukin-10, and interleukin-12) was inversely related to the endotoxin level in the bedding, indicating a marked down-regulation of immune responses in exposed children. Conclusions: A subject's environmental exposure to endotoxin may have a crucial role in the development of tolerance to ubiquitous allergens found in natural environments.	Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Childrens Hosp Salzburg, Salzburg, Austria; Hosp Univ Marburg, Dept Clin Chem & Mol Diagnost, Marburg, Germany; Dr von Hauner Childrens Hosp, Munich, Germany; Ruhr Univ Bochum, Dept Expt Pneumol, D-4630 Bochum, Germany; Univ Zurich, Childrens Hosp, Zurich, Switzerland; Univ Munich, Inst Occupat & Environm Med, Munich, Germany	University of Basel; University of Munich; Ruhr University Bochum; University Children's Hospital Zurich; University of Zurich; University of Munich	Braun-Fahrlander, C (corresponding author), Univ Basel, Inst Social & Prevent Med, Steinengraben 49, CH-4051 Basel, Switzerland.		Fahimifar, Sepideh/M-5303-2019; Lauener, Roger P/O-8612-2016; riedler, josef/AAQ-4666-2020	Lauener, Roger P/0000-0002-8412-606X; von Mutius, Erika/0000-0002-8893-4515; Bufe, Albrecht/0000-0001-7335-9362				AbouZeid C, 1997, INFECT IMMUN, V65, P1856, DOI 10.1128/IAI.65.5.1856-1862.1997; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Cleveland MG, 1996, INFECT IMMUN, V64, P1906, DOI 10.1128/IAI.64.6.1906-1912.1996; D'Amato G, 2000, J INVEST ALLERG CLIN, V10, P123; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348, DOI 10.1164/ajrccm.162.4.9909118; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gold DR, 2000, ENVIRON HEALTH PERSP, V108, P643, DOI 10.2307/3454400; HOLLANDER A, 1993, AM IND HYG ASSOC J, V54, P647, DOI 10.1202/0002-8894(1993)054<0647:IAEITA>2.0.CO;2; ISAAC Steering Committee, 1998, PHAS 2 MOD INT STUD; Kabesch M, 1999, EUR RESPIR J, V13, P577, DOI 10.1183/09031936.99.13357799; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; *MATHS, 2000, S PLUS; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; Park JH, 2000, ENVIRON HEALTH PERSP, V108, P1023, DOI 10.2307/3434953; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; RYLANDER R, 1989, AM REV RESPIR DIS, V140, P981, DOI 10.1164/ajrccm/140.4.981; *SAS I, 2001, SAS REL 8 02; Schade FU, 1996, J ENDOTOXIN RES, V3, P455, DOI 10.1177/096805199600300603; Silverman M, 1997, THORAX, V52, P936, DOI 10.1136/thx.52.11.936; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Strachan DP, 1996, BRIT MED J, V312, P1195; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	27	1338	1369	3	167	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					869	877		10.1056/NEJMoa020057	http://dx.doi.org/10.1056/NEJMoa020057			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239255				2022-12-24	WOS:000178040700002
J	Bignall, J				Bignall, J			"Chimps plead hands off our genome"	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Bignall, J (corresponding author), The Lancet, London NW1 7BY, England.							BASKIN GB, 2002, PATHOLOGY NONHUMAN P; Bignall J, 1999, LANCET, V353, P610, DOI 10.1016/S0140-6736(99)00058-6; BRAY RS, 1963, J PARASITOL, V49, P888, DOI 10.2307/3275713	3	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2002	360	9332					504	504		10.1016/S0140-6736(02)09761-1	http://dx.doi.org/10.1016/S0140-6736(02)09761-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585EZ	12241652				2022-12-24	WOS:000177512800006
J	Stelling, J; Klamt, S; Bettenbrock, K; Schuster, S; Gilles, ED				Stelling, J; Klamt, S; Bettenbrock, K; Schuster, S; Gilles, ED			Metabolic network structure determines key aspects of functionality and regulation	NATURE			English	Article							ESCHERICHIA-COLI; BIOCHEMICAL NETWORKS; COMPLEX NETWORKS; PATHWAY; DEFINITION; TRANSCRIPTOME; CAPABILITIES; ORGANIZATION	The relationship between structure, function and regulation in complex cellular networks is a still largely open question(1-3). Systems biology aims to explain this relationship by combining experimental and theoretical approaches(4). Current theories have various strengths and shortcomings in providing an integrated, predictive description of cellular networks. Specifically, dynamic mathematical modelling of large-scale networks meets difficulties because the necessary mechanistic detail and kinetic parameters are rarely available. In contrast, structure-oriented analyses only require network topology, which is well known in many cases. Previous approaches of this type focus on network robustness(5) or metabolic phenotype(2,6), but do not give predictions on cellular regulation. Here, we devise a theoretical method for simultaneously predicting key aspects of network functionality, robustness and gene regulation from network structure alone. This is achieved by determining and analysing the non-decomposable pathways able to operate coherently at steady state (elementary flux modes). We use the example of Escherichia coli central metabolism to illustrate the method.	Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Stelling, J (corresponding author), Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany.		Stelling, Joerg/F-7499-2010; Bettenbrock, Katja/AAN-5812-2020	Stelling, Joerg/0000-0002-1145-891X; Klamt, Steffen/0000-0003-2563-7561				Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bilke S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.036106; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1111/j.1574-6968.2001.tb10892.x; Cleveland W., 1993, VISUALIZING DATA; Cornish-Bowden A, 2001, TRENDS BIOCHEM SCI, V26, P463, DOI 10.1016/S0968-0004(01)01920-X; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Csete ME, 2002, SCIENCE, V295, P1664, DOI 10.1126/science.1069981; Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Heinrich R., 1996, REGULATION CELLULAR; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KLAMT S, IN PRESS BIOINFORMAT; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Oh MK, 2000, BIOTECHNOL PROGR, V16, P278, DOI 10.1021/bp000002n; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Stelling J., 2001, P 2 INT C SYST BIOL, P181; Stelling Jorg, 2001, P189; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085	29	552	583	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					190	193		10.1038/nature01166	http://dx.doi.org/10.1038/nature01166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432396				2022-12-24	WOS:000179200900049
J	Page, SE; Siegert, F; Rieley, JO; Boehm, HDV; Jaya, A; Limin, S				Page, SE; Siegert, F; Rieley, JO; Boehm, HDV; Jaya, A; Limin, S			The amount of carbon released from peat and forest fires in Indonesia during 1997	NATURE			English	Article								Tropical peatlands are one of the largest near-surface reserves of terrestrial organic carbon, and hence their stability has important implications for climate change(1-3). In their natural state, lowland tropical peatlands support a luxuriant growth of peat swamp forest overlying peat deposits up to 20 metres thick(4,5). Persistent environmental change-in particular, drainage and forest clearing-threatens their stability 2, and makes them susceptible to fire(6). This was demonstrated by the occurrence of widespread fires throughout the forested peatlands of Indonesia(7-10) during the 1997 El Nino event. Here, using satellite images of a 2.5 million hectare study area in Central Kalimantan, Borneo, from before and after the 1997 fires, we calculate that 32% (0.79 Mha) of the area had burned, of which peatland accounted for 91.5% (0.73 Mha). Using ground measurements of the burn depth of peat, we estimate that 0.19-0.23 gigatonnes (Gt) of carbon were released to the atmosphere through peat combustion, with a further 0.05 Gt released from burning of the overlying vegetation. Extrapolating these estimates to Indonesia as a whole, we estimate that between 0.81 and 2.57 Gt of carbon were released to the atmosphere in 1997 as a result of burning peat and vegetation in Indonesia. This is equivalent to 13-40% of the mean annual global carbon emissions from fossil fuels, and contributed greatly to the largest annual increase in atmospheric CO2 concentration detected since records began in 1957 (ref. 1).	Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England; Univ Munich, Dept Biol 2, D-80333 Munich, Germany; Remote Sensing Solut GmbH, D-81667 Munich, Germany; Kalteng Consultants, D-81663 Munich, Germany; Univ Nottingham, Sch Geog, Nottingham NG7 2RD, England; Univ Palangka Raya, Fac Agr, Ctr Int Cooperat Management Trop Peatland, Palangka Raya 73112, Indonesia	University of Leicester; University of Munich; University of Nottingham; Universitas Palangka Raya (UPR)	Page, SE (corresponding author), Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England.	sep5@le.ac.uk	Jaya, Adi/X-4840-2018; Nahas, Alberth/C-8379-2013	Jaya, Adi/0000-0002-5946-8631; Page, Susan/0000-0002-3392-9241				*ADB BAPPENAS, 1999, 2999INO TA FORT ADB; Barber C, 2000, TRIAL FIRE FOREST FI; BOMPARD JM, 1999, LAND MANAGEMENT S SU; BOWEN MR, 2000, FOREST FIRES REGIONA, P52; Fuller DO, 2001, INT J REMOTE SENS, V22, P691, DOI 10.1080/01431160010013504; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; JORDAN CF, 1983, ECOSYSTEMS WORLD, V14, P117; LIEW SC, 1998, P 1998 INT GEOSC REM, P87; Neuzil S.G., 1997, BIODIVERSITY SUSTAIN, P55; Page S.E., 1999, PHILOS T R SOC B, V354, P1; Page S.E., 1998, INT PEAT J, V8, P95; Rieley j. O., 1996, Tropical lowland peatlands of Southeast Asia. Proceedings of a workshop on integrated planning and management of tropical lowland peatlands, Cisarua, Indonesia, 3-8 July 1992., P17; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Siegert F, 2000, INT J REMOTE SENS, V21, P831, DOI 10.1080/014311600210632; SORENSEN KW, 1993, CHEMOSPHERE, V27, P1065, DOI 10.1016/0045-6535(93)90068-G; STIEBIG HJ, 2000, FOREST COVER CHANGE; ULABY FT, 1986, MICROWAVE REMOTE SEN, V3, P1811; Watson RT, 2000, LAND USE LAND USE CH	18	1127	1175	2	310	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 7	2002	420	6911					61	65		10.1038/nature01131	http://dx.doi.org/10.1038/nature01131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422213				2022-12-24	WOS:000179068100035
J	Simon, P; Weiss, FU; Zimmer, KP; Rand, S; Brinkmann, B; Domschke, W; Lerch, MM				Simon, P; Weiss, FU; Zimmer, KP; Rand, S; Brinkmann, B; Domschke, W; Lerch, MM			Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEREDITARY PANCREATITIS		Univ Munster, Dept Mol Gastroenterol, D-4400 Munster, Germany; Univ Munster, Dept Pediat, D-4400 Munster, Germany; Univ Klinikum Munster, Dept Forens Med, Munster, Germany; Univ Munster, Dept Med B, D-4400 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Simon, P (corresponding author), Univ Munster, Dept Mol Gastroenterol, D-4400 Munster, Germany.		Weiss, Frank Ulrich/A-6386-2009; Zimmer, Klaus-Peter/AAY-9261-2020; Lerch, Markus M./E-2206-2016; Zimmer, Klaus-Peter/AAY-9351-2020	Weiss, Frank Ulrich/0000-0003-3369-6369; Lerch, Markus M./0000-0002-9643-8263; 				Brinkmann B, 2001, INT J LEGAL MED, V114, P173, DOI 10.1007/s004140000174; Ellis I, 2001, PANCREATOLOGY, V1, P405, DOI 10.1159/000055840; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Simon P, 2002, J BIOL CHEM, V277, P5404, DOI 10.1074/jbc.M108073200; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2002, J PEDIATR GASTR NUTR, V34, P125, DOI 10.1097/00005176-200202000-00006	6	35	37	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2122	2122		10.1001/jama.288.17.2122	http://dx.doi.org/10.1001/jama.288.17.2122			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413370				2022-12-24	WOS:000179048100021
J	Venkitaraman, AR				Venkitaraman, AR			Connecting Fanconi's anaemia to breast cancer predisposition	LANCET			English	Editorial Material							BRCA1		Univ Cambridge, CR UK Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England	University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, CR UK Dept Oncol, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk						de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	11	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2002	360	9343					1344	1345		10.1016/S0140-6736(02)11414-0	http://dx.doi.org/10.1016/S0140-6736(02)11414-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	612ND	12423977				2022-12-24	WOS:000179081600004
J	Winkler, W; Nahvi, A; Breaker, RR				Winkler, W; Nahvi, A; Breaker, RR			Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; SELECTION; SWITCHES; SELEX	Although proteins fulfil most of the requirements that biology has for structural and functional components such as enzymes and receptors, RNA can also serve in these capacities. For example, RNA has sufficient structural plasticity to form ribozyme(1,2) and receptor(3,4) elements that exhibit considerable enzymatic power and binding specificity. Moreover, these activities can be combined to create allosteric ribozymes(5,6) that are modulated by effector molecules. It has also been proposed(7-12) that certain messenger RNAs might use allosteric mechanisms to mediate regulatory responses depending on specific metabolites. We report here that mRNAs encoding enzymes involved in thiamine (vitamin B-1) biosynthesis in Escherichia coli can bind thiamine or its pyrophosphate derivative without the need for protein cofactors. The mRNA-effector complex adopts a distinct structure that sequesters the ribosome-binding site and leads to a reduction in gene expression. This metabolite-sensing regulatory system provides an example of a 'riboswitch' whose evolutionary origin might pre-date the emergence of proteins.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.		Breaker, Ronald/E-9679-2010	Breaker, Ronald/0000-0002-2165-536X				BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Breaker RR, 1997, CHEM REV, V97, P371, DOI 10.1021/cr960008k; CECH TR, 1998, RNA WORLD, P321; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gold L, 1997, CURR OPIN GENET DEV, V7, P848, DOI 10.1016/S0959-437X(97)80050-0; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gold L, 1997, P NATL ACAD SCI USA, V94, P59, DOI 10.1073/pnas.94.1.59; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MILLER JH, 1992, SHORT COURSE BACTERI, V72; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Soukup GA, 2001, RNA, V7, P524, DOI 10.1017/S1355838201002175; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; VANDERHORN PB, 1993, J BACTERIOL, V175, P982, DOI 10.1128/JB.175.4.982-992.1993; Webb E, 1996, J BACTERIOL, V178, P2533, DOI 10.1128/jb.178.9.2533-2538.1996; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; WHITING MJ, 1982, SURG GASTROENTEROL, V1, P17; Zuker M., 1999, V70, P11	27	892	994	9	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					952	956		10.1038/nature01145	http://dx.doi.org/10.1038/nature01145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410317				2022-12-24	WOS:000178909700050
J	Wu, L; Bauer, CS; Zhen, XG; Xie, C; Yang, J				Wu, L; Bauer, CS; Zhen, XG; Xie, C; Yang, J			Dual regulation of voltage-gated calcium channels by PtdIns(4,5)P-2	NATURE			English	Article							PHOSPHOLIPASE-C; ATP; MODULATION; INHIBITION; EXPRESSION; MECHANISM; CURRENTS; RECEPTOR; NEURONS; SYNAPSE	Voltage-gated calcium channels (VGCCs) conduct calcium into cells after membrane depolarization and are vital for diverse biological events(1). They are regulated by various signalling pathways, which has profound functional consequences(1,2). The activity of VGCCs decreases with time in whole-cell and inside-out patch-clamp recordings(3). This rundown reflects persistent intrinsic modulation of VGCCs in intact cells. Although several mechanisms have been reported to contribute to rundown of L-type channels(3-6), the mechanism of rundown of other types of VGCC is poorly understood. Here we show that phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2), an essential regulator of ion channels and transporters(7-14), is crucial for maintaining the activity of P/Q- and N-type channels. Activation of membrane receptors that stimulate hydrolysis of PtdIns(4,5)P-2 causes channel inhibition in oocytes and neurons. PtdIns(4,5)P-2 also inhibits P/Q- type channels by altering the voltage dependence of channel activation and making the channels more difficult to open. This inhibition is alleviated by phosphorylation by protein kinase A. The dual actions of PtdIns(4,5)P-2 and the crosstalk between PtdIns(4,5)P-2 and protein kinase A set up a dynamic mechanism through which the activity of VGCCs can be finely tuned by various neurotransmitters, hormones and trophic factors.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jy160@columbia.edu	Tuluc, Petronel/C-2527-2011					ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEAN BP, 1994, ION CHANNELS CARDIOV, P237; BOLAND LM, 1993, J NEUROSCI, V13, P516; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; Choi DY, 2001, MOL CELL BIOL, V21, P2695, DOI 10.1128/MCB.21.8.2695-2705.2001; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cremona O, 2001, J CELL SCI, V114, P1041; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Hao LY, 1999, J PHYSIOL-LONDON, V514, P687, DOI 10.1111/j.1469-7793.1999.687ad.x; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; HILGEMANN DW, 2001, SCIENCE STKE; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RUNNELS LW, 2000, NATURE CELL BIOL, V4, P329; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Womack KB, 2000, J NEUROSCI, V20, P2792; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B	30	179	185	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					947	952		10.1038/nature01118	http://dx.doi.org/10.1038/nature01118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410316				2022-12-24	WOS:000178909700049
J	Zheng, HW; You, H; Zhou, XZ; Murray, SA; Uchida, T; Wulf, G; Gu, L; Tang, XR; Lu, KP; Xiao, ZXJ				Zheng, HW; You, H; Zhou, XZ; Murray, SA; Uchida, T; Wulf, G; Gu, L; Tang, XR; Lu, KP; Xiao, ZXJ			The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response	NATURE			English	Article							DEPENDENT PROLINE ISOMERIZATION; PHOSPHORYLATION; PROTEIN; APOPTOSIS; BINDING; JUN	p53 is activated in response to various genotoxic stresses resulting in cell cycle arrest or apoptosis(1,2). It is well documented that DNA damage leads to phosphorylation and activation of p53 (refs 1-3), yet how p53 is activated is still not fully understood. Here we report that DNA damage specifically induces p53 phosphorylation on Ser/Thr-Pro motifs, which facilitates its interaction with Pin1, a member of peptidyl-prolyl isomerase(4-9). Furthermore, the interaction of Pin1 with p53 is dependent on the phosphorylation that is induced by DNA damage. Consequently, Pin1 stimulates the DNA-binding activity and transactivation function of p53. The Pin1-mediated p53 activation requires the WW domain, a phosphorylated Ser/Thr-Pro motif interaction module, and the isomerase activity of Pin1. Moreover, Pin1-deficient cells are defective in p53 activation and timely accumulation of p53 protein, and exhibit an impaired checkpoint control in response to DNA damage. Together, these data suggest a mechanism for p53 regulation in cellular response to genotoxic stress.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Tohoku Univ, Inst Dev Aging & Canc, Dept Pathol, Sendai, Miyagi 980, Japan	Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tohoku University	Xiao, ZXJ (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	jxiao@bu.edu	Wulf, Gerburg/AAS-6713-2021	Uchida, Takafumi/0000-0003-3665-4906; Zheng, Hongwu/0000-0002-5823-4913; Tang, Xiaoren/0000-0002-2402-3659				Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Hunter T, 1998, CELL, V92, P141, DOI 10.1016/S0092-8674(00)80906-X; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu K P, 2000, Prog Cell Cycle Res, V4, P83; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; MILNER J, 1990, EMBO J, V9, P2885, DOI 10.1002/j.1460-2075.1990.tb07478.x; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rippmann JF, 2000, CELL GROWTH DIFFER, V11, P409; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037	30	316	327	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					849	853		10.1038/nature01116	http://dx.doi.org/10.1038/nature01116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397361				2022-12-24	WOS:000178769800049
J	Howard, SC; Gajjar, AJ; Cheng, C; Kritchevsky, SB; Somes, GW; Harrison, PL; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; de Armendi, AJ; Razzouk, BI; Pui, CH				Howard, SC; Gajjar, AJ; Cheng, C; Kritchevsky, SB; Somes, GW; Harrison, PL; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; de Armendi, AJ; Razzouk, BI; Pui, CH			Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBROSPINAL-FLUID ANALYSIS; BACTERIAL-MENINGITIS; PREDICTIVE VALUE; BACTEREMIA; TAP; THROMBOCYTOPENIA; DIAGNOSIS; NEEDLE	Context Traumatic or bloody lumbar puncture (LP) reduces the diagnostic value of the procedure and may worsen the outcome of patients with acute lymphoblastic leukemia (ALL). Little is known about the risk factors for traumatic and bloody LP. Objectives To determine the risk factors for traumatic and bloody LP. Design, Setting, and Patients Retrospective cohort study of 956 consecutive patients with newly diagnosed childhood ALL who were treated at a pediatric cancer center between February 1984 and July 1998. Interventions All patients underwent a diagnostic LP followed by a median of 4 LPs to instill intrathecal chemotherapy. Main Outcome Measure Traumatic LP was defined as an LP in which cerebrospinal fluid contained at least 10 red blood cells (RBCs) per microliter and bloody LP as one in which the cerebrospinal fluid contained at least 500 RBcs per microliter. Results Of the 5609 LPs evaluated, 1643 (29%) were traumatic and 581 (10%) were bloody. The estimated odds ratios (ORs) and 95% confidence intervals (CIS) for traumatic LP were 1.5 (95% CI, 1.2-1.8) for black vs white race, 2.3 (95% CI, 1.7-3.0) for age younger than 1 year vs 1 year or older, 1.4 (95% CI, 1.2-1.7) for early vs recent (dedicated procedure area-and general anesthesia) treatment era, 1.5 (95% CI, 1.2-1.8) for platelet count of 100 x 10(3)/muL or more vs less than 100 x 10(3)/muL, 10.8 (95% CI, 7.7-15.2) for short (1 day) vs longer (>1 5 days) interval since the previous LP, and 1.4 (95%-CI, 1.1-1.8) for the least vs the most experienced practitioners. Analyses for bloody LP yielded similar results. Conclusions The unmodifiable risk factors for traumatic and bloody LP include black race, age younger than 1 year, a traumatic or bloody previous LP performed within the past 2 weeks, and a previous LP performed when the platelet count was 50 x 10(3)/muL or less. Modifiable risk factors include procedural factors reflected in treatment era, platelet count of 100 x 10(3)/muL or less, an interval of 15 days or less between LPs, and a less experienced practitioner.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Anesthesia, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Howard, SC (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, Barry Longinotti Bldg,Room S2014C,332 N Lauderdal, Memphis, TN 38105 USA.	scott.howard@stjude.org	Rubnitz, Jeffrey E/N-2619-2018; Howard, Scott C/K-3401-2013; Gajjar, Amar/N-8059-2018; Pui, Ching-Hon/N-8076-2018; Cheng, Cheng/N-8075-2018	Rubnitz, Jeffrey E/0000-0001-9885-3527; Howard, Scott C/0000-0003-2244-1686; Pui, Ching-Hon/0000-0003-0303-5658; Kritchevsky, Stephen/0000-0003-3336-6781; Razzouk, Bassem/0000-0003-0536-6135	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANBAR RD, 1986, AM J DIS CHILD, V140, P737, DOI 10.1001/archpedi.1986.02140220019006; ANDREW M, 1987, J PEDIATR-US, V110, P457, DOI 10.1016/S0022-3476(87)80517-6; ANMBAR RD, 1988, CLIN PEDIAT PHILA, V27, P53; BAKER RC, 1989, PEDIATR INFECT DIS J, V8, P329; BOCKER H, 1987, DEUT MED WOCHENSCHR, V112, P120; BONADIO WA, 1990, J INFECT DIS, V162, P251, DOI 10.1093/infdis/162.1.251; BREUER AC, 1982, CANCER-AM CANCER SOC, V49, P2168, DOI 10.1002/1097-0142(19820515)49:10<2168::AID-CNCR2820491031>3.0.CO;2-O; CARRACCIO C, 1995, PEDIATRICS, V96, P48; Craig F, 1997, ARCH DIS CHILD, V77, P450, DOI 10.1136/adc.77.5.450; ENG RHK, 1981, JAMA-J AM MED ASSOC, V245, P1456, DOI 10.1001/jama.245.14.1456; FISHMAN RA, 1995, MERRITS TXB NEUROLOG, P93; Gajjar A, 2000, BLOOD, V96, P3381; Gaur AH, 2001, CLIN INFECT DIS, V32, P1456, DOI 10.1086/320154; Hanson P, 1998, ACTA ANAT, V162, P226; Hanson P, 1998, ARCH PHYS MED REHAB, V79, P1545, DOI 10.1016/S0003-9993(98)90417-8; HARKER LA, 1972, NEW ENGL J MED, V287, P155, DOI 10.1056/NEJM197207272870401; Heldrich F J, 1986, Pediatr Emerg Care, V2, P180, DOI 10.1097/00006565-198609000-00008; HELWIG H, 1986, DEUT MED WOCHENSCHR, V111, P1461; Howard SC, 2000, JAMA-J AM MED ASSOC, V284, P2222, DOI 10.1001/jama.284.17.2222; IZQUIERDO PF, 1980, AN ESP PEDIATR, V13, P733; JACOB J, 1977, AM J DIS CHILD, V131, P46, DOI 10.1001/archpedi.1977.02120140048007; KRUSKALL MS, 1983, NEW ENGL J MED, V308, P697, DOI 10.1056/NEJM198303243081206; LIANG KY, 1986, BIOMETRIKA, V78, P153; MAYEFSKY JH, 1987, AM J MED, V82, P1175, DOI 10.1016/0002-9343(87)90221-X; MEHL AL, 1986, CLIN PEDIATR, V25, P523, DOI 10.1177/000992288602501008; MEHL AL, 1986, CLIN PEDIATR, V25, P575, DOI 10.1177/000992288602501108; OSBORNE JP, 1981, ARCH DIS CHILD, V56, P400, DOI 10.1136/adc.56.5.400; Parzen E., 1962, STOCHASTIC PROCESSES; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; RIDER LG, 1995, PEDIATR EMERG CARE, V11, P226, DOI 10.1097/00006565-199508000-00009; RUBENSTEIN JS, 1985, J PEDIATR-US, V107, P249, DOI 10.1016/S0022-3476(85)80137-2; SCHREINER RL, 1979, DEV MED CHILD NEUROL, V21, P483; STANTON A, 1988, BRIT MED J, V296, P574, DOI 10.1136/bmj.296.6621.574-c; SWAIMAN KE, 1999, PEDIAT NEUROLOGY PRI, P115; TEELE DW, 1981, NEW ENGL J MED, V305, P1079, DOI 10.1056/NEJM198110293051810; WINTERGERST U, 1986, MONATSSCHR KINDERH, V134, P826; YURDAKOK M, 1992, PEDIATR NEUROSURG, V17, P199; 1982, N ENGL J MED, V306, P608	39	110	114	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2002	288	16					2001	2007		10.1001/jama.288.16.2001	http://dx.doi.org/10.1001/jama.288.16.2001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	606QW	12387652	Bronze			2022-12-24	WOS:000178745500023
J	Rutter, J; Probst, BL; McKnight, SL				Rutter, J; Probst, BL; McKnight, SL			Coordinate regulation of sugar flux and translation by PAS kinase	CELL			English	Article							YEAST GLYCOGEN-SYNTHETASE; P70 S6 KINASE; GLUCOSE 6-PHOSPHATE-DEPENDENT FORM; IN-GEL DIGESTION; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; UDP-GLUCOSE; DEPENDENT TRANSLATION; INITIATION FACTOR-4E; DOMAIN	PAS kinase is a serine/threonine kinase regulated in cis by a PAS domain. A genetic study of the two PAS kinase genes in budding yeast gave evidence of the involvement of these enzymes in the control of sugar metabolism and translation. Using a biochemical screen for PAS kinase substrates, three translation factors were identified as direct phosphorylation targets. PAS kinase was also found to phosphorylate UDP-glucose pyrophosphorylase and glycogen synthase, the enzymes catalyzing the two final steps in the glycogen biosynthetic pathway. Genetic, biochemical, and physiological data provide evidence that both of these enzymes are inhibited by PAS kinase-dependent phosphorylation, thereby downregulating carbohydrate storage. These studies provide evidence of a cell-autonomous signaling system that both controls and connects the balance of fuel consumption/storage to protein synthesis.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	smckni@biochem.swmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008291] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52031] Funding Source: Medline; NIGMS NIH HHS [5-T32-GM08291-12] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN M, 1989, NUCLEIC ACIDS RES, V17, P7520, DOI 10.1093/nar/17.18.7520; ALTMANN M, 1989, NUCLEIC ACIDS RES, V17, P5923, DOI 10.1093/nar/17.15.5923; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; AMEZCUA CA, 2002, IN PRESS STRUCTURE, V10; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; BOLES E, 1994, EUR J BIOCHEM, V220, P83, DOI 10.1111/j.1432-1033.1994.tb18601.x; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; Chaudhuri J, 1997, J BIOL CHEM, V272, P7883, DOI 10.1074/jbc.272.12.7883; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; DARAN JM, 1995, EUR J BIOCHEM, V233, P520, DOI 10.1111/j.1432-1033.1995.520_2.x; Daran JM, 1997, FEMS MICROBIOL LETT, V153, P89, DOI 10.1016/S0378-1097(97)00240-1; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; FloresDiaz M, 1997, J BIOL CHEM, V272, P23784, DOI 10.1074/jbc.272.38.23784; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARDY TA, 1994, J BIOL CHEM, V269, P27907; HARDY TA, 1993, J BIOL CHEM, V268, P23799; Hawkins NC, 1997, DEVELOPMENT, V124, P4801; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Huang DQ, 1997, J BIOL CHEM, V272, P22495, DOI 10.1074/jbc.272.36.22495; HUANG KP, 1974, J BIOL CHEM, V249, P3851; HUANG KP, 1974, J BIOL CHEM, V249, P3858; Johnston M., 1992, MOL CELLULAR BIOL YE, P193; Kimball Sr, 2000, COLD SPRING HARBOR M, V39, P561; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; LIN K, 1995, J BIOL CHEM, V270, P26833, DOI 10.1074/jbc.270.45.26833; Lin K, 1996, SCIENCE, V273, P1539, DOI 10.1126/science.273.5281.1539; Masuda CA, 2001, J BIOL CHEM, V276, P37794; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; MEISENBERG G, 1998, PRINCIPLES MED BOCHE; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Patel J, 2001, BIOCHEM J, V358, P497, DOI 10.1042/0264-6021:3580497; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; ROACH PJ, 1976, TRENDS BIOCHEM SCI, V1, P110, DOI 10.1016/0968-0004(76)90321-2; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; ROTHMANDENES LB, 1971, BIOCHEMISTRY-US, V10, P1236; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SHERMAN F, 1991, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sobel SG, 1999, MOL BIOL CELL, V10, P3849, DOI 10.1091/mbc.10.11.3849; Stephenson K, 2001, P NATL ACAD SCI USA, V98, P15251, DOI 10.1073/pnas.251408398; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178; ZANCHIN NIT, 1995, J BIOL CHEM, V270, P26505, DOI 10.1074/jbc.270.44.26505	67	89	94	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2002	111	1					17	28		10.1016/S0092-8674(02)00974-1	http://dx.doi.org/10.1016/S0092-8674(02)00974-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372297	Bronze			2022-12-24	WOS:000178461900005
J	Langewitz, W; Denz, M; Keller, A; Kiss, A; Ruttimann, S; Wossmer, B				Langewitz, W; Denz, M; Keller, A; Kiss, A; Ruttimann, S; Wossmer, B			Spontaneous talking time at start of consultation in outpatient clinic: cohort study	BRITISH MEDICAL JOURNAL			English	Article									Univ Basel Hosp, Dept Internal Med, Div Psychosomat Med, CH-4031 Basel, Switzerland; Univ Hosp, Zurich, Switzerland; Forel Klin, Ellikon An Der Thur, Switzerland; Kantonsspital, Dept Internal Med, Schaffhausen, Switzerland	University of Basel; University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA)	Langewitz, W (corresponding author), Univ Basel Hosp, Dept Internal Med, Div Psychosomat Med, CH-4031 Basel, Switzerland.							BLAU JN, 1989, BRIT MED J, V298, P39, DOI 10.1136/bmj.298.6665.39; Martina B, 1994, Schweiz Rundsch Med Prax, V83, P147; Martina B, 1997, J GEN INTERN MED, V12, P459, DOI 10.1046/j.1525-1497.1997.00083.x; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283	4	100	104	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2002	325	7366					682	+		10.1136/bmj.325.7366.682	http://dx.doi.org/10.1136/bmj.325.7366.682			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600JV	12351359	Bronze, Green Published			2022-12-24	WOS:000178387600019
J	Rahi, JS; Logan, S; Borja, MC; Timms, C; Russell-Eggitt, I; Taylor, D				Rahi, JS; Logan, S; Borja, MC; Timms, C; Russell-Eggitt, I; Taylor, D			Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye	LANCET			English	Article								Amblyopia arises from abnormal visual experiences in early childhood. Improved function of the amblyopic eye after visual loss in the non-amblyopic eye could be a model for residual neural plasticity. We aimed to establish the likelihood of, and predictive factors for, this improvement in function. We identified 254 individuals aged 11 years or older with unilateral amblyopia who were visually impaired after loss of vision in their non-amblyopic eye but had no other disorder affecting their amblyopic eye. 25 (10%) of 254 people had improved visual acuity in their amblyopic eye. These findings suggest there is some plasticity in the visual system of a few visually mature individuals with amblyopia, which warrants further study. Children should remain the focus of detection and treatment.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, Dept Ophthalmol, London, England; Inst Ophthalmol, Dept Epidemiol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahi, JS (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Borja, Mario Cortina/A-3847-2009	Borja, Mario Cortina/0000-0003-0627-2624; Rahi, Jugnoo/0000-0002-5718-9209; Logan, Stuart/0000-0002-9279-261X				DAW NW, 1994, INVEST OPHTH VIS SCI, V35, P4168; El Mallah MK, 2000, BRIT J OPHTHALMOL, V84, P952, DOI 10.1136/bjo.84.9.952; Levi DM, 1996, P NATL ACAD SCI USA, V93, P6830, DOI 10.1073/pnas.93.13.6830; Moseley MJ, 1997, BRIT J OPHTHALMOL, V81, P956, DOI 10.1136/bjo.81.11.956; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220	5	57	59	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 24	2002	360	9333					621	622		10.1016/S0140-6736(02)09775-1	http://dx.doi.org/10.1016/S0140-6736(02)09775-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241937				2022-12-24	WOS:000177600400015
J	Kouznetsov, AV; Prinz, JC				Kouznetsov, AV; Prinz, JC			Molecular diagnosis of syphilis: the Schaudinn-Hoffmann lymph-node biopsy	LANCET			English	Article							HIV	Although serological tests are usually sufficient for the diagnosis of syphilis, they can be unhelpful in identifying the stage of Treponema pallidum infection in various situations. We used fine-needle aspiration of inguinal lymph nodes followed by PCR and Southern blotting to test for treponemal DNA In three patients with suspected secondary or latent syphilis. All three patients were positive by this technique. This approach could serve as a useful new tool for the diagnosis of syphilis in uncertain cases.	Univ Munich, Dept Dermatol, D-80337 Munich, Germany; IM Sechenov Med Acad, Moscow, Russia	University of Munich; Sechenov First Moscow State Medical University	Prinz, JC (corresponding author), Univ Munich, Dept Dermatol, Frauenlobstr 9-11, D-80337 Munich, Germany.		Prinz, Jörg/AAP-9472-2021					Blocker ME, 2000, SEX TRANSM DIS, V27, P53, DOI 10.1097/00007435-200001000-00011; Schaudinn F, 1905, DEUT MED WOCHENSCHR, V31, P711, DOI 10.1055/s-0029-1188114; Schofer H, 1996, GENITOURIN MED, V72, P176; SELL S, 1983, PATHOGENESIS IMMUNOL, P297; Zoechling N, 1997, BRIT J DERMATOL, V136, P683, DOI 10.1046/j.1365-2133.1997.6561614.x	5	11	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					388	389		10.1016/S0140-6736(02)09598-3	http://dx.doi.org/10.1016/S0140-6736(02)09598-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241783				2022-12-24	WOS:000177255600016
J	Lu, YJ; Hing, S; Williams, R; Pinkerton, R; Shipley, J; Pritchard-Jones, K				Lu, YJ; Hing, S; Williams, R; Pinkerton, R; Shipley, J; Pritchard-Jones, K		UK Childrens Canc Study Grp	Chromosome 1q expression profiling and relapse in Wilms' tumour	LANCET			English	Article							GENE-EXPRESSION; CLASSIFICATION	Gene-expression patterns have proved useful for tumour classification and prediction of prognosis. We investigated a new gene-expression profiling method that targets individual chromosomes-comparative expressed sequence hybridisation (CESH)-to establish if any expression pattern was associated with relapse, and if this pattern could accurately predict outcome. We studied IS cases of Wilms' tumour with favourable histological findings. Relative overexpression of genes on the long arm of chromosome 1 was shown in all tumours that subsequently relapsed but in none of those from patients in remission (odds ratio 357, 95% Cl 6.4-19 960). This finding shows the value of CESH analysis to rapidly screen for chromosomal regions that carry genes whose differential expression is important in establishment of tumour behaviour.	Inst Canc Res, Paediat Sect, Sutton, Surrey, England; Inst Canc Res, Sect Mol Carcinogenesis, Sutton, Surrey, England; Royal Marsden Hosp NHS Trust, Sutton, Surrey, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Pritchard-Jones, K (corresponding author), Inst Canc Res, Paediat Sect, Sutton, Surrey, England.		pinkerton, ross/I-4808-2014; Pritchard-Jones, Kathy/F-4286-2014	Pritchard-Jones, Kathy/0000-0002-2384-9475; Lu, Yong-Jie/0000-0001-6174-6621; Shipley, Janet/0000-0001-6748-8678				Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Grundy P, 1996, MED PEDIATR ONCOL, V27, P429, DOI 10.1002/(SICI)1096-911X(199611)27:5<429::AID-MPO7>3.0.CO;2-O; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; Lu YJ, 2001, P NATL ACAD SCI USA, V98, P9197, DOI 10.1073/pnas.161272798; Pritchard-Jones K, 1997, CRIT REV ONCOGENESIS, V8, P1	5	44	45	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					385	386		10.1016/S0140-6736(02)09596-X	http://dx.doi.org/10.1016/S0140-6736(02)09596-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241781				2022-12-24	WOS:000177255600014
J	Sankar, P; Cho, MK				Sankar, P; Cho, MK			Toward a new vocabulary of human genetic variation	SCIENCE			English	Editorial Material							RACE; PHARMACOGENOMICS; POPULATIONS; DIVERSITY; GENOMICS		Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University	Sankar, P (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	sankarp@mail.med.upenn.edu; micho@stanford.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002189] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002189-01, R01 HGO 2189-02, R01 HG002189-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anand S S, 1999, Ethn Health, V4, P241, DOI 10.1080/13557859998029; Angier Natalie, 2000, NY TIMES        1107, pF1; [Anonymous], 1996, BRIT MED J, V312, P1094; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Collins FS, 2001, CANCER, V91, P221, DOI 10.1002/1097-0142(20010101)91:1+<221::AID-CNCR8>3.3.CO;2-0; Crawford DC, 2000, AM J HUM GENET, V66, P480, DOI 10.1086/302762; Cyranoski D, 2002, NATURE, V416, P115, DOI 10.1038/416115a; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Freeman HP, 1998, CANCER, V82, P219, DOI 10.1002/(SICI)1097-0142(19980101)82:1<219::AID-CNCR27>3.0.CO;2-4; Fritsche E, 2000, MUTAT RES-GENOMICS, V432, P1, DOI 10.1016/S1383-5726(99)00009-6; Gilbert W., 1992, CODE CODES SCI SOCIA, P84; Haynes MA, 1999, UNEQUAL BURDEN CANC, DOI 10.17226/6377; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kalow W, 2001, CLIN PHARMACOL THER, V70, P1, DOI 10.1067/mcp.2001.116714; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Marks J., 2002, WHAT IT MEANS BE PRI; Montague A., 1942, MANS MOST DANGEROUS; Nebert DW, 2001, TRENDS BIOTECHNOL, V19, P519, DOI 10.1016/S0167-7799(01)01805-4; Oppenheimer GM, 2001, AM J PUBLIC HEALTH, V91, P1049, DOI 10.2105/AJPH.91.7.1049; Owens K, 1999, SCIENCE, V286, P451, DOI 10.1126/science.286.5439.451; Risch N., 2002, GENOME BIOL, V3; Rivara FP, 2001, ARCH PEDIAT ADOL MED, V155, P119, DOI 10.1001/archpedi.155.2.119; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shriver MD, 1997, AM J HUM GENET, V60, P957; Stolberg S G, 2001, N Y Times Web, pA16; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008; 2001, NATURE GENET, V29, P239; 2000, NATURE GENET, V24, P97	29	104	107	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2002	298	5597					1337	1338		10.1126/science.1074447	http://dx.doi.org/10.1126/science.1074447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434037	Green Accepted			2022-12-24	WOS:000179223100022
J	Heaney, DC; MacDonald, BK; Everitt, A; Stevenson, S; Leonardi, GS; Wilkinson, P; Sander, JW				Heaney, DC; MacDonald, BK; Everitt, A; Stevenson, S; Leonardi, GS; Wilkinson, P; Sander, JW			Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; POPULATION; DISORDERS	Objective To determine the incidence of epilepsy in a general practice population and its variation with socioeconomic deprivation. Design Prospective surveillance for new cases over an 18 or 24 month period. Participants All patients on practice registers categorised for deprivation with the Carstairs score of their postcodc. Setting 20 general practices in London and south cast England. Main outcome measure Confirmed diagnosis of epilepsy. Results 190 new cases of epilepsy were identified during 369 283 person years of observation (crude incidence 51.5 (95% confidence interval 44.4 to 59.3) per 100 000 per year). The incidence was 190 (138 to 262) per 100 000 in children aged 0-4 years, 30.8 (21.3 to 44.6) in those aged 45-64 years, and 58.7 (42.5 to 81.0) in those aged greater than or equal to65 years. There was no apparent difference in incidence between males and females. The incidence showed a strong association with socioeconomic deprivation, the age and sex adjusted incidence in the most deprived fifth of the study population being 2.33 (1.46 to 3.72) times that in the least deprived fifth (P=0.001 for trend across fifths). Adjustment for area (London v outside London) weakened the association with deprivation (rate ratio 1.62 (0.91 to 2.88), P=0.12 for trend). Conclusions The incidence of epilepsy seems to increase with socioeconomic deprivation, though the association may be confounded by other factors.	UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; Univ London London Sch Hyg & Trop Med, Environm Epidemiol Unit, London WC1E 7HT, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Sander, JW (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.	l.sander@ion.ucl.ac.uk	Leonardi, Giovanni/AAS-7603-2020; Sander, Josemir W/C-1576-2008; Leonardi, Giovanni S/E-5700-2015	Sander, Josemir W/0000-0001-6041-9661; Wilkinson, Paul/0000-0001-7456-259X; Leonardi, Giovanni S./0000-0001-7477-1762	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHESON D, 1998, INDEPENDENT INQUIRY, P1; Carstairs V., 1991, DEPRIVATION HLTH SCO; Department of Health, 1997, NEW NHS MOD DEP; HAERER AF, 1986, EPILEPSIA, V27, P66, DOI 10.1111/j.1528-1157.1986.tb03503.x; HART YM, 1995, EPILEPSY RES, V21, P43, DOI 10.1016/0920-1211(95)00007-W; Jacoby A, 1998, EPILEPSIA, V39, P776, DOI 10.1111/j.1528-1157.1998.tb01164.x; Jacoby A, 1996, EPILEPSIA, V37, P148, DOI 10.1111/j.1528-1157.1996.tb00006.x; LISLE JR, 1986, BRIT MED J, V292, P305, DOI 10.1136/bmj.292.6516.305-a; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Morgan CLI, 2000, J NEUROL NEUROSUR PS, V69, P13, DOI 10.1136/jnnp.69.1.13; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Ottman R, 1996, ANN NEUROL, V39, P442, DOI 10.1002/ana.410390406; RODIN E, 1972, EPILEPSIA, V13, P149, DOI 10.1111/j.1528-1157.1972.tb04562.x; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; SHAMANSKY SL, 1979, EPILEPSIA, V20, P457, DOI 10.1111/j.1528-1157.1979.tb04828.x; *WHO, 1985, TARG ALL; Wright J, 2000, SEIZURE-EUR J EPILEP, V9, P309, DOI 10.1053/seiz.2000.0422	17	130	133	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2002	325	7371					1013	1016		10.1136/bmj.325.7371.1013	http://dx.doi.org/10.1136/bmj.325.7371.1013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JU	12411362	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-24	WOS:000179415600024
J	Alexander, JM; Nelson, CA; van Berkel, V; Lau, EK; Studts, JM; Brett, TJ; Speck, SH; Handel, TM; Virgin, HW; Fremont, DH				Alexander, JM; Nelson, CA; van Berkel, V; Lau, EK; Studts, JM; Brett, TJ; Speck, SH; Handel, TM; Virgin, HW; Fremont, DH			Structural basis of chemokine sequestration by a herpesvirus decoy receptor	CELL			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; BINDING-PROTEIN; CC-CHEMOKINE; CRYSTAL-STRUCTURE; HEPARIN-BINDING; MCP-1 RECEPTOR; IDENTIFICATION; COMPLEX; RESIDUES; FRAGMENT	The M3 protein encoded by murine gammaherpesvirus68 (gammaHV68) functions as an immune system saboteur by the engagement of chemoattractant cytokines, thereby altering host antiviral inflammatory responses. Here we report the crystal structures of M3 both alone and in complex with the CC chemokine MCP-1. M3 is a two-domain beta sandwich protein with a unique sequence and topology, forming a tightly packed antiparallel dimer. The stoichiometry of the MCP-1:M3 complex is 2:2, with two monomeric chemokines embedded at distal ends of the preassociated M3 dimer. Conformational flexibility and electrostatic complementation are both used by M3 to achieve high-affinity and broad-spectrum chemokine engagement. M3 also employs structural mimicry to promiscuously sequester chemokines, engaging conservative structural elements associated with both chemokine homodimerization and binding to G protein-coupled receptors.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Mol Biophys & Med Scientist Training Program, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Emory Univ, Div Microbiol & Immunol, Atlanta, GA 30329 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley; Emory University	Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	fremont@pathbox.wustl.edu	Speck, Samuel/L-5893-2019; Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Virgin, Herbert/0000-0001-8580-7628; Fremont, Daved/0000-0002-8544-2689	NATIONAL CANCER INSTITUTE [R01CA074730, R01CA086803, R55CA074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414] Funding Source: NIH RePORTER; NCI NIH HHS [CA74730, CA86803-04] Funding Source: Medline; NHLBI NIH HHS [HL60090] Funding Source: Medline; NIAID NIH HHS [AI051426-01] Funding Source: Medline; NIAMS NIH HHS [AR32788-18] Funding Source: Medline; NIGMS NIH HHS [GM62414] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leong SR, 1997, PROTEIN SCI, V6, P609; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Louie GV, 1997, MOL CELL, V1, P67, DOI 10.1016/S1097-2765(00)80008-8; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mellado M, 2001, CELL MOL BIOL, V47, P575; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sundberg EJ, 2000, STRUCTURE, V8, pR137, DOI 10.1016/S0969-2126(00)00167-2; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851	48	99	103	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2002	111	3					343	356		10.1016/S0092-8674(02)01007-3	http://dx.doi.org/10.1016/S0092-8674(02)01007-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419245	Bronze			2022-12-24	WOS:000179010100007
J	Irvine, DJ; Purbhoo, MA; Krogsgaard, M; Davis, MM				Irvine, DJ; Purbhoo, MA; Krogsgaard, M; Davis, MM			Direct observation of ligand recognition by T cells	NATURE			English	Article							PEPTIDE COMPLEXES; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; MINIMAL NUMBER; LIVING CELLS; MHC; ACTIVATION; CD4; SURFACE; BINDING	The activation of T cells through interaction of their T-cell receptors with antigenic peptide bound to major histocompatibility complex (MHC) on the surface of antigen presenting cells (APCs) is a crucial step in adaptive immunity. Here we use three-dimensional fluorescence microscopy to visualize individual peptide-I-E-k class II MHC complexes labelled with the phycobiliprotein phycoerythrin in an effort to characterize T-cell sensitivity and the requirements for forming an immunological synapse(1-3) in single cells. We show that T cells expressing the CD4 antigen respond with transient calcium signalling to even a single agonist peptide-MHC ligand, and that the organization of molecules in the contact zone of the T cell and APC takes on the characteristics of an immunological synapse when only about ten agonists are present. This sensitivity is highly dependant on CD4, because blocking this molecule with antibodies renders T cells unable to detect less than about 30 ligands.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				ANDERSON P, 1988, J IMMUNOL, V140, P1732; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Triantafilou K, 2000, CYTOMETRY, V41, P226, DOI 10.1002/1097-0320(20001101)41:3<226::AID-CYTO11>3.0.CO;2-1; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.ne.12.030189.001303; Vidal K, 1999, J IMMUNOL, V163, P4811; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200	30	585	605	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 24	2002	419	6909					845	849		10.1038/nature01076	http://dx.doi.org/10.1038/nature01076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397360				2022-12-24	WOS:000178769800048
J	Gardner-Medwin, JMM; Dolezalova, P; Cummins, C; Southwood, TR				Gardner-Medwin, JMM; Dolezalova, P; Cummins, C; Southwood, TR			Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins	LANCET			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; RHEUMATOLOGY 1990 CRITERIA; PEDIATRIC-RHEUMATOLOGY; UNITED-KINGDOM; CLASSIFICATION; EPIDEMIOLOGY; POPULATION; DERMATOMYOSITIS; ASSOCIATION; PREVALENCE	Background The frequency and ethnic variation of Henoch-Schonlein purpura, Kawasaki disease, and rarer vasculitides during childhood are not well characterised. Our aim was to ascertain the incidence, and ethnic distribution of these conditions in children resident in a region of the UK with a diverse ethnic mix. Methods 1.1 million children younger than age 17 years live in the West Midlands. Between Sept 1, 1996, and Aug 31, 1999, we surveyed this population with monthly questionnaires sent to 321 consultants, a single questionnaire sent to 2860 family doctors, and review of 406 case notes with diagnostic codes for vasculitis. We included in the analyses children who fulfilled established criteria for vasculitis with disease onset during the study, and calculated incidence rates from population rates derived from the census of 1991. Findings We identified 586 new instances of vasculitis and connective tissue disease. The estimated annual incidence of Henoch-Schonlein purpura was 20.4 per 100 000, and was highest between the ages of 4 years and 6 years (70.3 per 100 000). The estimated annual incidence of Kawasaki disease was 5.5 per 100 000 in children younger than 5 years, and was highest in Indian subcontinent Asian children (14.6 per 100 000). Indian subcontinent Asian and black children had the highest incidence of systemic lupus erythematosus, juvenile dermatomyositis, and other primary systemic vasculitides. Interpretation Childhood Henoch-Schonlein purpura is more frequent in the West Midlands than previously reported, and Kawasaki disease has a higher incidence than previously indicated in the UK, with the highest incidence in Indian subcontinental Asian children. Other vasculitis is rare in childhood.	Univ Birmingham, Dept Rheumatol, Birmingham, W Midlands, England; Univ Birmingham, Inst Child Hlth, Birmingham, W Midlands, England; Charles Univ, Dept Paediat & Adolescent Med, Prague, Czech Republic	University of Birmingham; University of Birmingham; Charles University Prague	Gardner-Medwin, JMM (corresponding author), Royal Hosp Sick Children, Dept Child Hlth, Glasgow GL3 8SJ, Lanark, Scotland.		Dolezalova, Pavla/N-6408-2017; Gardner-Medwin, Janet/J-2512-2012	Dolezalova, Pavla/0000-0001-8375-661X; Cummins, Carole/0000-0001-5464-1944				*AM HEART ASS COMM, 1990, AM J DIS CHILD, V144, P1218; Bhopal R, 1998, AM J PUBLIC HEALTH, V88, P1303, DOI 10.2105/AJPH.88.9.1303; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bowyer S, 1996, J RHEUMATOL, V23, P1968; Bundey Sarah, 1993, European Journal of Human Genetics, V1, P206; DENARDO BA, 1994, J RHEUMATOL, V21, P1553; GALLA JH, 1984, LANCET, V2, P522; HALL SM, 1989, ARCH DIS CHILD, V64, P121; Hook EB, 1999, J CLIN EPIDEMIOL, V52, P917, DOI 10.1016/S0895-4356(99)00060-8; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; KaipiainenSeppanen O, 1996, CLIN EXP RHEUMATOL, V14, P441; Knox E., 1964, APPL STATIST, V13, P25, DOI DOI 10.2307/2985220; Kumar Lata, 1996, Indian Journal of Pediatrics, V63, P323, DOI 10.1007/BF02751524; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Malleson PN, 1996, J RHEUMATOL, V23, P1981; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; NAIUDET P, 1993, ADV NEPHROL NECKER H, V2, P121; NIELSEN HE, 1988, ACTA PAEDIATR SCAND, V77, P125, DOI 10.1111/j.1651-2227.1988.tb10610.x; NIELSEN HE, 1990, AM J DIS CHILD, V144, P620, DOI 10.1001/archpedi.1990.02150300014008; SCHILLER B, 1995, ACTA PAEDIATR, V84, P769, DOI 10.1111/j.1651-2227.1995.tb13753.x; Schrag SJ, 2000, PEDIATR INFECT DIS J, V19, P17, DOI 10.1097/00006454-200001000-00005; SHULMAN ST, 1987, AM J DIS CHILD, V141, P420, DOI 10.1001/archpedi.1987.04460040078020; SILMAN AJ, 1990, LANCET, V335, P1078; STEWART M, 1988, EUR J PEDIATR, V147, P113, DOI 10.1007/BF00442205; SYMMONS DPM, 1995, BRIT J RHEUMATOL, V34, P732; Symmons DPM, 1996, J RHEUMATOL, V23, P1975; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TAUBERT KA, 1994, PEDIATR INFECT DIS J, V13, P704, DOI 10.1097/00006454-199408000-00005; Watts RA, 2000, ARTHRITIS RHEUM, V43, P414, DOI 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0; YANAGAWA H, 1986, LANCET, V2, P1138; 1997, OFFICE NATL STAT CEN	34	435	471	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1197	1202		10.1016/S0140-6736(02)11279-7	http://dx.doi.org/10.1016/S0140-6736(02)11279-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401245				2022-12-24	WOS:000178708100008
J	van de Wetering, M; Sancho, E; Verweij, C; de Lau, W; Oving, I; Hurlstone, A; van der Horn, K; Batlle, E; Coudreuse, D; Haramis, AP; Tion-Pon-Fong, M; Moerer, P; van den Born, M; Soete, G; Pals, S; Eilers, M; Medema, R; Clevers, H				van de Wetering, M; Sancho, E; Verweij, C; de Lau, W; Oving, I; Hurlstone, A; van der Horn, K; Batlle, E; Coudreuse, D; Haramis, AP; Tion-Pon-Fong, M; Moerer, P; van den Born, M; Soete, G; Pals, S; Eilers, M; Medema, R; Clevers, H			The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells	CELL			English	Article							BETA-CATENIN; GENE-EXPRESSION; COLON-CARCINOMA; MICE LACKING; C-MYC; CYCLIN D1; DIFFERENTIATION; APC; P27(KIP1); MUTATIONS	The transactivation of TCF target genes induced by Writ pathway mutations constitutes the primary transforming event in colorectal cancer (CRC). We show that disruption of beta-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest and blocks a genetic program that is physiologically active in the proliferative compartment of colon crypts. Coincidently, an intestinal differentiation program is induced. The TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21(CIP1/WAF1) promoter. Following disruption of beta-catenin/TCF-4 activity, the decreased expression of c-MYC releases p21(CIP1/WAF1), transcription, which in turn mediates G1 arrest and differentiation. Thus, the beta-catenin/TCF-4 complex constitutes the master switch that controls proliferation versus differentiation in healthy and malignant intestinal epithelial cells.	Univ Med Ctr, Dept Immunol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr, Ctr Biomed Genet, NL-3584 CX Utrecht, Netherlands; VU Med Ctr, Dept Mol Cellular Biol, NL-1081 BT Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Inst Mol Biol & Tumor Res, D-35033 Marburg, Germany; Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Medema, Rene H/E-2981-2013; Batlle, Eduard/K-8080-2014; Eckhardt, Erik/G-1567-2010; Medema, Rene H/G-5415-2011; Sancho, Elena/ABH-4867-2020	Batlle, Eduard/0000-0003-2422-0326; Sancho, Elena/0000-0002-8182-513X; Hurlstone, Adam/0000-0001-5260-9457; Eilers, Martin/0000-0002-0376-6533; Coudreuse, Damien/0000-0003-2534-1621; Pals, Steven/0000-0002-1419-0939; Medema, Rene/0000-0002-6754-0381				Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; CASTROP J, 1995, BLOOD, V86, P3050, DOI 10.1182/blood.V86.8.3050.bloodjournal8683050; CICLITIRA PJ, 1987, J PATHOL, V151, P293, DOI 10.1002/path.1711510409; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; ELDEIRY WS, 1995, CANCER RES, V55, P2910; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; Evers BM, 1996, AM J PHYSIOL-GASTR L, V271, pG722, DOI 10.1152/ajpgi.1996.271.4.G722; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fujita M, 2001, CANCER RES, V61, P7722; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HARPER JW, 1993, CELL, V75, P805; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Kim JS, 2002, CANCER RES, V62, P2744; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kitahara O, 2001, CANCER RES, V61, P3544; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mariadason JM, 2001, CANCER RES, V61, P3465; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; MELHEM MF, 1992, CANCER RES, V52, P5853; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Oba SM, 2001, CANCER LETT, V164, P97, DOI 10.1016/S0304-3835(00)00716-3; Philipp-Staheli J, 2002, CANCER CELL, V1, P355, DOI 10.1016/S1535-6108(02)00054-5; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Quaroni A, 2000, AM J PHYSIOL-CELL PH, V279, pC1045, DOI 10.1152/ajpcell.2000.279.4.C1045; RAMSAY RG, 1992, CELL GROWTH DIFFER, V3, P723; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Yang WC, 2001, CANCER RES, V61, P6297; Yang WC, 2001, CANCER RES, V61, P565; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	51	1626	1690	3	76	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 18	2002	111	2					241	250		10.1016/S0092-8674(02)01014-0	http://dx.doi.org/10.1016/S0092-8674(02)01014-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408868	Green Published, Bronze			2022-12-24	WOS:000178753500013
J	Flegal, KM; Carroll, MD; Ogden, CL; Johnson, CL				Flegal, KM; Carroll, MD; Ogden, CL; Johnson, CL			Prevalence and trends in obesity among US adults, 1999-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; LIFE-STYLE; HEALTH EXAMINATION; NATIONAL-HEALTH; PUBLIC-HEALTH; PREVENTION; GLUCOSE	Context The prevalence of obesity and overweight increased in the United States between 1978 and 1991. More recent reports have suggested continued increases but are based on self-reported data. Objective To examine trends and prevalences of overweight (body mass index [BMI] greater than or equal to25) and obesity (BMI; greater than or equal to30), using measured height and weight data. Design, Setting, and Participants Survey of 4115 adult men and women conducted in 1999 and 2000 as part of the National Health and Nutrition Examination Survey (NHANES), a nationally representative sample of the US population. Main Outcome Measure Age-adjusted prevalence of overweight,, obesity, and extreme obesity compared with prior surveys, and sex-, age-, and race/ethnicity-specific estimates. Results The age-adjusted prevalence of obesity was 30.5% in 1999-2000 compared with 22.9% in NHANES III (1988-1994; P<.001). The prevalence of overweight also increased during this period from 55.9% to 64.5% (P<.001). Extreme obesity (BMI; greater than or equal to40) also increased significantly in the population, from 2.9% to 4.7% (P=.002). Although not all changes were statistically significant,, increases occurred for both men and women in all age groups and for non-Hispanic whites, non-Hispanic blacks, And Mexican Americans. Racial/ethnic groups did not differ significantly in the prevalence of obesity or overweight for men. Among women, obesity and overweight prevalences were highest among non-Hispanic black women. More than half of non-Hispanic black women aged 40 years or older were obese and more than 80% were overweight. Conclusions The increases in the prevalences of obesity and overweight previously observed continued in 1999-2000. The potential health benefits from reduction in overweight and obesity are of considerable public health importance.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 6525 Belcrest Rd,Room 900, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013; Kohn, Geoffrey P/A-9056-2009; Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783; Flegal, Katherine/0000-0002-0838-469X				[Anonymous], MORB MORT 2002 CHART; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; [Anonymous], 1994, VITAL HLTH STAT, V1, P1, DOI DOI 10.1136/BMJ.L42; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Costa DL, 1997, NAT BUR EC, P47; Douketis JD, 1999, CAN MED ASSOC J, V160, P513; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Jeffery RW, 2001, AM J HEALTH BEHAV, V25, P252, DOI 10.5993/AJHB.25.3.12; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Martinez JA, 2000, P NUTR SOC, V59, P337, DOI 10.1017/S0029665100000380; McDowell A, 1981, Vital Health Stat 1, P1; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; *NAT CTR HLTH STAT, 1973, VITAL HLTH STAT, V1, P1; *NAT CTR HLTH STAT, 1965, VITAL HLTH STAT, V4, P1; National Cholesterol Education Program, 2002, 3 NAT CHOL ED PROGR; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Russell A, 2000, WMJ, V99, P53; SORENSON TIA, 2000, DIABETES CARE S2, V23, P81; Taubes G, 1998, SCIENCE, V280, P1367, DOI 10.1126/science.280.5368.1367; TAYLOR H, 2002, HARRIS POLL     0306; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Velleman P. F., 1981, APPL BASICS COMPUTIN; WHO Consultation on Obesity, 2000, WHO TECHN REP SER, V894; Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117; Wolter K., 1990, INTRO VARIANCE ESTIM	31	4629	4758	1	233	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2002	288	14					1723	1727		10.1001/jama.288.14.1723	http://dx.doi.org/10.1001/jama.288.14.1723			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	602BJ	12365955	Bronze			2022-12-24	WOS:000178484700024
J	Ogden, CL; Flegal, KM; Carroll, MD; Johnson, CL				Ogden, CL; Flegal, KM; Carroll, MD; Johnson, CL			Prevalence and trends in overweight among US children and adolescents, 1999-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-HEALTH; OBESITY; EPIDEMIC; GLUCOSE	Context The prevalence of overweight among children in the United States increased between 1976-1980 and 1988-1994, but estimates for the current decade are unknown. Objective To determine the prevalence of overweight in US children using the most recent national data with measured weights and heights and to examine trends in overweight prevalence. Design, Setting, and Participants Survey of 4722 children from birth through 19 years of age with weight and height measurements obtained in 1995-2000 as part of the National Health and Nutrition Examination Survey (NHANES), a cross-sectional, stratified, multistage probability sample of the US population. Main Outcome Measure Prevalence of overweight among US children by sex, age group, and race/ethnicity. Overweight among those aged 2 through 19 years was defined as at or above the 95th percentile of the sex-specific body mass index (BMI) for age growth charts. Results The prevalence of overweight was 15.5% among 12- through 19-year-olds, 15.3% among 6- through 11-year-olds, and 10.4% among 2-through 5-year-olds, compared with 10.5%, 11.3%, and 7.2%, respectively, in 1988-1994 (NHANES 111). The prevalence of overweight among non-Hispanic black and Mexican-American adolescents increased more than 10 percentage points between 1988-1994 and 1999-2000. Conclusion The prevalence of overweight among children in the United States is continuing to increase, especially among Mexican-American and non-Hispanic black adolescents.	Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, 6525 Belcrest Rd,Room 900, Hyattsville, MD 20782 USA.	cao9@cdc.gov	Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X				[Anonymous], PREV OV CHILDR AD US; [Anonymous], [No title captured]; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, pSS1; Dietz WH, 1998, PEDIATRICS, V101, P518; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Fagot-Campagna A, 2000, J PEDIATR ENDOCR MET, V13, P1395; Goran MI, 2001, PEDIATR CLIN N AM, V48, P931, DOI 10.1016/S0031-3955(05)70349-7; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; *I MED, 1996, WIC NUTR RISK CRIT S; Kuczmarski RJ., 2000, VITAL HLTH STAT, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; McDowell A, 1981, Vital Health Stat 1, P1; *NAT CTR HLTH STAT, 1904, VITAL HLTH STAT, V1, P1; *NAT CTR HLTH STAT, 1967, VIT HLTH STAT 1, V1, P1; *NAT CTR HLTH STAT, 1973, VITAL HLTH STAT, V1, P1; *NAT CTR HLTH STAT, 1969, VIT HLTH STAT 1, V1, P1; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Spruijt-Metz D, 2002, AM J CLIN NUTR, V75, P581, DOI 10.1093/ajcn/75.3.581; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; WHO Consultation on Obesity, 2000, WHO TECHN REP SER, V894; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280	30	2690	2753	0	173	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2002	288	14					1728	1732		10.1001/jama.288.14.1728	http://dx.doi.org/10.1001/jama.288.14.1728			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	602BJ	12365956	Bronze			2022-12-24	WOS:000178484700025
J	Wilson, JR; Jing, C; Walker, PA; Martin, SR; Howell, SA; Blackburn, GM; Gamblin, SJ; Xiao, B				Wilson, JR; Jing, C; Walker, PA; Martin, SR; Howell, SA; Blackburn, GM; Gamblin, SJ; Xiao, B			Crystal structure and functional analysis of the histone methyltransferase SET7/9	CELL			English	Article							CHROMATIN-STRUCTURE; LYSINE 9; METHYLATION; H3; HETEROCHROMATIN; BINDING; PROTEIN; TRANSCRIPTION; ACETYLATION; REPRESSOR	Methylation of lysine residues in the N-terminal tails of histones is thought to represent an important component of the mechanism that regulates chromatin structure. The evolutionarily conserved SET domain occurs in most proteins known to possess histone lysine methyltransferase activity. We present here the crystal structure of a large fragment of human SET7/9 that contains a N-terminal beta-sheet domain as well as the conserved SET domain. Mutagenesis identifies two residues in the C terminus of the protein that appear essential for catalytic activity toward lysine-4 of histone H3. Furthermore, we show how the cofactor AdoMet binds to this domain and present biochemical data supporting the role of invariant residues in catalysis, binding of AdoMet, and interactions with the peptide substrate.	Natl Inst Med Res, Struct Biol Grp, London NW7 1AA, England; Univ Sheffield, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England	MRC National Institute for Medical Research; University of Sheffield	Gamblin, SJ (corresponding author), Natl Inst Med Res, Struct Biol Grp, Ridgeway,Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TAKUSAGAWA F, 1998, S ADENOSYL METHIONIN, V1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson MJ, 1999, J ORG CHEM, V64, P7467, DOI 10.1021/jo9907742; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolffe AP., 1998, CHROMATIN STRUCTURE; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	35	178	194	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2002	111	1					105	115		10.1016/S0092-8674(02)00964-9	http://dx.doi.org/10.1016/S0092-8674(02)00964-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372304	Bronze			2022-12-24	WOS:000178461900012
J	Blau, HM				Blau, HM			A twist of fate	NATURE			English	Editorial Material							CELL		Stanford Univ, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA.							Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; FENYO EM, 1973, JNCI-J NATL CANCER I, V51, P1865, DOI 10.1093/jnci/51.6.1865; WIENER F, 1972, NATURE-NEW BIOL, V238, P155, DOI 10.1038/newbio238155a0	4	62	64	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					437	437		10.1038/419437a	http://dx.doi.org/10.1038/419437a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12374136	Bronze			2022-12-24	WOS:000178348400019
J	Wiltschko, W; Traudt, J; Gunturkun, O; Prior, H; Wiltschko, R				Wiltschko, W; Traudt, J; Gunturkun, O; Prior, H; Wiltschko, R			Lateralization of magnetic compass orientation in a migratory bird	NATURE			English	Article							EUROPEAN ROBINS; VISUAL-SYSTEM; AVIAN BRAIN; PIGEONS; LIGHT; MAGNETORECEPTION; INFORMATION; ASYMMETRIES; MEMORY; MODEL	Lateralization of brain functions, once believed to be a human characteristic, has now been found to be widespread among vertebrates(1-3). In birds, asymmetries of visual functions are well studied, with each hemisphere being specialized for different tasks(4-8). Here we report lateralized functions of the birds' visual system associated with magnetoperception, resulting in an extreme asymmetry of sensing the direction of the magnetic field. We found that captive migrants tested in cages with the magnetic field as the only available orientation cue were well oriented in their appropriate migratory direction when using their right eye only, but failed to show a significant directional preference when using their left eye. This implies that magnetoreception for compass orientation, assumed to take place in the eyes alongside the visual processes(9-11), is strongly lateralized, with a marked dominance of the right eye/left brain hemisphere.	Univ Frankfurt, Inst Zool, Fachbereich Biol, D-60054 Frankfurt, Germany; Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany	Goethe University Frankfurt; Ruhr University Bochum	Wiltschko, W (corresponding author), Univ Frankfurt, Inst Zool, Fachbereich Biol, Siesmayerstr 70, D-60054 Frankfurt, Germany.							Batschelet E, 1981, CIRCULAR STAT BIOL; BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; CLAYTON N, 1993, J COMP PHYSIOL A, V171, P799, DOI 10.1007/BF00213076; Diekamp B, 2001, NEUROSCI LETT, V305, P103, DOI 10.1016/S0304-3940(01)01819-5; Gunturkun O, 1999, BEHAV BRAIN RES, V98, P193, DOI 10.1016/S0166-4328(98)00084-9; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; Hunt GR, 2001, NATURE, V414, P707, DOI 10.1038/414707a; MAI JK, 1990, J HIRNFORSCH, V31, P331; Prior H, 2001, LEARN MEMORY, V8, P44, DOI 10.1101/lm.36201; PRIOR H, 2001, ORIENTATION NAVIGATI; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rogers L, 1996, NEUROSCI BIOBEHAV R, V20, P487, DOI 10.1016/0149-7634(95)00024-0; Rogers LJ., 2002, COMP VERTEBRATE LATE; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; Tommasi L, 2001, BEHAV NEUROSCI, V115, P602, DOI 10.1037//0735-7044.115.3.602; Ulrich C, 1999, BEHAV BRAIN RES, V104, P169, DOI 10.1016/S0166-4328(99)00062-5; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 1996, BEHAV BRAIN RES, V74, P135, DOI 10.1016/0166-4328(95)00037-2; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 2001, NATURWISSENSCHAFTEN, V88, P387, DOI 10.1007/s001140100248; Wiltschko W, 2001, J EXP BIOL, V204, P3295; WILTSCHKO W, 1972, SCIENCE, V176, P42; [No title captured]	25	146	154	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					467	470		10.1038/nature00958	http://dx.doi.org/10.1038/nature00958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368853				2022-12-24	WOS:000178348400034
J	Singler, J; Farmer, P				Singler, J; Farmer, P			Treating HIV in resource-poor settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AIDS		Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Singler, J (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							*CDCP, 1999, HIV AIDS SURV REP, P11; Dore GJ, 2002, J ACQ IMMUN DEF SYND, V29, P388, DOI 10.1097/00126334-200204010-00010; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; Farmer P., 1999, INFECT INEQUALITIES; *JOINT UN PROGR HI, 2002, NEW UNAIDS REP WARNS; *JOINT UN PROGR HI, 2002, REP GLOB HIV AIDS EP; *JOINT UN PROGR HI, 2002, 14 INT C AICS BARC S; Kim J. Y., 2000, DYING GROWTH GLOBAL; LASANTE Z, 2002, RAPPORTS TRIMESTERIE; McNaghten AD, 1999, AIDS, V13, P1687, DOI 10.1097/00002030-199909100-00012; *MED SANS FRONT, AIDS TRIPL THER LESS; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; PAPE J, 1993, CLIN INFECT DIS, V17, pS341, DOI 10.1093/clinids/17.Supplement_2.S341; Raviola G, 2002, CULT MED PSYCHIAT, V26, P55, DOI 10.1023/A:1015289132151; United Nations Development Program, 2000, HUM DEV REP 2000; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; HIV AIDS BRAZIL CLAI; 2002, B EPIDEMIOLOGICO AID	19	7	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1652	1653		10.1001/jama.288.13.1652	http://dx.doi.org/10.1001/jama.288.13.1652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350202				2022-12-24	WOS:000178314000031
J	Hohler, T; Reuss, E; Evers, N; Dietrich, E; Rittner, C; Freitag, CM; Vollmar, J; Schneider, PM; Fimmers, R				Hohler, T; Reuss, E; Evers, N; Dietrich, E; Rittner, C; Freitag, CM; Vollmar, J; Schneider, PM; Fimmers, R			Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins	LANCET			English	Article							VIRAL-HEPATITIS; INFECTION; ASSOCIATION; HLA; SUSCEPTIBILITY; TUBERCULOSIS; AFRICANS; MHC	Background The course of viral hepatitis is thought to be affected by genetic host variability and, in particular, by genes of the major histocompatibility locus. Hepatitis A and B vaccination is a useful model to. study the effect of host factors on the immune response to viral antigens. We aimed to assess the heritability of the HBsAg (anti-HBs) and anti-hepatitis A virus (anti-HAV) immune response and to estimate the effect of the HLA-DRB1 locus and other genetic loci unlinked to HLA. Methods We did an open prospective study and vaccinated 202 twin pairs with a combined recombinant HBsAg/inactivated hepatitis A vaccine. We measured antibodies to HBsAg and HAV and determined HLA-DRB1* alleles. Heritability was calculated based on variance of antibody response within pairs. Model-fitting analyses were done to analyse genetic and environmental components of vaccine responses. Findings Anti-HBs and anti-HAV showed heritabilities of 0.61 (95% CI 0.41 to 0.81) and 0.36 (-0.02 to 0.73), respectively. For the anti-HBs immune response, 60% of the phenotypic variance was explained by additive genetic and 40% by non-shared environmental effects. The heritability of the HBsAg vaccine response accounted for by the DRB1* locus was estimated to be 0.25, leaving the remaining heritability of 0.36 to other gene loci. Interpretation Genetic factors have a strong effect on the immune response to HBsAg. Although genes encoded within the MHC are important for this immune response, more than half the heritability is determined outside this complex. Identification of these genes will help us to understand regulation of immune responses to viral proteins.	Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Dept Internal Med, D-55101 Mainz, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; GlaxoSmithKline, Munich, Germany; Johannes Gutenberg Univ Mainz, Inst Legal Med, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Bonn; GlaxoSmithKline; Johannes Gutenberg University of Mainz	Hohler, T (corresponding author), Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, Dept Internal Med, D-55101 Mainz, Germany.	hoehler@mail.uni-mainz.de	Schneider, Peter M./A-6661-2011	Schneider, Peter M./0000-0003-0744-2349; Freitag, Christine Margarete/0000-0001-9676-4782				Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; ALMARRI A, 1994, LANCET, V344, P1194, DOI 10.1016/S0140-6736(94)90510-X; ALPER CA, 1989, NEW ENGL J MED, V321, P708, DOI 10.1056/NEJM198909143211103; BEIN G, 1992, TISSUE ANTIGENS, V39, P68, DOI 10.1111/j.1399-0039.1992.tb01909.x; Bellamy R, 1998, QJM-INT J MED, V91, P13, DOI 10.1093/qjmed/91.1.13; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; CRAVEN DE, 1986, ANN INTERN MED, V105, P356, DOI 10.7326/0003-4819-105-3-356; Desombere I, 1998, TISSUE ANTIGENS, V51, P593, DOI 10.1111/j.1399-0039.1998.tb03001.x; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hohler T, 1998, EXP CLIN IMMUNOGENET, V15, P130, DOI 10.1159/000019064; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Hohler T, 1998, HUM IMMUNOL, V59, P212, DOI 10.1016/S0198-8859(98)00014-7; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Karayiannis P, 1995, HEPATOLOGY, V22, P1628, DOI 10.1016/0270-9139(95)90183-3; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lemon SM, 1997, NEW ENGL J MED, V336, P196, DOI 10.1056/NEJM199701163360307; LIN TM, 1989, ANTICANCER RES, V9, P737; Martin MP, 1998, IMMUNOGENETICS, V47, P503, DOI 10.1007/s002510050392; Neale M. C., 1999, MX STAT MODELING; Neale MC, 1992, METHODOLOGY GENETIC; *SAS I INC, 1997, SAS ETS SOFTW CHANG; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thoelen S, 1999, VACCINE, V17, P1657, DOI 10.1016/S0264-410X(98)00421-6; Thomas HC, 1996, LANCET, V348, P1417, DOI 10.1016/S0140-6736(96)05409-8; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Vogel F., 1997, HUMAN GENETICS PROBL; Zhang L, 2000, HEPATOLOGY, V32, p392A	28	145	158	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2002	360	9338					991	995		10.1016/S0140-6736(02)11083-X	http://dx.doi.org/10.1016/S0140-6736(02)11083-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597YU	12383669				2022-12-24	WOS:000178249000012
J	Llave, C; Xie, ZX; Kasschau, KD; Carrington, JC				Llave, C; Xie, ZX; Kasschau, KD; Carrington, JC			Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA	SCIENCE			English	Article							C-ELEGANS; GENE; INTERFERENCE; EXPRESSION; ENCODES; DICER; STEP	Micro-RNAs ( miRNAs) are regulatory molecules that mediate effects by interacting with messenger RNA ( mRNA) targets. Here we show that Arabidopsis thaliana miRNA 39 ( also known as miR171), a 21-ribonucleotide species that accumulates predominantly in inflorescence tissues, is produced from an intergenic region in chromosome III and functionally interacts with mRNA targets encoding several members of the Scarecrow-like (SCL) family of putative transcription factors. miRNA 39 is complementary to an internal region of three SCL mRNAs. The interaction results in specific cleavage of target mRNA within the region of complementarity, indicating that this class of miRNA functions like small interfering RNA associated with RNA silencing to guide sequence-specific cleavage in a developmentally controlled manner.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@orst.edu	Llave, Cesar/ABF-5827-2021; Carrington, James C/A-4656-2012	Carrington, James C/0000-0003-3572-129X; Xie, Zhixin/0000-0002-6191-5170	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI027832, R01AI027832, R01AI043288, R37AI043288, R21AI043288] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43288, AI27832] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bolle C, 2000, GENE DEV, V14, P1269; CARRINGTON JC, 1990, EMBO J, V9, P1347, DOI 10.1002/j.1460-2075.1990.tb08249.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; FEINBERG AP, 1983, ANAL BIOCHEM, V257, P8569; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; LLAVE C, UNPUB; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	34	1218	1414	16	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					2053	2056		10.1126/science.1076311	http://dx.doi.org/10.1126/science.1076311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242443				2022-12-24	WOS:000178078500047
J	Claxton, K; Sculpher, M; Drummond, M				Claxton, K; Sculpher, M; Drummond, M			A rational framework for decision making by the National Institute for Clinical Excellence (NICE)	LANCET			English	Editorial Material								Regulatory and reimbursement authorities face uncertain choices when considering the adoption of health-care technologies. in this Viewpoint, we present an analytic framework that separates the issue of whether a technology should be adopted on the basis of existing evidence from whether more research should be demanded to support future decisions. We show the application of this framework to the assessment of heath-care technologies using a published analysis of a new drug treatment for Alzheimer's disease. The results of the analysis show that the amount and type of evidence required to support the adoption of a health technology will differ substantially between technologies with different characteristics. Additionally, the analysis can be used to aid the efficient design of research. We discuss the implications of adoption of this new framework for regulatory and reimbursement decisions.	Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Claxton, K (corresponding author), Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England.	kpc1@york.ac.uk		Sculpher, Mark/0000-0003-3746-9913				Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9; Claxton K, 2001, INT J TECHNOL ASSESS, V17, P38, DOI 10.1017/S0266462301104058; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; CLAXTON K, 1999, MED DECIS MAKING, V19, P4; CLEGG A, 2000, HEALTH TECHNOL ASSES, V5, P1; Commonwealth Department of Health Housing and Community Services, 1992, GUID PHARM IND PREP; CRITCHFIELD GC, 1986, MED DECIS MAKING, V6, P85, DOI 10.1177/0272989X8600600205; Drummond M F, 1991, Int J Technol Assess Health Care, V7, P561; Felli JC, 1998, MED DECIS MAKING, V18, P95, DOI 10.1177/0272989X9801800117; Fenwick E, 2000, 179 U YORK CTR HLTH; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Langley PC, 1999, PHARMACOECONOMICS, V16, P211, DOI 10.2165/00019053-199916030-00001; McDonagh M S, 2000, Health Technol Assess, V4, P1; Ministry of Health (Ontario), 1994, ONT GUID EC AN PHARM; Neumann PJ, 1999, NEUROLOGY, V52, P1138, DOI 10.1212/WNL.52.6.1138; Neumann PJ, 2000, HEALTH AFFAIR, V19, P129, DOI 10.1377/hlthaff.19.5.129; Sculpher M, 1997, J Health Serv Res Policy, V2, P26; SHERLAWJOHNSON C, 1994, J CLIN PATHOL, V47, P430, DOI 10.1136/jcp.47.5.430; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Thompson KM, 1997, RISK ANAL, V17, P253, DOI 10.1111/j.1539-6924.1997.tb00864.x	22	329	338	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2002	360	9334					711	715		10.1016/S0140-6736(02)09832-X	http://dx.doi.org/10.1016/S0140-6736(02)09832-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590AM	12241891				2022-12-24	WOS:000177795100026
J	Smith, RJH				Smith, RJH			Deafness: from bedside to bench and back	LANCET			English	Editorial Material							HEARING-LOSS; MUTATIONS; ATTITUDES; GENE		Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, Iowa City, IA 52242 USA	University of Iowa	Smith, RJH (corresponding author), Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu		Smith, Richard/0000-0003-1201-6731				Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; ARNOS KS, 1991, ANN NY ACAD SCI, V630, P212, DOI 10.1111/j.1749-6632.1991.tb19590.x; Brunger JW, 2000, AM J HUM GENET, V67, P1621, DOI 10.1086/316901; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Cryns K, 2002, HUM GENET, V110, P389, DOI 10.1007/s00439-002-0719-1; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Middleton A, 1998, AM J HUM GENET, V63, P1175, DOI 10.1086/302060; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999; 2002, HEREDITARY HEARING L	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2002	360	9334					656	657		10.1016/S0140-6736(02)09881-1	http://dx.doi.org/10.1016/S0140-6736(02)09881-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241869				2022-12-24	WOS:000177795100004
J	Ma, JY; Wollmann, R; Lindquist, S				Ma, JY; Wollmann, R; Lindquist, S			Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol	SCIENCE			English	Article							STRAUSSLER-SCHEINKER-DISEASE; MUTANT PRION PROTEIN; TRANSGENIC MICE; THERMODYNAMIC STABILITY; ENDOPLASMIC-RETICULUM; INSERTIONAL MUTATION; SCRAPIE; CELLS; TRANSMISSION; EXPRESSION	Changes in prion protein (PrP) folding are associated with fatal neurodegenerative disorders, but the neurotoxic species is unknown. Like other proteins that traffic through the endoplasmic reticulum, misfolded PrP is retrograde transported to the cytosol for degradation by proteasomes. Accumulation of even small amounts of cytosolic PrP was strongly neurotoxic in cultured cells and transgenic mice. Mice developed normally but acquired severe ataxia, with cerebellar degeneration and gliosis. This establishes a mechanism for converting wild-type PrP to a highly neurotoxic species that is distinct from the self-propagating PrPSc isoform and suggests a potential common framework for seemingly diverse PrP neurodegenerative disorders.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Lindquist, S (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			Ma, Jiyan/0000-0001-7150-1898	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2000, INVEST NEW DRUG, V18, P109, DOI 10.1023/A:1006321828515; Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Andre P, 1998, P NATL ACAD SCI USA, V95, P13120, DOI 10.1073/pnas.95.22.13120; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1997, TRENDS CELL BIOL, V7, P56, DOI 10.1016/S0962-8924(96)10054-4; CHESEBRO B, 1993, DEV BIOL STAND, V80, P131; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Doyle D, 1998, TRENDS GENET, V14, P171, DOI 10.1016/S0168-9525(98)01454-1; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holscher C, 2001, J BIOL CHEM, V276, P13388, DOI 10.1074/jbc.M007331200; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RUSSELAKISCARNE.M, 2002, J BIOL CHEM, V18, P18; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	41	380	396	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1781	1785		10.1126/science.1073725	http://dx.doi.org/10.1126/science.1073725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12386337				2022-12-24	WOS:000179494800043
J	Deecke, VB; Slater, PJB; Ford, JKB				Deecke, VB; Slater, PJB; Ford, JKB			Selective habituation shapes acoustic predator recognition in harbour seals	NATURE			English	Article							WHALES ORCINUS-ORCA; RESIDENT KILLER WHALES; GENETIC DIFFERENTIATION; POPULATIONS; EVOLUTION; BEHAVIOR	Predation is a major force in shaping the behaviour of animals(1-3), so that precise identification of predators will confer substantial selective advantages on animals that serve as food to others. Because experience with a predator can be lethal, early researchers studying birds suggested that predator recognition does not require learning(4,5). However, a predator image that can be modified by learning and experience will be advantageous in situations where cues associated with the predator are highly variable or change over time. In this study, we investigated the response of harbour seals (Phoca vitulina) to the underwater calls of different populations of killer whales (Orcinus orca). We found that the seals responded strongly to the calls of mammal-eating killer whales and unfamiliar fish-eating killer whales but not to the familiar calls of the local fish-eating population. This demonstrates that wild harbour seals are capable of complex acoustic discrimination and that they modify their predator image by selectively habituating to the calls of harmless killer whales. Fear in these animals is therefore focused on local threats by learning and experience.	Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; Vancouver Aquarium Marine Sci Ctr, Vancouver, BC V6B 3X8, Canada; Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada	University of St Andrews; Fisheries & Oceans Canada	Deecke, VB (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland.	vd2@st-andrews.ac.uk		Deecke, Volker/0000-0003-2781-5915				BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; BARRETTLENNARD LG, 2000, THESIS U BRIT COLUMB; Bigg M.A., 1990, REP INT WHALING COMM, V12, P384; Bradbury Jack W., 1998, pi; CURIO E, 1993, ADV STUD BEHAV, V22, P135, DOI 10.1016/S0065-3454(08)60407-6; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; KROODSMA DE, 1989, ANIM BEHAV, V37, P600, DOI 10.1016/0003-3472(89)90039-0; Lorenz K., 1939, VERH DTSCH ZOOL GES, P69; MILLER P.J.O., 2000, THESIS MIT; MOHL B, 1968, Journal of Auditory Research, V8, P27; Nichol LM, 1996, CAN J ZOOL, V74, P983, DOI 10.1139/z96-111; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; SCHLEIDT WM, 1961, NATURWISSENSCHAFTEN, V48, P141, DOI 10.1007/BF00631948; Tinbergen N., 1948, Wilson Bulletin, V60, P6; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; Wiley R. Haven, 1994, P157; Yurk H, 2002, ANIM BEHAV, V63, P1103, DOI 10.1006/anbe.2002.3012; Zar JH, 1996, BIOSTATISTICAL ANAL	25	144	152	0	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 14	2002	420	6912					171	173		10.1038/nature01030	http://dx.doi.org/10.1038/nature01030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432391				2022-12-24	WOS:000179200900044
J	Edwards, JE; McQuay, HJ				Edwards, JE; McQuay, HJ			Dipyrone and agranulocytosis: what is the risk?	LANCET			English	Editorial Material									Univ Oxford, Oxford Radcliffe Hosp NHS Trust, Pain Res & Nuffield Dept Anaesthet, Oxford OX3 7LJ, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford	Edwards, JE (corresponding author), Univ Oxford, Oxford Radcliffe Hosp NHS Trust, Pain Res & Nuffield Dept Anaesthet, S Parks Rd, Oxford OX3 7LJ, England.							Bensenor I M, 2001, Sao Paulo Med J, V119, P190; Hedenmalm K, 2002, EUR J CLIN PHARMACOL, V58, P265, DOI 10.1007/s00228-002-0465-2; KRAMER MS, 1987, J CHRON DIS, V40, P1073, DOI 10.1016/0021-9681(87)90073-7; Shapiro S, 1999, AM J TROP MED HYG, V60, P573, DOI 10.4269/ajtmh.1999.60.573; The International Agranulocytosis and Aplastic Anemia Study, 1986, JAMA-J AM MED ASSOC, V256, P1749; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Tramer MR, 1997, BRIT J ANAESTH, V78, P642, DOI 10.1093/bja/78.6.642; van der Klauw MM, 1999, ARCH INTERN MED, V159, P369, DOI 10.1001/archinte.159.4.369	8	43	45	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 9	2002	360	9344					1438	1438		10.1016/S0140-6736(02)11489-9	http://dx.doi.org/10.1016/S0140-6736(02)11489-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JV	12433507				2022-12-24	WOS:000179186000004
J	Dickson, JAD				Dickson, JAD			Fossil echinoderms as monitor of the Mg/Ca ratio of phanerozoic oceans	SCIENCE			English	Article							SEAWATER CHEMISTRY; CALCITE; REEF; MG; TEMPERATURE; MAGNESIUM; CEMENTS; TRANSFORMATION; OSCILLATIONS; LIMESTONES	Opinion has long been divided as to whether the Mg/Ca ratio of seawater remained constant during the Phanerozoic or underwent substantial secular change. Existing empirical evidence for the Mg/Ca of ancient seawater provides a poorly resolved and often controversial signal. Echinoderm fossils that have retained their bulk original chemistry, despite micrometer-scale changes, preserve a record of seawater Mg/Ca and confirm that major changes in Mg/Ca occurred during the Phanerozoic. Echinoderms from the Cambrian and from the Carboniferous to the Triassic indicate a seawater Mg/Ca of 3.3, whereas echinoderms from the Jurassic to the Cretaceous indicate a Mg/Ca of 1.4. The present seawater Mg/Ca is 5.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Dickson, JAD (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	jadd1@esc.cam.ac.uk						ALEXANDERSSON T, 1974, J SEDIMENT PETROL, V44, P7; ANDREWS JE, 1988, SCOT J GEOL, V24, P233, DOI 10.1144/sjg24030233; Burns SJ, 2000, SEDIMENTOLOGY, V47, P49, DOI 10.1046/j.1365-3091.2000.00004.x; BURTON EA, 1993, CHEM GEOL, V105, P163, DOI 10.1016/0009-2541(93)90124-2; Carpenter S.J., 1991, GEOCHIM COSMOCHIM AC, V55; CHAVE KE, 1954, J GEOL, V62, P266, DOI 10.1086/626162; de Villiers S, 1999, SCIENCE, V285, P721, DOI 10.1126/science.285.5428.721; Dickson JAD, 2001, GEOCHIM COSMOCHIM AC, V65, P443, DOI 10.1016/S0016-7037(00)00547-0; Dickson JAD, 2001, J SEDIMENT RES, V71, P764, DOI 10.1306/2DC40966-0E47-11D7-8643000102C1865D; DICKSON JAD, 1965, NATURE, V205, P587, DOI 10.1038/205587a0; GINSBURG RN, 1973, SEDIMENTOLOGY, V20, P575, DOI 10.1111/j.1365-3091.1973.tb01633.x; GREGOR CB, 1988, CHEM CYCLES EVOLUTIO; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hartley G, 1996, GEOCHIM COSMOCHIM AC, V60, P315, DOI 10.1016/0016-7037(95)00388-6; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Holland HD, 2000, INT GEOL REV, V42, P481, DOI 10.1080/00206810009465093; Holland HD, 1998, GEOLOGY, V26, P92; Holland HD, 1996, GEOLOGY, V24, P993, DOI 10.1130/0091-7613(1996)024<0993:OTSVIT>2.3.CO;2; JAMES NP, 1983, J SEDIMENT PETROL, V53, P1051; JAMES NP, 1976, J SEDIMENT PETROL, V46, P523; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; MACINTYRE IG, 1977, J SEDIMENT PETROL, V47, P503; MACKENZIE FT, 1992, GEOCHIM COSMOCHIM AC, V56, P3281, DOI 10.1016/0016-7037(92)90305-3; MCKENZIE JA, 1982, TECTONOPHYSICS, V86, P149, DOI 10.1016/0040-1951(82)90065-8; MILLIMAN JD, 1973, SEDIMENTOLOGY, V20, P29, DOI 10.1111/j.1365-3091.1973.tb01605.x; MORSE JW, 1990, CHEM GEOL, V82, P265, DOI 10.1016/0009-2541(90)90085-L; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Muller J., 1974, INT ASS SEDIMENTOLOG, V1, P235; PIGOTT JD, 1986, MAR CHEM, V19, P355, DOI 10.1016/0304-4203(86)90056-3; Rimstidt JD, 1998, GEOCHIM COSMOCHIM AC, V62, P1851, DOI 10.1016/S0016-7037(98)00125-2; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; SCHLAGER W, 1978, SEDIMENTOLOGY, V25, P675, DOI 10.1111/j.1365-3091.1978.tb00325.x; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; WEBER JN, 1973, J GEOL, V81, P543, DOI 10.1086/627906; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; WILKINSON BH, 1985, J SEDIMENT PETROL, V55, P171; Wilson PA, 2002, GEOLOGY, V30, P607, DOI 10.1130/0091-7613(2002)030<0607:TTCGHU>2.0.CO;2	37	183	192	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1222	1224		10.1126/science.1075882	http://dx.doi.org/10.1126/science.1075882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424375				2022-12-24	WOS:000179080400046
J	Ling, K; Doughman, RL; Firestone, AJ; Bunce, MW; Anderson, RA				Ling, K; Doughman, RL; Firestone, AJ; Bunce, MW; Anderson, RA			Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions	NATURE			English	Article							4-PHOSPHATE 5-KINASE; TALIN; BINDING; DOMAIN; ACTIN; TYROSINE; ASSOCIATION; ACTIVATION; PROTEINS; VINCULIN	The ability of cells to form cell contacts, adhere to the extracellular matrix, change morphology, and migrate is essential for development, wound healing, metastasis, cell survival and the immune response. These events depend on the binding of integrin to the extracellular matrix, and assembly of focal adhesions, which are complexes comprising scaffolding and signalling proteins organized by adhesion to the extracellular matrix(1-3). Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2) regulates interactions between these proteins, including the interaction of vinculin with actin and talin(4-9). The binding of talin to beta-integrin is strengthened by PtdIns(4,5)P-2, suggesting that the basis of focal adhesion assembly is regulated by this lipid mediator(9,10). Here we show that the type I phosphatidylinositol phosphate kinase isoform-gamma 661 (PIPKI-gamma661), an enzyme that makes PtdIns(4,5)P-2, is targeted to focal adhesions by an association with talin. PIPKIgamma661 is tyrosine phosphorylated by focal adhesion associated kinase signalling, increasing both the activity of phosphatidylinositol phosphate kinase and its association with talin. This defines a mechanism for spatial generation of PtdIns(4,5)P-2 at focal adhesions.	Univ Wisconsin, Sch Med, Dept Pharmacol, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med, Dept Pharmacol, Program Mol & Cellular Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@facstaff.wisc.edu		Anderson, Richard/0000-0001-6265-8359; Firestone, Ari/0000-0001-9902-443X				ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; CARY LA, 1999, FRONT BIOSCI, V4, P102; CHAN PY, 1994, J BIOL CHEM, V269, P20567; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DECLUE JE, 1987, MOL CELL BIOL, V7, P371, DOI 10.1128/MCB.7.1.371; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; James P, 1996, GENETICS, V144, P1425; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Rodriguez-Fernandez JL, 1998, J BIOL CHEM, V273, P19321, DOI 10.1074/jbc.273.30.19321; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	31	367	379	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2002	420	6911					89	93		10.1038/nature01082	http://dx.doi.org/10.1038/nature01082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422220				2022-12-24	WOS:000179068100042
J	Helmuth, B; Harley, CDG; Halpin, PM; O'Donnell, M; Hofmann, GE; Blanchette, CA				Helmuth, B; Harley, CDG; Halpin, PM; O'Donnell, M; Hofmann, GE; Blanchette, CA			Climate change and latitudinal patterns of intertidal thermal stress	SCIENCE			English	Article							COMMUNITY STRUCTURE; TEMPERATURE; LIMITS; ORGANISMS; ABUNDANCE; PREDATOR; MUSSELS	The interaction of climate and the timing of low tides along the West Coast of the United States creates a complex mosaic of thermal environments, in which northern sites can be more thermally stressful than southern sites. Thus, climate change may not lead to a poleward shift in the distribution of intertidal organisms, as has been proposed, but instead will likely cause localized extinctions at a series of "hot spots". Patterns of exposure to extreme climatic conditions are temporally variable, and tidal predictions suggest that in the next 3 to 5 years "hot spots" are likely to appear at several northern sites.	Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; Univ Washington, Dept Zool, Seattle, WA 98195 USA; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Washington; University of Washington Seattle; Stanford University; Oregon State University; University of California System; University of California Santa Barbara	Helmuth, B (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.		Helmuth, Brian/AAD-2664-2019; Harley, Christopher D. G./K-5593-2012	Helmuth, Brian/0000-0003-0180-3414; Harley, Christopher D. G./0000-0003-4099-943X; O'Donnell, Michael/0000-0001-7016-0614				BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; BELL EC, 1995, J EXP MAR BIOL ECOL, V191, P29, DOI 10.1016/0022-0981(95)00037-R; BELL EC, 1992, THESIS STANFORD U; Bertness MD, 1999, OECOLOGIA, V120, P446, DOI 10.1007/s004420050877; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Buckley BA, 2001, J EXP BIOL, V204, P3571; Dahlhoff EP, 2001, ECOLOGY, V82, P2816, DOI 10.2307/2679963; Denny MW, 1998, BIOL BULL, V194, P108, DOI 10.2307/1543040; DOTY MS, 1946, ECOLOGY, V27, P315, DOI 10.2307/1933542; FIELDS PA, 1993, TRENDS ECOL EVOL, V8, P361, DOI 10.1016/0169-5347(93)90220-J; FRANK PW, 1975, MAR BIOL, V31, P181, DOI 10.1007/BF00391630; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; GILMAN SE, 2002, 35 ANN M W SOC MAL A; Helmuth B, 1999, ECOLOGY, V80, P15; HELMUTH B, IN PRESS INTEGR COMP; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; Hofmann GE, 1996, MOL MAR BIOL BIOTECH, V5, P175; HOFMANN GE, UNPUB; JOHNSON SE, 1975, PERSPECTIVES BIOPHYS, P559; Lubchenco Jane, 1993, P147; MENGE B, COMMUNICATION; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; ORTON J. H., 1929, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V16, P289; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; Paine R. T., 1994, MARINE ROCKY SHORES; Roberts DA, 1997, BIOL BULL, V192, P309, DOI 10.2307/1542724; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; SOUTHWARD AJ, 1958, J MAR BIOL ASSOC UK, V37, P49, DOI 10.1017/S0025315400014818; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Tomanek L, 1999, J EXP BIOL, V202, P2925; WETHEY DS, 1983, BIOL BULL-US, V165, P330, DOI 10.2307/1541373; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2; [No title captured]	38	530	536	1	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					1015	1017		10.1126/science.1076814	http://dx.doi.org/10.1126/science.1076814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411702				2022-12-24	WOS:000178932000053
J	Nunez, L; Grosjean, M; Cartajena, I				Nunez, L; Grosjean, M; Cartajena, I			Human occupations and climate change in the Puna de Atacama, Chile	SCIENCE			English	Article							NORTHERN; DESERT; RECORD; PRECIPITATION; CULTURE; HISTORY	Widespread evidence for human occupation of the Atacama Desert, 20degrees to 25degreesS in northern Chile, has been found from 13,000 calibrated 14 C years before the present (cal yr B. P.) to 9500 cal yr B. P., and again after 4500 cal yr B. P. Initial human occupation coincided with a change from very dry environments to humid environments. More than 39 open early Archaic campsites at elevations above 3600 meters show that hunters lived around late glacial/early Holocene paleolakes on the Altiplano. Cessation of the use of the sites between 9500 and 4500 cal yr B. P. is associated with drying of the lakes. The mid-Holocene collapse of human occupation is also recorded in cave deposits. One cave contained Pleistocene fauna associated with human artifacts. Faunal diversity was highest during the humid early Holocene.	Univ Bern, Natl Ctr Competence Res Climate, CH-3012 Bern, Switzerland; Univ Catolica Norte, Inst Invest Arqueol & Museo, San Pedro, Atacama, Chile; Univ Chile, Dept Antropol, Santiago, Chile	University of Bern; Universidad Catolica del Norte; Universidad de Chile	Grosjean, M (corresponding author), Univ Bern, Natl Ctr Competence Res Climate, 9A Erlachstr, CH-3012 Bern, Switzerland.	grosjean@giub.unibe.ch	Cartajena, Isabel/AAO-8406-2021	Cartajena, Isabel/0000-0003-4048-5359				ALBERDI MT, COMMUNICATION; ALDENDERFER M, 1988, SCIENCE, V241, P1828, DOI 10.1126/science.241.4874.1828; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Betancourt JL, 2000, SCIENCE, V289, P1542, DOI 10.1126/science.289.5484.1542; DILLEHAY TD, 1989, SCIENCE, V245, P1436; Fernandez J., 1991, Geoarchaeology, V6, P251, DOI 10.1002/gea.3340060303; *FOND NAC DES CIEN, 1930022 FOND NAC DES; Geyh MA, 1999, QUATERNARY RES, V52, P143, DOI 10.1006/qres.1999.2060; Grosjean M, 2001, SCIENCE, V292; Grosjean M, 1997, QUATERNARY RES, V48, P239, DOI 10.1006/qres.1997.1917; Grosjean M, 2001, GLOBAL PLANET CHANGE, V28, P35, DOI 10.1016/S0921-8181(00)00063-1; Latorre C, 2002, GEOL SOC AM BULL, V114, P349, DOI 10.1130/0016-7606(2002)114<0349:VIIADA>2.0.CO;2; LYNCH TF, 1992, QUATERNARY RES, V37, P117, DOI 10.1016/0033-5894(92)90010-G; Meltzer DJ, 1997, AM ANTIQUITY, V62, P659, DOI 10.2307/281884; N??ez AL., 1999, ESTUD ATACAMENOS, V17, P125; N??ez L., 2001, INTERHEMISPHERIC CLI, P105; *NAT GEOGR SOC, 583696 NAT GEOGR SOC; Sandweiss DH, 1999, SCIENCE, V283, P499, DOI 10.1126/science.283.5401.499; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Seltzer GO, 1998, GEOLOGY, V26, P167, DOI 10.1130/0091-7613(1998)026<0167:HRSRPF>2.3.CO;2; *SWISS NAT SCI FDN, 2157073 SWISS NAT SC; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; TONNI EP, COMMUNICATION	23	197	213	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					821	824		10.1126/science.1076449	http://dx.doi.org/10.1126/science.1076449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399589				2022-12-24	WOS:000178791200057
J	Herndon, LA; Schmeissner, PJ; Dudaronek, JM; Brown, PA; Listner, KM; Sakano, Y; Paupard, MC; Hall, DH; Driscoll, M				Herndon, LA; Schmeissner, PJ; Dudaronek, JM; Brown, PA; Listner, KM; Sakano, Y; Paupard, MC; Hall, DH; Driscoll, M			Stochastic and genetic factors influence tissue-specific decline in ageing C-elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN; STRESS RESISTANCE; QUANTITATIVE MEASURES; CELL-DEATH; GERM-LINE; EXPRESSION; MECHANISMS; MUTATIONS; LONGEVITY	The nematode Caenorhabditis elegans is an important model for studying the genetics of ageing, with over 50 life-extension mutations known so far. However, little is known about the pathobiology of ageing in this species, limiting attempts to connect genotype with senescent phenotype. Using ultrastructural analysis and visualization of specific cell types with green fluorescent protein, we examined cell integrity in different tissues as the animal ages. We report remarkable preservation of the nervous system, even in advanced old age, in contrast to a gradual, progressive deterioration of muscle, resembling human sarcopenia. The age-1 (hx546) mutation, which extends lifespan by 60-100%, delayed some, but not all, cellular biomarkers of ageing. Strikingly, we found strong evidence that stochastic as well as genetic factors are significant in C. elegans ageing, with extensive variability both among same-age animals and between cells of the same type within individuals.	Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs A232, Piscataway, NJ 08854 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine	Driscoll, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs A232, 604 Allison Rd, Piscataway, NJ 08854 USA.	hall@aecom.yu.edu; driscoll@mbcl.rutgers.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER; NCRR NIH HHS [R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; BOLANOWSKI MA, 1983, MECH AGEING DEV, V21, P295, DOI 10.1016/0047-6374(83)90048-9; BOLANOWSKI MA, 1981, MECH AGEING DEV, V15, P279, DOI 10.1016/0047-6374(81)90136-6; Braeckman BP, 2001, MECH AGEING DEV, V122, P673, DOI 10.1016/S0047-6374(01)00222-6; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Driscoll M, 1996, BRAIN PATHOL, V6, P411, DOI 10.1111/j.1750-3639.1996.tb00873.x; DUHON SA, 1995, J GERONTOL A-BIOL, V50, pB254, DOI 10.1093/gerona/50A.5.B254; Epstein J, 1972, MECH AGEING DEV, V1, P245, DOI 10.1016/0047-6374(72)90091-7; Finch C, 2000, CHANCE DEV AGING; FRIEDMAN DB, 1988, GENETICS, V118, P75; FUJISAWA K, 1975, J NEUROL SCI, V24, P447, DOI 10.1016/0022-510X(75)90170-7; Garigan D, 2002, GENETICS, V161, P1101; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hall DH, 1997, J NEUROSCI, V17, P1033; Hall DH, 1995, METHOD CELL BIOL, V48, P395; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Helfand SL, 1996, MECH DEVELOP, V55, P45, DOI 10.1016/0925-4773(95)00489-0; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hughes SM, 1999, ACTA PHYSIOL SCAND, V167, P307; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; JOHNSON TE, 1987, P NATL ACAD SCI USA, V84, P3777, DOI 10.1073/pnas.84.11.3777; JOHNSON TE, 1985, MECH AGEING DEV, V30, P285, DOI 10.1016/0047-6374(85)90118-6; Jucker M, 2000, EXP GERONTOL, V35, P1383, DOI 10.1016/S0531-5565(00)00190-X; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirkwood TBL, 1996, BIOESSAYS, V18, P1009, DOI 10.1002/bies.950181211; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Kirkwood TBL, 2002, NEUROBIOL AGING, V23, P21, DOI 10.1016/S0197-4580(01)00260-3; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; MADURO M, 1995, GENETICS, V141, P977; MITANI S, 1993, DEVELOPMENT, V119, P773; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Paupard MC, 2001, J HISTOCHEM CYTOCHEM, V49, P949, DOI 10.1177/002215540104900803; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rogina B, 1998, CURR BIOL, V8, P475, DOI 10.1016/S0960-9822(98)70184-8; Sozou PD, 2001, J THEOR BIOL, V213, P573, DOI 10.1006/jtbi.2001.2432; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TAKAHASHI A, 1970, J GERONTOL, V25, P222, DOI 10.1093/geronj/25.3.222; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Waterston R., 1988, NEMATODE C ELEGANS, P281; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	48	777	800	2	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					808	814		10.1038/nature01135	http://dx.doi.org/10.1038/nature01135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397350				2022-12-24	WOS:000178769800038
J	Czermin, B; Melfi, R; McCabe, D; Seitz, V; Imhof, A; Pirrotta, V				Czermin, B; Melfi, R; McCabe, D; Seitz, V; Imhof, A; Pirrotta, V			Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites	CELL			English	Article							GROUP GENE; HETEROCHROMATIN PROTEIN-1; EPIGENETIC INHERITANCE; TRANSCRIPTION FACTORS; CORE PARTICLES; LYSINE 9; HP1; METHYLATION; CHROMATIN; CONTAINS	Enhancer of Zeste is a Polycomb Group protein essential for the establishment and maintenance of repression of homeotic and other genes. In the early embryo it is found in a complex that includes ESC and is recruited to Polycomb Response Elements. We show that this complex contains a methyltransferase activity that methylates lysine 9 and lysine 27 of histone H3, but the activity is lost when the E(Z) SET domain is mutated. The lysine 9 position is trimethylated and this mark is closely associated with Polycomb binding sites on polytene chromosomes but is also found in centric heterochromatin, chromosome 4, and telomeric sites. Histone H3 methylated in vitro by the E(Z)/ ESC complex binds specifically to Polycomb protein.	Univ Geneva, Dept Zool, CH-1011 Lausanne, Switzerland; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	University of Geneva; University of Munich	Pirrotta, V (corresponding author), Univ Geneva, Dept Zool, 30 Quai Ernest Ansermet, CH-1011 Lausanne, Switzerland.	pirrotta@zoo.unige.ch	Imhof, Axel/AAU-5313-2021; jia, xu/A-8386-2016	Imhof, Axel/0000-0003-2993-8249; MELFI, Raffaella/0000-0003-4463-8156				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Birve A, 2001, DEVELOPMENT, V128, P3371; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; FAUVARQUE MO, 1995, MECH DEVELOP, V52, P343, DOI 10.1016/0925-4773(95)00412-T; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Guenther MG, 2000, GENE DEV, V14, P1048; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JONES RS, 1990, GENETICS, V126, P185; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; MARTIN EC, 1993, DEVELOPMENT, V117, P641; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; PHILLIPS MD, 1990, GENETICS, V125, P91; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Platero JS, 1996, CHROMOSOMA, V104, P393, DOI 10.1007/BF00352263; Poux S, 2002, DEVELOPMENT, V129, P2483; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Poux S, 2001, DEVELOPMENT, V128, P75; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SATHE SS, 1995, MECH DEVELOP, V52, P77, DOI 10.1016/0925-4773(95)00392-E; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; SIMON J, 1995, MECH DEVELOP, V53, P197, DOI 10.1016/0925-4773(95)00434-3; Tie F, 2001, DEVELOPMENT, V128, P275; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5	42	1210	1253	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2002	111	2					185	196		10.1016/S0092-8674(02)00975-3	http://dx.doi.org/10.1016/S0092-8674(02)00975-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408863	Bronze			2022-12-24	WOS:000178753500008
J	Iyer, R; Iverson, TM; Accardi, A; Miller, C				Iyer, R; Iverson, TM; Accardi, A; Miller, C			A biological role for prokaryotic ClC chloride channels	NATURE			English	Article							ESCHERICHIA-COLI; ACID RESISTANCE; POTASSIUM CHANNEL; LIGAND-BINDING; MECHANISMS; EXPRESSION; GLUTAMATE; DISRUPTION; PROTEINS; HOMOLOG	An unexpected finding emerging from large-scale genome analyses is that prokaryotesexpress ion channels belonging to molecular families long studied in neurons. Bacteria and archaea are now known to carry genes for potassium channels of the voltage-gated, inward rectifier and calcium-activated classes(1-3), ClC-type chloride channels(4), an ionotropic glutamate receptor(5) and a sodium channel(6). For two potassium channels and a chloride channel, these homologues have provided a means to direct structure determination(3,7-9). And yet the purposes of these ion channels in bacteria are unknown. Strong conservation of functionally important sequences from bacteria to vertebrates, and of structure itself(10), suggests that prokaryotes use ion channels in roles more adaptive than providing high-quality protein to structural biologists. Here we show that Escherichia coli uses chloride channels of the widespread ClC family in the extreme acid resistance response. We propose that the channels function as an electrical shunt for an outwardly directed virtual proton pump that is linked to amino acid decarboxylation.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.		Iyer, Ram/AAQ-1329-2020	Iyer, Ram/0000-0002-3638-2421; Accardi, Alessio/0000-0002-6584-0102				Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Foster JW, 1999, NOVART FDN SYMP, V221, P55; GUTKNECHT J, 1981, BIOCHIM BIOPHYS ACTA, V641, P183, DOI 10.1016/0005-2736(81)90582-4; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Merrell DS, 2002, CURR OPIN MICROBIOL, V5, P51, DOI 10.1016/S1369-5274(02)00285-0; MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MINDELL JA, 2001, GENOME BIOL, V2; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Purdy MD, 2000, FEBS LETT, V466, P26, DOI 10.1016/S0014-5793(99)01740-8; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Small PLC, 1998, TRENDS MICROBIOL, V6, P214, DOI 10.1016/S0966-842X(98)01285-2; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J	30	161	172	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					715	718		10.1038/nature01000	http://dx.doi.org/10.1038/nature01000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384697				2022-12-24	WOS:000178615200039
J	Whitmire, E; Khan, B; Coue, M				Whitmire, E; Khan, B; Coue, M			Cdc6 synthesis regulates replication competence in Xenopus oocytes	NATURE			English	Article							DNA-REPLICATION; NUCLEAR EXPORT; PROTEIN; KINASE; CHROMATIN; EXTRACTS; COMPLEX; MCM; LOCALIZATION; INITIATION	The early division cycles of an embryo rely on the oocyte's ability to replicate DNA. During meiosis, oocytes temporarily lose this ability. After a single round of pre-meiotic S-phase, oocytes enter meiosis and rapidly arrest at prophase of meiosis I (G2)(1). Upon hormonal stimulation, arrested oocytes resume meiosis, reestablish DNA replication competence in meiosis I shortly after germinal vesicle breakdown (GVBD), but repress replication until fertilization(2,3). How oocytes lose and regain replication competence during meiosis are important questions underlying the production of functional gametes. Here we show that the inability of immature Xenopus oocytes to replicate is linked to the absence of the Cdc6 protein and the cytoplasmic localization of other initiation proteins. Injection of Cdc6 protein into immature oocytes does not induce DNA replication. However, injection of Cdc6 into oocytes undergoing GVBD is sufficient to induce DNA replication in the absence of protein synthesis. Our results show that GVBD and Cdc6 synthesis are the only events that limit the establishment of the oocyte's replication competence during meiosis.	Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Coue, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.	martine.coue@ttmc.ttuhsc.edu						Blow JJ, 2001, EMBO J, V20, P3293, DOI 10.1093/emboj/20.13.3293; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; COX LS, 1990, J CELL SCI, V97, P177; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Findeisen M, 1999, EUR J BIOCHEM, V264, P415, DOI 10.1046/j.1432-1327.1999.00613.x; Fisher D, 1998, BIOL CELL, V90, P497; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; GURDON JB, 1967, P NATL ACAD SCI USA, V58, P545, DOI 10.1073/pnas.58.2.545; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kubota Y, 1997, EMBO J, V16, P3320, DOI 10.1093/emboj/16.11.3320; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; LASKEY RA, 1983, CIBA F SYMP, V98, P25; Lemaitre JM, 2002, NATURE, V419, P718, DOI 10.1038/nature01046; LENO GH, 1991, METHOD CELL BIOL, V36, P561; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	29	35	36	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2002	419	6908					722	725		10.1038/nature01032	http://dx.doi.org/10.1038/nature01032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384699				2022-12-24	WOS:000178615200041
J	Auboeuf, D; Honig, A; Berget, SM; O'Malley, BW				Auboeuf, D; Honig, A; Berget, SM; O'Malley, BW			Coordinate regulation of transcription and splicing by steroid receptor coregulators	SCIENCE			English	Article							COMBINATORIAL CONTROL; ESTROGEN-RECEPTORS; NUCLEAR RECEPTORS; COACTIVATOR; PROTEIN; EXON	Recent observations indicating that promoter identity influences alternative RNA-processing decisions have created interest in the regulatory interactions between RNA polymerase II transcription and precursor messenger RNA (pre-mRNA) processing. We examined the impact of steroid receptor mediated transcription on RNA processing with reporter genes subject to alternative splicing driven by steroid- sensitive promoters. Steroid hormones affected the processing of pre-mRNA synthesized from steroid-sensitive promoters, but not from steroid-unresponsive promoters, in a steroid receptor dependent and receptor-selective manner. Several nuclear receptor coregulators showed differential splicing effects, suggesting that steroid hormone receptors may simultaneously control gene transcription activity and exon content of the product mRNA by recruiting coregulators involved in both processes.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	Auboeuf, Didier/M-4610-2014	Auboeuf, Didier/0000-0002-3757-0002	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038526] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-08818] Funding Source: Medline; NIGMS NIH HHS [GM 38526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Hirose Y, 2000, GENE DEV, V14, P1415; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lou H, 1999, MOL CELL BIOL, V19, P78; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Nilsson S, 2002, CRIT REV BIOCHEM MOL, V37, P1, DOI 10.1080/10409230290771438; Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341	16	286	295	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2002	298	5592					416	419		10.1126/science.1073734	http://dx.doi.org/10.1126/science.1073734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376702				2022-12-24	WOS:000178510400049
J	Luo, J; Kaplitt, MG; Fitzsimons, HL; Zuzga, DS; Liu, YH; Oshinsky, ML; During, MJ				Luo, J; Kaplitt, MG; Fitzsimons, HL; Zuzga, DS; Liu, YH; Oshinsky, ML; During, MJ			Subthalamic GAD gene therapy in a Parkinson's disease rat model	SCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; NIGRA PARS RETICULATA; STRIATAL LESIONS; NUCLEUS LESIONS; GRANULE CELLS; NEURONS; GABA; EXPRESSION; GLUTAMATE; ACID	The motor abnormalities of Parkinson's disease (PD) are caused by alterations in basal ganglia network activity, including disinhibition of the subthalamic nucleus (STN), and excessive activity of the major output nuclei. Using adeno-associated viral vector mediated somatic cell gene transfer, we expressed glutamic acid decarboxylase (GAD), the enzyme that catalyzes synthesis of the neurotransmitter GABA, in excitatory glutamatergic neurons of the STN in rats. The transduced neurons, when driven by electrical stimulation, produced mixed inhibitory responses associated with GABA release. This phenotypic shift resulted in strong neuroprotection of nigral dopamine neurons and rescue of the parkinsonian behavioral phenotype. This strategy suggests that there is plasticity between excitatory and inhibitory neurotransmission in the mammalian brain that could be exploited for therapeutic benefit.	Univ Auckland, Dept Mol Med & Pathol, Funct Genom & Translat Neurosci Lab, Auckland 1, New Zealand; Thomas Jefferson Univ, Jefferson Med Coll, CNS Gene Therapy Ctr, Philadelphia, PA 19107 USA; Cornell Univ, Weill Med Coll, Dept Neurol Surg, Ctr Stereotact & Funct Neurosurg, New York, NY 10021 USA	University of Auckland; Jefferson University; Cornell University	During, MJ (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Funct Genom & Translat Neurosci Lab, Auckland 1, New Zealand.		Andalman, Aaron S/C-7694-2011; During, Matthew/AAC-1388-2020	Fitzsimons, Helen/0000-0001-7825-3911; Oshinsky, Michael/0000-0002-0976-1047				Alvarez L, 2001, MOVEMENT DISORD, V16, P72, DOI 10.1002/1531-8257(200101)16:1<72::AID-MDS1019>3.0.CO;2-6; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Cao YX, 1996, P NATL ACAD SCI USA, V93, P9844, DOI 10.1073/pnas.93.18.9844; Carvalho GA, 2001, EXP NEUROL, V171, P405, DOI 10.1006/exnr.2001.7742; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Esclapez M, 1999, J COMP NEUROL, V412, P488; Gill SS, 1997, LANCET, V350, P1224, DOI 10.1016/S0140-6736(05)63455-1; HEFTI F, 1980, PHARMACOL BIOCHEM BE, V12, P185, DOI 10.1016/0091-3057(80)90353-6; Henderson JM, 1999, EUR J NEUROSCI, V11, P2749, DOI 10.1046/j.1460-9568.1999.00692.x; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Levy R, 2001, BRAIN, V124, P2105, DOI 10.1093/brain/124.10.2105; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Mastakov MY, 2002, J VIROL, V76, P8446, DOI 10.1128/JVI.76.16.8446-8454.2002; Nakao N, 1999, ANN NEUROL, V45, P640, DOI 10.1002/1531-8249(199905)45:5<640::AID-ANA13>3.3.CO;2-L; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Obeso JA, 2000, NEUROLOGY, V55, pS7; Piallat B, 1996, EUR J NEUROSCI, V8, P1408, DOI 10.1111/j.1460-9568.1996.tb01603.x; RINVIK E, 1993, J CHEM NEUROANAT, V6, P19, DOI 10.1016/0891-0618(93)90004-N; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; Su PC, 2001, ANN NEUROL, V50, P514, DOI 10.1002/ana.1232; Wichmann T, 2001, EXP NEUROL, V167, P410, DOI 10.1006/exnr.2000.7572; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	28	226	245	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					425	429		10.1126/science.1074549	http://dx.doi.org/10.1126/science.1074549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376704				2022-12-24	WOS:000178510400052
J	Martin-Lluesma, S; Stucke, VM; Nigg, EA				Martin-Lluesma, S; Stucke, VM; Nigg, EA			Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2	SCIENCE			English	Article							BUDDING YEAST; MITOTIC CHECKPOINT; MICROTUBULE ATTACHMENT; PROMOTING COMPLEX; MAMMALIAN-CELLS; PROTEIN MAD2; CENP-E; CHROMOSOME; ANAPHASE; CDC20	The spindle checkpoint delays sister chromatid separation until all chromosomes have undergone bipolar spindle attachment. Checkpoint failure may result in chromosome mis-segregation and may contribute to tumorigenesis. We showed that the human protein Hec1 was required for the recruitment of Mps1 kinase and Mad1/Mad2 complexes to kinetochores. Depletion of Hec1 impaired chromosome congression and caused persistent activation of the spindle checkpoint, indicating that high steady-state levels of Mad1/Mad2 complexes at kinetochores were not essential for checkpoint signaling. Simultaneous depletion of Hec1 and Mad2 caused catastrophic mitotic exit, making Hec1 an attractive target for the selective elimination of spindle checkpoint deficient cells.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Martin Lluesma, Silvia Martin/AFK-1632-2022; Lluesma, Silvia Martin/P-8307-2019	Martin Lluesma, Silvia Martin/0000-0001-7491-1876; Lluesma, Silvia Martin/0000-0001-7491-1876; nigg, erich/0000-0003-4835-5719				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; MARTINLLUESMA S, UNPUB; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; MUSACCHIO A, IN PRESS NATURE REV; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; STUCKE VM, UNPUB; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	36	358	379	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2267	2270		10.1126/science.1075596	http://dx.doi.org/10.1126/science.1075596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12351790				2022-12-24	WOS:000178222000049
J	Shan, L; Molberg, O; Parrot, I; Hausch, F; Filiz, F; Gray, GM; Sollid, LM; Khosla, C				Shan, L; Molberg, O; Parrot, I; Hausch, F; Filiz, F; Gray, GM; Sollid, LM; Khosla, C			Structural basis for gluten intolerance in Celiac sprue	SCIENCE			English	Article							T-CELL EPITOPE; TISSUE TRANSGLUTAMINASE; PEPTIDE BINDING; DISEASE; GLIADIN; IDENTIFICATION	Celiac Sprue, a widely prevalent autoimmune disease of the small intestine, is induced in genetically susceptible individuals by exposure to dietary gluten. A 33-mer peptide was identified that has several characteristics suggesting it is the primary initiator of the inflammatory response to gluten in Celiac Sprue patients. In vitro and in vivo studies in rats and humans demonstrated that it is stable toward breakdown by all gastric, pancreatic, and intestinal brush-border membrane proteases. The peptide reacted with tissue transglutaminase, the major autoantigen in Celiac Sprue, with substantially greater selectivity than known natural substrates of this extracellular enzyme. It was a potent inducer of gut-derived human T cell lines from 14 of 14 Celiac Sprue patients. Homologs of this peptide were found in all food grains that are toxic to Celiac Sprue patients but are absent from all nontoxic food grains. The peptide could be detoxified in in vitro and in vivo assays by exposure to a bacterial prolyl endopeptidase, suggesting a strategy for oral peptidase supplement therapy for Celiac Sprue.	Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway	Stanford University; Stanford University; Stanford University; Stanford University; University of Oslo; National Hospital Norway	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.		Sollid, Ludvig/N-9691-2015; parrot, isabelle/AAS-5546-2020	Sollid, Ludvig/0000-0001-8860-704X; Shan, Lu/0000-0003-2334-9216; Khosla, Chaitan/0000-0001-6529-495X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100619] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHNEN DJ, 1983, J BIOL CHEM, V258, P5960; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen EH, 2000, GUT, V46, P46, DOI 10.1136/gut.46.1.46; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Bordusa F, 1998, BIOORGAN MED CHEM, V6, P1775, DOI 10.1016/S0968-0896(98)00145-X; CHARLES IG, 1991, EUR J IMMUNOL, V21, P1147, DOI 10.1002/eji.1830210509; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; DARGENIO G, 1988, ENZYME, V39, P227, DOI 10.1159/000469123; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Falk K, 2000, J EXP MED, V191, P717, DOI 10.1084/jem.191.4.717; GRAY GM, 1991, HDB PHYSL, P411; Guipponi M, 2001, HUM GENET, V109, P569, DOI 10.1007/s004390100607; HAUSCH F, IN PRESS AM J PHYSL; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Maki M, 1997, LANCET, V349, P1755, DOI 10.1016/S0140-6736(96)70237-4; McAdam SN, 2000, GUT, V47, P743, DOI 10.1136/gut.47.6.743; Molberg O, 2001, EUR J IMMUNOL, V31, P1317, DOI 10.1002/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521; SHAN LY, UNPUB; SMITHSON KW, 1977, J CLIN INVEST, V60, P665, DOI 10.1172/JCI108818; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stienekemeier M, 2001, P NATL ACAD SCI USA, V98, P13872, DOI 10.1073/pnas.241504598; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6	32	1117	1205	6	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2275	2279		10.1126/science.1074129	http://dx.doi.org/10.1126/science.1074129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12351792				2022-12-24	WOS:000178222000051
J	Chen, F; Kook, H; Milewski, R; Gitler, AD; Lu, MM; Li, J; Nazarian, R; Schnepp, R; Jen, K; Biben, C; Runke, G; Mackay, JP; Novotny, J; Schwartz, RJ; Harvey, RP; Mullins, MC; Epstein, JA				Chen, F; Kook, H; Milewski, R; Gitler, AD; Lu, MM; Li, J; Nazarian, R; Schnepp, R; Jen, K; Biben, C; Runke, G; Mackay, JP; Novotny, J; Schwartz, RJ; Harvey, RP; Mullins, MC; Epstein, JA			Hop is an unusual homeobox gene that modulates cardiac development	CELL			English	Article							SERUM RESPONSE FACTOR; HOMEODOMAIN-DNA INTERACTIONS; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; TINMAN HOMOLOG; AMINO-ACID; HEART; NKX2-5; EXPRESSION; COMPLEX	Hop is a small, divergent homeodomain protein that lacks certain conserved residues required for DNA binding. Hop gene expression initiates early in cardiogenesis and continues in cardiomyocytes throughout embryonic and postnatal development. Genetic and biochemical data indicate that Hop functions directly downstream of Nkx2-5. Inactivation of Hop in mice by homologous recombination results in a partially penetrant embryonic lethal phenotype with severe developmental cardiac defects involving the myocardium. Inhibition of Hop activity in zebrafish embryos likewise disrupts cardiac development and results in severely impaired cardiac function. Hop physically interacts with serum response factor (SRF) and inhibits activation of SRF-dependent transcription by inhibiting SRF binding to DNA. Hop encodes an unusual homeodomain protein that modulates SRF-dependent cardiac-specific gene expression and cardiac development.	Univ Penn, Hlth Syst, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Hlth Syst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Fac Med & Life Sci, Kensington, NSW 2051, Australia; Univ Sydney, Sch Mol & Microbiol Biosci, Sydney, NSW 2006, Australia; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Sydney; Baylor College of Medicine	Epstein, JA (corresponding author), Univ Penn, Hlth Syst, Dept Med, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu	Jen, Kuang-Yu/AAM-5722-2020; Jen, Kuang-Yu/AAM-5429-2020; Mackay, Joel P/D-6834-2011; Kook, Hyun/AAR-5405-2021	Mackay, Joel P/0000-0001-7508-8033; Kook, Hyun/0000-0002-0740-1806; Harvey, Richard/0000-0002-9950-9792; Jen, Kuang-Yu/0000-0003-2815-5912; Gitler, Aaron/0000-0001-8603-1526	NHLBI NIH HHS [K08 HL04491, HL61475, HL62974] Funding Source: Medline; NIDDK NIH HHS [DK57050, DK59176] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004491, R01HL062974, R01HL061475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057050, R01DK059176] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; CHEN WS, 1995, ONCOL REP, V2, P5; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Fu YC, 1998, DEVELOPMENT, V125, P4439; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Ranganayakulu G, 1998, DEVELOPMENT, V125, P3037; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; SIPPL MJ, 1992, PROTEINS, V13, P258, DOI 10.1002/prot.340130308; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; TREISMAN J, 1989, CELL, V59, P553; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wawersik S, 2000, METH MOL B, V137, P87; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WITTMAN KS, 1968, J EXP ZOOL, V168, P137, DOI 10.1002/jez.1401680202; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5	35	215	227	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2002	110	6					713	723		10.1016/S0092-8674(02)00932-7	http://dx.doi.org/10.1016/S0092-8674(02)00932-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	596TV	12297045	Bronze			2022-12-24	WOS:000178182800007
J	Goss, KH; Risinger, MA; Kordich, JJ; Sanz, MM; Straughen, JE; Slovek, LE; Capobianco, AJ; German, J; Boivin, GP; Groden, J				Goss, KH; Risinger, MA; Kordich, JJ; Sanz, MM; Straughen, JE; Slovek, LE; Capobianco, AJ; German, J; Boivin, GP; Groden, J			Enhanced tumor formation in mice heterozygous for Blm mutation	SCIENCE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; SYNDROME GENE-PRODUCT; BLOOMS-SYNDROME; HELICASE; RECOMBINATION; FREQUENCY; ADENOMAS; MIN	Persons with the autosomal recessive disorder Bloom syndrome are predisposed to cancers of many types due to loss-of-function mutations in the BLM gene, which encodes a recQ-like helicase. Here we show that mice heterozygous for a targeted null mutation of Blm, the murine homolog of BLM, develop lymphoma earlier than wild-type littermates in response to challenge with murine leukemia virus and develop twice the number of intestinal tumors when crossed with mice carrying a mutation in the Apc tumor suppressor. These observations indicate that Blm is a modi er of tumor formation in the mouse and that Blm haploinsufficiency is associated with tumor predisposition, a finding with important implications for cancer risk in humans.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Howard Hughes Med Inst, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA	University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cornell University	Groden, J (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	Joanna.Groden@uc.edu		Capobianco, Anthony/0000-0002-3706-6797; Goss, Kathleen/0000-0002-7379-5639	NCI NIH HHS [CA63507, CA88460, CA84291] Funding Source: Medline; NIEHS NIH HHS [ES06096] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA088460, R29CA063507, U01CA084291, R01CA063507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bahr A, 1998, ONCOGENE, V17, P2565, DOI 10.1038/sj.onc.1202389; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; German J, 1996, CLIN GENET, V49, P223; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1977, AM J HUM GENET, V29, P248; GRODEN J, 1992, HUM GENET, V90, P360; GRODEN J, 1990, P NATL ACAD SCI USA, V87, P4315, DOI 10.1073/pnas.87.11.4315; GRODEN J, UNPUB; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Langland G, 2002, CANCER RES, V62, P2766; LEVY DB, 1994, CANCER RES, V54, P5953; Li L, 1998, MOL GENET METAB, V64, P286, DOI 10.1006/mgme.1998.2733; Lowy AM, 2001, GASTROENTEROLOGY, V121, P435, DOI 10.1053/gast.2001.26259; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; LUONGO C, 1993, GENOMICS, V15, P3, DOI 10.1006/geno.1993.1002; LUONGO C, 1994, CANCER RES, V54, P5947; MARTIN RH, 1994, AM J HUM GENET, V55, P1242; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; SANZ MM, UNPUB; Shahrabani-Gargir L, 1998, GENET TEST, V2, P293, DOI 10.1089/gte.1998.2.293; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636	28	164	169	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2002	297	5589					2051	2053		10.1126/science.1074340	http://dx.doi.org/10.1126/science.1074340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242442				2022-12-24	WOS:000178078500046
J	Hunt, JF; Weinkauf, S; Henry, L; Fak, JJ; McNicholas, P; Oliver, DB; Deisenhofer, J				Hunt, JF; Weinkauf, S; Henry, L; Fak, JJ; McNicholas, P; Oliver, DB; Deisenhofer, J			Nucleotide control of interdomain interactions in the conformational reaction cycle of SecA	SCIENCE			English	Article							ESCHERICHIA-COLI SECA; TRANSLOCASE SUBUNIT SECA; ELECTRON-DENSITY MAPS; DISTINCT ATP-BINDING; INITIATION-FACTOR 4A; BOX RNA HELICASE; CRYSTAL-STRUCTURE; PROTEIN TRANSLOCATION; PREPROTEIN TRANSLOCASE; BACILLUS-SUBTILIS	The SecA adenosine triphosphatase (ATPase) mediates extrusion of the amino termini of secreted proteins from the eubacterial cytosol based on cycles of reversible binding to the SecYEG translocon. We have determined the crystal structure of SecA with and without magnesium adenosine diphosphate bound to the high-affinity ATPase site at 3.0 and 2.7 angstrom resolution, respectively. Candidate sites for preprotein binding are located on a surface containing the SecA epitopes exposed to the periplasm upon binding to SecYEG and are thus positioned to deliver preprotein to SecYEG. Comparisons with structurally related ATPases, including superfamily I and II ATP-dependent helicases, suggest that the interaction geometry of the tandem motor domains in SecA is modulated by nucleotide binding, which is shown by fluorescence anisotropy experiments to reverse an endothermic domain-dissociation reaction hypothesized to gate binding to SecYEG.	Columbia Univ, Dept Biol Sci, Fairchild Ctr 702A, New York, NY 10027 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Tech Univ Munich, Dept Chem, D-85748 Garching, Germany; Wesleyan Univ, Dept Biochem & Mol Biol, Middletown, CT 06459 USA	Columbia University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Technical University of Munich; Wesleyan University	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 702A, MC2434, New York, NY 10027 USA.		Weinkauf, Sevil/C-1415-2010					ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BAUD C, 2002, J BIOL CHEM; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CARTUTHERS JM, 2002, CURR OPIN STRUC BIOL, V12, P123; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; den Blaauwen T, 1999, FEBS LETT, V458, P145, DOI 10.1016/S0014-5793(99)01139-4; denBlaauwen T, 1996, BIOCHEMISTRY-US, V35, P11994, DOI 10.1021/bi9605088; Ding HY, 2001, BIOCHEMISTRY-US, V40, P1835, DOI 10.1021/bi002058w; Drenth J, 1994, PRINCIPLES PROTEIN X; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FAK JJ, UNPUB; Fekkes P, 1999, BIOCHEMISTRY-US, V38, P5111, DOI 10.1021/bi982818r; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; FIKES JD, 1989, J BACTERIOL, V171, P402, DOI 10.1128/jb.171.1.402-409.1989; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUIE JL, 1995, J BACTERIOL, V177, P3518, DOI 10.1128/jb.177.12.3518-3526.1995; HUNT JD, UNPUB; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KIMURA E, 1991, J BIOL CHEM, V266, P6600; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KOONIN EV, 1992, FEBS LETT, V298, P6, DOI 10.1016/0014-5793(92)80009-6; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P1, DOI 10.1007/978-0-387-46312-4/COVER; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Machius M, 1999, P NATL ACAD SCI USA, V96, P11717, DOI 10.1073/pnas.96.21.11717; Matsumoto G, 2000, GENES CELLS, V5, P991, DOI 10.1046/j.1365-2443.2000.00388.x; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAJAPANDI T, 1994, BIOCHEM BIOPH RES CO, V200, P1477, DOI 10.1006/bbrc.1994.1617; Rajapandi T, 1996, MOL MICROBIOL, V20, P43, DOI 10.1111/j.1365-2958.1996.tb02487.x; Ramamurthy V, 1998, J BACTERIOL, V180, P6419; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Salavati R, 1997, J MOL BIOL, V265, P142, DOI 10.1006/jmbi.1996.0724; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Schmidt M, 2000, J BIOL CHEM, V275, P15440, DOI 10.1074/jbc.M000605200; Shilton B, 1998, FEBS LETT, V436, P277, DOI 10.1016/S0014-5793(98)01141-7; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Snyders S, 1997, J BIOL CHEM, V272, P11302; Song M, 1997, J BIOCHEM-TOKYO, V122, P1010; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; van Voorst F, 2000, FEBS LETT, V486, P57, DOI 10.1016/S0014-5793(00)02209-2; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weinkauf S, 2001, ACTA CRYSTALLOGR D, V57, P559, DOI 10.1107/S0907444901001202; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102	78	234	237	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2002	297	5589					2018	2026		10.1126/science.1074424	http://dx.doi.org/10.1126/science.1074424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594XV	12242434				2022-12-24	WOS:000178078500037
J	Kinchen, KS; Sadler, J; Fink, N; Brookmeyer, R; Klag, MJ; Levey, AS; Powe, NR				Kinchen, KS; Sadler, J; Fink, N; Brookmeyer, R; Klag, MJ; Levey, AS; Powe, NR			The timing of specialist evaluation in chronic kidney disease and mortality	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC-RENAL-FAILURE; MAINTENANCE DIALYSIS; COMORBIDITY ASSESSMENT; COEXISTENT DISEASES; REPLACEMENT THERAPY; SERUM CREATININE; OUTCOMES; CARE; HEMODIALYSIS; INITIATION	Background: Care for chronic renal failure involves management of complications and preparation for possible dialysis. Patients often are not evaluated by nephrologists in a timely manner. Objective: To identify factors associated with late evaluation by a nephrologist and to assess whether late evaluation is associated with worse survival once patients develop end-stage renal disease (ESRD). Design: National prospective cohort study. Setting: 81 dialysis facilities throughout the United States. Patients: 828 patients with new-onset ESRD. Measurements: Time from first evaluation by a nephrologist to initiation of dialysis, classified as late (<4 months), intermediate (4 to 12 months), or early (>12 months); rate of death, from initiation of dialysis to an average of 2.2 years of follow-up; and demographic, clinical, and laboratory characteristics. Results: After adjustment for potential confounders, late evaluation was more common among black men than white men (44.8% vs. 24.5%; P < 0.05), uninsured patients than insured patients (56.7% vs. 29.0%; P < 0.05) and patients with severe comorbid disease than those with mild comorbid disease (35.0% vs. 23.0%; P < 0.05). Compared with patients who had early evaluation, the risk for death was greater among patients evaluated late and was graded (hazard ratio, 1.3 [95% CI, 0.87 to 2.06] for patients with intermediate evaluation and 1.8 [CI, 1.21 to 2.61] for those with late evaluation) after adjustment for dialysis method, demographic characteristics, and socioeconomic status in Cox proportional hazards regression analysis. After additional adjustment for such factors as the presence and severity of comorbid conditions, the association remained graded (hazard ratio, 1.2 [CI, 0.73 to 1.82] for patients evaluated at an intermediate point and 1.6 [CI, 1.04 to 2.39] for those evaluated late). Conclusions: Late evaluation of patients with chronic renal failure by a nephrologist is associated with greater burden and severity of comorbid disease, black ethnicity, lack of health insurance, and shorter duration of survival.	Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Robert Wood Johnson Clin Scholars Program, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Independent Dialysis Fdn, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tufts Medical Center	Powe, NR (corresponding author), Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Sch Med, 2024 E Monument Sr,Suite 2-600, Baltimore, MD 21205 USA.	npowe@jhmi.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616, K24DK002643, K24DK002856] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS-08365] Funding Source: Medline; NIDDK NIH HHS [K24DK02856, K24DK02643, R01 DK59616] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1997, Am J Kidney Dis, V30, pS67; [Anonymous], 2006, SURVIVAL ANAL TECHNI; Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Campbell JD, 1989, DIALYSIS TRANSPLANT, V18, P660; Eknoyan G, 2000, AM J KIDNEY DIS, V35, pS69, DOI 10.1016/S0272-6386(00)70232-0; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; HOOD SA, 1995, ASAIO J, V41, pM422, DOI 10.1097/00002480-199507000-00044; Hood SA, 1998, SEMIN DIALYSIS, V11, P175, DOI 10.1111/j.1525-139X.1998.tb00329.x; INNES A, 1992, NEPHROL DIAL TRANSPL, V7, P467; Ismail N, 1998, NEPHROL DIAL TRANSPL, V13, P246, DOI 10.1093/ndt/13.2.246; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; JUNGERS P, 1993, NEPHROL DIAL TRANSPL, V8, P1089; Jungers P, 2001, NEPHROL DIAL TRANSPL, V16, P2357, DOI 10.1093/ndt/16.12.2357; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KHAN IH, 1994, Q J MED, V87, P559; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Miskulin DC, 2001, KIDNEY INT, V60, P1498, DOI 10.1046/j.1523-1755.2001.00954.x; Miskulin DC, 2002, AM J KIDNEY DIS, V39, P324, DOI 10.1053/ajkd.2002.30552; *NAT KIDN FDN, 2002, AM J KIDNEY DIS S, V39, pS65; Nicolucci A, 1992, ASAIO J, V38, pM291, DOI 10.1097/00002480-199207000-00040; *NIH, PROSP COH STUD CHRON; Obrador GT, 1999, J AM SOC NEPHROL, V10, P1793; Obrador GT, 1998, AM J KIDNEY DIS, V31, P398, DOI 10.1053/ajkd.1998.v31.pm9506677; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; Powe NR, 1996, SEMIN DIALYSIS, V9, P9, DOI 10.1111/j.1525-139X.1996.tb00890.x; RATCLIFFE PJ, 1984, BRIT MED J, V288, P441, DOI 10.1136/bmj.288.6415.441; Ritz E, 1999, DIABETES CARE, V22, pB80; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Sesso R, 1996, NEPHROL DIAL TRANSPL, V11, P2417, DOI 10.1093/oxfordjournals.ndt.a027207; *US REN DAT SYST, 2000, USRDS 2000 ANN DAT R; US Renal Data System, 1999, USRDS 1999 ANN DAT R; US Renal Data System, 1998, USRDS 1998 ANN DAT R; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; 2000, CAN FAM PHYSICIAN, V46, P661	40	370	377	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					479	486		10.7326/0003-4819-137-6-200209170-00007	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230348				2022-12-24	WOS:000178069100001
J	Takagi, J; Petre, BM; Walz, T; Springer, TA				Takagi, J; Petre, BM; Walz, T; Springer, TA			Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling	CELL			English	Article							GLYCOPROTEIN-IIB-IIIA; ELECTRON-MICROSCOPY; ACTIVATION; AFFINITY; ANTAGONISTS; MECHANISM; SUBUNIT; LIGANDS; BINDING; ANTIBODIES	How ligand binding alters integrin conformation in outside-in signaling, and how inside-out signals alter integrin affinity for ligand, have been mysterious. We address this with electron microscopy, physicochemical measurements, mutational introduction of disulfides, and ligand binding to alphaVbeta3 and alphaIIbbeta3 integrins. We show that a highly bent integrin conformation is physiological and has low affinity for biological ligands. Addition of a high affinity ligand mimetic peptide or Mn2+ results in a switch blade-like opening to an extended structure. An outward swing of the hybrid domain at its junction with the I-like domain shows conformational change within the headpiece that is linked to ligand binding. Breakage of a C-terminal clasp between the alpha and beta subunits enhances Mn2+ induced unbending and ligand binding.	Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu		Walz, Thomas/0000-0003-2606-2835	NHLBI NIH HHS [HL48675] Funding Source: Medline; NIGMS NIH HHS [GM62580] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO;2-D; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Billheimer JT, 2002, BLOOD, V99, P3540, DOI 10.1182/blood.V99.10.3540; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; DU XP, 1993, J BIOL CHEM, V268, P23087; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giblin PA, 2001, ANNU REP MED CHEM, V36, P181, DOI 10.1016/S0065-7743(01)36058-X; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HUBER W, 1995, EUR J BIOCHEM, V227, P647, DOI 10.1111/j.1432-1033.1995.tb20184.x; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; KOUNS WC, 1992, BLOOD, V80, P2539; Legler DF, 2001, J CELL SCI, V114, P1545; Liu SC, 2000, J CELL SCI, V113, P3563; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Petersen A, 1998, AUST J SOC ISSUES, V33, P92; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SMITH JW, 1994, J BIOL CHEM, V269, P960; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tanford C., 1961, PHYS CHEM MACROMOLEC; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200	45	889	920	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					599	611		10.1016/S0092-8674(02)00935-2	http://dx.doi.org/10.1016/S0092-8674(02)00935-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230977	Bronze			2022-12-24	WOS:000177943700007
J	Karanja, DMS; Hightower, AW; Colley, DG; Mwinzi, PNM; Galil, K; Andove, J; Secor, WE				Karanja, DMS; Hightower, AW; Colley, DG; Mwinzi, PNM; Galil, K; Andove, J; Secor, WE			Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study	LANCET			English	Article							IMMUNE-RESPONSES; WESTERN KENYA; INDIVIDUALS; HAEMATOBIUM; CHEMOTHERAPY; VACCINES; IGG4; VIEW; AGE; IGE	Background Previous studies have reported age-dependent development of resistance to reinfection by schistosomes and identified immunological correlates of this resistance. However, whether resistance exists that is independent of age effects has been questioned. We did a longitudinal investigation of reinfection by Schistosoma mansoni in an adult population with high occupational exposure. Methods We monitored a cohort of 96 male car washers working along the shores of Lake Victoria, Kenya during 349.7 person-years for frequency of water contact and infection with S mansoni. Patients were treated with praziquantel upon study entry and after reinfection with S mansoni. Bivariate analyses and a multivariate proportional hazards model were used to assess the effects of water contact, previous infections, and HIV-1 on S mansoni reinfection rates. Findings 13 car washers did not get reinfected or only became reinfected after an extended time (91 weeks). 47 initially had a short time to reinfection (15 weeks) but on subsequent treatments showed increased time to reinfection (29-38 weeks). 36 consistently displayed short times to reinfection (<15 weeks) despite multiple reinfection and treatment cycles. Decreased CD4 T-cell counts in HIV-1-positive individuals corresponded to increased susceptibility to S mansoni reinfection. Interpretation Adults similarly exposed to schistosomiasis are either resistant to reinfection; susceptible, but develop resistance to reinfection after multiple treatments; or remain susceptible to reinfection. Thus, immunological resistance to reinfection with S mansoni exists or can develop independent of age effects. The consequence of HIV-1 co-infection suggests that CD4 T cells contribute to this resistance.	CDCP, Immunol Branch, Div Parasit Dis,Natl Ctr Infect Dis, US PHS,US Dept HHS, Atlanta, GA 30341 USA; Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; United States Public Health Service; Kenya Medical Research Institute	Secor, WE (corresponding author), CDCP, Immunol Branch, Div Parasit Dis,Natl Ctr Infect Dis, US PHS,US Dept HHS, 4770 Buford Hihway NE,MS-F13, Atlanta, GA 30341 USA.				FIC NIH HHS [D43 TW007123] Funding Source: Medline; NIAID NIH HHS [R01 AI053695] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053695] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABEL L, 1991, AM J HUM GENET, V51, P206; BENSTEDSMITH R, 1987, T ROY SOC TROP MED H, V81, P651, DOI 10.1016/0035-9203(87)90442-1; BUTTERWORTH AE, 1985, T ROY SOC TROP MED H, V79, P393, DOI 10.1016/0035-9203(85)90391-8; Fulford AJC, 1998, PARASITOL TODAY, V14, P23, DOI 10.1016/S0169-4758(97)01168-X; Grogan JL, 1997, J INFECT DIS, V176, P1344, DOI 10.1086/514131; Gryseels B, 2000, PARASITOL TODAY, V16, P46, DOI 10.1016/S0169-4758(99)01597-5; Hagan P, 2000, PARASITOL TODAY, V16, P322, DOI 10.1016/S0169-4758(00)01711-7; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; Karanja DHS, 1998, AM J TROP MED HYG, V59, P307, DOI 10.4269/ajtmh.1998.59.307; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Lawn SD, 2000, AIDS, V14, P2437, DOI 10.1097/00002030-200011100-00004; Medhat A, 1998, J INFECT DIS, V178, P512, DOI 10.1086/515630; Mutapi F, 1998, J INFECT DIS, V178, P289, DOI 10.1086/517456; Mwinzi PNM, 2001, J INFECT DIS, V184, P488, DOI 10.1086/322783; ROBERTS M, 1993, INFECT IMMUN, V61, P4984, DOI 10.1128/IAI.61.12.4984-4993.1993; WARREN KS, 1973, J INFECT DIS, V127, P595, DOI 10.1093/infdis/127.5.595; Woolhouse MEJ, 1999, NAT MED, V5, P1225, DOI 10.1038/15169	18	110	111	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 24	2002	360	9333					592	596		10.1016/S0140-6736(02)09781-7	http://dx.doi.org/10.1016/S0140-6736(02)09781-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241930				2022-12-24	WOS:000177600400008
J	von Schirnding, Y				von Schirnding, Y			Health and sustainable development: can we rise to the challenge?	LANCET			English	Article							GLOBALIZATION	The forthcoming World Summit on Sustainable Development is an unprecedented opportunity to place health higher on the environmental and development agenda. The world's leaders will be grappling with some of the major challenges of our times-how to eradicate poverty and meet the world's development needs In a way that does not destroy the environment. Topping the agenda are water, energy, health, agriculture, and biodiversity. Improvement of access of the world's poor people to clean water, sanitation, and safe sources of household energy would have a huge effect on the main killers of young children-pneumonia and diarrhoea. Similarly, improved environmental management could substantially affect many infectious disease outcomes. At the same time, the growing epidemic of non-communicable diseases could be reversed if people's consumption patterns and lifestyles could be put on a more sustainable and healthy footing. A shared health, environmental, and development agenda could address the large share of the burden of disease that is environmentally related, and vice versa. The health sector Increasingly needs to work in partnership with others rather than work alone. New tools are needed to ensure that intersectoral action becomes embedded in the way that the health sector does business. Improving coordination might be one of the most important ways in which we can help put the planet back on a healthy and sustainable path.	WHO, CH-1211 Geneva, Switzerland	World Health Organization	von Schirnding, Y (corresponding author), WHO, CH-1211 Geneva, Switzerland.	vonschirndingy@who.int						ANNAN K, 2002, SUSTAINABLE FUTURE; BRUNDTLAND GH, 2001, WHO REG COMM AM 53 S; BRUNDTLAND GH, 2001, HRH PRINC WAL BUS EN; BRUNDTLAND GH, 2000, SUMM ROLL BACK MAL A; BRUNDTLAND GH, 2002, 55 WORLD HLTH ASS GE; DIALLO D, 2002, CHOICES MAGAZINE, V12, P2; DOBSON A, 1997, BIODIVERSITY HUMAN H, P87; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; GARRET L, 1998, MED J AUSTRALIA, V168, P568; Gordon L J, 1992, J Public Health Policy, V13, P407, DOI 10.2307/3342530; MCGRANAHAN G, 1999, ENV CHANGE HUMAN HLT; McMichael AJ, 2001, J ROY SOC MED, V94, P111, DOI 10.1177/014107680109400303; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; *UN, 2002, JOH SUMM 2002 PREP P; *UN, 2002, C ENV DEV RIO DE JAN; UN, 1972, C HUM ENV; *UN, 2000, MILL ASS 55 SESS NEW; *UN, 2002, UN INT C FIN DEV MON; *UNAIDS, 2001, REP GLOB HIV AIDS EP; United Nations, 2002, WORLD SUMMIT SUSTAIN; United Nations department of economic and social affairs, 2001, WORLD POP PROSP 2000; VONSCHINDING YE, 2001, SUSTAINABLE DEV INT, V3, P171; VONSCHINDING YE, 2002, ADDRESSING IMPACT HO; VONSCHIRNDING Y, 1991, ENVIRON HEALTH PERSP, V94, P125, DOI 10.2307/3431305; VONSCHIRNDING Y, 1997, ECOSYST HEALTH, V3, P220; VONSCHIRNDING YE, 2000, CITY DEV STRATEGIES, P2; *VONSCHIRNDING YE, 1997, INTERSECTORAL ACTION; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; *WHO, 2002, WHO M MAK HLTH CENTR; *WHO, 2002, WHO M OSL NOV 29 DEC; *WHO, 2002, WHO M LOND MAY 21 22; WHO, 2001, MACR HLTH INV HLTH D; *WHO, 2002, HLTH SUST DEV M SEN; *WHO, 1999, CORP STRAT WHO SECR; *WHO, 2000, GLOB POL ER PROGR; *WHO UNICEF JOINT, 2000, GLOB WAT SUPPL SAN A; [WHO] World Health Organization, 1997, HLTH ENV SUST DEV 5; WHO - World Health Organization, 2002, HLTH SUST DEV KEY HL; *WORLD BANK IMF, 2002, REV POV RED STRAT PA; World Commission on Environment and Development, 1987, OUR COMMON FUTURE; *WORLD EN COUNC, 2001, ANN REP 2001; World Health Organization, 2002, JOH DECL HLTH SUST D; World Health Organization, 1994, 2 EUR C ENV HLTH HEL; *WORLD RES I UNEP, 1998, 1998 99 WORLD RES GU; *WORLD TRAD ORG, 2001, WORLD TRAD ORG 4 MIN; Yach D, 2000, TOB CONTROL, V9, P206, DOI 10.1136/tc.9.2.206; [No title captured]	49	41	41	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2002	360	9333					632	637		10.1016/S0140-6736(02)09777-5	http://dx.doi.org/10.1016/S0140-6736(02)09777-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241950				2022-12-24	WOS:000177600400027
J	Sandkuhler, J				Sandkuhler, J			Fear the pain	LANCET			English	Editorial Material							SENSITIZATION; MEMORY		Univ Vienna, Sch Med, Brain Res Inst, A-1090 Vienna, Austria	University of Vienna	Sandkuhler, J (corresponding author), Univ Vienna, Sch Med, Brain Res Inst, Waehringer Guertel 18, A-1090 Vienna, Austria.		Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X				Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Jensen TS, 2001, ACTA ANAESTH SCAND, V45, P1128, DOI 10.1034/j.1399-6576.2001.450913.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; RICHMOND CE, 1993, LANCET, V342, P73, DOI 10.1016/0140-6736(93)91284-S; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sarkar S, 2000, LANCET, V356, P1154, DOI 10.1016/S0140-6736(00)02758-6; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Willis WD, 2001, ANN NY ACAD SCI, V933, P142	11	11	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					426	426		10.1016/S0140-6736(02)09683-6	http://dx.doi.org/10.1016/S0140-6736(02)09683-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241712				2022-12-24	WOS:000177342900006
J	Di Paolo, G; Pellegrini, L; Letinic, K; Cestra, G; Zoncu, R; Voronov, S; Chang, SH; Guo, J; Wenk, MR; De Camilli, P				Di Paolo, G; Pellegrini, L; Letinic, K; Cestra, G; Zoncu, R; Voronov, S; Chang, SH; Guo, J; Wenk, MR; De Camilli, P			Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 gamma by the FERM domain of talin	NATURE			English	Article							SH3 DOMAIN; MEMBRANE; PHOSPHOINOSITIDES; ADHESION; BINDING; DISRUPTION; MOLECULES	Membrane phosphoinositides control a variety of cellular processes through the recruitment and/or regulation of cytosolic proteins(1-4). One mechanism ensuring spatial specificity in phosphoinositide signalling is the targeting of enzymes that mediate their metabolism to specific subcellular sites. Phosphatidylinositol phosphate kinase type 1gamma (PtdInsPKIgamma) is a phosphatidylinositol-4-phosphate 5-kinase that is expressed at high levels in brain, and is concentrated at synapses(5,6). Here we show that the predominant brain splice variant of PtdInsPKIg (PtdInsPKIgamma-90) binds, by means of a short carboxy-terminal peptide, to the FERM domain of talin, and is strongly activated by this interaction. Talin, a principal component of focal adhesion plaques 7,is also present at synapses. PtdInsPKIgamma-90 is expressed in non-neuronal cells, albeit at much lower levels than in neurons, and is concentrated at focal adhesion plaques, where phosphatidylinositol-4,5-bisphosphate has an important regulatory role. Overexpression of PtdInsPKIgamma-90, or expression of its C-terminal domain, disrupts focal adhesion plaques, probably by local disruption of normal phosphoinositide balance. These findings define an interaction that has a regulatory role in cell adhesion and suggest new similarities between molecular interactions underlying synaptic junctions and general mechanisms of cell adhesion.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Chang, Sunghoe/J-2784-2012; cestra, gianluca/AAL-4736-2021; Wenk, Markus Rene/D-1441-2014		Fondazione Telethon Funding Source: Custom; Telethon [485/B] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merilainen J, 1997, J BIOL CHEM, V272, P23278, DOI 10.1074/jbc.272.37.23278; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Sechi AS, 2000, J CELL SCI, V113, P3685; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43889	30	360	368	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2002	420	6911					85	89		10.1038/nature01147	http://dx.doi.org/10.1038/nature01147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422219				2022-12-24	WOS:000179068100041
J	Tahirov, TH; Temiakov, D; Anikin, M; Patlan, V; McAllister, WT; Vassylyev, DG; Yokoyama, S				Tahirov, TH; Temiakov, D; Anikin, M; Patlan, V; McAllister, WT; Vassylyev, DG; Yokoyama, S			Structure of a T7 RNA polymerase elongation complex at 2.9 angstrom resolution	NATURE			English	Article							CRYSTAL-STRUCTURE; TRANSCRIPTION INITIATION; PROMOTER; BACTERIOPHAGE-T7; HOLOENZYME; MOLSCRIPT; INSIGHTS; BINDING; BUBBLE	The single-subunit bacteriophage T7 RNA polymerase carries out the transcription cycle in an identical manner to that of bacterial and eukaryotic multisubunit enzymes. Here we report the crystal structure of a T7 RNA polymerase elongation complex, which shows that incorporation of an 8-base-pair RNA-DNA hybrid into the active site of the enzyme induces a marked rearrangement of the amino-terminal domain. This rearrangement involves alternative folding of about 130 residues and a marked reorientation (about 130degrees rotation) of a stable core subdomain, resulting in a structure that provides elements required for stable transcription elongation. A wide opening on the enzyme surface that is probably an RNA exit pathway is formed, and the RNA-DNA hybrid is completely buried in a newly formed, deep protein cavity. Binding of 10 base pairs of downstream DNA is stabilized mostly by long-distance electrostatic interactions. The structure implies plausible mechanisms for the various phases of the transcription cycle, and reveals important structural similarities with the multisubunit RNA polymerases.	RIKEN, Harima Inst SPring 8, Structurome Res Grp, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, High Throughput Factory, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; SUNY Hlth Sci Ctr, Dept Microbiol, Morse Inst Mol Genet, Brooklyn, NY 11203 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; RIKEN; University of Tokyo	Vassylyev, DG (corresponding author), RIKEN, Harima Inst SPring 8, Structurome Res Grp, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@yumiyoshi.harima.riken.go.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Vassylyev, Dmitry/A-9005-2008; Patlan, Vsevolod/K-1825-2013	Yokoyama, Shigeyuki/0000-0003-3133-7338; Tahirov, Tahir/0000-0002-1238-0069	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038147, R01 GM038147-14S1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BONNER G, 1994, J BIOL CHEM, V269, P25120; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Brieba LG, 2001, J BIOL CHEM, V276, P10306, DOI 10.1074/jbc.M009866200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; GUNDERSON SI, 1987, BIOCHEMISTRY-US, V26, P1539, DOI 10.1021/bi00380a007; He B, 1997, J MOL BIOL, V265, P275, DOI 10.1006/jmbi.1996.0741; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Lyakhov DL, 1997, J MOL BIOL, V269, P28, DOI 10.1006/jmbi.1997.1015; MA K, IN PRESS J BIOL CHEM; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; MCALLISTER WT, 1997, NUCL ACIDS MOL BIOL, V11, P15; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OSUMIDAVIS PA, 1992, J MOL BIOL, V226, P37, DOI 10.1016/0022-2836(92)90122-Z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; Rong MQ, 1998, P NATL ACAD SCI USA, V95, P515, DOI 10.1073/pnas.95.2.515; Severinov K, 2001, P NATL ACAD SCI USA, V98, P5, DOI 10.1073/pnas.021535298; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; TEMIAKOV D, UNPUB ACTA CRYSTALLO; TEMIAKOV D, IN PRESS J BIOL CHEM; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Woody AYM, 1998, BIOCHEMISTRY-US, V37, P15958, DOI 10.1021/bi9805801; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	50	188	202	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2002	420	6911					43	50		10.1038/nature01129	http://dx.doi.org/10.1038/nature01129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422209				2022-12-24	WOS:000179068100031
J	de Bono, M; Tobin, DM; Davis, MW; Avery, L; Bargmann, CI				de Bono, M; Tobin, DM; Davis, MW; Avery, L; Bargmann, CI			Social feeding in Caenorhabditis elegans is induced by neurons that detect aversive stimuli	NATURE			English	Article							NEUROPEPTIDE-Y RECEPTOR; C-ELEGANS; VANILLOID RECEPTOR; NATURAL VARIATION; PATHWAY; PROTEIN; GENE; ENVIRONMENT; EXPRESSION; RESPONSES	Natural Caenorhabditis elegans isolates exhibit either social or solitary feeding on bacteria. We show here that social feeding is induced by nociceptive neurons that detect adverse or stressful conditions. Ablation of the nociceptive neurons ASH and ADL transforms social animals into solitary feeders. Social feeding is probably due to the sensation of noxious chemicals by ASH and ADL neurons; it requires the genes ocr-2 and osm-9, which encode TRP-related transduction channels, and odr-4 and odr-8, which are required to localize sensory chemoreceptors to cilia. Other sensory neurons may suppress social feeding, as social feeding in ocr-2 and odr-4 mutants is restored by mutations in osm-3, a gene required for the development of 26 ciliated sensory neurons. Our data suggest a model for regulation of social feeding by opposing sensory inputs: aversive inputs to nociceptive neurons promote social feeding, whereas antagonistic inputs from neurons that express osm-3 inhibit aggregation.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Genet Program, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Genet Program, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94143 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; MRC Laboratory Molecular Biology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	de Bono, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA.	debono@mrc-lmb.cam.ac.uk		Davis, Mikel/0000-0003-1867-1593; Tobin, David/0000-0003-3465-5518; de Bono, Mario/0000-0001-8347-0443; Bargmann, Cornelia/0000-0002-8484-0618	NHLBI NIH HHS [R01 HL046154] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046154] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1990, COLD SH Q B, V55, P529; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Choe JC, 1997, EVOLUTION SOCIAL BEH; CLARK SG, 1994, GENETICS, V137, P987; Colbert HA, 1997, J NEUROSCI, V17, P8259; CROLL NA, 1970, BEHAV NEMATODES, P18; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DRISCOLL M, 1997, NEMATODE C ELEGANS, V2, P645; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; GREWAL PS, 1991, NEMATOLOGICA, V37, P72, DOI 10.1163/187529291X00079; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; Hodgkin J, 1997, GENETICS, V146, P149; Hodgkin J, 1997, C ELEGANS, P881; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Marroquin LD, 2000, GENETICS, V155, P1693; MCBRIDE JM, 1966, NATURE, V211, P545, DOI 10.1038/211545b0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Naveilhan P, 2001, NATURE, V409, P513, DOI 10.1038/35054063; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, C ELEGANS, P739; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SHORROCKS B, 1995, P ROY SOC B-BIOL SCI, V260, P305, DOI 10.1098/rspb.1995.0096; Sulston J, 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; THOMAS JH, 1993, GENETICS, V134, P1105; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wilson E.O., 1975, P1	40	188	221	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					899	903		10.1038/nature01169	http://dx.doi.org/10.1038/nature01169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410303	Green Accepted			2022-12-24	WOS:000178909700035
J	Schiermeier, Q				Schiermeier, Q			Low stocks prompt calls for North Atlantic fishing ban	NATURE			English	News Item																		2002, NATURE, V419, P664	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					866	866		10.1038/419866b	http://dx.doi.org/10.1038/419866b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410268	Bronze			2022-12-24	WOS:000178909700004
J	Sherman, G; Visscher, PK				Sherman, G; Visscher, PK			Honeybee colonies achieve fitness through dancing	NATURE			English	Article							COMMUNICATION; BEHAVIOR; DANCES	The honeybee dance language, in which foragers perform dances containing information about the distance and direction to food sources, is the quintessential example of symbolic communication in non-primates(1,2). The dance language has been the subject of controversy(3,4), and of extensive research into the mechanisms of acquiring(1,5,6), decoding(7,8) and evaluating(9) the information in the dance. The dance language has been hypothesized, but not shown, to increase colony food collection(1,9,10). Here we show that colonies with disoriented dances (lacking direction information) recruit less effectively to syrup feeders than do colonies with oriented dances. For colonies foraging at natural sources, the direction information sometimes increases food collected, but at other times it makes no difference. The food-location information in the dance is presumably important when food sources are hard to find, variable in richness and ephemeral. Recruitment based simply on arousal of foragers and communication of floral odour, as occurs in honeybees(1), bumble bees(11) and some stingless bees(12), can be equally effective under other circumstances. Clarifying the condition-dependent payoffs of the dance language provides new insight into its function in honeybee ecology.	Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Visscher, PK (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.							Batschelet E, 1981, CIRCULAR STAT BIOL; BRINES ML, 1979, SCIENCE, V206, P571, DOI 10.1126/science.206.4418.571; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; DYER FC, 1985, J COMP PHYSIOL A, V157, P183, DOI 10.1007/BF01350026; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Esch HE, 1996, J EXP BIOL, V199, P155; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; KIRCHNER WH, 1993, APIDOLOGIE, V24, P297, DOI 10.1051/apido:19930309; Kirchner WH, 1998, J INSECT BEHAV, V11, P169, DOI 10.1023/A:1021098405564; LINDAUER M, 1971, COMMUNICATION SOCIAL; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; SEELEY TD, 1995, WISDOM HIVE SOCIAL P, P69; SHERMAN G, 2002, THESIS U CALIFORNIA; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; VISSCHER PK, 1994, 12 C INT UN STUD SOC; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; WEHNER R, 1985, EXPT BEHAV ECOLOGY S, P11; WENNER AM, 1990, ANATOMY CONTROVERSY, P57	20	121	122	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					920	922		10.1038/nature01127	http://dx.doi.org/10.1038/nature01127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410309				2022-12-24	WOS:000178909700042
J	Patsalis, PC; Sismani, C; Quintana-Murci, L; Taleb-Bekkouche, F; Krausz, C; McElreavey, K				Patsalis, PC; Sismani, C; Quintana-Murci, L; Taleb-Bekkouche, F; Krausz, C; McElreavey, K			Effects of transmission of Y chromosome AZFc deletions	LANCET			English	Article							MICRODELETIONS; MOSAICISM	Deletions of specific regions on the Y chromosome cause male infertility. Recent advances in infertility treatment allow Y chromosome deletions to be transmitted to male offspring with the assumption that there will be no clinical consequences other than infertility in adult life. We screened 12 patients, who had a 45X/46XY karyotype and presented with Turner stigmata or sexual ambiguities, or both, for Y chromosome microdeletions with PCR. A third of these patients had Y chromosome microdeletions of distal Yq, the most common microdeletion seen in infertile men with azoospermia or severe oligozoospermia. Transmission of Y chromosome microdeletions could potentially have severe clinical consequences other than male infertility, such as the development of sexual ambiguities and Turner stigmata.	Inst Pasteur, Dept Dev Biol, F-75724 Paris, France; Cyprus Inst Neurol & Genet, Nicosia, Cyprus; Univ Florence, Androl Unit, Florence, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Florence	McElreavey, K (corresponding author), Inst Pasteur, Dept Dev Biol, F-75724 Paris, France.		Quintana-Murci, Lluis/AAB-7468-2022	Krausz, Csilla Gabriella/0000-0001-6748-8918; Quintana-Murci, Lluis/0000-0003-2429-6320				CHANG HJ, 1990, AM J HUM GENET, V46, P156; McElreavey K, 2000, Results Probl Cell Differ, V28, P211; Papadimas J, 2001, FERTIL STERIL, V76, P1261, DOI 10.1016/S0015-0282(01)02877-1; Siffroi JP, 2000, HUM REPROD, V15, P2559, DOI 10.1093/humrep/15.12.2559; van Golde RJT, 2001, HUM REPROD, V16, P289, DOI 10.1093/humrep/16.2.289	5	67	72	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1222	1224		10.1016/S0140-6736(02)11248-7	http://dx.doi.org/10.1016/S0140-6736(02)11248-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401251				2022-12-24	WOS:000178708100014
J	Barbour, V				Barbour, V			Celebrating death - the 2002 Nobel prize in physiology or medicine	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Barbour, V (corresponding author), The Lancet, London NW1 7BY, England.			Barbour, Virginia/0000-0002-2358-2440					0	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 12	2002	360	9340					1117	1117		10.1016/S0140-6736(02)11240-2	http://dx.doi.org/10.1016/S0140-6736(02)11240-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604QF	12387956				2022-12-24	WOS:000178632000008
J	Wake, M; Hesketh, K				Wake, M; Hesketh, K			Teething symptoms: cross sectional survey of five groups of child health professionals	BRITISH MEDICAL JOURNAL			English	Article							INFANT		Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Wake, M (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.		Wake, Melissa/J-1396-2012; Hesketh, Kylie/B-7031-2013	Wake, Melissa/0000-0001-7501-9257; Hesketh, Kylie/0000-0002-2702-7110				COREIL J, 1995, CLIN PEDIATR, V34, P591, DOI 10.1177/000992289503401104; Macknin ML, 2000, PEDIATRICS, V105, P747, DOI 10.1542/peds.105.4.747; Wake M, 2000, PEDIATRICS, V106, P1374, DOI 10.1542/peds.106.6.1374; Wake M, 1999, J PAEDIATR CHILD H, V35, P446, DOI 10.1046/j.1440-1754.1999.355395.x; 1975, BMJ, V4, P604	5	23	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2002	325	7368					814	814		10.1136/bmj.325.7368.814	http://dx.doi.org/10.1136/bmj.325.7368.814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604YM	12376443	Bronze, Green Published			2022-12-24	WOS:000178648700020
J	Band, PR; Le, ND; Fang, R; Deschamps, M				Band, PR; Le, ND; Fang, R; Deschamps, M			Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer	LANCET			English	Article							POSTMENOPAUSAL WOMEN; UNITED-STATES; MENOPAUSE; EXPOSURE; DISEASE; DIET	Background Results of epidemiological studies, assessing the relation between smoking and breast cancer, have been inconclusive. Our aim was to assess the carcinogenic and possibly antioestrogenic effects of cigarette smoke on risk of breast cancer. Methods We sent a questionnaire to 1431 women younger than age 75 years who had breast cancer and were listed on the population-based British Columbia cancer registry between June 1, 1988, and June 30, 1989. We also sent questionnaires to 1502 age-matched controls, randomly selected from the 1989 provincial voters list. We obtained information on all known and suspected risk factors for breast cancer, and on lifetime smoking, alcohol consumption, and occupational history. We assessed the effect of smoking separately for premenopausal and postmenopausal women, adjusting for confounding variables. Findings 318 premenopausal women and 340 controls replied. Risk of breast cancer was significantly increased (adjusted odds ratio 1.69, 95% CI 1.13-2.51) in women who had been pregnant and who started to smoke within 5 years of menarche, and in nulliparous women who smoked 20 cigarettes daily or more (7.08, 1.63-30.8) and had smoked for 20 cumulative pack-years or more (7.48, 1.59-35.2). Postmenopausal women (700 breast cancer and 685 controls) whose body-mass index increased from age 18 to current and who started to smoke after a first fullterm pregnancy had a significantly reduced risk of breast cancer (0.49, 0.27-0.89). Interpretation Our results suggest that cigarette smoke exerts a dual action on the breast, with different effects in premenopausal and postmenopausal women. Our observations reinforce the importance of smoking prevention, especially in early adolescence, and draw attention to the timing of exposure in relation to susceptibility and refractory windows in the design of studies to investigate associations between environmental carcinogens or putative endocrine disruptors and risk of breast cancer.	Hlth Canada, Longueuil, PQ J4K 1C7, Canada; Univ Ottawa, Inst Populat Hlth, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON K1N 6N5, Canada; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Sociaux Montreal Ctr, Regie Reg Sante & Serv, Direct Sante Publ, Montreal, PQ, Canada	Health Canada; University of Ottawa; British Columbia Cancer Agency	Band, PR (corresponding author), Hlth Canada, 1001 St Laurent O, Longueuil, PQ J4K 1C7, Canada.							Band PR, 2000, J OCCUP ENVIRON MED, V42, P284, DOI 10.1097/00043764-200003000-00010; Baron JA, 1996, CANCER EPIDEM BIOMAR, V5, P399; Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; ClavelChapelon F, 1997, CANCER DETECT PREV, V21, P426; EWERTZ M, 1990, CANCER CAUSE CONTROL, V1, P31, DOI 10.1007/BF00053181; Gammon MD, 1998, CANCER CAUSE CONTROL, V9, P583, DOI 10.1023/A:1008868922799; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HIATT RA, 1986, JNCI-J NATL CANCER I, V76, P833; Ishibe N, 1998, CANCER RES, V58, P667; Jefcoate C R, 2000, J Natl Cancer Inst Monogr, P95; JOHN EM, 1993, EPIDEMIOL REV, V15, P157, DOI 10.1093/oxfordjournals.epirev.a036099; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; KADOHAMA N, 1993, CANCER LETT, V75, P175, DOI 10.1016/0304-3835(93)90060-M; KAUFMAN DW, 1980, AM J PUBLIC HEALTH, V70, P420, DOI 10.2105/AJPH.70.4.420; Li DH, 1999, CANCER DETECT PREV, V23, P454, DOI 10.1046/j.1525-1500.1999.99059.x; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Morabia A, 1996, AM J EPIDEMIOL, V143, P918, DOI 10.1093/oxfordjournals.aje.a008835; PALMER JR, 1993, EPIDEMIOL REV, V15, P145, DOI 10.1093/oxfordjournals.epirev.a036098; PETRAKIS NL, 1993, EPIDEMIOL REV, V15, P188, DOI 10.1093/oxfordjournals.epirev.a036104; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; RUSSO J, 1995, CANCER LETT, V90, P81, DOI 10.1016/0304-3835(94)03681-8; Russo J, 1993, Eur J Cancer Prev, V2 Suppl 3, P85; Trentham-Dietz A, 2000, CANCER CAUSE CONTROL, V11, P533, DOI 10.1023/A:1008961931534; Wartenberg D, 2000, J NATL CANCER I, V92, P1666, DOI 10.1093/jnci/92.20.1666; Willett WC, 2001, CANCER EPIDEM BIOMAR, V10, P3	28	146	149	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 5	2002	360	9339					1044	1049		10.1016/S0140-6736(02)11140-8	http://dx.doi.org/10.1016/S0140-6736(02)11140-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	602BN	12383984				2022-12-24	WOS:000178485200009
J	Cowman, AF; Crabb, BS				Cowman, AF; Crabb, BS			The Plasmodium falciparum genome - a blueprint for erythrocyte invasion	SCIENCE			English	Editorial Material							SURFACE PROTEIN-1 COMPLEX; MEROZOITES; GENES; VIVAX; IDENTIFICATION; COMPONENT; HOMOLOG; IMMUNE		PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Cowman, AF (corresponding author), PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Crabb, Brendan/F-5287-2013; Cowman, Alan F/C-7642-2013	Cowman, Alan F/0000-0001-5145-9004				Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Barnwell John W., 1998, P93; Black CG, 1999, INFECT IMMUN, V67, P2075, DOI 10.1128/IAI.67.5.2075-2081.1999; Black CG, 2001, MOL BIOCHEM PARASIT, V114, P217, DOI 10.1016/S0166-6851(01)00265-1; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; COWMAN AF, 1985, CELL, V40, P775, DOI 10.1016/0092-8674(85)90337-X; DREW DR, UNPUB; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holder AA, 1996, PARASITOL TODAY, V12, P173, DOI 10.1016/0169-4758(96)20009-2; HOLDER AA, 1985, MOL BIOCHEM PARASIT, V14, P293, DOI 10.1016/0166-6851(85)90057-X; Marshall VM, 1998, MOL BIOCHEM PARASIT, V94, P13, DOI 10.1016/S0166-6851(98)00045-0; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER SK, IN PRESS J BIOL CHEM; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9	26	23	24	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2002	298	5591					126	128		10.1126/science.1078169	http://dx.doi.org/10.1126/science.1078169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364790				2022-12-24	WOS:000178370500047
J	Riehle, MA; Garczynski, SF; Crim, JW; Hill, CA; Brown, MR				Riehle, MA; Garczynski, SF; Crim, JW; Hill, CA; Brown, MR			Neuropeptides and peptide hormones in Anopheles gambiae	SCIENCE			English	Article							AEDES-AEGYPTI; MOSQUITO; IDENTIFICATION; INSULIN; CDNA; ACTIVATION; MECHANISMS; EXPRESSION; RECEPTOR; DIPTERA	The African malaria mosquito, Anopheles gambiae, is specialized for rapid completion of development and reproduction. A vertebrate blood meal is required for egg production, and multiple feedings subsequently allow transmission of malaria parasites, Plasmodium spp. Regulatory peptides from 35 genes annotated from the A. gambiae genome likely coordinate these and other physiological processes. Plasmodium parasites may affect actions of newly identified insulin-like peptides, which coordinate growth and reproduction of its vector, A. gambiae, as in Drosophila melanogaster, Caenorhabditis elegans, and mammals. This genomic information provides a basis to expand understanding of hematophagy and pathogen transmission in this mosquito.	Univ Georgia, Dept Entomol, Athens, GA 30602 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Notre Dame	Brown, MR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mbrown@bugs.ent.uga.edu	Crim, Joe/GWC-6878-2022; Riehle, Michael A/O-2852-2017	Riehle, Michael/0000-0001-9747-3872	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033108, U01AI050687, U01AI048846] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI033108, AI33108, U01 AI48846, U01 AI50687] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BROWN MA, UNPUB; Brown MR, 1998, J BIOL CHEM, V273, P3967, DOI 10.1074/jbc.273.7.3967; BROWN MR, 2001, J INSECT SCI; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; Clark TM, 1998, AM J PHYSIOL-RENAL, V274, pF834, DOI 10.1152/ajprenal.1998.274.5.F834; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hopwood JA, 2001, J EXP BIOL, V204, P2773; Horodyski FM, 1996, J INSECT PHYSIOL, V42, P917, DOI 10.1016/0022-1910(96)00035-2; JENKINS SP, 1992, INSECT BIOCHEM MOLEC, V22, P553, DOI 10.1016/0965-1748(92)90032-A; Klowden MJ, 1997, ARCH INSECT BIOCHEM, V35, P491, DOI 10.1002/(SICI)1520-6327(1997)35:4<491::AID-ARCH10>3.3.CO;2-5; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Ozes ON, 1999, NATURE, V401, P82; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Riehle MA, 2002, CELL TISSUE RES, V308, P409, DOI 10.1007/s00441-002-0561-8; SHAPIRO JP, 1983, INSECT BIOCHEM, V13, P273, DOI 10.1016/0020-1790(83)90049-5; Stanek DM, 2002, PEPTIDES, V23, P1367, DOI 10.1016/S0196-9781(02)00074-8; Stracker TH, 2002, J MED ENTOMOL, V39, P331, DOI 10.1603/0022-2585-39.2.331; TAGHERT PH, IN PRESS ADV GENET; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; Veenstra JA, 1999, PEPTIDES, V20, P1145, DOI 10.1016/S0196-9781(99)00117-5; Veenstra JA, 1997, PEPTIDES, V18, P937, DOI 10.1016/S0196-9781(97)00032-6; Veenstra JA, 1997, J BIOL CHEM, V272, P10402, DOI 10.1074/jbc.272.16.10402; VEENSTRA JA, 1995, HISTOCHEM CELL BIOL, V104, P337, DOI 10.1007/BF01458127; Yu MJ, 2001, J INSECT PHYSIOL, V47, P263, DOI 10.1016/S0022-1910(00)00084-6	29	216	225	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					172	175		10.1126/science.1076827	http://dx.doi.org/10.1126/science.1076827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364794				2022-12-24	WOS:000178370500051
J	Gardner, MJ; Hall, N; Fung, E; White, O; Berriman, M; Hyman, RW; Carlton, JM; Pain, A; Nelson, KE; Bowman, S; Paulsen, IT; James, K; Eisen, JA; Rutherford, K; Salzberg, SL; Craig, A; Kyes, S; Chan, MS; Nene, V; Shallom, SJ; Suh, B; Peterson, J; Angiuoli, S; Pertea, M; Allen, J; Selengut, J; Haft, D; Mather, MW; Vaidya, AB; Martin, DMA; Fairlamb, AH; Fraunholz, MJ; Roos, DS; Ralph, SA; McFadden, GI; Cummings, LM; Subramanian, GM; Mungall, C; Venter, JC; Carucci, DJ; Hoffman, SL; Newbold, C; Davis, RW; Fraser, CM; Barrell, B				Gardner, MJ; Hall, N; Fung, E; White, O; Berriman, M; Hyman, RW; Carlton, JM; Pain, A; Nelson, KE; Bowman, S; Paulsen, IT; James, K; Eisen, JA; Rutherford, K; Salzberg, SL; Craig, A; Kyes, S; Chan, MS; Nene, V; Shallom, SJ; Suh, B; Peterson, J; Angiuoli, S; Pertea, M; Allen, J; Selengut, J; Haft, D; Mather, MW; Vaidya, AB; Martin, DMA; Fairlamb, AH; Fraunholz, MJ; Roos, DS; Ralph, SA; McFadden, GI; Cummings, LM; Subramanian, GM; Mungall, C; Venter, JC; Carucci, DJ; Hoffman, SL; Newbold, C; Davis, RW; Fraser, CM; Barrell, B			Genome sequence of the human malaria parasite Plasmodium falciparum	NATURE			English	Review							2C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE; RED-CELL SURFACE; INFECTED ERYTHROCYTES; SHIKIMATE PATHWAY; TOXOPLASMA-GONDII; SUBCELLULAR-LOCALIZATION; RIBONUCLEOTIDE REDUCTASE; SACCHAROMYCES-CEREVISIAE; ISOPRENOID BIOSYNTHESIS; SUBTELOMERIC REGIONS	The parasite Plasmodium falciparum is responsible for hundreds of millions of cases of malaria, and kills more than one million African children annually. Here we report an analysis of the genome sequence of P. falciparum clone 3D7. The 23-megabase nuclear genome consists of 14 chromosomes, encodes about 5,300 genes, and is the most (A + T)-rich genome sequenced to date. Genes involved in antigenic variation are concentrated in the subtelomeric regions of the chromosomes. Compared to the genomes of free-living eukaryotic microbes, the genome of this intracellular parasite encodes fewer enzymes and transporters, but a large proportion of genes are devoted to immune evasion and host-parasite interactions. Many nuclear-encoded proteins are targeted to the apicoplast, an organelle involved in fatty-acid and isoprenoid metabolism. The genome sequence provides the foundation for future studies of this organism, and is being exploited in the search for new drugs and vaccines to fight malaria.	Inst Genom Res, Rockville, MD 20850 USA; Wellcome Trust Genome, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Dundee DD1 5EH, Scotland; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Genom Inst, Philadelphia, PA 19104 USA; Univ Melbourne, Sch Bot, Plant Res Ctr, Melbourne, Vic 3010, Australia; Celera Genom, Rockville, MD 20850 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Ctr Advancement Genom, Rockville, MD 20850 USA; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA	J. Craig Venter Institute; Wellcome Trust Sanger Institute; Stanford University; Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; Drexel University; University of Dundee; University of Pennsylvania; University of Pennsylvania; University of Melbourne; University of California System; University of California Berkeley; J. Craig Venter Institute; United States Department of Defense; United States Navy	Gardner, MJ (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	gardner@tigr.org	Fairlamb, Alan/A-5272-2009; Angiuoli, Samuel V/H-7340-2014; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Pain, Arnab/L-5766-2015; Pertea, Mihaela/AAT-2705-2021; Martin, David/C-2984-2009; Mungall, Chris/I-6006-2019; Berriman, Matthew/A-7618-2011; Paulsen, Ian T/K-3832-2012; McFadden, Geoffrey McFadden I/F-7667-2014; Rutherford, Kim/Y-7995-2018; Eisen, Jonathan A./H-2706-2019; Hall, Neil/A-8717-2013; Ralph, Stuart/C-8590-2014	Fairlamb, Alan/0000-0001-5134-0329; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Pain, Arnab/0000-0002-1755-2819; Pertea, Mihaela/0000-0003-0762-8637; Mungall, Chris/0000-0002-6601-2165; Berriman, Matthew/0000-0002-9581-0377; Paulsen, Ian T/0000-0001-9015-9418; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Rutherford, Kim/0000-0001-6277-726X; Eisen, Jonathan A./0000-0002-0159-2197; Hall, Neil/0000-0002-7995-3810; Ralph, Stuart/0000-0003-0114-7808; Roos, David Siker/0000-0001-6725-4089; Fraunholz, Martin/0000-0002-4581-6244; Mather, Michael/0000-0002-1062-0137; Martin, David/0000-0002-8732-204X; Nene, Vishvanath/0000-0001-7066-4169; Allen, Jonathan/0000-0002-4359-8263; Craig, Alister/0000-0003-0914-6164; Hall, Neil/0000-0003-2808-0009; Fraser, Claire/0000-0003-1462-2428; Angiuoli, Samuel/0000-0001-9525-4350; Newbold, Chris/0000-0002-9274-3789	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042243, R01AI028398] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI028398] Funding Source: Medline; Wellcome Trust [061524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams KL, 2002, PLANT CELL, V14, P931, DOI 10.1105/tpc.010483; Adisa A, 2001, J CELL SCI, V114, P3377; Albano FR, 1999, EUR J CELL BIOL, V78, P453, DOI 10.1016/S0171-9335(99)80072-7; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BABIKER HA, 1991, T ROY SOC TROP MED H, V85, P578, DOI 10.1016/0035-9203(91)90349-4; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BLUM JJ, 1984, J PROTOZOOL, V31, P167, DOI 10.1111/j.1550-7408.1984.tb04310.x; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Breman JG, 2001, AM J TROP MED HYG, V64, P1; BUCKWITZ D, 1988, MOL BIOCHEM PARASIT, V27, P225, DOI 10.1016/0166-6851(88)90041-2; BUCKWITZ D, 1990, BIOCHEM J, V267, P353, DOI 10.1042/bj2670353; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; CHAKRABARTI D, 1993, P NATL ACAD SCI USA, V90, P12020, DOI 10.1073/pnas.90.24.12020; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Clarke JL, 2001, EUR J BIOCHEM, V268, P2013, DOI 10.1046/j.1432-1327.2001.02078.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; de Macedo CS, 2002, FEMS MICROBIOL LETT, V207, P13, DOI 10.1111/j.1574-6968.2002.tb11021.x; DEBRUIN D, 1994, P NATL ACAD SCI USA, V91, P619, DOI 10.1073/pnas.91.2.619; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DeRocher A, 2000, J CELL SCI, V113, P3969; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; DIECKMANN A, 1986, MOL BIOCHEM PARASIT, V19, P143, DOI 10.1016/0166-6851(86)90119-2; DUNCAN K, 1987, BIOCHEM J, V246, P375, DOI 10.1042/bj2460375; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; DYER M, 1994, BBA-BIOENERGETICS, V1186, P133, DOI 10.1016/0005-2728(94)90145-7; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Elliott JL, 2001, BIOCHEM J, V355, P733, DOI 10.1042/bj3550733; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Fitzpatrick T, 2001, MOL MICROBIOL, V40, P65, DOI 10.1046/j.1365-2958.2001.02366.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; FOSTER J, 1995, PARASITOL TODAY, V11, P1, DOI 10.1016/0169-4758(95)80092-1; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gamain B, 1996, FREE RADICAL BIO MED, V21, P559, DOI 10.1016/0891-5849(96)00120-7; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Haltiwanger BM, 2000, BIOCHEMISTRY-US, V39, P763, DOI 10.1021/bi9923151; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Hayashi M, 2001, J BIOL CHEM, V276, P15249, DOI 10.1074/jbc.M011709200; He CY, 2001, J BIOL CHEM, V276, P28436, DOI 10.1074/jbc.M102000200; HernandezRivas R, 1996, MOL BIOCHEM PARASIT, V78, P137, DOI 10.1016/S0166-6851(96)02618-7; HINTERBERG K, 1994, EMBO J, V13, P4174, DOI 10.1002/j.1460-2075.1994.tb06735.x; Hoffman SL, 1997, NATURE, V387, P647, DOI 10.1038/42571; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kapp C, 2002, LANCET, V359, P414, DOI 10.1016/S0140-6736(02)07634-1; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 1999, NATURE, V397, P219, DOI 10.1038/16618; Kemp LE, 2002, P NATL ACAD SCI USA, V99, P6591, DOI 10.1073/pnas.102679799; KNAPP B, 1989, MOL BIOCHEM PARASIT, V37, P47, DOI 10.1016/0166-6851(89)90101-1; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V112, P219, DOI 10.1016/S0166-6851(00)00372-8; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Lai ZW, 1999, NAT GENET, V23, P309, DOI 10.1038/15484; LANGUNNASCH N, 1992, MOL BIOCHEM PARASIT, V50, P17, DOI 10.1016/0166-6851(92)90240-K; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; LI J, 1994, MOL BIOCHEM PARASIT, V65, P283, DOI 10.1016/0166-6851(94)90079-5; LOUIS EJ, 1994, GENETICS, V136, P789; Loyevsky M, 2001, BLOOD, V98, P2555, DOI 10.1182/blood.V98.8.2555; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; McConkey GA, 1999, ANTIMICROB AGENTS CH, V43, P175, DOI 10.1128/AAC.43.1.175; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; Murphy AD, 1999, ANTIMICROB AGENTS CH, V43, P651, DOI 10.1128/AAC.43.3.651; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nchinda TC, 1998, EMERG INFECT DIS, V4, P398, DOI 10.3201/eid0403.980313; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OQUENDO P, 1986, MOL BIOCHEM PARASIT, V18, P89, DOI 10.1016/0166-6851(86)90053-8; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Palmer JD, 1996, P NATL ACAD SCI USA, V93, P7432, DOI 10.1073/pnas.93.15.7432; Papa S, 2000, J BIOENERG BIOMEMBR, V32, P401, DOI 10.1023/A:1005584221456; Pastrana DV, 1998, INFECT IMMUN, V66, P5955, DOI 10.1128/IAI.66.12.5955-5963.1998; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Pearson W R, 2000, Methods Mol Biol, V132, P185; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; PETERSON DS, 1995, P NATL ACAD SCI USA, V92, P7100, DOI 10.1073/pnas.92.15.7100; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Rohdich F, 2001, EUR J BIOCHEM, V268, P3190, DOI 10.1046/j.1432-1327.2001.02204.x; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; RUBIN H, 1993, P NATL ACAD SCI USA, V90, P9280, DOI 10.1073/pnas.90.20.9280; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sato S, 2000, INT J PARASITOL, V30, P427, DOI 10.1016/S0020-7519(99)00185-X; Sato S, 2002, CURR GENET, V40, P391, DOI 10.1007/s00294-002-0273-3; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; SCHERF A, 1992, EMBO J, V11, P2293, DOI 10.1002/j.1460-2075.1992.tb05288.x; Sherman Irwin W., 1998, P177; Sherman Irwin W., 1998, P135; Smith JD, 2001, TRENDS PARASITOL, V17, P538, DOI 10.1016/S1471-4922(01)02079-7; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Tarassov IA, 1996, BIOCHIMIE, V78, P502, DOI 10.1016/0300-9084(96)84756-0; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; VAIDYA AB, MEMBRANE STRUCTURE D; Vaidya Akhil B., 1998, P355; van Dooren GG, 2000, PARASITOL TODAY, V16, P421, DOI 10.1016/S0169-4758(00)01792-0; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2001, BBA-MOL CELL RES, V1541, P34, DOI 10.1016/S0167-4889(01)00154-9; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; VERNICK KD, 1988, MOL BIOCHEM PARASIT, V28, P85, DOI 10.1016/0166-6851(88)90055-2; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Watanabe J, 2001, NUCLEIC ACIDS RES, V29, P70, DOI 10.1093/nar/29.1.70; WATERS AP, 1994, ADV PARASIT, V34, P33, DOI 10.1016/S0065-308X(08)60136-0; WEBER JL, 1988, MOL BIOCHEM PARASIT, V29, P117, DOI 10.1016/0166-6851(88)90066-7; Wilson CM, 1996, MOL BIOCHEM PARASIT, V75, P271, DOI 10.1016/0166-6851(95)02531-6; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wiser MF, 1997, P NATL ACAD SCI USA, V94, P9108, DOI 10.1073/pnas.94.17.9108; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; Woodrow CJ, 2000, P NATL ACAD SCI USA, V97, P9931, DOI 10.1073/pnas.170153097; Yung S, 2001, MOL BIOCHEM PARASIT, V118, P11, DOI 10.1016/S0166-6851(01)00359-0; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	165	3238	3591	10	499	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					498	511		10.1038/nature01097	http://dx.doi.org/10.1038/nature01097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368864	Bronze, Green Accepted			2022-12-24	WOS:000178348400045
J	Lunardi, C; Bason, C; Leandri, M; Navone, R; Lestani, M; Millo, E; Benatti, U; Cilli, M; Beri, R; Corrocher, R; Puccetti, A				Lunardi, C; Bason, C; Leandri, M; Navone, R; Lestani, M; Millo, E; Benatti, U; Cilli, M; Beri, R; Corrocher, R; Puccetti, A			Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome	LANCET			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SUPPORTING-CELL ANTIGEN; CONNEXIN-26; EXPRESSION; DEAFNESS; ANTIBODIES; VASCULITIS; MUTATIONS; INFECTION; APOPTOSIS	Background Cogan's syndrome is a chronic inflammatory disease of unknown origin, characterised by sensorineural hearing loss, episclentis, and vasculitis. An autoimmune origin has been suggested but not proven. Our aim was to establish whether or not an autoimmune process is the cause of the disease. Methods We used pooled IgG immunoglobulins derived from eight patients with Cogan's syndrome to screen a random peptide library to identify disease relevant autoantigen peptides. Among the identified peptides, one was recognised by all the patients' sera. Antibodies against peptides were affinity purified from patients' sera and used to characterise the autoantigen, to stain human cochlea, and to transfer the features of Cogan's disease into animals. Findings We identified an immunodominant peptide that shows similarity with autoantigens such as SSA/Ro and with the reovirus III major core protein lambda 1. The peptide sequence shows similarity also with the cell-density enhanced protein tyrosine phosphatase-1 (DEP-1/CD148), which is expressed on the sensory epithelia of the inner ear and on endothelial cells. IgG antibodies against the peptide, purified from the patients' sera, recognised autoantigens and DEP-1/CD148 protein, bound human cochlea, and inhibited proliferation of cells expressing DEP-1/CD148. The same antibodies bound connexin 26, gene mutations of which lead to congenital inner ear deafness. Furthermore, these antibodies were able to induce the features of Cogan's disease in mice. Interpretation Our results indicate that Cogan's syndrome is an autoimmune disease, characterised by the presence of autoantibodies able to induce tissue damage on binding of cell-surface molecules present on the sensory epithelia of the inner ear and on endothelial cells.	Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; Univ Verona, Dept Pathol, I-37100 Verona, Italy; Univ Genoa, Dept Expt Med, Genoa, Italy; Inst Giannina Gaslini, Genoa, Italy; Univ Genoa, Interuniv Ctr Pain Neurophysiol, Genoa, Italy; Natl Canc Inst IST, Genoa, Italy	University of Verona; University of Verona; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Lunardi, C (corresponding author), Univ Verona, Dept Expt Med, Sect Internal Med, Policlin GB Rossi, Piazzale LA Scuro, I-37134 Verona, Italy.		Millo, Enrico/K-3218-2018; Cilli, Michele/AAB-8529-2019	Millo, Enrico/0000-0002-4019-0051; Cilli, Michele/0000-0003-4083-8986; Leandri, Massimo/0000-0002-5197-7431				Albayram MS, 2001, AM J NEURORADIOL, V22, P751; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; BARTLETT JA, 1988, VIROLOGY, V167, P31, DOI 10.1016/0042-6822(88)90051-7; BICKNELL JM, 1978, NEUROLOGY, V28, P278, DOI 10.1212/WNL.28.3.278; CALLEJO FJG, 2001, AN ESP PEDIATR, V55, P87; de la Fuente-Garcia MA, 1998, BLOOD, V91, P2800, DOI 10.1182/blood.V91.8.2800.2800_2800_2809; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Disher MJ, 1997, ANN NY ACAD SCI, V830, P253, DOI 10.1111/j.1749-6632.1997.tb51896.x; DONG Y, 1994, EUR J CELL BIOL, V64, P95; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; HEMCHEN C, 1999, ACTA OTORYNGOL, V119, P528; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; HUGHES GB, 1983, OTOLARYNG HEAD NECK, V91, P24, DOI 10.1177/019459988309100106; Ikeda M, 2002, ANN RHEUM DIS, V61, P761, DOI 10.1136/ard.61.8.761; Keane MM, 1996, CANCER RES, V56, P4236; Kelley PM, 2000, BRAIN RES REV, V32, P184, DOI 10.1016/S0165-0173(99)00080-6; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kruger RP, 1999, J NEUROSCI, V19, P4815; Lefebvre PP, 2000, BRAIN RES REV, V32, P159; Lunardi C, 1998, EUR J IMMUNOL, V28, P936, DOI 10.1002/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.3.CO;2-O; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Oliveri M, 2001, EUR J IMMUNOL, V31, P743, DOI 10.1002/1521-4141(200103)31:3<743::AID-IMMU743>3.0.CO;2-9; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; REICHLIN M, 1991, British Journal of Rheumatology, V30, P58; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SPANAKIS SG, 1998, INVEST OPHTH VIS SCI, V39, P1198; St Clair E W, 1999, Curr Opin Rheumatol, V11, P47, DOI 10.1097/00002281-199901000-00008; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Van Doornum S, 2001, ANN RHEUM DIS, V60, P69, DOI 10.1136/ard.60.1.69; VOLLERTSEN RS, 1986, MAYO CLIN PROC, V61, P344, DOI 10.1016/S0025-6196(12)61951-X; VOLLERTSEN RS, 1990, RHEUM DIS CLIN N AM, V16, P433; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	34	150	159	1	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 21	2002	360	9337					915	921		10.1016/S0140-6736(02)11028-2	http://dx.doi.org/10.1016/S0140-6736(02)11028-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AU	12354474				2022-12-24	WOS:000178142200011
J	Simpson, AGB; MacQuarrie, EK; Roger, AJ				Simpson, AGB; MacQuarrie, EK; Roger, AJ			Eukaryotic evolution - Early origin of canonical introns	NATURE			English	Article							SPLICEOSOMAL INTRONS; CARPEDIEMONAS; HISTORY		Dalhousie Univ, Dept Biochem & Mol Biol, Program Evolutionary Biol, Canadian Inst Adv Res, Halifax, NS B3H 4H7, Canada	Canadian Institute for Advanced Research (CIFAR); Dalhousie University	Simpson, AGB (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Program Evolutionary Biol, Canadian Inst Adv Res, Halifax, NS B3H 4H7, Canada.	simpson@hades.biochem.dal.ca		Simpson, Alastair/0000-0002-4133-1709				Archibald JM, 2002, MOL BIOL EVOL, V19, P422, DOI 10.1093/oxfordjournals.molbev.a004097; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Dacks J, 1999, J MOL EVOL, V48, P779, DOI 10.1007/PL00013156; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FAST NM, 1999, MOL BIOCHEM PARASIT, V99, P514; Johnson PJ, 2002, P NATL ACAD SCI USA, V99, P3359, DOI 10.1073/pnas.072084199; Logsdon JM, 1998, CURR OPIN GENET DEV, V8, P637, DOI 10.1016/S0959-437X(98)80031-2; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Palmer JD, 1991, CURR OPIN GENET DEV, V1, P470, DOI 10.1016/S0959-437X(05)80194-7; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Simpson AGB, 1999, EUR J PROTISTOL, V35, P353, DOI 10.1016/S0932-4739(99)80044-3; Simpson AGB, 2002, MOL BIOL EVOL, V19, P1782, DOI 10.1093/oxfordjournals.molbev.a004000; Sogin ML, 1997, CURR OPIN GENET DEV, V7, P792, DOI 10.1016/S0959-437X(97)80042-1	13	48	52	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					270	270		10.1038/419270a	http://dx.doi.org/10.1038/419270a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239559				2022-12-24	WOS:000178056300037
J	Soteriades, ES; Evans, JC; Larson, MG; Chen, MH; Chen, L; Benjamin, EJ; Levy, D				Soteriades, ES; Evans, JC; Larson, MG; Chen, MH; Chen, L; Benjamin, EJ; Levy, D			Incidence and prognosis of syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM FOLLOW-UP; RECURRENT UNEXPLAINED SYNCOPE; UNKNOWN ORIGIN; UNDETERMINED ORIGIN; DIAGNOSING SYNCOPE; HISTORY; BIAS; RISK	Background: Little is known about the epidemiology and prognosis of syncope in the general population. Methods: We evaluated the incidence, specific causes, and prognosis of syncope among women and men participating in the Framingham Heart Study from 1971 to 1998. Results: Of 7814 study participants followed for an average of 17 years, 822 reported syncope. The incidence of a first report of syncope was 6.2 per 1000 person-years. The most frequently identified causes were vasovagal (21.2 percent), cardiac (9.5 percent), and orthostatic (9.4 percent); for 36.6 percent the cause was unknown. The multivariable-adjusted hazard ratios among participants with syncope from any cause, as compared with those who did not have syncope, were 1.31 (95 percent confidence interval, 1.14 to 1.51) for death from any cause, 1.27 (95 percent confidence interval, 0.99 to 1.64) for myocardial infarction or death from coronary heart disease, and 1.06 (95 percent confidence interval, 0.77 to 1.45) for fatal or nonfatal stroke. The corresponding hazard ratios among participants with cardiac syncope were 2.01 (95 percent confidence interval, 1.48 to 2.73), 2.66 (95 percent confidence interval, 1.69 to 4.19), and 2.01 (95 percent confidence interval, 1.06 to 3.80). Participants with syncope of unknown cause and those with neurologic syncope had increased risks of death from any cause, with multivariable-adjusted hazard ratios of 1.32 (95 percent confidence interval, 1.09 to 1.60) and 1.54 (95 percent confidence interval, 1.12 to 2.12), respectively. There was no increased risk of cardiovascular morbidity or mortality associated with vasovagal (including orthostatic and medication-related) syncope. Conclusions: Persons with cardiac syncope are at increased risk for death from any cause and cardiovascular events, and persons with syncope of unknown cause are at increased risk for death from any cause. Vasovagal syncope appears to have a benign prognosis.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Med Ctr, Dept Cardiol, Boston, MA USA; Boston Med Ctr, Dept Prevent Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston Medical Center; Boston Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Beth Israel Deaconess Medical Center	Levy, D (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; NINDS NIH HHS [NS-17950] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry D, 1996, STAT MED, V15, P2603; BASS EB, 1988, AM J CARDIOL, V62, P1186, DOI 10.1016/0002-9149(88)90257-3; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAY SC, 1982, AM J MED, V73, P15, DOI 10.1016/0002-9343(82)90913-5; DERMKSIAN G, 1958, JAMA-J AM MED ASSOC, V168, P1200, DOI 10.1001/jama.1958.03000090030007; DERMKSIAN G, 1958, JAMA-J AM MED ASSOC, V168, P1623, DOI 10.1001/jama.1958.03000120029005; DOHERTY JU, 1985, AM J CARDIOL, V55, P703, DOI 10.1016/0002-9149(85)90140-7; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; EAGLE KA, 1985, AM J MED, V79, P455, DOI 10.1016/0002-9343(85)90032-4; Getchell WS, 1999, J GEN INTERN MED, V14, P677, DOI 10.1046/j.1525-1497.1999.03199.x; GOUELLO JP, 1995, PRESSE MED, V24, P387; HESS DS, 1982, AM J CARDIOL, V50, P1309, DOI 10.1016/0002-9149(82)90468-4; HOUDENT C, 1988, PRESSE MED, V17, P626; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPOOR WN, 1987, AM J MED, V82, P20, DOI 10.1016/0002-9343(87)90372-X; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Kapoor WN, 1996, AM J MED, V100, P646, DOI 10.1016/S0002-9343(95)00052-6; KAPOOR WN, 1995, MED CLIN N AM, V79, P1153, DOI 10.1016/S0025-7125(16)35877-1; KAPOOR WN, 1983, NEW ENGL J MED, V309, P197, DOI 10.1056/NEJM198307283090401; KROL RB, 1987, J AM COLL CARDIOL, V10, P358, DOI 10.1016/S0735-1097(87)80019-0; KUSHNER JA, 1989, J AM COLL CARDIOL, V14, P391, DOI 10.1016/0735-1097(89)90191-5; Lamb LE, 1960, AEROSPACE MED, V31, P973; LEE RT, 1988, J GEN INTERN MED, V3, P337, DOI 10.1007/BF02595791; Linzer M, 1997, ANN INTERN MED, V127, P76, DOI 10.7326/0003-4819-127-1-199707010-00014; LINZER M, 1990, AM J CARDIOL, V66, P214, DOI 10.1016/0002-9149(90)90591-N; Linzer M, 1997, ANN INTERN MED, V126, P989, DOI 10.7326/0003-4819-126-12-199706150-00012; LIPSITZ LA, 1985, Q J MED, V55, P45; MARTIN GJ, 1984, ANN EMERG MED, V13, P499, DOI 10.1016/S0196-0644(84)80511-9; Martin TP, 1997, ANN EMERG MED, V29, P459, DOI 10.1016/S0196-0644(97)70217-8; MOAZEZ F, 1991, AM HEART J, V121, P81, DOI 10.1016/0002-8703(91)90959-L; MORADY F, 1983, J AM COLL CARDIOL, V2, P1053, DOI 10.1016/S0735-1097(83)80329-5; MURDOCH BD, 1980, S AFR MED J, V57, P771; OLSHANSKY B, 1985, J AM COLL CARDIOL, V5, P216, DOI 10.1016/S0735-1097(85)80040-1; Olshansky B, 1999, AM HEART J, V137, P878, DOI 10.1016/S0002-8703(99)70412-6; *SAS I, 1997, SAS STAT SOFTW CHANG, P413; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; SILVERSTEIN MD, 1982, JAMA-J AM MED ASSOC, V248, P1185, DOI 10.1001/jama.248.10.1185; SRA JS, 1991, ANN INTERN MED, V114, P1013, DOI 10.7326/0003-4819-114-12-1013; TEICHMAN SL, 1985, AM HEART J, V110, P469, DOI 10.1016/0002-8703(85)90171-1; WILLIAMS RL, 1962, AEROSPACE MED, V33, P545	43	801	854	1	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2002	347	12					878	885		10.1056/NEJMoa012407	http://dx.doi.org/10.1056/NEJMoa012407			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594GJ	12239256	Bronze			2022-12-24	WOS:000178040700003
J	Rupert, PB; Massey, AP; Sigurdsson, ST; Ferre-D'Amare, AR				Rupert, PB; Massey, AP; Sigurdsson, ST; Ferre-D'Amare, AR			Transition state stabilization by a catalytic RNA	SCIENCE			English	Article							HAIRPIN RIBOZYME CLEAVAGE; URIDINE VANADATE COMPLEX; RIBONUCLEASE-A; BINDING-ENERGY; MECHANISM; ANALOG; ENZYME; LOOP; ION	The hairpin ribozyme catalyzes sequence-specific cleavage of RNA through transesterification of the scissile phosphate. Vanadate has previously been used as a transition state mimic of protein enzymes that catalyze the same reaction. Comparison of the 2.2 angstrom resolution structure of a vanadate-hairpin ribozyme complex with structures of precursor and product complexes reveals a rigid active site that makes more hydrogen bonds to the transition state than to the precursor or product. Because of the paucity of RNA functional groups capable of general acid-base or electrostatic catalysis, transition state stabilization is likely to be an important catalytic strategy for ribozymes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Sigurdsson, Snorri Th/B-9359-2008	Sigurdsson, Snorri Th/0000-0003-2492-1456	NCRR NIH HHS [RR15943] Funding Source: Medline; NIGMS NIH HHS [GM56947, GM63576] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576, R01GM056947] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Butcher SE, 1999, NAT STRUCT BIOL, V6, P212; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Deng H, 1998, J AM CHEM SOC, V120, P4717, DOI 10.1021/ja972824v; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Hertel KJ, 1997, P NATL ACAD SCI USA, V94, P8497, DOI 10.1073/pnas.94.16.8497; KRAUSS M, 1992, J AM CHEM SOC, V114, P3630, DOI 10.1021/ja00036a008; Lebruska LL, 2002, CHEM BIOL, V9, P465, DOI 10.1016/S1074-5521(02)00130-8; LINDQUIST RN, 1973, J AM CHEM SOC, V95, P8762, DOI 10.1021/ja00807a043; Massey A., UNPUB; Messmore JM, 2000, J AM CHEM SOC, V122, P9911, DOI 10.1021/ja0021058; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; NARLIKAR GJ, 1995, P NATL ACAD SCI USA, V92, P3668, DOI 10.1073/pnas.92.9.3668; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Ryder SP, 2002, NUCLEIC ACIDS RES, V30, P1287, DOI 10.1093/nar/30.6.1287; Ryder SP, 2001, RNA, V7, P1454; Saenger W., 1984, PRINCIPLES NUCL ACID, P107; Shan SO, 1999, METHOD ENZYMOL, V308, P246; VEENSTRA TD, 1994, BIOPHYS J, V67, P331, DOI 10.1016/S0006-3495(94)80485-0; Wladkowski BD, 1998, J AM CHEM SOC, V120, P5488, DOI 10.1021/ja972296n; WLODAWER A, 1983, P NATL ACAD SCI-BIOL, V80, P3628, DOI 10.1073/pnas.80.12.3628; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	28	232	238	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1421	1424		10.1126/science.1076093	http://dx.doi.org/10.1126/science.1076093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12376595				2022-12-24	WOS:000179223100052
J	Paulson, RJ; Boostanfar, R; Saadat, P; Mor, E; Tourgeman, DE; Slater, CC; Francis, MM; Jain, JK				Paulson, RJ; Boostanfar, R; Saadat, P; Mor, E; Tourgeman, DE; Slater, CC; Francis, MM; Jain, JK			Pregnancy in the sixth decade of life - Obstetric outcomes in women of advanced reproductive age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OOCYTE DONATION; IN-VITRO; INFANTS	Context As a result of oocyte donation, women in their sixth decade of life are now able to conceive and carry pregnancies to term. However, little is known about pregnancy outcomes in this population. Objective To describe pregnancy outcomes in women aged 50 years or older who conceived after in vitro fertilization with donor oocytes. Design and Setting Retrospective analysis of cycles conducted at a US university assisted reproduction program during calendar years 1991-2001. Patients Seventy-seven postmenopausal women with no chronic medical conditions (mean [SDI age, 52.8 [2.91 years; range, 50-63 years) who underwent 121 embryo transfer procedures (89 fresh and 32 frozen). Pregnancy outcomes were ascertained by chart review and telephone follow-up. Main Outcome Measures Maternal and neonatal outcomes. Results There were 55 clinical pregnancies for a total pregnancy rate of 45.5%. The live birth rate was 37.2%. Of the 45 live births, 31 were singletons, 12 were twins, and 2 were triplets, for which the mean (SD) gestational ages at delivery were 38.4 (2.1) weeks, 35.8 (2.8) weeks, and 32.2 weeks, respectively. Mean (SD) birth weights were 3039 g (703 g), 2254 g (581 g), and 1913 g, respectively. Apgar scores at 1 and 5 minutes were 8.2 (0.9) and 9.1 (0.5), respectively. Of singletons, 68% were delivered by cesarean, and all multiples were delivered by cesarean. Mild preeclampsia was noted in 25% of patients and severe preeclampsia in 10%. Gestational diabetes required diet modification in 17.5%, and 2.5% required insulin. Conclusions Appropriately screened women aged 50 years or older can successfully conceive via oocyte donation and experience similar pregnancy rates, multiple gestation rates, and spontaneous abortion rates as younger recipients. During pregnancy, they appear at increased risk of preeclampsia and gestational diabetes. A majority can expect to deliver via cesarean. However, there does not appear to be any definitive medical reason for excluding these women from attempting pregnancy on the basis of age alone.	Univ So Calif, Womens & Childrens Hosp, Dept Obstet & Gynecol, Keck Sch Med,Div Reprod Endocrinol & Infertil, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California	Paulson, RJ (corresponding author), Univ So Calif, Womens & Childrens Hosp, Dept Obstet & Gynecol, Keck Sch Med,Div Reprod Endocrinol & Infertil, 1240 N Mission Rd,Room 8K9, Los Angeles, CA 90033 USA.	rpaulson@usc.edu						ANTINORI S, 1993, HUM REPROD, V8, P1487, DOI 10.1093/oxfordjournals.humrep.a138284; Behr B, 1999, HUM REPROD, V14, P454, DOI 10.1093/humrep/14.2.454; Cunningham FG, 2001, WILLIAMS OBSTET, V23rd; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; KIRZ DS, 1985, AM J OBSTET GYNECOL, V152, P7, DOI 10.1016/S0002-9378(85)80166-6; LEHMANN DK, 1987, AM J OBSTET GYNECOL, V157, P738, DOI 10.1016/S0002-9378(87)80041-8; MESTMAN JH, 1980, DIABETES CARE, V3, P447, DOI 10.2337/diacare.3.3.447; NARAYAN H, 1992, EUR J OBSTET GYN R B, V47, P47, DOI 10.1016/0028-2243(92)90213-I; NEWMAN RB, 1989, AM J OBSTET GYNECOL, V161, P547, DOI 10.1016/0002-9378(89)90354-2; PANTOS K, 1993, HUM REPROD, V8, P488, DOI 10.1093/oxfordjournals.humrep.a138077; Paulson RJ, 1997, FERTIL STERIL, V67, P949, DOI 10.1016/S0015-0282(97)81413-6; Paulson RJ, 2001, FERTIL STERIL, V75, P14, DOI 10.1016/S0015-0282(00)01719-2; Paulson RJ, 1997, HUM REPROD, V12, P835, DOI 10.1093/humrep/12.4.835; Salha O, 1999, HUM REPROD, V14, P2268, DOI 10.1093/humrep/14.9.2268; SAUER MV, 1993, LANCET, V341, P321, DOI 10.1016/0140-6736(93)90132-Z; SAUER MV, 1992, JAMA-J AM MED ASSOC, V268, P1275, DOI 10.1001/jama.268.10.1275; SAUER MV, 1995, FERTIL STERIL, V64, P111, DOI 10.1016/S0015-0282(16)57665-1; Sauer MV, 1996, HUM REPROD, V11, P2540; SAUER MV, 1990, NEW ENGL J MED, V323, P1157, DOI 10.1056/NEJM199010253231702; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; SERHAL PF, 1989, LANCET, V1, P1185; SPELLACY WN, 1990, OBSTET GYNECOL, V75, P168; SPELLACY WN, 1986, OBSTET GYNECOL, V68, P452; Ventura S J, 2000, Natl Vital Stat Rep, V48, P1; Zeitz J, 2002, FERTIL STERIL, V77, P18	26	165	175	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2002	288	18					2320	2323		10.1001/jama.288.18.2320	http://dx.doi.org/10.1001/jama.288.18.2320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JZ	12425710	Bronze			2022-12-24	WOS:000179186400032
J	Snow, CD; Nguyen, N; Pande, VS; Gruebele, M				Snow, CD; Nguyen, N; Pande, VS; Gruebele, M			Absolute comparison of simulated and experimental protein-folding dynamics	NATURE			English	Article							TERTIARY STRUCTURE; MODEL; APOMYOGLOBIN; MECHANICS; SECONDARY; PATHWAYS; KINETICS; PEPTIDE; DESIGN	Protein folding is difficult to simulate with classical molecular dynamics. Secondary structure motifs such as alpha-helices and beta-hairpins can form in 0.1-10 mus (ref. 1), whereas small proteins have been shown to fold completely in tens of microseconds(2). The longest folding simulation to date is a single 1-mus simulation of the villin headpiece(3); however, such single runs may miss many features of the folding process as it is a heterogeneous reaction involving an ensemble of transition states(4,5). Here, we have used a distributed computing implementation to produce tens of thousands of 5-20-ns trajectories (700 mus) to simulate mutants of the designed mini-protein BBA5. The fast relaxation dynamics these predict were compared with the results of laser temperature-jump experiments. Our computational predictions are in excellent agreement with the experimentally determined mean folding times and equilibrium constants. The rapid folding of BBA5 is due to the swift formation of secondary structure. The convergence of experimentally and computationally accessible timescales will allow the comparison of absolute quantities characterizing in vitro and in silico (computed) protein folding(6).	Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Stanford Univ, Biophys Program, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pande, VS (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.		Snow, Christopher/L-5624-2013; Pande, Vijay/ABE-8145-2020	Snow, Christopher/0000-0002-7690-3519; 				ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Ballew RM, 1996, P NATL ACAD SCI USA, V93, P5759, DOI 10.1073/pnas.93.12.5759; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; CHANDLER D, 1978, J CHEM PHYS, V68, P2959, DOI 10.1063/1.436049; Daura X, 1998, J MOL BIOL, V280, P925, DOI 10.1006/jmbi.1998.1885; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Eaton WA, 1998, ACCOUNTS CHEM RES, V31, P745, DOI 10.1021/ar9700825; Ervin J, 2000, J PHOTOCH PHOTOBIO B, V54, P1, DOI 10.1016/S1011-1344(00)00002-6; Ferrara P, 2000, J PHYS CHEM B, V104, P5000, DOI 10.1021/jp994157t; Ferrara P, 2000, P NATL ACAD SCI USA, V97, P10780, DOI 10.1073/pnas.190324897; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163; Gilmanshin R, 1997, P NATL ACAD SCI USA, V94, P3709, DOI 10.1073/pnas.94.8.3709; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; MOORE S, 1951, J BIOL CHEM, V192, P663; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Struthers M, 1998, FOLD DES, V3, P95, DOI 10.1016/S1359-0278(98)00015-7; Struthers MD, 1996, SCIENCE, V271, P342, DOI 10.1126/science.271.5247.342; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zagrovic B, 2001, J MOL BIOL, V313, P151, DOI 10.1006/jmbi.2001.5033	29	573	579	0	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					102	106		10.1038/nature01160	http://dx.doi.org/10.1038/nature01160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422224				2022-12-24	WOS:000179068100045
J	Pitman, NCA; Jorgensen, PM				Pitman, NCA; Jorgensen, PM			Estimating the size of the world's threatened flora	SCIENCE			English	Article									Duke Univ, Ctr Trop Conservat, Durham, NC 27706 USA; Missouri Bot Garden, St Louis, MO 63166 USA	Duke University; Missouri Botanical Gardens	Pitman, NCA (corresponding author), Duke Univ, Ctr Trop Conservat, Box 90381, Durham, NC 27706 USA.	ncp@duke.edu	Pitman, Nigel C A/A-7681-2008	Pitman, Nigel C A/0000-0002-9211-2880				BRAMWELL D, 2002, PLANT TALK, V28, P32; Davis S.D., 1997, CTR PLANT DIVERSITY, VVolume 3; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Jorgensen P.M., 1999, CATALOGUE VASCULAR P; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; Valencia R., 2000, LIBRO ROJO PLANTAS E; Walter KS, 1998, 1997 IUCN RED LIST T, pIxiv	8	146	163	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2002	298	5595					989	989		10.1126/science.298.5595.989	http://dx.doi.org/10.1126/science.298.5595.989			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411696				2022-12-24	WOS:000178932000045
J	Jankowski, J; Jones, R; Delaney, B; Dent, J				Jankowski, J; Jones, R; Delaney, B; Dent, J			10-minute consultation - Gastro-oesophageal reflux disease	BRITISH MEDICAL JOURNAL			English	Article									Leicester Royal Infirm, Ctr Digest Dis, Leicester LE1 5WW, Leics, England; Leicester Royal Infirm, Epithelial Off, Dept Med, Leicester LE1 5WW, Leics, England; Leicester Royal Infirm, Epithelial Off, Dept Oncol, Leicester LE1 5WW, Leics, England; Univ London Kings Coll, Guys Kings & St Thomass Sch Med, London WC2R 2LS, England; Univ Birmingham, Birmingham, W Midlands, England; Royal Adelaide Hosp, Adelaide, SA 5000, Australia	University of Leicester; University of Leicester; University of Leicester; University of London; King's College London; University of Birmingham; Royal Adelaide Hospital	Jankowski, J (corresponding author), Leicester Royal Infirm, Ctr Digest Dis, Leicester LE1 5WW, Leics, England.		Jankowski, Janusz/H-2706-2012; Delaney, Brendan C/C-5578-2008	Jankowski, Janusz/0000-0003-2130-9181; Delaney, Brendan/0000-0002-3518-0131				de Caestecker J, 2001, BRIT MED J, V323, P736, DOI 10.1136/bmj.323.7315.736; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5	2	2	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2002	325	7370					945	945		10.1136/bmj.325.7370.945	http://dx.doi.org/10.1136/bmj.325.7370.945			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610XB	12399346	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000178986300019
J	Lelieveld, J; Berresheim, H; Borrmann, S; Crutzen, PJ; Dentener, FJ; Fischer, H; Feichter, J; Flatau, PJ; Heland, J; Holzinger, R; Korrmann, R; Lawrence, MG; Levin, Z; Markowicz, KM; Mihalopoulos, N; Minikin, A; Ramanathan, V; de Reus, M; Roelofs, GJ; Scheeren, HA; Sciare, J; Schlager, H; Schultz, M; Siegmund, P; Steil, B; Stephanou, EG; Stier, P; Traub, M; Warneke, C; Williams, J; Ziereis, H				Lelieveld, J; Berresheim, H; Borrmann, S; Crutzen, PJ; Dentener, FJ; Fischer, H; Feichter, J; Flatau, PJ; Heland, J; Holzinger, R; Korrmann, R; Lawrence, MG; Levin, Z; Markowicz, KM; Mihalopoulos, N; Minikin, A; Ramanathan, V; de Reus, M; Roelofs, GJ; Scheeren, HA; Sciare, J; Schlager, H; Schultz, M; Siegmund, P; Steil, B; Stephanou, EG; Stier, P; Traub, M; Warneke, C; Williams, J; Ziereis, H			Global air pollution crossroads over the Mediterranean	SCIENCE			English	Article							INDIAN-OCEAN EXPERIMENT; TROPOSPHERIC OZONE; BACKGROUND OZONE; AEROSOL; TRANSPORT; RAINFALL; CLIMATE; SULFUR; ISLAND; DISTRIBUTIONS	The Mediterranean Intensive Oxidant Study, performed in the summer of 2001, uncovered air pollution layers from the surface to an altitude of 15 kilometers. In the boundary layer, air pollution standards are exceeded throughout the region, caused by West and East European pollution from the north. Aerosol particles also reduce solar radiation penetration to the surface, which can suppress precipitation. In the middle troposphere, Asian and to a lesser extent North American pollution is transported from the west. Additional Asian pollution from the east, transported from the monsoon in the upper troposphere, crosses the Mediterranean tropopause, which pollutes the lower stratosphere at middle latitudes.	Max Planck Inst Chem, D-55020 Mainz, Germany; German Weather Serv, Meteorol Observ, D-82383 Hohenpeissenberg, Germany; Johannes Gutenberg Univ Mainz, Inst Atmospher Phys, D-55099 Mainz, Germany; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Joint Res Ctr, Inst Environm, I-21020 Ispra, Va, Italy; Max Planck Inst Meteorol, D-20146 Hamburg, Germany; USN, Res Lab, Monterey, CA 93943 USA; German Aerosp Ctr DLR, Inst Atmospher Phys, D-82230 Wessling, Germany; Tel Aviv Univ, Dept Geophys & Planetary Sci, IL-69978 Tel Aviv, Israel; Warsaw Univ, Inst Geophys, PL-02093 Warsaw, Poland; Univ Crete, Environm Chem Proc Lab, Iraklion 71409, Greece; Univ Utrecht, Inst Marine & Atmospher Res, NL-3584 CC Utrecht, Netherlands; Lab Environm & Climate Sci, F-91191 Gif Sur Yvette, France; Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; NOAA, Aeron Lab, Boulder, CO 80305 USA	Max Planck Society; Deutscher Wetterdienst; Johannes Gutenberg University of Mainz; University of California System; University of California San Diego; Scripps Institution of Oceanography; European Commission Joint Research Centre; EC JRC ISPRA Site; Italian Institute for Environmental Protection & Research (ISPRA); Max Planck Society; United States Department of Defense; United States Navy; Naval Research Laboratory; Helmholtz Association; German Aerospace Centre (DLR); Tel Aviv University; University of Warsaw; University of Crete; Utrecht University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Royal Netherlands Meteorological Institute; National Oceanic Atmospheric Admin (NOAA) - USA	Lelieveld, J (corresponding author), Max Planck Inst Chem, POB 3060, D-55020 Mainz, Germany.	lelieveld@mpch-mainz.mpg.de	sciare, jean/A-9529-2008; Berresheim, Harald/F-9670-2011; Schultz, Martin G/I-9512-2012; Crutzen, Paul J/F-6044-2012; Flatau, Piotr/E-2219-2011; Lelieveld, Jos/A-1986-2013; Borrmann, Stephan/E-3868-2010; Warneke, Carsten/E-7174-2010; Holzinger, Rupert/C-9160-2009; Minikin, Andreas/A-3904-2011; Mihalopoulos, Nikolaos/ABF-2255-2020; Stier, Philip/B-2258-2008; Williams, Jonathan/K-7686-2017; Mihalopoulos, Nikolaos/H-5327-2016	Schultz, Martin G/0000-0003-3455-774X; Lelieveld, Jos/0000-0001-6307-3846; Borrmann, Stephan/0000-0002-4774-9380; Holzinger, Rupert/0000-0003-1902-1824; Minikin, Andreas/0000-0003-0999-4657; Stier, Philip/0000-0002-1191-0128; Williams, Jonathan/0000-0001-9421-1703; Mihalopoulos, Nikolaos/0000-0002-1282-0896; Scheeren, Bert/0000-0001-6333-8402; sciare, jean/0000-0002-9908-6718; Lawrence, Mark/0000-0002-2178-4903; Markowicz, Krzysztof/0000-0003-4190-0243				Andreae TW, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD900252; [Anonymous], 2002, MEDITERRANEAN CLIMAT; Avila A, 2002, ATMOS ENVIRON, V36, P2881, DOI 10.1016/S1352-2310(02)00098-5; Board AS, 1999, J GEOPHYS RES-ATMOS, V104, P16181, DOI 10.1029/1999JD900021; Browell EV, 2001, J GEOPHYS RES-ATMOS, V106, P32481, DOI 10.1029/2001JD900001; CHEN P, 1995, J GEOPHYS RES-ATMOS, V100, P16661, DOI 10.1029/95JD01264; Clarke AD, 2001, J GEOPHYS RES-ATMOS, V106, P32555, DOI 10.1029/2000JD900842; Dethof A, 2000, J GEOPHYS RES-ATMOS, V105, P12279, DOI 10.1029/2000JD900127; Formenti P, 2001, J GEOPHYS RES-ATMOS, V106, P9807, DOI 10.1029/2000JD900609; GANGIOTI G, 2001, ATMOS ENV, V35; Ganor E, 2000, ATMOS ENVIRON, V34, P3453, DOI 10.1016/S1352-2310(00)00077-7; Gros V., 1999, CHEMOSPHERE GLOBAL C, V1, P163, DOI DOI 10.1016/S1465-9972(99)00009-4; Hauglustaine DA, 2001, J GEOPHYS RES-ATMOS, V106, P32337, DOI 10.1029/2001JD900175; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Hoor P, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000289; Kouvarakis G, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000081; Kouvarakis G, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000291; Kouvarakis G, 2000, J GEOPHYS RES-ATMOS, V105, P4399, DOI 10.1029/1999JD900984; Lawrence MG, 1999, J GEOPHYS RES-ATMOS, V104, P26245, DOI 10.1029/1999JD900425; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Lelieveld J, 2001, SCIENCE, V291, P1031, DOI 10.1126/science.1057103; Luria M, 1996, J GEOPHYS RES-ATMOS, V101, P25917, DOI 10.1029/96JD01579; Maheras P, 1999, THEOR APPL CLIMATOL, V64, P189, DOI 10.1007/s007040050122; MARACCHI G, 2000, 3 EUR C APPL CLIM PI; Markowicz KM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015767; Mihalopoulos N, 1997, TELLUS B, V49, P314, DOI 10.1034/j.1600-0889.49.issue3.7.x; Millan MM, 1997, J GEOPHYS RES-ATMOS, V102, P8811, DOI 10.1029/96JD03610; Millan MM, 2000, J APPL METEOROL, V39, P487, DOI 10.1175/1520-0450(2000)039<0487:OCITWM>2.0.CO;2; Mylona S, 1996, TELLUS B, V48, P662, DOI 10.1034/j.1600-0889.1996.t01-2-00005.x; Nicholson SE, 2000, J CLIMATE, V13, P2628, DOI 10.1175/1520-0442(2000)013<2628:AAORRC>2.0.CO;2; Nolle M, 2002, ATMOS ENVIRON, V36, P1391, DOI 10.1016/S1352-2310(01)00505-2; Novelli PC, 1998, J GEOPHYS RES-ATMOS, V103, P19015, DOI 10.1029/98JD01366; OZSOY T, 2000, GLOBAL ATMOS OCEAN S, V7, P185; Palutikof JP., 1996, MEDITERRANEAN DESERT, P43; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; RAYNER NA, 1996, 74 HADL CTR; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; Roelofs GJ, 2000, J GEOPHYS RES-ATMOS, V105, P22697, DOI 10.1029/2000JD900316; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rotstayn LD, 2002, J CLIMATE, V15, P2103, DOI 10.1175/1520-0442(2002)015&lt;2103:TRTATI&gt;2.0.CO;2; ROWELL DP, 1995, Q J ROY METEOR SOC, V121, P669, DOI 10.1256/smsqj.52310; Schultz MG, 1999, J GEOPHYS RES-ATMOS, V104, P5829, DOI 10.1029/98JD02309; Sciare J, 2001, J ATMOS CHEM, V39, P281, DOI 10.1023/A:1010631305307; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; TRAGOU E, IN PRESS J GEOPHYS R; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; [No title captured]	48	744	755	1	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2002	298	5594					794	799		10.1126/science.1075457	http://dx.doi.org/10.1126/science.1075457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399583				2022-12-24	WOS:000178791200050
J	Buchanan, M				Buchanan, M			A game of chance	NATURE			English	Editorial Material																		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; CALDARELLI G, CONDMAT0107228; Parisi G, 1999, PHYSICA A, V263, P557, DOI 10.1016/S0378-4371(98)00524-X; Rodriguez-lturbe I., 1999, FRACTAL RIVER BASINS	4	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 24	2002	419	6909					787	787		10.1038/419787a	http://dx.doi.org/10.1038/419787a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397334	Bronze			2022-12-24	WOS:000178769800023
J	Adams, DL; Horton, JC				Adams, DL; Horton, JC			Shadows cast by retinal blood vessels mapped in primary visual cortex	SCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; MACAQUE STRIATE CORTEX; MONOCULAR DEPRIVATION; MONKEY; CATS; ORGANIZATION; PERIODICITY; VARIABILITY; PLASTICITY; PATTERN	The mammalian eye is a remarkable optical device, but its design is not perfect. The blood vessels that supply the inner retina are located in front of the photoreceptor layer, blocking access to light. Their shadows create a pattern of blindness in the field of vision that corresponds precisely to the location of the largest vessels in the eye. We show here that in squirrel monkeys, focal deprivation by blood vessels leads to rewiring of the eye's geniculocortical projections, imprinting an image of the retinal vascular tree onto the primary visual cortex. This process illustrates vividly that local imbalances in neuronal activity can influence column formation during normal development.	Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Adams, DL (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, 10 Kirkham St, San Francisco, CA 94143 USA.		Adams, Daniel L/A-5229-2009	Adams, Daniel L/0000-0003-0376-4949; Horton, Jonathan/0000-0002-3952-435X	NCRR NIH HHS [RR00169, P51 RR000169] Funding Source: Medline; NEI NIH HHS [R01 EY010217, R01 EY010217-19, R01 EY10217, EY02162, P30 EY002162] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010217, P30EY002162] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEGATE RA, 1990, INVEST OPHTH VIS SCI, V31, P2088; BLASDEL GG, 1984, J NEUROSCI, V4, P880; COWEY A, 1964, J NEUROPHYSIOL, V27, P366, DOI 10.1152/jn.1964.27.3.366; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; EVANS JN, 1926, AM J OPHTHALMOL, V9, P489; GOODHILL GJ, 1993, BIOL CYBERN, V69, P109, DOI 10.1007/BF00226194; Goodhill GJ, 1998, NETWORK-COMP NEURAL, V9, P419, DOI 10.1088/0954-898X/9/3/009; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; Horton JC, 1997, J NEUROSCI, V17, P3684; Horton JC, 1996, J NEUROSCI, V16, P5510; Horton JC, 1996, J NEUROSCI, V16, P7228; Horton JC, 1996, J NEUROSCI, V16, P1791; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; JONES DG, 1991, J NEUROSCI, V11, P3794; Kaschube M, 2002, J NEUROSCI, V22, P7206; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Livingstone MS, 1996, J NEUROSCI, V16, P2086; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Schiefer U, 1999, VISION RES, V39, P1897, DOI 10.1016/S0042-6989(98)00295-8; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SWINDALE NV, 1981, PROC R SOC SER B-BIO, V213, P435, DOI 10.1098/rspb.1981.0074; SWINDALE NV, 1980, PROC R SOC SER B-BIO, V208, P243, DOI 10.1098/rspb.1980.0051; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; von der Malsburg C., 1976, EXP BRAIN RES, V(Suppl 1), P463; VONHELMHOLTZ H, 1924, HDB PHYSL OPTICS, V2, P28; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5	33	47	47	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 18	2002	298	5593					572	576		10.1126/science.1074887	http://dx.doi.org/10.1126/science.1074887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12386328	Green Accepted, Green Submitted			2022-12-24	WOS:000178634800033
J	Lemaitre, JM; Bocquet, S; Mechali, M				Lemaitre, JM; Bocquet, S; Mechali, M			Competence to replicate in the unfertilized egg is conferred by Cdc6 during meiotic maturation	NATURE			English	Article							CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; CELL-CYCLE; XENOPUS-LAEVIS; CHROMOSOME-REPLICATION; CHROMATIN ASSOCIATION; OOCYTE MATURATION; CYTOSTATIC FACTOR; PROTO-ONCOGENE; MCM COMPLEX	Meiotic maturation, the final step of oogenesis, is a crucial stage of development in which an immature oocyte becomes a fertilizable egg(1). In Xenopus, the ability to replicate DNA is acquired during maturation at breakdown of the nuclear envelope 2 by translation of a DNA synthesis inducer that is not present in the oocyte(2,3). Here we identify Cdc6, which is essential for recruiting the minichromosome maintenance (MCM) helicase to the prereplication complex, as this inducer of DNA synthesis. We show that maternal cdc6 mRNA but not protein is stored in the oocyte. Cdc6 protein is synthesized during maturation, but this process can be blocked by degrading the maternal cdc6 mRNA by oligonucleotide antisense injections or by translation inhibition. Rescue experiments using recombinant Cdc6 protein show that Cdc6 is the only missing replication factor whose translation is necessary and sufficient to confer DNA replication competence to the egg before fertilization. The licence to replicate is given by Cdc6 at the end of meiosis I, but the cytostatic factor (CSF) pathway, which maintains large amounts of active Cdc2/Cyclin B2, prevents the entry into S phase until fertilization.	CNRS, Inst Human Genet, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 5, France.		LEMAITRE, Jean-Marc/I-4989-2016	LEMAITRE, Jean-Marc/0000-0002-6492-5219				Abrieu A, 2001, J CELL SCI, V114, P257; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Calzada A, 2001, NATURE, V412, P355, DOI 10.1038/35085610; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; GURDON JB, 1967, P NATL ACAD SCI USA, V58, P545, DOI 10.1073/pnas.58.2.545; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lei M, 2001, J CELL SCI, V114, P1447; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Madine MA, 2000, J STRUCT BIOL, V129, P198, DOI 10.1006/jsbi.2000.4218; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Menut S, 1999, ADV MOLEC BIOL, P196; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pelizon C, 2000, GENE DEV, V14, P2526, DOI 10.1101/gad.176300; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; TAYLOR MV, 1986, EMBO J, V5, P3563, DOI 10.1002/j.1460-2075.1986.tb04683.x; Tian JD, 1997, P NATL ACAD SCI USA, V94, P10729, DOI 10.1073/pnas.94.20.10729; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Whitmire E, 2002, NATURE, V419, P722, DOI 10.1038/nature01032; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	30	45	46	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					718	722		10.1038/nature01046	http://dx.doi.org/10.1038/nature01046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384698				2022-12-24	WOS:000178615200040
J	Eddleston, M; Karalliedde, L; Buckley, N; Fernando, R; Hutchinson, G; Isbister, G; Konradsen, F; Murray, D; Piola, JC; Senanyake, N; Sheriff, R; Singh, S; Siwach, SB; Smit, L				Eddleston, M; Karalliedde, L; Buckley, N; Fernando, R; Hutchinson, G; Isbister, G; Konradsen, F; Murray, D; Piola, JC; Senanyake, N; Sheriff, R; Singh, S; Siwach, SB; Smit, L			Pesticide poisoning in the developing world - a minimum pesticides list	LANCET			English	Article							EPIDEMIC; PATTERN	In parts of the developing world, pesticide poisoning causes more deaths than infectious diseases. Use of pesticides is poorly regulated and often dangerous; their easy availability also makes them a popular method of self-harm. In 1985, the UN Food and Agriculture Organisation (FAO) produced a voluntary code of conduct for the pesticide industry in an attempt to limit the harmful effects of pesticides. Unfortunately, a lack of adequate government resources in the developing world makes this code ineffective, and thousands of deaths continue today. WHO has recommended that access to highly toxic pesticides be restricted-where this has been done, suicide rates have fallen. Since an Essential Drugs List was established in 1977, use of a few essential drugs has rationalised drug use in many regions. An analogous Minimum Pesticides List would identify a restricted number of less dangerous pesticides to do specific tasks within an Integrated pest management system. Use of safer pesticides should result in fewer deaths, just as the change from barbiturates to benzodiazepines has reduced the number of deaths from pharmaceutical self-poisoning.	Univ Oxford, Ctr Trop Med, Oxford OX1 2JD, England; Univ Colombo, Fac Med, Dept Clin Med, Oxford Colombo Collaborat, Colombo 08, Sri Lanka; Guys & St Thomas Hosp, Med Toxicol Unit, London SE1 9RT, England; Canberra Hosp, Dept Clin Pharmacol & Toxicol, Canberra, ACT, Australia; Natl Hosp Sri Lanka, Natl Poisons Informat Ctr, Colombo, Sri Lanka; Univ Colombo, Dept Forens Med & Toxicol, Colombo, Sri Lanka; Univ W Indies, Dept Med, St Augustine, Trinidad Tobago; Univ W Indies, Dept Pathol, St Augustine, Trinidad Tobago; Mater Hosp, Dept Clin Pharmacol & Toxicol, Newcastle, NSW, Australia; Univ Copenhagen, Dept Int Hlth, Copenhagen, Denmark; Colorado State Univ, Dept Sociol, Ft Collins, CO 80523 USA; Sanatorio de Ninos, Serv Toxicol, Rosario, Argentina; Univ Peradeniya, Dept Med, Peradeniya, Sri Lanka; Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India; Postgrad Inst Med Sci, Dept Med, Rohtak, Haryana, India; Int Water Management Inst, Colombo, Sri Lanka	University of Oxford; University of Colombo; Guy's & St Thomas' NHS Foundation Trust; Australian National University; Canberra Hospital; University of Colombo; University West Indies Mona Jamaica; University West Indies Saint Augustine; University West Indies Mona Jamaica; University West Indies Saint Augustine; University of Copenhagen; Colorado State University; University of Peradeniya; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; CGIAR; International Water Management Institute (IWMI)	Eddleston, M (corresponding author), Univ Colombo, Fac Med, Dept Clin Med, Oxford Colombo Collaborat, POB 271,25 Kynsey Rd, Colombo 08, Sri Lanka.	edlestonm@eureka.lk	Smit, Lidwien AM/AFC-8689-2022; Isbister, Geoffrey K/G-8052-2015; Buckley, Nicholas A/D-4030-2012	Smit, Lidwien AM/0000-0003-0292-0946; Isbister, Geoffrey K/0000-0003-1519-7419; Buckley, Nicholas A/0000-0002-6326-4711; Konradsen, Flemming/0000-0003-1036-6949	Wellcome Trust [063560] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*AD HOC COMM HLTH, 1996, WHOTDRGEN961 AD HOC; ALRAGHEB SYA, 1989, AM J FOREN MED PATH, V10, P221, DOI 10.1097/00000433-198909000-00010; Bowles J. R., 1995, PREVENTIVE STRATEGIE, P173; Bull D, 1982, GROWING PROBLEM PEST; CHUGH SN, 1991, INDIAN J MED RES-B, V94, P232; *CROPL INT, 2001, INT PEST MAN; *CROPL INT, 2001, WORLD FOOD SEC; Daisley H, 1998, LANCET, V352, P1393, DOI 10.1016/S0140-6736(05)60796-9; Dinham Barbara, 1993, PESTICIDE HAZARD GLO; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eddleston M, 1999, TROP MED INT HEALTH, V4, P266, DOI 10.1046/j.1365-3156.1999.00397.x; Eddleston M, 1998, BRIT MED J, V317, P133, DOI 10.1136/bmj.317.7151.133; HETTIARACHCHI J, 1989, INT J EPIDEMIOL, V18, P418, DOI 10.1093/ije/18.2.418; HOGERZEIL HV, 1989, LANCET, V1, P141; MCCONNELL R, 1993, AM J PUBLIC HEALTH, V83, P1559, DOI 10.2105/AJPH.83.11.1559; MCKENZIE W, 2001, ANN REV CROP PROTECT; Meister R T., 1999, FARM CHEM HDB 99; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Murray Douglas L., 1994, CULTIVATING CRISIS H; Piola J. C., 2001, REV MED ROSARIO REV MED ROSARIO, V67, P19; *PRES SECR, 1999, SUIC RED OPP IMPR TR; PROUDFOOT AT, 1978, BRIT MED J, V1, P90, DOI 10.1136/bmj.1.6105.90; Singh D, 1999, AM J FOREN MED PATH, V20, P203, DOI 10.1097/00000433-199906000-00019; Singh S., 1997, J ASSOC PHYSICIAN I, V45, P194; Siwach S B, 1995, J Assoc Physicians India, V43, P756; *SRI LANK MIN HLTH, 1997, ANN HLTH B; STONE R, 1992, SCIENCE, V256, P1272, DOI 10.1126/science.1598564; *UN FOOD AGR ORG, 1990, 25 SESS FAO C NOV 19; Van der Hoek W, 1998, SOC SCI MED, V46, P495, DOI 10.1016/S0277-9536(97)00193-7; Wesseling C, 1997, INT J HEALTH SERV, V27, P273, DOI 10.2190/E259-N3AH-TA1Y-H591; *WHO COLL UNEP, 1990, PUBL HLTH IMP PEST U; *WHO EXP COMM US E, 1995, WHO TECHN REP SER, V850; World Health Organisation, 2001, MENT DIS AFF ON 4 PE; World Health Organization, 2000, WHO REC CLASS PEST H	34	304	317	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2002	360	9340					1163	1167		10.1016/S0140-6736(02)11204-9	http://dx.doi.org/10.1016/S0140-6736(02)11204-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604QF	12387969				2022-12-24	WOS:000178632000021
J	Blomqvist, D; Andersson, M; Kupper, C; Cuthill, IC; Kis, J; Lanctot, RB; Sandercock, BK; Szekely, T; Wallander, J; Kempenaers, B				Blomqvist, D; Andersson, M; Kupper, C; Cuthill, IC; Kis, J; Lanctot, RB; Sandercock, BK; Szekely, T; Wallander, J; Kempenaers, B			Genetic similarity between mates and extra-pair parentage in three species of shorebirds	NATURE			English	Article							GREAT REED WARBLER; HATCHING FAILURE; BIRDS; PATERNITY; MICROSATELLITES; FERTILIZATIONS; PROMISCUITY; SURVIVAL; REVEAL; LEKS	Matings between close relatives often reduce the fitness of offspring, probably because homozygosity leads to the expression of recessive deleterious alleles(1-5). Studies of several animals have shown that reproductive success is lower when genetic similarity between parents is high(4-7), and that survival and other measures of fitness increase with individual levels of genetic diversity(8-11). These studies indicate that natural selection may favour the avoidance of matings with genetically similar individuals. But constraints on social mate choice, such as a lack of alternatives, can lead to pairing with genetically similar mates. In such cases, it has been suggested that females may seek extra-pair copulations with less related males(4), but the evidence is weak or lacking(4,5). Here we report a strong positive relationship between the genetic similarity of social pair members and the occurrence of extra-pair paternity and maternity ('quasi-parasitism') in three species of shorebirds. We propose that extra-pair parentage may represent adaptive behavioural strategies to avoid the negative effects of pairing with a genetically similar mate.	Max Planck Res Ctr Ornithol, D-82305 Seewiesen, Germany; Austrian Acad Sci, Konrad Lorenz Inst Comparat Ethol, A-1160 Vienna, Austria; Univ Gothenburg, Dept Zool, SE-40530 Gothenburg, Sweden; Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England; Szent Istvan Univ, Fac Vet Sci, Inst Zool, Behav Biol Res Grp, H-1400 Budapest, Hungary; US Fish & Wildlife Serv, Anchorage, AK 99503 USA; Kansas State Univ, Div Biol, Manhattan, KS 66505 USA; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Max Planck Society; Austrian Academy of Sciences; University of Gothenburg; University of Bristol; Hungarian University of Agriculture & Life Sciences; United States Department of the Interior; US Fish & Wildlife Service; Kansas State University; University of Bath	Kempenaers, B (corresponding author), Max Planck Res Ctr Ornithol, POB 1564, D-82305 Seewiesen, Germany.		Kis, Janos/D-2558-2013; Kis, Janos/AAG-3738-2019; Sandercock, Brett K/L-1644-2016; Küpper, Clemens/D-8116-2011; Szekely, Tamas/I-7089-2016	Kis, Janos/0000-0001-9354-1292; Sandercock, Brett K/0000-0002-9240-0268; Küpper, Clemens/0000-0002-1507-8033; Szekely, Tamas/0000-0003-2093-0056; Kempenaers, Bart/0000-0002-7505-5458				Alves MAS, 1998, ANIM BEHAV, V56, P1323, DOI 10.1006/anbe.1998.0910; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; BENSCH S, 1994, EVOLUTION, V48, P317, DOI 10.1111/j.1558-5646.1994.tb01314.x; BROOKER MG, 1990, BEHAV ECOL SOCIOBIOL, V26, P191; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Carter Royston E., 2000, P113; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kempenaers B, 1996, P ROY SOC B-BIOL SCI, V263, P179, DOI 10.1098/rspb.1996.0029; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Olsson M, 2001, J HERED, V92, P190, DOI 10.1093/jhered/92.2.190; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; SHIN HS, 1985, NATURE, V317, P445, DOI 10.1038/317445a0; Shorey L, 2000, NATURE, V408, P352, DOI 10.1038/35042562; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; VANNOORDWIJK AJ, 1981, EVOLUTION, V35, P674, DOI 10.1111/j.1558-5646.1981.tb04929.x; Wallander J, 2001, ETHOLOGY, V107, P561, DOI 10.1046/j.1439-0310.2001.00695.x; WESTNEAT DF, 1993, BEHAV ECOL, V4, P49, DOI 10.1093/beheco/4.1.49; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	30	177	182	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	2002	419	6907					613	615		10.1038/nature01104	http://dx.doi.org/10.1038/nature01104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374978				2022-12-24	WOS:000178483100044
J	Sachs, JD				Sachs, JD			A new global effort to control malaria	SCIENCE			English	Editorial Material									Columbia Univ, Earth Inst, New York, NY 10027 USA; WHO, Commiss Macroecon & Hlth, Geneva, Switzerland	Columbia University; World Health Organization	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.							Dietz K., 1988, MALARIA PRINCIPLES P, V2, P1091; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Long CA, 2002, SCIENCE, V297, P345, DOI 10.1126/science.1074484; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Spielman A, 2002, IND ANTIMALARIA POLI; Utzinger J, 2002, TROP MED INT HEALTH, V7, P657, DOI 10.1046/j.1365-3156.2002.00916.x; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; *WORLD EC FOR, 2002, GLOB HLTH IN RES PAP; World Health Organization, 2001, COMM MACR HLTH INV H	11	52	57	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2002	298	5591					122	124		10.1126/science.1077900	http://dx.doi.org/10.1126/science.1077900			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364788	Green Submitted			2022-12-24	WOS:000178370500045
J	Florens, L; Washburn, MP; Raine, JD; Anthony, RM; Grainger, M; Haynes, JD; Moch, JK; Muster, N; Sacci, JB; Tabb, DL; Witney, AA; Wolters, D; Wu, YM; Gardner, MJ; Holder, AA; Sinden, RE; Yates, JR; Carucci, DJ				Florens, L; Washburn, MP; Raine, JD; Anthony, RM; Grainger, M; Haynes, JD; Moch, JK; Muster, N; Sacci, JB; Tabb, DL; Witney, AA; Wolters, D; Wu, YM; Gardner, MJ; Holder, AA; Sinden, RE; Yates, JR; Carucci, DJ			A proteomic view of the Plasmodium falciparum life cycle	NATURE			English	Article							MALARIA PARASITE; GENE-EXPRESSION; CHROMOSOMAL DOMAINS; IDENTIFICATION; SEQUENCE; PROTEINS; STAGE; MOSQUITO; TRANSCRIPTOME; ERYTHROCYTES	The completion of the Plasmodium falciparum clone 3D7 genome provides a basis on which to conduct comparative proteomics studies of this human pathogen. Here, we applied a high-throughput proteomics approach to identify new potential drug and vaccine targets and to better understand the biology of this complex protozoan parasite. We characterized four stages of the parasite life cycle (sporozoites, merozoites, trophozoites and gametocytes) by multidimensional protein identification technology. Functional profiling of over 2,400 proteins agreed with the physiology of each stage. Unexpectedly, the antigenically variant proteins of var and rif genes, defined as molecules on the surface of infected erythrocytes, were also largely expressed in sporozoites. The detection of chromosomal clusters encoding co-expressed proteins suggested a potential mechanism for controlling gene expression.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Syngenta Res & Technol, Dept Proteom & Metabolom, Torrey Mesa Res Inst, San Diego, CA 92121 USA; Univ London Imperial Coll Sci Technol & Med, Infect & Immun Sect, Dept Biol Sci, London SW7 2AZ, England; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Dept Immunol, Silver Spring, MD 20910 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Amer Type Culture Collect, Malaria Res & Reference Resource Ctr, Manassas, VA 20110 USA; Inst Genom Res, Rockville, MD 20850 USA	Scripps Research Institute; Syngenta; Imperial College London; United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); MRC National Institute for Medical Research; University of Washington; University of Washington Seattle; J. Craig Venter Institute	Yates, JR (corresponding author), Scripps Res Inst, Dept Cell Biol, SR-11,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyates@scripps.edu	Holder, Anthony A/A-7554-2013; Pain, Arnab/L-5766-2015	Holder, Anthony A/0000-0002-8490-6058; Pain, Arnab/0000-0002-1755-2819; Witney, Adam/0000-0003-4561-7170; Gardner, Malcolm/0000-0003-2180-5089; Washburn, Michael/0000-0001-7568-2585; Tabb, David/0000-0001-7223-578X; Florens, Laurence/0000-0002-9310-6650	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carter R, 1993, Methods Mol Biol, V21, P67; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COPPEL RL, 1983, NATURE, V306, P751, DOI 10.1038/306751a0; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Haynes J David, 2002, Methods Mol Med, V72, P535, DOI 10.1385/1-59259-271-6:535; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; HernandezRivas R, 1997, MOL CELL BIOL, V17, P604, DOI 10.1128/MCB.17.2.604; Holder Anthony A., 1996, P77; KANAANI J, 1989, J BIOL CHEM, V264, P3194; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; MELLOUK S, 1990, B WORLD HEALTH ORGAN, V68, P52; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PACHECO ND, 1979, J PARASITOL, V65, P414, DOI 10.2307/3280286; Pinder JC, 1998, J CELL SCI, V111, P1831; Rabilloud T, 1999, ELECTROPHORESIS, V20, P3603, DOI 10.1002/(SICI)1522-2683(19991201)20:18&lt;3603::AID-ELPS3603&gt;3.0.CO;2-V; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Sinden RE, 1996, ADV PARASIT, V38, P53, DOI 10.1016/S0065-308X(08)60033-0; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	45	1008	1054	2	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					520	526		10.1038/nature01107	http://dx.doi.org/10.1038/nature01107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368866				2022-12-24	WOS:000178348400047
J	Gardner, MJ; Shallom, SJ; Carlton, JM; Salzberg, SL; Nene, V; Shoaibi, A; Ciecko, A; Lynn, J; Rizzo, M; Weaver, B; Jarrahi, B; Brenner, M; Parvizi, B; Tallon, L; Moazzez, A; Granger, D; Fujii, C; Hansen, C; Pederson, J; Feldblyum, T; Peterson, J; Suh, B; Angiuoli, S; Pertea, M; Allen, J; Selengut, J; White, O; Cummings, LM; Smith, HO; Adams, MD; Venter, JC; Carucci, DJ; Hoffman, SL; Fraser, CM				Gardner, MJ; Shallom, SJ; Carlton, JM; Salzberg, SL; Nene, V; Shoaibi, A; Ciecko, A; Lynn, J; Rizzo, M; Weaver, B; Jarrahi, B; Brenner, M; Parvizi, B; Tallon, L; Moazzez, A; Granger, D; Fujii, C; Hansen, C; Pederson, J; Feldblyum, T; Peterson, J; Suh, B; Angiuoli, S; Pertea, M; Allen, J; Selengut, J; White, O; Cummings, LM; Smith, HO; Adams, MD; Venter, JC; Carucci, DJ; Hoffman, SL; Fraser, CM			Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14	NATURE			English	Article							PROTEINS; RESOURCE; GENOME; SITES; MAP	The mosquito-borne malaria parasite Plasmodium falciparum kills an estimated 0.7-2.7 million people every year, primarily children in sub-Saharan Africa. Without effective interventions, a variety of factors-including the spread of parasites resistant to antimalarial drugs and the increasing insecticide resistance of mosquitoes-may cause the number of malaria cases to double over the next two decades(1). To stimulate basic research and facilitate the development of new drugs and vaccines, the genome of Plasmodium falciparum clone 3D7 has been sequenced using a chromosome- by-chromosome shotgun strategy(2-4). We report here the nucleotide sequences of chromosomes 10, 11 and 14, and a re-analysis of the chromosome 2 sequence(5). These chromosomes represent about 35% of the 23-megabase P. falciparum genome.	Inst Genom Res, Rockville, MD 20850 USA; USN, Malaria Program, Med Res Ctr, Silver Spring, MD 20910 USA	J. Craig Venter Institute; United States Department of Defense; United States Navy	Gardner, MJ (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven L/F-6162-2011; Pertea, Mihaela/AAT-2705-2021; Angiuoli, Samuel V/H-7340-2014; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Pertea, Mihaela/0000-0003-0762-8637; Salzberg, Steven/0000-0002-8859-7432; Angiuoli, Samuel/0000-0001-9525-4350; Nene, Vishvanath/0000-0001-7066-4169; Harper, David/0000-0002-8313-3516; Fraser, Claire/0000-0003-1462-2428; Allen, Jonathan/0000-0002-4359-8263				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Cawley SE, 2001, MOL BIOCHEM PARASIT, V118, P167, DOI 10.1016/S0166-6851(01)00363-2; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; FOSTER J, 1995, PARASITOL TODAY, V11, P1, DOI 10.1016/0169-4758(95)80092-1; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Huestis R, 2001, MOL BIOCHEM PARASIT, V118, P187, DOI 10.1016/S0166-6851(01)00376-0; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai ZW, 1999, NAT GENET, V23, P309, DOI 10.1038/15484; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	30	146	155	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					531	534		10.1038/nature01094	http://dx.doi.org/10.1038/nature01094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368868				2022-12-24	WOS:000178348400049
J	Chiu, RWK; Lau, TK; Leung, TN; Chow, KCK; Chui, DHK; Lo, YMD				Chiu, RWK; Lau, TK; Leung, TN; Chow, KCK; Chui, DHK; Lo, YMD			Prenatal exclusion of beta thalassaemia major by examination of maternal plasma	LANCET			English	Article								The discovery of the presence of fetal DNA in maternal plasma has provided a new approach for non-Invasive prenatal diagnosis. At present, the prenatal diagnosis of beta thalassaemia relies on invasive methods. We designed allele-specific primers and a fluorescent probe for detection of the codon 41/42 (-CTTT) mutation in the beta globin gene from maternal plasma by real-time PCR. The specificity and sensitivity of the allele-specific assay was confirmed by subjecting plasma, buffy coat, and amniotic fluid samples from 100 pregnancies to screening for the mutation. Subsequently, the assay was applied to the prenatal testing of eight fetuses at risk of beta thalassaemia major, the aim being to exclude fetal inheritance of paternally transmitted codon 41/42 mutation. The fetal genotype was completely concordant with conventional analysis and beta thalassaemia major was excluded in two of the pregnancies non-invasively.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; McMaster University	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Room 38023,1-F Clin Sci Bldg,30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.		Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410; Chui, David/0000-0002-1475-7309				Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Weatherall DJ, 1997, BRIT MED J, V314, P1675, DOI 10.1136/bmj.314.7095.1675	5	204	250	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 28	2002	360	9338					998	1000		10.1016/S0140-6736(02)11086-5	http://dx.doi.org/10.1016/S0140-6736(02)11086-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597YU	12383672				2022-12-24	WOS:000178249000015
J	Spickard, A; Gabbe, SG; Christensen, JF				Spickard, A; Gabbe, SG; Christensen, JF			Mid-career burnout in generalist and specialist physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							JOB-SATISFACTION; STRESS; HEALTH; CARE; MEDICINE; DOCTORS; IMPACT; WOMEN; LIFE		Vanderbilt Univ, Med Ctr, Nashville, TN USA; Legacy Hlth Syst, Portland, OR USA	Vanderbilt University; Legacy Health	Spickard, A (corresponding author), Ctr Profess Hlth, 1107 Oxford House, Nashville, TN 37232 USA.	Anderson.Spickard-Jr@vanderbilt.edu						[Anonymous], 1998, CAN MED ASSOC J, V158, P1191; Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Baruch-Feldman Caren, 2002, J Occup Health Psychol, V7, P84, DOI 10.1037/1076-8998.7.1.84; Buchbinder SB, 1999, AM J MANAG CARE, V5, P1431; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; Christensen JB, 2001, WESTERN J MED, V174, P75, DOI 10.1136/ewjm.174.1.75; CHRISTENSEN JF, 1992, J GEN INTERN MED, V7, P424, DOI 10.1007/BF02599161; CHRISTENSEN JF, 2002, MED ENCOUNTER, V16, P20; Crane M, 1998, Med Econ, V75, P210; Crouse B J, 1995, Minn Med, V78, P29; DECKARD GJ, 1992, J INFECT DIS, V165, P224, DOI 10.1093/infdis/165.2.224; DOANWIGGINS L, 1995, ACAD EMERG MED, V2, P556, DOI 10.1111/j.1553-2712.1995.tb03261.x; Epstein R, 2001, WESTERN J MED, V174, P63, DOI 10.1136/ewjm.174.1.63; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Freeborn DK, 2001, WESTERN J MED, V174, P13, DOI 10.1136/ewjm.174.1.13; GABBARD GO, 1989, JAMA-J AM MED ASSOC, V261, P2378, DOI 10.1001/jama.261.16.2378; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; Gabbe SG, 2002, AM J OBSTET GYNECOL, V186, P601, DOI 10.1067/mob.2002.122391; GARDNER JW, 1992, WESTERN J MED, V157, P457; Gautam M, 2001, WESTERN J MED, V174, P37, DOI 10.1136/ewjm.174.1.37; Gundersen L, 2001, ANN INTERN MED, V135, P145, DOI 10.7326/0003-4819-135-2-200107170-00023; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Hirsch G, 1999, Physician Exec, V25, P30; Jackson SH, 1999, ACTA ANAESTH SCAND, V43, P583, DOI 10.1034/j.1399-6576.1999.430601.x; JOHNSON JV, 1995, J OCCUP ENVIRON MED, V37, P1151, DOI 10.1097/00043764-199509000-00018; Kmietowicz Z, 2001, BRIT MED J, V323, P887, DOI 10.1136/bmj.323.7318.887; LINN LS, 1985, JAMA-J AM MED ASSOC, V254, P2775, DOI 10.1001/jama.254.19.2775; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; MASLACH C, 1997, TRUTH BURNOUT, P13; MCCUE JD, 1982, NEW ENGL J MED, V306, P458, DOI 10.1056/NEJM198202253060805; McMurray JE, 2000, J GEN INTERN MED, V15, P372, DOI 10.1111/j.1525-1497.2000.im9908009.x; MCPHEE SJ, 2001, W J MED, V174, P75; Murray A, 2001, J GEN INTERN MED, V16, P451, DOI 10.1007/s11606-001-0040-z; Myers DG, 2000, AM PSYCHOL, V55, P56, DOI 10.1037/0003-066X.55.1.56; MYERS M, 1994, MED MARRIAGES LOOK P; NEUWIRTH ZE, 1999, NEWSWEEK        0913, P79; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; OConnor PG, 1997, MED CLIN N AM, V81, P1037, DOI 10.1016/S0025-7125(05)70562-9; Osler W., 1899, ALBANY MED ANN, V20, P307; Puddester D, 2001, WESTERN J MED, V174, P5, DOI 10.1136/ewjm.174.1.5; *RES SERV COMM, 1998, ANN INTERN MED, V109, P154; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryff CD, 1996, PSYCHOTHER PSYCHOSOM, V65, P14, DOI 10.1159/000289026; SATTERFIELD JM, 2001, W J MED, V173, P26; Schmoldt R A, 1994, HMO Pract, V8, P58; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Spickard Jr A, 1998, FED B, V85, P8; Suchman AL, 2001, WESTERN J MED, V174, P43, DOI 10.1136/ewjm.174.1.43; Sullivan P, 1998, CAN MED ASSOC J, V159, P525; VAILLANT GE, 1972, NEW ENGL J MED, V287, P372, DOI 10.1056/NEJM197208242870802; Warde CM, 1999, J GEN INTERN MED, V14, P157, DOI 10.1046/j.1525-1497.1999.00307.x; Weiner EL, 2001, WESTERN J MED, V174, P19, DOI 10.1136/ewjm.174.1.19; WHITLEY TW, 1994, ANN EMERG MED, V23, P1068, DOI 10.1016/S0196-0644(94)70105-9; Williams ES, 2001, HEALTH CARE MANAGE R, V26, P7, DOI 10.1097/00004010-200101000-00002; Yamey G, 2001, BRIT MED J, V322, P252, DOI 10.1136/bmj.322.7281.252; Yao DC, 2000, JAMA-J AM MED ASSOC, V284, P1099, DOI 10.1001/jama.284.9.1099	57	341	350	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2002	288	12					1447	1450		10.1001/jama.288.12.1447	http://dx.doi.org/10.1001/jama.288.12.1447			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	596AT	12243624				2022-12-24	WOS:000178142000002
J	Belluscio, L; Lodovichi, C; Feinstein, P; Mombaerts, P; Katz, LC				Belluscio, L; Lodovichi, C; Feinstein, P; Mombaerts, P; Katz, LC			Odorant receptors instruct functional circuitry in the mouse olfactory bulb	NATURE			English	Article							INTRABULBAR ASSOCIATIONAL SYSTEM; SENSORY MAP; TOPOGRAPHIC ORGANIZATION; REPRESENTATIONS; MICE; PROJECTIONS; GLOMERULUS; DENDRITES; SYNAPSE	The mammalian olfactory system detects and discriminates thousands of odorants using many different receptors expressed by sensory neurons in the nasal epithelium(1). Axonal projections from these neurons to the main olfactory bulbs form reproducible patterns of glomeruli in two widely separated regions of each bulb, creating two mirror-symmetric maps of odorant receptor projections(2). To investigate whether odorant receptors organize neural circuitry in the olfactory bulb, we have examined a genetically modified mouse line, rI7 --> M71, in which a functionally characterized receptor, rI7(3,4), has been substituted into the M71 receptor locus(5). Here we show that despite their ectopic location the resulting glomeruli are responsive to known ligands of the rI7 receptor, attract postsynaptic innervation by mitral/tufted cell dendrites, and endow these cells with responses that are characteristic of the rI7 receptor. External tufted cells receiving input from rI7 --> M71 glomeruli form precise intrabulbar projections that link medial and lateral rI7 --> M71 glomeruli anatomically, thus providing a substrate for coordinating isofunctional glomeruli. We conclude that odorant receptor identity in epithelial neurons determines not only glomerular convergence and function, but also functional circuitry in the olfactory bulb.	Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA; Rockefeller Univ, New York, NY 10021 USA	Duke University; Howard Hughes Medical Institute; Rockefeller University	Belluscio, L (corresponding author), NINDS, NIH, 36 Convent Dr, Bethesda, MD 20892 USA.	belluscl@ninds.nih.gov		Lodovichi, Claudia/0000-0002-0490-4846				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAMANTIA AS, 1989, NATURE, V341, P646, DOI 10.1038/341646a0; LIU WL, 1994, J COMP NEUROL, V346, P541, DOI 10.1002/cne.903460407; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHOENFELD TA, 1985, J COMP NEUROL, V235, P503, DOI 10.1002/cne.902350408; Shipley MT, 1996, J NEUROBIOL, V30, P123; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	29	124	126	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					296	300		10.1038/nature01001	http://dx.doi.org/10.1038/nature01001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239567				2022-12-24	WOS:000178056300045
J	Li, C; Thompson, CB				Li, C; Thompson, CB			DNA damage, deamidation, and death	SCIENCE			English	Editorial Material							APOPTOSIS; PROTEINS		Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Li, C (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.							Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Horiguchi Y, 1997, P NATL ACAD SCI USA, V94, P11623, DOI 10.1073/pnas.94.21.11623; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Schmitt CA, 1999, J PATHOL, V187, P127; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	10	20	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1346	1347		10.1126/science.1079168	http://dx.doi.org/10.1126/science.1079168			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434041				2022-12-24	WOS:000179223100029
J	Kolar, CS; Lodge, DM				Kolar, CS; Lodge, DM			Ecological predictions and risk assessment for alien fishes in North America	SCIENCE			English	Article							BIOLOGICAL INVADERS; INVASIONS	Methods of risk assessment for alien species, especially for nonagricultural systems, are largely qualitative. Using a generalizable risk assessment approach and statistical models of fish introductions into the Great Lakes, North America, we developed a quantitative approach to target prevention efforts on species most likely to cause damage. Models correctly categorized established, quickly spreading, and nuisance fishes with 87 to 94% accuracy. We then identified fishes that pose a high risk to the Great Lakes if introduced from unintentional ( ballast water) or intentional pathways ( sport, pet, bait, and aquaculture industries).	Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Kolar, CS (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, 2630 Fanta Reed Rd, La Crosse, WI 54603 USA.		Lodge, David Michael/AAX-1781-2021; Ebersole, Joseph L/A-8371-2009					*COMM ENV NAT RES, 1999, CENR599001 NAT SCI T; *COMM SCI BAS PRED, 2002, PRED INV NON PLANTS; CUDMOREVOKEY B, 2000, 2550 CAN DEP FISH OC; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; GODDARD CI, 1997, COMMUNICATION   0708; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Groves RH, 2001, WEED RISK ASSESSMENT; ILLIES J, 1978, LIMNOFAUNA EUROPEA; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Krebs C.J., 1999, ECOLOGICAL METHODOLO; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mooney H., 2000, INVASIVE SPECIES CHA; MOYLE PB, 1996, INTRO ICHTHYOLOGY; *NAT INV SPEC COUN, 2001, NATL MAN PLAN M INV; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Risk Assessment and Management Committee, 1996, GEN NON AQ ORG RISK; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SHARP E, 2002, DETROIT FREE PR 0411; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; U.S. Congress O.T.A., 1993, HARMF NON SPEC US; USFWS (U.S. Fish and Wildlife Service), 2002, FED REGISTER, V67, P49280	26	593	637	12	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 8	2002	298	5596					1233	1236		10.1126/science.1075753	http://dx.doi.org/10.1126/science.1075753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424378				2022-12-24	WOS:000179080400050
J	Bjornstad, ON; Peltonen, M; Liebhold, AM; Baltensweiler, W				Bjornstad, ON; Peltonen, M; Liebhold, AM; Baltensweiler, W			Waves of larch budmoth outbreaks in the European Alps	SCIENCE			English	Article							POPULATION-DYNAMICS; TRAVELING WAVES; TIME; SYNCHRONY; PATTERNS; MODELS	Spatially extended population models predict complex spatiotemporal patterns, such as spiral waves and spatial chaos, as a result of the reaction-diffusion dynamics that arise from trophic interactions. However, examples of such patterns in ecological systems are scarce. We develop a quantitative technique to demonstrate the existence of waves in Central European larch budmoth (Zeiraphera diniana Gn.) outbreaks. We show that these waves travel toward the northeast-east at 210 kilometers per year. A theoretical model involving a moth-enemy interaction predicts directional waves, but only if dispersal is directionally biased or habitat productivity varies across the landscape. Our study confirms that nonlinear ecological interactions can lead to complex spatial dynamics at a regional scale.	Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; US Forest Serv, USDA, Morgantown, WV 26505 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); United States Forest Service	Bjornstad, ON (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.		Villsen, Kurt/C-7965-2015; Bjornstad, Ottar N/I-4518-2012; Liebhold, Andrew M./C-1423-2008	Liebhold, Andrew M./0000-0001-7427-6534				BALTENSWEILER W, 1993, OECOLOGIA, V94, P62, DOI 10.1007/BF00317302; Baltensweiler Werner, 1999, Forest Snow and Landscape Research, V74, P1; Bjornstad ON, 2001, J ANIM ECOL, V70, P924, DOI 10.1046/j.0021-8790.2001.00560.x; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Gurney WSC, 1998, ECOLOGY, V79, P2516; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hastings A, 1997, P ROY SOC B-BIOL SCI, V264, P1837, DOI 10.1098/rspb.1997.0253; Haydon DT, 2000, THEOR POPUL BIOL, V58, P239, DOI 10.1006/tpbi.2000.1489; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; MAY RM, 1986, PROC R SOC SER B-BIO, V228, P241, DOI 10.1098/rspb.1986.0054; Ranta E, 1997, ECOGRAPHY, V20, P454, DOI 10.1111/j.1600-0587.1997.tb00412.x; Wilson WG, 1999, J ANIM ECOL, V68, P94, DOI 10.1046/j.1365-2656.1999.00265.x; [No title captured]; [No title captured]	18	138	142	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					1020	1023		10.1126/science.1075182	http://dx.doi.org/10.1126/science.1075182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12411704				2022-12-24	WOS:000178932000055
J	Long, SB; Casey, PJ; Beese, LS				Long, SB; Casey, PJ; Beese, LS			Reaction path of protein farnesyltransferase at atomic resolution	NATURE			English	Article							CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PYROPHOSPHATE BINDING; CONSERVED RESIDUES; SUBSTRATE-BINDING; PRODUCT RELEASE; BETA-SUBUNIT; TRANSFERASE; GERANYLGERANYLTRANSFERASE; INHIBITORS	Protein farnesyltransferase (FTase) catalyses the attachment of a farnesyl lipid group to numerous essential signal transduction proteins, including members of the Ras superfamily(1). The farnesylation of Ras oncoproteins, which are associated with 30% of human cancers, is essential for their transforming activity(2). FTase inhibitors are currently in clinical trials for the treatment of cancer(2-4). Here we present a complete series of structures representing the major steps along the reaction coordinate of this enzyme. From these observations can be deduced the determinants of substrate specificity and an unusual mechanism in which product release requires binding of substrate, analogous to classically processive enzymes. A structural model for the transition state consistent with previous mechanistic studies was also constructed. The processive nature of the reaction suggests the structural basis for the successive addition of two prenyl groups to Rab proteins by the homologous enzyme geranylgeranyltransferase type-II. Finally, known FTase inhibitors seem to differ in their mechanism of inhibiting the enzyme.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Long, SB (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.		beese, lorena/G-4993-2010	Casey, Patrick/0000-0002-7366-9309				Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Bell IM, 2002, J MED CHEM, V45, P2388, DOI 10.1021/jm010531d; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Desnoyers L, 1998, P NATL ACAD SCI USA, V95, P12266, DOI 10.1073/pnas.95.21.12266; Dolence JM, 1997, BIOCHEMISTRY-US, V36, P9246, DOI 10.1021/bi970039p; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; Huang CC, 2000, BIOCHEMISTRY-US, V39, P2593, DOI 10.1021/bi992356x; Johnston SRD, 2001, LANCET ONCOL, V2, P18, DOI 10.1016/S1470-2045(00)00191-1; Karp JE, 2001, CURR OPIN ONCOL, V13, P470, DOI 10.1097/00001622-200111000-00009; KOBLAN KS, 1995, PROTEIN SCI, V4, P681; Kral AM, 1997, J BIOL CHEM, V272, P27319, DOI 10.1074/jbc.272.43.27319; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; Long SB, 2001, P NATL ACAD SCI USA, V98, P12948, DOI 10.1073/pnas.241407898; Mathis JR, 1997, BIOCHEMISTRY-US, V36, P6367, DOI 10.1021/bi9629182; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; REISS Y, 1992, J BIOL CHEM, V267, P6403; STRADLEY SJ, 1993, BIOCHEMISTRY-US, V32, P12586, DOI 10.1021/bi00210a006; Strickland CL, 1999, J MED CHEM, V42, P2125, DOI 10.1021/jm990030g; Strickland CL, 1998, BIOCHEMISTRY-US, V37, P16601, DOI 10.1021/bi981197z; Thoma NH, 2001, J BIOL CHEM, V276, P48631, DOI 10.1074/jbc.M106470200; Thoma NH, 2001, BIOCHEMISTRY-US, V40, P268, DOI 10.1021/bi002034p; Tschantz WR, 1997, J BIOL CHEM, V272, P9989; Wu Z, 1999, BIOCHEMISTRY-US, V38, P11239, DOI 10.1021/bi990583t; Yokoyama K, 1997, J BIOL CHEM, V272, P3944, DOI 10.1074/jbc.272.7.3944; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7	30	168	175	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	2002	419	6907					645	650		10.1038/nature00986	http://dx.doi.org/10.1038/nature00986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374986				2022-12-24	WOS:000178483100052
J	della Torre, A; Costantini, C; Besansky, NJ; Caccone, A; Petrarca, V; Powell, JR; Coluzzi, M				della Torre, A; Costantini, C; Besansky, NJ; Caccone, A; Petrarca, V; Powell, JR; Coluzzi, M			Speciation within Anopheles gambiae - the glass is half full	SCIENCE			English	Editorial Material							GENETIC DIFFERENTIATION; CHROMOSOMAL FORMS; MALARIA VECTOR; MOPTI; TAXA; AREA; FLOW; S.S.; MALI		Univ Roma La Sapienza, Dept Publ Hlth, Parasitol Unit, I-00185 Rome, Italy; Univ Roma La Sapienza, Dept Genet & Mol Biol, I-00185 Rome, Italy; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Sapienza University Rome; Sapienza University Rome; University of Notre Dame; Yale University	della Torre, A (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth, Parasitol Unit, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	ale.dellatorre@uniroma1.it; carlo.constantini@uniroma1.it	Caccone, Adalgisa/AAE-4238-2021; Costantini, Carlo/F-3470-2012	Caccone, Adalgisa/0000-0002-8949-9260; Costantini, Carlo/0000-0003-1016-129X				Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; CARRARA GC, 2002, PARASSITOLOGIA, V44, P43; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; COLUZZI M, 1984, B WORLD HEALTH ORGAN, V62, P107; COLUZZI M, 2002, IN PRESS SCIENC 1003, DOI DOI 10.1126/SCIENCE.1077769; Costantini C., 1999, Parassitologia (Rome), V41, P595; COSTANTINI C, UNPUB; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Fanello C, 2000, T R SOC TROP MED HYG, V94, P132; FANELLO C, UNPUB; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Gentile G, 2002, GENETICS, V161, P1561; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; LEHMANN T, UNPUB; Mukabayire O, 2001, INSECT MOL BIOL, V10, P33, DOI 10.1046/j.1365-2583.2001.00238.x; Power E, 1999, CRIT-Q LIT ART, V41, P101; SAGNON NF, 2000, PARASSITOLOGIA, V42, P157; SANTOLAMAZZA F, 2002, PARASSITOLOGIA, V44, P165; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Taylor C, 2001, GENETICS, V157, P743; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; TOURE YT, 1994, GENETICA, V94, P213, DOI 10.1007/BF01443435; Toure YT, 1996, MED VET ENTOMOL, V10, P197, DOI 10.1111/j.1365-2915.1996.tb00731.x; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; ZAHAR AR, 1985, VBC853MAP853 WHO	30	169	176	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					115	117		10.1126/science.1078170	http://dx.doi.org/10.1126/science.1078170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364784				2022-12-24	WOS:000178370500041
J	Bergfeldt, K; Rydh, B; Granath, F; Gronberg, H; Thalib, L; Adami, HO; Hall, P				Bergfeldt, K; Rydh, B; Granath, F; Gronberg, H; Thalib, L; Adami, HO; Hall, P			Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study	LANCET			English	Article							BRCA2 MUTATIONS; SERIES	Background Patients with breast cancer who have mutations in the high penetrance genes BRCA1 and BRCA2, have an increased risk of ovarian cancer. Because these mutations are rare, easily obtained information such as age and family history of breast or ovarian cancer might be preferable for assessment of ovarian cancer risk in clinical practice. Methods We linked data from the Swedish Cancer Register to the Swedish Generation Register and generated a cohort of 30 552 breast-cancer patients born after 1931, with information on breast and ovarian cancer diagnosis from 146 117 first-degree relatives. Standardised incidence ratios (SIRs) with 95% Cis were calculated with nationwide rates of ovarian cancer, adjusted for age and calendar year. Findings During a mean follow-up of 6 years, 122 incident ovarian cancers were identified in the cohort, yielding an overall SIR of 2.0 (95% Cl 1.6-2.4). The risk was higher in breast-cancer patients diagnosed before the age of 40 years, with a family history of breast cancer (5.6; 1.8-13.1) or ovarian cancer (17.0; 3.5-50.0). A consistently increased risk was noted in patients with a relative who was diagnosed before the age of 50 years, with either breast or ovarian cancer. Women with a family history of ovarian cancer have an almost 10% risk of developing ovarian cancer before the age of 70. Interpretation In young women with breast cancer, the risk of ovarian cancer is greatly raised when a family history of breast or ovarian cancer is present. Close medical surveillance, and perhaps even prophylactic oophorectomy, might be justified in high-risk groups.	Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; Univ Umea Hosp, Dept Oncol, S-90185 Umea, Sweden; Kuwait Univ, Fac Med, Kuwait, Kuwait	Karolinska Institutet; Karolinska Institutet; Umea University; Kuwait University	Bergfeldt, K (corresponding author), Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden.		Bergfeldt, Kjell/C-3581-2012	Thalib, Lukman/0000-0002-1211-6495				BRENNER H, 1993, EUR J CANCER, V29A, P1410, DOI 10.1016/0959-8049(93)90013-6; Breslow N E, 1987, IARC Sci Publ, P1; Dees EC, 2001, SEMIN ONCOL, V28, P322, DOI 10.1053/sonc.2001.26143; Dorum A, 1996, EUR J CANCER, V32A, P1645, DOI 10.1016/0959-8049(96)00137-2; Ewertz M, 1985, Natl Cancer Inst Monogr, V68, P325; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Harvey E B, 1985, Natl Cancer Inst Monogr, V68, P99; Hensley ML, 2000, ONCOLOGY-NY, V14, P1601; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Menon U, 2000, CURR OPIN OBSTET GYN, V12, P39, DOI 10.1097/00001703-200002000-00007; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Papelard H, 2000, BRIT J CANCER, V83, P719, DOI 10.1054/bjoc.2000.1331; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; SurisSwirtz PJ, 1996, BREAST CANCER RES TR, V41, P21, DOI 10.1007/BF01807033; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Volk N, 1997, CANCER CAUSE CONTROL, V8, P764, DOI 10.1023/A:1018487506546; 2000, CANC INCIDENCE SWEDE; 2000, CAUSES DEATH 1997; 2000, COCHRANE DATABASE SY, V3	21	50	53	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 21	2002	360	9337					891	894		10.1016/S0140-6736(02)11023-3	http://dx.doi.org/10.1016/S0140-6736(02)11023-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AU	12354469				2022-12-24	WOS:000178142200006
J	McPherson, K				McPherson, K			Epidemiology on trial - confessions of an expert witness	LANCET			English	Editorial Material							3RD-GENERATION ORAL-CONTRACEPTIVES; VENOUS THROMBOEMBOLISM; RISK		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	McPherson, K (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.							Brock P, 2001, BRIT MED J, V322, P1605, DOI 10.1136/bmj.322.7302.1605; Cox D. R., 1984, ANAL SURVIVAL DATA; Farmer RDT, 2000, BMJ-BRIT MED J, V321, P477, DOI 10.1136/bmj.321.7259.477; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Lewis MA, 1999, HUM REPROD, V14, P1493, DOI 10.1093/humrep/14.6.1493; Lidegaard O, 2002, CONTRACEPTION, V65, P187, DOI 10.1016/S0010-7824(01)00307-9; Poulter NR, 1996, LANCET, V347, P547; Skegg DCG, 2000, BMJ-BRIT MED J, V321, P1171, DOI 10.1136/bmj.321.7270.1171; Spitzer WO, 1996, BRIT MED J, V312, P83; *WHO, 1998, WHO TECHN REP SER, V877; 2002, LANCET, V360, P421	12	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 21	2002	360	9337					889	890		10.1016/S0140-6736(02)11070-1	http://dx.doi.org/10.1016/S0140-6736(02)11070-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AU	12354468				2022-12-24	WOS:000178142200005
J	Walters, RW; Freimuth, P; Moninger, TO; Ganske, I; Zabner, J; Welsh, MJ				Walters, RW; Freimuth, P; Moninger, TO; Ganske, I; Zabner, J; Welsh, MJ			Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape	CELL			English	Article							CILIATED AIRWAY EPITHELIA; CELL-ADHESION; GENE-TRANSFER; MOLECULAR-BASIS; RECEPTOR; COXSACKIEVIRUS; BINDING; SURFACE; DOMAIN; ENTRY	Adenovirus binds its receptor (CAR), enters cells, and replicates. It must then escape to the environment to infect a new host. We found that following infection, human airway epithelia first released adenovirus to the basolateral surface. Virus then traveled between epithelial cells to emerge on the apical surface. Adenovirus fiber protein, which is produced during viral replication, facilitated apical escape. Fiber binds CAR, which sits on the basolateral membrane where it maintains tight junction integrity. When fiber bound CAR, it disrupted junctional integrity, allowing virus to filter between the cells and emerge apically. Thus, adenovirus exploits its receptor for two important but distinct steps in its life cycle: entry into host cells and escape across epithelial barriers to the environment.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; United States Department of Energy (DOE); Brookhaven National Laboratory	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	michael-weish@uiowa.edu		Zabner, Joseph/0000-0002-9606-1339; Welsh, Michael/0000-0002-1646-6206	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036251, F31AI136251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NIAID NIH HHS [AI36251] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Carson SD, 1999, J VIROL, V73, P7077, DOI 10.1128/JVI.73.8.7077-7079.1999; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Compans RW, 1995, CURR TOP MICROBIOL, V202, P209; Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761; Freire E, 1999, APPL MATH LETT, V12, P73, DOI 10.1016/S0893-9659(98)00152-9; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HENRY LJ, 1994, J VIROL, V68, P5239, DOI 10.1128/JVI.68.8.5239-5246.1994; HIRST GK, 1950, J EXP MED, V91, P161, DOI 10.1084/jem.91.2.161; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; HORWITZ MS, 1999, VIROLOGY, P1723; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; HUEBNER RJ, 1954, NEW ENGL J MED, V251, P1077, DOI 10.1056/NEJM195412302512701; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; LOUIS N, 1994, J VIROL, V68, P4104, DOI 10.1128/JVI.68.6.4104-4106.1994; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Van't Hof W, 2001, HUM GENE THER, V12, P25, DOI 10.1089/104303401450933; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Wang GS, 1998, J VIROL, V72, P9818, DOI 10.1128/JVI.72.12.9818-9826.1998; Welsh MJ, 1999, J CLIN INVEST, V104, P1165, DOI 10.1172/JCI8634; WHITE JM, 1989, CELL, V56, P725, DOI 10.1016/0092-8674(89)90674-0; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996	39	301	315	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2002	110	6					789	799		10.1016/S0092-8674(02)00912-1	http://dx.doi.org/10.1016/S0092-8674(02)00912-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	596TV	12297051	Bronze			2022-12-24	WOS:000178182800013
J	Dellinger, AM; Staunton, CE				Dellinger, AM; Staunton, CE		CDC	Barriers to children walking and biking to school - United States, 1999 (Reprinted from MMWR, vol 51, pg 701-704, 2002)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA; CDC, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dellinger, AM (corresponding author), Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA.							*CDC, 2001, NAT STRAT ADV CHILD; *CDC, 1990, ANN MORT TAP; *CDC, 2001, DAT NAT EL INJ SURV; *CDC NAT HIGHW TRA, 2001, NAT STRAT ADV BIC SA; Department of Health and Human Services, 1999, HUMAN KINETICS; *MAR COUNT BIC COA, 2001, SAF ROUT SCH DEM PRO; Schieber R A, 1996, Inj Prev, V2, P228, DOI 10.1136/ip.2.3.228; *US CENS BUR, 1999, POP EST PROGR IND PO; *US DEP TRANSP, 1997, FHWAPL97028 US DEP T; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; 2002, MMWR, V51, P701	11	32	32	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2002	288	11					1343	1344						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	593TB	12240658				2022-12-24	WOS:000178008300004
J	Krantz, MJ; Lewkowiez, L; Hays, H; Woodroffe, MA; Robertson, AD; Mehler, PS				Krantz, MJ; Lewkowiez, L; Hays, H; Woodroffe, MA; Robertson, AD; Mehler, PS			Torsade de Pointes associated with very-high-dose methadone	ANNALS OF INTERNAL MEDICINE			English	Article							LEVOMETHADYL ACETATE	Background: Methadone is an effective treatment for opioid dependency and chronic pain. A methadone derivative, levacetyl-methadol, was withdrawn from the European market after being associated with torsade de pointes. To date, no association between methadone and this arrhythmia has been described. Objective: To evaluate a series of methadone-treated patients experiencing torsade de pointes. Design: Retrospective case series. Setting: Methadone maintenance treatment programs in the United States and a pain management center in Canada. Patients: 17 methadone-treated patients who developed torsade de pointes. Measurements: Chart review for concomitant arrhythmia risk factors and quantification of corrected QT interval (QTc). Results: The mean daily methadone dose was 397 +/- 283 mg, and the mean QTc interval was 615 +/- 77 msec. Fourteen patients had a predisposing risk factor for arrhythmia. A cardiac defibrillator or pacemaker was placed in 14 patients; all 17 patients survived. Conclusions: This series raises concern that very-high-dose methadone may be associated with torsade de pointes. Given the likely expansion of methadone treatment into primary care, further investigation of these findings is warranted.	Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Alberta, Edmonton, AB, Canada	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta	Krantz, MJ (corresponding author), Denver Hlth Med Ctr, Div Cardiol, Mail Code 0960,777 Bannock St, Denver, CO 80204 USA.							Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; D'Aunno T, 1999, AM J DRUG ALCOHOL AB, V25, P681, DOI 10.1081/ADA-100101886; Deamer RL, 2001, J ADDICT DIS, V20, P7, DOI 10.1300/J069v20n04_02; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; European Agency for the Evaluation of Medical Products, 2001, EMEA877601; HAYS H, 1999, PAIN RES MANAG, V4, P23; Huber A, 2001, DRUG ALCOHOL DEPEN, V63, pS70; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Katchman AN, 2001, PHARMACOLOGIST, V43, P98; KOMTHONG S, 1987, P SOC EXP BIOL MED, V184, P40; KURITA T, 1993, PACE, V16, P33, DOI 10.1111/j.1540-8159.1993.tb01532.x; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; McCaffrey BR, 2001, J ADDICT DIS, V20, P93, DOI 10.1300/J069v20n01_09; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; RENDIG SV, 1980, J PHARMACOL EXP THER, V215, P259; Vastag B, 2001, JAMA-J AM MED ASSOC, V285, P1435, DOI 10.1001/jama.285.11.1435-b; Vincent G. Michael, 2000, Cardiology Clinics, V18, P309; WESLEY RC, 1992, AM HEART J, V123, P794, DOI 10.1016/0002-8703(92)90525-Z; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416	19	272	280	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					501	504		10.7326/0003-4819-137-6-200209170-00010	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230351				2022-12-24	WOS:000178069100004
J	Craddock, C; Hochhauser, D				Craddock, C; Hochhauser, D			Realising the potential of targeted therapies in oncology	LANCET			English	Editorial Material									Univ Hosp, Dept Haematol, Birmingham B15 2TH, W Midlands, England; UCL Royal Free & Univ Coll Med Sch, Dept Oncol, London, England	University of Birmingham; University of London; University College London; UCL Medical School	Craddock, C (corresponding author), Univ Hosp, Dept Haematol, Birmingham B15 2TH, W Midlands, England.	Charles.Craddock@uhb.nhs.uk		Craddock, Charles/0000-0001-5041-6678; Hochhauser, Daniel/0000-0001-5522-9281				Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; O'Brien SG, 2001, LANCET, V358, P1902; Rosenwald A, 2002, SEMIN ONCOL, V29, P258, DOI 10.1053/sonc.2002.32901; Willman CL, 2001, LEUKEMIA, V15, P690, DOI 10.1038/sj.leu.2402087	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					424	425		10.1016/S0140-6736(02)09692-7	http://dx.doi.org/10.1016/S0140-6736(02)09692-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241710				2022-12-24	WOS:000177342900004
J	Wade, DT				Wade, DT			The dis-integration of death	LANCET			English	Editorial Material									Oxford Ctr Enablement, Oxford OX3 7LD, England	University of Oxford	Wade, DT (corresponding author), Oxford Ctr Enablement, Windmill Rd, Oxford OX3 7LD, England.			Wade, Derick/0000-0002-1188-8442				Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841	2	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					425	426		10.1016/S0140-6736(02)09682-4	http://dx.doi.org/10.1016/S0140-6736(02)09682-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241711				2022-12-24	WOS:000177342900005
J	Searle, IR; Men, AE; Laniya, TS; Buzas, DM; Iturbe-Ormaetxe, I; Carroll, BJ; Gresshoff, PM				Searle, IR; Men, AE; Laniya, TS; Buzas, DM; Iturbe-Ormaetxe, I; Carroll, BJ; Gresshoff, PM			Long-distance signaling in nodulation directed by a CLAVATA1-like receptor kinase	SCIENCE			English	Article							GENETIC-ANALYSIS; MUTANTS; SHOOT; ARABIDOPSIS	Proliferation of legume nodule primordia is controlled by shoot-root signaling known as autoregulation of nodulation (AON). Mutants defective in AON show supernodulation and increased numbers of lateral roots. Here, we demonstrate that AON in soybean is controlled by the receptor-like protein kinase GmNARK (Glycine max nodule autoregulation receptor kinase), similar to Arabidopsis CLAVATA1 (CLV1). Whereas CLV1 functions in a protein complex controlling stem cell proliferation by short-distance signaling in shoot apices, GmNARK expression in the leaf has a major role in long-distance communication with nodule and lateral root primordia.	Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Land & Food Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Life Sci, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Carroll, BJ (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia.		Searle, Iain/AAE-8869-2019; Carroll, Bernard/C-7690-2009; Buzas, Diana M/J-3826-2014; Buzas, Diana Mihaela/AAA-1431-2020; Han, Liqi/K-6127-2013	Buzas, Diana Mihaela/0000-0002-8625-7872; Carroll, Bernard/0000-0002-1976-8269				AKAO S, 1992, SOIL SCI PLANT NUTR, V38, P183, DOI 10.1080/00380768.1992.10416966; Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; CARROLL BJ, 1985, P NATL ACAD SCI USA, V82, P4162, DOI 10.1073/pnas.82.12.4162; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DELVES AC, 1988, J GENET, V67, P1, DOI 10.1007/BF02927732; DELVES AC, 1992, PLANT CELL ENVIRON, V15, P249, DOI 10.1111/j.1365-3040.1992.tb01479.x; DELVES AC, 1986, PLANT PHYSIOL, V82, P588, DOI 10.1104/pp.82.2.588; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; FRANCISCO PB, 1995, PLANT SCI, V107, P167, DOI 10.1016/0168-9452(95)04107-6; GREMAUD MF, 1989, PLANT PHYSIOL, V89, P169, DOI 10.1104/pp.89.1.169; Gresshoff P. M., 1986, A genetic approach to plant biochemistry, P159; Kolchinsky A, 1997, MOL GEN GENET, V254, P29, DOI 10.1007/s004380050387; LANDAUELLIS D, 1991, MOL GEN GENET, V228, P221, DOI 10.1007/BF00282469; MEN AE, IN PRESS GENOME LETT; PARK SJ, 1988, CAN J PLANT SCI, V68, P199, DOI 10.4141/cjps88-019; PIERCE M, 1983, PLANT PHYSIOL, V73, P286, DOI 10.1104/pp.73.2.286; POSTMA JG, 1988, J PLANT PHYSIOL, V132, P424, DOI 10.1016/S0176-1617(88)80056-7; SEARLE IR, UNPUB; SEARLE IR, 2002, THESIS U QUEENSLAND; Spaink HP, 2000, ANNU REV MICROBIOL, V54, P257, DOI 10.1146/annurev.micro.54.1.257; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Takayama S, 2002, CURR OPIN PLANT BIOL, V5, P382, DOI 10.1016/S1369-5266(02)00284-4; TOMPKINS JP, 1999, PLANT MOL BIOL, V41, P25; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wopereis J, 2000, PLANT J, V23, P97, DOI 10.1046/j.1365-313x.2000.00799.x; Yamamoto E, 2000, BBA-GENE STRUCT EXPR, V1491, P333, DOI 10.1016/S0167-4781(00)00061-0	28	386	418	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					109	112		10.1126/science.1077937	http://dx.doi.org/10.1126/science.1077937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12411574				2022-12-24	WOS:000180165800045
J	Shen, XT; Xiao, H; Ranallo, R; Wu, WH; Wu, C				Shen, XT; Xiao, H; Ranallo, R; Wu, WH; Wu, C			Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates	SCIENCE			English	Article							MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; PHOSPHATES; EXPRESSION; BINDING; KINASE; CELLS; GENES; NURF	Eukaryotes use adenosine triphosphate (ATP)-dependent chromatin-remodeling complexes to regulate gene expression. Here, we show that inositol polyphosphates can modulate the activities of several chromatin-remodeling complexes in vitro. Inositol hexakisphosphate (IP6) inhibits nucleosome mobilization by NURF, ISW2, and INO80 complexes. In contrast, nucleosome mobilization by the yeast SWI/SNF complex is stimulated by inositol tetrakisphosphate (IP4) and inositol pentakisphosphate (IP5). We demonstrate that mutations in genes encoding inositol polyphosphate kinases that produce IP4, IP5, and IP6 impair transcription in vivo. These results provide a link between inositol polyphosphates, chromatin remodeling, and gene expression.	NCI, Ctr Canc Res, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, C (corresponding author), NCI, Ctr Canc Res, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.			Shen, Xuetong/0000-0002-4267-5298	NATIONAL CANCER INSTITUTE [Z01BC005263, ZIABC005263] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Shears SB, 2000, BIOESSAYS, V22, P786, DOI 10.1002/1521-1878(200009)22:9<786::AID-BIES3>3.3.CO;2-S; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Shen X., UNPUB; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	29	274	280	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					112	114		10.1126/science.1078068	http://dx.doi.org/10.1126/science.1078068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12434013	Green Published			2022-12-24	WOS:000180165800046
J	Steger, DJ; Haswell, ES; Miller, AL; Wente, SR; O'Shea, EK				Steger, DJ; Haswell, ES; Miller, AL; Wente, SR; O'Shea, EK			Regulation of chromatin remodeling by inositol polyphosphates	SCIENCE			English	Article							TRANSCRIPTION FACTOR PHO4; MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; YEAST; COMPLEX; KINASE; PHOSPHORYLATION; PROMOTER; DOMAIN; RECRUITMENT	Chromatin remodeling is required for efficient transcription of eukaryotic genes. In a genetic selection for budding yeast mutants that were defective in induction of the phosphate-responsive PHO5 gene, we identified mutations in ARG82/IPK2, which encodes a nuclear inositol polyphosphate kinase. In arg82 mutant strains, remodeling of PHO5 promoter chromatin is impaired, and the adenosine triphosphate-dependent chromatin-remodeling complexes SWI/SNF and INO80 are not efficiently recruited to phosphate-responsive promoters. These results suggest a role for the small molecule inositol polyphosphate in the regulation of chromatin remodeling and transcription.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37212 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Vanderbilt University	O'Shea, EK (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Haswell, Elizabeth/AAE-9370-2021	Haswell, Elizabeth/0000-0002-4246-065X	NIGMS NIH HHS [GM51219, GM51377, R01 GM051377] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051219, R01GM051377, R01GM051219] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; El Bakkoury M, 2000, MOL MICROBIOL, V35, P15, DOI 10.1046/j.1365-2958.2000.01665.x; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	24	300	308	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					114	116		10.1126/science.1078062	http://dx.doi.org/10.1126/science.1078062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12434012	Green Accepted			2022-12-24	WOS:000180165800047
J	Wang, B; Matsuoka, S; Carpenter, PB; Elledge, SJ				Wang, B; Matsuoka, S; Carpenter, PB; Elledge, SJ			53BP1, a mediator of the DNA damage checkpoint	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; PROTEIN; PHOSPHORYLATION; BRCA1; MODULE; ATM; P53	53BP1 binds to the tumor suppressor protein p53 and has a potential role in DNA damage responses. We used small interfering RNA (siRNA) directed against 53BP1 in mammalian cells to demonstrate that 53BP1 is a key transducer of the DNA damage checkpoint signal. 53BP1 was required for p53 accumulation, G(2)-M checkpoint arrest, and the intra-S-phase checkpoint in response to ionizing radiation. 53BP1 played a partially redundant role in phosphorylation of the downstream checkpoint effector proteins Brca1 and Chk2 but was required for the formation of Brca1 foci in a hierarchical branched pathway for the recruitment of repair and signaling proteins to sites of DNA damage.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Health Science Center Houston	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.							Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; DITULLIO R, COMMUNICATION; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Wang B., UNPUB; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Xia ZF, 2001, J BIOL CHEM, V276, P2708, DOI 10.1074/jbc.M007665200; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	20	455	471	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1435	1438		10.1126/science.1076182	http://dx.doi.org/10.1126/science.1076182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12364621				2022-12-24	WOS:000179223100056
J	Wang, KC; Kim, JA; Sivasankaran, R; Segal, R; He, ZG				Wang, KC; Kim, JA; Sivasankaran, R; Segal, R; He, ZG			p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp	NATURE			English	Article							NEUROTROPHIN RECEPTOR; AXON REGENERATION; RHO; PROTEIN; GROWTH; CNS; IDENTIFICATION; EXPRESSION; INHIBITION; OUTGROWTH	In inhibiting neurite outgrowth, several myelin components, including the extracellular domain of Nogo-A (Nogo-66)(1), oligodendrocyte myelin glycoprotein (OMgp)(2) and myelin-associated glycoprotein (MAG)(3,4), exert their effects through the same Nogo receptor (NgR). The glycosyl phosphatidylinositol (GPI)-anchored nature of NgR indicates the requirement for additional transmembrane protein(s) to transduce the inhibitory signals into the interior of responding neurons. Here, we demonstrate that p75, a transmembrane protein known to be a receptor for the neurotrophin family of growth factors(5,6), specifically interacts with NgR. p75 is required for NgR-mediated signalling, as neurons from p75 knockout mice are no longer responsive to myelin and to each of the known NgR ligands. Blocking the p75-NgR interaction also reduces the activities of these inhibitors. Moreover, a truncated p75 protein lacking the intracellular domain, when overexpressed in primary neurons, attenuates the same set of inhibitory activities, suggesting that p75 is a signal transducer of the NgR-p75 receptor complex. Thus, interfering with p75 and its downstream signalling pathways may allow lesioned axons to overcome most of the inhibitory activities associated with central nervous system myelin.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	He, ZG (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.			Wang, Kevin/0000-0002-5305-6791				Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	25	659	713	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					74	78		10.1038/nature01176	http://dx.doi.org/10.1038/nature01176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422217				2022-12-24	WOS:000179068100039
J	Shafran, SD; Mashinter, LD; Phillips, P; Lalonde, RG; Gill, MJ; Walmsley, SL; Toma, E; Conway, B; Fong, IW; Rachlis, AR; Williams, KE; Garber, GE; Schlech, WF; Smaill, F				Shafran, SD; Mashinter, LD; Phillips, P; Lalonde, RG; Gill, MJ; Walmsley, SL; Toma, E; Conway, B; Fong, IW; Rachlis, AR; Williams, KE; Garber, GE; Schlech, WF; Smaill, F			Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SECONDARY PROPHYLAXIS; AIDS; RESOLUTION; BACTEREMIA; PATIENT; TRIAL	Background: Highly active antiretroviral therapy (HAART) is associated with improvement or resolution of several HIV-associated opportunistic infections. Although prophylaxis against disseminated Mycobacterium avium, complex infection may be successfully discontinued after a favorable response to HAART, the 1999 guidelines from the U.S. Public Health Service/infectious Diseases Society of America recommend continuing therapy for disseminated M. avium complex infection, regardless of the response to HAART. Objective: To examine the outcome among patients with disseminated M. avium complex infection whose antimycobacterial therapy was discontinued after a favorable response to HAART. Design: Retrospective chart review between May 2000 and May 2001. Setting: 13 Canadian HIV clinics. Patients: 52 HIV-infected adults (43 men; mean age, 37.3 years) in whom successful anti mycobacterial therapy for disseminated M. avium, complex infection was discontinued after a favorable virologic response to HAART. Measurements: Survival, survival free of disseminated M. avium complex infection, and CD4(+) cell count responses. Results: At the time of diagnosis of disseminated M. avium, complex infection, the median CD4(+) cell count was 0.016 x 109 cells/L, and the median plasma HIV RNA level was 90 000 copies/mL (plasma HIV RNA levels were available for only 21 patients). The patients received a median of 32 months of antimycobacterial therapy that included ethambutol plus either clarithromycin or azithromycin. When anti mycobacterial therapy was discontinued, the median CD4(+) cell count was 0.23 x 10(9) cells/L and the median plasma HIV RNA level was less than 50 copies/mL. A median of 20 months after discontinuation of antimycobacterial therapy, only 1 patient had developed recurrent M. avium complex disease (37 months after stopping antimycobacterial therapy). This patient had stopped HAART 2 months earlier because of uncontrolled HIV viremia. Twenty months after stopping anti mycobacterial therapy, the other 51 patients had a median CD4(+) cell count of 0.288 x 10(9) cells/L; 34 (67%) had undetectable plasma HIV RNA levels, and 8 (15%) had plasma HIV RNA levels of 50 to 1000 copies/mL. Conclusions: Discontinuation of successful disseminated M. avium complex therapy after a successful response to HAART is safe and reduces patients' pill burdens, potential drug adverse effects, drug interactions, and costs of therapy.	Univ Alberta, Edmonton, AB, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; McGill Univ, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada; Univ Calgary, Calgary, AB, Canada; Univ Toronto, Toronto, ON, Canada; Univ Saskatchewan, Saskatoon, SK, Canada; Univ Ottawa, Ottawa, ON, Canada; Dalhousie Univ, Halifax, NS, Canada; McMaster Univ, Hamilton, ON, Canada	University of Alberta; University of British Columbia; McGill University; Universite de Montreal; University of Calgary; University of Toronto; University of Saskatchewan; University of Ottawa; Dalhousie University; McMaster University	Shafran, SD (corresponding author), Univ Alberta Hosp, Div Infect Dis, 8440 112 St,WMC 2E4-16, Edmonton, AB T6G 2B7, Canada.	shafran@uah.ualberta.ca	Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Walmsley, Sharon/0000-0002-3959-5692; Gill, Michael John/0000-0002-8546-8790				Aberg JA, 1998, J INFECT DIS, V178, P1446, DOI 10.1086/314469; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Cinti SK, 2000, CLIN INFECT DIS, V30, P511, DOI 10.1086/313705; Currier JS, 2000, ANN INTERN MED, V133, P493, DOI 10.7326/0003-4819-133-7-200010030-00008; de Quiros JCLB, 2001, NEW ENGL J MED, V344, P159, DOI 10.1056/NEJM200101183440301; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; Guex AC, 2000, CLIN INFECT DIS, V30, P602, DOI 10.1086/313733; Hadad DJ, 1998, CLIN INFECT DIS, V26, P758, DOI 10.1086/514577; Hicks CB, 1997, CLIN INFECT DIS, V24, P1023, DOI 10.1093/clinids/24.5.1023; KAPLAN JE, 1995, CLIN INFECT DIS    S, V1, pS1; KEMPER CA, 1994, J INFECT DIS, V170, P488, DOI 10.1093/infdis/170.2.488; Macdonald JC, 1998, J INFECT DIS, V177, P1182, DOI 10.1086/515281; Martinez E, 1999, AIDS, V13, P147; Masur H, 1999, ANN INTERN MED, V131, P873, DOI 10.7326/0003-4819-131-11-199912070-00022; Miralles P, 1998, AIDS, V12, P2467, DOI 10.1097/00002030-199818000-00016; Murray R, 2001, EUR J CLIN MICROBIOL, V20, P199, DOI 10.1007/PL00011252; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Soriano V, 2000, AIDS, V14, P383, DOI 10.1097/00002030-200003100-00011; *USPHS IDSA PREV O, 2002, 2001 USPHS IDSA GUID; Zingman BS, 1996, NEW ENGL J MED, V334, P1674, DOI 10.1056/NEJM199606203342516	20	28	28	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2002	137	9					734	737		10.7326/0003-4819-137-9-200211050-00008	http://dx.doi.org/10.7326/0003-4819-137-9-200211050-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	612BA	12416943				2022-12-24	WOS:000179052400004
J	Munro, PT; Smith, RD; Parke, TRJ				Munro, PT; Smith, RD; Parke, TRJ			Effect of patients' age on management of acute intracranial haematoma: prospective national study	BRITISH MEDICAL JOURNAL			English	Article							HEAD-INJURY; HEMATOMAS	Objective To determine whether the management of head injuries differs between patients aged greater than or equal to65 years and those < 65. Design Prospective observational national study over four years. Setting 25 Scottish hospitals that admit trauma patients. Participants 527 trauma patients with extradural or acute subdural haematomas. Main outcome measures Time to cranial computed tomography in the first hospital attended, rates of transfer to neurosurgical care, rates of neurosurgical intervention, length of time to operation, and mortality in inpatients in the three months after admission. Results Patients aged &GE; 65 years had lower survival rates than patients < 65 years. Rates were 15/18 (83%) v 165/167 (99%) for Extradural haematoma. (P=0.007) and 61/93 (66%) v 229/249 (92%) for acute subdural haematoma (P <0.001). Older patients were less likely to be transferred to specialist neurosurgical care (10 (56%) v 142 (85%) for extradural haematoma (P=0.005) and 56 (60%) v 192 (77%) for subdural haematoma (P=0.004)). There was no significant difference between age groups in the incidence of neurosurgical interventions in patients who were transferred. Logistic regression analysis showed that age had a significant independent effect on transfer and on survival. Older patients had higher rates of coexisting medical conditions than younger patients but when severity of injury, initial physiological status at presentation, or previous health were controlled for in a log linear analysis, transfer rates were still lower in older patients than in younger patients (P<0.001). Conclusions Compared with those aged under 65 years, people aged 65 and over have a worse prognosis after head injury complicated by intracranial haematoma. The decision to transfer such patients to neurosurgical care seems to be biased against older patients.	So Gen Hosp, Dept Accid & Emergency, Glasgow G51 4TF, Lanark, Scotland; Royal Infirm Edinburgh NHS Trust, Scottish Trauma Audit Grp, Edinburgh EH3 9YW, Midlothian, Scotland	University of Glasgow; Royal Infirmary of Edinburgh; University of Edinburgh	Munro, PT (corresponding author), So Gen Hosp, Dept Accid & Emergency, Glasgow G51 4TF, Lanark, Scotland.							AMACHER AL, 1987, NEUROSURGERY, V20, P954; American Association for Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Beard D, 2000, Health Bull (Edinb), V58, P118; BROWN G, 1993, AGE AGEING, V22, P240, DOI 10.1093/ageing/22.4.240; BULLOCK R, 1996, ABC MAJOR TRAUMA, P25; DAVIS CS, 1988, J AM GERIATR SOC, V36, P225, DOI 10.1111/j.1532-5415.1988.tb01805.x; FENELLI FC, 1989, J TRAUMA, V29, P541; GENTLEMAN D, 1992, INJURY, V23, P471, DOI 10.1016/0020-1383(92)90066-2; Grant PT, 2000, INJURY, V31, P519, DOI 10.1016/S0020-1383(00)00038-3; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; JARNJOOM A, 1992, BRIT J NEUROSURG, V6, P27; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; MENDELOW AD, 1993, BRAINS DIS NERVOUS S, P192; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Rozelle CJ, 1995, J AM GERIATR SOC, V43, P240; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; VANAALST JA, 1991, J TRAUMA, V31, P1096; Wood R., 2001, HLTH WELL BEING OLDE	21	49	51	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 2	2002	325	7371					1001	1003		10.1136/bmj.325.7371.1001	http://dx.doi.org/10.1136/bmj.325.7371.1001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618JU	12411357	Bronze, Green Published			2022-12-24	WOS:000179415600019
J	Wu, JW; Krawitz, AR; Chai, JJ; Li, WY; Zhang, FJ; Luo, KX; Shi, YG				Wu, JW; Krawitz, AR; Chai, JJ; Li, WY; Zhang, FJ; Luo, KX; Shi, YG			Structural mechanism of Smad4 recognition by the nuclear oncoprotein ski: Insights on Ski-mediated repression of TGF-beta signaling	CELL			English	Article							CRYSTAL-STRUCTURE; CO-REPRESSOR; DNA-BINDING; PROTEIN; DOMAIN; ACTIVATION; ONCOGENE; SNON; COACTIVATORS; ACTS	The Ski family of nuclear oncoproteins represses TGF-beta signaling through interactions with the Smad proteins. The crystal structure of the Smad4 binding domain of human c-Ski in complex with the MH2 domain of Smad4 reveals specific recognition of the Smad4 L3 loop region by a highly conserved interaction loop (I loop) from Ski. The Ski binding surface on Smad4 significantly overlaps with that required for binding of the R-Smads. Indeed, Ski disrupts the formation of a functional complex between the Co- and R-Smads, explaining how it could lead to repression of TGF-beta, activin, and BMP responses. Intriguingly, the structure of the Ski fragment, stabilized by a bound zinc atom, resembles the SAND domain, in which the corresponding I loop is responsible for DNA binding.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Luo, KX (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	kluo@uclink.berkeley.edu; yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X; Krakowski, Ari/0000-0003-0554-1669; Chai, Jijie/0000-0001-7591-3873	NATIONAL CANCER INSTITUTE [R01CA082171, R01CA087940] Funding Source: NIH RePORTER; NCI NIH HHS [CA82171, CA87940] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; BOYER PL, 1993, ONCOGENE, V8, P457; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Colmenares C, 1990, Semin Cancer Biol, V1, P383; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; FUMAGALLI S, 1993, MELANOMA RES, V3, P23, DOI 10.1097/00008390-199304000-00004; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Sakashita E, 1996, J BIOCHEM, V120, P1028; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shi YG, 2001, BIOESSAYS, V23, P223, DOI 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.3.CO;2-L; STAVNEZER E, 1986, J VIROL, V57, P1073, DOI 10.1128/JVI.57.3.1073-1083.1986; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	46	162	178	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2002	111	3					357	367		10.1016/S0092-8674(02)01006-1	http://dx.doi.org/10.1016/S0092-8674(02)01006-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419246	Bronze			2022-12-24	WOS:000179010100008
J	Kelber, A; Balkenius, A; Warrant, EJ				Kelber, A; Balkenius, A; Warrant, EJ			Scotopic colour vision in nocturnal hawkmoths	NATURE			English	Article							WAVELENGTH DISCRIMINATION; LIGHT; SENSITIVITY	Humans are colour-blind at night, and it has been assumed that this is true of all animals. But colour vision is as useful for discriminating objects(1) at night as it is during the day. Here we show, through behavioural experiments, that the nocturnal hawkmoth Deilephila elpenor uses colour vision to discriminate coloured stimuli at intensities corresponding to dim starlight (0.0001 cd m(-2)). It can do this even if the illumination colour changes, thereby showing colour constancy-a property of true colour vision systems(2). In identical conditions humans are completely colour-blind. Our calculations show that the possession of three photoreceptor classes reduces the absolute sensitivity of the eye, which indicates that colour vision has a high ecological relevance in nocturnal moths. In addition, the photoreceptors of a single ommatidium absorb too few photons for reliable discrimination, indicating that spatial and/or temporal summation must occur for colour vision to be possible. Taken together, our results show that colour vision occurs at nocturnal intensities in a biologically relevant context.	Lund Univ, Dept Cell Organism Biol, Vis Grp, S-22362 Lund, Sweden	Lund University	Kelber, A (corresponding author), Lund Univ, Dept Cell Organism Biol, Vis Grp, Helgonavagen 3, S-22362 Lund, Sweden.	almut.kelber@zool.lu.se	Kelber, Almut/H-6216-2014	Kelber, Almut/0000-0003-3937-2808; Warrant, Eric/0000-0001-7480-7016				De Vries H, 1943, PHYSICA, V10, P553, DOI 10.1016/S0031-8914(43)90575-0; Frisch K. von, 1914, Zool Jahrb Allg Jena, V35; HOGLUND G, 1973, J COMP PHYSIOL, V86, P265, DOI 10.1007/BF00696344; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; KELBER A, IN PRESS BIOL REV; Knoll F, 1926, Z VERGL PHYSIOL, V2, P328; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; MENZEL R, 1981, J COMP PHYSIOL, V141, P389, DOI 10.1007/BF00609941; Minnaert M., 1993, LIGHT COLOR OUTDOORS, DOI 10.1007/978-1-4612-2722-9; Neumeyer C., 1998, PERCEPTUAL CONSTANCY, P323; Pittaway A. R., 1993, HAWKMOTHS W PALAEARC; POWERS MK, 1978, VISION RES, V18, P1149, DOI 10.1016/0042-6989(78)90098-6; RAGUSO RA, IN PRESS P 3 INT S B; Rose A., 1942, PROC I RADIO ENG NEW, V30, P293, DOI [10.1109/jrproc.1942.230998, DOI 10.1109/JRPROC.1942.230998]; SCHLECHT P, 1979, J COMP PHYSIOL, V129, P257, DOI 10.1007/BF00657662; SCHWEMER J, 1973, J COMP PHYSIOL, V86, P215, DOI 10.1007/BF00696341; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Vogel S, 1954, BLUTENBIOLOGISCHE TY; Warrant E, 1996, P ROY SOC B-BIOL SCI, V263, P1521, DOI 10.1098/rspb.1996.0222; WARRANT EJ, 1990, J COMP PHYSIOL A, V167, P805; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; WELSCH B, 1977, CYTOBIOLOGIE, V14, P378; WHITE RH, 1994, BIOTROPICA, V26, P427, DOI 10.2307/2389237	24	170	174	2	99	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					922	925		10.1038/nature01065	http://dx.doi.org/10.1038/nature01065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410310				2022-12-24	WOS:000178909700043
J	Petersen, PH; Zou, KY; Hwang, JK; Jan, YN; Zhong, WM				Petersen, PH; Zou, KY; Hwang, JK; Jan, YN; Zhong, WM			Progenitor cell maintenance requires numb and numblike during mouse neurogenesis	NATURE			English	Article							CORTICAL NEUROGENESIS; NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; ASYMMETRIC LOCALIZATION; PATTERN-FORMATION; MAMMALIAN NUMB; GLIAL-CELLS; STEM-CELLS; EXPRESSION; GENE	Neurons in most regions of the mammalian nervous system are generated over an extended period of time during development. Maintaining sufficient numbers of progenitors over the course of neurogenesis is essential to ensure that neural cells are produced in correct numbers and diverse types(1-3). The underlying molecular mechanisms, like those governing stem-cell self-renewal in general, remain poorly understood. We report here that mouse numb and numblike (Nbl)(4-6), two highly conserved homologues of Drosophila numb(7,8), play redundant but critical roles in maintaining neural progenitor cells during embryogenesis, by allowing their progenies to choose progenitor over neuronal fates. In Nbl mutant embryos also conditionally mutant for mouse numb in the nervous system, early neurons emerge in the expected spatial and temporal pattern, but at the expense of progenitor cells, leading to a nearly complete depletion of dividing cells shortly after the onset of neurogenesis. Our findings show that a shared molecular mechanism, with mouse Numb and Nbl as key components, governs the self-renewal of all neural progenitor cells, regardless of their lineage or regional identities.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Yale University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		, PeturHenry/H-1506-2011	Jan, Yuh Nung/0000-0003-1367-6299	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Campos LS, 2001, J NEUROSCI RES, V64, P590, DOI 10.1002/jnr.1111.abs; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; GU M, 1994, SCIENCE, V265, P103; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Qian XM, 1998, DEVELOPMENT, V125, P3143; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; VERDI JM, 1996, CURR BIOL, V6, P113; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; ZHONG WM, 1994, MOL CELL BIOL, V14, P7276, DOI 10.1128/MCB.14.11.7276; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	29	262	273	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					929	934		10.1038/nature01124	http://dx.doi.org/10.1038/nature01124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410312				2022-12-24	WOS:000178909700045
J	Buckley, RH				Buckley, RH			Gene therapy for SCID - a complication after remarkable progress	LANCET			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW TRANSPLANTATION		Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Buckley, RH (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.		Buckley, Rebecca/AAB-1578-2019					Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Haddad E, 1999, BLOOD, V94, P2923, DOI 10.1182/blood.V94.8.2923.420k44_2923_2930; Haddad E, 1998, BLOOD, V91, P3646; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Smogorzewska Elzbieta M., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P111	9	58	59	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1185	1186		10.1016/S0140-6736(02)11290-6	http://dx.doi.org/10.1016/S0140-6736(02)11290-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401240				2022-12-24	WOS:000178708100003
J	Marsden, VS; O'Connor, L; O'Reilly, LA; Silke, J; Metcalf, D; Ekert, PG; Huang, DCS; Cecconi, F; Kuida, K; Tomaselli, KJ; Roy, S; Nicholson, DW; Vaux, DL; Bouillet, P; Adams, JM; Strasser, A				Marsden, VS; O'Connor, L; O'Reilly, LA; Silke, J; Metcalf, D; Ekert, PG; Huang, DCS; Cecconi, F; Kuida, K; Tomaselli, KJ; Roy, S; Nicholson, DW; Vaux, DL; Bouillet, P; Adams, JM; Strasser, A			Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome	NATURE			English	Article							PROGRAMMED CELL-DEATH; BCL-2; MITOCHONDRIA; PATHWAYS; PROTEASE; MICE; DISTINCT; APAF1; DNA	Apoptosis is an evolutionarily conserved cell suicide process executed by cysteine proteases (caspases) and regulated by the opposing factions of the Bcl-2 protein family(1,2). Mammalian caspase-9 and its activator Apaf-1 were thought to be essential, because mice lacking either of them display neuronal hyperplasia and their lymphocytes and fibroblasts seem resistant to certain apoptotic stimuli(3-6). Because Apaf-1 requires cytochrome c to activate caspase-9, and Bcl-2 prevents mitochondrial cytochrome c release, Bcl-2 is widely believed to inhibit apoptosis by safeguarding mitochondrial membrane integrity(7-9). Our results suggest a different, broader role, because Bcl-2 overexpression increased lymphocyte numbers in mice and inhibited many apoptotic stimuli, but the absence of Apaf-1 or caspase-9 did not. Caspase activity was still discernible in cells lacking Apaf-1 or caspase-9, and a potent caspase antagonist both inhibited apoptosis and retarded cytochrome c release. We conclude that Bcl-2 regulates a caspase activation programme independently of the cytochrome c/Apaf-1/caspase-9 'apoptosome', which seems to amplify rather than initiate the caspase cascade.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Murdoch Childrens Res Inst, Melbourne, Vic 3050, Australia; Univ Roma Tor Vergata, Dept Biol, Rome, Italy; Vertex Pharmaceut, Genom Pharmacol, Cambridge, MA 02139 USA; Idun Pharmaceut, San Diego, CA 92121 USA; Merck Frosst Canada Inc, Pointe Claire, PQ H9H 3L1, Canada	Walter & Eliza Hall Institute; Murdoch Children's Research Institute; University of Rome Tor Vergata; Vertex Pharmaceuticals; Merck & Company	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Ekert, Paul G/C-7247-2013; Strasser, Andreas/C-7581-2013; Ekert, Paul/Q-1842-2015; Silke, John/B-7622-2008; Huang, David C. S./C-7586-2013; Bouillet, Philippe/E-1241-2013; Cecconi, Francesco/K-3969-2016; Adams, Jerry M/E-1199-2013; Vaux, David L/C-7249-2013	Ekert, Paul G/0000-0002-2976-8617; Strasser, Andreas/0000-0002-5020-4891; Ekert, Paul/0000-0002-2976-8617; Silke, John/0000-0002-7611-5774; Huang, David C. S./0000-0002-3101-4873; Bouillet, Philippe/0000-0002-9012-6058; Cecconi, Francesco/0000-0002-5614-4359; Vaux, David L/0000-0003-2703-1651; Adams, Jerry/0000-0002-4360-8628	Telethon [TCP99038] Funding Source: Medline	Telethon(Fondazione Telethon)		ADAMS JM, IN PRESS CURR OPIN C; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoglen NC, 2001, J PHARMACOL EXP THER, V297, P811; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; Wang XD, 2001, GENE DEV, V15, P2922; Wu JC, 1999, METHODS, V17, P320, DOI 10.1006/meth.1999.0746; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	30	460	477	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	2002	419	6907					634	637		10.1038/nature01101	http://dx.doi.org/10.1038/nature01101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374983				2022-12-24	WOS:000178483100049
J	Murakami, S; Nakashima, R; Yamashita, E; Yamaguchi, A				Murakami, S; Nakashima, R; Yamashita, E; Yamaguchi, A			Crystal structure of bacterial multidrug efflux transporter AcrB	NATURE			English	Article							ESCHERICHIA-COLI; MOLECULAR ARCHITECTURE; RESISTANCE; PUMP; PROTEINS; CRYSTALLIZATION; ANTIBIOTICS; PERIPLASM; SYSTEM; FAMILY	AcrB is a major multidrug exporter in Escherichia coli. It cooperates with a membrane fusion protein, AcrA, and an outer membrane channel, TolC. We have determined the crystal structure of AcrB at 3.5 Angstrom resolution. Three AcrB protomers are organized as a homotrimer in the shape of a jellyfish. Each protomer is composed of a transmembrane region 50 Angstrom thick and a 70 Angstrom protruding headpiece. The top of the headpiece opens like a funnel, where TolC might directly dock into AcrB. A pore formed by three alpha-helices connects the funnel with a central cavity located at the bottom of the headpiece. The cavity has three vestibules at the side of the headpiece which lead into the periplasm. In the transmembrane region, each protomer has twelve transmembrane alpha-helices. The structure implies that substrates translocated from the cell interior through the transmembrane region and from the periplasm through the vestibules are collected in the central cavity and then actively transported through the pore into the TolC tunnel.	Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Osaka 5670047, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yamaguchi, A (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp	Yamashita, Eiki/V-6758-2019; Murakami, Satoshi/E-8155-2015	Yamashita, Eiki/0000-0002-4278-0039; Murakami, Satoshi/0000-0001-5553-7663				Avila-Sakar AJ, 2001, J STRUCT BIOL, V136, P81, DOI 10.1006/jsbi.2001.4418; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fujihira E, 2002, J BIOCHEM, V131, P145, DOI 10.1093/oxfordjournals.jbchem.a003069; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Heymann JAW, 2001, EMBO J, V20, P4408, DOI 10.1093/emboj/20.16.4408; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; Mazzariol A, 2000, ANTIMICROB AGENTS CH, V44, P1387, DOI 10.1128/AAC.44.5.1387-1390.2000; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nikaido H, 2000, TRENDS MICROBIOL, V8, P481, DOI 10.1016/S0966-842X(00)01864-3; Nikaido H, 1998, J BACTERIOL, V180, P4686, DOI 10.1128/JB.180.17.4686-4692.1998; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1991, CCP4 P, V80; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Yin CC, 2000, MOL MICROBIOL, V38, P482, DOI 10.1046/j.1365-2958.2000.02149.x; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059	45	736	770	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2002	419	6907					587	593		10.1038/nature01050	http://dx.doi.org/10.1038/nature01050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374972				2022-12-24	WOS:000178483100037
J	Lancaster, L; Kiel, MC; Kaji, A; Noller, HF				Lancaster, L; Kiel, MC; Kaji, A; Noller, HF			Orientation of ribosome recycling factor in the ribosome from directed hydroxyl radical probing	CELL			English	Article							ELONGATION-FACTOR-G; RELEASE FACTOR RF3; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; FACTOR RRF; PROTEIN-BIOSYNTHESIS; TRANSFER-RNA; TRANSLATION TERMINATION; ANGSTROM RESOLUTION; TETHERED FE(II)	Ribosome recycling factor (RRF) disassembles post-termination complexes in conjunction with elongation factor EF-G, liberating ribosomes for further rounds of translation. The striking resemblance of its L-shaped structure to that of tRNA has suggested that the mode of action of RRF may be based on mimicry of tRNA. Directed hydroxyl radical probing of 16S and 23S rRNA from Fe(II) tethered to ten positions on the surface of E. coli RRF constrains it to a well-defined location in the subunit interface cavity. Surprisingly, the orientation of RRF in the ribosome differs markedly from any of those previously observed for tRNA, suggesting that structural mimicry does not necessarily reflect functional mimicry.	Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of California System; University of California Santa Cruz; University of Pennsylvania	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu			NIGMS NIH HHS [GM59140, GM17129] Funding Source: Medline; CGH CDC HHS [GH60429] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017129, R01GM059140, R37GM017129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CGH CDC HHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Culver GM, 1999, J MOL BIOL, V286, P355, DOI 10.1006/jmbi.1998.2483; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; Heilek GM, 1996, SCIENCE, V272, P1659, DOI 10.1126/science.272.5268.1659; HEILEK GM, 1995, P NATL ACAD SCI USA, V92, P1113, DOI 10.1073/pnas.92.4.1113; Heilek GM, 1996, RNA, V2, P597; HIRASHIM.A, 1970, BIOCHEM BIOPH RES CO, V41, P877, DOI 10.1016/0006-291X(70)90165-8; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; HIROKAWA G, 2002, IN PRESS J BIOL CHEM; Inokuchi Y, 2000, EMBO J, V19, P3788, DOI 10.1093/emboj/19.14.3788; Ishino T, 2000, GENES CELLS, V5, P953, DOI 10.1046/j.1365-2443.2000.00382.x; Ito K, 2002, MOL CELL, V9, P1263, DOI 10.1016/S1097-2765(02)00547-6; Janosi L, 2000, J MOL BIOL, V295, P815, DOI 10.1006/jmbi.1999.3401; Janosi L, 1996, BIOCHIMIE, V78, P959, DOI 10.1016/S0300-9084(97)86718-1; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Janosi L, 1996, ADV BIOPHYS, V32, P121, DOI 10.1016/0065-227X(96)84743-5; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Joseph S, 1997, SCIENCE, V278, P1093, DOI 10.1126/science.278.5340.1093; Kaji A, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P527; Kaji A, 2001, COLD SPRING HARB SYM, V66, P515, DOI 10.1101/sqb.2001.66.515; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Kim KK, 2000, EMBO J, V19, P2362, DOI 10.1093/emboj/19.10.2362; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lancaster L, 2000, RNA, V6, P717, DOI 10.1017/S1355838200000303; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOAZED D, 1995, J MOL BIOL, V248, P207, DOI 10.1016/S0022-2836(95)80042-5; Nakamura Y, 2000, CELL, V101, P349, DOI 10.1016/S0092-8674(00)80845-4; Nissen P, 2000, EMBO J, V19, P489, DOI 10.1093/emboj/19.4.489; Noller HF, 2001, COLD SPRING HARB SYM, V66, P57, DOI 10.1101/sqb.2001.66.57; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; OGAWA K, 1975, EUR J BIOCHEM, V58, P411, DOI 10.1111/j.1432-1033.1975.tb02388.x; Pavlov MY, 1997, J MOL BIOL, V273, P389, DOI 10.1006/jmbi.1997.1324; Poole E, 2000, BBA-GENE STRUCT EXPR, V1493, P1, DOI 10.1016/S0167-4781(00)00162-7; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; ROBERTSON JM, 1981, J MOL BIOL, V151, P57, DOI 10.1016/0022-2836(81)90221-7; Rolland N, 1999, P NATL ACAD SCI USA, V96, P5464, DOI 10.1073/pnas.96.10.5464; RYOJI M, 1981, P NATL ACAD SCI-BIOL, V78, P5973, DOI 10.1073/pnas.78.10.5973; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; SHIMIZU I, 1991, J BACTERIOL, V173, P5181, DOI 10.1128/jb.173.16.5181-5187.1991; STERN S, 1988, METHOD ENZYMOL, V164, P481; Toyoda T, 2000, RNA, V6, P1432, DOI 10.1017/S1355838200001060; Yoshida T, 2001, BIOCHEMISTRY-US, V40, P2387, DOI 10.1021/bi002474g; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	57	100	104	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2002	111	1					129	140		10.1016/S0092-8674(02)00938-8	http://dx.doi.org/10.1016/S0092-8674(02)00938-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372306	Bronze			2022-12-24	WOS:000178461900014
J	Zhang, X; Tamaru, H; Khan, SI; Horton, JR; Keefe, LJ; Selker, EU; Cheng, XD				Zhang, X; Tamaru, H; Khan, SI; Horton, JR; Keefe, LJ; Selker, EU; Cheng, XD			Structure of the neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase	CELL			English	Article							HP1 CHROMO DOMAIN; CRYSTAL-STRUCTURE; METHYLATION; DNA; INSIGHTS; SITE	AdoMet-dependent methylation of histones is part of the "histone code" that can profoundly influence gene expression. We describe the crystal structure of Neurospora DIM-5, a histone H3 lysine 9 methyltranferase (HKMT), determined at 1.98 Angstrom resolution, as well as results of biochemical characterization and site-directed mutagenesis of key residues. This SET domain protein bears no structural similarity to previously characterized AdoMet-dependent methyltransferases but includes notable features such as a triangular Zn(3)Cys(9) zinc cluster in the pre-SET domain and a AdoMet binding site in the SET domain essential for methyl transfer. The structure suggests a mechanism for the methylation reaction and provides the structural basis for functional characterization of the HKMT family and the SET domain.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Argonne Natl Lab, Adv Photon Source IMCA CAT, Argonne, IL 60439 USA	Emory University; University of Oregon; United States Department of Energy (DOE); Argonne National Laboratory	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.		Horton, John/F-2375-2010; Hu, Ruogu/B-2203-2008; ID, IMCACAT/D-5867-2014; Horton, John R/ABB-4770-2020	Horton, John/0000-0001-9749-8068	NIGMS NIH HHS [R01 GM035690, R01 GM049245, R37 GM035690, R01 GM061355, R01 GM061355-03, GM49245, GM61355, GM35690] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061355, R01GM049245, R37GM035690, R01GM035690] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Blumenthal RM, 2001, NAT STRUCT BIOL, V8, P101, DOI 10.1038/84072; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; DUERRE JA, 1975, J BIOL CHEM, V250, P8457; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; ROBBINS AH, 1991, J MOL BIOL, V221, P1269, DOI 10.1016/0022-2836(91)90933-W; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	54	193	203	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 4	2002	111	1					117	127		10.1016/S0092-8674(02)00999-6	http://dx.doi.org/10.1016/S0092-8674(02)00999-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372305	Green Accepted, Bronze			2022-12-24	WOS:000178461900013
J	Bird, AW; Yu, DY; Pray-Grant, MG; Qiu, QF; Harmon, KE; Megee, PC; Grant, PA; Smith, MM; Christman, MF				Bird, AW; Yu, DY; Pray-Grant, MG; Qiu, QF; Harmon, KE; Megee, PC; Grant, PA; Smith, MM; Christman, MF			Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ACETYLTRANSFERASE HBO1; NUCLEOSOMAL DNA; YEAST; PROTEIN; COMPLEX; TRANSCRIPTION; RECOMBINATION; REPLICATION; INVOLVEMENT	Although the acetylation of histones has a well-documented regulatory role in transcription(1-4), its role in other chromosomal functions remains largely unexplored. Here we show that distinct patterns of histone H4 acetylation are essential in two separate pathways of double-strand break repair. A budding yeast strain with mutations in wild-type H4 acetylation sites shows defects in nonhomologous end joining repair and in a newly described pathway of replication-coupled repair. Both pathways require the ESA1 histone acetyl transferase (HAT), which is responsible for acetylating all H4 tail lysines, including ectopic lysines that restore repair capacity to a mutant H4 tail. Arp4, a protein that binds histone H4 tails and is part of the Esa1-containing NuA4 HAT complex, is recruited specifically to DNA double-strand breaks that are generated in vivo. The purified Esa1-Arp4 HAT complex acetylates linear nucleosomal arrays with far greater efficiency than circular arrays in vitro, indicating that it preferentially acetylates nucleosomes near a break site. Together, our data show that histone tail acetylation is required directly for DNA repair and suggest that a related human HAT complex may function similarly.	Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Boston Univ, Med Ctr, Dept Genet & Genom, Boston, MA 02118 USA	University of Virginia; University of Virginia; Boston University	Christman, MF (corresponding author), Univ Virginia, Dept Microbiol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.			Bird, Alexander/0000-0002-1061-0799; Megee, Paul/0000-0002-9397-2161				ALLFREY VG, 1968, SCIENCE, V159, P314, DOI 10.1126/science.159.3812.314; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; DARPA P, 1990, CANCER RES, V50, P6919; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Owen-Hughes T, 1999, METH MOL B, V119, P319; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599	27	426	438	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2002	419	6905					411	415		10.1038/nature01035	http://dx.doi.org/10.1038/nature01035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353039				2022-12-24	WOS:000178195400050
J	Rollins, NC; Dedicoat, M; Danaviah, S; Page, T; Bishop, K; Kleinschmidt, I; Coovadia, HM; Cassol, SA				Rollins, NC; Dedicoat, M; Danaviah, S; Page, T; Bishop, K; Kleinschmidt, I; Coovadia, HM; Cassol, SA		Child Hlth Grp	Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa	LANCET			English	Article								Simple, robust approaches are needed to monitor prevalence, incidence, and mother-to-child transmission of HIV-1 in rural Africa. We have designed a method that uses antibody and viral RNA testing of dried blood spots obtained from mother-infant pairs attending routine immunisation clinics. In our study, prevalence and incidence of HIV-1 was highest in young women in their late teens and early twenties. In children born to infected mothers, prevalence increased from 14% in infants younger than 6 weeks of age to 24% at 3-6 months. The blood-spot approach is an effective method for surveillance of HIV-1 in women and children, and for early identification of incidence of this infection in women of child-bearing age.	Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; Univ Natal, Dept Paediat & Child Hlth, ZA-4001 Durban, South Africa; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; S African Med Council, Durban, South Africa; Univ Natal, Ctr HIV AIDS Networking, ZA-4001 Durban, South Africa	University of Kwazulu Natal; Liverpool School of Tropical Medicine; University of Liverpool; University of Kwazulu Natal	Cassol, SA (corresponding author), Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa.		Dedicoat, Martin/AFC-7815-2022; Bishop, Karen/G-7073-2015	Bishop, Karen/0000-0003-4935-7708; Green, Taryn Natalie/0000-0001-9527-5960; Dedicoat, Martin/0000-0001-9833-4882				Biggar RJ, 2001, AIDS, V15, P1311, DOI 10.1097/00002030-200107060-00015; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; *REP S AFR DEP HLT, 2000, NAT HIV SYPH SER SUR	5	45	46	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					389	390		10.1016/S0140-6736(02)09599-5	http://dx.doi.org/10.1016/S0140-6736(02)09599-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241784				2022-12-24	WOS:000177255600017
J	Feskanich, D; Willett, W; Colditz, G				Feskanich, D; Willett, W; Colditz, G			Walking and leisure-time activity and risk of hip fracture in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; RANDOMIZED CONTROLLED TRIAL; HORMONE REPLACEMENT THERAPY; PHYSICAL-ACTIVITY; OLDER WOMEN; FALL RISK; BODY-SIZE; EXERCISE; STRENGTH; BALANCE	Context Physical activity can reduce the risk of hip fractures in older women, although the required type and duration of activity have not been determined. Walking is the most common activity among older adults, and evidence suggests that it can increase femoral bone density and reduce fracture risk. Objective To assess the relationship of walking, leisure-time activity, and risk of hip fracture among postmenopausal women. Design, Setting, and Participants Prospective analysis begun in 1986 with 12 years of follow-up in the Nurses' Health Study cohort of registered nurses within 11 US states. A total of 61200 postmenopausal women (aged 40-77 years and 98% white) without diagnosis of cancer, heart disease, stroke, or osteoporosis at baseline. Main Outcome Measures Incident hip fracture resulting from low or moderate trauma, analyzed by intensity and duration of leisure-time activity and by time spent walking, sitting, and standing, measured at baseline and updated throughout follow-up. Results From 1986 to 1998, 415 incident hip fracture cases were identified. After controlling for age, body mass index, use of postmenopausal hormones, smoking, and dietary intakes in proportional hazards models, risk of hip fracture was lowered by 6% (95% confidence interval [CI], 4%-9%; P<.001) for each increase of 3 metabolic equivalent (MET)-hours per week of activity (equivalent to 1 h/wk of walking at an average pace). Active women with at least 24 MET-h/wk had a 55% lower risk of hip fracture (relative risk [RR], 0.45; 95% CI, 0.32-0.63) compared with sedentary women with less than 3 MET-h/wk. Even women with a lower risk of hip fracture due to higher body weight experienced a further reduction in risk with higher levels of activity. Risk of hip fracture decreased linearly with increasing level of activity among women not taking postmenopausal hormones (P<.001), but not among women taking hormones (P=.24). Among women who did no other exercise, walking for at least 4 h/wk was associated with a 41% lower risk of hip fracture (RR, 0.59; 95% CI, 0.37-0.94) compared with less than 1 h/wk. More time spent standing was also independently associated with lower risks. Conclusion Moderate levels of activity, including walking, are associated with substantially lower risk of hip fracture in postmenopausal women.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Feskanich, D (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [CA87969] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P166; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Coupland CAC, 1999, INT J EPIDEMIOL, V28, P241, DOI 10.1093/ije/28.2.241; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; Ensrud KE, 1997, ARCH INTERN MED, V157, P857, DOI 10.1001/archinte.157.8.857; Farahmand BY, 2000, EPIDEMIOLOGY, V11, P214, DOI 10.1097/00001648-200003000-00022; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x; Gregg EW, 1998, ANN INTERN MED, V129, P81, DOI 10.7326/0003-4819-129-2-199807150-00002; Hoidrup S, 2001, AM J EPIDEMIOL, V154, P60, DOI 10.1093/aje/154.1.60; Hoidrup S, 1999, AM J EPIDEMIOL, V150, P1085, DOI 10.1093/oxfordjournals.aje.a009933; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Jette AM, 1999, AM J PUBLIC HEALTH, V89, P66, DOI 10.2105/AJPH.89.1.66; Joakimsen RM, 1997, OSTEOPOROSIS INT, V7, P503, DOI 10.1007/BF02652555; Kelley GA, 1998, AM J PHYS MED REHAB, V77, P76, DOI 10.1097/00002060-199801000-00015; Kerr D, 1996, J BONE MINER RES, V11, P218; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Kohrt WM, 1998, J APPL PHYSIOL, V84, P1506, DOI 10.1152/jappl.1998.84.5.1506; Kohrt WM, 1997, J BONE MINER RES, V12, P1253, DOI 10.1359/jbmr.1997.12.8.1253; KRALL EA, 1994, AM J MED, V96, P20, DOI 10.1016/0002-9343(94)90111-2; LANYON LE, 1996, BONE S1, V18, P37; Layne JE, 1999, MED SCI SPORT EXER, V31, P25, DOI 10.1097/00005768-199901000-00006; LONGCOPE C, 1981, MATURITAS, V3, P215, DOI 10.1016/0378-5122(81)90028-1; Lord SR, 1996, ARCH PHYS MED REHAB, V77, P232, DOI 10.1016/S0003-9993(96)90103-3; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; Margolis KL, 2000, ANN INTERN MED, V133, P123, DOI 10.7326/0003-4819-133-2-200007180-00011; Michaelsson K, 1998, OSTEOPOROSIS INT, V8, P540, DOI 10.1007/s001980050096; NELSON ME, 1991, AM J CLIN NUTR, V53, P1304, DOI 10.1093/ajcn/53.5.1304; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Paganini-Hill A, 1991, Epidemiology, V2, P16; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; PRINCE R, 1995, J BONE MINER RES, V10, P1068, DOI 10.1002/jbmr.5650100711; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.1995.03520410035023; ShumwayCook A, 1997, PHYS THER, V77, P46, DOI 10.1093/ptj/77.1.46; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; Specker BL, 1996, J BONE MINER RES, V11, P1539; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stevens JA, 1997, ANN EPIDEMIOL, V7, P54, DOI 10.1016/S1047-2797(96)00110-X; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208, DOI 10.1111/j.1532-5415.1999.tb05201.x; Weiss M, 1998, CALCIFIED TISSUE INT, V62, P47, DOI 10.1007/s002239900393; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; ZYLSTRA S, 1989, INT J SPORTS MED, V10, P181, DOI 10.1055/s-2007-1024897	49	290	304	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2002	288	18					2300	2306		10.1001/jama.288.18.2300	http://dx.doi.org/10.1001/jama.288.18.2300			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JZ	12425707	Bronze			2022-12-24	WOS:000179186400029
J	Hobbs, MR; Udhayakumar, V; Levesque, MC; Booth, J; Roberts, JM; Tkachuk, AN; Pole, A; Coon, H; Kariuki, S; Nahlen, BL; Mwaikambo, ED; Lal, AL; Granger, DL; Anstey, NM; Weinberg, JB				Hobbs, MR; Udhayakumar, V; Levesque, MC; Booth, J; Roberts, JM; Tkachuk, AN; Pole, A; Coon, H; Kariuki, S; Nahlen, BL; Mwaikambo, ED; Lal, AL; Granger, DL; Anstey, NM; Weinberg, JB			A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children	LANCET			English	Article							TRANSCRIPTIONAL REGULATION; FALCIPARUM-MALARIA; INTERFERON-GAMMA; CEREBRAL MALARIA; DISEASE SEVERITY; SYNTHASE GENE; TRANSMISSION; INDUCTION; GENOME; MICE	Background Nitric oxide (NO) is a mediator of immunity to malaria, and genetic polymorphisms in the promoter of the inducible NO synthase gene (NOS2) could modulate production of NO. We postulated that NOS2 promoter polymorphisms would affect resistance to severe malaria. Methods We assessed genomic DNA from healthy children and from those diagnosed with malaria from Tanzania (n=47 and n=138, respectively) and Kenya (n=1106) for polymorphisms by single-stranded conformational polymorphism (SSCP) analysis and sequencing. We also measured in-vivo NO production in Tanzanian children. Findings We identified a novel single nucleotide polymorphism, -1173 C-->T, in the NOS2 promoter that was significantly associated with protection from symptomatic malaria (odds ratio 0.12, 95% CI 0.03-0.48, p=0.0006) in 179 Tanzanian children, and significantly associated with protection from severe malarial anaemia (adjusted relative risk 0.25, 95% CI 0.09-0.66, p=0.0005) in 1106 Kenyan children studied over 5 years. The risk of parasitaemia was not significantly different in wild-type or -1173 C-->T individuals. -1173 C-->T protection in Tanzanians was independent of the previously recognised NOS2-954 G-->C polymorphism. The (CCTTT)(n) NOS2 polymorphism (Tanzania and Kenya) was not associated with severe malaria outcomes. -1173 C-->T was associated with increased fasting urine and plasma NO metabolite concentrations in Tanzanian children, suggesting that the polymorphism was functional in vivo. Interpretation The NOS2 promoter -1173 C-->T single nucleotide polymorphism is associated with protection against cerebral malaria and severe malarial anaemia. Increased NO production in individuals with the -1173 C-->T polymorphism lends support to a protective role for NO against these syndromes. Targeted interventions to increase NO delivery or production could provide novel preventive and therapeutic strategies against these major causes of mortality in African children.	Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; VA Med Ctr, Salt Lake City, UT USA; Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA USA; VA & Duke Univ Med Ctr, Dept Med, Durham, NC USA; Univ Utah, Dept Psychiat, Salt Lake City, UT USA; WHO, Rollback Malaria Program, CH-1211 Geneva, Switzerland; Hubert Kairuki Mem Univ, Dept Paediat & Child Hlth, Dar Es Salaam, Tanzania; Menzies Sch Hlth Res, Div Infect Dis, Darwin, NT, Australia; Flinders Univ No Terr Clin Sch, Darwin, NT, Australia	Utah System of Higher Education; University of Utah; Centers for Disease Control & Prevention - USA; Duke University; Utah System of Higher Education; University of Utah; World Health Organization; Charles Darwin University; Menzies School of Health Research; Flinders University South Australia	Weinberg, JB (corresponding author), VA & Duke Med Ctr, 508 Fulton St, Durham, NC 27705 USA.		Nahlen, Bernard/AAH-2051-2021	Tkachuk, Ariana/0000-0001-8991-9643; Coon, Hilary/0000-0002-8877-5446	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041764, R21AI041764] Funding Source: NIH RePORTER; NCI NIH HHS [5P30CA42014] Funding Source: Medline; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NIAID NIH HHS [R01 AI041764, AI41764] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; ALLEY EW, 1995, GENE, V158, P247, DOI 10.1016/0378-1119(94)00892-V; [Anonymous], 1996, Wkly Epidemiol Rec, V71, P17; Anstey NM, 1997, AM J TROP MED HYG, V57, P187, DOI 10.4269/ajtmh.1997.57.187; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; ANSTEY NM, 1999, NITRIC OXIDE INFECT, P311; Bloland PB, 1999, AM J TROP MED HYG, V60, P635, DOI 10.4269/ajtmh.1999.60.635; Burgner D, 1998, LANCET, V352, P1193, DOI 10.1016/S0140-6736(05)60531-4; Clark I, 2002, CRIT CARE MED, V30, pS263, DOI 10.1097/00003246-200205001-00015; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DE CR, 1995, J CLIN INVEST, V96, P60; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; Kun JFJ, 1998, LANCET, V351, P265, DOI 10.1016/S0140-6736(05)78273-8; Levesque M. C., 2001, Sepsis, V4, P217, DOI 10.1023/A:1012913023602; Levesque MC, 1999, J INFECT DIS, V180, P1994, DOI 10.1086/315140; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Morahan G, 2002, GENES IMMUN, V3, P414, DOI 10.1038/sj.gene.6363909; Ohashi J, 2002, J INFECT DIS, V186, P578, DOI 10.1086/341779; Pance A, 2002, FASEB J, V16, P631, DOI 10.1096/fj.01-0450fje; Perkins DJ, 1999, INFECT IMMUN, V67, P4977, DOI 10.1128/IAI.67.9.4977-4981.1999; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x; Xu WM, 1997, GENE, V204, P165, DOI 10.1016/S0378-1119(97)00538-6; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	35	149	156	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 9	2002	360	9344					1468	1475		10.1016/S0140-6736(02)11474-7	http://dx.doi.org/10.1016/S0140-6736(02)11474-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JV	12433515				2022-12-24	WOS:000179186000012
J	Neff, JC; Townsend, AR; Gleixner, G; Lehman, SJ; Turnbull, J; Bowman, WD				Neff, JC; Townsend, AR; Gleixner, G; Lehman, SJ; Turnbull, J; Bowman, WD			Variable effects of nitrogen additions on the stability and turnover of soil carbon	NATURE			English	Article							LEAF-LITTER DECOMPOSITION; FOREST ECOSYSTEMS; TEMPERATE FOREST; STORAGE; AVAILABILITY; DEPOSITION; DYNAMICS; LIGNIN; CYCLE	Soils contain the largest near-surface reservoir of terrestrial carbon(1) and so knowledge of the factors controlling soil carbon storage and turnover is essential for understanding the changing global carbon cycle. The influence of climate on decomposition of soil carbon has been well documented(2,3), but there remains considerable uncertainty in the potential response of soil carbon dynamics to the rapid global increase in reactive nitrogen (coming largely from agricultural fertilizers and fossil fuel combustion). Here, using C-14, C-13 and compound-specific analyses of soil carbon from long-term nitrogen fertilization plots, we show that nitrogen additions significantly accelerate decomposition of light soil carbon fractions (with decadal turnover times) while further stabilizing soil carbon compounds in heavier, mineral-associated fractions (with multidecadal to century lifetimes). Despite these changes in the dynamics of different soil pools, we observed no significant changes in bulk soil carbon, highlighting a limitation inherent to the still widely used single-pool approach to investigating soil carbon responses to changing environmental conditions. It remains to be seen if the effects observed here-caused by relatively high, short-term fertilizer additions-are similar to those arising from lower, long-term additions of nitrogen to natural ecosystems from atmospheric deposition, but our results suggest nonetheless that current models of terrestrial carbon cycling do not contain the mechanisms needed to capture the complex relationship between nitrogen availability and soil carbon storage.	US Geol Survey, Denver Fed Ctr, Geol Div, Earth Surface Proc Team, Denver, CO 80225 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Max Planck Inst Biogeochem, Jena, Germany	United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder; Max Planck Society	Neff, JC (corresponding author), US Geol Survey, Denver Fed Ctr, Geol Div, Earth Surface Proc Team, MS 980, Denver, CO 80225 USA.		Townsend, Alan/AAE-9602-2019; Neff, Jason/A-1211-2012; Turnbull, Jocelyn C/E-1426-2016; Gleixner, Gerd/O-4215-2019; Gleixner, Gerd/M-8519-2017	Turnbull, Jocelyn C/0000-0002-0306-9658; Gleixner, Gerd/0000-0002-4616-0953; Gleixner, Gerd/0000-0002-4616-0953; NEFF, JASON/0000-0002-8290-1472				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; BOWMAN WD, 1993, ECOLOGY, V74, P2085, DOI 10.2307/1940854; Burns SF, 1980, ALPINE SOIL DISTRIBU; Epstein HE, 2002, ECOLOGY, V83, P320, DOI 10.1890/0012-9658(2002)083[0320:RPODAP]2.0.CO;2; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Hobbie SE, 2000, ECOSYSTEMS, V3, P484, DOI 10.1007/s100210000042; Kuder T, 1998, ORG GEOCHEM, V29, P1355, DOI 10.1016/S0146-6380(98)00092-8; LEVIN I, 1997, TRENDS COMPENDIUM DA; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Nierop KGJ, 2001, SOIL BIOL BIOCHEM, V33, P755, DOI 10.1016/S0038-0717(00)00223-6; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Schmidt H.-L., 1998, STABLE ISOTOPES INTE, P13; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; TRUMBORE SE, 1993, GLOBAL BIOGEOCHEM CY, V7, P275, DOI 10.1029/93GB00468; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Williams MW, 2001, WATER RESOUR RES, V37, P2569, DOI 10.1029/2001WR000485	25	559	691	48	527	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					915	917		10.1038/nature01136	http://dx.doi.org/10.1038/nature01136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410307				2022-12-24	WOS:000178909700040
J	Putsep, K; Carlsson, G; Boman, HG; Andersson, M				Putsep, K; Carlsson, G; Boman, HG; Andersson, M			Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study	LANCET			English	Article							INFANTILE GENETIC AGRANULOCYTOSIS; ANTIMICROBIAL PEPTIDES; HUMAN NEUTROPHILS; LL-37; CATHELICIDIN; EXPRESSION; DEFENSINS; HCAP-18; FAMILY; ELISA	Background Antibacterial peptices, such as defensins and LL-37, are natural bactericidal components similar in potency to classic antibiotics. These peptices are produced at mucosal linings in the body and the skin, and by leucocytes such as neutrophils and natural killer cells. Patients with morbus Kostmann-a severe congenital neutropenia-are treated by recombinant granulocyte-colony stimulating factor, which restores their levels of neutrophils. Despite this treatment, patients still have recurrent infections and periodontal disease. Our aim was to investigate if defensins and LL-37 are deficient in patients with morbus Kostmann. Methods We studied samples of neutrophils, plasma, and saliva from six patients with congenital neutropenia and 22 healthy controls for presence of antibacterial peptides. Neutrophils were analysed by high-performance liquid chromatography and mass spectrometry for alpha-defensins. All samples were analysed by western blot for cathelin-LL-37 (precursor of LL-37) and LL-37. Neutrophils were also tested for lactoferrin and ability to produce oxidative burst. Findings Neutrophils from patients with morbus Kostmann were deficient in cathelin-LL-37 and had reduced concentrations of alpha-defensins HNP1-3. No cathelin-LL-37 could be detected in plasma and saliva from patients. One patient with morbus Kostmann who had had bone-marrow transplantation had almost normal concentrations of LL-37. Lactoferrin concentrations and oxidative burst were normal in all patients. All patients with morbus Kostmann had severe periodontal disease, apart from the individual who had had a bone-marrow transplant, whose dental status was normal. Interpretation Antibacterial peptides are a vital part of the first line of antibacterial immune defence. Deficiency in saliva LL-37 accords with occurrence of periodontal disease in patients with morbus Kostmann.	Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden; Sunderby Hosp, Lulea, Sweden	Karolinska Institutet; Sunderby Hospital	Andersson, M (corresponding author), Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden.	mats.andersson@mtc.ki.se	Andersson, Mats L/M-9124-2014; Andersson, Mats/A-2903-2008	Andersson, Mats L/0000-0001-7582-8791; 				Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Aprikyan AAG, 2001, CURR OPIN IMMUNOL, V13, P535, DOI 10.1016/S0952-7915(00)00254-5; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Borregaard N, 1997, ANN NY ACAD SCI, V832, P62, DOI 10.1111/j.1749-6632.1997.tb46237.x; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Defraia E, 2001, J Clin Pediatr Dent, V26, P99; Ellwood R, 1997, J CLIN PERIODONTOL, V24, P141, DOI 10.1111/j.1600-051X.1997.tb00482.x; Figueredo CMS, 2000, J CLIN PERIODONTOL, V27, P313, DOI 10.1034/j.1600-051x.2000.027005313.x; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; GUDMUNDSSON GH, 1995, P NATL ACAD SCI USA, V92, P7085, DOI 10.1073/pnas.92.15.7085; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; KOSTMANN R, 1975, ACTA PAEDIATR SCAND, V64, P362, DOI 10.1111/j.1651-2227.1975.tb03847.x; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LOLLIKE K, 1995, LEUKEMIA, V9, P159; Nagaoka I, 1998, J LEUKOCYTE BIOL, V64, P845, DOI 10.1002/jlb.64.6.845; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Raj PA, 2000, BIOCHEM J, V347, P633, DOI 10.1042/0264-6021:3470633; ROESLER J, 1991, EUR J HAEMATOL, V46, P112; Slots J, 2000, PERIODONTOL 2000, V22, P7; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Tanaka D, 2000, ORAL MICROBIOL IMMUN, V15, P226, DOI 10.1034/j.1399-302x.2000.150403.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	28	395	417	3	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2002	360	9340					1144	1149		10.1016/S0140-6736(02)11201-3	http://dx.doi.org/10.1016/S0140-6736(02)11201-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604QF	12387964				2022-12-24	WOS:000178632000016
J	Ghose, GM; Maunsell, JHR				Ghose, GM; Maunsell, JHR			Attentional modulation in visual cortex depends on task timing	NATURE			English	Article							PARIETAL CORTEX; ORIENTING ATTENTION; SELECTIVE ATTENTION; NEURONAL RESPONSES; NEURAL MECHANISMS; TIME PERCEPTION; SINGLE NEURONS; CORTICAL AREAS; SHIFTS; V4	Paying attention to a stimulus selectively increases the ability to process it. For example, when subjects attend to a specific region of a visual scene, their sensitivity to changes at that location increases. A large number of studies describe the behavioural consequences and neurophysiological correlates of attending to spatial locations(1-8). There has, in contrast, been little study of the allocation of attention over time(9,10). Because subjects can anticipate predictable events with great temporal precision(11-15), it seems probable that they might dynamically shift their attention when performing a familiar perceptual task whose constraints changed over time. We trained monkeys to respond to a stimulus change where the probability of occurrence changed over time. Recording from area V4 of the visual cortex in these animals, we found that the modulation of neuronal responses changed according to the probability of the change occurring at that instant. Thus, we show that the attentional modulation of sensory neurons reflects a subject's anticipation of the timing of behaviourally relevant events.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Ghose, GM (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.		Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439; Ghose, Geoffrey/0000-0002-2227-3179				Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 2001, CEREB CORTEX, V11, P592, DOI 10.1093/cercor/11.7.592; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Harrington DL, 1998, J NEUROSCI, V18, P1085; KROSE BJA, 1989, VISION RES, V29, P1607, DOI 10.1016/0042-6989(89)90142-9; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Migliore M, 2001, J NEUROPHYSIOL, V86, P2754, DOI 10.1152/jn.2001.86.6.2754; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; SAARINEN J, 1991, P NATL ACAD SCI USA, V88, P1812, DOI 10.1073/pnas.88.5.1812; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; STEINMETZ MA, 1994, J NEUROPHYSIOL, V72, P1020, DOI 10.1152/jn.1994.72.2.1020; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; Westheimer G, 2000, VISUAL NEUROSCI, V17, P551, DOI 10.1017/S095252380017405X; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96)80057-4, DOI 10.1016/S0166-4115(96)80057-4]	24	211	212	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 10	2002	419	6907					616	620		10.1038/nature01057	http://dx.doi.org/10.1038/nature01057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374979				2022-12-24	WOS:000178483100045
J	Cheung, YB; Khoo, KS; Karlberg, J; Machin, D				Cheung, YB; Khoo, KS; Karlberg, J; Machin, D			Association between psychological symptoms in adults and growth in early life: longitudinal follow up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MALAISE INVENTORY; GESTATIONAL-AGE; BIRTH-WEIGHT; FETAL GROWTH; HYPOTHESIS; ORIGINS; STRESS; COHORT	Objectives 16 test the hypothesis that birth weight for gestational age and weight gain in early childhood have a long term association with psychological distress in adults. Design Longitudinal study of 1958 birth cohort followed to age 42 years. Setting Population based birth cohort study. Participants 9731 cohort members with valid perinatal, postnatal, and adult data. Main outcome measures Malaise inventory scores measured at ages 23, 33, and 42 years. Generalised estimating equations approach used to analyse repeated measures. Results Psychological distress score was inversely related to birthweight z score and weight gain from birth to the age of 7 years. A unit increase in birthweight z score or childhood weight gain was associated with a mean reduction in psychological distress score of 0.10 (95% confidence interval 0.05 to 0.14) and 0.06 (0.02 to 0.10), respectively. Birth weight and weight gain were also inversely related to the odds of having a high level of psychological distress, with odds ratios being 0.90 (0.85 to 0.95) and 0;93 (0.89 to 0.98), respectively. Conclusions Psychological health in adults is related to fetal growth and growth in early childhood.	Natl Canc Ctr, Div Clin Trials & Epidemiol Sci, Singapore 169610, Singapore; Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China; Univ Sheffield, Clin Trial Res Unit, Sheffield S5 7AU, S Yorkshire, England	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); University of Hong Kong; University of Sheffield	Cheung, YB (corresponding author), Natl Canc Ctr, Div Clin Trials & Epidemiol Sci, Singapore 169610, Singapore.	ctecyb@nccs.com.sg	Karlberg, Johan Petter Einar/C-4290-2009; Karlberg, Johan/AAZ-7864-2020					BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cheung YB, 2002, SOC SCI MED, V55, P937, DOI 10.1016/S0277-9536(01)00225-8; Cheung YB, 2001, J CLIN EPIDEMIOL, V54, P1238, DOI 10.1016/S0895-4356(01)00403-6; Cheung YB, 2000, HYPERTENSION, V36, P795, DOI 10.1161/01.HYP.36.5.795; Cianfarani S, 1999, ARCH DIS CHILD-FETAL, V81, pF71, DOI 10.1136/fn.81.1.F71; Fayers P., 2007, QUALITY LIFE ASSESSM; FAYERS PM, 2000, BIOMETRIKA; FERRI E, 1993, LIFE 33 5 FOLLOW NAT; GRANT G, 1990, SOC PSYCH PSYCH EPID, V25, P170; HIRST MA, 1983, J PSYCHOSOM RES, V27, P193, DOI 10.1016/0022-3999(83)90022-3; LAGERSTROM M, 1994, INT J PSYCHOPHYSIOL, V17, P175, DOI 10.1016/0167-8760(94)90033-7; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Nilsson PM, 2001, INT J EPIDEMIOL, V30, P75, DOI 10.1093/ije/30.1.75; Power C., 1991, HLTH CLASS EARLY YEA; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; RUTTER M, 1970, EDUC HLTH BEHAV; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625	19	63	63	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2002	325	7367					749	751		10.1136/bmj.325.7367.749	http://dx.doi.org/10.1136/bmj.325.7367.749			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603AU	12364303	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000178537300017
J	Hamer, D				Hamer, D			Rethinking behavior genetics	SCIENCE			English	Editorial Material							MONOAMINE-OXIDASE; POLYMORPHISM; RISK		NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hamer, D (corresponding author), NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA.							Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Copeland P., 1998, LIVING OUR GENES; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Murphy DL, 2001, BRAIN RES BULL, V56, P487, DOI 10.1016/S0361-9230(01)00622-0; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	12	107	113	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2002	298	5591					71	72		10.1126/science.1077582	http://dx.doi.org/10.1126/science.1077582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364769	Green Submitted			2022-12-24	WOS:000178370500028
J	Holt, RA; Subramanian, GM; Halpern, A; Sutton, GG; Charlab, R; Nusskern, DR; Wincker, P; Clark, AG; Ribeiro, JMC; Wides, R; Salzberg, SL; Loftus, B; Yandell, M; Majoros, WH; Rusch, DB; Lai, ZW; Kraft, CL; Abril, JF; Anthouard, V; Arensburger, P; Atkinson, PW; Baden, H; de Berardinis, V; Baldwin, D; Benes, V; Biedler, J; Blass, C; Bolanos, R; Boscus, D; Barnstead, M; Cai, S; Center, A; Chatuverdi, K; Christophides, GK; Chrystal, MA; Clamp, M; Cravchik, A; Curwen, V; Dana, A; Delcher, A; Dew, I; Evans, CA; Flanigan, M; Grundschober-Freimoser, A; Friedli, L; Gu, ZP; Guan, P; Guigo, R; Hillenmeyer, ME; Hladun, SL; Hogan, JR; Hong, YS; Hoover, J; Jaillon, O; Ke, ZX; Kodira, C; Kokoza, E; Koutsos, A; Letunic, I; Levitsky, A; Liang, Y; Lin, JJ; Lobo, NF; Lopez, JR; Malek, JA; McIntosh, TC; Meister, S; Miller, J; Mobarry, C; Mongin, E; Murphy, SD; O'Brochta, DA; Pfannkoch, C; Qi, R; Regier, MA; Remington, K; Shao, HG; Sharakhova, MV; Sitter, CD; Shetty, J; Smith, TJ; Strong, R; Sun, JT; Thomasova, D; Ton, LQ; Topalis, P; Tu, ZJ; Unger, MF; Walenz, B; Wang, AH; Wang, J; Wang, M; Wang, XL; Woodford, KJ; Wortman, JR; Wu, M; Yao, A; Zdobnov, EM; Zhang, HY; Zhao, Q; Zhao, SY; Zhu, SPC; Zhimulev, I; Coluzzi, M; della Torre, A; Roth, CW; Louis, C; Kalush, F; Mural, RJ; Myers, EW; Adams, MD; Smith, HO; Broder, S; Gardner, MJ; Fraser, CM; Birney, E; Bork, P; Brey, PT; Venter, JC; Weissenbach, J; Kafatos, FC; Collins, FH; Hoffman, SL				Holt, RA; Subramanian, GM; Halpern, A; Sutton, GG; Charlab, R; Nusskern, DR; Wincker, P; Clark, AG; Ribeiro, JMC; Wides, R; Salzberg, SL; Loftus, B; Yandell, M; Majoros, WH; Rusch, DB; Lai, ZW; Kraft, CL; Abril, JF; Anthouard, V; Arensburger, P; Atkinson, PW; Baden, H; de Berardinis, V; Baldwin, D; Benes, V; Biedler, J; Blass, C; Bolanos, R; Boscus, D; Barnstead, M; Cai, S; Center, A; Chatuverdi, K; Christophides, GK; Chrystal, MA; Clamp, M; Cravchik, A; Curwen, V; Dana, A; Delcher, A; Dew, I; Evans, CA; Flanigan, M; Grundschober-Freimoser, A; Friedli, L; Gu, ZP; Guan, P; Guigo, R; Hillenmeyer, ME; Hladun, SL; Hogan, JR; Hong, YS; Hoover, J; Jaillon, O; Ke, ZX; Kodira, C; Kokoza, E; Koutsos, A; Letunic, I; Levitsky, A; Liang, Y; Lin, JJ; Lobo, NF; Lopez, JR; Malek, JA; McIntosh, TC; Meister, S; Miller, J; Mobarry, C; Mongin, E; Murphy, SD; O'Brochta, DA; Pfannkoch, C; Qi, R; Regier, MA; Remington, K; Shao, HG; Sharakhova, MV; Sitter, CD; Shetty, J; Smith, TJ; Strong, R; Sun, JT; Thomasova, D; Ton, LQ; Topalis, P; Tu, ZJ; Unger, MF; Walenz, B; Wang, AH; Wang, J; Wang, M; Wang, XL; Woodford, KJ; Wortman, JR; Wu, M; Yao, A; Zdobnov, EM; Zhang, HY; Zhao, Q; Zhao, SY; Zhu, SPC; Zhimulev, I; Coluzzi, M; della Torre, A; Roth, CW; Louis, C; Kalush, F; Mural, RJ; Myers, EW; Adams, MD; Smith, HO; Broder, S; Gardner, MJ; Fraser, CM; Birney, E; Bork, P; Brey, PT; Venter, JC; Weissenbach, J; Kafatos, FC; Collins, FH; Hoffman, SL			The genome sequence of the malaria mosquito Anopheles gambiae	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; INCIPIENT SPECIATION; FAMILIES; LOCI; DIFFERENTIATION; REFRACTORINESS; IDENTIFICATION; RESISTANCE; EVOLUTION	Anopheles gambiae is the principal vector of malaria, a disease that afflicts more than 500 million people and causes more than 1 million deaths each year. Tenfold shotgun sequence coverage was obtained from the PEST strain of A. gambiae and assembled into scaffolds that span 278 million base pairs. A total of 91% of the genome was organized in 303 scaffolds; the largest scaffold was 23.1 million base pairs. There was substantial genetic variation within this strain, and the apparent existence of two haplotypes of approximately equal frequency ("dual haplotypes") in a substantial fraction of the genome likely reflects the outbred nature of the PEST strain. The sequence produced a conservative inference of more than 400,000 single-nucleotide polymorphisms that showed a markedly bimodal density distribution. Analysis of the genome sequence revealed strong evidence for about 14,000 protein-encoding transcripts. Prominent expansions in specific families of proteins likely involved in cell adhesion and immunity were noted. An expressed sequence tag analysis of genes regulated by blood feeding provided insights into the physiological adaptations of a hematophagous insect.	Celera Genom, Rockville, MD 20850 USA; Genoscope Ctr Natl Sequencage, F-91057 Evry 06, France; CNRS, UMR 8030, F-91057 Evry 06, France; Cornell Univ, Ithaca, NY 14853 USA; NIAID, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; Inst Genom Res TIGR, Rockville, MD 20850 USA; CRG, UPF, IMIM, Grp Recerca Informat Biomed, Barcelona, Catalonia, Spain; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; Univ Notre Dame, Ctr Trop Dis Res & Training, Notre Dame, IN 46556 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Maryland, Inst Biotechnol, Agr Biotechnol Ctr, College Pk, MD 20742 USA; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece; Univ Crete, Dept Biol, GR-71110 Iraklion, Crete, Greece; European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, I-00185 Rome, Italy; Inst Pasteur, Unite Biochim & Biol Mol Insectes, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Bar Ilan University; J. Craig Venter Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of California System; University of California Riverside; European Molecular Biology Laboratory (EMBL); Virginia Polytechnic Institute & State University; University of Notre Dame; Wellcome Trust Sanger Institute; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Foundation for Research & Technology - Hellas (FORTH); University of Crete; European Molecular Biology Laboratory (EMBL); Sapienza University Rome; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Holt, RA (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Room 3427,600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	rholt@bcgsc.ca; frank.h.collins.75@nd.edu	Louis, Christos/F-2527-2012; Zdobnov, Evgeny/AAB-2745-2022; Meister, Stephan/M-6608-2014; Ferrando, Josep F Abril/B-3877-2014; Letunic, Ivica/K-1102-2019; Gasull, Martina/J-4076-2019; Letunic, Ivica/A-6032-2009; Salzberg, Steven/Q-6514-2019; Zdobnov, Evgeny M/K-1133-2012; Holt, Robert A/C-3303-2009; Bork, Peer/F-1813-2013; Kokoza, E l e n a/N-8507-2015; Jaillon, Olivier/GRY-6287-2022; Zhimulev, Igor F/N-7978-2015; Guigo, Roderic/D-1303-2010; Salzberg, Steven L/F-6162-2011	Zdobnov, Evgeny/0000-0002-5178-1498; Meister, Stephan/0000-0003-2436-7037; Ferrando, Josep F Abril/0000-0001-7793-589X; Letunic, Ivica/0000-0003-3560-4288; Salzberg, Steven/0000-0002-8859-7432; Holt, Robert A/0000-0002-7259-1247; Bork, Peer/0000-0002-2627-833X; Guigo, Roderic/0000-0002-5738-4477; Salzberg, Steven L/0000-0002-8859-7432; Wu, Martin/0000-0003-3093-4077; Zhimulev, Igor/0000-0002-6220-3028; de Berardinis, Veronique/0000-0002-3273-4135; Wortman, Jennifer/0000-0002-8713-1227; loftus, brendan/0000-0001-8871-8356; Jaillon, Olivier/0000-0002-7237-9596; Birney, Ewan/0000-0001-8314-8497; Miller, Jason/0000-0002-6912-2925; Ribeiro, Jose/0000-0002-9107-0818; Clark, Andrew/0000-0001-7159-8511; Benes, Vladimir/0000-0002-0352-2547; Christophides, George/0000-0002-3323-1687; Fraser, Claire/0000-0003-1462-2428	NIAID NIH HHS [U01AI50687, U01AI48846, R01AI44273] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000810, R01AI044273, ZIAAI000810, U01AI048846, U01AI050687] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abril JF, 2000, BIOINFORMATICS, V16, P743, DOI 10.1093/bioinformatics/16.8.743; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; AQUADRO CF, 1991, P NATL ACAD SCI USA, V88, P305, DOI 10.1073/pnas.88.1.305; ASHBURNER M, 1989, DROSOPHILA LAB HDB, P74; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; BESANSKY NJ, 1992, J MED ENTOMOL, V29, P125, DOI 10.1093/jmedent/29.1.125; Breman JG, 2001, AM J TROP MED HYG, V64, P1; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clements A. N., 1992, BIOL MOSQUITOES, V1; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; COLLINS FS, UNPUB; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Comeron JM, 2001, CURR OPIN GENET DEV, V11, P652, DOI 10.1016/S0959-437X(00)00249-5; Cornel AJ, 2000, J HERED, V91, P364, DOI 10.1093/jhered/91.5.364; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; MASON GF, 1967, GENET RES, V10, P205, DOI 10.1017/S001667230001096X; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Mukabayire O, 1996, CHROMOSOMA, V104, P585, DOI 10.1007/BF00352298; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SALZBERG SL, UNPUB; Thomasova D, 2002, P NATL ACAD SCI USA, V99, P8179, DOI 10.1073/pnas.082235599; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Yeates DK, 1999, ANNU REV ENTOMOL, V44, P397, DOI 10.1146/annurev.ento.44.1.397; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao SY, 2001, GENOME RES, V11, P1736, DOI 10.1101/gr.179201; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	52	1547	1895	5	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					129	+		10.1126/science.1076181	http://dx.doi.org/10.1126/science.1076181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364791				2022-12-24	WOS:000178370500048
J	Engert, F; Tao, HZW; Zhang, LI; Poo, MM				Engert, F; Tao, HZW; Zhang, LI; Poo, MM			Moving visual stimuli rapidly induce direction sensitivity of developing tectal neurons	NATURE			English	Article							LONG-TERM POTENTIATION; DEVELOPING RETINOTECTAL SYNAPSES; STROBOSCOPIC ILLUMINATION; RECEPTIVE-FIELDS; CORTEX; CIRCUITS; MAP; COMPETITION; PLASTICITY; XENOPUS	During development of the visual system, the pattern of visual inputs may have an instructive role in refining developing neural circuits(1-4). How visual inputs of specific spatiotemporal patterns shape the circuit development remains largely unknown. We report here that, in the developing Xenopus retinotectal system, the receptive field of tectal neurons can be 'trained' to become direction-sensitive within minutes after repetitive exposure of the retina to moving bars in a particular direction. The induction of direction-sensitivity depends on the speed of the moving bar, can not be induced by random visual stimuli, and is accompanied by an asymmetric modification of the tectal neuron's receptive field. Furthermore, such training-induced changes require spiking of the tectal neuron and activation of a NMDA (N-methyl-D-aspartate) subtype of glutamate receptors during training, and are attributable to an activity-induced enhancement of glutamate-mediated inputs. Thus, developing neural circuits can be modified rapidly and specifically by visual inputs of defined spatiotemporal patterns, in a manner consistent with predictions based on spike-time-dependent synaptic modification.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu	Tao, Huizhong W/HDM-9767-2022					Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boettiger CA, 2001, NEURON, V31, P809, DOI 10.1016/S0896-6273(01)00403-2; CYNADER M, 1973, P NATL ACAD SCI USA, V70, P1353, DOI 10.1073/pnas.70.5.1353; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rao RPN, 2001, NOVART FDN SYMP, V239, P208; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; SCHMIDT JT, 1985, NEUROSCIENCE, V14, P535, DOI 10.1016/0306-4522(85)90308-2; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; ZANKER JM, 2000, MOTION VISION COMPUT; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	30	109	109	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					470	475		10.1038/nature00988	http://dx.doi.org/10.1038/nature00988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368854				2022-12-24	WOS:000178348400035
J	Jorgensen, CM				Jorgensen, CM			Scientific recommendations and human behaviour: sitting out in the sun	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Commun & Behav Sci Branch, Div Canc Prevent & Control, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Jorgensen, CM (corresponding author), Ctr Dis Control & Prevent, Commun & Behav Sci Branch, Div Canc Prevent & Control, Atlanta, GA 30333 USA.							AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bandura A, 1995, SELF EFFICACY CHANGI, DOI DOI 10.1017/CBO9780511527692; Geller AC, 2002, PEDIATRICS, V109, P1009, DOI 10.1542/peds.109.6.1009; GLANZ K, 1997, HLTH BEHAV HLTH ED T; HALLI, 2002, PUBLIC HLTH REP, V116, P353; Severi G, 2002, EUR J CANCER, V38, P820, DOI 10.1016/S0959-8049(02)00015-1; Simons-Morton B.G., 1995, INTRO HLTH ED HLTH P	7	6	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					351	352		10.1016/S0140-6736(02)09601-0	http://dx.doi.org/10.1016/S0140-6736(02)09601-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241770				2022-12-24	WOS:000177255600003
J	Shore, B				Shore, B			Grace notes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2002	288	18					2231	2231		10.1001/jama.288.18.2231	http://dx.doi.org/10.1001/jama.288.18.2231			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JZ	12425682				2022-12-24	WOS:000179186400001
J	Tauchi, H; Kobayashi, J; Morishima, K; van Gent, DC; Shiraishi, T; Verkaik, NS; vanHeems, D; Ito, E; Nakamura, A; Sonodo, E; Takata, M; Takeda, S; Matsuura, S; Komatsu, K				Tauchi, H; Kobayashi, J; Morishima, K; van Gent, DC; Shiraishi, T; Verkaik, NS; vanHeems, D; Ito, E; Nakamura, A; Sonodo, E; Takata, M; Takeda, S; Matsuura, S; Komatsu, K			Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells	NATURE			English	Article							STRAND BREAK REPAIR; GENE CONVERSION; HUMAN MRE11; COMPLEX; PROTEIN; YEAST; INTEGRATION; CLONING; ROLES	Double-strand breaks occur during DNA replication and are also induced by ionizing radiation. There are at least two pathways which can repair such breaks: non-homologous end joining and homologous recombination (HR). Although these pathways are essentially independent of one another, it is possible that the proteins Mre11, Rad50 and Xrs2 are involved in both pathways in Saccharomyces cerevisiae(1). In vertebrate cells, little is known about the exact function of the Mre11-Rad50-Nbs1 complex in the repair of double-strand breaks because Mre11-andRad50-null mutations are lethal(2). Here we show that Nbs1 is essential for HR-mediated repair in higher vertebrate cells. The disruption of Nbs1 reduces gene conversion and sister chromatid exchanges, similar to other HR-deficient mutants(3). In fact, a site-specific double-strand break repair assay showed a notable reduction of HR events following generation of such breaks in Nbs1-disrupted cells. The rare recombinants observed in the Nbs1-disrupted cells were frequently found to have aberrant structures, which possibly arise from unusual crossover events, suggesting that the Nbs1 complex might be required to process recombination intermediates.	Ibaraki Univ, Fac Sci, Dept Environm Sci, Mito, Ibaraki 3108512, Japan; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Biol, Minami Ku, Hiroshima 7348553, Japan; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Kyoto Univ, Fac Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Radiat Biol Res Ctr, Sakyo Ku, Kyoto 6068501, Japan; Kawasaki Med Sch, Okayama 7010192, Japan	Ibaraki University; Hiroshima University; Erasmus University Rotterdam; Kyoto University; Kyoto University; Kawasaki Medical School	Tauchi, H (corresponding author), Ibaraki Univ, Fac Sci, Dept Environm Sci, Bunkyo 2-1-1, Mito, Ibaraki 3108512, Japan.	htauchi@mx.ibaraki.ac.jp; komatsu@house.rbc.kyoto-u.ac.jp	Matsuura, Shinya/U-4182-2017; Kobayashi, Junya/AAX-6390-2021	Matsuura, Shinya/0000-0001-5294-081X; Kobayashi, Junya/0000-0003-4645-7500; Takata, Minoru/0000-0002-4926-3675; van Gent, Dik C./0000-0003-1473-8148; Tauchi, Hiroshi/0000-0003-4934-2944				Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Moreau S, 1999, MOL CELL BIOL, V19, P556; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; PETRINI JHJ, 1995, GENOMICS, V29, P80, DOI 10.1006/geno.1995.1217; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tauchi H, 2001, J BIOL CHEM, V276, P12, DOI 10.1074/jbc.C000578200; TAVASSOLI M, 1995, NUCLEIC ACIDS RES, V23, P383, DOI 10.1093/nar/23.3.383; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; VERKAIK NS, IN PRESS EUR J IMMUN; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	30	230	237	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2002	420	6911					93	98		10.1038/nature01125	http://dx.doi.org/10.1038/nature01125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422221				2022-12-24	WOS:000179068100043
J	Kuwana, T; Mackey, MR; Perkins, G; Ellisman, MH; Latterich, M; Schneiter, R; Green, DR; Newmeyer, DD				Kuwana, T; Mackey, MR; Perkins, G; Ellisman, MH; Latterich, M; Schneiter, R; Green, DR; Newmeyer, DD			Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane	CELL			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; RAT-LIVER MITOCHONDRIA; BCL-2 FAMILY MEMBER; CELL-FREE APOPTOSIS; CASPASE ACTIVATION; EGG EXTRACTS; CONTACT SITES; ION-CHANNEL; BH3 DOMAIN	Bcl-2 family proteins regulate the release of proteins like cytochrome c from mitochondria during apoptosis. We used cell-free systems and ultimately a vesicular reconstitution from defined molecules to show that outer membrane permeabilization by Bcl-2 family proteins requires neither the mitochondrial matrix, the inner membrane, nor other proteins. Bid, or its BH3-domain peptide, activated monomeric Bax to produce membrane openings that allowed the passage of very large (2 megadalton) dextran molecules, explaining the translocation of large mitochondrial proteins during apoptosis. This process required cardiolipin and was inhibited by antiapoptotic Bcl-x(L). We conclude that mitochondrial protein release in apoptosis can be mediated by supramolecular openings in the outer mitochondrial membrane, promoted by BH3/Bax/lipid interaction and directly inhibited by Bcl-x(L).	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Diversa Corp, San Diego, CA 92121 USA; Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	La Jolla Institute for Immunology; University of California System; University of California San Diego; Graz University of Technology	Newmeyer, DD (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417; Perkins, Guy/0000-0002-1834-6646; Schneiter, Roger/0000-0002-9102-8396	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062289] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NIAID NIH HHS [AI40646] Funding Source: Medline; NIGMS NIH HHS [GM62289, GM50284] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Kroon AIPM, 1999, MOL MEMBR BIOL, V16, P205; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; HOVIUS R, 1993, FEBS LETT, V330, P71, DOI 10.1016/0014-5793(93)80922-H; HUI SW, 1983, CHEM PHYS LIPIDS, V33, P113, DOI 10.1016/0009-3084(83)90015-4; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KAN FWK, 1993, J HISTOCHEM CYTOCHEM, V41, P649, DOI 10.1177/41.5.8468446; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Mayer A, 1995, METHOD ENZYMOL, V260, P252, DOI 10.1016/0076-6879(95)60143-0; MAYER A, 1993, J CELL BIOL, V121, P1233, DOI 10.1083/jcb.121.6.1233; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Polster BM, 2001, J BIOL CHEM, V276, P37887; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 1996, ONCOGENE, V13, P21; SIEGEL DP, 1984, BIOPHYS J, V45, P399, DOI 10.1016/S0006-3495(84)84164-8; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; SMAAL EB, 1987, BIOCHIM BIOPHYS ACTA, V897, P191, DOI 10.1016/0005-2736(87)90327-0; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; von Ahsen O, 2000, METHOD ENZYMOL, V322, P183; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; Zhai DY, 2001, EUR J BIOCHEM, V268, P48, DOI 10.1046/j.1432-1327.2001.01841.x; Zhai DY, 2000, FEBS LETT, V472, P293, DOI 10.1016/S0014-5793(00)01471-X; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	63	1173	1242	4	69	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					331	342		10.1016/S0092-8674(02)01036-X	http://dx.doi.org/10.1016/S0092-8674(02)01036-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419244	Green Published, Bronze			2022-12-24	WOS:000179010100006
J	Faili, A; Aoufouchi, S; Flatter, E; Gueranger, Q; Reynaud, CA; Weill, JC				Faili, A; Aoufouchi, S; Flatter, E; Gueranger, Q; Reynaud, CA; Weill, JC			Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota	NATURE			English	Article							CYTIDINE DEAMINASE AID; POL-IOTA; IG; ETA; DEFICIENCY; MUTATION; RNA	Somatic hypermutation of immunoglobulin genes is a unique, targeted, adaptive process. While B cells are engaged in germinal centres in T-dependent responses, single base substitutions are introduced in the expressed V-H/V-L genes to allow the selection of mutants with a higher affinity for the immunizing antigen. Almost every possible DNA transaction has been proposed to explain this process, but each of these models includes an error-prone DNA synthesis step that introduces the mutations(1,2). The Y family of DNA polymerases(3)-pol eta, pol iota, pol kappa and rev1-are specialized for copying DNA lesions and have high rates of error when copying a normal DNA template(4,5). By performing gene inactivation in a Burkitt's lymphoma cell line inducible for hypermutation, we show here that somatic hypermutation is dependent on DNA polymerase iota.	Hop Necker Enfants Malad, INSERM, U373, F-75730 Paris 15, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Weill, JC (corresponding author), Hop Necker Enfants Malad, INSERM, U373, 156 Rue Vaugirard, F-75730 Paris 15, France.	weill@necker.fr	Aoufouchi, Said/I-2985-2016; AOUFOUCHI, Said/P-9926-2019	AOUFOUCHI, Said/0000-0001-6547-2664; Gueranger, Quentin/0000-0002-9507-8315; Flatter, Eric/0000-0001-6812-5887				Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Dorner T, 1998, IMMUNOL REV, V162, P161, DOI 10.1111/j.1600-065X.1998.tb01439.x; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; MITTRUCKER HW, 1993, INT IMMUNOL, V5, P985, DOI 10.1093/intimm/5.8.985; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Poltoratsky V, 2001, P NATL ACAD SCI USA, V98, P7976, DOI 10.1073/pnas.141222198; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Tissier A, 2000, GENE DEV, V14, P1642; Weill JC, 2002, ADV IMMUNOL, V80, P183, DOI 10.1016/S0065-2776(02)80015-3; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang T, 2001, INT IMMUNOL, V13, P975, DOI 10.1093/intimm/13.8.975	29	165	173	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					944	947		10.1038/nature01117	http://dx.doi.org/10.1038/nature01117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410315				2022-12-24	WOS:000178909700048
J	Syntichaki, P; Xu, KL; Driscoll, M; Tavernarakis, N				Syntichaki, P; Xu, KL; Driscoll, M; Tavernarakis, N			Specific aspartyl and calpain proteases are required for neurodegeneration in C-elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; DOUBLE-STRANDED-RNA; CELL-DEATH; GENETIC INTERFERENCE; FAMILY; IDENTIFICATION; CATHEPSIN; SUBUNIT; ENCODES; MEMBER	Necrotic cell death underlies the pathology of numerous human neurodegenerative conditions(1). In the nematode Caenorhabditis elegans, gain-of-function mutations in specific ion channel genes such as the degenerin genes deg-1 and mec-4, the acetylcholine receptor channel subunit gene deg-3 and the G(s) protein alpha-subunit gene gsa-1 evoke an analogous pattern of degenerative (necrotic-like) cell death in neurons that express the mutant proteins(2-6). An increase in concentrations of cytoplasmic calcium in dying cells, elicited either by extracellular calcium influx or by release of endoplasmic reticulum stores, is thought to comprise a major death-signalling event(7,8). But the biochemical mechanisms by which calcium triggers cellular demise remain largely unknown. Here we report that neuronal degeneration inflicted by various genetic lesions in C. elegans requires the activity of the calcium-regulated CLP-1 and TRA-3 calpain proteases and aspartyl proteases ASP-3 and ASP-4. Our findings show that two distinct classes of proteases are involved in necrotic cell death and suggest that perturbation of intracellular concentrations of calcium may initiate neuronal degeneration by deregulating proteolysis. Similar proteases may mediate necrotic cell death in humans.	Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Syntichaki, Popi/ABA-7218-2020	Tavernarakis, Nektarios/0000-0002-5253-1466; Syntichaki, Popi/0000-0001-9536-8905				Adamec E, 2000, NEUROSCIENCE, V100, P663, DOI 10.1016/S0306-4522(00)00281-5; Barger AJ, 1998, J NEUROSCI, V18, P2871; BARNES W, 1996, AUSTR J EMERGENCY CA, V3, P15; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall DH, 1997, J NEUROSCI, V17, P1033; HAWDON JM, 1989, BIOCHEM J, V264, P161, DOI 10.1042/bj2640161; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; JACOBSON LA, 1988, GENETICS, V119, P355; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Korswagen HC, 1997, GENE DEV, V11, P1493, DOI 10.1101/gad.11.12.1493; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Rogalski TM, 2001, BIOCHEM SOC T, V29, P171, DOI 10.1042/BST0290171; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Sokol SB, 2000, GENE DEV, V14, P901; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Stracher A, 1999, ANN NY ACAD SCI, V884, P52, DOI 10.1111/j.1749-6632.1999.tb08635.x; Syntichaki P, 2002, EMBO REP, V3, P604, DOI 10.1093/embo-reports/kvf138; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X	30	228	258	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2002	419	6910					939	944		10.1038/nature01108	http://dx.doi.org/10.1038/nature01108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410314				2022-12-24	WOS:000178909700047
J	Cheeseman, LM; Anderson, S; Jwa, M; Green, EM; Kang, JS; Yates, JR; Chan, CSM; Drubin, DG; Barnes, G				Cheeseman, LM; Anderson, S; Jwa, M; Green, EM; Kang, JS; Yates, JR; Chan, CSM; Drubin, DG; Barnes, G			Phospho-regulation of kinetochore-microtubule attachments by the aurora kinase Ipl1p	CELL			English	Article							YEAST CHROMOSOME SEGREGATION; TYPE-1 PROTEIN PHOSPHATASE; MITOTIC SPINDLE INTEGRITY; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; DUO1P/DAM1P COMPLEX; OUTER KINETOCHORE; MITOSIS; CENTROMERE; DAM1P	The Aurora kinase lpL1p plays a crucial role in regulating kinetochore-microtubule attachments in budding yeast, but the underlying basis for this regulation is not known. To identify IpI1p targets, we first purified 28 kinetochore proteins from yeast protein extracts. These studies identified five previously uncharacterized kinetochore proteins and defined two additional kinetochore subcomplexes. We then used mass spectrometry to identify 18 phosphorylation sites in 7 of these 28 proteins. Ten of these phosphorylation sites are targeted directly by lpL1p, allowing us to identify a consensus phosphorylation site for an Aurora kinase. Our systematic mutational analysis of the IpI1p phosphorylation sites demonstrated that the essential microtubule binding protein Dam1p is a key IpI1p target for regulating kinetochore-microtubule attachments in vivo.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Texas, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of California System; University of California Berkeley; Scripps Research Institute; University of Texas System; University of Texas Austin	Barnes, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	gbarnes@socrates.berkeley.edu	Green, Erin/J-6098-2019	Cheeseman, Iain/0000-0002-3829-5612; Green, Erin/0000-0003-3923-6726	NCRR NIH HHS [P41 RR11823] Funding Source: Medline; NIGMS NIH HHS [GM-47842, GM-45185] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM047842, R01GM045185, R01GM047842] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2000, J CELL SCI, V113, P507; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Ghosh SK, 2001, MOL GENET GENOMICS, V265, P249, DOI 10.1007/s004380000408; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Hofmann C, 1998, J CELL BIOL, V143, P1029, DOI 10.1083/jcb.143.4.1029; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Jones MH, 2001, P NATL ACAD SCI USA, V98, P13675, DOI 10.1073/pnas.241417098; Jones MH, 1999, MOL BIOL CELL, V10, P2377, DOI 10.1091/mbc.10.7.2377; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	39	497	529	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2002	111	2					163	172		10.1016/S0092-8674(02)00973-X	http://dx.doi.org/10.1016/S0092-8674(02)00973-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408861	Bronze			2022-12-24	WOS:000178753500006
J	Li, XC; Schuler, MA; Berenbaum, MR				Li, XC; Schuler, MA; Berenbaum, MR			Jasmonate and salicylate induce expression of herbivore cytochrome P450 genes	NATURE			English	Article							LYCOPERSICON-ESCULENTUM; INDUCED RESISTANCE; MOLECULAR-CLONING; INDUCED INCREASES; HELICOVERPA-ZEA; PLANTS; ACID; DEFENSE; SIGNAL; BIOSYNTHESIS	Jasmonate and salicylate are plant-produced signals that activate plant defence genes after herbivory(1-3) or pathogen(4) attack. Amplification of these signals, evoked by either enemy attack or experimental manipulation, leads to an increase in the synthesis of toxic compounds (allelochemicals)(5-8) and defence proteins(6,9,10) in the plants. Although the jasmonate and salicylate signal cascades activate different sets of plant defence genes(10),or even act antagonistically(11,12), there is substantial communication between the pathways(2,3,13). Jasmonate and salicylate also contribute to protecting plants against herbivores by causing plants that experience insect damage to increase their production of volatile molecules that attract natural enemies of herbivorous insects(14). In response to plant defences, herbivores increase their production of enzymes that detoxify allelochemicals, including cytochrome P450s (refs 15, 16). But herbivores are potentially vulnerable to toxic allelochemicals in the duration between ingesting toxins and induction of detoxification systems. Here we show that the corn earworm Helicoverpa zea uses jasmonate and salicylate to activate four of its cytochrome P450 genes that are associated with detoxification either before or concomitantly with the biosynthesis of allelochemicals. This ability to 'eavesdrop' on plant defence signals protects H. zea against toxins produced by host plants.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Nanjing Agr Univ, Dept Plant Protect, Nanjing, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing Agricultural University	Berenbaum, MR (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.							Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; BERENBAUM MR, 1999, MOL BIOL TOXIC RESPO, P553; Bi JL, 1997, J CHEM ECOL, V23, P1805, DOI 10.1023/B:JOEC.0000006452.81324.b8; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; KIDDLE GA, 1994, J EXP BOT, V45, P1343, DOI 10.1093/jxb/45.9.1343; Li XC, 2002, INSECT BIOCHEM MOLEC, V32, P311, DOI 10.1016/S0965-1748(01)00092-3; Li XC, 2002, INSECT MOL BIOL, V11, P343, DOI 10.1046/j.1365-2583.2002.00341.x; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; McCloud ES, 1997, PLANTA, V203, P430, DOI 10.1007/s004250050210; Miksch M, 1996, EXPERIENTIA, V52, P739, DOI 10.1007/BF01925585; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609; Royo J, 1999, P NATL ACAD SCI USA, V96, P1146, DOI 10.1073/pnas.96.3.1146; SAMBROOK J, 1989, MOL CLONING LABORATO, V7, P26; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stout MJ, 1999, PHYSIOL MOL PLANT P, V54, P115, DOI 10.1006/pmpp.1998.0193; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; TIETZ HM, 1972, INDEX DESCRIBED LIFE, V1; Tscharntke T, 2001, BIOCHEM SYST ECOL, V29, P1025, DOI 10.1016/S0305-1978(01)00048-5; VOLKER S, 1999, PHYTOCHEMISTRY, V50, P1141; WALDBAUER GP, 1984, GREAT LAKES ENTOMOL, V17, P113; Zangerl AR, 1997, OECOLOGIA, V109, P433, DOI 10.1007/s004420050103; [No title captured]	29	176	215	6	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					712	715		10.1038/nature01003	http://dx.doi.org/10.1038/nature01003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384696				2022-12-24	WOS:000178615200038
J	Fiore, MC; Hatsukami, DK; Baker, TB				Fiore, MC; Hatsukami, DK; Baker, TB			Effective tobacco dependence treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; IMPACT; CALIFORNIA		Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med, Madison, WI 53711 USA; Univ Wisconsin, Dept Med, Sch Med, Madison, WI 53711 USA; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Fiore, MC (corresponding author), Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med, 1930 Monroe St, Madison, WI 53711 USA.	mcf@ctri.medicine.wisc.edu			NCI NIH HHS [1 P50 CA84724] Funding Source: Medline; NIDA NIH HHS [1 P50 DA1333] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA084724] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bondurant, 2001, CLEARING SMOKE ASSES; [Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC)], 2001, INV TOB CONTR STAT H; Centers for Disease Control and Prevention, 1994, PREV TOB US YOUNG PE; Centers for Disease Control and Prevention, 2000, RED TOB US REP SURG; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P140; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; Daynard RA, 2001, AM J PUBLIC HEALTH, V91, P1967, DOI 10.2105/AJPH.91.12.1967; DiFranza JR, 2000, TOB CONTROL, V9, P313, DOI 10.1136/tc.9.3.313; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; FIORE MC, 2000, TREATING TOBACCO US; France EK, 2001, PREV MED, V32, P376, DOI 10.1006/pmed.2000.0824; Halpern MT, 2001, TOB CONTROL, V10, P233, DOI 10.1136/tc.10.3.233; Hays JT, 2001, ANN INTERN MED, V135, P423, DOI 10.7326/0003-4819-135-6-200109180-00011; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; Houston T, 2000, JAMA-J AM MED ASSOC, V284, P752, DOI 10.1001/jama.284.6.752; Irvin J E, 2000, Nicotine Tob Res, V2, P79; JACKSON FN, 1985, PRIMARY CARE, V12, P197; Lipkus IM, 2000, AM J PREV MED, V18, P1, DOI 10.1016/S0749-3797(99)00106-3; Moskowitz JM, 2000, AM J PUBLIC HEALTH, V90, P757, DOI 10.2105/AJPH.90.5.757; *NCI, 2000, NIH PUBL; *NCI, 2001, NIH PUBL; Owen L, 2000, TOB CONTROL, V9, P148, DOI 10.1136/tc.9.2.148; Piasecki TM, 1998, J ABNORM PSYCHOL, V107, P238, DOI 10.1037/0021-843X.107.2.238; Pronk NP, 1999, JAMA-J AM MED ASSOC, V282, P2235, DOI 10.1001/jama.282.23.2235; Rigotti NA, 2000, JAMA-J AM MED ASSOC, V284, P699, DOI 10.1001/jama.284.6.699; RIMER BK, 1990, CHEST, V97, P547, DOI 10.1378/chest.97.3.547; Robbins AS, 2000, TOB CONTROL, V9, P389, DOI 10.1136/tc.9.4.389; *US DEP HHS, 2000, TRACK HLTH PEOPL 201; 1996, MMWR MORB MORTAL WKL, V45, P996; 2001, MMWR MORB MORTAL WKL, V50, P869	31	69	70	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2002	288	14					1768	1771		10.1001/jama.288.14.1768	http://dx.doi.org/10.1001/jama.288.14.1768			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	602BJ	12365962				2022-12-24	WOS:000178484700031
J	Deverman, BE; Cook, BL; Manson, SR; Niederhoff, RA; Langer, EM; Rosova, I; Kulans, LA; Fu, XY; Weinberg, JS; Heinecke, JW; Roth, KA; Weintraub, SJ				Deverman, BE; Cook, BL; Manson, SR; Niederhoff, RA; Langer, EM; Rosova, I; Kulans, LA; Fu, XY; Weinberg, JS; Heinecke, JW; Roth, KA; Weintraub, SJ			Bcl-X-L deamidation is a critical switch in the regulation of the response to DNA damage	CELL			English	Article							CYCLIN-DEPENDENT KINASES; P53-DEPENDENT G(1) ARREST; CELL-CYCLE; RETINOBLASTOMA PROTEIN; HUMAN FIBROBLASTS; APOPTOSIS; BCL-X(L); CANCER; FAMILY; INHIBITION	The therapeutic value of DNA-damaging antineoplastic agents is dependent upon their ability to induce tumor cell apoptosis while sparing most normal tissues. Here, we show that a component of the apoptotic response to these agents in several different types of tumor cells is the deamidation of two asparagines in the unstructured loop of Bcl-X-L, and we demonstrate that deamidation of these asparagines imports susceptibility to apoptosis by disrupting the ability of BcI-X-L to block the proapoptotic activity of BH3 domain-only proteins. Conversely, Bcl-X-L deamidation is actively suppressed in fibroblasts, and suppression of deamidation is an essential component of their resistance to DNA damage-induced apoptosis. Our results suggest that the regulation of Bcl-X-L deamidation has a critical role in the tumor-specific activity of DNA-damaging antineoplastic agents.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, Div Urol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Weintraub, SJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Div Urol, 660 S Euclid Ave,Campus Box 8052, St Louis, MO 63110 USA.		Weinbaum, Justin S/C-3192-2009	Weinbaum, Justin S/0000-0002-0626-6083; Roth, Kevin/0000-0002-0643-995X				ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Amundson SA, 2000, CANCER RES, V60, P6101; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FAN SJ, 1995, CANCER RES, V55, P1649; FLATMARK T, 1966, ACTA CHEM SCAND, V20, P1487, DOI 10.3891/acta.chem.scand.20-1487; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HAASKOGAN DA, 1995, EMBO J, V14, P461, DOI 10.1002/j.1460-2075.1995.tb07022.x; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; Hawkins DS, 1996, CANCER RES, V56, P892; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; Knudsen KE, 1999, J BIOL CHEM, V274, P27632, DOI 10.1074/jbc.274.39.27632; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; POIRIER MC, 1987, PROG EXP TUMOR RES, V31, P104; POIRIER MC, 1992, PROG CLIN BIOL RES, V374, P197; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Robinson A B, 1974, Curr Top Cell Regul, V8, P247; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Schmitt CA, 1999, J PATHOL, V187, P127; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Tan XQ, 1998, TRENDS CELL BIOL, V8, P116, DOI 10.1016/S0962-8924(97)01208-7; Taylor JK, 1999, ONCOGENE, V18, P4495, DOI 10.1038/sj.onc.1202836; TERHEGGEN PMAB, 1987, CANCER RES, V47, P6719; TILBY MJ, 1991, CANCER RES, V51, P123; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	47	190	193	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 4	2002	111	1					51	62		10.1016/S0092-8674(02)00972-8	http://dx.doi.org/10.1016/S0092-8674(02)00972-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372300	Bronze			2022-12-24	WOS:000178461900008
J	Daborn, PJ; Yen, JL; Bogwitz, MR; Le Goff, G; Feil, E; Jeffers, S; Tijet, N; Perry, T; Heckel, D; Batterham, P; Feyereisen, R; Wilson, TG; ffrench-Constant, RH				Daborn, PJ; Yen, JL; Bogwitz, MR; Le Goff, G; Feil, E; Jeffers, S; Tijet, N; Perry, T; Heckel, D; Batterham, P; Feyereisen, R; Wilson, TG; ffrench-Constant, RH			A single P450 allele associated with insecticide resistance in Drosophila	SCIENCE			English	Article							LONG TERMINAL REPEAT; CYTOCHROME-P-450 SYSTEM; MELANOGASTER DIPTERA; GENETIC-REGULATION; EXPRESSION; LUFENURON; DDT	Insecticide resistance is one of the most widespread genetic changes caused by human activity, but we still understand little about the origins and spread of resistant alleles in global populations of insects. Here, via microarray analysis of all P450s in Drosophila melanogaster, we show that DDT-R, a gene conferring resistance to DDT, is associated with overtranscription of a single cytochrome P450 gene, Cyp6g1. Transgenic analysis of Cyp6g1 shows that overtranscription of this gene alone is both necessary and sufficient for resistance. Resistance and up-regulation in Drosophila populations are associated with a single Cyp6g1 allele that has spread globally. This allele is characterized by the insertion of an Accord transposable element into the 5' end of the Cyp6g1 gene.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Melbourne, Ctr Environm Stress & Adaptat Res, Dept Genet, Parkville, Vic 3052, Australia; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; INRA, Ctr Rech Antibes, F-06560 Valbonne, France	University of Bath; University of Melbourne; Colorado State University; University of Arizona; INRAE	ffrench-Constant, RH (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.		Legoff, Gaelle/B-7501-2015; Feyereisen, René/I-3140-2012; Batterham, Philip/G-5914-2012; Perry, Trent/A-7206-2012; Heckel, David G/K-2138-2013; Feyereisen, René/Y-7514-2019	Legoff, Gaelle/0000-0003-1973-7136; Feyereisen, René/0000-0002-9560-571X; Batterham, Philip/0000-0001-9840-9119; Perry, Trent/0000-0002-8045-0487; Heckel, David G/0000-0001-8991-2150; Feyereisen, René/0000-0002-9560-571X; ffrench-Constant, Richard/0000-0001-5385-9888				Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; BRAND AH, 1993, DEVELOPMENT, V118, P401; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; DELPUECH JM, 1993, P NATL ACAD SCI USA, V90, P5643, DOI 10.1073/pnas.90.12.5643; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; FFRENCHCONSTANT RH, 1998, MOL BIOL TOXIC RESPO, P533; FFRENCHCONSTANT RH, 1992, MOL APPROACHES PURE, P1; GEORGHIOU GP, 1969, PESTICIDE RESISTANCE, P14; HALLSTROM I, 1985, CHEM-BIOL INTERACT, V56, P157, DOI 10.1016/0009-2797(85)90003-1; HALLSTROM I, 1985, CHEM-BIOL INTERACT, V56, P173, DOI 10.1016/0009-2797(85)90004-3; Kikkawa, 1961, ANN REP SCI WORKS FS, V9, P1; KIKKAWA H., 1964, Botyu-Kagaku = Scientific Insect Control, V29, P37; Lewis DFV, 2002, DRUG METAB REV, V34, P69, DOI 10.1081/DMR-120001391; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; OGITA Z., 1961, Botyu-Kagaku = Scientific Insect Control, V26, P88; Ogita Z., 1960, BOTYU KAGAKU, V26, P7; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; RAYMOND M, 1992, RESISTANCE 91 : ACHIEVEMENTS AND DEVELOPMENTS IN COMBATING PESTICIDE RESISTANCE, P19; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Sabourault C, 2001, INSECT MOL BIOL, V10, P609, DOI 10.1046/j.0962-1075.2001.00303.x; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; WATERS LC, 1992, P NATL ACAD SCI USA, V89, P4855, DOI 10.1073/pnas.89.11.4855; WILSON TG, 1993, J ECON ENTOMOL, V86, P645, DOI 10.1093/jee/86.3.645; Wilson TG, 1997, J ECON ENTOMOL, V90, P1131, DOI 10.1093/jee/90.5.1131; WILSON TG, 1988, J ECON ENTOMOL, V81, P22, DOI 10.1093/jee/81.1.22; WILSON TG, 1996, ACS SYM SER, V645, P141	30	624	675	8	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2253	2256		10.1126/science.1074170	http://dx.doi.org/10.1126/science.1074170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12351787				2022-12-24	WOS:000178222000045
J	Sears, MR; Greene, JM; Willan, AR; Taylor, DR; Flannery, EM; Cowan, JO; Herbison, GP; Poulton, R				Sears, MR; Greene, JM; Willan, AR; Taylor, DR; Flannery, EM; Cowan, JO; Herbison, GP; Poulton, R			Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study	LANCET			English	Article							CHILDHOOD ASTHMA; INFANTS; EPIDEMIOLOGY; MICROFLORA; ALLERGY; DISEASE; BIRTH	Background Breastfeeding is widely advocated to reduce risk of atopy and asthma, but the evidence for such an effect is conflicting. We aimed to assess long-term outcomes of asthma and atopy related to breastfeeding in a New Zealand birth cohort. Methods Our cohort consisted of 1037 of 1139 children born in Dunedin, New Zealand, between April, 1972, and March, 1973, and residing in Otago province at age 3 years. Children were assessed every 2-5 years from ages 9 to 26 years with respiratory questionnaires, pulmonary function, bronchial challenge, and allergy skin tests. History of breastfeeding had been independently recorded in early childhood. Findings 504 (49%) of 1037 eligible children were breastfed (4 weeks or longer) and 533 (51%) were not. More children who were breastfed were atopic at all ages from 13 to 21 years to cats (p=0.0001), house dust mites (p=0.0010), and grass pollen (p<0.0001) than those who were not. More children who were breastfed reported current asthma at each assessment between age 9 (p=0.0008) and 26 years (p=0.0008) than those who were not. Breastfeeding effects were not affected by parental history of hayfever or asthma. Multifactor analysis controlling for socioeconomic status, parental smoking, birth order, and use of sheepskin bedding in infancy, showed odds ratios of 1.94 (95% Cl 1.42-2-65, p<0.0001) for any allergen positive at age 13 years, 2.40 (1-36-4.26, p=0.0003) for current asthma at 9 years, and 1.83 (1.35-2.47, p<0.0001) for current asthma at 9-26 years by repeated-measures analysis. Interpretation Breastfeeding does not protect children against atopy and asthma and may even increase the risk.	McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	McMaster University; McMaster University; University of Otago; University of Otago	Sears, MR (corresponding author), St Josephs Healthcare & McMaster Univ, Firestone Inst Resp Hlth, 50 Charlton Ave, Hamilton, ON L8N 4A6, Canada.	searsm@mcmaster.ca		Herbison, Graham Peter/0000-0002-5684-024X				Aarts C, 2000, INT J EPIDEMIOL, V29, P1041, DOI 10.1093/ije/29.6.1041; ABERG N, 1989, ACTA PAEDIATR SCAND, V78, P246, DOI 10.1111/j.1651-2227.1989.tb11064.x; BALDWIN A, 1999, UNPUB PLUNKET SOC PE; BEREZIN S, 1989, AM J DIS CHILD, V143, P361, DOI 10.1001/archpedi.1989.02150150119029; Bottcher MF, 2002, CLIN EXP ALLERGY, V32, P159, DOI 10.1046/j.1365-2222.2002.01343.x; BUCKFIELD PM, 1978, NEW ZEAL MED J, V88, P244; BURNEY P, 1987, CHEST, V91, pS79, DOI 10.1378/chest.91.6.79S; Chandra RK, 1997, J PEDIATR GASTR NUTR, V24, P380, DOI 10.1097/00005176-199704000-00005; Diggle PJ, 2002, ANAL LONGITUDINAL DA; ELLEY WB, 1976, NEW ZEAL J EDUC STUD, V11, P25; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Heinig MJ, 2001, PEDIATR CLIN N AM, V48, P105, DOI 10.1016/S0031-3955(05)70288-1; HOOD LJ, 1978, NEW ZEAL MED J, V88, P273; JONES DT, 1987, BRIT J DIS CHEST, V81, P332, DOI 10.1016/0007-0971(87)90181-1; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; KAPLAN BA, 1985, J EPIDEMIOL COMMUN H, V39, P152, DOI 10.1136/jech.39.2.152; KAUFMAN HS, 1976, ANN ALLERGY, V37, P410; KRAMER MS, 1988, J PEDIATR-US, V112, P181, DOI 10.1016/S0022-3476(88)80054-4; LAKE AM, 1982, J PEDIATR-US, V101, P906, DOI 10.1016/S0022-3476(82)80008-5; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Romieu I, 2000, J ASTHMA, V37, P575, DOI 10.3109/02770900009090812; Rook GAW, 1998, IMMUNOL TODAY, V19, P113, DOI 10.1016/S0167-5699(97)01204-8; Rubaltelli FF, 1998, J PERINAT MED, V26, P186, DOI 10.1515/jpme.1998.26.3.186; Rusconi F, 1999, AM J RESP CRIT CARE, V160, P1617, DOI 10.1164/ajrccm.160.5.9811002; SEARS MR, 1986, THORAX, V41, P283, DOI 10.1136/thx.41.4.283; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; SEARS MR, 1982, NEW ZEAL MED J, V95, P533; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; TAYLOR B, 1983, J EPIDEMIOL COMMUN H, V37, P95, DOI 10.1136/jech.37.2.95; TOELLE BG, 1992, AM REV RESPIR DIS, V146, P633, DOI 10.1164/ajrccm/146.3.633; Wafula EM, 1999, E AFR MED J, V76, P606; Wright AL, 1999, J ALLERGY CLIN IMMUN, V104, P589, DOI 10.1016/S0091-6749(99)70328-3; WRIGHT AL, 1989, BRIT MED J, V299, P946, DOI 10.1136/bmj.299.6705.946; Wright AL, 2001, THORAX, V56, P192, DOI 10.1136/thorax.56.3.192	37	406	423	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2002	360	9337					901	907		10.1016/S0140-6736(02)11025-7	http://dx.doi.org/10.1016/S0140-6736(02)11025-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AU	12354471				2022-12-24	WOS:000178142200008
J	Yamagata, M; Weiner, JA; Sanes, JR				Yamagata, M; Weiner, JA; Sanes, JR			Sidekicks: Synaptic adhesion molecules that promote lamina-specific connectivity in the retina	CELL			English	Article							GANGLION-CELLS; IMMUNOGLOBULIN SUPERFAMILY; AMACRINE CELLS; EXPRESSION; RECEPTORS; ORGANIZATION; SEGREGATION; PARALLEL; CADHERIN; BINDING	A major determinant of specific connectivity in the central nervous system is that synapses made by distinct afferent populations are restricted to particular laminae in their target area. We identify Sidekick (Sdk)-1 and -2, homologous transmembrane immunoglobulin superfamily molecules that mediate homophilic adhesion in vitro and direct laminar targeting of neurites in vivo. sdk-1 and -2 are expressed by non-overlapping subsets of retinal neurons; each sdk is expressed by presynaptic (amacrine and bipolar) and postsynaptic (ganglion) cells that project to common inner plexiform (synaptic) sublaminae. Sdk proteins are concentrated at synaptic sites, and Sdk-positive synapses are restricted to the 2 (of 10) sublaminae to which sdk-expressing cells project. Ectopic expression of Sdk in Sdk-negative cells redirects their processes to a Sdk-positive sublamina. These results implicate Sdks as determinants of lamina-specific synaptic connectivity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	sanesj@pcg.wustl.edu	Weiner, Joshua/AAA-6532-2021; Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931; Weiner, Joshua/0000-0002-3352-2847				Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bisti S, 1998, J NEUROSCI, V18, P5019; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Cajal SR., 1893, CELLULE, V9, P119; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; ELLIS JH, 1991, CELL TISSUE RES, V264, P197, DOI 10.1007/BF00313956; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FRENCH PW, 1986, J NEUROSCI RES, V16, P479, DOI 10.1002/jnr.490160304; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Holt CE, 1998, CURR OPIN NEUROBIOL, V8, P98, DOI 10.1016/S0959-4388(98)80013-5; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kaprielian Z, 2000, ANAT REC, V261, P176; KARTEN HJ, 1982, CYTOCHEMICAL METHODS, P189; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Layer PG, 1997, CELL TISSUE RES, V288, P407, DOI 10.1007/s004410050827; Lohmann C, 2001, J NEUROBIOL, V48, P150, DOI 10.1002/neu.1048; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MILLAR TJ, 1987, NEUROSCIENCE, V21, P725, DOI 10.1016/0306-4522(87)90033-9; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Nguyen DNT, 1997, DEVELOPMENT, V124, P3303; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCOTT LJC, 1988, J NEUROSCI, V8, P932; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SHEPPARD AM, 1991, NEUROSCI LETT, V123, P87, DOI 10.1016/0304-3940(91)90164-O; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Williams RR, 2001, VISUAL NEUROSCI, V18, P233, DOI 10.1017/S0952523801182088; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; YAMAGATA M, 1995, DEVELOPMENT, V121, P189; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	40	266	271	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2002	110	5					649	660		10.1016/S0092-8674(02)00910-8	http://dx.doi.org/10.1016/S0092-8674(02)00910-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230981	Bronze			2022-12-24	WOS:000177943700011
J	Wolfson, C; Talbot, P				Wolfson, C; Talbot, P			Bacterial infection as a cause of multiple sclerosis	LANCET			English	Editorial Material							BORRELIA-BURGDORFERI ANTIBODIES		McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Lady Davis Inst Med Res, Ctr Clin Epidemiol & Community Studies, Montreal, PQ, Canada; Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada	McGill University; Lady Davis Institute; McGill University; University of Quebec; Institut national de la recherche scientifique (INRS)	Wolfson, C (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.							Alvarez-Lafuente R, 2002, ARCH NEUROL-CHICAGO, V59, P929, DOI 10.1001/archneur.59.6.929; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Brorson O, 2001, INFECTION, V29, P315, DOI 10.1007/s15010-001-9144-y; Chmielewska-Badora J, 2000, ANN AGR ENV MED, V7, P141; COYLE PK, 1989, NEUROLOGY, V39, P760, DOI 10.1212/WNL.39.6.760; Granieri E, 2001, NEUROL SCI, V22, P179, DOI 10.1007/s100720170021; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Karussis D, 1999, MULT SCLER J, V5, P395, DOI 10.1191/135245899678846429; Marrie Ruth Ann, 2002, Can J Infect Dis, V13, P111; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; SCHMUTZHARD E, 1988, J NEUROL NEUROSUR PS, V51, P1215, DOI 10.1136/jnnp.51.9.1215; Talbot PJ, 2001, CURR TOP MICROBIOL, V253, P247; Wolfson C, 1997, NEUROLOGY, V49, pS5, DOI 10.1212/WNL.49.2_Suppl_2.S5; Wolfson C, 2001, EPIDEMIOLOGY, V12, P298, DOI 10.1097/00001648-200105000-00007	14	19	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					352	353		10.1016/S0140-6736(02)09603-4	http://dx.doi.org/10.1016/S0140-6736(02)09603-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241771				2022-12-24	WOS:000177255600004
J	Egorov, AV; Hamam, BN; Fransen, E; Hasselmo, ME; Alonso, AA				Egorov, AV; Hamam, BN; Fransen, E; Hasselmo, ME; Alonso, AA			Graded persistent activity in entorhinal cortex neurons	NATURE			English	Article							MEMORY; HIPPOCAMPAL; CONNECTIONS; RESPONSES; CHANNELS; NETWORK; MONKEY; CA1	Working memory represents the ability of the brain to hold externally or internally driven information for relatively short periods of time(1,2). Persistent neuronal activity is the elementary process underlying working memory but its cellular basis remains unknown. The most widely accepted hypothesis is that persistent activity is based on synaptic reverberations in recurrent circuits. The entorhinal cortex in the parahippocampal region is crucially involved in the acquisition, consolidation and retrieval of long-term memory traces for which working memory operations are essential(2). Here we show that individual neurons from layer V of the entorhinal cortex-which link the hippocampus to extensive cortical regions(3)-respond to consecutive stimuli with graded changes in firing frequency that remain stable after each stimulus presentation. In addition, the sustained levels of firing frequency can be either increased or decreased in an input-specific manner. This firing behaviour displays robustness to distractors; it is linked to cholinergic muscarinic receptor activation, and relies on activity-dependent changes of a Ca2+-sensitive cationic current. Such an intrinsic neuronal ability to generate graded persistent activity constitutes an elementary mechanism for working memory.	Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal, PQ H3A 2B4, Canada; Royal Inst Technol, Dept Numer Anal & Comp Sci, S-10044 Stockholm, Sweden; Boston Univ, Dept Psychol, Program Neurosci, Boston, MA 02215 USA; Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	McGill University; McGill University; Royal Institute of Technology; Boston University; Boston University	Alonso, AA (corresponding author), Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	angel.alonso@mcgill.ca		Egorov, Alexei/0000-0003-4899-8407; Hasselmo, Michael/0000-0002-9925-6377				ALONSO JR, 1995, J COMP NEUROL, V355, P135, DOI 10.1002/cne.903550202; ANDRADE R, 1991, BRAIN RES, V548, P81, DOI 10.1016/0006-8993(91)91109-E; BOEIJINGA PH, 1989, BRAIN RES, V478, P257, DOI 10.1016/0006-8993(89)91506-0; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; Dickson CT, 1997, J NEUROSCI, V17, P6729; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; Fraser DD, 1996, J NEUROSCI, V16, P4113; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; Hamam BN, 2000, J COMP NEUROL, V418, P457; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; KRNJEVIC K, 1993, PROG BRAIN RES, V98, P285; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; ROOM P, 1986, J COMP NEUROL, V251, P415, DOI 10.1002/cne.902510402; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stern CE, 2001, HIPPOCAMPUS, V11, P337; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Young BJ, 1997, J NEUROSCI, V17, P5183	30	564	572	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2002	420	6912					173	178		10.1038/nature01171	http://dx.doi.org/10.1038/nature01171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432392				2022-12-24	WOS:000179200900045
J	Hermanson, O; Jepsen, K; Rosenfeld, MG				Hermanson, O; Jepsen, K; Rosenfeld, MG			N-CoR controls differentiation of neural stem cells into astrocytes	NATURE			English	Article							FIBRILLARY ACIDIC PROTEIN; NUCLEAR RECEPTOR-COREPRESSOR; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION; KINASE; ROLES; GENE	Understanding the gene programmes that regulate maintenance and differentiation of neural stem cells is a central question in stem cell biology. Virtually all neural stem cells maintain an undifferentiated state and the capacity to self-renew in response to fibroblast growth factor-2 (FGF2)(1-5). Here we report that a repressor of transcription, the nuclear receptor co-repressor (NCoR), is a principal regulator in neural stem cells, as FGF2-treated embryonic cortical progenitors from N-CoR gene-disrupted mice display impaired self-renewal and spontaneous differentiation into astroglia-like cells. Stimulation of wild-type neural stem cells with ciliary neurotrophic factor (CNTF), a differentiation-inducing cytokine(3), results in phosphatidylinositol-3-OH kinase/Akt1 kinase-dependent phosphorylation of N-CoR, and causes a temporally correlated redistribution of N-CoR to the cytoplasm. We find that this is a critical strategy for cytokine-induced astroglia differentiation and lineage-characteristic gene expression. Recruitment of protein phosphatase-1 to a specific binding site on N-CoR exerts a reciprocal effect on the cellular localization of N-CoR. We propose that repression by NCoR, modulated by opposing enzymatic activities, is a critical mechanism in neural stem cells that underlies the inhibition of glial differentiation.	Univ Calif San Diego, Sch Med, Dept Mol Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Dept Mol Med, Howard Hughes Med Inst, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.		, Ola/AAF-5126-2021	Hermanson, Ola/0000-0001-9320-7921				Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BESNARD F, 1991, J BIOL CHEM, V266, P18877; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; CHOI BH, 1988, GLIA, V1, P308, DOI 10.1002/glia.440010503; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Frisen J, 2001, BIOESSAYS, V23, P3, DOI 10.1002/1521-1878(200101)23:1<3::AID-BIES1001>3.0.CO;2-F; Ghosh MM, 1995, BIOREMED SER, V3, P15; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kahn MA, 1997, J NEUROCHEM, V68, P1413; KANEKO R, 1994, P NATL ACAD SCI USA, V91, P4529, DOI 10.1073/pnas.91.10.4529; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrison SJ, 2002, NAT MED, V8, P16, DOI 10.1038/nm0102-16; Palmer TD, 1999, J NEUROSCI, V19, P8487; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Raballo R, 2000, J NEUROSCI, V20, P5012; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249	28	242	265	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 31	2002	419	6910					934	939		10.1038/nature01156	http://dx.doi.org/10.1038/nature01156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609MN	12410313				2022-12-24	WOS:000178909700046
J	Hoek, G; Brunekreef, B; Goldbohm, S; Fischer, P; van den Brandt, PA				Hoek, G; Brunekreef, B; Goldbohm, S; Fischer, P; van den Brandt, PA			Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study	LANCET			English	Article							PARTICLES; OUTDOOR; HEALTH; CHILDREN; POLLUTANTS; EXHAUST; CANCER	Background Long-term exposure to particulate matter air pollution has been associated with increased cardiopulmonary mortality in the USA. We aimed to assess the relation between traffic-related air pollution and mortality in participants of the Netherlands Cohort study on Diet and Cancer (NLCS), an ongoing study. Methods We investigated a random sample of 5000 people from the full cohort of the NLCS study (age 55-69 years) from 1986 to 1994. Long-term exposure to traffic-related air pollutants (black smoke and nitrogen dioxide) was estimated for the 1986 home address. Exposure was characterised with the measured regional and urban background concentration and an indicator variable for living near major roads. The association between exposure to air pollution and (cause specific) mortality was assessed with Cox's proportional hazards models, with adjustment for potential confounders. Findings 489 (11%) of 4492 people with data died during the follow-up period. Cardiopulmonary mortality was associated with living near a major road (relative risk 1.95, 95% CI 1.09-3.52) and, less consistently, with the estimated ambient background concentration (1.34, 0.68-2.64). The relative risk for living near a major road was 1.41 (0.94-2.12) for total deaths. Non-cardiopulmonary, non-lung cancer deaths were unrelated to air pollution (1.03, 0.54-1.96 for living near a major road). Interpretation Long-term exposure to traffic-related air pollution may shorten life expectancy.	Univ Utrecht, Inst Risk Assessment Sci, Environm & Occupat Hlth Grp, NL-3508 TD Utrecht, Netherlands; Netherlands Org Appl Sci Res Nutr & Food Res, Dept Nutr Epidemiol, Zeist, Netherlands; Natl Inst Publ Hlth & Environm, Lab Exposure Assessment & Environm Epidemiol, NL-3720 BA Bilthoven, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Utrecht University; Netherlands Organization Applied Science Research; Netherlands National Institute for Public Health & the Environment; Maastricht University	Hoek, G (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Environm & Occupat Hlth Grp, POB 80176, NL-3508 TD Utrecht, Netherlands.	g.hoek@iras.uu.nl		brunekreef, bert/0000-0001-9908-0060; van den Brandt, Piet/0000-0001-8781-8099				Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; Babisch W, 1999, ARCH ENVIRON HEALTH, V54, P210, DOI 10.1080/00039899909602261; BLOEMEN HJT, 1998, 650010006 NAT I PUBL; Briggs DJ, 1997, INT J GEOGR INF SCI, V11, P699, DOI 10.1080/136588197242158; Brunekreef B, 1997, EPIDEMIOLOGY, V8, P298, DOI 10.1097/00001648-199705000-00012; Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781; Burnett R, 2001, ENVIRON HEALTH PERSP, V109, P375, DOI 10.2307/3434784; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; EDWARDS J, 1994, ARCH ENVIRON HEALTH, V49, P223, DOI 10.1080/00039896.1994.9937471; Fischer PH, 2000, ATMOS ENVIRON, V34, P3713, DOI 10.1016/S1352-2310(00)00067-4; Hoek G, 1996, ATMOS ENVIRON, V30, P3141, DOI 10.1016/1352-2310(96)00032-5; Hoek G, 1997, ATMOS ENVIRON, V31, P3609, DOI 10.1016/S1352-2310(97)00158-1; Hoek G, 2001, J EXPO ANAL ENV EPID, V11, P459, DOI 10.1038/sj.jea.7500189; Krewski D., 2000, REANALYSIS HARVARD 6; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; Lebret E, 2000, ATMOS ENVIRON, V34, P177, DOI 10.1016/S1352-2310(99)00292-7; Nyberg F, 2000, EPIDEMIOLOGY, V11, P487, DOI 10.1097/00001648-200009000-00002; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1995, INHAL TOXICOL, V7, P1, DOI 10.3109/08958379509014267; Rijnders E, 2001, ENVIRON HEALTH PERSP, V109, P411, DOI 10.2307/3434789; Roorda-Knape MC, 1998, ATMOS ENVIRON, V32, P1921, DOI 10.1016/S1352-2310(97)00496-2; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; van der Wal JT, 2000, ATMOS ENVIRON, V34, P3675, DOI 10.1016/S1352-2310(00)00085-6; van Wijnen J. H., 1998, Reviews on Environmental Health, V13, P1; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Wallace L, 1996, J AIR WASTE MANAGE, V46, P98, DOI 10.1080/10473289.1996.10467451; Weiland Stephan K., 1994, Annals of Epidemiology, V4, P243; *WHO, 2000, EUR SER WHO, V91; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596	33	1094	1127	3	273	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2002	360	9341					1203	1209		10.1016/S0140-6736(02)11280-3	http://dx.doi.org/10.1016/S0140-6736(02)11280-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401246	Green Submitted			2022-12-24	WOS:000178708100009
J	Ware, LB; Matthay, MA				Ware, LB; Matthay, MA			Measuring microvascular blood flow in sepsis - a continuing challenge	LANCET			English	Editorial Material									Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; Vanderbilt Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vanderbilt University	Matthay, MA (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA.		Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702				De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2001, Curr Opin Crit Care, V7, P200, DOI 10.1097/00075198-200106000-00010; Fisher CJ, 2000, CRIT CARE MED, V28, pS49, DOI 10.1097/00003246-200009001-00011; GREENE R, 1981, AM REV RESPIR DIS, V124, P593; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307	9	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 19	2002	360	9341					1187	1188		10.1016/S0140-6736(02)11292-X	http://dx.doi.org/10.1016/S0140-6736(02)11292-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	605ZZ	12401242				2022-12-24	WOS:000178708100005
J	Liu, YC; Fallon, L; Lashuel, HA; Liu, ZH; Lansbury, PT				Liu, YC; Fallon, L; Lashuel, HA; Liu, ZH; Lansbury, PT			The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility	CELL			English	Article							UBIQUITIN-PROTEASOME SYSTEM; C-TERMINAL HYDROLASES; GAD MUTANT MOUSE; CRYSTAL-STRUCTURE; NERVE-TERMINALS; DEUBIQUITINATING ENZYMES; POLYUBIQUITIN CHAINS; INHIBITION; NEURODEGENERATION; IDENTIFICATION	The assumption that each enzyme expresses a single enzymatic activity in vivo is challenged by the linkage of the neuronal enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) to Parkinson's disease (PD). UCH-L1, especially those variants linked to higher susceptibility to PD, causes the accumulation of alpha-synuclein in cultured cells, an effect that cannot be explained by its recognized hydrolase activity. UCH-L1 is shown here to exhibit a second, dimerization-dependent, ubiquityl ligase activity. A polymorphic variant of UCH-L1 that is associated with decreased PD risk (S18Y) has reduced ligase activity but comparable hydrolase activity as the wild-type enzyme. Thus, the ligase activity as well as the hydrolase activity of UCH-L1 may play a role in proteasomal protein degradation, a critical process for neuronal health.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Lansbury, PT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, 65 Landsdowne St, Cambridge, MA 02139 USA.		Longo, Kenneth A/A-5631-2010; Lashuel, Hilal/M-3500-2017		NINDS NIH HHS [NS38375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; CHAIN DG, 1995, J NEUROSCI, V15, P7592; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Hell JW, 1998, METHOD ENZYMOL, V296, P116; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kurihara LJ, 2001, HUM MOL GENET, V10, P1963, DOI 10.1093/hmg/10.18.1963; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levecque C, 2001, J NEURAL TRANSM, V108, P979, DOI 10.1007/s007020170017; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; MIURA H, 1993, NEUROPATH APPL NEURO, V19, P41, DOI 10.1111/j.1365-2990.1993.tb00403.x; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; MUKOYAMA M, 1989, ACTA NEUROPATHOL, V79, P294, DOI 10.1007/BF00294664; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; ODA K, 1992, NEUROPATH APPL NEURO, V18, P265, DOI 10.1111/j.1365-2990.1992.tb00789.x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Satoh J, 2001, J NEUROL SCI, V189, P113, DOI 10.1016/S0022-510X(01)00555-X; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang J, 2002, MOVEMENT DISORD, V17, P767, DOI 10.1002/mds.10179; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wu J, 1995, No To Shinkei, V47, P881	47	637	677	0	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 18	2002	111	2					209	218		10.1016/S0092-8674(02)01012-7	http://dx.doi.org/10.1016/S0092-8674(02)01012-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	606UX	12408865	Bronze, Green Published			2022-12-24	WOS:000178753500010
J	Imai, S; Tsuge, N; Tomotake, M; Nagatome, Y; Sawada, H; Nagata, T; Kumagai, H				Imai, S; Tsuge, N; Tomotake, M; Nagatome, Y; Sawada, H; Nagata, T; Kumagai, H			An onion enzyme that makes the eyes water - A flavoursome, user-friendly bulb would give no cause for tears when chopped up.	NATURE			English	Article							LACHRYMATORY FACTOR; S-OXIDE		House Foods Corp, Somatech Ctr, Chiba 2840033, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan	House Foods Corporation; University of Tokyo; Kyoto University	Imai, S (corresponding author), House Foods Corp, Somatech Ctr, Chiba 2840033, Japan.							ADAMU I, 1982, EXPERIENTIA, V38, P899, DOI 10.1007/BF01953641; ARIGA T, 1981, LANCET, V1, P150; BLOCK E, 1992, ANGEW CHEM INT EDIT, V31, P1135, DOI 10.1002/anie.199211351; BLOCK E, 1979, J AM CHEM SOC, V101, P2200, DOI 10.1021/ja00502a044; BRODNITZ MH, 1971, J AGR FOOD CHEM, V19, P269, DOI 10.1021/jf60174a009; MAKHEJA AN, 1990, AGENTS ACTIONS, V29, P360, DOI 10.1007/BF01966468; Shen CX, 2000, J AGR FOOD CHEM, V48, P6254, DOI 10.1021/jf000711g	7	121	138	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					685	685		10.1038/419685a	http://dx.doi.org/10.1038/419685a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384686	Bronze			2022-12-24	WOS:000178615200028
J	Fiellin, DA; O'Connor, PG				Fiellin, DA; O'Connor, PG			New federal initiatives to enhance the medical treatment of opioid dependence	ANNALS OF INTERNAL MEDICINE			English	Review							METHADONE TREATMENT PRACTICES; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; NARCOTIC ADDICTION; DRUG-ABUSE; FOLLOW-UP; MAINTENANCE; BUPRENORPHINE; DEPRESSION; OUTCOMES	Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.	Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Fiellin, DA (corresponding author), Yale Univ, Sch Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	david.fiellin@yale.edu		Fiellin, David/0000-0002-4006-010X	NATIONAL INSTITUTE ON DRUG ABUSE [K12DA000167] Funding Source: NIH RePORTER; NIDA NIH HHS [K12 DA00167] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		*AM PSYCH ASS, ONL CME PROGR BUPR T; American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; [Anonymous], 1995, FEDERAL REGULATION M; COOPER JR, 1995, JAMA-J AM MED ASSOC, V273, P1619, DOI 10.1001/jama.273.20.1619; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253; DOLE VP, 1995, JAMA-J AM MED ASSOC, V274, P1307; DOLE VP, 1966, ARCH INTERN MED, V118, P304, DOI 10.1001/archinte.118.4.304; DOLE VP, 1988, JAMA-J AM MED ASSOC, V260, P3025, DOI 10.1001/jama.260.20.3025; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; Fiellin DA, 2001, JAMA-J AM MED ASSOC, V286, P1724, DOI 10.1001/jama.286.14.1724; FIELLIN DA, 2002, NATL I DRUG ABUSE RE, P24; FLEMING M, 1995, TRAINING ALCOHOL SUB; Gossop M, 1999, BRIT J GEN PRACT, V49, P31; Hecht FM, 1999, ANN INTERN MED, V131, P136, DOI 10.7326/0003-4819-131-2-199907200-00011; Henney JE, 2000, JAMA-J AM MED ASSOC, V284, P2178, DOI 10.1001/jama.284.17.2178; Judd LL, 1998, JAMA-J AM MED ASSOC, V280, P1936; KAMEROW DB, 1986, JAMA-J AM MED ASSOC, V255, P2054, DOI 10.1001/jama.255.15.2054; LEPAY D, 2000, DEAR COLLEAGUE  0330; Lewis DC, 1997, MED CLIN N AM, V81, P831, DOI 10.1016/S0025-7125(05)70551-4; LOPEZ F, 1994, CONFIDENTIALITY PATI, V13; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Moatti JP, 1998, ADDICTION, V93, P1567, DOI 10.1046/j.1360-0443.1998.9310156714.x; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; NESTLER EJ, 1997, NEW TREATMENTS OPIAT, P286; NEWMAN RG, 1987, NEW ENGL J MED, V317, P447, DOI 10.1056/NEJM198708133170710; NOVICK DM, 1994, J GEN INTERN MED, V9, P127, DOI 10.1007/BF02600025; O'Connor PG, 2000, ANN INTERN MED, V133, P40, DOI 10.7326/0003-4819-133-1-200007040-00008; *OFF NAT DRUG CONT, 1999, POL PAP OP AG TR MAR; Rounsaville BJ, 2000, JAMA-J AM MED ASSOC, V283, P1337, DOI 10.1001/jama.283.10.1337; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; Schwartz RP, 1999, AM J ADDICTION, V8, P293; Senay Edward C., 1993, Journal of Addictive Diseases, V12, P59, DOI 10.1300/J069v12n04_05; Weinrich M, 2000, JAMA-J AM MED ASSOC, V283, P1343, DOI 10.1001/jama.283.10.1343; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Woods J, 2001, MT SINAI J MED, V68, P75; 1999, FED REG, V64, P39810; WEB BASED BUPRENORPH; 2000, H R, V4365, P122; 2001, FED REG, V66, P4076	39	63	64	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2002	137	8					688	692		10.7326/0003-4819-137-8-200210150-00014	http://dx.doi.org/10.7326/0003-4819-137-8-200210150-00014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604WL	12379070				2022-12-24	WOS:000178644000009
J	Cebria, F; Kobayashi, C; Umesono, Y; Nakazawa, M; Mineta, K; Ikeo, K; Gojobori, T; Itoh, M; Taira, M; Alvarado, AS; Agata, K				Cebria, F; Kobayashi, C; Umesono, Y; Nakazawa, M; Mineta, K; Ikeo, K; Gojobori, T; Itoh, M; Taira, M; Alvarado, AS; Agata, K			FGFR-related gene nou-darake restricts brain tissues to the head region of planarians	NATURE			English	Article							DOUBLE-STRANDED-RNA; STEM-CELLS; NEURAL INDUCTION; EXPRESSION; REGENERATION; INTERFERENCE; REVEALS; SEF	The study of planarian regeneration may help us to understand how we can rebuild organs and tissues after injury, disease or ageing(1). The robust regenerative abilities of planarians are based upon a population of totipotent stem cells (neoblasts)(2-4), and among the organs regenerated by these animals is a well-organized central nervous system(5,6). In recent years, methodologies such as whole-mount in situ hybridizations and double-stranded RNA have been extended to planarians with the aim of unravelling the molecular basis of their regenerative capacities(7-11). Here we report the identification and characterization of nou-darake (ndk), a gene encoding a fibroblast growth factor receptor (FGFR)-like molecule specifically expressed in the head region of the planarian Dugesia japonica. Loss of function of ndk by RNA interference results in the induction of ectopic brain tissues throughout the body. This ectopic brain formation was suppressed by inhibition of two planarian FGFR homologues (FGFR1 and FGFR2). Additionally, ndk inhibits FGF signalling in Xenopus embryos. The data suggest that ndk may modulate FGF signalling in stem cells to restrict brain tissues to the head region of planarians.	RIKEN Kobe, Ctr Dev Biol, Grp Evolutionary Regenerat Biol, Kobe, Hyogo 6500047, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, DNA Data Bank Japan, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Ctr Informat Biol, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan; Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	RIKEN; Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Japan Science & Technology Agency (JST); Utah System of Higher Education; University of Utah; Okayama University	Agata, K (corresponding author), RIKEN Kobe, Ctr Dev Biol, Grp Evolutionary Regenerat Biol, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	agata@cdb.riken.go.jp	TAIRA, MASANORI/G-4923-2014; Mineta, Katsuhiko/A-5455-2012; Cebria, Francesc/C-5574-2017	Mineta, Katsuhiko/0000-0002-4727-045X; Cebria, Francesc/0000-0002-4028-3135; Agata, Kiyokazu/0000-0002-5195-2576; Sanchez Alvarado, Alejandro/0000-0002-1966-6959				Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Cebria F, 2002, MECH DEVELOP, V116, P199, DOI 10.1016/S0925-4773(02)00134-X; Cebria F, 2002, DEV GROWTH DIFFER, V44, P135; Conlon FL, 1999, DEV BIOL, V213, P85, DOI 10.1006/dbio.1999.9330; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Kato K, 1999, DEVELOPMENT, V126, P1031; Kobayashi C, 1999, MECH DEVELOP, V89, P25, DOI 10.1016/S0925-4773(99)00192-6; Launay C, 1996, DEVELOPMENT, V122, P869; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Orii H, 1999, DEV BIOL, V210, P456, DOI 10.1006/dbio.1999.9275; Pearson H, 2001, NATURE, V414, P388, DOI 10.1038/35106653; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Tazaki A, 1999, BIOCHEM BIOPH RES CO, V260, P426, DOI 10.1006/bbrc.1999.0933; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Umesono Y, 1999, DEV GENES EVOL, V209, P31, DOI 10.1007/s004270050224; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332	30	217	225	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2002	419	6907					620	624		10.1038/nature01042	http://dx.doi.org/10.1038/nature01042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602AT	12374980				2022-12-24	WOS:000178483100046
J	Chapple, A; Ziebland, S; Shepperd, S; Miller, R; Herxheimer, A; McPherson, A				Chapple, A; Ziebland, S; Shepperd, S; Miller, R; Herxheimer, A; McPherson, A			Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To explore the attitudes of men with confirmed or suspected prostate cancer to testing for prostate specific antigen. Design Qualitative interview study with a purposive sample. Setting Great Britain. Participants 52 men with suspected or confirmed prostate cancer, recruited through general practitioners, urologists, patient support groups, and charities. Results Almost all men remembered their prostate specific antigen test but recalled being given little information beforehand. Arguments in favour of increased access to testing included the belief that early diagnosis would reduce mortality, improve quality of life, and save the NHS money. Men also thought that a national screening programme should be available because symptoms can be ambiguous, screening for cancer is responsible health behaviour, and screening would encourage men to be tested. Four men who opposed a screening programme had gathered information alerting them to uncertainty about the benefits of treatment, and two regretted that they had been tested., Others thought that access to testing is restricted in the United Kingdom because of a lack of government backing, concerns about the accuracy of the test, and a lack of resources. Conclusions The few men in this study who subscribed to the argument that evidence of the benefits of treatment is a prerequisite for a screening programme did not want to see screening introduced. Men who proposed an alternative set of principles for testing gave reasons that did not all relate to overoptimism about the benefits of early diagnosis. People who plan services and people who respond to requests for testing need to understand men's perspectives and concerns.	Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, DIPEx, Oxford OX3 7LF, England; Univ Oxford, Dept Primary Hlth Care, Canc Res UK Gen Practice Res Grp, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Chapple, A (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, DIPEx, Oxford OX3 7LF, England.			Shepperd, Sasha/0000-0001-6384-8322; Ziebland, Sue/0000-0002-6496-4859				Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Brawley OW, 1997, CANCER-AM CANCER SOC, V80, P1857, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Donovan JL, 2001, BMJ-BRIT MED J, V323, P763, DOI 10.1136/bmj.323.7316.763; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Herxheimer A, 2000, LANCET, V355, P1540, DOI 10.1016/S0140-6736(00)02174-7; Howson A, 1999, SOCIOL HEALTH ILL, V21, P401, DOI 10.1111/1467-9566.00164; LEEPOTTER L, 2000, DAILY MAIL      0708, P4; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Morse JM, 1997, QUAL HEALTH RES, V7, P445, DOI 10.1177/104973239700700401; Neal D E, 2000, Lancet Oncol, V1, P17, DOI 10.1016/S1470-2045(00)00005-X; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; SILVERMAN D, 1994, INTERPRETING QUALITA; SLEVIN T, 1997, MED J AUSTRALIA, V171, P185; STUTTAFORD T, 2000, TIMES           0608, P21; STUTTAFORD T, 2000, TIMES           0914, P10; TANNOCK IF, 2000, LANCET ONCOL     MAY, P17; Taylor KL, 1999, CANCER, V85, P1305, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1305::AID-CNCR13>3.0.CO;2-I; UK National Screening Committee, 2000, 2 REP UK NAT SCREEN; Volk RJ, 2000, J FAM PRACTICE, V49, P425; Ward JE, 1997, MED J AUSTRALIA, V167, P250, DOI 10.5694/j.1326-5377.1997.tb125048.x; 2000, PSA NEWSLETTER, V4, P2	23	34	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 5	2002	325	7367					737	739		10.1136/bmj.325.7367.737	http://dx.doi.org/10.1136/bmj.325.7367.737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603AU	12364299	Green Published, Bronze			2022-12-24	WOS:000178537300013
J	Alphey, L; Beard, CB; Billingsley, P; Coetzee, M; Crisanti, A; Curtis, C; Eggleston, P; Godfray, C; Hemingway, J; Jacobs-Lorena, M; James, AA; Kafatos, FC; Mukwaya, LG; Paton, M; Powell, JR; Schneider, W; Scott, TW; Sina, B; Sinden, R; Sinkins, S; Spielman, A; Toure, Y; Collins, FH				Alphey, L; Beard, CB; Billingsley, P; Coetzee, M; Crisanti, A; Curtis, C; Eggleston, P; Godfray, C; Hemingway, J; Jacobs-Lorena, M; James, AA; Kafatos, FC; Mukwaya, LG; Paton, M; Powell, JR; Schneider, W; Scott, TW; Sina, B; Sinden, R; Sinkins, S; Spielman, A; Toure, Y; Collins, FH			Malaria control with genetically manipulated insect vectors	SCIENCE			English	Editorial Material							ANOPHELES-GAMBIAE; TRANSFORMATION; MOSQUITOS		Univ Oxford, Oxford OX1 2JD, England; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Univ Aberdeen, Aberdeen AB9 1FX, Scotland; S African Inst Med Res, ZA-2000 Johannesburg, South Africa; Univ London Imperial Coll Sci Technol & Med, London, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Calif Irvine, Irvine, CA 92717 USA; European Mol Biol Lab, Heidelberg, Germany; Uganda Virus Res Inst, Entebbe, Uganda; Hlth & Safety Execut, HSC, Sheffield S3 7HQ, S Yorkshire, England; Yale Univ, New Haven, CT 06520 USA; US EPA, Washington, DC 20460 USA; Univ Calif Davis, Davis, CA 95616 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; WHO, Special Programme Res & Training Trop Dis, Geneva, Switzerland; Univ Notre Dame, Notre Dame, IN 46556 USA	University of Oxford; Centers for Disease Control & Prevention - USA; University of Aberdeen; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Case Western Reserve University; University of California System; University of California Irvine; European Molecular Biology Laboratory (EMBL); Uganda Virus Research Institute; Yale University; United States Environmental Protection Agency; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; University of Notre Dame	Alphey, L (corresponding author), Univ Oxford, Oxford OX1 2JD, England.		Coetzee, Maureen/AAW-4739-2020; Coetzee, Maureen/AAI-1413-2020	Coetzee, Maureen/0000-0003-2019-866X; James, Anthony/0000-0001-5577-3308; Alphey, Luke/0000-0002-2916-3802; Hemingway, Janet/0000-0002-3200-7173; Crisanti, Andrea/0000-0002-2406-4426				[Anonymous], 1991, TDRBCVMALENT913 WHO; Black WC, 2001, INSECT MOL BIOL, V10, P3, DOI 10.1046/j.1365-2583.2001.00234.x; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Morel CM, 2002, SCIENCE, V298, P79, DOI 10.1126/science.1078047; Onyabe DY, 2001, HEREDITY, V87, P647, DOI 10.1046/j.1365-2540.2001.00957.x; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Walton C, 2001, MOL ECOL, V10, P569, DOI 10.1046/j.1365-294x.2001.01201.x; Wang R, 1999, PARASITOL TODAY, V15, P33, DOI 10.1016/S0169-4758(98)01360-X	15	185	195	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					119	121		10.1126/science.1078278	http://dx.doi.org/10.1126/science.1078278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364786				2022-12-24	WOS:000178370500043
J	Chen, JY; Huang, DY				Chen, JY; Huang, DY			A possible Lower Cambrian chaetognath (arrow worm)	SCIENCE			English	Article									Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Chen, JY (corresponding author), Nanjing Inst Geol & Paleontol, Nanjing 210008, Peoples R China.							Bone Q., 1991, BIOL CHAETOGNATHS; Brusca R.C., 1990, INVERTEBRATES; SCHRAM FR, 1973, J PALEONTOL, V47, P985; SZANIAWSKI H, 1982, J PALEONTOL, V56, P806; Walcott C.D., 1911, SMITHSONIAN MISCELLA, V57, P109, DOI DOI 10.1126/SCIENCE.1091376	5	55	65	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2002	298	5591					187	187		10.1126/science.1075059	http://dx.doi.org/10.1126/science.1075059			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364798				2022-12-24	WOS:000178370500055
J	Miller, LH; Greenwood, B				Miller, LH; Greenwood, B			Malaria - a shadow over Africa	SCIENCE			English	Editorial Material							GENOME SEQUENCE; RESISTANCE		NIAID, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1B 3DP, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; London School of Hygiene & Tropical Medicine	Miller, LH (corresponding author), NIAID, Lab Malaria & Vector Res, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, Z01AI000241] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; LINDSAY SW, 1989, MED VET ENTOMOL, V3, P263, DOI 10.1111/j.1365-2915.1989.tb00226.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Molineaux L, 1980, THE GARKI PROJECT; Packard R. M., 1994, Parassitologia (Rome), V36, P197; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Rosenthal P.J., 2001, ANTIMALARIAL CHEMOTH; Sachs JD, 2002, SCIENCE, V298, P122, DOI 10.1126/science.1077900; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2	14	22	22	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					121	122		10.1126/science.1078048	http://dx.doi.org/10.1126/science.1078048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364787				2022-12-24	WOS:000178370500044
J	Stadler, RH; Blank, I; Varga, N; Robert, F; Hau, J; Guy, PA; Robert, MC; Riediker, S				Stadler, RH; Blank, I; Varga, N; Robert, F; Hau, J; Guy, PA; Robert, MC; Riediker, S			Acrylamide from Maillard reaction products	NATURE			English	Article									Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland	Nestle SA	Stadler, RH (corresponding author), Nestle Res Ctr, Vers Chez Blanc, CH-1000 Lausanne 26, Switzerland.		Hau, Jann/C-8692-2012	Hau, Jann/0000-0001-8586-5705; Guy, philippe/0000-0002-2968-8625				[Anonymous], CARBOHYDRATES CHEM B; CHEN JT, 1989, Z NATURFORSCH B, V44, P459; European Commission Scientific Committee on Food, 2002, OP SCI COMM FOOD NEW; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; Rosen J, 2002, ANALYST, V127, P880, DOI 10.1039/b204938d; VONEULER H, 1926, CHEM BER, V59, P1581; *WHO, 2002, FAOWHO CONS HLTH IMP	7	1204	1291	14	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					449	450		10.1038/419449a	http://dx.doi.org/10.1038/419449a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368845				2022-12-24	WOS:000178348400026
J	Taverna, SD; Coyne, RS; Allis, CD				Taverna, SD; Coyne, RS; Allis, CD			Methylation of histone H3 at lysine 9 targets programmed DNA elimination in Tetrahymena	CELL			English	Article							MACRONUCLEAR DEVELOPMENT; CHROMODOMAIN PROTEIN; DEVELOPMENTAL-CHANGES; PARENTAL EXPRESSION; EUCHROMATIC GENES; CONJUGATING CELLS; HP1; HETEROCHROMATIN; CHROMATIN; THERMOPHILA	Histone H3 lysine 9 methylation [Me(Lys9)H3] is an epigenetic mark for heterochromatin-dependent gene silencing, mediated by direct binding to chromodomain-containing proteins such as Heterochromatin Protein 1. In the ciliate Tetrahymena, two chromodomain proteins, Pdd1p and Pdd3p, are involved in the massive programmed DNA elimination that accompanies macronuclear development. We report that both proteins bind H3(Lys9)Me in vitro. In vivo, H3(Lys9)Me is confined to the time period and location where DNA elimination occurs, and associates with eliminated sequences. Loss of parental Pdd1p expression drastically reduces H3(Lys9)Me. Finally, tethering Pdd1p is sufficient to promote DNA excision. These results extend the range of H3(Lys9)Me involvement in chromatin activities outside transcriptional regulation and also strengthen the link between heterochromatin formation and programmed DNA elimination.	Univ Virginia, Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Allis, CD (corresponding author), Univ Virginia, Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	allis@virginia.edu		Taverna, Sean/0000-0003-0278-0592	NIGMS NIH HHS [GM-53512] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R37GM053512] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; ALLIS CD, 1984, DEV BIOL, V101, P282, DOI 10.1016/0012-1606(84)90142-8; ALLIS CD, 1982, DEV BIOL, V93, P519, DOI 10.1016/0012-1606(82)90139-7; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; AUSTERBERRY CF, 1984, P NATL ACAD SCI-BIOL, V81, P7383, DOI 10.1073/pnas.81.23.7383; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bruns PJ, 2000, METHOD CELL BIOL, V62, P501; Callebaut I, 1997, BIOCHEM BIOPH RES CO, V235, P103, DOI 10.1006/bbrc.1997.6748; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chalker DL, 1999, MOL CELL BIOL, V19, P5631; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chau MF, 1996, BIOL CELL, V86, P111, DOI 10.1016/0248-4900(96)84773-3; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; Coyne RS, 1996, ANNU REV GENET, V30, P557, DOI 10.1146/annurev.genet.30.1.557; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; DEDON PC, 1991, MOL CELL BIOL, V11, P1729, DOI 10.1128/MCB.11.3.1729; Duharcourt S, 2002, EUKARYOT CELL, V1, P293, DOI 10.1128/EC.1.2.293-303.2002; Gaertig J, 2000, METHOD CELL BIOL, V62, P485; GODISKA R, 1990, CELL, V61, P1237, DOI 10.1016/0092-8674(90)90688-B; GODISKA R, 1993, GENE DEV, V7, P2357, DOI 10.1101/gad.7.12a.2357; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; GUTTMAN SD, 1980, CELL, V22, P299, DOI 10.1016/0092-8674(80)90177-4; HEINONEN TYK, 1994, J BIOL CHEM, V269, P17428; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KATOH M, 1993, NUCLEIC ACIDS RES, V21, P2409, DOI 10.1093/nar/21.10.2409; Klotz I. M., 1997, LIGAND RECEPTOR ENER; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN RL, 1991, GENE DEV, V5, P1601, DOI 10.1101/gad.5.9.1601; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MADIREDDI MT, 1994, DEV BIOL, V165, P418, DOI 10.1006/dbio.1994.1264; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Meyer E, 2002, ADV GENET, V46, P305; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; MULLER J, 1995, EMBO J, V14, P1209, DOI 10.1002/j.1460-2075.1995.tb07104.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nikiforov MA, 1999, GENE DEV, V13, P2852, DOI 10.1101/gad.13.21.2852; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Poux S, 2001, DEVELOPMENT, V128, P75; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SAVELIEV SV, 1995, GENE DEV, V9, P248, DOI 10.1101/gad.9.2.248; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Smothers JF, 1997, DEVELOPMENT, V124, P4537; Smothers JF, 1997, J EUKARYOT MICROBIOL, V44, P79, DOI 10.1111/j.1550-7408.1997.tb05942.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; VANHOLDE KE, 1988, CHROMATIN, P111; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Wolffe AP., 1998, CHROMATIN STRUCTURE; YAO MC, 1991, P NATL ACAD SCI USA, V88, P9493, DOI 10.1073/pnas.88.21.9493; Yao MC, 2002, MOBILE DNA, P730; YOKOYAMA RW, 1982, CHROMOSOMA, V85, P11, DOI 10.1007/BF00344591; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	68	228	241	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2002	110	6					701	711		10.1016/S0092-8674(02)00941-8	http://dx.doi.org/10.1016/S0092-8674(02)00941-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	596TV	12297044	Bronze			2022-12-24	WOS:000178182800006
J	Eswaran, H; Wilson, JD; Preissl, H; Robinson, SE; Vrba, J; Murphy, P; Rose, DF; Lowery, CL				Eswaran, H; Wilson, JD; Preissl, H; Robinson, SE; Vrba, J; Murphy, P; Rose, DF; Lowery, CL			Magnetoencephalographic recordings of visual evoked brain activity in the human fetus	LANCET			English	Article							LIGHT STIMULATION	We investigated the feasibility of recording visual evoked brain activity in the human fetus by use of non-invasive magnetoencephalography (MEG). Each recording lasted 6 min and consisted of a sequence of 180 flashes with 33 ms duration delivered 2 s apart over the maternal abdomen. Four of ten fetuses included showed a response; the ranges of amplitude and latency of peak response were 15-30x10(-15) Tesla and 180-390 ms, respectively. Six fetuses showed no discernible response. With improvement, this method could aid in the testing of fetal neurological status throughout pregnancy.	Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; Univ Arkansas, Grad Inst Technol, Little Rock, AR 72204 USA; Univ Tubingen, Inst Med Psychol & Behav Neurobiol, MEG Ctr, Tubingen, Germany; CTF Syst, Port Coquitlam, BC, Canada; Childrens Hosp Med Ctr Cincinnati, Dept Pediat & Neurol, Cincinnati, OH USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lowery, CL (corresponding author), Univ Arkansas Med Sci, Dept Obstet & Gynecol, 4301 W Markham,Slot 518, Little Rock, AR 72205 USA.		Preißl, Hubert/E-9070-2012	Preißl, Hubert/0000-0002-8859-4661	NINDS NIH HHS [1R01NS36277] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036277] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLUM T, 1985, BRIT J OBSTET GYNAEC, V92, P1224, DOI 10.1111/j.1471-0528.1985.tb04866.x; Hykin J, 1999, LANCET, V354, P645, DOI 10.1016/S0140-6736(99)02901-3; Kiuchi M, 2000, EARLY HUM DEV, V58, P153, DOI 10.1016/S0378-3782(00)00074-8; PELEG D, 1980, J PERINAT MED, V8, P38; Shepherd AJ, 1999, DEV MED CHILD NEUROL, V41, P9, DOI 10.1017/S0012162299000031	5	62	62	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 7	2002	360	9335					779	780		10.1016/S0140-6736(02)09905-1	http://dx.doi.org/10.1016/S0140-6736(02)09905-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241838				2022-12-24	WOS:000177933000021
J	Ostermeier, GC; Dix, DJ; Miller, D; Khatri, P; Krawetz, SA				Ostermeier, GC; Dix, DJ; Miller, D; Khatri, P; Krawetz, SA			Spermatozoal RNA profiles of normal fertile men	LANCET			English	Article							EMBRYONIC GENOME ACTIVATION; GENE-EXPRESSION; INFERTILITY; MECHANISMS; OOCYTE	Background Findings from several studies support the conclusion that spermatozoa contain a complex repertoire of mRNAs. Even though these mRNAs are thought to provide an insight into past events of spermatogenesis, their complexity and function have yet to be established. Our aim was to determine whether we could use spermatozoal mRNAs to generate a genetic fingerprint of normal fertile men. Methods We used a suite of microarrays containing 27 016 unique expressed sequence tags (ESTs) to investigate cDNAs from a pool of 19 testes, cDNAs from a pool of nine individual ejaculate spermatozoal mRNAs, and cDNAs constructed from spermatozoal mRNAs from a single ejaculate. We also used ontological data mining to determine the function of the genes identified in each EST profile. Findings The cDNAs from the testes, pooled ejaculate, and single ejaculate hybridised to 7157, 3281, and 2780 ESTs, respectively. The testicular population contained all of the ESTs identified by the cDNAs from the pooled and individual ejaculate. The pooled ejaculate population contained all but four ESTs identified from the individual ejaculate. A subset of the spermatozoal mRNAs was associated with embryo development. Interpretation The microarray data from testes and spermatozoa (pooled and individual) were concordant, supporting the view that a spermatozoal mRNA fingerprint can be obtained from normal fertile men. Thus, profiling can be used to monitor past events-ie, gene expression of spermatogenesis. Moreover, the data suggest that, in addition to delivering the paternal genome, spermatozoa provide the zygote with a unique suite of paternal mRNAs. Ejaculate spermatozoa can now be used as a non-invasive proxy for investigations of testis-specific infertility.	Wayne State Univ, Dept Obstet & Gynecol, Ctr Mol Med & Genet, Detroit, MI USA; Wayne State Univ, Inst Comp Sci, Detroit, MI USA; Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; US EPA, Off Res & Dev, Washington, DC 20460 USA; Univ Leeds, Reprod Biol Grp, Leeds, W Yorkshire, England	Wayne State University; Wayne State University; Wayne State University; United States Environmental Protection Agency; University of Leeds	Krawetz, SA (corresponding author), 253 CS Mott Ctr 275 E Hancock, Detroit, MI 48201 USA.	steve@compbio.med.wayne.edu	krawetz, stephen/GQQ-3308-2022; Ostermeier, G. Charles/Y-1172-2019	Ostermeier, G. Charles/0000-0002-3951-512X; Khatri, Purvesh/0000-0002-4143-4708	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036512] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36512] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BETLACH CJ, 1976, J EXP ZOOL, V198, P49, DOI 10.1002/jez.1401980107; BHASIN S, 1994, J CLIN ENDOCR METAB, V79, P1525, DOI 10.1210/jc.79.6.1525; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Conover W, 1980, PRACTICAL NONPARAMET, P99; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JACOBS PA, 1980, NATURE, V286, P714, DOI 10.1038/286714a0; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kramer JA, 1997, MOL HUM REPROD, V3, P473, DOI 10.1093/molehr/3.6.473; Kramer JA, 2000, MOL REPROD DEV, V56, P254, DOI 10.1002/(SICI)1098-2795(200006)56:2+<254::AID-MRD9>3.0.CO;2-#; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; LISSENS W, 1999, MOL BIOL REPROD MED, P479; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Miller D, 1999, GENE, V237, P385, DOI 10.1016/S0378-1119(99)00324-8; MILLER D, 1994, HUM REPROD, V9, P864, DOI 10.1093/oxfordjournals.humrep.a138607; Neilson L, 2000, GENOMICS, V63, P13, DOI 10.1006/geno.1999.6059; Ostermeier GC, 2002, BIOINFORMATICS, V18, P949, DOI 10.1093/bioinformatics/18.7.949; OSTERMEIER GC, 2000, THESIS U WISCONSIN M; Reid KJ, 2001, BIOTECHNIQUES, V30, P20, DOI 10.2144/01301bm01; Richter W, 1999, MOL HUM REPROD, V5, P732, DOI 10.1093/molehr/5.8.732; Sathanathan AH, 1996, HUM REPROD, V11, P345, DOI 10.1093/HUMREP/11.2.345; SIMERLY C, 1995, NAT MED, V1, P47, DOI 10.1038/nm0195-47; Stanton JL, 2001, MOL HUM REPROD, V7, P521, DOI 10.1093/molehr/7.6.521; Swann K, 1999, J EXP ZOOL, V285, P267, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;267::AID-JEZ10&gt;3.0.CO;2-P; Taylor E, 2001, BIOTECHNIQUES, V31, P62, DOI 10.2144/01311st01; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546	29	396	426	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2002	360	9335					772	777		10.1016/S0140-6736(02)09899-9	http://dx.doi.org/10.1016/S0140-6736(02)09899-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592HX	12241836				2022-12-24	WOS:000177933000019
J	Krause, TG; Koch, A; Friborg, J; Poulsen, LK; Kristensen, B; Melbye, M				Krause, TG; Koch, A; Friborg, J; Poulsen, LK; Kristensen, B; Melbye, M			Frequency of atopy in the Arctic in 1987 and 1998	LANCET			English	Article							ALLERGY; IGE	Few studies have measured the frequency of atopy with objective measures, and most of these studies have been done in industrialised countries. We analysed serum samples from 859 15-80-year-old Greenlanders who had participated in population-based screening campaigns in 1987 and in 1998. We defined atopy as a positive result In an assay that tests for specific IgE against the eight most common inhalant allergens in one pool (grass, birch, mugwort, dog, cat, horse, Cladosporum herbarum, house dust mite). The frequency of atopy doubled between 1987 (39 [10%] of 392) and 1998 (87 [19%] of 467; risk ratio 1-88 [95% Cl 1.31-2.68]). This increase was largest in 15-19-year olds, but also occurred in older people, suggesting that the risk factors responsible for the increase in atopy do not operate only in childhood.	Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen S, Denmark; Natl Univ Hosp, Allergy Unit, Copenhagen, Denmark; Pharmacia, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Pfizer	Krause, TG (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, Artillerivej 5, DK-2300 Copenhagen S, Denmark.		Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X; Koch, Anders/0000-0001-9205-1048; Friborg, Jeppe/0000-0001-5423-0627; melbye, mads/0000-0001-8264-6785				Linneberg A, 2000, J ALLERGY CLIN IMMUN, V106, P247, DOI 10.1067/mai.2000.108312; Misfeldt J, 1988, Arctic Med Res, V47, P173; Olsen O R, 2000, Ugeskr Laeger, V162, P4652; Paganelli R, 1998, ALLERGY, V53, P763; Wieringa MH, 2001, CLIN EXP ALLERGY, V31, P1553, DOI 10.1046/j.1365-2222.2001.01188.x	5	68	69	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 31	2002	360	9334					691	692		10.1016/S0140-6736(02)09841-0	http://dx.doi.org/10.1016/S0140-6736(02)09841-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241878				2022-12-24	WOS:000177795100013
J	Makarov, EM; Makarova, OV; Urlaub, H; Gentzel, M; Will, CL; Wilm, M; Luhrmann, R				Makarov, EM; Makarova, OV; Urlaub, H; Gentzel, M; Will, CL; Wilm, M; Luhrmann, R			Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome	SCIENCE			English	Article							EXON JUNCTION COMPLEX; PROTEIN-COMPOSITION; MASS-SPECTROMETRY; COMPONENTS	Major structural changes occur in the spliceosome during its activation just before catalyzing the splicing of pre-messenger RNAs (pre-mRNAs). Whereas changes in small nuclear RNA ( snRNA) conformation are well documented, little is known about remodeling of small nuclear ribonucleoprotein ( snRNP) structures during spliceosome activation. Here, human 45S activated spliceosomes and a previously unknown 35S U5 snRNP were isolated by immunoaffinity selection and were characterized by mass spectrometry. Comparison of their protein components with those of other snRNP and spliceosomal complexes revealed a major change in protein composition during spliceosome activation. Our data also suggest that the U5 snRNP is dramatically remodeled at this stage, with the Prp19 complex and other factors tightly associating, possibly in exchange for other U5 proteins, and suggest that after catalysis the remodeled U5 is eventually released from the postsplicing complex as a 35S snRNP particle.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; European Mol Biol Lab, Bioanalyt Res Grp, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany.			Wilm, Matthias/0000-0002-5461-6834; Gentzel, Marc/0000-0002-4482-6010; Makarov, Evgeny/0000-0003-2543-9637				Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; BACH M, 1989, P NATL ACAD SCI USA, V86, P6038, DOI 10.1073/pnas.86.16.6038; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Burge CB, 1999, RNA WORLD, P525; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Gottschalk A, 2001, RNA, V7, P1554; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; HARTMUTH K, UNPUB; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	17	292	297	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2205	2208		10.1126/science.1077783	http://dx.doi.org/10.1126/science.1077783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12411573	Green Submitted			2022-12-24	WOS:000179773700052
J	Zhang, JM; Xu, F; Hashimshony, T; Keshet, N; Cedar, H				Zhang, JM; Xu, F; Hashimshony, T; Keshet, N; Cedar, H			Establishment of transcriptional competence in early and late S phase	NATURE			English	Article							BETA-GLOBIN LOCUS; HISTONE ACETYLATION; DNA-REPLICATION; CHROMATIN STRUCTURE; ORIGINS; ACTIVATION; CHROMOSOME; INVITRO; REGION; CELLS	In animal cells, the process of DNA replication takes place in a programmed manner, with each gene region designated to replicate at a fixed time slot in S phase. Housekeeping genes undergo replication in the first half of S phase in all cell types, whereas the replication of many tissue specific genes is developmentally controlled, being late in most tissues but early in the tissue of expression(1). Here we employ nuclear DNA injection as an experimental system to test whether this phenomenon is due to differences in the ability to set up transcriptional competence during S phase(2,3). Our results show that, regardless of sequence, exogenous genes are a better template for transcription when injected into nuclei of cells in early as opposed to late S phase, and this expression state, once initiated, is preserved after cell division. DNA injected in late S phase is apparently repressed because it is packaged into chromatin containing deacetylated histones, and the same is true for late replicating chromosomal DNA. These findings suggest a mechanistic connection between replication timing and gene expression that might help to explain how epigenetic states can be maintained in vivo.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel	Hebrew University of Jerusalem	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel.							Allshire R, 2000, CELL, V102, P705, DOI 10.1016/S0092-8674(00)00058-1; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; BROWN DD, 1984, CELL, V37, P359, DOI 10.1016/0092-8674(84)90366-0; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; GOTTESFELD J, 1982, CELL, V28, P781, DOI 10.1016/0092-8674(82)90057-5; GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; OHE Y, 1995, HUM GENE THER, V6, P325, DOI 10.1089/hum.1995.6.3-325; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Simon I, 2001, EMBO J, V20, P6150, DOI 10.1093/emboj/20.21.6150; SIMON I, 1996, DNA REPLICATION EUKA, P387; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; SOLOMON MJ, 1987, MOL CELL BIOL, V7, P3822, DOI 10.1128/MCB.7.10.3822; WEINTRAUB H, 1979, NUCLEIC ACIDS RES, V7, P781, DOI 10.1093/nar/7.3.781; Wolffe A. P., 1996, DNA REPLICATION EUKA, P271; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; YANG L, 1991, NATURE, V353, P628, DOI 10.1038/353628a0	28	141	141	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					198	202		10.1038/nature01150	http://dx.doi.org/10.1038/nature01150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432398				2022-12-24	WOS:000179200900051
J	Ball, K; Berch, DB; Helmers, KF; Jobe, JB; Leveck, MD; Marsiske, M; Morris, JN; Rebok, GW; Smith, DM; Tennstedt, SL; Unverzagt, FW; Willis, SL				Ball, K; Berch, DB; Helmers, KF; Jobe, JB; Leveck, MD; Marsiske, M; Morris, JN; Rebok, GW; Smith, DM; Tennstedt, SL; Unverzagt, FW; Willis, SL		ACTIVE Study Grp	Effects of cognitive training interventions with older adults - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; MEMORY; AGE; PERFORMANCE; YOUNG; IMPAIRMENT; HEALTH; RECALL; CRASH; NORMS	Context Cognitive function in older adults is related to independent living and need for care. However, few studies have addressed whether improving cognitive functions might have short- or long-term effects on activities related to living independently: Objective To evaluate whether 3 cognitive training interventions improve mental abilities and daily functioning in older, independent-living adults. Design Randomized, controlled, single-blind trial with recruitment conducted from March 1998 to October 1999 and 2-year follow-up through December 2001. Setting and Participants Volunteer sample of 2832 persons aged 65 to 94 years recruited from senior housing, community centers, and hospital/clinics in 6 metropolitan areas in the United States. Interventions Participants were randomly assigned to 1 of 4 groups: 10-session group training for memory (verbal episodic memory; n=711), or reasoning (ability to solve problems that follow a serial pattern; n=705), or speed of processing (visual search and identification; n=712); or a no-contact control group (n=704). For the 3 treatment groups, 4-session booster training was offered to a 60% random sample 11 months later. Main Outcome Measures Cognitive function and cognitively demanding everyday functioning. Results Thirty participants were incorrectly randomized and were excluded from the analysis. Each intervention improved the targeted cognitive ability compared with baseline, durable to 2 years (P<.001 for all). Eighty-seven percent of speed-, 74% of reasoning-, and 26% of memory-trained participants demonstrated reliable cognitive improvement immediately after the intervention period. Booster training enhanced training gains in speed (P<.001) and reasoning (P<.001) interventions (speed booster, 92%; no booster, 68%; reasoning booster, 72%;. no booster, 49%), which were maintained at 2-year follow-up (P<.001 for both). No training effects on everyday functioning were detected at -2 years. Conclusions Results support the effectiveness and durability of the cognitive training interventions in improving targeted cognitive abilities: Training effects were of a magnitude equivalent to the amount of decline expected in elderly persons without dementia over 7- to 14-year intervals. Because of minimal functional decline across all groups, longer follow-up is likely required to observe training effects on everyday function.	Univ Alabama Birmingham, Dept Psychol, Ctr Res Appl Gerontol, Birmingham, AL 35294 USA; NIA, NIH, Bethesda, MD 20892 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Univ Florida, Inst Aging, Gainesville, FL USA; Univ Florida, Dept Hlth Policy & Epidemiol, Gainesville, FL USA; Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; Hebrew Rehabil Ctr Aged, Roslindale, MA USA; Johns Hopkins Univ, Dept Mental Hyg, Baltimore, MD USA; Indiana Univ, Sch Med, Dept Psychiat, Bloomington, IN USA; New England Res Inst, Watertown, MA 02172 USA; Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA	University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University; Maryland Department of Health & Mental Hygiene; Indiana University System; Indiana University Bloomington; HealthCore, Inc; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ball, K (corresponding author), Univ Alabama Birmingham, Dept Psychol, Ctr Res Appl Gerontol, 924 19th St S,101 Holley Mears Bldg, Birmingham, AL 35294 USA.	kball@uab.edu		Ball, Karlene/0000-0003-1811-9870; Marsiske, Michael/0000-0001-5973-2116	NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004508, U01NR004507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG014276, U01AG014260, U01AG014289, U01AG014263, U01AG014282] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K, 1993, J Am Optom Assoc, V64, P71; BALL K, 1988, Investigative Ophthalmology and Visual Science, V29, P448; Ball K., 2000, MOBILITY TRANSPORTAT, P213; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Baltes P. B., 1982, AGING COGNITIVE PROC, P353, DOI DOI 10.1007/978-1-4684-4178-9_19; Blom G., 1958, STAT ESTIMATES TRANS; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Callahan CM, 1996, ARCH NEUROL-CHICAGO, V53, P134, DOI 10.1001/archneur.1996.00550020038013; CHURCHILL JD, IN PRESS NEUROBIOL A; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; COHEN GD, 1995, AM J GERIAT PSYCHIAT, V3, P1, DOI 10.1097/00019442-199524310-00001; Cohen J., 1988, STAT POWER ANAL BEHA; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DIEHL M, 1995, PSYCHOL AGING, V10, P478, DOI 10.1037/0882-7974.10.3.478; Diehl M, 1998, ANN M GER SOC AM NOV; DUDEK FJ, 1979, PSYCHOL BULL, V86, P335, DOI 10.1037/0033-2909.86.2.335; EDWARDS JD, IN PRESS GERONTOLOGY; Ekstrom R., 1976, MANUAL KIT FACTOR RE; *FED INT FOR AG RE, 2000, OLD AM 2000 KEY IND; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gonda J, 1985, SCHAIE THURSTONE MEN; GREENBERG C, 1987, ED GERONTOL, V12, P385; HOFLAND BF, 1981, J EDUC PSYCHOL, V73, P573, DOI 10.1037/0022-0663.73.4.573; Jobe JB, 2001, CONTROL CLIN TRIALS, V22, P453, DOI 10.1016/S0197-2456(01)00139-8; KLIEGL R, 1990, DEV PSYCHOL, V26, P894, DOI 10.1037/0012-1649.26.6.894; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; LACHMAN ME, 1992, J GERONTOL, V47, pP293, DOI 10.1093/geronj/47.5.P293; LEIRER VO, 1988, J AM GERIATR SOC, V36, P877; LOWENTHAL MF, 1967, AGING MENTAL DISORDE; MCHORNEY CA, 1994, MED CARE, V32, P551, DOI 10.1097/00005650-199406000-00002; MORRIS J, 1997, MEASUREMENT ELDERLY; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; OWSLEY C, IN PRESS GERONTOLOGY; Rasmusson DX, 1999, AGING NEUROPSYCHOL C, V6, P56, DOI 10.1076/anec.6.1.56.790; REBOK GW, 1989, DEV PSYCHOL, V25, P714, DOI 10.1037/0012-1649.25.5.714; RECANZONE GH, 2000, NEW COGNITIVE NEUROS, P237; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schaie K. W., 1996, INTELLECTUAL DEV ADU; Small BJ, 1999, J GERONTOL B-PSYCHOL, V54, pP107, DOI 10.1093/geronb/54B.2.P107; Thurstone L. L., 1949, EXAMINER MANUAL SRA; WILLIS S, 1990, NEUROPSYCHOLOGY EVER, P183; Willis S L, 1986, Psychol Aging, V1, P239, DOI 10.1037/0882-7974.1.3.239; WILLIS SL, 1992, RES AGING, V14, P68, DOI 10.1177/0164027592141004; WILLIS SL, 1990, DEV PSYCHOL, V26, P905, DOI 10.1037/0012-1649.26.6.905; Willis SL., 1993, MANUAL EVERYDAY PROB; WILSON B, 1985, RIVER MEAD BEHAV MEM; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; YESAVAGE JA, 1985, AM J PSYCHIAT, V142, P600; Zelinski EM, 1997, PSYCHOL AGING, V12, P503, DOI 10.1037/0882-7974.12.3.503	57	1297	1343	8	219	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2002	288	18					2271	2281		10.1001/jama.288.18.2271	http://dx.doi.org/10.1001/jama.288.18.2271			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JZ	12425704	Bronze, Green Accepted			2022-12-24	WOS:000179186400026
J	Newberg, A; Alavi, A; van Rhijn, S; Cotter, A; Reilly, P				Newberg, A; Alavi, A; van Rhijn, S; Cotter, A; Reilly, P			Radiologic diagnosis of brain death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SCINTIGRAPHY		Hosp Univ Penn, Dept Med, Div Nucl Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Newberg, A (corresponding author), Hosp Univ Penn, Dept Med, Div Nucl Med, Philadelphia, PA 19104 USA.			Newberg, Andrew/0000-0001-8230-1752				Jenkins D. H., 1997, Journal of Nuclear Medicine, V38, p275P; LARAR GN, 1992, J NUCL MED, V33, P2209; ROSENBERG JH, 1995, NEUROLOGY, V45, P1012; WIELER H, 1993, CLIN NUCL MED, V18, P104, DOI 10.1097/00003072-199302000-00002; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	5	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2121	2122		10.1001/jama.288.17.2121	http://dx.doi.org/10.1001/jama.288.17.2121			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413369				2022-12-24	WOS:000179048100020
J	Battie, MC; Videman, T; Gibbons, LE; Manninen, H; Gill, K; Pope, M; Kaprio, J				Battie, MC; Videman, T; Gibbons, LE; Manninen, H; Gill, K; Pope, M; Kaprio, J			Occupational driving and lumbar disc degeneration: a case-control study	LANCET			English	Article							WHOLE-BODY VIBRATION; LOW-BACK-PAIN; VITAMIN-D-RECEPTOR; INTERVERTEBRAL DISC; IDENTICAL-TWINS; DISEASE; RISK; VOLVO	Background Back problems are reported more by occupational drivers than by any other occupational group. One explanation is that whole-body vibration caused by the vehicle leads to accelerated disc degeneration, herniation, and associated symptoms. We aimed to investigate the effects of lifetime driving exposure on lumbar disc degeneration in monozygotic twins with very different histories of occupational driving during their life. Methods We assessed 45 male monozygotic twin pairs from the population-based Finnish Twin Cohort who had greatly different patterns of occupational driving during their life. Data were obtained for driving exposures and potential confounding factors through an extensive, structured interview. We assessed disc degeneration with lumbar MRI. Findings Disc degeneration did not differ between occupational drivers and their twin brothers. We also did not identify any overall tendency for greater degeneration or pathology in occupational drivers than their twin brothers. Interpretations Although driving may exacerbate symptoms of back problems, it does not damage the disc. Our inability to identify structural damage should be encouraging to those employed in occupations involving motorised vehicles and operation of heavy equipment.	Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA; Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; SW Orthoped Inst, Dept Orthoped Surg, Dallas, TX USA; Univ Aberdeen, Dept Environm & Occupat Med, Aberdeen, Scotland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland	University of Alberta; University of Washington; University of Washington Seattle; Kuopio University Hospital; University of Eastern Finland; University of Aberdeen; University of Helsinki	Battie, MC (corresponding author), Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada.		Battie, Michele C/C-6155-2018; Kaprio, Jaakko/A-1820-2008	Battie, Michele C/0000-0001-8499-2040; Kaprio, Jaakko/0000-0002-3716-2455	NIAMS NIH HHS [R01 AR40857] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040857] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; BATTIE MC, 1991, SPINE, V16, P1015, DOI 10.1097/00007632-199109000-00001; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Bijkerk C, 1999, ARTHRITIS RHEUM, V42, P1729, DOI 10.1002/1529-0131(199908)42:8<1729::AID-ANR23>3.0.CO;2-H; BOOS N, 1993, RADIOLOGY, V188, P351, DOI 10.1148/radiology.188.2.8327677; Bovenzi M, 1999, INT ARCH OCC ENV HEA, V72, P351, DOI 10.1007/s004200050387; Brinckmann P, 1998, CLIN BIOMECH, V13, pS1, DOI 10.1016/S0268-0033(98)00050-3; BRINCKMANN P, 1988, CLIN BIOMECH, V3, P1; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DUPUIS H, 1994, INT ARCH OCC ENV HEA, V66, P303, DOI 10.1007/BF00378362; DUPUIS H, 1986, EFFECTS WHOLE BODY V, P31; Frank JW, 1996, SPINE, V21, P2908, DOI 10.1097/00007632-199612150-00024; GERTLING PO, 1987, TRILLEN SCHOKKEN TIJ; HANSSON T, 1991, CLIN BIOMECH, V6, P173, DOI 10.1016/0268-0033(91)90030-T; HELIOVAARA M, 1987, J CHRON DIS, V40, P259, DOI 10.1016/0021-9681(87)90162-7; HOLM S, 1985, Orthopaedic Transactions, V9, P525; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; *INT ORG STAND, 1985, 26311 ISO; Jensen MV, 1996, SPINE, V21, P2352, DOI 10.1097/00007632-199610150-00009; Jones G, 1998, ANN RHEUM DIS, V57, P94, DOI 10.1136/ard.57.2.94; Keller M., 1988, Molecular Plant-Microbe Interactions, V1, P267, DOI 10.1094/MPMI-1-267; KELSEY JL, 1975, AM J EPIDEMIOL, V102, P63, DOI 10.1093/oxfordjournals.aje.a112135; KJELLBERG A, 1994, ARBETE HALSA, V41, P1; Kumar A, 1999, SPINE, V24, P2506, DOI 10.1097/00007632-199912010-00013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lings S, 2000, INT ARCH OCC ENV HEA, V73, P290, DOI 10.1007/s004200000118; Luoma K, 1998, SCAND J WORK ENV HEA, V24, P358, DOI 10.5271/sjweh.356; MCLAIN RF, 1994, SPINE, V19, P1455, DOI 10.1097/00007632-199407000-00006; Portney L, 2000, FDN CLIN RES APPL PR, P565; Rantasalo, 1979, FINNISH TWIN REGISTR; Ronnemaa T, 1997, ANN INTERN MED, V126, P26, DOI 10.7326/0003-4819-126-1-199701010-00004; Videman T, 2000, CLIN BIOMECH, V15, P83, DOI 10.1016/S0268-0033(99)00047-9; Videman T, 1998, SPINE, V23, P2477, DOI 10.1097/00007632-199812010-00002; WUKASCH W, 1979, THESIS ZENTRALINSTIT	34	83	85	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 2	2002	360	9343					1369	1374		10.1016/S0140-6736(02)11399-7	http://dx.doi.org/10.1016/S0140-6736(02)11399-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	612ND	12423982				2022-12-24	WOS:000179081600009
J	Kousteni, S; Chen, JR; Bellido, T; Han, L; Ali, AA; O'Brien, CA; Plotkin, L; Fu, Q; Mancino, AT; Wen, Y; Vertino, AM; Powers, CC; Stewart, SA; Ebert, R; Parfitt, AM; Weinstein, RS; Jilka, RL; Manolagas, SC				Kousteni, S; Chen, JR; Bellido, T; Han, L; Ali, AA; O'Brien, CA; Plotkin, L; Fu, Q; Mancino, AT; Wen, Y; Vertino, AM; Powers, CC; Stewart, SA; Ebert, R; Parfitt, AM; Weinstein, RS; Jilka, RL; Manolagas, SC			Reversal of bone loss in mice by nongenotropic signaling of sex steroids	SCIENCE			English	Article							ESTROGEN; RECEPTOR; ACTIVATION; MECHANISMS; HORMONES	We show that sex steroids protect the adult murine skeleton through a mechanism that is distinct from that used to preserve the mass and function of reproductive organs. The classical genotropic actions of sex steroid receptors are dispensable for their bone protective effects, but essential for their effects on reproductive tissues. A synthetic ligand (4-estren-3alpha, 17beta-diol) that reproduces the nongenotropic effects of sex steroids, without affecting classical transcription, increases bone mass and strength in ovariectomized females above the level of the estrogen-replete state and is at least as effective as dihydrotestosterone in orchidectomized males, without affecting reproductive organs. Such ligands merit investigation as potential therapeutic alternatives to hormone replacement for osteoporosis of bone mass in both women and men.	Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Div Biometry, Little Rock, AR 72205 USA; Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Manolagas, SC (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Little Rock, AR 72205 USA.		O'Brien, Charles A./AAL-5078-2020; Plotkin, Lilian/H-7188-2019	Plotkin, Lilian/0000-0002-9537-4544	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR002127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; NIAMS NIH HHS [KO2-AR02127] Funding Source: Medline; NIA NIH HHS [P01-AG13918] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; de Jager T, 2001, J BIOL CHEM, V276, P27873, DOI 10.1074/jbc.M010984200; Doran PM, 2001, J BONE MINER RES, V16, P2118, DOI 10.1359/jbmr.2001.16.11.2118; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fitzpatrick JL, 2002, J NEUROCHEM, V82, P674, DOI 10.1046/j.1471-4159.2002.01000.x; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2002, J BONE MINER RES, V17, pS169; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2001, ENDOCRINOLOGY, V142, P2200, DOI 10.1210/en.142.6.2200; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; Ott SM, 2002, J BONE MINER RES, V17, P341, DOI 10.1359/jbmr.2002.17.2.341; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Samuels A, 1999, J BONE MINER RES, V14, P178, DOI 10.1359/jbmr.1999.14.2.178	21	345	371	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 25	2002	298	5594					843	846		10.1126/science.1074935	http://dx.doi.org/10.1126/science.1074935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607KR	12399595				2022-12-24	WOS:000178791200064
J	Mendell, JT; Rhys, CMJP; Dietz, HC				Mendell, JT; Rhys, CMJP; Dietz, HC			Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts	SCIENCE			English	Article							OPEN READING FRAME; PREMATURE TERMINATION CODON; MESSENGER-RNA; DEPENDENT MANNER; MAMMALIAN-CELLS; MEDIATED DECAY; GENE; TRANSLATION; EXON; SURVEILLANCE	The mechanism by which disruption of reading frame can influence pre-messenger RNA (pre-mRNA) processing is poorly understood. We assessed the role of factors essential for nonsense-mediated mRNA decay (NMD) in nonsense-mediated altered splicing (NAS) with the use of RNA interference (RNAi) in mammalian cells. Inhibition of rent1/hUpf1 expression abrogated both NMD and NAS of nonsense T cell receptor beta transcripts. In contrast, inhibition of rent2/hUpf2 expression did not disrupt NAS despite achieving comparable stabilization of nonsense transcripts. We also demonstrate that NAS and NMD are genetically separable functions of rent1/hUpf1. Additionally, rent1/hUpf1 enters the nucleus where it may directly influence early events in mRNA biogenesis. This provides compelling evidence that NAS relies on a component of the nonsense surveillance machinery but is not an indirect consequence of NMD.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 858 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055239] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55239] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEQUIST SE, 1997, NUCLEIC ACIDS RES, V25, P15; Caputi M, 2002, GENE DEV, V16, P1754, DOI 10.1101/gad.997502; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; Gersappe A, 1999, J BIOL CHEM, V274, P22452, DOI 10.1074/jbc.274.32.22452; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Li BH, 2002, P NATL ACAD SCI USA, V99, P5277, DOI 10.1073/pnas.082095299; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; MAQUAT LE, 1995, RNA, V1, P453; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113	25	219	230	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					419	422		10.1126/science.1074428	http://dx.doi.org/10.1126/science.1074428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12228722				2022-12-24	WOS:000178510400050
J	Freedman, DS; Khan, LK; Serdula, MK; Galuska, DA; Dietz, WH				Freedman, DS; Khan, LK; Serdula, MK; Galuska, DA; Dietz, WH			Trends and correlates of class 3 obesity in the United States from 1990 through 2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; SOCIOECONOMIC-STATUS; RELATIVE WEIGHT; US ADULTS; OVERWEIGHT; MORTALITY; HEALTH; ADIPOSITY; POPULATION	Context Although the prevalence of obesity has markedly increased among US adults, health risks vary according to the severity of obesity. Persons with class 3 obesity (body mass index [BMI] greater than or equal to 40) are at greatest risk, but there is little information about this subgroup. Objective To examine correlates of class 3 obesity and secular trends. Design, Setting, and Participants Adults (aged greater than or equal to 18 years) in the United States who participated in the Behavioral Risk Factor Surveillance System telephone survey between 1990 (75600 persons) and 2000 (164250 persons). Main Outcome Measure Body mass index calculated from self-reported weight and height. Results The prevalence of class 3 obesity increased from 0.78% (1990) to 2.2% (2000). In 2000, class 3 obesity was highest among black women (6.0%), persons who had not completed high school (3.4%), and persons who are short. During the 11-year period, the median BMI level increased by 1.2 units and the 95th percentile increased by 3.2 units. Conclusion The prevalence of class 3 obesity is increasing rapidly among adults. Because these extreme BMI levels are associated with the most severe. health complications, the incidence of various diseases will increase substantially in the future.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Freedman, DS (corresponding author), CDC, Mailstop K-26,4770 Buford Hwy, Atlanta, GA 30341 USA.			Freedman, David/0000-0001-8014-0289				[Anonymous], 2001, NIH PUBL; BILLEWICZ WZ, 1962, BRIT J PREV SOC MED, V16, P183; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; BRAY GA, 1997, HDB OBESITY, P31; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cleveland W.S., 1985, ELEMENTS GRAPHING DA, P135; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 1999, MED SCI SPORT EXER, V31, pS509, DOI 10.1097/00005768-199911001-00004; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Folsom AR, 1996, INT J OBESITY, V20, P704; Freedman DS, 1997, PEDIATRICS, V99, P420, DOI 10.1542/peds.99.3.420; FREEMAN JV, 1995, INT J EPIDEMIOL, V24, P970, DOI 10.1093/ije/24.5.970; Galuska DA, 1996, AM J PUBLIC HEALTH, V86, P1729, DOI 10.2105/AJPH.86.12.1729; Gentry E M, 1985, Am J Prev Med, V1, P9; GutierrezFisac JL, 1996, J CLIN EPIDEMIOL, V49, P351, DOI 10.1016/0895-4356(95)00535-8; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Kuczmarski RJ, 2000, AM J CLIN NUTR, V72, P1074; Lahmann PH, 2000, INT J OBESITY, V24, P685, DOI 10.1038/sj.ijo.0801219; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; LEDERMAN SA, 2000, OBSTET GYNECOL, V24, P685; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Maillard G, 1999, INT J OBESITY, V23, P389, DOI 10.1038/sj.ijo.0800831; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nieto-Garcia F J, 1990, Epidemiology, V1, P146, DOI 10.1097/00001648-199003000-00011; NIH Consensus Development Conference Panel, 1992, AM J CLIN NUTR, V55, p615S; Rahkonen O, 1998, J PUBLIC HEALTH POL, V19, P88, DOI 10.2307/3343091; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Shah BV, 1997, SUDAAN USERS MANUAL; SJOSTROM L V, 1992, American Journal of Clinical Nutrition, V55, p508S, DOI 10.1093/ajcn/55.2.508s; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; Welborn TA, 2000, INT J OBESITY, V24, P108, DOI 10.1038/sj.ijo.0801093; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854; 1999, PREVALENCE OVERWEIGH	39	323	326	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2002	288	14					1758	1761		10.1001/jama.288.14.1758	http://dx.doi.org/10.1001/jama.288.14.1758			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	602BJ	12365960				2022-12-24	WOS:000178484700029
J	Wellems, TE				Wellems, TE			Plasmodium chloroquine resistance and the search for a replacement antimalarial drug	SCIENCE			English	Editorial Material							HEMATIN POLYMERIZATION; FALCIPARUM; MALARIA; INHIBITION; MUTATIONS; BINDING		NIAID, Lab Malaria & Vector Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wellems, TE (corresponding author), NIAID, Lab Malaria & Vector Res, 9000 Rockville Pike, Bethesda, MD 20892 USA.	tew@helix.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000483, ZIAAI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		De DY, 1996, AM J TROP MED HYG, V55, P579, DOI 10.4269/ajtmh.1996.55.579; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HASTINGS MD, IN PRESS P NATL ACAD; Hawley SR, 1996, ANTIMICROB AGENTS CH, V40, P2345, DOI 10.1128/AAC.40.10.2345; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kwiatkowski D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P233; Levin BR, 2000, GENETICS, V154, P985; Maguire JD, 2002, LANCET, V360, P58, DOI 10.1016/S0140-6736(02)09336-4; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Ridley RG, 1996, ANTIMICROB AGENTS CH, V40, P1846, DOI 10.1128/AAC.40.8.1846; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Vippagunta SR, 1999, J MED CHEM, V42, P4630, DOI 10.1021/jm9902180; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; Wiesner J, 2002, ANTIMICROB AGENTS CH, V46, P2889, DOI 10.1128/AAC.46.9.2889-2894.2002; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	23	85	92	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					124	126		10.1126/science.1078167	http://dx.doi.org/10.1126/science.1078167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364789				2022-12-24	WOS:000178370500046
J	Gordeliy, VI; Labahn, J; Moukhametzianov, R; Efremov, R; Granzin, J; Schlesinger, R; Buldt, G; Savopol, T; Scheidig, AJ; Klare, JP; Engelhard, M				Gordeliy, VI; Labahn, J; Moukhametzianov, R; Efremov, R; Granzin, J; Schlesinger, R; Buldt, G; Savopol, T; Scheidig, AJ; Klare, JP; Engelhard, M			Molecular basis of transmembrane signalling by sensory rhodopsin II-transducer complex	NATURE			English	Article							STRUCTURAL-CHANGES; SERINE CHEMOTAXIS; PHOTOCYCLE; RECEPTOR; PROTEIN; DIFFRACTION; RESOLUTION; MEMBRANE; INSIGHTS; DOMAIN	Microbial rhodopsins, which constitute a family of seven-helix membrane proteins with retinal as a prosthetic group, are distributed throughout the Bacteria, Archaea and Eukaryota(1-3). This family of photoactive proteins uses a common structural design for two distinct functions: light-driven ion transport and phototaxis. The sensors activate a signal transduction chain similar to that of the two-component system of eubacterial chemotaxis(4). The link between the photoreceptor and the following cytoplasmic signal cascade is formed by a transducer molecule that binds tightly and specifically 5 to its cognate receptor by means of two transmembrane helices (TM1 and TM2). It is thought that light excitation of sensory rhodopsin II from Natronobacterium pharaonis (SRII) in complex with its transducer (HtrII) induces an outward movement of its helix F (ref. 6), which in turn triggers a rotation of TM2 (ref. 7). It is unclear how this TM2 transition is converted into a cellular signal. Here we present the X-ray structure of the complex between N. pharaonis SRII and the receptor-binding domain of HtrII at 1.94 Angstrom resolution, which provides an atomic picture of the first signal transduction step. Our results provide evidence for a common mechanism for this process in phototaxis and chemotaxis.	Res Ctr Julich, Inst Struct Biol IBI2, D-52425 Julich, Germany; Moscow Phys Tech Inst, Ctr Biophys & Phys Chem Supramol Struct, Dolgoprudnyi 141700, Moscow District, Russia; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; Max Planck Society	Buldt, G (corresponding author), Res Ctr Julich, Inst Struct Biol IBI2, D-52425 Julich, Germany.	g.bueldt@fz-juelich.de; martin.engelhard@mpi-dortmund.mpg.de	Klare, Johann P./C-1428-2009; Granzin, Joachim/G-8937-2013; Buldt, Georg/K-5345-2013; Büldt, Georg/H-9509-2014; Gordeliy, Valentin I/J-3636-2013; Efremov, Rouslan/P-9085-2015; Savopol, Tudor/B-5670-2011; Labahn, Jörg/G-9593-2013; Scheidig, Axel/C-9141-2011; Schlesinger, Ramona/W-2620-2018	Klare, Johann P./0000-0002-5761-5968; Granzin, Joachim/0000-0001-6604-950X; Gordeliy, Valentin I/0000-0001-5782-5896; Efremov, Rouslan/0000-0001-7516-8658; Savopol, Tudor/0000-0001-7231-3581; Labahn, Jörg/0000-0002-0648-8145; Schlesinger, Ramona/0000-0002-7716-4439				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; GERWERT K, 1990, FEBS LETT, V261, P449, DOI 10.1016/0014-5793(90)80613-N; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Hou SB, 1998, J BACTERIOL, V180, P1600, DOI 10.1128/JB.180.6.1600-1602.1998; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Klostermeier D, 1998, J MOL BIOL, V279, P841, DOI 10.1006/jmbi.1998.1816; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; LESLIE AGW, 2002, CCP4 ESF EACMB NEWSL, V26; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; LYNCH BA, 1992, FEBS LETT, V307, P3, DOI 10.1016/0014-5793(92)80891-J; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Rudolph J, 1996, J MOL BIOL, V258, P548, DOI 10.1006/jmbi.1996.0267; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zhang WS, 1996, P NATL ACAD SCI USA, V93, P8230, DOI 10.1073/pnas.93.16.8230; Zhang XN, 1999, P NATL ACAD SCI USA, V96, P857, DOI 10.1073/pnas.96.3.857	31	324	335	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2002	419	6906					484	487		10.1038/nature01109	http://dx.doi.org/10.1038/nature01109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368857				2022-12-24	WOS:000178348400038
J	Prince, AS				Prince, AS			Clinical implications of basic research: Biofilms, antimicrobial resistance, and airway infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Prince, AS (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.							Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a	2	139	143	1	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2002	347	14					1110	1111		10.1056/NEJMcibr021776	http://dx.doi.org/10.1056/NEJMcibr021776			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599KD	12362015				2022-12-24	WOS:000178332900012
J	Snow, M; Cox, SL; Jenkin, G; Trounson, A; Shaw, J				Snow, M; Cox, SL; Jenkin, G; Trounson, A; Shaw, J			Generation of live young from xenografted mouse ovaries	SCIENCE			English	Article							FOLLICULAR DEVELOPMENT; FOLLICLES; TISSUE; MICE		Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; Monash Univ, Monash Inst Reprod & Dev, Clayton, Vic 3800, Australia	Monash University; Monash University	Cox, SL (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.			Trounson, Alan/0000-0001-5469-0500				GOSDEN RG, 1994, J REPROD FERTIL, V101, P619, DOI 10.1530/jrf.0.1010619; Gunasena KT, 1998, ANIM REPROD SCI, V53, P265, DOI 10.1016/S0378-4320(98)00132-8; Mattiske D, 2002, REPRODUCTION, V123, P143, DOI 10.1530/reprod/123.1.143; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Wolvekamp MCJ, 2001, ANIM REPROD SCI, V65, P135, DOI 10.1016/S0378-4320(00)00228-1	7	60	77	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2002	297	5590					2227	2227		10.1126/science.1073693	http://dx.doi.org/10.1126/science.1073693			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	597LA	12351780				2022-12-24	WOS:000178222000036
J	Ford, MGJ; Mills, IG; Peter, BJ; Vallis, Y; Praefcke, GJK; Evans, PR; McMahon, HT				Ford, MGJ; Mills, IG; Peter, BJ; Vallis, Y; Praefcke, GJK; Evans, PR; McMahon, HT			Curvature of clathrin-coated pits driven by epsin	NATURE			English	Article							ENTH DOMAIN; VESICLE FORMATION; BINDING; EPS15; AMPHIPHYSIN; UNDERGOES; DYNAMIN; NUMBER	Clathrin-mediated endocytosis involves cargo selection and membrane budding into vesicles with the aid of a protein coat. Formation of invaginated pits on the plasma membrane and subsequent budding of vesicles is an energetically demanding process that involves the cooperation of clathrin with many different proteins. Here we investigate the role of the brain-enriched protein epsin 1 in this process. Epsin is targeted to areas of endocytosis by binding the membrane lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5) P-2). We show here that epsin 1 directly modifies membrane curvature on binding to PtdIns(4,5) P-2 in conjunction with clathrin polymerization. We have discovered that formation of an amphipathic alpha-helix in epsin is coupled to PtdIns(4,5)P-2 binding. Mutation of residues on the hydrophobic region of this helix abolishes the ability to curve membranes. We propose that this helix is inserted into one leaflet of the lipid bilayer, inducing curvature. On lipid monolayers epsin alone is sufficient to facilitate the formation of clathrin-coated invaginations.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	pre@mrc-lmb.cam.ac.uk; hmm@mrc-lmb.cam.ac.uk	Peter, Brian/AAZ-7323-2020; Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Praefcke, Gerrit/0000-0001-8818-1499				Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; McPherson PS, 1998, BIOCHEM BIOPH RES CO, V244, P701, DOI 10.1006/bbrc.1998.8331; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Nossal R, 2001, TRAFFIC, V2, P138, DOI 10.1034/j.1600-0854.2001.020208.x; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	27	756	768	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2002	419	6905					361	366		10.1038/nature01020	http://dx.doi.org/10.1038/nature01020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353027				2022-12-24	WOS:000178195400037
J	Klein, JA; Longo-Guess, CM; Rossmann, MP; Seburn, KL; Hurd, RE; Frankel, WN; Bronson, RT; Ackerman, SL				Klein, JA; Longo-Guess, CM; Rossmann, MP; Seburn, KL; Hurd, RE; Frankel, WN; Bronson, RT; Ackerman, SL			The harlequin mouse mutation down-regulates apoptosis-inducing factor	NATURE			English	Article							NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSGENIC MICE; CYCLE; PROTEIN; GENE; NEURODEGENERATION; EXPRESSION; MECHANISM	Harlequin (Hq) mutant mice have progressive degeneration of terminally differentiated cerebellar and retinal neurons. We have identified the Hq mutation as a proviral insertion in the apoptosis-inducing factor (Aif) gene, causing about an 80% reduction in AIF expression. Mutant cerebellar granule cells are susceptible to exogenous and endogenous peroxide-mediated apoptosis, but can be rescued by AIF expression. Overexpression of AIF in wild-type granule cells further decreases peroxide-mediated cell death, suggesting that AIF serves as a free radical scavenger. In agreement, dying neurons in aged Hq mutant mice show oxidative stress. In addition, neurons damaged by oxidative stress in both the cerebellum and retina of Hq mutant mice re-enter the cell cycle before undergoing apoptosis. Our results provide a genetic model of oxidative stress-mediated neurodegeneration and demonstrate a direct connection between cell cycle re-entry and oxidative stress in the ageing central nervous system.	Jackson Lab, Bar Harbor, ME 04609 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Jackson Laboratory; Tufts University	Ackerman, SL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	sla@jax.org	Rossmann, Marlies/AAJ-1943-2021	Rossmann, Marlies/0000-0003-2056-6792				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; BAILLIE TA, 1991, ACCOUNTS CHEM RES, V24, P264, DOI 10.1021/ar00009a003; Barber BR, 1971, MOUSE NEWS LETT, V45, P34; BRONSON RT, 1990, MOUSE GENOME, V87, P110; Busser J, 1998, J NEUROSCI, V18, P2801; CAMBRAYDEAKIN MA, 1995, NEURAL CELL CULTURE, P3; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; COFFIN JM, 1989, ANN NY ACAD SCI, V567, P39, DOI 10.1111/j.1749-6632.1989.tb16457.x; COFFIN JM, 1984, RNA TUMOR VIRUSES 1, P261; Costa GL, 2000, J IMMUNOL, V164, P3581, DOI 10.4049/jimmunol.164.7.3581; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; ElShamy WM, 1998, NEURON, V21, P1003, DOI 10.1016/S0896-6273(00)80619-4; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Frade JM, 2000, J CELL SCI, V113, P1139; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Grignani F, 1998, CANCER RES, V58, P14; HAMMANG JP, 1993, NEURON, V10, P1197, DOI 10.1016/0896-6273(93)90067-2; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Heintz N, 2000, ANNU REV PHYSIOL, V62, P779, DOI 10.1146/annurev.physiol.62.1.779; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kimura H, 1996, GENES CELLS, V1, P977, DOI 10.1046/j.1365-2443.1996.840284.x; KURKI P, 1986, EXP CELL RES, V166, P209, DOI 10.1016/0014-4827(86)90520-3; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Lynn RB, 1997, J AUTONOM NERV SYST, V62, P174, DOI 10.1016/S0165-1838(96)00125-7; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; McShea A, 1999, MED HYPOTHESES, V52, P525, DOI 10.1054/mehy.1997.0680; Migheli A, 1999, AM J PATHOL, V155, P365, DOI 10.1016/S0002-9440(10)65133-4; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Mundy WR, 2000, NEUROTOXICOLOGY, V21, P1135; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nagy Z, 1997, ACTA NEUROPATHOL, V93, P294, DOI 10.1007/s004010050617; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Sayre LM, 2001, CURR MED CHEM, V8, P721, DOI 10.2174/0929867013372922; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TAYLOR BA, 1989, GENOMICS, V5, P221, DOI 10.1016/0888-7543(89)90050-5; White AR, 1998, J NEUROSCI, V18, P6207; WILLIAMS J, 1995, CHEM BIOCH FLAVOENZY, P121; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001	47	480	499	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2002	419	6905					367	374		10.1038/nature01034	http://dx.doi.org/10.1038/nature01034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	596ZB	12353028				2022-12-24	WOS:000178195400038
J	Rahi, JS; Logan, S; Timms, C; Russell-Eggitt, I; Taylor, D				Rahi, JS; Logan, S; Timms, C; Russell-Eggitt, I; Taylor, D			Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study	LANCET			English	Article							PREVALENCE; CHILDREN; BLINDNESS; GLAUCOMA	Background Screening for amblyopia in early childhood is done in many countries to ensure that affected children are detected and treated within the critical period, and achieve a level of vision in their amblyopic eye that would be useful should they lose vision in their non-amblyopic eye later in life. We aimed to investigate the risk, causes, and outcomes of visual impairment attributable to loss of vision in the non-amblyopic eye. Methods For 24 months from July, 1997, national surveillance was done to identify all individuals in the UK with unilateral amblyopia (acuity worse than 6/12) who had newly acquired vision loss in the non-amblyopic eye, resulting in acuity of worse than 6/12 or visual-field restriction precluding driving. Information about participants was obtained at presentation and 1 year later. Participants were categorised as having socially significant visual impairment, or visual impairment, severe visual impairment, or blindness, in accordance with WHO taxonomy. Findings Of 370 eligible individuals, at presentation 104 (28%) had socially significant visual impairment, 180 (49%) visual impairment, and 86 (23%) severe visual impairment or blindness. The minimum risk of permanent visual impairment by age 95 years was 32.9 (95% Cl 29.1-36.9) per 100 000 total population. The projected lifetime risk of vision loss for an individual with amblyopia was at least 1.2% (95% Cl 1.1-1.4). Only 36 (35%) of 102 people previously in paid employment were able to continue. Interpretation In the UK, where screening for amblyopia is under review, risk of serious vision loss affecting the nonamblyopic eye and its results are greater than that previously assumed. Thus, in addition to the-benefits of improved vision in the amblyopic eye, treatment of amblyopia during childhood is a potentially valuable strategy to prevent incapacitating vision loss later in life.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, Dept Ophthalmol, London, England; Inst Ophthalmol, Dept Epidemiol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahi, JS (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	j.rahi@ich.ucl.ac.uk		Rahi, Jugnoo/0000-0002-5718-9209; Logan, Stuart/0000-0002-9279-261X				Adams GGW, 1999, BRIT J OPHTHALMOL, V83, P380; Arnold JJ, 2000, BRIT MED J, V321, P741, DOI 10.1136/bmj.321.7263.741; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Bray LC, 1996, EYE, V10, P714, DOI 10.1038/eye.1996.166; Breslow NE., 1987, STAT METHODS CANC RE, P81; *BRIT OPHTH SURV U, 2000, BOSU NEWS BRIT OPHTH; CAMPOS E, 1995, SURV OPHTHALMOL, V40, P23, DOI 10.1016/S0039-6257(95)80044-1; Dandona L, 1999, OPHTHALMOLOGY, V106, P497, DOI 10.1016/S0161-6420(99)90107-0; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; Evans J., 1995, STUDIES MED POPULATI, V57; Hattenhauer MG, 1998, OPHTHALMOLOGY, V105, P2099, DOI 10.1016/S0161-6420(98)91133-2; JAKOBSSON P, 1997, T 24 M EUR STRAB ASS, P317; KEECH RV, 1995, J PEDIATR OPHTHALMOL, V32, P89; Klein R, 1997, LANCET, V350, P197, DOI 10.1016/S0140-6736(97)04195-0; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; Kvarnstrom G, 1998, ACTA PAEDIATR, V87, P1173; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; MacEwen CJ, 1999, BRIT J OPHTHALMOL, V83, P933, DOI 10.1136/bjo.83.8.933; McCarty CA, 2001, BRIT J OPHTHALMOL, V85, P322, DOI 10.1136/bjo.85.3.322; MUNTON G, 1995, MED ASPECTS FITNESS, P118; Newman D K, 2000, Ophthalmic Epidemiol, V7, P67, DOI 10.1076/0928-6586(200003)7:1;1-2;FT067; *OFF NAT STAT, 2000, POP TRENDS, V102; Reidy A, 1998, BRIT MED J, V316, P1643, DOI 10.1136/bmj.316.7145.1643; Risser WL, 1996, PEDIATRICS, V98, P311; SNOWDON S, 1997, 9 CRD NHS; Stanford MR, 1997, BRIT J OPHTHALMOL, V81, P932, DOI 10.1136/bjo.81.11.932; TAYLOR D, 1985, T OPHTHAL SOC UK, V104, P637; Taylor HR, 2001, BRIT J OPHTHALMOL, V85, P261, DOI 10.1136/bjo.85.3.261; THOMPSON JR, 1991, PUBLIC HEALTH, V105, P455, DOI 10.1016/S0033-3506(05)80616-X; TOMMILA V, 1981, BRIT J OPHTHALMOL, V65, P575, DOI 10.1136/bjo.65.8.575; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220; VINDING T, 1991, ACTA OPHTHALMOL, V69, P796; Von Noorden GK, 1995, BINOCULAR VISION OCU, V5; World Health Organization, 1992, INT STAT CLASS DIS H; WORMALD RPL, 1992, BRIT MED J, V304, P1226, DOI 10.1136/bmj.304.6836.1226	36	162	168	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2002	360	9333					597	602		10.1016/S0140-6736(02)09782-9	http://dx.doi.org/10.1016/S0140-6736(02)09782-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586TD	12241931				2022-12-24	WOS:000177600400009
J	Abele, D				Abele, D			The radical life-giver	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, Dept Ecotoxicol & Ecophysiol, D-27568 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Abele, D (corresponding author), Alfred Wegener Inst Polar & Marine Res, Dept Ecotoxicol & Ecophysiol, Columbusstr, D-27568 Bremerhaven, Germany.			Abele, Doris/0000-0002-5766-5017				Chandel NS, 2000, J APPL PHYSIOL, V88, P1880, DOI 10.1152/jappl.2000.88.5.1880; Maier CM, 2001, J NEUROSURG, V94, P90, DOI 10.3171/jns.2001.94.1.0090; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; TAYLOR AC, 1976, J MAR BIOL ASSOC UK, V56, P95, DOI 10.1017/S0025315400020464	4	75	77	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					27	27		10.1038/420027a	http://dx.doi.org/10.1038/420027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422197	Green Published			2022-12-24	WOS:000179068100020
J	Mariano, NA				Mariano, NA			The changing room	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2091	2091		10.1001/jama.288.17.2091	http://dx.doi.org/10.1001/jama.288.17.2091			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413353				2022-12-24	WOS:000179048100001
J	Cao, R; Wang, LJ; Wang, HB; Xia, L; Erdjument-Bromage, H; Tempst, P; Jones, RS; Zhang, Y				Cao, R; Wang, LJ; Wang, HB; Xia, L; Erdjument-Bromage, H; Tempst, P; Jones, RS; Zhang, Y			Role of histone H3 lysine 27 methylation in polycomb-group silencing	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CHROMO DOMAIN; GROUP GENE; BITHORAX COMPLEX; GROUP PROTEINS; ENHANCER; ZESTE; HP1; REPRESSION; SITE	Polycomb group (PcG) proteins play important roles in maintaining the silent state of HOX genes. Recent studies have implicated histone methylation in long-term gene silencing. However, a connection between PcG-mediated gene silencing and histone methylation has not been established. Here we report the purification and characterization of an EED-EZH2 complex, the human counterpart of the Drosophila ESC-E(Z) complex. We demonstrate that the complex specifically methylates nucleosomal histone H3 at lysine 27 (H3-K27). Using chromatin immunoprecipitation assays, we show that H3-K27 methylation colocalizes with, and is dependent on, E(Z) binding at an Ultrabithorax (Ubx) Polycomb response element (PRE), and that this methylation correlates with Ubx repression. Methylation on H3-K27 facilitates binding of Polycomb (PC), a component of the PRC1 complex, to histone H3 amino-terminal tail. Thus, these studies establish a link between histone methylation and PcG-mediated gene silencing.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Southern Methodist University; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.			Zhang, Yi/0000-0002-2789-0811; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Wang, Hengbin/0000-0003-2414-0609				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Birve A, 2001, DEVELOPMENT, V128, P3371; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; CABRERA CV, 1985, NATURE, V318, P569, DOI 10.1038/318569a0; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Fritsch C, 1999, DEVELOPMENT, V126, P3905; He GP, 1999, J BIOL CHEM, V274, P14678, DOI 10.1074/jbc.274.21.14678; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JONES RS, 1990, GENETICS, V126, P185; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Platero JS, 1996, CHROMOSOMA, V104, P393, DOI 10.1007/BF00352263; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tie F, 2001, DEVELOPMENT, V128, P275; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	33	2697	2802	3	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 1	2002	298	5595					1039	1043		10.1126/science.1076997	http://dx.doi.org/10.1126/science.1076997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609XQ	12351676				2022-12-24	WOS:000178932000061
J	Takeda, S; Elefteriou, F; Levasseur, R; Liu, XY; Zhao, LP; Parker, KL; Armstrong, D; Ducy, P; Karsenty, G				Takeda, S; Elefteriou, F; Levasseur, R; Liu, XY; Zhao, LP; Parker, KL; Armstrong, D; Ducy, P; Karsenty, G			Leptin regulates bone formation via the sympathetic nervous system	CELL			English	Article							DOPAMINE-BETA-HYDROXYLASE; VENTROMEDIAL HYPOTHALAMUS; GLUCOCORTICOID RECEPTOR; POSTMENOPAUSAL WOMEN; FRAMESHIFT MUTATION; TRANSGENIC MICE; POMC NEURONS; DNA-BINDING; OB-R; OBESITY	We previously showed that leptin inhibits bone formation by an undefined mechanism. Here, we show that hypothalamic leptin-dependent antiosteogenic and anorexigenic networks differ, and that the peripheral mediators of leptin antiosteogenic function appear to be neuronal. Neuropeptides mediating leptin anorexigenic function do not affect bone formation. Leptin deficiency results in low sympathetic tone, and genetic or pharmacological ablation of adrenergic signaling leads to a leptin-resistant high bone mass. beta-adrenergic receptors on osteoblasts regulate their proliferation, and a beta-adrenergic agonist decreases bone mass in leptin-deficient and wild-type mice while a beta-adrenergic antagonist increases bone mass in wild-type and ovariectomized mice. None of these manipulations affects body weight. This study demonstrates a leptin-dependent neuronal regulation of bone formation with potential therapeutic implications for osteoporosis.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program Texas, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		takeda, shu/B-5195-2012; Elefteriou, Florent/P-2586-2017; Elefteriou, Florent/GMW-8429-2022	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058883, R01DK054480] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24054] Funding Source: Medline; NIDDK NIH HHS [DK58883, DK54480] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI JD, 1993, SEMIN ARTHRITIS RHEU, V22, P375, DOI 10.1016/S0049-0172(05)80029-0; Alaniz RC, 1999, P NATL ACAD SCI USA, V96, P2274, DOI 10.1073/pnas.96.5.2274; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; Bliziotes M, 2000, BONE, V26, P15, DOI 10.1016/S8756-3282(99)00232-X; Bray GA, 1998, RECENT PROG HORM RES, V53, P95; Cooper Cyrus, 1996, P419; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DEBONS AF, 1962, AM J PHYSIOL, V4, P743; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dellovade TL, 2000, J COMP NEUROL, V423, P579, DOI 10.1002/1096-9861(20000807)423:4<579::AID-CNE4>3.0.CO;2-#; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; HARRIS RBS, 1984, AM J PHYSIOL, V247, pR380, DOI 10.1152/ajpregu.1984.247.2.R380; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Karst H, 2000, NAT NEUROSCI, V3, P977, DOI 10.1038/79910; KAUFMAN JM, 1992, J CLIN ENDOCR METAB, V74, P118, DOI 10.1210/jc.74.1.118; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MINKOWITZ B, 1991, J ORTHOPAED RES, V9, P869, DOI 10.1002/jor.1100090613; Moore DD, 1995, GLOB MOB SURV; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Ruffin MP, 1999, BRAIN RES, V846, P23, DOI 10.1016/S0006-8993(99)01922-8; Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schwartzman RJ, 2000, NEW ENGL J MED, V343, P654, DOI 10.1056/NEJM200008313430911; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thomas SA, 1998, J NEUROCHEM, V70, P2468; TREMOLLIERES FA, 1993, J CLIN ENDOCR METAB, V77, P683, DOI 10.1210/jc.77.3.683; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI, P665	46	1215	1306	2	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 1	2002	111	3					305	317		10.1016/S0092-8674(02)01049-8	http://dx.doi.org/10.1016/S0092-8674(02)01049-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419242	Bronze			2022-12-24	WOS:000179010100004
J	Mannikko, R; Elinder, F; Larsson, HP				Mannikko, R; Elinder, F; Larsson, HP			Voltage-sensing mechanism is conserved among ion channels gated by opposite voltages	NATURE			English	Article							SHAKER K+ CHANNEL; CA1 PYRAMIDAL NEURONS; PACEMAKER CHANNEL; POTASSIUM CHANNEL; XENOPUS OOCYTES; SODIUM-CHANNELS; MOLECULAR-BASIS; S4 SEGMENT; MOVEMENT; INACTIVATION	Hyperpolarization-activated cyclic-nucleotide-gated (HCN) ion channels are found in rhythmically firing cells in the brain and in the heart(1), where the cation current through HCN channels (called I-h or I-f) causes these cells to fire repeatedly(2). These channels are also found in non-pacing cells, where they control resting membrane properties, modulate synaptic transmission, mediate long-term potentiation, and limit extreme hyperpolarizations(3-7). HCN channels share sequence motifs with depolarization-activated potassium (Kv) channels, such as the fourth transmembrane segment S4(8,9). S4 is the main voltage sensor of Kv channels, in which transmembrane movement of S4 charges triggers the opening of the activation gate(10-17). Here, using cysteine accessibility methods(10-12), we investigate whether S4 moves in an HCN channel. We show that S4 movement is conserved between Kv and HCN channels, which indicates that S4 is also the voltage sensor in HCN channels. Our results suggest that a conserved voltage-sensing mechanism operates in the oppositely voltage-gated Kv and HCN channels, but that there are different coupling mechanisms between the voltage sensor and activation gate in the two different channels.	Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA; Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, SE-17177 Stockholm, Sweden	Oregon Health & Science University; Karolinska Institutet	Larsson, HP (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.		Mannikko, Roope/Q-3567-2016	Mannikko, Roope/0000-0002-8727-9184; Elinder, Fredrik/0000-0001-9125-5583				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ALLENDE CC, 1977, J BIOL CHEM, V252, P4662; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Keynes RD, 1999, P ROY SOC B-BIOL SCI, V266, P843, DOI 10.1098/rspb.1999.0714; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1998, J NEUROSCI, V18, P7613; MALLER JL, 1979, J BIOL CHEM, V254, P579; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Vaca L, 2000, FEBS LETT, V479, P35, DOI 10.1016/S0014-5793(00)01837-8; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	30	148	154	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 24	2002	419	6909					837	841		10.1038/nature01038	http://dx.doi.org/10.1038/nature01038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397358				2022-12-24	WOS:000178769800046
J	Tanasescu, N; Leitzmann, MF; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB				Tanasescu, N; Leitzmann, MF; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB			Exercise type and intensity in relation to coronary heart disease in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIME PHYSICAL-ACTIVITY; CARDIOVASCULAR RISK-FACTORS; LEISURE-TIME; WOMEN; PREVENTION; WALKING; HEALTH; MORTALITY; METAANALYSIS; FITNESS	Context Studies have shown an inverse relationship between exercise and risk of coronary heart disease (CHD), but data on type and intensity are sparse. Objective To assess the amount, type, and intensity of physical activity in relation to risk of CHD among men. Design, Setting, and Participants A cohort of 44452 US men enrolled in the Health Professionals' Follow-up Study, followed up at 2-year intervals from 1986 through January 31, 1998, to assess potential CHD risk factors, identify newly diagnosed cases of CHD, and assess levels of leisure-time physical activity. Main Outcome Measure Incident nonfatal myocardial infarction or fatal CHD occurring during the follow-up period. Results During 475755 person-years, we documented 1700 new cases of CHD. Total physical activity, running, weight training, and rowing were each inversely associated with risk of CHID. The RRs (95% confidence intervals [CIs]) corresponding to quintiles of metabolic equivalent tasks (METs) for total physical activity adjusted for age, smoking, and other cardiovascular risk factors were 1.0, 0.90 (0.78-1.04), 0.87 (0.75-1.00), 0.83 (0.71-0.96), and 0.70 (0.59-0.82) (P<.001 for trend). Men who ran for an hour or more per week had a 42% risk reduction (RR, 0.58; 95% CI, 0.44-0.77) compared with men who did not run (P<.001 for trend). Men who trained with weights for 30 minutes or more per week had a 23% risk reduction (RR, 0.77; 95% CI, 0.61-0.98) compared with men who did not train with weights (P=.03 for trend). Rowing for 1 hour or more per week was associated with an 18% risk reduction (RR, 0.82; 05% CI, 0.68-0.99). Average exercise intensity was associated with reduced CHD risk independent of the total volume of physical activity. The RRs (95% CIs) corresponding to moderate (4-6 MET's) and high (6-12 METs) activity intensities were 0.94 (0.83-1.04) and 0.83 (0.72-0.97) compared with low activity intensity (<4 ME Ts) (P=.02 for trend). A half-hour per day or more of brisk walking was associated with an 18% risk reduction (RR, 0.82; 95% CI, 0.67-1.00). Walking pace was associated with reduced CHD risk independent of the number of walking hours. Conclusions Total physical activity, running, weight training, and walking were each associated with reduced CHID risk. Average exercise intensity was associated with reduced risk independent of the number of MET-hours spent in physical activity.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University	Tanasescu, N (corresponding author), Loma Linda Univ, Dept Nutr, Nichol Hall,Room 1120, Loma Linda, CA 92350 USA.		Hu, Frank/C-1919-2013		NCI NIH HHS [CA 55075] Funding Source: Medline; NHLBI NIH HHS [HL 35464] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Crespo CJ, 1996, ARCH INTERN MED, V156, P93, DOI 10.1001/archinte.156.1.93; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Drygas W, 2000, INT J SPORTS MED, V21, P235, DOI 10.1055/s-2000-309; Folsom AR, 1997, MED SCI SPORT EXER, V29, P901, DOI 10.1097/00005768-199707000-00009; Francis K, 1996, PHYS THER, V76, P456, DOI 10.1093/ptj/76.5.456; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; HARDMAN AE, 1994, BRIT J SPORT MED, V28, P261, DOI 10.1136/bjsm.28.4.261; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hurley BF, 2000, SPORTS MED, V30, P249, DOI 10.2165/00007256-200030040-00002; LaCroix AZ, 1996, J AM GERIATR SOC, V44, P113, DOI 10.1111/j.1532-5415.1996.tb02425.x; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; LEON AS, 1991, INT J EPIDEMIOL, V20, P690, DOI 10.1093/ije/20.3.690; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Mensink GBM, 1996, EPIDEMIOLOGY, V7, P391, DOI 10.1097/00001648-199607000-00009; MORRIS JN, 1990, BRIT HEART J, V63, P325; Paffenbarger RSLI, 1996, PREVENTION MYOCARDIA, P172; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Poehlman ET, 2000, J CLIN ENDOCR METAB, V85, P2463, DOI 10.1210/jc.85.7.2463; Poehlman ET, 1998, INT J SPORT NUTR, V8, P143, DOI 10.1123/ijsn.8.2.143; Prabhakaran B, 1999, BRIT J SPORT MED, V33, P190, DOI 10.1136/bjsm.33.3.190; Prakash M, 2001, CHEST, V120, P1003, DOI 10.1378/chest.120.3.1003; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Sesso HD, 2000, CIRCULATION, V102, P975, DOI 10.1161/01.CIR.102.9.975; SHAPER AG, 1991, BRIT HEART J, V66, P384; Therneau T.M., 1997, P 1 SEATTL S BIOST S, P51; Walker KZ, 1999, DIABETES CARE, V22, P555, DOI 10.2337/diacare.22.4.555; Wannamethee SG, 2001, SPORTS MED, V31, P101, DOI 10.2165/00007256-200131020-00003; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012	34	578	595	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2002	288	16					1994	2000		10.1001/jama.288.16.1994	http://dx.doi.org/10.1001/jama.288.16.1994			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	606QW	12387651				2022-12-24	WOS:000178745500022
J	Bernard, L; Vuagnat, A; Peytavin, G; Hallouin, MC; Bouhour, D; Nguyen, TH; Vilde, JL; Bricaire, F; Raguin, G; de Truchis, P; Ghez, D; Duong, M; Perronne, C				Bernard, L; Vuagnat, A; Peytavin, G; Hallouin, MC; Bouhour, D; Nguyen, TH; Vilde, JL; Bricaire, F; Raguin, G; de Truchis, P; Ghez, D; Duong, M; Perronne, C			Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy	ANNALS OF INTERNAL MEDICINE			English	Article							PROTEASE-INHIBITOR; RESISTANCE; INFECTION; AIDS	Background: Suboptimal levels of antiretroviral drugs result in virologic failure in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Objective: To assess the relationship between levels of indinavir in hair and virologic outcome. Design: Cross-sectional study. Setting: 7 AIDS clinics in France. Patients: 89 HIV-infected patients who received HAART that included indinavir. Measurements: Patients were classified as responders or nonresponders on the basis of viremia at the time of hair collection. in nonresponders, levels of indinavir in hair and resistance mutations in the protease gene were assessed at baseline and at the time of indinavir measurement. Results: Mean indinavir levels (+/-SD) were significantly higher in the 65 responders than in the 24 nonresponders (24.4 +/- 16 mug/g vs. 12.9 +/- 8.6 mug/g) (P < 0.001). Nonresponders with intermediate levels of indinavir in hair had more mutations in the protease gene than did nonresponders with low levels of indinavir in hair. Conclusion: Indinavir levels in hair are associated with virologic outcome in patients receiving HAART.	Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva, Switzerland; Virol Lab, Geneva, Switzerland; Hop Paul Brousse, Villejuif, France; Hop Croix Rousse, F-69317 Lyon, France; Hop Bichat Claude Bernard, F-75877 Paris, France; Hop Rothschild, F-75571 Paris, France; Hop La Pitie Salpetriere, Paris, France; Hop Croix St Simon, Paris, France; Hop Raymond Poincare, Garches, France; Hop Bocage, Dijon, France	University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; CHU Dijon Bourgogne	Bernard, L (corresponding author), Univ Hosp Geneva, Div Infect Dis, Rue Micheli Du Crest, CH-1211 Geneva, Switzerland.	louis.bernard@hcuge.ch						Bernard L, 1998, LANCET, V352, P1757, DOI 10.1016/S0140-6736(05)79831-7; Condra JH, 1998, ANN INTERN MED, V128, P951, DOI 10.7326/0003-4819-128-11-199806010-00017; Condra JH, 1998, HAEMOPHILIA, V4, P610, DOI 10.1046/j.1365-2516.1998.440610.x; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Diggle PJ, 2002, ANAL LONGITUDINAL DA; GRAHAM K, 1989, JAMA-J AM MED ASSOC, V262, P3328, DOI 10.1001/jama.262.23.3328; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hirschel B, 1998, NEW ENGL J MED, V338, P906, DOI 10.1056/NEJM199803263381310; KINTZ P, 1993, INT J LEGAL MED, V105, P283, DOI 10.1007/BF01370386; Nakahara Y, 1999, J CHROMATOGR B, V733, P161, DOI 10.1016/S0378-4347(99)00059-6; Nijhuis M, 1998, P NATL ACAD SCI USA, V95, P14441, DOI 10.1073/pnas.95.24.14441; Singh N, 1996, AIDS CARE, V8, P261, DOI 10.1080/09540129650125696; TRACQUI A, 1992, HUM EXP TOXICOL, V11, P363, DOI 10.1177/096032719201100511; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; WOOLF E, 1995, J CHROMATOGR A, V692, P45, DOI 10.1016/0021-9673(94)00608-C; 1999, AIDS S1, V13, pS61	18	35	36	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2002	137	8					656	659		10.7326/0003-4819-137-8-200210150-00009	http://dx.doi.org/10.7326/0003-4819-137-8-200210150-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604WL	12379065				2022-12-24	WOS:000178644000004
J	Schmidt, LE; Knudsen, TT; Dalhoff, K; Bendtsen, F				Schmidt, LE; Knudsen, TT; Dalhoff, K; Bendtsen, F			Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury	LANCET			English	Article							N-ACETYLCYSTEINE	Acetylcysteine treatment reduces liver damage after paracetamol overdose, but can affect the prothrombin index, which is used to assess the progress of overdose patients. We aimed to assess retrospectively the effect of intravenous acetylcysteine on the prothrombin index in patients with paracetamol poisoning without signs of hepatocellular injury. Prothrombin index had been recorded before, and serially during, acetylcysteine treatment in 87 patients. After initiation of treatment, prothrombin index decreased (mean 0.33, 95% CI 0.29-0.38) in all patients, and was strongly associated with the start of acetylcysteine infusion. In patients with uncomplicated paracetamol poisoning, a fall in this index might be misinterpreted as a sign of liver failure, leading to prolonged treatment time.	Univ Copenhagen, Rigshosp, Dept Hepatol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Dept Clin Pharmacol, DK-2100 Copenhagen, Denmark; Hvidovre Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Schmidt, LE (corresponding author), Univ Copenhagen, Rigshosp, Dept Hepatol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.							JEPSEN S, 1994, SCAND J CLIN LAB INV, V54, P543, DOI 10.3109/00365519409088566; JEPSEN S, 1992, CRIT CARE MED, V20, P918, DOI 10.1097/00003246-199207000-00004; KOTERBA AP, 1995, ALCOHOL, V12, P49, DOI 10.1016/0741-8329(94)00069-P; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097	5	46	47	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 12	2002	360	9340					1151	1152		10.1016/S0140-6736(02)11194-9	http://dx.doi.org/10.1016/S0140-6736(02)11194-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604QF	12387966				2022-12-24	WOS:000178632000018
J	Sidhu, ABS; Verdier-Pinard, D; Fidock, DA				Sidhu, ABS; Verdier-Pinard, D; Fidock, DA			Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations	SCIENCE			English	Article							DIGESTIVE VACUOLE; P-GLYCOPROTEIN; PFMDR1 GENE; AMPLIFICATION; ANTIMALARIALS; AMODIAQUINE; SENSITIVITY; MEFLOQUINE; MECHANISM; VERAPAMIL	Plasmodium falciparum chloroquine resistance is major cause of worldwide increases in malaria mortality and morbidity. Recent laboratory and clinical studies have associated chloroquine resistance with point mutations in the gene pfcrt. However, direct proof of causal relationship has remained elusive and most models have posited multigenic basis of resistance. Here, we provide conclusive evidence that mutant haplotypes of the pfcrt gene product of Asian, African, or South American origin confer chloroquine resistance with characteristic verapamil reversibility and reduced chloroquine accumulation. pfcrt mutations increased susceptibility to artemisinin and quinine and minimally affected amodiaquine activity; hence, these antimalarials warrant further investigation as agents to control chloroquine-resistant falciparum malaria.	Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fidock, DA (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dfidock@aecom.yu.edu		Fidock, David/0000-0001-6753-8938	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050234, R01AI050234] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI050234, R01 AI50234, R01 AI050234, R01 AI050234-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Basco LK, 1995, MOL BIOCHEM PARASIT, V74, P157, DOI 10.1016/0166-6851(95)02492-1; BASCO LK, 1993, AM J TROP MED HYG, V48, P120, DOI 10.4269/ajtmh.1993.48.120; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; BRASSEUR P, 1992, AM J TROP MED HYG, V46, P1; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Bray PG, 1996, MOL PHARMACOL, V50, P1559; Chaiyaroj SC, 1999, AM J TROP MED HYG, V61, P780, DOI 10.4269/ajtmh.1999.61.780; CHILDS GE, 1989, AM J TROP MED HYG, V40, P7, DOI 10.4269/ajtmh.1989.40.7; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; CREMER G, 1995, EXP PARASITOL, V81, P1, DOI 10.1006/expr.1995.1086; De DY, 1996, AM J TROP MED HYG, V55, P579, DOI 10.4269/ajtmh.1996.55.579; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Ginsburg H, 1999, PARASITOL TODAY, V15, P357, DOI 10.1016/S0169-4758(99)01502-1; KROGSTAD DJ, 1992, BIOCHEM PHARMACOL, V43, P57, DOI 10.1016/0006-2952(92)90661-2; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; O'Neill PM, 1998, PHARMACOL THERAPEUT, V77, P29, DOI 10.1016/S0163-7258(97)00084-3; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Ridley RG, 1996, ANTIMICROB AGENTS CH, V40, P1846, DOI 10.1128/AAC.40.8.1846; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; Ursos LMB, 2000, MOL BIOCHEM PARASIT, V110, P125, DOI 10.1016/S0166-6851(00)00262-0; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	40	532	552	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2002	298	5591					210	213		10.1126/science.1074045	http://dx.doi.org/10.1126/science.1074045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	600BJ	12364805	Green Accepted			2022-12-24	WOS:000178370500062
J	O'Flynn, N; Rymer, J				O'Flynn, N; Rymer, J			Women's attitudes to the sex of medical students in a gynaecology clinic: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England	University of London; King's College London	O'Flynn, N (corresponding author), Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.							Ching SL, 2000, AM J OBSTET GYNECOL, V182, P1429, DOI 10.1067/mob.2000.106133; General Medical Council, 1993, TOM DOCT; Kleinman DE, 1996, ACAD MED, V71, P1239, DOI 10.1097/00001888-199611000-00021	3	47	52	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2002	325	7366					683	684		10.1136/bmj.325.7366.683	http://dx.doi.org/10.1136/bmj.325.7366.683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600JV	12351360	Green Published, Bronze			2022-12-24	WOS:000178387600020
J	Eldar, A; Dorfman, R; Weiss, D; Ashe, H; Shilo, BZ; Barkai, N				Eldar, A; Dorfman, R; Weiss, D; Ashe, H; Shilo, BZ; Barkai, N			Robustness of the BMP morphogen gradient in Drosophila embryonic patterning	NATURE			English	Article							TWISTED GASTRULATION; DPP ACTIVITY; I RECEPTORS; SPECIFICATION; ACTIVATION; POLARITY; SAX; SOG	Developmental patterning relies on morphogen gradients, which generally involve feedback loops to buffer against perturbations caused by fluctuations in gene dosage and expression(1). Although many gene components involved in such feedback loops have been identified, how they work together to generate a robust pattern remains unclear. Here we study the network of extracellular proteins that patterns the dorsal region of the Drosophila embryo by establishing a graded activation of the bone morphogenic protein (BMP) pathway. We find that the BMP activation gradient itself is robust to changes in gene dosage. Computational search for networks that support robustness shows that transport of the BMP class ligands (Scw and Dpp) into the dorsal midline by the BMP inhibitor Sog is the key event in this patterning process. The mechanism underlying robustness relies on the ability to store an excess of signalling molecules in a restricted spatial domain where Sog is largely absent. It requires extensive diffusion of the BMP-Sog complexes, coupled with restricted diffusion of the free ligands. We show experimentally that Dpp is widely diffusible in the presence of Sog but tightly localized in its absence, thus validating a central prediction of our theoretical study.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	Weizmann Institute of Science; Weizmann Institute of Science; University of Manchester	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il		Shilo, Ben Zion/0000-0003-4903-8889; Dorfman, Ruslan/0000-0002-3421-5582; Eldar, Avigdor/0000-0001-8485-9370				ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dorfman R, 2001, DEVELOPMENT, V128, P965; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kosman D, 1997, DEVELOPMENT, V124, P1343; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WHARTON KA, 1993, DEVELOPMENT, V117, P807	23	338	366	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2002	419	6904					304	308		10.1038/nature01061	http://dx.doi.org/10.1038/nature01061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239569				2022-12-24	WOS:000178056300047
J	Casellas, R; Jankovic, M; Meyer, G; Gazumyan, A; Luo, Y; Roeder, RG; Nussenzweig, MC				Casellas, R; Jankovic, M; Meyer, G; Gazumyan, A; Luo, Y; Roeder, RG; Nussenzweig, MC			OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes	CELL			English	Article							B-CELL DEVELOPMENT; COACTIVATOR OBF-1; HISTONE ACETYLATION; HEAVY-CHAIN; CHROMATIN STRUCTURE; SEQUENCE ELEMENTS; PROMOTER ACTIVITY; BINDING PROTEINS; MICE LACKING; RECEPTOR	OcaB, a transcriptional coactivator also known as Bob-1 or OBF-1, was isolated on the basis of its ability to enhance transcription of immunoglobulin (Ig) genes in vitro. Paradoxically, OcaB(-/-) mice showed no apparent deficiency in Ig gene transcription, only cellular immune defects including absence of germinal centers (GC) and decreased numbers of immature B cells; the genes targeted by OcaB were not determined. Here we report that OcaB is essential for V(D)J recombination of a subset of IgK genes. We show that OcaB modulates recombination by directly enhancing IgK gene transcription in vivo.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019					Aranburu A, 2001, BIOCHEM J, V354, P431, DOI 10.1042/0264-6021:3540431; Bemark M, 1998, IMMUNOGENETICS, V47, P183, DOI 10.1007/s002510050347; Bemark M, 1998, J BIOL CHEM, V273, P18881, DOI 10.1074/jbc.273.30.18881; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; ENGLER P, 1993, MOL CELL BIOL, V13, P571, DOI 10.1128/MCB.13.1.571; FRANKE S, 1994, J BIOL CHEM, V269, P20075; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Greiner A, 2000, AM J PATHOL, V156, P501, DOI 10.1016/S0002-9440(10)64754-2; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Nussenzweig MC, 1998, CELL, V95, P875, DOI 10.1016/S0092-8674(00)81711-0; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P15, DOI 10.1016/0968-0004(89)90083-2; Pelletier MR, 1997, NUCLEIC ACIDS RES, V25, P3995, DOI 10.1093/nar/25.20.3995; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schubart DB, 1996, NUCLEIC ACIDS RES, V24, P1913, DOI 10.1093/nar/24.10.1913; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; SCHWARZENBACH H, 1995, J BIOL CHEM, V270, P898, DOI 10.1074/jbc.270.2.898; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SIGVARDSSON M, 1995, MOL CELL BIOL, V15, P1343; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Tantin D, 2002, MOL CELL BIOL, V22, P1460, DOI 10.1128/MCB.22.5.1460-1473.2002; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Whitehurst CE, 2000, IMMUNITY, V13, P703, DOI 10.1016/S1074-7613(00)00069-8; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	57	58	58	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					575	585		10.1016/S0092-8674(02)00911-X	http://dx.doi.org/10.1016/S0092-8674(02)00911-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230975	Bronze			2022-12-24	WOS:000177943700005
J	Tsuda, L; Nagaraj, R; Zipursky, SL; Banerjee, U				Tsuda, L; Nagaraj, R; Zipursky, SL; Banerjee, U			An EGFR/Ebi/Sno pathway promotes delta expression by inactivating Su(H)/SMRTER repression during inductive Notch signaling	CELL			English	Article							DEVELOPING DROSOPHILA RETINA; EGF RECEPTOR PATHWAY; EYE DEVELOPMENT; C-ELEGANS; TRANSCRIPTIONAL REPRESSION; COREPRESSOR COMPLEX; SMRT COREPRESSOR; TYROSINE KINASES; CELL FATES; ACTIVATION	The Notch and Epidermal Growth Factor Receptor (EGFR) pathways both regulate proliferation and differentiation, and the cellular response to each is often influenced by the other. Here, we describe a mechanism that links them in a sequential fashion, in the developing compound eye of Drosophila. EGFR activation induces photoreceptor (R cell) differentiation and promotes their expression of Delta. This Notch ligand then induces neighboring cells to become nonneuronal cone cells. ebi and strawberry notch (sno) regulate EGFR-dependent Delta transcription by antagonizing a repressor function of Suppressor of Hairless (Su(H)). Sno binds to Su(H), and Ebi, an F-box/WD40 protein, forms a complex with Su(H) and the corepressor SMRTER. EGFR-activated transcriptional derepression requires ebi and sno, is proteasome-dependent, and correlates with the translocation of SMRTER to the cytoplasm.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Human Genet, Los Angeles, CA 90095 USA; RIKEN, Ctr Dev Biol, Morphogenet Signaling Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; RIKEN	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181	NEI NIH HHS [EY08152, EY08772] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008772, R01EY008152] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Carmena A, 2002, DEV BIOL, V244, P226, DOI 10.1006/dbio.2002.0606; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; COYLETHOMPSON CA, 1993, DEVELOPMENT, V119, P377; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Frankfort BJ, 2002, DEVELOPMENT, V129, P1295; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; Freeman M, 1997, DEVELOPMENT, V124, P261; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Guenther MG, 2000, GENE DEV, V14, P1048; Hong SH, 1998, MOL ENDOCRINOL, V12, P1161, DOI 10.1210/me.12.8.1161; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2002, J CELL SCI, V115, P689; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KENYON C, 1995, CELL, V82, P171, DOI 10.1016/0092-8674(95)90302-X; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(02)08063-7; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lecourtois M, 1997, PERSPECT DEV NEUROBI, V4, P305; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8; Lim YM, 2000, P NATL ACAD SCI USA, V97, P12233, DOI 10.1073/pnas.210253497; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Majumdar A, 1997, GENE DEV, V11, P1341, DOI 10.1101/gad.11.10.1341; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Nagaraj R, 1999, DEVELOPMENT, V126, P975; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Parks AL, 2000, DEVELOPMENT, V127, P1373; PARKS AL, 1995, MECH DEVELOP, V50, P201, DOI 10.1016/0925-4773(94)00336-L; Polakis P, 2001, CELL, V105, P563, DOI 10.1016/S0092-8674(01)00379-8; Privalsky ML, 2001, CURR TOP MICROBIOL, V254, P117; Queenan AM, 1997, DEVELOPMENT, V124, P3871; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; SAVILLE KJ, 1993, P NATL ACAD SCI USA, V90, P8842, DOI 10.1073/pnas.90.19.8842; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; Spencer SA, 1998, DEVELOPMENT, V125, P4777; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Tio M, 1997, DEVELOPMENT, V124, P343; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; Tomlinson A, 2001, MOL CELL, V7, P487, DOI 10.1016/S1097-2765(01)00196-4; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Weber U, 2000, DEVELOPMENT, V127, P3619; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	68	135	140	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					625	637		10.1016/S0092-8674(02)00875-9	http://dx.doi.org/10.1016/S0092-8674(02)00875-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230979	Bronze			2022-12-24	WOS:000177943700009
J	Bedu-Addo, G; Bates, I				Bedu-Addo, G; Bates, I			Causes of massive tropical splenomegaly in Ghana	LANCET			English	Article							SPLENIC LYMPHOMA; B-CELL; MALARIA; IGM	Background The causes and diagnosis of massive tropical splenomegaly are not well studied, especially with modern investigative methods.. We aimed to identify features that would help local clinicians differentiate between the underlying conditions. Methods We collected prospective clinical and laboratory data on 221 Ghanaian patients with spleen size of at least 10 cm. We identified conditions associated with massive splenomegaly with molecular and immunological investigations as well as routine tests. Patients were assigned to diagnostic categories on the basis of these test results and predetermined criteria. Findings Hyper-reactive malarial splenomegaly (HMS; 91 patients [41%]) and B-lymphoproliferative disorders (48 [22%]) were the most common disorders associated with massive splenomegaly. Of the remaining patients, 32 (14%) had haematological disorders, and in 50 (23%) we could not identify the cause of splenomegaly. Male sex predominated in all diagnostic groups except HMS and tropical splenic lymphoma. Age less than 40 years and absolute lymphocyte count (less than 10 x 10(9)/L) were the only useful and widely available discriminators for distinguishing patients with HMS from those with lymphoproliferative disorders. Interpretation B-lymphoproliferative disorders are a previously unrecognised cause of massive tropical splenomegaly. This finding has major implications for management of massive splenomegaly. Diagnosis of the less common causes of this disorder is usually straightforward, but differentiating between B-lymphoproliferative disorders and HMS can be difficult. HMS is associated with younger age, a higher proportion of women, and lower absolute lymphocyte counts than lymphoproliferative disorders.	Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England; Komfo Anokye Teaching Hosp, Dept Haematol, Kumasi, Ghana	Liverpool School of Tropical Medicine; University of Liverpool; Kwame Nkrumah University Science & Technology	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England.	ibates@liv.ac.uk		bates, imelda/0000-0002-0862-8199				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BATES I, 1991, LANCET, V337, P505, DOI 10.1016/0140-6736(91)91293-4; Bates I, 1997, LANCET, V349, P1178, DOI 10.1016/S0140-6736(05)63061-9; Bates I, 1997, LEUKEMIA, V11, P2162, DOI 10.1038/sj.leu.2400878; Bedu-Addo G, 2000, POSTGRAD MED J, V76, P107, DOI 10.1136/pmj.76.892.107; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; BRYCESON A, 1983, T ROY SOC TROP MED H, V77, P879, DOI 10.1016/0035-9203(83)90319-X; Bryceson A D, 1976, Acta Trop, V33, P185; Cook GC, 1980, TROPICAL GASTROENTER, P205; CRANE G, 1986, PAPUA NEW GUINEA MED, V29, P35; CRANE G G, 1986, Parasitology Today, V2, P4, DOI 10.1016/0169-4758(86)90067-0; DECOCK KM, 1986, J TROP MED HYG, V89, P119; FAKUNLE YM, 1981, CLIN HAEMATOL, V10, P963; FAKUNLE YM, 1979, TROP GEOGR MED, V31, P353; FLEMING AF, 1996, MANSONS TROPICAL DIS, P112; GREENWOOD BM, 1987, ANN TROP MED PARASIT, V81, P345, DOI 10.1080/00034983.1987.11812130; HAMILTON PJ, 1966, BRIT MED J, V2, P548, DOI 10.1136/bmj.2.5513.548; HAMILTON PJS, 1966, E AFR MED J, V42, P191; Jimmy EO, 1996, T ROY SOC TROP MED H, V90, P37, DOI 10.1016/S0035-9203(96)90472-1; LOWENTHAL M. N., 1966, Central African Journal of Medicine, V12, P99; LOWENTHAL MN, 1980, T ROY SOC TROP MED H, V74, P91, DOI 10.1016/0035-9203(80)90019-X; PITNEY WR, 1968, T ROY SOC TROP MED H, V62, P717, DOI 10.1016/0035-9203(68)90124-7; PRYOR DS, 1967, Q J MED, V36, P321; RAMASAMY I, 1992, J CLIN PATHOL, V45, P770, DOI 10.1136/jcp.45.9.770; REES PH, 1982, E AFR MED J, V59, P658; SAGOE AS, 1970, BRIT MED J, V3, P378, DOI 10.1136/bmj.3.5719.378; SCHNITZER B, 1976, LANCET, V2, P258; UKAEJIOFO E O, 1987, African Journal of Medicine and Medical Sciences, V16, P113; UKAEJIOFO EO, 1979, J TROP MED HYG, V82, P197; Wallace S, 1998, T ROY SOC TROP MED H, V92, P463, DOI 10.1016/S0035-9203(98)91095-1; YAMADA H, 1992, INTERNAL MED, V31, P1381, DOI 10.2169/internalmedicine.31.1381; Zhu DL, 1999, BRIT J HAEMATOL, V107, P114, DOI 10.1046/j.1365-2141.1999.01679.x	32	30	33	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2002	360	9331					449	454		10.1016/S0140-6736(02)09680-0	http://dx.doi.org/10.1016/S0140-6736(02)09680-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241718				2022-12-24	WOS:000177342900012
J	Lauener, RP; Birchler, T; Adamski, J; Braun-Fahrlander, C; Bufe, A; Herz, U; von Mutius, E; Nowak, D; Riedler, J; Waser, M; Sennhauser, FH				Lauener, RP; Birchler, T; Adamski, J; Braun-Fahrlander, C; Bufe, A; Herz, U; von Mutius, E; Nowak, D; Riedler, J; Waser, M; Sennhauser, FH		ALEX Study Grp	Expression of CD14 and Toll-like receptor 2 in farmers' and nonfarmers' children	LANCET			English	Article							ASTHMA	Children of farmers are at decreased risk of developing allergies. Results of epidemiological studies suggest increased exposure to microbial compounds might be responsible for this reduced risk. Alterations in adaptive immune response are thought to be the underlying mechanism. We measured expression of receptors for microbial compounds known to trigger the innate immune response. We showed that blood cells from farmers' children express significantly higher amounts of CD14 (0.96 vs 0.43, p = 0.0013), and Toll-like receptor 2 (0.11 vs 0.04, p < 0.0001) than those from nonfarmers' children. We propose that the innate immune system responds to the microbial burden in the environment and modulates the development of allergic disease.	Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland; Univ Basel, Inst Social & Prevent Med, CH-4003 Basel, Switzerland; Ruhr Univ Bochum, D-4630 Bochum, Germany; Hosp Philipps Univ, Marburg, Germany; Univ Munich, Dr von Hauner Childrens Hosp, D-80539 Munich, Germany; Univ Munich, Inst Occupat & Environm Med, D-80539 Munich, Germany; Childrens Hosp Salzburg, Salzburg, Austria	University Children's Hospital Zurich; University of Zurich; University of Basel; Ruhr University Bochum; Philipps University Marburg; University of Munich; University of Munich	Lauener, RP (corresponding author), Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland.		Lauener, Roger P/O-8612-2016; riedler, josef/AAQ-4666-2020	Lauener, Roger P/0000-0002-8412-606X; von Mutius, Erika/0000-0002-8893-4515; Bufe, Albrecht/0000-0001-7335-9362				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Martin P, 1999, APPL MICROW WIREL, V11, P12; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3	5	236	243	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 10	2002	360	9331					465	466		10.1016/S0140-6736(02)09641-1	http://dx.doi.org/10.1016/S0140-6736(02)09641-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582GZ	12241724				2022-12-24	WOS:000177342900018
J	Sommer, M; Koch, MA; Paulus, W; Weiller, C; Buchel, C				Sommer, M; Koch, MA; Paulus, W; Weiller, C; Buchel, C			Disconnection of speech-relevant brain areas in persistent developmental stuttering	LANCET			English	Article							POSITRON EMISSION TOMOGRAPHY; DIFFUSION TENSOR; FLUENT SPEAKERS; RECOVERY; CORTEX; PET	Background The neuronal basis of persistent developmental stuttering is unknown. The disorder could be related to a reduced left hemisphere dominance, which functional neuroimaging data suggest might lead to right hemispheric motor and premotor overactivation. Alternatively, the core deficit underlying stuttering might be located in the speech-dominant left hemisphere. Furthermore, magnetoencephalography study results show profound timing disturbances between areas involved in language preparation and execution in the left hemisphere, suggesting that persistent developmental stuttering might be related to impaired neuronal communication, possibly caused by a disruption of white matter fibre tracts. We aimed to establish whether disconnection between speech-related cortical areas was the structural basis of persistent developmental stuttering. Methods We analysed the speech of 15 people with persistent developmental stuttering and 15 closely matched controls for the percentage of syllables stuttered. We used diffusion tensor imaging to assess participants' brain tissue structure, and used voxel-based morphometry and two-sample t test to compare diffusion characteristics between groups. Findings Diffusion characteristics of the group with persistent developmental stuttering and controls differed significantly immediately below the laryngeal and tongue representation in the left sensorimotor cortex (mean difference in fractional anisotropy 0.04 [95% Cl 0.03-0.05]). Interpretation Our findings show that persistent developmental stuttering results from disturbed timing of activation in speech-relevant brain areas, and suggest that right hemisphere overactivation merely reflects a compensatory mechanism, analogous to right hemisphere activation in aphasia.	Univ Hamburg, Dept Neurol, Neurolmage Nord, D-20246 Hamburg, Germany; Univ Gottingen, Dept Clin Neurophysiol, D-3400 Gottingen, Germany	University of Hamburg; University of Gottingen	Buchel, C (corresponding author), Univ Hamburg, Dept Neurol, Neurolmage Nord, Martinistr 52, D-20246 Hamburg, Germany.		Paulus, Walter/A-3544-2009; Sommer, Martin/F-1503-2015	Paulus, Walter/0000-0001-5549-8377; 				Ambrose NG, 1997, J SPEECH LANG HEAR R, V40, P567, DOI 10.1044/jslhr.4003.567; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bloodstein O., 1995, HDB STUTTERING; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Foundas AL, 2001, NEUROLOGY, V57, P207, DOI 10.1212/WNL.57.2.207; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Nakagawa H, 1998, AM J NEURORADIOL, V19, P1129; Nolte UG, 2000, MAGNET RESON MED, V44, P731, DOI 10.1002/1522-2594(200011)44:5<731::AID-MRM11>3.0.CO;2-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onslow M, 1996, J SPEECH HEAR RES, V39, P734, DOI 10.1044/jshr.3904.734; Orton ST, 1928, NEW ENGL J MED, V199, P1046, DOI 10.1056/NEJM192811221992108; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PERKINS WH, 1991, J SPEECH HEAR RES, V34, P734, DOI 10.1044/jshr.3404.734; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Salmelin R, 1998, NEUROREPORT, V9, P2225, DOI 10.1097/00001756-199807130-00014; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; TONKONOGY J, 1981, ARCH NEUROL-CHICAGO, V38, P486, DOI 10.1001/archneur.1981.00510080048005; TRAVIS LE, 1978, J SPEECH HEAR DISORD, V43, P278, DOI 10.1044/jshd.4303.278; WEBSTER WG, 1991, J SPEECH HEAR RES, V34, P708, DOI 10.1044/jshr.3404.708; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; Wildgruber D, 1996, NEUROREPORT, V7, P2791, DOI 10.1097/00001756-199611040-00077; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097	30	260	264	1	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 3	2002	360	9330					380	383		10.1016/S0140-6736(02)09610-1	http://dx.doi.org/10.1016/S0140-6736(02)09610-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241779				2022-12-24	WOS:000177255600012
J	Thomson, AB; Campbell, AJ; Irvine, DS; Anderson, RA; Kelnar, CJH; Wallace, WHB				Thomson, AB; Campbell, AJ; Irvine, DS; Anderson, RA; Kelnar, CJH; Wallace, WHB			Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study	LANCET			English	Article							INTRACYTOPLASMIC SPERM INJECTION; LONG-TERM SURVIVORS; COMBINATION CHEMOTHERAPY; HODGKINS-DISEASE; GONADAL-FUNCTION; MALE-FERTILITY; INHIBIN B; FERTILIZATION; DAMAGE; CELL	Background Treatment of childhood cancer can result in impaired spermatogenesis. Intracytoplasmic sperm injection (ICSI), however, can enable men to achieve fatherhood, and has focused attention on gamete integrity in men with oligozoospermia. Our aim was to assess testicular function in survivors of childhood cancer. Methods We assessed testicular function in 33 survivors of childhood cancer and 66 age-matched controls. The median age at diagnosis and at the start of the trial was 10.0 years (range 2.2-16.9) and 21.9 years (16.5-35.2), respectively. We assessed pubertal staging, measured plasma sex steroid hormone concentrations, and analysed semen quality, including spermatozoal DNA integrity. Findings Ten (30%) individuals were azoospermic and six (18%) oligozoospermic (sperm concentration <20 x 10(6)/mL). Sperm concentration was significantly lower in the non-azoospermic group than in controls (median 37.1 x 10(6)/mL, IQR 19.7 x 10(6) to 89.9 x 10(6), vs 90.7 x 10(6)/mL, 50-5 x 10(6) to 121.5 x 10(6); p = 0.002). In the non-azoospermic cancer survivor group, inhibin B concentrations were lower than in controls (mean 153.3 ng/L, SEM 17.8, vs 223.7 ng/L, 8.8; p < 0.001), and FSH concentrations were higher (6.6 U/L, 0.9, vs 3.2 U/L, 0.2; p < 0.001). Only 11 (33%) survivors of childhood cancer had normal semen quality. There was no significant difference in sperm DNA integrity between the non-azoospermic and control groups (9%, 5-13, vs 11%, 7-16; p = 0.06). Interpretation Sperm concentration is reduced after treatment for cancer. However, the sperm produced seems to carry as much healthy DNA as those produced by the healthy population, suggesting that assisted conception can be considered as a treatment option for these men.	Univ Edinburgh, Dept Reprod & Dev Sci, Sect Child Life & Hlth, Edinburgh, Midlothian, Scotland; MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LW, Midlothian, Scotland.	hamish.wallace@luht.scot.nhs.uk		wallace, william, hamish/0000-0001-8080-5674				Aboulghar MA, 1997, FERTIL STERIL, V68, P108, DOI 10.1016/S0015-0282(97)81484-7; Anderson RA, 2000, INT J ANDROL, V23, P136, DOI 10.1046/j.1365-2605.2000.00229.x; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P4451, DOI 10.1210/jc.83.12.4451; Andreu JAL, 2000, PEDIATR HEMAT ONCOL, V17, P21, DOI 10.1080/088800100276631; Biggers J.D., 1971, CULTURE MOUSE EMBRYO; Bonduelle M, 1999, HUM REPROD, V14, P243, DOI 10.1093/humrep/14.suppl_1.243; CUMMINS JM, 1995, HUM REPROD, V10, P138, DOI 10.1093/humrep/10.suppl_1.138; Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jc.81.4.1401; Grundy R, 2001, ARCH DIS CHILD, V84, P355, DOI 10.1136/adc.84.4.355; HAWKINS MM, 1989, INT J CANCER, V43, P975, DOI 10.1002/ijc.2910430604; Humpl T, 1999, ARCH ANDROLOGY, V43, P123, DOI 10.1080/014850199262625; Irvine DS, 2000, J ANDROL, V21, P33; LENDON M, 1978, LANCET, V2, P439; Mackie EJ, 1996, MED PEDIATR ONCOL, V27, P74, DOI 10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q; MUSTIELES C, 1995, MED PEDIATR ONCOL, V24, P347, DOI 10.1002/mpo.2950240603; Ramaswamy S, 1999, J ANDROL, V20, P430; RAUTONEN J, 1992, EUR J CANCER, V28A, P1837, DOI 10.1016/0959-8049(92)90016-U; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Schover LR, 1999, MED PEDIATR ONCOL, V33, P53, DOI 10.1002/(SICI)1096-911X(199907)33:1<53::AID-MPO10>3.0.CO;2-K; SHALET SM, 1989, J ENDOCRINOL, V120, P161, DOI 10.1677/joe.0.1200161; SHELBY MD, 1994, ENVIRON MOL MUTAGEN, V23, P30, DOI 10.1002/em.2850230609; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; SPEISER B, 1973, CANCER, V32, P692, DOI 10.1002/1097-0142(197309)32:3<692::AID-CNCR2820320323>3.0.CO;2-I; Sun JG, 1997, BIOL REPROD, V56, P602, DOI 10.1095/biolreprod56.3.602; Sutcliffe AG, 2001, LANCET, V357, P2080, DOI 10.1016/S0140-6736(00)05180-1; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thomson AB, 2002, EUR J CANCER, V38, P468, DOI 10.1016/S0959-8049(01)00335-5; TOURNAYE H, 1993, FERTIL STERIL, V60, P197; TRASLER JM, 1985, NATURE, V316, P144, DOI 10.1038/316144a0; Twigg JP, 1998, HUM REPROD, V13, P1864, DOI 10.1093/humrep/13.7.1864; VIVIANI S, 1985, EUR J CANCER CLIN ON, V21, P601, DOI 10.1016/0277-5379(85)90088-4; WALLACE WHB, 1989, MED PEDIATR ONCOL, V17, P409; WALLACE WHB, 1991, INT J ANDROL, V14, P312, DOI 10.1111/j.1365-2605.1991.tb01098.x; WALLACE WHB, 1997, PAEDIAT ONCOLOGY CLI, P706; Waring AB, 2000, HOSP MED, V61, P550, DOI 10.12968/hosp.2000.61.8.1398; WATSON AR, 1985, BRIT MED J, V291, P1457, DOI 10.1136/bmj.291.6507.1457; WHITEHEAD E, 1982, ARCH DIS CHILD, V57, P287, DOI 10.1136/adc.57.4.287; World Health Organization, 1999, WHO LAB MAN EX HUM S; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125	39	129	135	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2002	360	9330					361	367		10.1016/S0140-6736(02)09606-X	http://dx.doi.org/10.1016/S0140-6736(02)09606-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	580UY	12241775				2022-12-24	WOS:000177255600008
J	Dong, F; Miller, RE				Dong, F; Miller, RE			Vibrational transition moment angles in isolated biomolecules: A structural tool	SCIENCE			English	Article							DOUBLE-RESONANCE SPECTROSCOPY; AB-INITIO; GAS-PHASE; ELECTRONIC-SPECTRA; MATRIX-ISOLATION; BASE-PAIRS; IR; DYNAMICS; CYTOSINE; TAUTOMERS	Infrared spectroscopy is used extensively in the study of isolated biomolecules, but it becomes less useful as it is applied to systems of increasing complexity. Even if the individual vibrational bands can be resolved spectroscopically, their assignment becomes problematic when they are more closely spaced than can be determined using ab initio methods. We describe a method that helps to alleviate this difficulty by measuring the direction of the vibrational transition moment for each vibrational band. The molecules of interest ( adenine and cytosine) are cooled to 0.37 kelvin in liquid helium nanodroplets and oriented in a large dc electric field. A polarized infrared laser is then used to determine the directions of the infrared transition moments relative to the permanent dipole moment. Comparisons with ab initio calculations provide detailed structural information, including experimental evidence for nonplanarity of adenine and three tautomers of cytosine.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dong, F (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.							Borst DR, 2002, J PHYS CHEM A, V106, P4022, DOI 10.1021/jp0140769; Callegari C, 2001, J CHEM PHYS, V115, P10090, DOI 10.1063/1.1418746; Civcir PU, 2000, J MOL STRUC-THEOCHEM, V532, P157, DOI 10.1016/S0166-1280(00)00556-X; Dian BC, 2002, SCIENCE, V296, P2369, DOI 10.1126/science.1071563; Dkhissi A, 2000, J PHYS CHEM A, V104, P9785, DOI 10.1021/jp0013053; Frisch M. J., 1998, GAUSSIAN 98; HARTMANN M, 1995, PHYS REV LETT, V75, P1566, DOI 10.1103/PhysRevLett.75.1566; Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255; Holmen A, 1997, J PHYS CHEM A, V101, P4361, DOI 10.1021/jp970381b; Kawahara S, 2002, J PHYS CHEM A, V106, P3207, DOI 10.1021/jp0139538; Kong W, 2001, INT J MOD PHYS B, V15, P3471, DOI 10.1142/S0217979201007816; KWIATKOWSKI JS, 1988, J AM CHEM SOC, V110, P2353, DOI 10.1021/ja00216a001; Lehmann KK, 1998, SCIENCE, V279, P2065, DOI 10.1126/science.279.5359.2065; Marsh D, 2000, BIOPHYS J, V78, P2499, DOI 10.1016/S0006-3495(00)76795-6; MICHL J, 1995, SPECTROSCOPY POLARIZ, P150; MILLER RE, 1988, SCIENCE, V240, P447, DOI 10.1126/science.240.4851.447; Mishra SK, 2000, SPECTROCHIM ACTA A, V56, P1355, DOI 10.1016/S1386-1425(99)00262-0; Mons M, 2002, J PHYS CHEM A, V106, P5088, DOI 10.1021/jp0139742; Nauta K, 1999, SCIENCE, V283, P1895, DOI 10.1126/science.283.5409.1895; Nauta K, 2001, SCIENCE, V292, P481, DOI 10.1126/science.1058896; Nir E, 2002, PHYS CHEM CHEM PHYS, V4, P732, DOI 10.1039/b107429f; Plutzer C, 2001, PHYS CHEM CHEM PHYS, V3, P5466, DOI 10.1039/b107997b; Pratt DW, 2002, SCIENCE, V296, P2347, DOI 10.1126/science.1073589; Radziszewski JG, 1996, J AM CHEM SOC, V118, P10275, DOI 10.1021/ja961668+; Snoek LC, 2002, PHYS CHEM CHEM PHYS, V4, P2130, DOI 10.1039/b200059h; SZCZESNIAK M, 1988, J AM CHEM SOC, V110, P8319, DOI 10.1021/ja00233a006; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+	27	134	136	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1227	1230		10.1126/science.1076947	http://dx.doi.org/10.1126/science.1076947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424376				2022-12-24	WOS:000179080400048
J	Deban, SM; Olson, WM				Deban, SM; Olson, WM			Biomechanics: Suction feeding by a tiny predatory tadpole	NATURE			English	Article									Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Deban, SM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.		Deban, Stephen/AFS-8445-2022; Deban, Stephen/AAI-7307-2020	Deban, Stephen/0000-0002-7979-4346; Deban, Stephen/0000-0002-7979-4346				CANNATELLA DC, 1988, J HERPETOL, V22, P439, DOI 10.2307/1564339; Deban SM, 2001, AM ZOOL, V41, P1280, DOI 10.1668/0003-1569(2001)041[1280:TEOTMC]2.0.CO;2; DROST MR, 1986, J FISH BIOL, V29, P371, DOI 10.1111/j.1095-8649.1986.tb04953.x; Hernandez LP, 2000, J EXP BIOL, V203, P3033; Hoff KV, 1999, TADPOLES, P215; MULLER M, 1984, Transactions of the Zoological Society of London, V37, P51; Osse J. W. M., 1999, Journal of Fish Biology, V55, P156, DOI 10.1006/jfbi.1999.1071; Sanderson S. Laurie, 1999, P301; SANDERSON SL, 1993, SKULL, V3, P37; SOKOL OM, 1962, COPEIA, P272; Vogel S, 1996, LIFE MOVING FLUIDS; WASSERSUG RJ, 1979, BIOL J LINN SOC, V12, P225, DOI 10.1111/j.1095-8312.1979.tb00056.x	12	39	40	4	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 7	2002	420	6911					41	42		10.1038/420041a	http://dx.doi.org/10.1038/420041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HJ	12422207				2022-12-24	WOS:000179068100029
J	Yang, Z; Yamada, J; Zhao, YW; Strauss, AW; Ibdah, JA				Yang, Z; Yamada, J; Zhao, YW; Strauss, AW; Ibdah, JA			Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE FATTY LIVER; A DEHYDROGENASE-DEFICIENCY; ACID OXIDATION; HELLP-SYNDROME; MOLECULAR CHARACTERIZATION; ALPHA-SUBUNIT; LOW PLATELETS; ENZYMES; PREVALENCE; MUTATIONS	Context Acute fatty liver of pregnancy (AFLP) and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome are serious complications of pregnancy. Studies in families with recessively inherited mitochondrial trifunctional protein defects documented an association between these maternal illnesses and fetal deficiency of long-chain 3-hydroxyacyl coenzyme A dehydrogenase; this enzyme resides in the alpha subunit of the trifunctional protein and catalyzes the third step in long-chain fatty acid beta oxidation. Objective To estimate the frequency of fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency in pregnancies complicated by AFLP or HELLP syndrome. Design, Setting, and Subjects Cohort study in which 108 consecutive blood samples from women who developed AFLP or HELLP syndrome, from their offspring, or from their partners were referred to our laboratory for molecular screening from January 1997 to December 2001. Twenty-seven women had AFLP and 81 had HELLP syndrome. We screened the DNA for mutations in the alpha subunit of the trifunctional protein. Main Outcome Measure Presence of mutations that cause 3-hydroxyacyl coenzyme A dehydrogenase deficiency in the offspring. Results We detected mutations causing pediatric long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency in 5 families (19%) with maternal history of AFLP (95% confidence interval, 9%-54%). The maternal allele carried a prevalent glutamic acid 474 to glutamine (E474Q) mutation. The paternal allele carried the E474Q mutation in 3 families and a stop codon mutation in the other 2 families. Only 1 woman with HELLP syndrome was heterozygous for the E474Q mutation; no mutations were detected in the newborn. Conclusion The association between AFLP and the E474Q mutation in the fetus is significant. Screening newborns for this mutation in pregnancies complicated by AFLP could allow early diagnosis and treatment in newborns and genetic counseling and prenatal diagnosis in subsequent pregnancies in affected families.	Wake Forest Univ, Bowman Gray Sch Med, Div Gastroenterol, Dept Internal Med, Winston Salem, NC 27157 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Wake Forest University; Wake Forest Baptist Medical Center; Vanderbilt University	Ibdah, JA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Div Gastroenterol, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.			Ibdah, Jamal/0000-0002-5646-9014	NIADDK NIH HHS [AM-20407] Funding Source: Medline; NIDDK NIH HHS [DK-02574] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002574] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894; Den Boer MEJ, 2000, PEDIATR RES, V48, P151, DOI 10.1203/00006450-200008000-00006; Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204; Ibdah JA, 1998, J CLIN INVEST, V102, P1193, DOI 10.1172/JCI2091; Ibdah JA, 2001, J PEDIATR-US, V138, P396, DOI 10.1067/mpd.2001.111503; IJIST L, 1996, J CLIN INVEST, V98, P1028; Innes AM, 2000, PEDIATR RES, V47, P43, DOI 10.1203/00006450-200001000-00010; Isaacs JD, 1996, PEDIATR RES, V40, P393, DOI 10.1203/00006450-199609000-00005; JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983; KAMIJO T, 1994, J CLIN INVEST, V93, P1740, DOI 10.1172/JCI117158; KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302; Knox TA, 1996, NEW ENGL J MED, V335, P569, DOI 10.1056/NEJM199608223350807; Mansouri A, 1996, J HEPATOL, V25, P781, DOI 10.1016/S0168-8278(96)80254-6; Marshall E, 2001, SCIENCE, V294, P2272, DOI 10.1126/science.294.5550.2272; Matern D, 2001, J PEDIATR-US, V138, P585, DOI 10.1067/mpd.2001.111814; Nelson J, 2000, J INHERIT METAB DIS, V23, P518, DOI 10.1023/A:1005676600975; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Riely CA, 1999, AM J GASTROENTEROL, V94, P1728; SCHOEMAN MN, 1991, GASTROENTEROLOGY, V100, P544, DOI 10.1016/0016-5085(91)90228-D; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I; SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841; TREEM WR, 1994, HEPATOLOGY, V19, P339; Treem WR, 1996, AM J GASTROENTEROL, V91, P2293; Tyni T, 1998, AM J OBSTET GYNECOL, V178, P603, DOI 10.1016/S0002-9378(98)70446-6; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Ushikubo S, 1996, AM J HUM GENET, V58, P979; WILCKEN B, 1993, LANCET, V341, P407, DOI 10.1016/0140-6736(93)92993-4	27	73	81	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2163	2166		10.1001/jama.288.17.2163	http://dx.doi.org/10.1001/jama.288.17.2163			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413376	Bronze			2022-12-24	WOS:000179048100027
J	Schuler, B; Lipman, EA; Eaton, WA				Schuler, B; Lipman, EA; Eaton, WA			Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy	NATURE			English	Article							TRANSFER CONFOCAL MICROSCOPY; COLD-SHOCK PROTEIN; DIFFUSING MOLECULES; THERMOTOGA-MARITIMA; BETA-SHEET; DYNAMICS; PEPTIDES; MODEL; DENATURATION; DEPENDENCE	Protein folding is inherently a heterogeneous process because of the very large number of microscopic pathways that connect the myriad unfolded conformations to the unique conformation of the native structure. In a first step towards the long-range goal of describing the distribution of pathways experimentally, Forster resonance energy transfer(1) (FRET) has been measured on single, freely diffusing molecules(2-4). Here we use this method to determine properties of the free-energy surface for folding that have not been obtained from ensemble experiments. We show that single-molecule FRET measurements of a small cold-shock protein expose equilibrium collapse of the unfolded polypeptide and allow us to calculate limits on the polypeptide reconfiguration time. From these results, limits on the height of the free-energy barrier to folding are obtained that are consistent with a simple statistical mechanical model, but not with the barriers derived from simulations using molecular dynamics. Unlike the activation energy, the free-energy barrier includes the activation entropy and thus has been elusive to experimental determination for any kinetic process in solution.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Eaton, WA (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.		Lipman, Everett/D-1696-2009; Schuler, Benjamin/E-7342-2011	Schuler, Benjamin/0000-0002-5970-4251	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029010, Z01DK029010] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN MP, 1987, COMPUTER SIMULATION, V192; ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Chan CK, 1997, P NATL ACAD SCI USA, V94, P1779, DOI 10.1073/pnas.94.5.1779; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Hagen SJ, 1997, J PHYS CHEM B, V101, P2352, DOI 10.1021/jp9622997; Jacob J, 1999, BIOPHYS J, V77, P1086, DOI 10.1016/S0006-3495(99)76958-4; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Jia YW, 1999, CHEM PHYS, V247, P69, DOI 10.1016/S0301-0104(99)00127-5; Klimov DK, 1997, PHYS REV LETT, V79, P317, DOI 10.1103/PhysRevLett.79.317; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kremer W, 2001, EUR J BIOCHEM, V268, P2527, DOI 10.1046/j.1432-1327.2001.02127.x; LAPIDUS LJ, IN PRESS J PHYS CH B; Mandelkern L., 1967, POLY A AMINO ACIDS, P675; MILLETT IS, IN PRESS ADV PROT CH; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Portman JJ, 2001, J CHEM PHYS, V114, P5082, DOI 10.1063/1.1334663; Reid KL, 1998, PROTEIN SCI, V7, P470; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Talaga DS, 2000, P NATL ACAD SCI USA, V97, P13021, DOI 10.1073/pnas.97.24.13021; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Wassenberg D, 1999, J MOL BIOL, V289, P187, DOI 10.1006/jmbi.1999.2772	31	746	761	6	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					743	747		10.1038/nature01060	http://dx.doi.org/10.1038/nature01060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384704	Green Published			2022-12-24	WOS:000178615200046
J	Bodenheimer, T; Wagner, EH; Grumbach, K				Bodenheimer, T; Wagner, EH; Grumbach, K			Improving primary care for patients with chronic illness - The chronic care model, part 2	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; IMPROVED GLYCEMIC CONTROL; QUALITY-OF-LIFE; SELF-MANAGEMENT; HEALTH-CARE; DIABETES MANAGEMENT; ECONOMIC-EVALUATION; COST-EFFECTIVENESS; EDUCATION-PROGRAM; GENERAL-PRACTICE	This article reviews research evidence showing to what extent the chronic care model can improve the management of chronic conditions (using diabetes as an example) and reduce health care costs. Thirty-two of 39 studies found that interventions based on chronic care model components improved at least 1 process or outcome measure for diabetic patients. Regarding whether chronic care model interventions can reduce costs, 18 of 27 studies concerned with 3 examples of chronic conditions (congestive heart failure, asthma, and diabetes) demonstrated reduced health care costs or lower use of health care services. Even though the chronic care model has the potential to improve care and reduce costs, several obstacles hinder its widespread adoption.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, MacColl Inst Healthcare Innovat, Seattle, WA 98101 USA	University of California System; University of California San Francisco; Group Health Cooperative	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Bldg 80-83,1001 Potrero Ave, San Francisco, CA 94110 USA.	Bodenheimer@Medsch.ucsf.edu	Grumbach, Kevin/L-9222-2016					BAILEY WC, 1990, ARCH INTERN MED, V150, P1664, DOI 10.1001/archinte.150.8.1664; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; BOLTON MB, 1991, J GEN INTERN MED, V6, P401, DOI 10.1007/BF02598160; BYRNES J, 1998, DIS MANAG, V1, P39; CLARK NM, 1986, J ALLERGY CLIN IMMUN, V78, P108, DOI 10.1016/0091-6749(86)90122-3; Cline CMJ, 1998, HEART, V80, P442, DOI 10.1136/hrt.80.5.442; DEWEERDT I, 1991, DIABETIC MED, V8, P338; Domurat ES, 1999, AM J MANAG CARE, V5, P1299; Dougherty G, 1999, PEDIATRICS, V103, P122, DOI 10.1542/peds.103.1.122; Gallefoss F, 2001, EUR RESPIR J, V17, P206, DOI 10.1183/09031936.01.17202060; Ghosh CS, 1998, SOC SCI MED, V46, P1087, DOI 10.1016/S0277-9536(97)10047-8; Greineder DK, 1999, J ALLERGY CLIN IMMUN, V103, P436, DOI 10.1016/S0091-6749(99)70468-9; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Kauppinen R, 2001, RESP MED, V95, P56, DOI 10.1053/rmed.2000.0971; Kelly CS, 2000, PEDIATRICS, V105, P1029, DOI 10.1542/peds.105.5.1029; KELSO TM, 1995, AM J EMERG MED, V13, P632, DOI 10.1016/0735-6757(95)90046-2; Lahdensuo A, 1998, BRIT MED J, V316, P1138, DOI 10.1136/bmj.316.7138.1138; MAYO PH, 1990, ANN INTERN MED, V112, P864, DOI 10.7326/0003-4819-112-11-864; MAZZE RS, 1994, DIABETES CARE, V17, P56; Morrison I, 2000, BRIT MED J, V321, P1541, DOI 10.1136/bmj.321.7276.1541; Munroe WP, 1997, CLIN THER, V19, P113, DOI 10.1016/S0149-2918(97)80078-1; Oddone E Z, 1999, Eff Clin Pract, V2, P201; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Oswald N, 2001, HEALTH AFFAIR, V20, P61, DOI 10.1377/hlthaff.20.6.61; PIEBER TR, 1995, DIABETIC MED, V12, P349, DOI 10.1111/j.1464-5491.1995.tb00491.x; RENDERS CM, 2001, INTERVENTIONS IMPROV; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Riegel B, 2000, J CARD FAIL, V6, P290, DOI 10.1054/jcaf.2000.19226; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; STEIN GH, 1974, MED CARE, V12, P885, DOI 10.1097/00005650-197410000-00008; Stewart S, 1999, ARCH INTERN MED, V159, P257, DOI 10.1001/archinte.159.3.257; SULLIVAN FM, 1991, PRACTICAL DIABETES, V8, P47; Tai SS, 1999, METHOD INFORM MED, V38, P177; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Vojta CL, 1999, J CLIN OUTCOMES MANA, V6, P30; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; WILSON SR, 1993, AM J MED, V94, P564, DOI 10.1016/0002-9343(93)90206-5	38	1484	1491	4	132	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2002	288	15					1909	1914		10.1001/jama.288.15.1909	http://dx.doi.org/10.1001/jama.288.15.1909			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604EU	12377092				2022-12-24	WOS:000178604200032
J	Fu, LN; Pelicano, H; Liu, JS; Huang, P; Lee, CC				Fu, LN; Pelicano, H; Liu, JS; Huang, P; Lee, CC			The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo	CELL			English	Article							C-MYC; CELL-CYCLE; INDUCED APOPTOSIS; SENSITIVE METHOD; P53; EXPRESSION; CLOCK; MPER2; PROLIFERATION; MECHANISM	The Period2 gene plays a key role in controlling circadian rhythm in mice. We report here that mice deficient in the mPer2 gene are cancer prone. After 7 radiation, these mice, show a marked increase in tumor development and reduced apoptosis in thymocytes. The core circadian genes are induced by gamma radiation in wildtype mice but not in mPer2 mutant mice. Temporal expression of genes involved in cell cycle regulation and tumor suppression, such as Cyclin D1, Cyclin A, Mdm-2, and Gadd45alpha, is deregulated in mPer2 mutant mice. In particular, the transcription of c-myc is controlled directly by circadian regulators and is deregulated in the mPer2 mutant. Our studies suggest that the mPer2 gene functions in tumor suppression by regulating DNA damage-responsive pathways.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lee, CC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	ching@bcm.tmc.edu						Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Anderson LE, 2000, CANCER LETT, V148, P121, DOI 10.1016/S0304-3835(99)00320-1; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; Barbason H, 1995, IN VIVO, V9, P539; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; Bjarnason G A, 2000, Prog Cell Cycle Res, V4, P193; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Gao CF, 2001, EXP CELL RES, V265, P145; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Hrushesky WJM, 2001, J CONTROL RELEASE, V74, P27, DOI 10.1016/S0168-3659(01)00307-8; KLEVECZ RR, 1987, CANCER RES, V47, P6267; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Lee TC, 1999, J BIOL CHEM, V274, P595, DOI 10.1074/jbc.274.2.595; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Ruifrok ACC, 1998, RADIAT RES, V149, P360, DOI 10.2307/3579698; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Winningham ML, 2001, CANCER-AM CANCER SOC, V92, P988, DOI 10.1002/1097-0142(20010815)92:4+<988::AID-CNCR1411>3.0.CO;2-O; Wood PA, 1998, EXP HEMATOL, V26, P523; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	54	953	1015	3	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2002	111	1					41	50		10.1016/S0092-8674(02)00961-3	http://dx.doi.org/10.1016/S0092-8674(02)00961-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	601RQ	12372299	Bronze			2022-12-24	WOS:000178461900007
J	Crawford, LM				Crawford, LM			Pharmacy compounding guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1579	1579		10.1001/jama.288.13.1579-c	http://dx.doi.org/10.1001/jama.288.13.1579-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350176				2022-12-24	WOS:000178314000005
J	Wright, RS; Reeder, GS; Herzog, CA; Albright, RC; Williams, BA; Dvorak, DL; Miller, WL; Murphy, JG; Kopecky, SL; Jaffe, AS				Wright, RS; Reeder, GS; Herzog, CA; Albright, RC; Williams, BA; Dvorak, DL; Miller, WL; Murphy, JG; Kopecky, SL; Jaffe, AS			Acute myocardial infarction and renal dysfunction: A high-risk combination	ANNALS OF INTERNAL MEDICINE			English	Article							END-SYSTOLIC VOLUME; LONG-TERM SURVIVAL; THERAPY; FAILURE; DISEASE	Background: Survival is poor in patients with acute myocardial infarction (MI) who also have severe renal disease. Less is known about the outcome of acute MI in patients with mild to moderate renal insufficiency. Objective: To compare outcomes after acute MI in patients with varying levels of renal disease and in patients without renal failure. Design: Retrospective cohort study. Setting: Academic medical center. Patients: 3106 total patients admitted with acute MI and endstage renal disease (n = 44), severe renal insufficiency (creatinine clearance < 0.59 mL/s [<35 mL/min]) (n = 391), moderate renal dysfunction (creatinine clearance greater than or equal to 0.59 mL/s [<35 mL/min] but less than or equal to0.84 mL/s [less than or equal to50 mL/min]) (n = 491), mild chronic renal insufficiency (creatinine clearance > 0.84 mL/s [>50 mL/min] but less than or equal to1.25 mL/s [less than or equal to75 mL/min]) (n = 860), or no renal disease (n 1320). Measurements: Clinical characteristics, treatment strategies, and short- and long-term survival were compared after patients were stratified by creatinine clearance. Results: in-hospital mortality rates were 2% in patients with normal renal function, 6% in those with mild renal failure, 14% in those with moderate renal failure, 21% in those with severe renal failure, and 30% in those with end-stage renal disease (P < 0.001). Compared with patients without renal disease, similar adjusted trends were present for post-discharge death in patients with end-stage renal disease (hazard ratio, 5.4 95% CI, 3.0 to 9.71; P < 0.001), severe renal insufficiency (hazard ratio, 1.9 [Cl, 1.2 to 3.0]; P = 0.006), moderate renal dysfunction (hazard ratio, 2.2 [CI, 1.5 to 3.3]; P < 0.001), and mild chronic renal insufficiency (hazard ratio, 2.4 [Cl, 1.7 to 3.3]; P < 0.001). Patients with renal failure received adjunctive and reperfusion therapies less frequently than those with normal renal function (P < 0.001). Postdischarge death was less likely in patients who received acute reperfusion therapy (odds ratio, 0.7 [Cl, 0.6 to 0.9]), aspirin (odds ratio, 0.7 [CI, 0.5 to 0.8]), and beta-blocker therapy (odds ratio, 0.7 [Cl, 0.6 to 0.9]). Conclusion: Patients with renal failure are at increased risk for death after acute MI and receive less aggressive treatment than patients with normal renal function.	Mayo Clin, Mayo Alliance Clin Trials, Div Cardiol, Rochester, MN 55902 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis, MN 55455 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Wright, RS (corresponding author), Mayo Clin, Mayo Alliance Clin Trials, Div Cardiol, Stabile 5,150 3rd St SW, Rochester, MN 55902 USA.	wright.scott@mayo.edu						[Anonymous], 1986, Lancet, V2, P57; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522; Becker BN, 1997, J AM SOC NEPHROL, V8, P475; Chertow GM, 2000, AM J KIDNEY DIS, V35, P1044, DOI 10.1016/S0272-6386(00)70038-2; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; *GUSTO ANG INV, 1992, NEW ENGL J MED, V329, P1615; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; HERLITZ J, 1991, J INTERN MED, V230, P233; Herzog CA, 2000, AM J KIDNEY DIS, V36, P145, DOI 10.1053/ajkd.2000.8287; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Herzog CA, 1997, CIRCULATION, V96, P2075; HJALMARSON A, 1985, EUR HEART J, V6, P199; Jungers P, 1997, NEPHROL DIAL TRANSPL, V12, P2597, DOI 10.1093/ndt/12.12.2597; Kasiske BL, 1996, J AM SOC NEPHROL, V7, P158; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; KIMMEL PJ, 1998, PRIMER KIDNEY DIS; KONG TQ, 1993, CIRCULATION, V88, P49; Luke RG, 1998, NEW ENGL J MED, V339, P841, DOI 10.1056/NEJM199809173391211; Migrino RQ, 1997, CIRCULATION, V96, P116; Mourad JJ, 1997, HYPERTENSION, V30, P1425, DOI 10.1161/01.HYP.30.6.1425; *NAT I DIAB DIG KI, 1998, US REN DAT SYST 1998, P79; *NAT I DIAB DIG KI, 1998, US REN DAT SYST 1998, P51; *NIH, 1997, NIH PUBL, P35; *NIH, 1992, NIH PUBL, P61; Orth SR, 1997, KIDNEY INT, V51, P1669, DOI 10.1038/ki.1997.232; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Ritz E, 1998, NEPHROL DIAL TRANSPL, V13, P16, DOI 10.1093/ndt/13.suppl_2.16; ROBERTS R, 1991, CIRCULATION, V83, P422, DOI 10.1161/01.CIR.83.2.422; Rubin Timothy A., 1996, Journal of the American College of Cardiology, V27, p67A; Venkatesan J, 1997, SEMIN NEPHROL, V17, P257; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; 1998, AM J KIDNEY DIS S1, V32, pS9	34	471	496	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2002	137	7					563	570		10.7326/0003-4819-137-7-200210010-00007	http://dx.doi.org/10.7326/0003-4819-137-7-200210010-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599VD	12353943				2022-12-24	WOS:000178355100002
J	Linkenhoker, BA; Knudsen, EI				Linkenhoker, BA; Knudsen, EI			Incremental training increases the plasticity of the auditory space map in adult barn owls	NATURE			English	Article							OPTIC TECTUM; SOUND LOCALIZATION; SENSITIVE PERIODS; EXPERIENCE; MECHANISMS; MIDBRAIN; BIRDSONG; SPEECH	The plasticity in the central nervous system that underlies learning is generally more restricted in adults than in young animals(1-4). In one well-studied example, the auditory localization pathway has been shown to be far more limited in its capacity to adjust to abnormal experience in adult than in juvenile barn owls(5). Plasticity in this pathway has been induced by exposing owls to prismatic spectacles that cause a large, horizontal shift of the visual field. With prisms, juveniles learn new associations between auditory cues, such as interaural time difference (ITD), and locations in visual space, and acquire new neurophysiological maps of ITD in the optic tectum, whereas adults do neither(6). Here we show that when the prismatic shift is experienced in small increments, maps of ITD in adults do change adaptively. Once established through incremental training, new ITD maps can be reacquired with a single large prismatic shift. Our results show that there is a substantially greater capacity for plasticity in adults than was previously recognized and highlight a principled strategy for tapping this capacity that could be applied in other areas of the adult central nervous system.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.							Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; Clawson DM, 2001, J EXP PSYCHOL-APPL, V7, P129, DOI 10.1037//1076-898X.7.2.129; Daw NW, 1997, OPTOMETRY VISION SCI, V74, P690, DOI 10.1097/00006324-199709000-00002; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FOX K, 1992, J NEUROSCI, V12, P1826; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; KING AJ, 1993, EXP PHYSIOL, V78, P559, DOI 10.1113/expphysiol.1993.sp003708; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1985, J NEUROSCI, V5, P3094; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Mooney R, 1999, CURR OPIN NEUROBIOL, V9, P121, DOI 10.1016/S0959-4388(99)80015-4; MURPHY EH, 1975, EXP NEUROL, V49, P386, DOI 10.1016/0014-4886(75)90096-5; Newport E. L., 2001, LANGUAGE BRAIN COGNI, P481, DOI DOI 10.1067/MHN.2001.115372; Perone M., 1988, HUMAN OPERANT CONDIT, P59; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	26	88	93	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2002	419	6904					293	296		10.1038/nature01002	http://dx.doi.org/10.1038/nature01002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594NH	12239566				2022-12-24	WOS:000178056300044
J	Rathore, SS; Wang, YF; Radford, MJ; Ordin, DL; Krumholz, HM				Rathore, SS; Wang, YF; Radford, MJ; Ordin, DL; Krumholz, HM			Sex differences in cardiac catheterization after acute myocardial infarction: The role of procedure appropriateness	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ANGIOGRAPHY; GENDER-DIFFERENCES; AMERICAN-COLLEGE; ELDERLY-PATIENTS; MANAGED CARE; WOMEN; MEN; REVASCULARIZATION; OUTCOMES; BIAS	Background: many studies have found that women are less likely than men to have cardiac catheterization after an acute myocardial infarction; however, it is unknown whether sex differences reflect inappropriate treatment. Objective: To ascertain whether cardiac catheterization use after acute myocardial infarction in men and women varied by sex and the appropriateness of the procedure, as determined by clinical guidelines. Design: Retrospective analysis of chart-abstracted data. Setting: U.S. acute-care hospitals. Patients: 143 444 Medicare patients who were hospitalized for acute myocardial infarction between 1994 and 1996. Measurements: Cardiac catheterization use within 60 days of hospitalization for acute myocardial infarction. Results: Women had lower crude rates of cardiac catheterization than men (35.7% for women vs. 46.5% for men [P < 0.001]; difference, 10.8 percentage points). Multivariable adjustment for demographic, clinical, and hospital characteristics reduced most of the sex differences in procedure use (risk-standardized rates, 40.3% for women vs. 41.9% for men [P < 0.001]; difference, 1.6 percentage points), Sex differences in cardiac catheterization use varied by the appropriateness of the procedure. Risk-standardized rates of cardiac catheterization were similar for men and women with strong indications for the procedure (44.1% for women vs. 44.6% for men [P > 0.2]; difference, 0.5 percentage point). Rates of cardiac catheterization use among patients with weak indications did not significantly differ between men and women (16.5% for women vs. 18.0% for men [P = 0.096]; difference, 1.5 percentage points). Sex differences in cardiac catheterization use were largest for patients with equivocal indications (39.4% for women vs. 42.5% for men [P < 0.001]; difference, 3.1 percentage points). Conclusions: Among elderly persons, women have lower rates of cardiac catheterization use after an acute myocardial infarction than men. However, this difference was attenuated after multivariable adjustment, and it occurred primarily in patients with equivocal indications. We found no sex variations in procedure use among patients who had strong indications for cardiac catheterization.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA; Ctr Medicare Serv, Boston, MA USA; Ctr Medicaid Serv, Boston, MA USA	Yale University; Yale University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Room 1E-61 SHM,333 Cedar St,POB 208025, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557				*AM HOSP ASS, 1994, ANN SURV HOSP DAT DO; [Anonymous], CORONARY ANGIOGRAPHY; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BELL MR, 1995, J AM COLL CARDIOL, V25, P1650, DOI 10.1016/0735-1097(95)00044-5; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; CHERKIN D, 1977, MED CARE, V15, P767; CHIRIBOGA DE, 1993, AM J CARDIOL, V71, P268, DOI 10.1016/0002-9149(93)90789-F; DHOORE W, 1994, AM J PUBLIC HEALTH, V84, P1013, DOI 10.2105/AJPH.84.6.1013; FUNK M, 1994, AM J CARDIOL, V74, P1170, DOI 10.1016/0002-9149(94)90475-8; GATSONIS CA, 1995, MED CARE, V33, P625, DOI 10.1097/00005650-199506000-00005; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; Guadagnoli E, 2000, NEW ENGL J MED, V343, P1460, DOI 10.1056/NEJM200011163432006; HACHAMOVITCH R, 1995, J AM COLL CARDIOL, V26, P1457, DOI 10.1016/0735-1097(95)00356-8; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; *HLTH CAR FIN ADM, 1997, INT CLASS DIS; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Kilaru PK, 2000, J AM COLL CARDIOL, V35, P974, DOI 10.1016/S0735-1097(99)00641-5; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; KYRIAKIDIS M, 1995, J CLIN EPIDEMIOL, V48, P723, DOI 10.1016/0895-4356(94)00194-U; Laouri M, 1997, INT J QUAL HEALTH C, V9, P15, DOI 10.1093/intqhc/9.1.15; Lauer MS, 1996, AM J CARDIOL, V78, P278, DOI 10.1016/S0002-9149(96)00277-9; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Maynard C, 1996, CIRCULATION, V94, P93; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V266, P559; PASHOS CL, 1993, JAMA-J AM MED ASSOC, V270, P1832, DOI 10.1001/jama.270.15.1832; PEARSON ML, 1992, JAMA-J AM MED ASSOC, V268, P1883, DOI 10.1001/jama.268.14.1883; Rathore SS, 2001, JAMA-J AM MED ASSOC, V286, P2849, DOI 10.1001/jama.286.22.2849; Ruiz MT, 1997, J EPIDEMIOL COMMUN H, V51, P106, DOI 10.1136/jech.51.2.106; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; *US BUR CENS, 1991, STAT METR AR DAT BOO; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wong BYY, 1996, CANCER BIOTHER RADIO, V11, P51, DOI 10.1089/cbr.1996.11.51; Wong CC, 1998, AM HEART J, V135, P435, DOI 10.1016/S0002-8703(98)70319-9	42	69	72	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2002	137	6					487	493		10.7326/0003-4819-137-6-200209170-00008	http://dx.doi.org/10.7326/0003-4819-137-6-200209170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594UJ	12230349				2022-12-24	WOS:000178069100002
J	Martinez, J; Patkaniowska, A; Urlaub, H; Luhrmann, R; Tuschl, T				Martinez, J; Patkaniowska, A; Urlaub, H; Luhrmann, R; Tuschl, T			Single-stranded antisense siRNAs guide target RNA cleavage in RNAi	CELL			English	Article							MESSENGER-RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; GENETIC INTERFERENCE; STEM-CELLS; INITIATION; EXPRESSION; PROTEINS; DEGRADATION	Small interfering RNAs (siRNAs) are the mediators of mRNA degradation in the process of RNA interference (RNAi). Here, we describe a human biochemical system that recapitulates siRNA-mediated target RNA degradation. By using affinity-tagged siRNAs, we demonstrate that a single-stranded siRNA resides in the RNA-induced silencing complex (RISC) together with eIF2C1 and/or eIF2C2 (human GERp95) Argonaute proteins. RISC is rapidly formed in HeLa cell cytoplasmic extract supplemented with 21 nt siRNA duplexes, but also by adding single-stranded antisense RNAs, which range in size between 19 and 29 nucleotides. Single-stranded antisense siRNAs are also effectively silencing genes in HeLa cells, especially when 5'-phosphorylated, and expand the repertoire of RNA reagents suitable for gene targeting.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.			Martinez, Javier/0000-0001-9152-7323				Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eckstein F., 1991, OLIGONUCLEOTIDES ANA; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; GUO S, 1995, CELL, V81, P613; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harborth J, 2001, J CELL SCI, V114, P4557; HUTVAGNER G, 2002, IN PRESS SCIENCE; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Koesters R, 1999, GENOMICS, V61, P210, DOI 10.1006/geno.1999.5951; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132; SCHWARZ D, 2002, IN PRESS MOL CELL; Schwarz DS, 2002, GENE DEV, V16, P1025, DOI 10.1101/gad.992502; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.3.CO;2-I; TUSCHL T, 2002, MOL INTERV, V2, P42; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2001, MOL CELL, V8, P1158, DOI 10.1016/S1097-2765(01)00418-X; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	55	1070	1393	6	108	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 6	2002	110	5					563	574		10.1016/S0092-8674(02)00908-X	http://dx.doi.org/10.1016/S0092-8674(02)00908-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	592NL	12230974	Green Published, Bronze			2022-12-24	WOS:000177943700004
J	Robbins, JB; Schneerson, R; Trollfors, B				Robbins, JB; Schneerson, R; Trollfors, B			Pertussis in developed countries	LANCET			English	Editorial Material							VACCINE		NICHHD, NIH, Bethesda, MD 20892 USA; Dept Paediat, Gothenburg, Sweden	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Robbins, JB (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	robbinsjo@mail.nih.gov						BERFORS B, 1999, INT J INFECT DIS, V3, P140; Boursaux-Eude C, 1999, VACCINE, V17, P2651, DOI 10.1016/S0264-410X(99)00038-9; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P73; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Kendrick P, 1935, AM J PUBLIC HEALTH N, V25, P147, DOI 10.2105/AJPH.25.2.147; MARCHANT CD, 1994, J INFECT DIS, V169, P1297, DOI 10.1093/infdis/169.6.1297; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; *ROYAL COLL GEN PR, 1981, BMJ-BRIT MED J, V282, P23; Schneerson R, 1996, LANCET, V348, P1289, DOI 10.1016/S0140-6736(96)05243-9; SHAHIN RD, 1990, J EXP MED, V171, P63, DOI 10.1084/jem.171.1.63; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Taranger J, 2001, CLIN INFECT DIS, V33, P1004, DOI 10.1086/322639; Taranger J, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e115; *WHO, 1991, CAS DEF PERT	16	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2002	360	9334					657	658		10.1016/S0140-6736(02)09882-3	http://dx.doi.org/10.1016/S0140-6736(02)09882-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590AM	12241870				2022-12-24	WOS:000177795100005
J	Zhong, HM; Molday, LL; Molday, RS; Yau, KW				Zhong, HM; Molday, LL; Molday, RS; Yau, KW			The heteromeric cyclic nucleotide gated channel adopts a 3A : 1B stoichiometry	NATURE			English	Article							ROD PHOTORECEPTOR; ION CHANNELS; BETA-SUBUNIT; C-ELEGANS; SENSITIVITY; ARRANGEMENT; NEURONS; FAMILY; CAMP	Cyclic nucleotide-gated (CNG) channels are crucial for visual and olfactory transductions(1-4). These channels are tetramers and in their native forms are composed of A and B subunits(5), with a stoichiometry thought to be 2A:2B (refs 6, 7). Here we report the identification of a leucine-zipper(8)-homology domain named CLZ (for carboxy-terminal leucine zipper). This domain is present in the distal C terminus of CNG channel A subunits but is absent from B subunits, and mediates an inter-subunit interaction. With cross-linking, non-denaturing gel electrophoresis and analytical centrifugation, this CLZ domain was found to mediate a trimeric interaction. In addition, a mutant cone CNG channel A subunit with its CLZ domain replaced by a generic trimeric leucine zipper produced channels that behaved much like the wild type, but less so if replaced by a dimeric or tetrameric leucine zipper. This A-subunit-only, trimeric interaction suggests that heteromeric CNG channels actually adopt a 3A:1B stoichiometry. Biochemical analysis of the purified bovine rod CNG channel confirmed this conclusion. This revised stoichiometry provides a new foundation for understanding the structure and function of the CNG channel family.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Ophthalmol, Vancouver, BC V6T 1Z3, Canada; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of British Columbia; University of British Columbia; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.			Zhong, Haining/0000-0002-7109-4724	NATIONAL EYE INSTITUTE [R37EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-14, R37 EY006837-15, R37 EY006837-15S1, R37 EY006837, R37 EY006837-13] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; Biel M, 1999, Rev Physiol Biochem Pharmacol, V135, P151, DOI 10.1007/BFb0033672; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1995, CURR OPIN NEUROBIOL, V5, P434, DOI 10.1016/0959-4388(95)80002-6; Kazmin D, 2002, ANAL BIOCHEM, V301, P91, DOI 10.1006/abio.2001.5488; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Laue MT, 1992, ANAL ULTRACENTRIFUGA, P90; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Molday R S, 1999, Methods Enzymol, V294, P246; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	31	180	187	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 14	2002	420	6912					193	198		10.1038/nature01201	http://dx.doi.org/10.1038/nature01201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614QM	12432397	Green Accepted			2022-12-24	WOS:000179200900050
J	Hoffmann, A; Levchenko, A; Scott, ML; Baltimore, D				Hoffmann, A; Levchenko, A; Scott, ML; Baltimore, D			The I kappa B-NF-kappa B signaling module: Temporal control and selective gene activation	SCIENCE			English	Article							DEFICIENT MICE; ALPHA; MECHANISMS; EPSILON; FAMILY; BETA	Nuclear localization of the transcriptional activator NFkappa-B (nuclear factor kappaB) is controlled in mammalian cells by three isoforms of NF-kappaB inhibitor protein: IkappaBalpha, -beta, and -epsilon. Based on simplifying reductions of the IkappaB-NF-kappaB signaling module in knockout cell lines, we present a computational model that describes the temporal control of NF-kappaB activation by the coordinated degradation and synthesis of IkappaB proteins. The model demonstrates that IkappaBalpha is responsible for strong negative feedback that allows for a fast turn-off of the NF-kappaB response, whereas IkappaBbeta and -epsilon function to reduce the system's oscillatory potential and stabilize NF-kappaB responses during longer stimulations. Bimodal signal-processing characteristics with respect to stimulus duration are revealed by the model and are shown to generate specificity in gene expression.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	California Institute of Technology; Johns Hopkins University; Massachusetts Institute of Technology (MIT)	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Levchenko, Andre/A-3328-2010; Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645				Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Han YQ, 1999, J BIOL CHEM, V274, P939, DOI 10.1074/jbc.274.2.939; HOFFMANN A, UNPUB; Kemler I, 1999, GLIA, V26, P212, DOI 10.1002/(SICI)1098-1136(199905)26:3<212::AID-GLIA3>3.0.CO;2-F; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Memet S, 1999, J IMMUNOL, V163, P5994; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SCOTT M, UNPUB; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	19	1392	1450	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2002	298	5596					1241	1245		10.1126/science.1071914	http://dx.doi.org/10.1126/science.1071914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424381				2022-12-24	WOS:000179080400053
J	Medalia, O; Weber, I; Frangakis, AS; Nicastro, D; Gerisch, G; Baumeister, W				Medalia, O; Weber, I; Frangakis, AS; Nicastro, D; Gerisch, G; Baumeister, W			Macromolecular architecture in eukaryotic cells visualized by cryoelectron tomography	SCIENCE			English	Article							AUTOMATIC ELECTRON TOMOGRAPHY; ARP2/3 COMPLEX; 26S PROTEASOME; F-ACTIN; DICTYOSTELIUM; CYTOKINESIS; FILAMENTS; MECHANISM; PROTEINS; PARTICLE	Electron tomography of vitrifed cells is a noninvasive three-dimensional imaging technique that opens up new vistas for exploring the supramolecular organization of the cytoplasm. We applied this technique to Dictyostelium cells, focusing on the actin cytoskeleton. In actin networks reconstructed without prior removal of membranes or extraction of soluble proteins, the cross-linking of individual micro laments, their branching angles, and membrane attachment sites can be analyzed. At a resolution of 5 to 6 nanometers, single macromolecules with distinct shapes, such as the 26S proteasome, can be identified in an unperturbed cellular environment.	Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Baumeister, W (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.		Weber, Igor/J-3947-2012	Weber, Igor/0000-0003-4296-3166; Frangakis, Achilleas/0000-0002-8067-6611; Nicastro, Daniela/0000-0002-0122-7173; Medalia, Ohad/0000-0003-0994-2937				Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DIERKSEN K, 1992, ULTRAMICROSCOPY, V40, P71, DOI 10.1016/0304-3991(92)90235-C; DIERKSEN K, 1993, ULTRAMICROSCOPY, V49, P109, DOI 10.1016/0304-3991(93)90217-L; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7; Grimm R, 1997, BIOPHYS J, V72, P482, DOI 10.1016/S0006-3495(97)78689-2; Grimm R, 1996, J MICROSC-OXFORD, V183, P60, DOI 10.1046/j.1365-2818.1996.77441.x; GRUNEWALD R, IN PRESS BIOPHYS CHE; HART RG, 1968, SCIENCE, V159, P1464, DOI 10.1126/science.159.3822.1464; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; HEGERL R, 1976, Z NATURFORSCH A, V31, P1717, DOI 10.1515/zna-1976-1241; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Insall R, 2001, CELL MOTIL CYTOSKEL, V50, P115, DOI 10.1002/cm.10005; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; Lee EY, 2001, BBA-GEN SUBJECTS, V1525, P217, DOI 10.1016/S0304-4165(01)00107-6; MCEWEN BF, 1995, ULTRAMICROSCOPY, V60, P357, DOI 10.1016/0304-3991(95)00082-8; McEwen BF, 2001, J HISTOCHEM CYTOCHEM, V49, P553, DOI 10.1177/002215540104900502; McEwen BF, 2001, CURR OPIN NEUROBIOL, V11, P594, DOI 10.1016/S0959-4388(00)00255-5; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nicastro D, 2000, J STRUCT BIOL, V129, P48, DOI 10.1006/jsbi.1999.4204; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PETERS JM, 1993, J MOL BIOL, V234, P932, DOI 10.1006/jmbi.1993.1646; Plitzko JM, 2002, TRENDS BIOTECHNOL, V20, pS40, DOI 10.1016/S0167-7799(02)02017-6; PODOLSKI JL, 1990, J BIOL CHEM, V265, P1312; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Resch GP, 2002, J CELL SCI, V115, P1877; Schliwa M, 2002, NAT REV MOL CELL BIO, V3, P291, DOI 10.1038/nrm781; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tsujioka M, 1999, CURR BIOL, V9, P389, DOI 10.1016/S0960-9822(99)80169-9; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958	43	610	629	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 8	2002	298	5596					1209	1213		10.1126/science.1076184	http://dx.doi.org/10.1126/science.1076184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612MQ	12424373				2022-12-24	WOS:000179080400042
J	Daynard, RA; Hash, LE; Robbins, A				Daynard, RA; Hash, LE; Robbins, A			Food litigation: Lessons from the tobacco wars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Northeastern Univ, Sch Law, Boston, MA 02115 USA; Harvard Univ, Sch Law, Cambridge, MA 02138 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Northeastern University; Harvard University; Tufts University	Daynard, RA (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							Daynard RA, 2001, CANCER CAUSE CONTROL, V12, P383, DOI 10.1023/A:1011248512615; Glantz S.A., 1996, CIGARETTE PAPERS; NESTLE M, 2002, FOOD POLITICS, P22; Putnam J., 2000, FoodReview, V23, P2; *US GEN ACC OFF, 2000, PUBL ED COMM ACT SCH	5	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2002	288	17					2179	2179		10.1001/jama.288.17.2179	http://dx.doi.org/10.1001/jama.288.17.2179			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611ZJ	12413385	hybrid			2022-12-24	WOS:000179048100035
J	Wuarin, J; Buck, V; Nurse, P; Millar, JBA				Wuarin, J; Buck, V; Nurse, P; Millar, JBA			Stable association of mitotic cyclin B/Cdc2 to replication origins prevents endoreduplication	CELL			English	Article							B-TYPE CYCLIN; DNA-REPLICATION; FISSION YEAST; S-PHASE; CELL-CYCLE; RECOGNITION COMPLEX; SCHIZOSACCHAROMYCES-POMBE; NEGATIVE REGULATION; LICENSING SYSTEM; BUDDING YEAST	We show that in fission yeast the mitotic B type cyclin Cdc13/Cdc2 kinase associates with replication origins in vivo. This association is dependent on the origin recognition complex (ORC), is established as chromosomes are replicated, and is maintained during G2 and early mitosis. Cells expressing an orp2 (ORC2) allele that reduces binding of Cdc13 to replication origins are acutely prone to chromosomal reduplication. In synchronized endoreduplicating cells, following Cdc13 ablation, replication origins are coordinately licensed prior to each successive round of S phase with the same periodicity as in a normal cell cycle. Thus, ORC bound mitotic Cyclin B/Cdc2 kinase imposes the dependency of S phase on an intervening mitosis but not the temporal licensing of replication origins between each S phase.	Natl Inst Med Res, Div East Genet, London NW7 1AA, England; Canc Res UK, Cell Cycle Lab, London WC1A 3PX, England	MRC National Institute for Medical Research; Cancer Research UK	Millar, JBA (corresponding author), Natl Inst Med Res, Div East Genet, Mill Hill, London NW7 1AA, England.	jmillar@nimr.mrc.ac.uk		Millar, Jonathan/0000-0002-9930-3989	MRC [MC_U117531948] Funding Source: UKRI; Medical Research Council [MC_U117531948] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Ayte J, 2001, NAT CELL BIOL, V3, P1043, DOI 10.1038/ncb1201-1043; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; CorreaBordes J, 1997, EMBO J, V16, P4657, DOI 10.1093/emboj/16.15.4657; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; DUBEY DD, 1994, EMBO J, V13, P3638, DOI 10.1002/j.1460-2075.1994.tb06671.x; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; GALLAGHER IM, 1993, MOL BIOL CELL, V4, P1087, DOI 10.1091/mbc.4.11.1087; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Leatherwood J, 1996, NATURE, V379, P360, DOI 10.1038/379360a0; Lopez-Girona A, 1998, MOL BIOL CELL, V9, P63, DOI 10.1091/mbc.9.1.63; Lygerou Z, 1999, J CELL SCI, V112, P3703; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Ogawa M, 1999, J POROUS MAT, V6, P19, DOI 10.1023/A:1009628900106; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Romanowski P, 2000, J BIOL CHEM, V275, P4239, DOI 10.1074/jbc.275.6.4239; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Vas A, 2001, MOL CELL BIOL, V21, P5767, DOI 10.1128/MCB.21.17.5767-5777.2001; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wuarin J, 1996, CELL, V85, P785, DOI 10.1016/S0092-8674(00)81261-1; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0; Yanow SK, 2001, EMBO J, V20, P4648, DOI 10.1093/emboj/20.17.4648	54	87	91	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2002	111	3					419	431		10.1016/S0092-8674(02)01042-5	http://dx.doi.org/10.1016/S0092-8674(02)01042-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	611HG	12419251	Bronze			2022-12-24	WOS:000179010100013
J	Iyengar, VK; Reeve, HK; Eisner, T				Iyengar, VK; Reeve, HK; Eisner, T			Paternal inheritance of a female moth's mating preference	NATURE			English	Article							SEXUALLY SELECTED TRAIT; ARCTIID MOTH; UTETHEISA-ORNATRIX; SELECTION; HERITABILITY; BEHAVIOR; DEFENSE; SIZE	Females of the arctiid moth Utetheisa ornatrix mate preferentially with larger males, receiving both direct phenotypic and indirect genetic benefits(1). Here we demonstrate that the female's mating preference is inherited through the father rather than the mother, indicating that the preference gene or genes lie mostly or exclusively on the Z sex chromosome, which is strictly paternally inherited by daughters. Furthermore, we show that the preferred male trait and the female preference for that trait are correlated, as females with larger fathers have a stronger preference for larger males. These findings are predicted by the protected invasion theory(2,3), which asserts that male homogametic sex chromosome systems (ZZ/ZW) found in lepidopterans and birds promote the evolution of exaggerated male traits through sexual selection. Specifically, the theory predicts that, because female preference alleles arising on the Z chromosome are transmitted to all sons that have the father's attractive trait rather than to only a fraction of the sons, such alleles will experience stronger positive selection and be less vulnerable to chance loss than would autosomal alleles.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14850 USA	Cornell University	Iyengar, VK (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14850 USA.	viyengar@wooster.edu						Andersson Malte, 1994; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; CONNER WE, 1981, BEHAV ECOL SOCIOBIOL, V9, P227, DOI 10.1007/BF00302942; CONNER WE, 1990, J CHEM ECOL, V16, P543, DOI 10.1007/BF01021785; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; Gonzalez A, 1999, P NATL ACAD SCI USA, V96, P5570, DOI 10.1073/pnas.96.10.5570; GRULA JW, 1980, EVOLUTION, V34, P688, DOI 10.1111/j.1558-5646.1980.tb04007.x; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P15013, DOI 10.1073/pnas.96.26.15013; Iyengar VK, 2001, BEHAV ECOL SOCIOBIOL, V49, P283, DOI 10.1007/s002650000292; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P9169, DOI 10.1073/pnas.96.16.9169; LAMUNYON CW, 1993, P NATL ACAD SCI USA, V90, P4689, DOI 10.1073/pnas.90.10.4689; LAMUNYON CW, 1994, P NATL ACAD SCI USA, V91, P7081, DOI 10.1073/pnas.91.15.7081; LaMunyon CW, 1997, ECOL ENTOMOL, V22, P69, DOI 10.1046/j.1365-2311.1997.00033.x; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lynch M., 1998, AM J HUM GENET; Opler P. A., 1984, BUTTERFLIES E GREAT; REEVE HK, 1993, PHILOS T R SOC B, V342, P335, DOI 10.1098/rstb.1993.0163; Reeve HK, 1997, EVOL ECOL, V11, P357, DOI 10.1023/A:1018472521277; Sharma Vijay Lakshmi, 1999, Bionature, V19, P65; Traut W, 1997, CHROMOSOME RES, V5, P283, DOI 10.1023/B:CHRO.0000038758.08263.c3; Wilkinson GS, 1998, BEHAV ECOL, V9, P525, DOI 10.1093/beheco/9.5.525; Wolfenbarger LL, 2001, EVOLUTION, V55, P103	24	74	75	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2002	419	6909					830	832		10.1038/nature01027	http://dx.doi.org/10.1038/nature01027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607BD	12397356				2022-12-24	WOS:000178769800044
J	Bradford, MA; Jones, TH; Bardgett, RD; Black, HIJ; Boag, B; Bonkowski, M; Cook, R; Eggers, T; Gange, AC; Grayston, SJ; Kandeler, E; McCaig, AE; Newington, JE; Prosser, JI; Setala, H; Staddon, PL; Tordoff, GM; Tscherko, D; Lawton, JH				Bradford, MA; Jones, TH; Bardgett, RD; Black, HIJ; Boag, B; Bonkowski, M; Cook, R; Eggers, T; Gange, AC; Grayston, SJ; Kandeler, E; McCaig, AE; Newington, JE; Prosser, JI; Setala, H; Staddon, PL; Tordoff, GM; Tscherko, D; Lawton, JH			Impacts of soil faunal community composition on model grassland ecosystems	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; DECOMPOSITION; BIODIVERSITY; AGROECOSYSTEMS; MINERALIZATION; DIVERSITY; NITROGEN; GROWTH	Human impacts, including global change, may alter the composition of soil faunal communities, but consequences for ecosystem functioning are poorly understood. We constructed model grassland systems in the Ecotron controlled environment facility and manipulated soil community composition through assemblages of different animal body sizes. Plant community composition, microbial and root biomass, decomposition rate, and mycorrhizal colonization were all markedly affected. However, two key ecosystem processes, aboveground net primary productivity and net ecosystem productivity, were surprisingly resistant to these changes. We hypothesize that positive and negative faunal-mediated effects in soil communities cancel each other out, causing no net ecosystem effects.	Univ London Imperial Coll Sci Technol & Med, Nat Environm Res Council Ctr Populat Biol, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Cardiff Univ, Cardiff Sch Biosci, Biodivers & Ecol Proc Res Grp, Cardiff CF10 3TL, S Glam, Wales; Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England; Ctr Ecol & Hydrol, Grange Over Sands LA11 6JU, Cumbria, England; Scottish Crop Res Inst, Dundee DD2 5DA, Scotland; Tech Univ Darmstadt, Fachbereich 10, D-64287 Darmstadt, Germany; Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales; Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland; Univ Hohenheim, Inst Soil Sci, D-70599 Stuttgart, Germany; Univ Aberdeen, Inst Med Sci, Dept Mol & Cell Biol, Aberdeen AB25 2ZD, Scotland; Univ Helsinki, Dept Ecol & Environm Sci, FIN-15140 Lahti, Finland; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; NERC, Swindon SN2 1EU, Wilts, England	Imperial College London; Cardiff University; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); James Hutton Institute; Technical University of Darmstadt; Aberystwyth University; University of London; Royal Holloway University London; James Hutton Institute; University Hohenheim; University of Aberdeen; University of Helsinki; University of York - UK; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Bradford, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Nat Environm Res Council Ctr Populat Biol, Dept Biol Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	m.a.bradford@ic.ac.uk	Tordoff, George/E-6365-2012; Jones, Hefin/A-4331-2010; Setälä, Heikki M/P-7354-2015; Turan, Veysel/G-7722-2011; Bradford, Mark A/G-3850-2012; Prosser, Jim/F-5280-2010; Bonkowski, Michael/C-3700-2013; McCaig, Allison/F-5054-2017	Bradford, Mark A/0000-0002-2022-8331; Prosser, Jim/0000-0003-1757-5102; Bonkowski, Michael/0000-0003-2656-1183; McCaig, Allison/0000-0002-7398-0244; Kandeler, Ellen/0000-0002-2854-0012; Jones, T Hefin/0000-0002-7874-3627; Tordoff, George/0000-0003-0067-2184				ANDERSON JM, 1995, LINKING SPECIES & ECOSYSTEMS, P94; Anderson JM, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P3, DOI 10.1079/9780851993942.0003; Andren O, 1999, APPL SOIL ECOL, V13, P105, DOI 10.1016/S0929-1393(99)00025-6; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1007, DOI 10.1016/S0038-0717(99)00014-0; BEARE MH, 1995, PLANT SOIL, V170, P5, DOI 10.1007/BF02183051; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; Brussaard L, 1997, AMBIO, V26, P563; Hedlund K, 2000, OIKOS, V88, P585, DOI 10.1034/j.1600-0706.2000.880315.x; HENDRIX PF, 1986, BIOSCIENCE, V36, P374, DOI 10.2307/1310259; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kampichler C, 2001, SOIL BIOL BIOCHEM, V33, P269, DOI 10.1016/S0038-0717(00)00140-1; Lavelle P, 1997, ADV ECOL RES, V27, P93, DOI 10.1016/S0065-2504(08)60007-0; Lawton JH, 1996, ECOLOGY, V77, P665, DOI 10.2307/2265488; Mikola J, 1998, OIKOS, V83, P180, DOI 10.2307/3546560; MIKOLA J, BIODIVERSITY ECOSYST; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Scheu S, 1999, OECOLOGIA, V119, P541, DOI 10.1007/s004420050817; SETALA H, 1991, ECOLOGY, V72, P665, DOI 10.2307/2937206; Setala H, 1996, SOIL BIOL BIOCHEM, V28, P1661, DOI 10.1016/S0038-0717(96)00252-0; Swift MJ., 1979, DECOMPOSITION TERRES, V5; VERHOEF HA, 1990, BIOGEOCHEMISTRY, V11, P175, DOI 10.1007/BF00004496; Wardle DA, 1999, AGROBIODIVERSITY: CHARACTERIZATION, UTILIZATION AND MANAGEMENT, P87; Wolters V, 2000, BIOSCIENCE, V50, P1089, DOI 10.1641/0006-3568(2000)050[1089:EOGCOA]2.0.CO;2; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	27	208	242	17	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2002	298	5593					615	618		10.1126/science.1075805	http://dx.doi.org/10.1126/science.1075805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604RL	12386334				2022-12-24	WOS:000178634800045
J	Tsutsui, KI; Sakata, H; Naganuma, T; Taira, M				Tsutsui, KI; Sakata, H; Naganuma, T; Taira, M			Neural correlates for perception of 3D surface orientation from texture gradient	SCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; DISPARITY SELECTIVITY; BINOCULAR DISPARITY; VISUAL-CORTEX; NEURONS; DISCRIMINATION; MACAQUE; FMRI	A goal in visual neuroscience is to reveal how the visual system reconstructs the three-dimensional (3D) representation of the world from two-dimensional retinal images. Although the importance of texture gradient cues in the process of 3D vision has been pointed out, most studies concentrate on the neural process based on binocular disparity. We report the neural correlates of depth perception from texture gradient in the cortex. In the caudal part of the lateral bank of intraparietal sulcus, many neurons were selective to 3D surface orientation defined by texture gradient, and their response was invariant over different types of texture pattern. Most of these neurons were also sensitive to a disparity gradient, suggesting that they integrate texture and disparity gradient signals to construct a generalized representation of 3D surface orientation.	Nihon Univ, Sch Med, Dept Physiol, Tokyo 1738610, Japan; Nihon Univ, Sch Med, Dept Neurol, Tokyo 1738610, Japan; Seitoku Jr Coll Nutr, Lab Anat & Physiol, Tokyo 1248530, Japan	Nihon University; Nihon University	Tsutsui, KI (corresponding author), Nihon Univ, Sch Med, Dept Physiol, Tokyo 1738610, Japan.		Tsutsui, Ken-Ichiro/B-4378-2008	Tsutsui, Ken-Ichiro/0000-0001-5781-2948				Adams DL, 2001, J NEUROPHYSIOL, V86, P2195, DOI 10.1152/jn.2001.86.5.2195; ADAMS DL, 1997, THESIS U COLL LONDON; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; Gallant Jack L., 1995, P89; Gibson J. J., 1950, PERCEPTION VISUAL WO; GULYAS B, 1994, P NATL ACAD SCI USA, V91, P1239, DOI 10.1073/pnas.91.4.1239; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Howard IP, 1995, BINOCULAR VISION STE; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Julesz B., 1971, FDN CYCLOPEAN PERCEP; NIKARA T, 1968, EXP BRAIN RES, V6, P353; OGLE KN, 1964, BINOCULAR VISION; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; STEVENS KA, 1981, BIOL CYBERN, V42, P95, DOI 10.1007/BF00336727; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Taira M, 2001, NEUROIMAGE, V14, P959, DOI 10.1006/nimg.2001.0895; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120	24	157	159	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 11	2002	298	5592					409	412		10.1126/science.1074128	http://dx.doi.org/10.1126/science.1074128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	602NB	12376700				2022-12-24	WOS:000178510400047
J	Chouard, T; Weiss, U; Dhand, R				Chouard, T; Weiss, U; Dhand, R			Good 'omics' for the poor?	NATURE			English	Editorial Material																		Weiss U, 2002, NATURE, V415, P669; 2002, NATURE, V419, P426; 2002, NATURE, V419, P493; 2001, NATURE MEDICINE, V7, P167	4	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2002	419	6906					489	489		10.1038/419489a	http://dx.doi.org/10.1038/419489a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	599RF	12368859	Bronze			2022-12-24	WOS:000178348400040
J	Goyal, M; Mehta, RL; Schneiderman, LJ; Sehgal, AR				Goyal, M; Mehta, RL; Schneiderman, LJ; Sehgal, AR			Economic and health consequences of selling a kidney in India	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNCONVENTIONAL RENAL-TRANSPLANTATION; ORGAN DONATION; HIGH MORTALITY; SINGLE-CENTER; RECIPIENTS; DONORS; LIFE; INCENTIVES; DIALYSIS; QUALITY	Context Many countries have a shortage of kidneys available for transplantation. Paying people to donate kidneys is often proposed or justified as a way to benefit recipients by increasing the supply of organs and to benefit donors by improving their economic status. However, whether individuals who sell their kidneys actually benefit from the sale is controversial. Objective To determine the economic and health effects of selling a kidney. Design, Setting, and Participants Cross-sectional survey conducted in February 2001 among 305 individuals who had sold a kidney in Chennai, India, an average of 6 years before the survey. Main Outcome Measures Reasons for selling kidney, amount received from sale, how money was spent, change in economic status, change in health status, advice for others contemplating selling a kidney. Results Ninety-six percent of participants sold their kidneys to pay off debts. The average amount received was $1070. Most of the money received was spent on debts, food, and clothing. Average family income declined by one third after nephrectomy (P<.001), and the number of participants living below the poverty line increased. Three fourths of participants were still in debt at the time of the survey. About 86% of participants reported a deterioration in their health status after nephrectomy. Seventy-nine percent would not recommend that others sell a kidney. Conclusions Among paid donors in India, selling a kidney does not lead to a long-term economic benefit and may be associated with a decline in health. Physicians and policy makers should reexamine the value of using financial incentives to increase the supply of organs for transplantation.	Geisinger Hlth Syst, Dept Internal Med, State Coll, PA 16801 USA; Univ Calif San Diego, Dept Nephrol, San Diego, CA 92103 USA; Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA; Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; Metrohlth Med Ctr, Div Nephrol, Cleveland, OH USA; Metrohlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biomed Eth, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Geisinger Health System; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; MetroHealth System; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Goyal, M (corresponding author), Geisinger Hlth Syst, Dept Internal Med, 200 Scenery Dr, State Coll, PA 16801 USA.	madhavg1@yahoo.com	Mehta, Ravindra/ACD-4769-2022	Mehta, Ravindra/0000-0002-0908-2968				ABOUNA GM, 1990, TRANSPLANT P, V22, P918; ALKHADER AA, 1990, LANCET, V336, P1002, DOI 10.1016/0140-6736(90)92460-Y; Bloembergen WE, 1996, J AM SOC NEPHROL, V7, P1139; CAPLAN AL, 1993, TRANSPL P, V25, P2740; Chengappa, 1990, INDIA TODAY     0731, P60; Chugh KS, 1996, KIDNEY INT, V49, P1181, DOI 10.1038/ki.1996.171; Cohen L, 1999, DAEDALUS, V128, P135; COLABAWALLA BN, 1990, LANCET, V336, P1194, DOI 10.1016/0140-6736(90)92811-U; Council o f The Transplantation Society, 1985, LANCET, V2, P715; DAAR AS, 1992, TRANSPLANT P, V24, P2207; Delmonico FL, 2002, NEW ENGL J MED, V346, P2002, DOI 10.1056/NEJMsb013216; DREZE J, 1995, IND EC DEV SOCIAL OP, P109; Drukker A, 1998, LANCET, V352, P483, DOI 10.1016/S0140-6736(05)79215-1; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Finkel M, 2001, N Y Times Mag, P26; *FRONTL, 2002, KIDN STILL SAL; *FRONTL, 2002, KARN UN KIDN TRAD; *GOV IND PLANN COM, 2002, POV EST 1999 2000; *INT LAB OFF, 2002, YB LAB STAT 2000; Jha V, 2001, AM J KIDNEY DIS, V37, P119, DOI 10.1053/ajkd.2001.20596; Josefson D, 2002, BRIT MED J, V324, P1541, DOI 10.1136/bmj.324.7353.1541; Kennedy I, 1998, LANCET, V351, P1650, DOI 10.1016/S0140-6736(97)08212-3; Khan IH, 1998, LANCET, V352, P484, DOI 10.1016/S0140-6736(05)79218-7; Kher V, 2002, KIDNEY INT, V62, P350, DOI 10.1046/j.1523-1755.2002.00426.x; *LAB BUR, 2002, GOV IND; Lopes CS, 1996, INT J EPIDEMIOL, V25, P1267, DOI 10.1093/ije/25.6.1267; Lyon S, 1998, LANCET, V352, P484, DOI 10.1016/S0140-6736(05)79216-3; MANI MK, 1992, TRANSPLANT P, V24, P1828; Marshall P A, 1998, Ann Transplant, V3, P7; MEDAWAR P, 1984, LANCET, V2, P1344; MURRAY TH, 1992, TRANSPLANT IMMUNOL L, V8, P5; Oreopoulos DG, 1998, LANCET, V352, P484, DOI 10.1016/S0140-6736(05)79217-5; PATEL CT, 1988, TRANSPLANT P, V20, P1068; PELLEGRINO ED, 1991, JAMA-J AM MED ASSOC, V265, P1305, DOI 10.1001/jama.265.10.1305; PETERS TG, 1991, JAMA-J AM MED ASSOC, V265, P1302, DOI 10.1001/jama.265.10.1302; RADCLIFFERICHAR.J, 1991, ORGAN REPLACEMENT TH, P191; Reddy K. C., 1991, ORGAN REPLACEMENT TH, P173; REDDY KC, 1990, TRANSPLANT P, V22, P910; SALAHUDEEN AK, 1990, LANCET, V336, P725, DOI 10.1016/0140-6736(90)92214-3; Saran R, 1997, NEPHROL DIAL TRANSPL, V12, P1615, DOI 10.1093/ndt/12.8.1615; Scheper-Hughes N, 2000, CURR ANTHROPOL, V41, P191, DOI 10.1086/300123; Sehgal AR, 1997, AM J KIDNEY DIS, V29, P410, DOI 10.1016/S0272-6386(97)90203-1; Soper C, 1998, LANCET, V352, P484, DOI 10.1016/S0140-6736(05)79219-9; *STAT GOV TAM NAD, 2002, TAM NAD GLANC 2000; THIAGARAJAN CM, 1990, TRANSPLANT P, V22, P912; *UN NETW ORG SHAR, 2002, US FACTS TRANSPL; *UN POP FUND UN SY, 1997, IND POP DEV GOALS; Velasco N, 1998, LANCET, V352, P483, DOI 10.1016/S0140-6736(98)26032-6; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zargooshi J, 2001, J UROLOGY, V166, P1790, DOI 10.1016/S0022-5347(05)65677-7; Zargooshi J, 2001, J UROLOGY, V165, P386, DOI 10.1097/00005392-200102000-00008; 2000, INDIA REDUCING POVER; 1994, STAT YB 1992, P341	53	252	254	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1589	1593		10.1001/jama.288.13.1589	http://dx.doi.org/10.1001/jama.288.13.1589			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350189	Bronze			2022-12-24	WOS:000178314000019
J	Prie, D; Huart, V; Bakouh, N; Planelles, G; Dellis, O; Gerard, B; Hulin, P; Benque-Blanchet, F; Silve, C; Grandchamp, B; Friedlander, G				Prie, D; Huart, V; Bakouh, N; Planelles, G; Dellis, O; Gerard, B; Hulin, P; Benque-Blanchet, F; Silve, C; Grandchamp, B; Friedlander, G			Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; IDIOPATHIC HYPERCALCIURIA; FAMILIAL RESEMBLANCE; RICKETS; HERITABILITY; ULTRASOUND; PREVALENCE; PHOSPHORUS; THRESHOLD; NPT2	Background: Epidemiologic studies suggest that genetic factors confer a predisposition to the formation of renal calcium stones or bone demineralization. Low serum phosphate concentrations due to a decrease in renal phosphate reabsorption have been reported in some patients with these conditions, suggesting that genetic factors leading to a decrease in renal phosphate reabsorption may contribute to them. We hypothesized that mutations in the gene coding for the main renal sodium-phosphate cotransporter (NPT2a) may be present in patients with these disorders. Methods: We studied 20 patients with urolithiasis or bone demineralization and persistent idiopathic hypophosphatemia associated with a decrease in maximal renal phosphate reabsorption. The coding region of the gene for NPT2a was sequenced in all patients. The functional consequences of the mutations identified were analyzed by expressing the mutated RNA in Xenopus laevis oocytes. Results: Two patients, one with recurrent urolithiasis and one with bone demineralization, were heterozygous for two distinct mutations. One mutation resulted in the substitution of phenylalanine for alanine at position 48, and the other in a substitution of methionine for valine at position 147. Phosphate-induced current and sodium-dependent phosphate uptake were impaired in oocytes expressing the mutant NPT2a. Coinjection of oocytes with wild-type and mutant RNA indicated that the mutant protein had altered function. Conclusions: Heterozygous mutations in the NPT2a gene may be responsible for hypophosphatemia and urinary phosphate loss in persons with urolithiasis or bone demineralization.	Univ Paris 07, INSERM, U426, F-75018 Paris, France; Hop Bichat, Assistance Publ Hop Paris, Serv Physiol Explorat Fonct, F-75877 Paris, France; Hop Bichat, Assistance Publ Hop Paris, Serv Biochim B, F-75877 Paris, France; Inst Federatif Rech, Paris, France; Univ Paris 07, INSERM, U409, F-75018 Paris, France; Fac Med Necker Enfants Malad, INSERM, U467, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prie, D (corresponding author), Univ Paris 07, INSERM, U426, 16 Rue Henri Huchard, F-75018 Paris, France.		Planelles, Gabrielle/F-9603-2013; Dellis, Olivier/E-8501-2011	Planelles, Gabrielle/0000-0002-7314-8837; Dellis, Olivier/0000-0003-0377-9163; Friedlander, Gerard/0000-0002-6854-4261				Arden NK, 1996, J BONE MINER RES, V11, P530; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; BUSCH A, 1994, P NATL ACAD SCI USA, V91, P8205, DOI 10.1073/pnas.91.17.8205; Chau Hien, 2001, Journal of the American Society of Nephrology, V12, p751A; COE FL, 1979, NEW ENGL J MED, V300, P337, DOI 10.1056/NEJM197902153000703; Danielson ME, 1999, J BONE MINER RES, V14, P102, DOI 10.1359/jbmr.1999.14.1.102; DEVERNEJOUL MC, 1982, CALCIFIED TISSUE INT, V34, P219, DOI 10.1007/BF02411240; Ferrari S, 1998, J CLIN ENDOCR METAB, V83, P358, DOI 10.1210/jc.83.2.358; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; GRAY RW, 1977, J CLIN ENDOCR METAB, V45, P299, DOI 10.1210/jcem-45-2-299; HANSEN MA, 1992, J BONE MINER RES, V7, P1037; Jones AO, 2001, J AM SOC NEPHROL, V12, P507, DOI 10.1681/ASN.V123507; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lambert G, 2000, J MEMBRANE BIOL, V176, P133, DOI 10.1007/s002320001082; LJUNGHALL S, 1985, BRIT J UROL, V57, P370, DOI 10.1111/j.1464-410X.1985.tb06290.x; LUTZ J, 1990, AM J CLIN NUTR, V52, P872, DOI 10.1093/ajcn/52.5.872; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; PABICO RC, 1983, P EUR DIAL TRANS, V20, P450; Polito C, 2000, PEDIATR NEPHROL, V14, P1102; PORTALE AA, 1989, J CLIN INVEST, V83, P1494, DOI 10.1172/JCI114043; PRIDGEN DB, 1968, LANCET, V1, P537; Prie D, 1998, J AM SOC NEPHROL, V9, P1264; Prie D, 2001, KIDNEY INT, V60, P272, DOI 10.1046/j.1523-1755.2001.00796.x; RESNICK M, 1968, NEW ENGL J MED, V278, P1313, DOI 10.1056/NEJM196806132782403; ROBERTSON WG, 1983, BRIT J UROL, V55, P595, DOI 10.1111/j.1464-410X.1983.tb03383.x; Shen F H, 1978, Adv Exp Med Biol, V103, P217; SUKI WN, 2000, BRENNER RECTORS KIDN, V1, P520; TIEDER M, 1987, NEW ENGL J MED, V316, P125, DOI 10.1056/NEJM198701153160302; van den Heuvel L, 2001, NEPHROL DIAL TRANSPL, V16, P48, DOI 10.1093/ndt/16.1.48; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Williams CP, 1996, J CLIN PATHOL, V49, P881, DOI 10.1136/jcp.49.11.881; Xiao YS, 1997, BIOCHEM J, V323, P401, DOI 10.1042/bj3230401	35	243	248	2	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2002	347	13					983	991		10.1056/NEJMoa020028	http://dx.doi.org/10.1056/NEJMoa020028			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596RD	12324554				2022-12-24	WOS:000178178400004
J	Ogiso, H; Ishitani, R; Nureki, O; Fukai, S; Yamanaka, M; Kim, JH; Saito, K; Sakamoto, A; Inoue, M; Shirouzu, M; Yokoyama, S				Ogiso, H; Ishitani, R; Nureki, O; Fukai, S; Yamanaka, M; Kim, JH; Saito, K; Sakamoto, A; Inoue, M; Shirouzu, M; Yokoyama, S			Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains	CELL			English	Article							SITE-DIRECTED MUTAGENESIS; BINDING-DOMAIN; FACTOR-ALPHA; SIGNAL-TRANSDUCTION; ERBB RECEPTORS; FACTOR EGF; LIGAND; DIMERIZATION; RESIDUES; IDENTIFICATION	Epidermal growth factor (EGF) regulates cell proliferation and differentiation by binding to the EGF receptor (EGFR) extracellular region, comprising domains I-IV, with the resultant dimerization of the receptor tyrosine kinase. In this study, the crystal structure of a 2:2 complex of human EGF and the EGFR extracellular region has been determined at 3.3 Angstrom resolution. EGFR domains I-III are arranged in a C shape, and EGF is docked between domains I and III. The 1:1 EGF.EGFR complex dimerizes through a direct receptor.receptor interaction, in which a protruding beta-hairpin arm of each domain II holds the body of the other. The unique "receptor-mediated dimerization" was verified by EGFR mutagenesis.	RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Japan Sci & Technol Corp, ERATO, Yokoyama CytoLog Project, Tokyo, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; SPring 8, Harima Inst, RIKEN, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; SPring 8, Harima Inst, RIKEN, Structurome Grp, Sayo, Hyogo 6795148, Japan	RIKEN; Japan Science & Technology Agency (JST); University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; RIKEN	Yokoyama, S (corresponding author), RIKEN, Genom Sci Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Fukai, Shuya/X-4838-2018; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Saito, Kazuki/K-6016-2012	Fukai, Shuya/0000-0002-1241-1443; Yokoyama, Shigeyuki/0000-0003-3133-7338; Saito, Kazuki/0000-0003-4663-1134; Ogiso, Hideo/0000-0002-8241-3006				Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; BROWN PM, 1994, EUR J BIOCHEM, V225, P223, DOI 10.1111/j.1432-1033.1994.00223.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMPION SR, 1990, BIOCHEMISTRY-US, V29, P9988, DOI 10.1021/bi00494a032; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Degenhardt M, 1998, ACTA CRYSTALLOGR D, V54, P999, DOI 10.1107/S0907444998001851; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Domagala T, 2000, GROWTH FACTORS, V18, P11, DOI 10.3109/08977190009003231; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; GUNTHER N, 1990, J BIOL CHEM, V265, P22082; HALEY JD, 1989, ONCOGENE, V4, P273; HARVEY TS, 1991, EUR J BIOCHEM, V198, P555, DOI 10.1111/j.1432-1033.1991.tb16050.x; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JH, 2002, EUR J BIOCHEM, V269, P2323, DOI 10.1046/j.1432-1033.2002.02877.x; KOHDA D, 1993, J BIOL CHEM, V268, P1976; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; KOIDE H, 1992, FEBS LETT, V302, P39, DOI 10.1016/0014-5793(92)80279-P; KOIDE H, 1992, BIOCHIM BIOPHYS ACTA, V1120, P257, DOI 10.1016/0167-4838(92)90245-9; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; MARQUARDT H, 1984, SCIENCE, V223, P1079, DOI 10.1126/science.6320373; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sato C, 2000, J BIOCHEM-TOKYO, V127, P65, DOI 10.1093/oxfordjournals.jbchem.a022585; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Summerfield AE, 1996, J BIOL CHEM, V271, P19656, DOI 10.1074/jbc.271.33.19656; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TADAKI DK, 1993, J BIOL CHEM, V268, P10114; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WARD CW, 1995, PROTEINS, V22, P141, DOI 10.1002/prot.340220207; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WOLTJER RL, 1992, P NATL ACAD SCI USA, V89, P7801, DOI 10.1073/pnas.89.16.7801; WU DG, 1989, J BIOL CHEM, V264, P17469; WU DG, 1990, P NATL ACAD SCI USA, V87, P3151, DOI 10.1073/pnas.87.8.3151; YAMAMOTO T, 1983, CELL, V35, P71, DOI 10.1016/0092-8674(83)90209-X	62	841	927	12	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2002	110	6					775	787		10.1016/S0092-8674(02)00963-7	http://dx.doi.org/10.1016/S0092-8674(02)00963-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	596TV	12297050	Bronze			2022-12-24	WOS:000178182800012
J	Hales, S; de Wet, N; Maindonald, J; Woodward, A				Hales, S; de Wet, N; Maindonald, J; Woodward, A			Potential effect of population and climate changes on global distribution of dengue fever: an empirical model	LANCET			English	Article							MALARIA; FUTURE; DISEASE	Background Existing theoretical models of the potential effects of climate change on vector-borne diseases do not account for social factors such as population increase, or interactions between climate variables. Our aim was to investigate the potential effects of global climate change on human health, and in particular, on the transmission of vector-borne diseases. Methods We modelled the reported global distribution of dengue fever on the basis of vapour pressure, which is a measure of humidity. We assessed changes in the geographical limits of dengue fever transmission, and in the number of people at risk of dengue by incorporating future climate change and human population projections into our model. Findings We showed that the current geographical limits of dengue fever transmission can be modelled with 89% accuracy on the basis of long-term average vapour pressure. In 1990, almost 30% of the world population, 1.5 billion people, lived in regions where the estimated risk of dengue transmission was greater than 50%. With population and climate change projections for 2085, we estimate that about 5-6 billion people (50-60% of the projected global population) would be at risk of dengue transmission, compared with 3.5 billion people, or 35% of the population, if climate change did not happen. Interpretation We conclude that climate change is likely to increase the area of land with a climate suitable for dengue fever transmission, and that if no other contributing factors were to change, a large proportion of the human population would then be put at risk.	Wellington Sch Med & Hlth Sci, Dept Publ Hlth, Wellington, New Zealand; Int Global Change Inst, Hamilton, New Zealand; Australian Natl Univ, Inst Math Sci, Canberra, ACT, Australia; Australian Natl Univ, John Curtin Sch Med Res, Ctr Bioinformat Sci, Canberra, ACT 2601, Australia	University of Otago; Australian National University; Australian National University; John Curtin School of Medical Research	Hales, S (corresponding author), Wellington Sch Med & Hlth Sci, Dept Publ Hlth, POB 7343,Mein St, Wellington, New Zealand.		hales, simon/E-5768-2010	Woodward, Alistair/0000-0001-5425-6018; Hales, Simon/0000-0002-4529-7595				Bos E, 1994, WORLD POPULATION PRO; Carter T. R., 1999, GUIDELINES USE SCENA; *COMM CLIM EC INF, 2001, WEATH CLIM EC INF DI; *DAT DISTR CTR, 2002, INT PAN CLIM CHANG; Emori S, 1999, J METEOROL SOC JPN, V77, P1299, DOI 10.2151/jmsj1965.77.6_1299; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Flato GM, 2000, CLIM DYNAM, V16, P451, DOI 10.1007/s003820050339; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Johns TC, 1997, CLIM DYNAM, V13, P103, DOI 10.1007/s003820050155; LI Y, 2002, GLOBAL POPULATION DI; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Roeckner E., 1996, ATMOSPHERIC GEN CIRC; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; World Health Organization, 2000, WHO REP GLOB SURV EP	20	589	629	8	217	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 14	2002	360	9336					830	834		10.1016/S0140-6736(02)09964-6	http://dx.doi.org/10.1016/S0140-6736(02)09964-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594MC	12243917				2022-12-24	WOS:000178053500008
J	Crawford, LM				Crawford, LM			FDA statement on Prempro	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1579	1579		10.1001/jama.288.13.1579-c	http://dx.doi.org/10.1001/jama.288.13.1579-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350176				2022-12-24	WOS:000178314000006
J	Crawford, LM				Crawford, LM			Device for young diabetics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2002	288	13					1579	1579		10.1001/jama.288.13.1579-c	http://dx.doi.org/10.1001/jama.288.13.1579-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599BJ	12350176				2022-12-24	WOS:000178314000004
J	Chicurel, M				Chicurel, M			Bioinformatics: Bringing it all together	NATURE			English	Article																			0	28	30	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 17	2002	419	6908					751	+		10.1038/419751a	http://dx.doi.org/10.1038/419751a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604JF	12384708	Bronze			2022-12-24	WOS:000178615200047
